Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,anterograde trans-synaptic signaling (GO:0098916),0.6302538430802801,2.7017512607164496,0.0,0.0,0.0,81/224,11.95%,GRIA2;GABRB3;DLG2;GRM5;KCND2;CACNA1A;GABRA5;GRIN1;NRXN1;GRIA4;RIT2;GABRB1;DLGAP1;SYT1;MBP;MTNR1B;CACNA1B;PRKAR2B;SYN2;PTCHD1;PLP1;GRM7;ASIC2;NLGN1;KCNQ3;CHRM3;GABRA2;GLRA1;GRM1;GRIN2A;GABRG3;DOC2A;GABRA3;MPZ;GRIA1;GRIK1;SNAP25;HTR2C;GABRA4;GRIN2B;HCRTR1;SNCA;APBA2;SLC18A3;CAMK4;GABRB2;SLC1A1;GLRA3;GRIK2;SLC12A6;KCNN1;PCDHB6;SLC1A2;KCNMB4;NRXN2;GABARAP;CACNA1E;AMPH;SLC6A2;SLC6A5;SYT10;GRIA3;HOMER1;CACNB2;GABRD;RPS6KA1;GPR176;GABRG2;SST;HCRTR2;GLRA2;RPS6KA2;CPLX1;GAD1;KCNQ2;CACNB4;HAP1;CALM1;NRGN;PNOC;NPTX1
prerank,chemical synaptic transmission (GO:0007268),0.6010466471689746,2.6328170802622433,0.0,0.0,0.0,98/284,11.95%,GRIA2;GABRB3;DLG2;GRM5;KCND2;CACNA1A;GABRA5;GRIN1;NRXN1;GRIA4;RIT2;GABRB1;DLGAP1;CDH8;PTPRN2;SYT1;MBP;MTNR1B;CACNA1B;PRKAR2B;RIMS1;SYN2;PTCHD1;PLP1;GRM7;ASIC2;NLGN1;KCNQ3;SHISA6;CHRM3;GABRA2;ERC2;GLRA1;GRM1;GRID1;GRIN2A;GRID2;GABRG3;DOC2A;GABRA3;MPZ;GRIA1;GRIK1;SNAP25;HTR2C;GABRA4;GRIN2B;HCRTR1;LIN7A;SNCA;SLC17A6;APBA2;SLC18A3;CAMK4;GABRB2;SLC1A1;GRIN2D;GLRA3;GRIK2;GRIK5;UNC13A;DLGAP2;SLC12A6;HSPA8;KCNN1;PPFIA3;PCDHB6;SLC1A2;KCNMB4;NRXN2;GABARAP;CACNA1E;AMPH;SNPH;SLC6A2;SLC6A5;SYT10;GRIA3;HOMER1;CACNB2;GABRD;RPS6KA1;GPR176;GABRG2;SST;HCRTR2;GLRA2;RPS6KA2;CPLX1;GAD1;KCNQ2;CACNB4;HAP1;CALM1;NRGN;DVL1;PNOC;NPTX1
prerank,cytoplasmic translation (GO:0002181),0.6617103947345776,2.5111528219872365,0.0,0.0,0.0,50/91,16.17%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL10;RPL15;RPL10A;RPS24;RPL27A;RPL22L1;RPS17;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;EIF2B3;EIF3I;RPL12;RPL13;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS3;RPS14;RPS2;RPS5;RPL18A;RPS28;RPS25;RPS29;RWDD1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.6689525777177413,2.478181299127367,0.0,0.0,0.0,45/87,15.84%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL10;RPL15;RPL10A;RPS24;RPL27A;RPS17;RPS8;RPS16;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL12;RPL13;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS3;RPS14;RPS2;RPS5;RPL18A;RPS28;RPS25;RPS29
prerank,cotranslational protein targeting to membrane (GO:0006613),0.6606739925477345,2.47280197382602,0.0,0.0,0.0,47/91,15.84%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL10;RPL15;RPL10A;RPS24;RPL27A;ARL6IP1;RPS17;RPS8;RPS16;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL12;RPL13;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS3;RPS14;RPS2;RPS5;RPL18A;RPS28;SRPRA;RPS25;RPS29
prerank,protein targeting to ER (GO:0045047),0.6158276519150269,2.3596323919794147,0.0,0.0,0.0,48/99,15.84%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL10;RPL15;RPL10A;RPS24;RPL27A;RPS17;RPS8;RPS16;RPS27A;RPLP1;SGTB;RPL41;RPLP0;RPL30;RPL7A;RPL12;RPL13;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS3;RPS14;RPS2;RPS5;RPL18A;RPS28;SRPRA;SEC61G;RPS25;RPS29
prerank,response to copper ion (GO:0046688),0.8216427334933585,2.3330988806569013,0.0,0.0,0.0,11/20,7.36%,MT2A;SNCA;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;ATP5F1D
prerank,cellular response to copper ion (GO:0071280),0.8679839396255405,2.3154154834511425,0.0,0.0,0.0,10/16,5.25%,MT2A;SNCA;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.6607869350776414,2.3098004593769828,0.0,0.0,0.0,24/57,11.95%,CAMK2A;GRIA2;DLG2;GRIN1;GRIA4;DLGAP1;LRRC7;NLGN1;MAPK8IP2;SHISA6;GRIN2A;NETO1;GRIA1;GRIN2B;DLGAP2;SHISA8;CACNG2;SHISA7;GRIA3;CACNG3;RELN;OPRM1;CACNG8;NPTX1
prerank,glutamate receptor signaling pathway (GO:0007215),0.7167667484069647,2.284284751583771,0.0,0.0,0.0,17/37,10.43%,GRIA2;GRM5;GRIN1;GRIA4;GRM7;GRM1;GRIN2A;GRID2;GRM8;GRIK1;GRIN2B;GRIK2;PLCB1;GRIA3;HOMER1;GRIN3A;HOMER2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5711534073259471,2.210425488556884,0.0,0.0,0.0,52/110,15.84%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;HELZ2;RPL10;RPL15;RPL10A;RPS24;PPP2R1A;RPL27A;RPS17;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL12;RPL13;RPS15;SMG8;PABPC1;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;MAGOHB;MAGOH;RPL8;RPS3;RPS14;RPS2;RPS5;RPL18A;RPS28;RPS25;RPS29
prerank,modulation of chemical synaptic transmission (GO:0050804),0.5557765405969268,2.180175252935565,0.0,0.00013190905024368312,0.002,32/107,7.79%,CAMK2A;NRG3;GRM5;CACNA1A;DLGAP1;LRP8;LRRC4C;SYT1;CACNA1B;RIMS1;GRM7;DGKI;TMEM108;NLGN1;MAPK8IP2;GRM1;GRID1;RIMS2;GRID2;GRM8;MCTP1;CDH2;GRIK1;RIMS3;GRIK2;GRIK5;UNC13A;DLGAP2;KCNMB4;KCTD13;HOMER1;CLSTN3
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.6964474651500031,2.17571466505691,0.0,0.00024352440044987653,0.004,15/34,8.68%,MPP2;GABRA5;GRIN1;MAPK8IP2;GABRA2;GLRA1;GRIN2A;GRID2;GABRG3;GABRA3;GABRA4;GRIN2B;GRIN2D;AKT1;GABRG2
prerank,regulation of NMDA receptor activity (GO:2000310),0.699814036394905,2.1746580412997236,0.0,0.00022612980041774252,0.004,15/32,9.74%,CAMK2A;GRIA2;DLG2;GRIN1;GRIA4;LRRC7;NLGN1;MAPK8IP2;GRIN2A;GRIA1;GRIN2B;GRIA3;CCL2;RELN;OPRM1
prerank,response to zinc ion (GO:0010043),0.7244794880450808,2.156738536881274,0.0,0.0008442179215595721,0.016,14/25,11.88%,MT2A;GLRA1;KHK;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;SLC30A3;GLRA2;SLC30A5
prerank,cellular response to zinc ion (GO:0071294),0.816984310053314,2.1443967387713916,0.0,0.0008409201953034801,0.017,11/15,9.58%,MT2A;GLRA1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;GLRA2
prerank,neurotransmitter secretion (GO:0007269),0.6480164100354284,2.1415643373723845,0.0,0.000791454301462099,0.017,19/44,11.69%,NRXN1;PTPRN2;SYT1;RIMS1;SYN2;PCLO;RIMS2;SNAP25;LIN7A;SNCA;UNC13A;HSPA8;PPFIA3;NRXN2;SNPH;SYT10;CPLX1;GAD1;DVL1
prerank,synapse assembly (GO:0007416),0.5951855712441608,2.1335503939723095,0.0,0.0008793936682912211,0.02,23/67,9.00%,SPOCK2;DNM3;DSCAM;GABRB3;KIRREL3;ADGRL3;NRXN1;LRRTM3;NLGN1;GPM6A;GABRA2;GRID2;DNER;CDH2;SHANK3;FGF13;GABRB2;PCDHB6;NRXN2;LGI2;NRCAM;GABRG2;SHANK2
prerank,peptide biosynthetic process (GO:0043043),0.5255581708066137,2.1280605798999694,0.0,0.000999731749215283,0.024,70/153,19.25%,RPS6;RPS19;RPS20;RPL38;RPL29;PCSK1;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;RPL10;RPL15;RPL10A;RPS24;RPL27A;RPS17;RPS6KB2;RPS8;RPS16;RPS27A;RPLP1;RPL41;CARNS1;RPLP0;RPL30;RPL7A;MRPS18A;RPL12;MRPL13;RPL13;MRPS7;RPS15;MRPS14;RPL14;EIF4EBP2;GGT7;FARSB;RPL5;RPS4X;RPL21;GGT1;RPS7;RPL23A;EEF1A2;RPL8;MRPL36;MRPL23;RPS3;RPS14;RPS2;RPS5;EEF1A1;RPL18A;RPS28;RPS25;RPS29;MRPS5;HBS1L;TNIP1;RPS9;RPL31;MRPL18;ASMT;RPL3;RPL19
prerank,extracellular structure organization (GO:0043062),-0.4977942719467753,-2.120409286497428,0.0,0.010709832538826826,0.008,74/204,14.04%,COL1A2;LAMA2;FBN1;COL3A1;SMOC1;COL4A5;COL5A2;ADAMTS2;ADAMTS10;TGFBR1;ITGA9;DAG1;THSD4;ADAMTSL3;ADAMTS12;COL5A1;COL8A1;COL4A6;COL1A1;COL22A1;DCN;NID1;COL4A3;ADAMTS6;ADAMTSL5;ITGAV;LOXL1;ECM2;COL6A3;LAMA1;COL4A4;ELN;LAMC3;BGN;VTN;COL6A1;COL23A1;SPARC;ITGA10;COL8A2;FBLN5;VIT;HSPG2;ITGB1;MFAP5;THBS1;ADAMTS5;COL6A2;CDH1;NID2;ITGA11;ITGB5;RECK;ST7;ADAMTSL4;COL15A1;LAMA3;LAMA4;ADAMTS9;TNC;COL13A1;COL5A3;ITGB8;SH3PXD2A;COL18A1;MMP14;COL27A1;ADAM19;ADAMTS15;FN1;MMP2;LUM;LOX;ADAMTS17
prerank,collagen fibril organization (GO:0030199),-0.5620836093706989,-2.1138768110283013,0.0,0.005354916269413413,0.008,31/88,11.59%,COL1A2;COL3A1;COL4A5;COL5A2;ADAMTS2;TGFBR1;COL5A1;COL8A1;COL4A6;COL1A1;COL12A1;COL22A1;COL4A3;LOXL1;COL6A3;COL4A4;COL25A1;COL6A1;COL23A1;COL8A2;COL26A1;PLOD2;COL6A2;COL15A1;LAMA3;COL13A1;CYP1B1;COL5A3;COL18A1;P4HA2;COL27A1
prerank,signal release from synapse (GO:0099643),0.6364509567715795,2.1030995065268883,0.0,0.0015037631727779876,0.038,18/43,11.69%,NRXN1;PTPRN2;SYT1;RIMS1;SYN2;PCLO;SNAP25;LIN7A;SNCA;UNC13A;HSPA8;PPFIA3;NRXN2;SNPH;SYT10;CPLX1;GAD1;DVL1
prerank,positive regulation of synaptic transmission (GO:0050806),0.5755494943233853,2.095958609301088,0.0,0.0015829086029241978,0.042,26/72,10.93%,MPP2;SLC24A2;NRXN1;SYT1;RIMS1;ADCY8;NLGN1;GRIN2A;RIMS2;SHANK3;RIMS3;GRIN2B;GRIN2D;GRIK2;CACNG2;NPTN;KCTD13;SHISA7;CLSTN3;CACNG3;CCL2;ADRA1A;SHANK2;RELN;CACNG8;HAP1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6673629316587235,2.091851220233358,0.0,0.0015829086029241978,0.043,10/35,5.76%,CDH12;CDH8;NLGN1;CDH19;CDH20;CDH7;PCDHGB4;CDH18;CDH10;PCDHB6
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.5111517891410889,2.077337291154661,0.0,0.0018926081121919758,0.053,53/159,12.08%,CLDN5;DSCAM;BSG;KIRREL3;ADGRL3;HMCN1;CDH12;CDH8;PTPRD;LRRC4C;CADM1;IGSF11;MAG;LRFN5;IL1RAPL1;NLGN1;TENM2;PLXNB3;CDH19;CDH20;CDH7;GRID2;TENM1;PCDHGB4;CDH18;PTPRT;CDH2;MPZ;CNTN6;ROBO4;TENM4;CDH10;TGFB2;PCDHB6;DSCAML1;UNC5D;NPTN;CLDN14;TENM3;VSTM2L;PECAM1;ROBO2;LRRC4B;NTNG1;DCHS1;ROBO3;CADM3;PTPRM;CELSR2;CRB1;CNTN4;NECTIN1;CNTN2
prerank,external encapsulating structure organization (GO:0045229),-0.4863176478374998,-2.0732160127765256,0.0,0.010313172074425832,0.025,73/205,14.04%,COL1A2;LAMA2;FBN1;COL3A1;SMOC1;COL4A5;COL5A2;ADAMTS2;ADAMTS10;ITGA9;DAG1;THSD4;ADAMTSL3;ADAMTS12;COL5A1;COL8A1;COL4A6;COL1A1;COL22A1;DCN;NID1;COL4A3;ADAMTS6;ADAMTSL5;ITGAV;LOXL1;ECM2;COL6A3;LAMA1;COL4A4;ELN;LAMC3;BGN;VTN;COL6A1;COL23A1;SPARC;ITGA10;COL8A2;FBLN5;VIT;HSPG2;ITGB1;MFAP5;THBS1;ADAMTS5;COL6A2;CDH1;NID2;ITGA11;ITGB5;RECK;ST7;ADAMTSL4;COL15A1;LAMA3;LAMA4;ADAMTS9;TNC;COL13A1;COL5A3;ITGB8;SH3PXD2A;COL18A1;MMP14;COL27A1;ADAM19;ADAMTS15;FN1;MMP2;LUM;LOX;ADAMTS17
prerank,chloride transmembrane transport (GO:1902476),0.6210168352262607,2.06863794923656,0.0,0.002275431116703534,0.067,20/48,10.96%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;SLC1A1;GLRA3;SLC12A6;ANO5;GABRD;GABRG2;ANO4;SLC12A3;GLRA2;CLCN1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.7455142787234903,2.060538427616269,0.0,0.0026276282808541684,0.077,9/18,4.76%,GRIA2;CDH8;GRID1;GRID2;GRIK1;SLC17A6;GRIK2;GRIK5;UNC13A
prerank,regulation of actomyosin structure organization (GO:0110020),-0.8490280811490507,-2.0525238545391824,0.0,0.01487476741503726,0.046,8/13,8.05%,AKAP13;ROCK2;ASAP3;ROCK1;ALMS1;SLC9A1;FHOD1;CDC42
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.5993911170516641,2.031122778067484,0.0,0.00426167700787284,0.125,19/46,10.91%,GRM5;NRXN1;SYT1;GRM7;DGKI;NLGN1;MAPK8IP2;GRM1;GRM8;CDH2;SHANK3;GRIK1;UNC13A;CACNG2;HOMER1;CACNG3;CCL2;RELN;CACNG8
prerank,regulation of cation channel activity (GO:2001257),0.5381748026766788,2.0245767850875174,0.0,0.004514220830561601,0.134,32/89,11.38%,CAMK2A;GRIA2;DLG2;GRIN1;GRIA4;LRRC7;FGF12;NLGN1;MAPK8IP2;SHISA6;GRIN2A;NETO1;FGF14;ANK3;GRIA1;FGF13;GRIN2B;SHISA8;CACNG2;SHISA7;GRIA3;HOMER1;CACNB2;KCNAB1;EPO;CACNG3;RELN;OPRM1;CACNB4;CACNG8;CALM1;JPH3
prerank,cellular zinc ion homeostasis (GO:0006882),0.6834726477600115,2.017498693758817,0.0,0.005200985409608078,0.156,13/26,11.88%,SLC39A10;MT2A;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;SLC30A1;SLC39A8;SLC30A5
prerank,regulation of glucose import (GO:0046324),-0.6680998872223352,-2.014871864275364,0.0,0.024513616699981405,0.093,11/30,4.70%,PRKAG2;IGF1;PID1;SORBS1;RHOQ;APPL2;GRB10;ENPP1;OSBPL8;CREBL2;IRS1
prerank,positive regulation of synapse assembly (GO:0051965),0.6612118550560431,1.9919141772171376,0.0,0.00785995995934774,0.225,10/27,8.27%,NRXN1;PTPRD;IL1RAPL1;EPHB1;NLGN1;GRID2;SEMA4A;SEMA4D;CLSTN3;LRRC4B
prerank,cell junction assembly (GO:0034329),0.5122263142557348,1.9768757659084053,0.0,0.009814033338130025,0.289,26/100,7.54%,SPOCK2;CLDN5;DNM3;DSCAM;KIRREL3;ADGRL3;NRXN1;CDH12;CDH8;ACTB;CTNND2;NLGN1;GPM6A;CDH19;CDH20;CDH7;ITGA6;DNER;CDH18;CDH2;SHANK3;CDH10;PCDHB6;NRXN2;NRCAM;VMP1
prerank,actin filament bundle assembly (GO:0051017),-0.638160529184147,-1.9726790323221461,0.0,0.04799591619252023,0.201,7/33,3.45%,CALD1;DPYSL3;PAWR;MYO1B;LIMA1;BAIAP2L1;SHROOM2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.662255011029029,-1.9706624833651554,0.0,0.041989343445876605,0.204,13/27,10.59%,EGFR;DDX5;BMP4;TNRC6B;PUM2;WTIP;DDX6;EIF4ENIF1;STAT3;DHX9;PUM1;MAP2K1;LIMD1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.8426706434264684,1.968901871330613,0.0,0.010876113949124326,0.314,7/10,8.68%,GABRA5;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRG2
prerank,actin filament bundle organization (GO:0061572),-0.6236031239035323,-1.9568723153721568,0.0,0.04640927433491625,0.247,7/33,3.45%,CALD1;DPYSL3;PAWR;MYO1B;LIMA1;BAIAP2L1;SHROOM2
prerank,eye development (GO:0001654),-0.5678059546129116,-1.9561938794177725,0.0,0.041517128607304,0.249,15/54,6.68%,PBX1;CACNA1C;FBN1;SMOC1;COL5A2;EFEMP1;COL5A1;FOXC1;SH3PXD2B;LAMA1;SHROOM2;RBP4;SKI;PBX3;RAB3GAP1
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6938430638818165,-1.9515230958636989,0.0019120458891013384,0.039983374811620155,0.264,8/21,10.64%,BMP6;TGFBR1;BMPR1A;RBPMS;DAB2;BMP4;CCN3;SMAD4
prerank,extracellular matrix organization (GO:0030198),-0.44334201789189454,-1.9507006719205682,0.0,0.03710578344260204,0.266,79/276,12.32%,COL1A2;LAMA2;FBN1;COL3A1;SMOC1;COL4A5;COL5A2;ADAMTS2;ADAMTS10;TGFBR1;ITGA9;DAG1;THSD4;ADAMTSL3;ADAMTS12;COL5A1;COL8A1;COL4A6;COL1A1;GSN;COL12A1;COL22A1;DCN;NID1;COL4A3;ADAMTS6;FLRT2;ADAMTSL5;ITGAV;LOXL1;ECM2;SH3PXD2B;COL6A3;LAMA1;COL4A4;ELN;LAMC3;BGN;COL25A1;VTN;COL6A1;COL23A1;SPARC;ITGA10;COL8A2;FBLN5;COL26A1;PLOD2;VIT;HSPG2;ITGB1;MFAP5;THBS1;ADAMTS5;COL6A2;CDH1;NID2;ITGA11;ITGB5;RECK;ST7;ADAMTSL4;COL15A1;LAMA3;LAMA4;ADAMTS9;TNC;COL13A1;CYP1B1;COL5A3;ITGB8;SH3PXD2A;COL18A1;P4HA2;MMP14;COL27A1;ADAM19;ADAMTS15;FN1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.6225036877281575,1.937769895456602,0.0021008403361344537,0.01679367095914891,0.447,14/33,11.46%,NRG3;CACNA1A;LRP8;LRRC4C;CACNA1B;NLGN1;GRID1;GRID2;GRIK1;GRIK2;GRIK5;RELN;EIF4EBP2;FABP5
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.7850254834766751,-1.9363932285369658,0.0,0.04135185341380358,0.307,6/13,2.60%,BMP6;TGFBR1;BMPR1A;RBPMS;DAB2;BMP4
prerank,neuron cell-cell adhesion (GO:0007158),0.7505112092341738,1.9291250033938365,0.002173913043478261,0.01858718435251899,0.489,9/14,12.30%,NCAM2;NRXN3;NRXN1;NLGN1;ASTN1;NRXN2;ASTN2;CNTN4;RET
prerank,inorganic anion transmembrane transport (GO:0098661),0.5462510703750795,1.9291196705467122,0.0,0.018040502459797842,0.489,23/63,10.96%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;SLC1A1;GLRA3;SLC12A6;SLC37A4;ANO5;SLC37A1;GABRD;SLC25A14;GABRG2;ANO4;SLC12A3;GLRA2;CLCN1
prerank,synaptic vesicle exocytosis (GO:0016079),0.592386663860898,1.9264886492914384,0.0,0.018316513833837145,0.506,14/40,10.85%,SYT1;RIMS1;PCLO;SYT7;RIMS2;SNAP25;RIMS3;SNCA;UNC13A;STX3;SNPH;SYT10;CPLX1;SYT2
prerank,neuromuscular process controlling balance (GO:0050885),0.782585035508814,1.9252790207524288,0.002136752136752137,0.018071539883384592,0.513,2/12,0.55%,PCDH15;NRXN1
prerank,dendrite self-avoidance (GO:0070593),0.7417128965211894,1.921300354119133,0.0,0.01867404338314628,0.536,10/16,12.08%,DSCAM;BSG;CNTN6;ROBO4;DSCAML1;NPTN;VSTM2L;ROBO3;CNTN4;CNTN2
prerank,embryonic limb morphogenesis (GO:0030326),-0.6160842415219708,-1.9198754269019254,0.0,0.049704607423786046,0.376,20/34,23.13%,CACNA1C;GLI3;LRP6;AFF3;OSR1;CYP26B1;WDPCP;RARG;SKI;CREBBP;ECE1;MAP3K20;NIPBL;HDAC1;PTCH1;SALL1;TBX2;MEGF8;FBXW4;HDAC2
prerank,odontogenesis (GO:0042476),-0.6109800581621305,-1.9138751711370712,0.0,0.050659207882069755,0.403,11/35,6.49%,COL1A2;LRP6;ANKRD11;GLI2;FOXC1;BMP4;BCOR;OSR1;EDA;WNT6;FGFR2
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.7354999993628502,-1.9080128850588935,0.0038022813688212928,0.052279849208050955,0.433,8/15,11.60%,ROCK2;IGF1;IL6ST;ROCK1;SLC9A1;MEF2A;CAMK2D;PARP1
prerank,mRNA destabilization (GO:0061157),-0.5924304998060514,-1.9051515739494074,0.0019193857965451055,0.051689816767254475,0.446,12/38,9.65%,ROCK2;CELF1;FTO;DIS3L2;ROCK1;YTHDF3;MOV10;RC3H1;PUM1;TUT4;DHX36;UPF1
prerank,regulation of regulated secretory pathway (GO:1903305),0.6065772122812413,1.9046185735704797,0.0,0.024160183939369334,0.632,10/34,3.38%,SYT1;RIMS1;SYT6;SYT7;RIMS2;DOC2A;SYT12;SYT11;PREPL;RIMS3
prerank,translation (GO:0006412),0.44866982130342614,1.8962506620380224,0.0,0.026625334449186508,0.676,83/208,19.25%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;RPL10;RPL15;VARS1;GARS1;RPL10A;RPS24;EEF1B2;RPL27A;RARS1;RPL22L1;RPS17;RPS6KB2;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;TUFM;MRPS18A;RPL12;MRPL13;RPL13;EEF1D;MRPS7;RPS15;MRPS14;RPL14;EIF4EBP2;FARSB;RPL5;RPS4X;RPL21;RPS7;RPL23A;EEF1A2;AIMP2;RPL8;MRPL36;MRPL23;RPS3;GATB;RPS14;RPS2;RPS5;IARS1;EEF1A1;RPL18A;GATC;RPS28;RPS25;RPS29;RWDD1;NDUFA7;MRPS5;HBS1L;TNIP1;RPS9;EEF2;RPL31;MRPS28;MRPL18;EEF1E1;ASMT;RPL3;RPL19
prerank,zinc ion homeostasis (GO:0055069),0.6327097490395938,1.8942046310702982,0.0,0.026850087177101703,0.683,11/28,5.94%,SLC39A10;MT2A;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;SLC30A1
prerank,chloride transport (GO:0006821),0.5238108708872572,1.8941040470184471,0.0,0.026272422055851622,0.685,21/74,9.58%,GABRB3;GABRA5;SLC4A1;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;CLIC5;GABRA4;GABRB2;SLC1A1;GLRA3;SLC12A6;ANO5;GABRD;GABRG2;ANO4;SLC12A3;GLRA2
prerank,eye morphogenesis (GO:0048592),-0.7051678363779285,-1.8938722724644608,0.0019305019305019305,0.05795909373953342,0.501,9/19,6.19%,FBN1;COL5A2;EFEMP1;COL5A1;SHROOM2;RARG;MFAP5;SKI;STAT3
prerank,bone development (GO:0060348),-0.5897600603899043,-1.887788179871839,0.0,0.06009406035675052,0.529,13/39,12.58%,AKAP13;RANBP3L;SULF1;LRP6;SH3PXD2B;CYP26B1;SULF2;SKI;FGFR2;SLC10A7;GJA1;MBTPS2;GNAS
prerank,calcium-ion regulated exocytosis (GO:0017156),0.6375568658939446,1.8828233775022738,0.0,0.03035792570608194,0.735,9/27,7.15%,SYT1;RIMS1;SYT6;SYT7;RIMS2;SYT12;SYT11;RIMS3;SYT10
prerank,regulation of stress fiber assembly (GO:0051492),-0.5126487163780311,-1.8827954196655627,0.0,0.06075168165299428,0.55,24/74,8.05%,PHLDB2;ROCK2;LPAR1;ARHGAP6;TGFBR1;CGNL1;ASAP3;TPM1;ARHGAP28;CCN2;ROCK1;ABL1;PPM1E;ARHGEF10L;ARAP1;ALMS1;WASF2;SLC9A1;PAK2;FHOD1;NRP1;RAPGEF3;S100A10;CDC42
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.6388152073408316,1.8784456792742372,0.0,0.031418895176646575,0.75,9/25,7.85%,MPP2;GRIN1;MAPK8IP2;GLRA1;GRIN2A;GRID2;GRIN2B;GRIN2D;AKT1
prerank,cell-matrix adhesion (GO:0007160),-0.4846116227852939,-1.877508401994795,0.0,0.06271201942179708,0.576,32/95,15.66%,ITGBL1;COL3A1;SORBS1;ADAMTS12;VCL;PKD1;ITGAV;ECM2;VTN;ITGA10;FBLN5;BCR;ITGB1;NID2;ITGA11;MKLN1;ITGB5;ACTN2;PTPRK;ADAMTS9;COL13A1;ITGB8;ADAM9;FN1;ZYX;CTTN;EMILIN1;MSLN;TMEM8B;WHAMM;DDR1;ITGA4
prerank,muscle organ development (GO:0007517),-0.5488573630521352,-1.8766246463455463,0.0,0.06023572480832231,0.58,19/54,15.11%,LAMA2;IGF1;LARGE1;FHL1;COL6A3;MEF2A;SPEG;MRAS;ITGA11;VAMP5;SMTN;CHD2;EVC;MEF2C;SRI;SOX6;FKTN;MKX;EMD
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.6758664615722877,1.8729848125298767,0.002183406113537118,0.0328093783151561,0.77,7/20,7.39%,MRAP2;BICD1;STMN1;YWHAB;SNCA;GRK2;RNF157
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.6565041296931908,-1.8720329194659484,0.0,0.06177085231990019,0.603,9/24,14.47%,SULF1;IL6ST;CCBE1;ARNT;SULF2;EIF2AK3;CYP1B1;HIF1A;RORA
prerank,regulation of muscle contraction (GO:0006937),-0.6481815507324604,-1.8683256674647426,0.0,0.06203424741088582,0.615,5/26,2.76%,ATP1A2;PLCE1;TPM1;PPP1R12B;ANXA6
prerank,response to ethanol (GO:0045471),0.7367497283000359,1.8655095915684115,0.002242152466367713,0.03505263161808807,0.799,6/14,10.33%,GRIN1;GLRA1;GRIN2A;GRIN2B;GLRA2;GRIN3A
prerank,regulation of establishment of cell polarity (GO:2000114),-0.7115328519448545,-1.861865758948649,0.0,0.06549855918421407,0.65,7/16,6.49%,ROCK2;GSN;ROCK1;RIPOR2;BCAS3;RAP1B;ARFGEF1
prerank,positive regulation of cell junction assembly (GO:1901890),0.5259201270506846,1.8591885843730829,0.0,0.03774892907408359,0.825,15/56,8.27%,CLDN5;CNTNAP2;NRXN1;TEK;PTPRD;IL1RAPL1;EPHB1;NLGN1;GRID2;PPM1F;KDR;THY1;PTPRJ;CLSTN3;LRRC4B
prerank,dermatan sulfate metabolic process (GO:0030205),-0.739218955948033,-1.8565289230564432,0.0,0.06801933643548239,0.677,4/13,3.00%,UST;DSE;DCN;BGN
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6707889597556596,-1.852246840648501,0.0,0.0699800596233599,0.704,8/20,6.93%,IGF1;LRP1;BMPR1A;IGFBP5;PDGFRB;VTN;IGFBP3;NRP1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.5894255936872878,-1.8520024657762877,0.0,0.06760857248790268,0.704,15/35,10.80%,RBFOX2;ZMIZ1;DDX5;NR3C2;YAP1;DDX17;PPARGC1B;NR3C1;UBR5;TRIP4;AR;MED1;PMEPA1;TADA3;CALCOCO1
prerank,endodermal cell differentiation (GO:0035987),-0.6129764728222665,-1.8518544695572665,0.0,0.06527897928427781,0.705,17/31,20.20%,COL8A1;COL12A1;ITGAV;VTN;COL6A1;ITGB5;CTR9;LAMA3;SETD2;RTF1;MMP14;FN1;MMP2;ITGA5;ITGA4;INHBA;CDC73
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.6359497069948973,-1.851251472114064,0.0,0.06343831841006235,0.71,9/26,14.47%,SULF1;IL6ST;CCBE1;ARNT;SULF2;EIF2AK3;CYP1B1;HIF1A;RORA
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.528479415103315,1.8509981771698136,0.0,0.040684118985796394,0.846,25/59,12.08%,DSCAM;BSG;KIRREL3;HMCN1;CADM1;IGSF11;PLXNB3;PTPRT;CDH2;CNTN6;ROBO4;PCDHB6;DSCAML1;NPTN;TENM3;VSTM2L;PECAM1;ROBO2;ROBO3;CADM3;PTPRM;CELSR2;CNTN4;NECTIN1;CNTN2
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.5455601625541979,-1.8461381331484843,0.0018796992481203006,0.06548864267260404,0.729,32/50,28.35%,ZIC1;GLI3;FBXL17;SMO;BTRC;DCDC2;GPC3;TTC23;IFT81;CREBBP;FGFR2;GAS1;GLIS2;TULP3;EVC;HERC4;ARMC9;SUFU;GLI1;RORA;PTCH1;WDR11;VCP;MEGF8;PDCL;DLG5;KIF7;MGRN1;GAS8;IFT122;PTCH2;KCTD6
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.6054154258486245,1.842880351176774,0.0045045045045045045,0.0442554863567557,0.874,8/29,6.84%,CAMK2A;SHISA6;NETO1;MCTP1;GRIK2;SHISA8;PPFIA3;SHISA7
prerank,regulation of osteoblast differentiation (GO:0045667),-0.4984014660345772,-1.8416609742137944,0.0,0.06740668795046562,0.752,36/82,18.73%,BMP6;RANBP3L;IGF1;SMOC1;CRIM1;BMPR1A;WNT4;SMAD6;DDX5;BMP7;TMEM64;IL6ST;BMP4;YAP1;SKI;FGFR2;REST;NBR1;LIMD1;MEF2C;IL6R;SUFU;TRPM4;CCN1;ATRAID;ACVR1;PTCH1;SUCO;RUNX2;TWIST2;PRKD1;PRKACA;FBN2;CCN4;NPNT;BMP2
prerank,alanine transport (GO:0032328),0.7722916867126047,1.8406155400341182,0.002197802197802198,0.04467678771110542,0.881,3/10,9.70%,SLC6A6;SLC6A17;SLC36A1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.6949659205970883,-1.8403767845157428,0.0,0.06634146267106618,0.758,12/17,17.00%,PBX1;RBPJ;KAT2B;EP300;CREBBP;NOTCH3;MAML2;WWC1;MAML1;STAT1;PLXND1;HEYL
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.5097181792602861,-1.83856685208166,0.0,0.06580957704834667,0.763,26/65,17.48%,FBN1;SMAD3;TGFBR1;LDLRAD4;SMAD6;LTBP1;SMURF2;TGFBR2;HTRA3;TGFB1I1;BCL9L;SMAD2;SKI;SNX6;SKIL;PDPK1;PMEPA1;CD109;IL17RD;STRAP;PPM1A;ASPN;EMILIN1;SMURF1;VASN;FBN2
prerank,pteridine-containing compound metabolic process (GO:0042558),0.7352297044022436,1.8376199335242893,0.008403361344537815,0.04500209158113494,0.888,6/13,17.06%,NOS3;PRKG2;AKT1;CALM1;GCH1;HSP90AA1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.7647026603038488,1.836487923620043,0.00641025641025641,0.04486459579464565,0.891,6/11,17.06%,NOS3;PRKG2;AKT1;CALM1;GCH1;HSP90AA1
prerank,potassium ion transport (GO:0006813),0.46443201648081495,1.8363146281781408,0.0,0.044077916481427656,0.891,31/120,8.25%,KCND2;HCN1;SLC24A4;SLC24A2;KCNH7;KCNJ3;KCNQ3;KCNC2;KCNJ6;KCNN2;KCNH5;KCNH8;KCNMB2;KCNMB3;KCNJ11;KCNN1;KCNK13;KCNMB4;KCNK10;HCN2;KCNJ10;KCND3;KCNH1;KCNC3;KCNQ5;KCNK9;KCNAB1;KCNN3;KCNC1;LRRC55;KCNK1
prerank,negative regulation of axonogenesis (GO:0050771),0.6029210174149647,1.8320761863218264,0.002109704641350211,0.04547128958400171,0.905,13/27,14.95%,DCC;MAG;MCF2;FGF13;MAP2;THY1;EFNB3;OMG;LINGO1;RTN4R;DIP2B;RTN4;GDI1
prerank,skeletal system development (GO:0001501),-0.4519767772214715,-1.8258202947477102,0.0,0.07619380861773205,0.82,38/148,13.44%,BMP6;AKAP13;COL1A2;SULF1;FBN1;IGF1;TGFBR1;SOX5;CREB3L2;COL1A1;PKD1;ANKRD11;GLI2;WWOX;BMP5;BMP7;SH3PXD2B;NPR3;PCSK5;CDH11;RBP4;SULF2;EXT1;ZBTB16;FGFR2;EIF2AK3;SLC10A7;GJA1;IGF2;TNFRSF11B;PRELP;COL13A1;ITGB8;EVC;MMP14;GNAS;SUFU;SOX6
prerank,transcription by RNA polymerase II (GO:0006366),-0.410522064408216,-1.8237387825168099,0.0,0.07666880119064919,0.831,131/305,28.12%,NOTCH2;MLLT3;MAF;SOX5;TEAD1;PRRX1;NFKB1;RBPJ;THRB;DDX5;GLIS3;NR1D2;RARB;CCN2;KAT2B;GTF2H2;NR3C2;NCOR1;CCNT2;PABPN1;TBL1X;TBL1XR1;CCNH;NR6A1;RREB1;NFIX;CCNT1;INTS4;WDR33;PCF11;YAP1;TAF3;RARG;NR3C1;CDK7;MED17;SCAF8;CREBBP;MED26;CPSF3;AR;CTR9;PHAX;PPARGC1A;TAF4;TBP;SSU72;ZBTB1;MED1;CCNK;CDK13;RPRD2;SETD2;TEAD3;MNAT1;SLBP;NR1H3;NOTCH3;AFF4;MAML2;RTF1;PARP1;ERCC3;TEAD2;TFCP2;IRF9;NABP2;COPS2;NELFB;MAML1;RORA;TAF5L;HDAC1;TAF8;TAF13;RXRA;MNT;SNAPC3;PIR;GTF2B;ICE1;RNGTT;PMF1;NR4A1;NR4A2;MED27;CSTF3;NFIC;POLR2H;SNRPF;INTS6;NFX1;CDC73;MED16;NFYA;TAF12;TRIP11;TAF9B;RPAP1;TAF2;DRAP1;INTS14;GTF2F1;CPSF4;CSTF1;EAF2;NUDT21;POLR2K;SNAPC1;TBPL1;GTF2H1;NR2F1;POLR2E;CTDP1;PPARA;CPSF1;LSM11;NR2C1;NCBP2;GTF2E2;TAF1C;TAF7;ESR1;ZBTB7B;GTF2H4;HDAC3;SNAPC5;THRA;NELFA;NELFE;POLR2D
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.7443946396439823,-1.8232634874898077,0.0039603960396039604,0.07500188281048786,0.834,4/12,3.00%,UST;DSE;DCN;BGN
prerank,axon development (GO:0061564),0.4880034095723135,1.8179280084511458,0.0,0.05343782190982986,0.936,22/78,11.59%,DCC;CTNNA2;ACTB;PLP1;GRM7;SPTBN4;ADGRB1;MAP1B;ANK3;APBB1;PAX2;DSCAML1;NRCAM;ZDHHC17;SHTN1;PLPPR4;NTNG2;NTNG1;TAOK2;BRSK2;CNTN4;SLITRK5
prerank,gene silencing by miRNA (GO:0035195),-0.5794291577352951,-1.8136177176222326,0.001996007984031936,0.08345950582058743,0.867,16/32,23.52%,DICER1;TNRC6B;PUM2;ZC3H7A;WTIP;TNRC6A;MOV10;PUM1;LIMD1;CNOT8;TNRC6C;CNOT1;AJUBA;RBM4;XPO5;AGO1
prerank,synaptic vesicle cycle (GO:0099504),0.5898123822977601,1.8114202823934147,0.0081799591002045,0.05709983033093833,0.947,10/30,12.18%,RIMS1;PCLO;NLGN1;SYT7;SNAP25;SNCA;SLC17A6;SYT10;CPLX1;PLD2
prerank,regulation of AMPA receptor activity (GO:2000311),0.6152081088280151,1.8100582259352322,0.004210526315789474,0.05691404414264058,0.95,10/25,10.91%,NLGN1;MAPK8IP2;SHISA6;SHANK3;SHISA8;CACNG2;SHISA7;CACNG3;RELN;CACNG8
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5443885755748228,-1.8074827599821681,0.0,0.08852835259433754,0.882,20/46,15.31%,ZIC1;SMAD3;TCF7L2;XPO4;GSK3B;FLNA;KHDRBS1;UBR5;CDH1;DHX9;RAPGEF3;JUP;BAG3;PRKCD;MAVS;TPR;YWHAE;EMD;ANP32B;EFCAB7
prerank,Rho protein signal transduction (GO:0007266),-0.5170708721955284,-1.8045566420450967,0.0,0.08991987604536371,0.887,17/53,18.25%,ROCK2;COL1A2;ARHGAP29;ARHGAP6;ROCK1;PDPN;RHOJ;CTNNAL1;CDC42;CDC42EP5;RHOA;AGTR1;ARHGDIB;ARHGEF11;ADRA2A;ARHGEF1;CDC42EP4
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.6587538434293106,-1.802560346280609,0.00808080808080808,0.09031958774410624,0.894,11/20,19.22%,CELF1;TNRC6B;WTIP;TNRC6A;MOV10;LIMD1;CNOT8;HELZ;TNRC6C;CNOT1;AJUBA
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.74852506256086,-1.8007064492894445,0.0,0.0897420114093565,0.899,7/12,19.13%,ROCK2;ROCK1;FLOT2;APOE;RANBP9;PICALM;ABCA7
prerank,excitatory postsynaptic potential (GO:0060079),0.6540266020196049,1.7988344052443521,0.0020964360587002098,0.0638300951547591,0.965,8/19,7.85%,MPP2;GRIN1;MAPK8IP2;GRIN2A;GRID2;GRIN2B;GRIN2D;AKT1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.6604041493596258,1.7981047236930443,0.004123711340206186,0.06326176106169466,0.968,6/18,3.17%,GRIN1;NRXN1;RIMS1;NLGN1;RIMS2;SHANK3
prerank,embryonic eye morphogenesis (GO:0048048),-0.7784592885504504,-1.7967654490969154,0.003937007874015748,0.09247855398606022,0.914,5/11,5.26%,FBN1;EFEMP1;LRP6;RARG;MFAP5
prerank,cell projection organization (GO:0030030),-0.5856401390255809,-1.796588569141249,0.0019455252918287938,0.09049393385520342,0.914,9/30,13.62%,PARVA;RHOQ;GSN;RHOJ;PACSIN2;ITGB1;CDC42;NCKAP1;P2RY12
prerank,axonogenesis (GO:0007409),0.4151047029015578,1.7965824317896224,0.0,0.06337000203571111,0.971,72/237,12.35%,DSCAM;BSG;NRXN3;NRXN1;DCC;CTNNA2;ACTB;EPHA6;SEMA3C;SPTBN4;EPHB1;DAB1;SEMA6A;CXCL12;UNC5C;SPTB;ADGRB1;EPHA5;SEMA4A;MAP1B;ANK3;SEMA4F;SHANK3;CNTN6;ROBO4;APBB1;PAX2;SEMA6D;SEMA4D;DOK6;SEMA7A;EFNB3;TNR;RPS6KA5;NOTCH1;DSCAML1;UNC5D;NCAM1;NPTN;SLIT3;SLIT1;ENAH;RAP1GAP;NRCAM;PRKCQ;VSTM2L;ZDHHC17;UNC5B;ROBO2;EFNA2;HSP90AB1;SPTBN5;SHTN1;EPHA10;B4GALT6;PLPPR4;NTNG2;NTNG1;RELN;TUBB3;TAOK2;ROBO3;FEZ1;BRSK2;CNTN4;SPTBN1;DOK5;SLITRK5;DOK2;CNTN2;RET;EPHA1
prerank,presynapse assembly (GO:0099054),0.6794260072263165,1.79368569295701,0.008620689655172414,0.06449033466413669,0.975,5/16,1.68%,PTPRD;LRRTM3;PCLO;IL1RAPL1;NLGN1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6782421133368332,-1.7907771416462392,0.0,0.09503624126625623,0.93,7/16,8.53%,IGF1;IGFBP2;IGFBP5;BMP5;IGFBP3;IGFBP6;IGFBP4
prerank,digestive tract development (GO:0048565),-0.5780107636375178,-1.7894920478372875,0.0036968576709796672,0.09432585843455626,0.932,18/32,22.22%,GLI3;PKD1;GLI2;CLMP;RARB;SMO;PCSK5;KIT;FGFR2;CHD8;NIPBL;GLI1;CCDC39;SALL1;MEGF8;PKDCC;ZIC3;GATA6
prerank,positive regulation of actin nucleation (GO:0051127),-0.7539415121025843,-1.788958283859911,0.0038095238095238095,0.09274094118766708,0.933,7/11,15.35%,GSN;FCHSD2;WASF2;BRK1;NCKAP1;WASF1;WHAMM
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.725203052227275,-1.7879679710489422,0.0018796992481203006,0.09175516104186388,0.936,4/13,1.77%,FSTL1;FBN1;LTBP1;NBL1
prerank,central nervous system neuron differentiation (GO:0021953),0.5713244745152946,1.787408372023919,0.002242152466367713,0.0680650699257405,0.981,15/33,17.10%,SPOCK1;MDGA2;PROX1;GRID2;CEND1;MAP2;TOX;NTRK2;LHX1;SIN3A;KNDC1;CHD5;SOX4;CTNNB1;FAIM2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.46235715509244196,-1.7871514553191035,0.0,0.09100878530100297,0.939,35/95,16.51%,TGFBR3;SMAD3;TGFBR1;LDLRAD4;SMAD6;SMURF2;NREP;DAB2;EP300;DKK3;TGFBR2;HTRA3;TGFB1I1;BCL9L;THBS1;SMAD2;SKI;SNX6;CREBBP;SKIL;PDPK1;ZEB2;PMEPA1;SMAD4;GIPC1;CD109;IL17RD;STRAP;PPM1A;ASPN;EMILIN1;LATS1;SMURF1;VASN;CITED2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.7887093742630739,-1.7862385670927434,0.0,0.0900743058650991,0.94,5/10,10.01%,PID1;APPL2;GRB10;ENPP1;SELENOS
prerank,glucose transmembrane transport (GO:1904659),0.6478914606540491,1.7811255850606442,0.008385744234800839,0.07170320663407435,0.985,4/18,2.70%,SLC2A1;SLC2A3;RAB4B;SLC2A5
prerank,actin cytoskeleton reorganization (GO:0031532),-0.5105270569783804,-1.7801535537611293,0.0,0.0960076988036165,0.956,25/63,18.43%,AUTS2;PARVA;PHACTR1;SIPA1L1;GSN;MCU;PTK7;KIT;FLNA;NRK;CXADR;DTNBP1;MKLN1;NRP1;ANXA1;FER;RHOA;RALA;RICTOR;CTTN;WHAMM;FARP2;EFS;PTPN1;GAB1
prerank,cellular response to purine-containing compound (GO:0071415),0.7597245270702682,1.7791897191804409,0.0064516129032258064,0.07212284356656999,0.986,5/10,7.05%,RYR2;RYR3;SLC8A1;TRPM2;P2RY1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5214432940517156,1.7763535336534928,0.002074688796680498,0.0733084546729269,0.986,17/54,7.94%,DPP10;KCNJ3;KCNIP4;KCNJ6;KCNN2;AKAP6;BIN1;KCNIP1;KCNMB2;KCNMB3;KCNN1;KCNMB4;DPP6;KCNJ10;GNG2;KCNAB1;KCNN3
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.6075655618893053,-1.7761113602929064,0.001869158878504673,0.09963177547013193,0.96,9/26,9.84%,ROCK2;ASAP3;ROCK1;PRKN;ALMS1;SLC9A1;FHOD1;CDC42;SYNPO2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5924722484278122,1.7758991830995792,0.0039447731755424065,0.07257027133406321,0.986,7/26,3.17%,GRIN1;NRXN1;RIMS1;TMEM108;NLGN1;RIMS2;SHANK3
prerank,chondrocyte differentiation (GO:0002062),-0.572701583287625,-1.774386244230952,0.0,0.09998132128661198,0.962,14/32,13.44%,SULF1;SOX5;CREB3L2;BMP4;OSR1;WNT5B;NFIB;SULF2;SLC39A14;EIF2AK3;RUNX1;CCN3;MEF2C;SOX6
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.6485421848622583,1.7743396719143891,0.008695652173913044,0.07286176266187444,0.986,8/18,10.91%,NRXN1;NLGN1;SHANK3;CACNG2;CACNG3;CCL2;RELN;CACNG8
prerank,Golgi organization (GO:0007030),-0.4562143899195298,-1.7735154875193309,0.0,0.0993073151346563,0.963,49/112,23.99%,VTI1A;GBF1;LRRK2;FBXW8;RAB30;CSNK1A1;ATL3;HUWE1;UBXN2B;BCAS3;GOLGB1;ATP8B1;SEC23IP;VTI1B;STX16;ARFGEF1;ARHGAP21;SEC22B;OBSL1;CDC42;USP6NL;VCPIP1;ATP8B2;ATL2;TBC1D20;COG3;COG7;STX5;SURF4;GOSR2;PRMT5;PRKD1;TMED3;VAMP4;TJAP1;TMED4;CSNK1D;TMED5;SEC16B;TRIP11;SEC16A;CUL7;STX17;PLEKHM2;COG4;PLK5;PI4K2B;LMAN1;BAG5
prerank,positive regulation of B cell proliferation (GO:0030890),0.5815159422538281,1.7728511049545244,0.0,0.07299098699603446,0.989,9/29,15.15%,TFRC;TIRAP;MIF;IL7;VAV3;TNFSF13B;CD40;NFATC2;CD38
prerank,regulation of transmembrane transport (GO:0034762),0.5745004784618284,1.7714920995660008,0.00202020202020202,0.0731164106144839,0.989,9/31,7.03%,ACTB;SLC2A1;KCNJ3;KCNJ6;SNCA;KCNJ11;OCLN;KCNJ10;TRIB3
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.46171780192759687,-1.7714273053515905,0.0019569471624266144,0.09984825356671678,0.965,41/108,21.97%,WLS;TRABD2B;SULF1;NXN;LRP1;MDFIC;WWOX;GRB10;PTK7;RNF43;PRKN;LRRK2;BTRC;VGLL4;DCDC2;GPC3;SULF2;RSPO3;AXIN1;SKI;FGFR2;RUNX1;DACT1;RSPO2;TLE1;TCF7L1;FZD7;EMD;CSNK2A1;FOXL1;SALL1;DACT3;BMP2;SFRP4;MDFI;CDC73;TERT;PPP2CA;FRZB;SPIN1;SENP2
prerank,inhibitory synapse assembly (GO:1904862),0.7420147826455553,1.7711270961999044,0.010752688172043012,0.07240086305548939,0.989,6/11,8.68%,GABRB3;GABRA2;FGF13;GABRB2;LGI2;GABRG2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.47143555076742205,-1.7697824793305665,0.0,0.10008825318103617,0.967,19/86,6.26%,BMP6;SULF1;TGFBR1;BMPR1A;FOXD1;RBPJ;RBPMS;ZNF423;BMP5;BMP7;DAB2;BMP4;EP300;NUMA1;TGFB1I1;THBS1;SMAD2;CREBBP;TWSG1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5502380836659824,1.769777260255793,0.0,0.07247460103388648,0.989,14/37,12.06%,HMCN1;PTPRD;CADM1;IL1RAPL1;NLGN1;TENM2;GRID2;TENM1;TENM4;TENM3;DCHS1;CADM3;CRB1;NECTIN1
prerank,carbohydrate transport (GO:0008643),0.7205864412777222,1.7686374604145938,0.008064516129032258,0.07246823118035359,0.989,3/11,2.70%,AQP9;AQP11;SLC2A5
prerank,heart development (GO:0007507),-0.4299364802459513,-1.7667272786281214,0.0,0.10153091244149719,0.971,53/150,19.73%,AKAP13;TGFBR3;CACNA1C;FBN1;COL3A1;TGFBR1;PLCE1;PKD1;NTRK3;PDLIM5;GLI2;FLRT2;BMP5;FOXC1;ADAP2;KAT2B;BMP7;BMP4;SH3PXD2B;BCOR;OSR1;TGFBR2;PCSK5;MICAL2;RBP4;GPC3;MEF2A;CXADR;PDLIM7;FOXC2;ECE1;NCOA6;KDM6A;ID2;MEF2C;PDLIM2;NIPBL;FN1;PKD2;SCUBE1;VEGFA;CHD7;ACVR1;FOXL1;SALL1;CITED2;TBX2;WDR11;EEF1AKMT4-ECE2;ZDHHC16;BMP2;PTPN11;MEGF8
prerank,regulation of ion transport (GO:0043269),0.4863861973361128,1.7662452503182997,0.0,0.07345135614402423,0.989,22/76,12.95%,NKAIN2;SYT1;KCNJ3;SYT6;SPTBN4;NKAIN1;SYT7;NKAIN3;KCNJ6;SYT12;SYT11;ANK3;SNCA;KCNJ11;CA2;KCNJ10;SYT10;SYT2;ATP1A1;P2RX7;KCNA2;KCNJ8
prerank,regulation of catecholamine secretion (GO:0050433),0.5730539268189002,1.7657622839157097,0.007920792079207921,0.0728896886127355,0.989,10/29,11.77%,SYT1;SYT6;SYT7;SYT12;SYT11;SNCA;GRK2;SYT10;SYT2;KCNA2
prerank,BMP signaling pathway (GO:0030509),-0.49282025778117566,-1.7647711359595055,0.0,0.10225489234926664,0.977,25/62,21.58%,BMP6;TGFBR3;SMAD3;BMPR1A;SMAD6;DDX5;BMP5;BMP7;BMP4;RGMB;SMAD2;RGMA;SMAD4;SLC33A1;SMURF1;ACVR1;ZFYVE16;TGFB3;PDCD4;RUNX2;BMP2;MEGF8;SMAD9;SMAD1;TMEM100
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5798212497682664,1.7630063103434297,0.002150537634408602,0.07425766506826152,0.989,8/32,16.04%,PGLYRP1;RPS19;S100A9;RPL30;CXCL14;HMGN2;DEFA6;RNASE3
prerank,negative regulation of translation (GO:0017148),-0.46860710950513357,-1.7618908699004128,0.0,0.10428750726984053,0.979,26/87,19.39%,SAMD4A;ROCK2;IGFBP5;CELF1;FTO;ROCK1;YTHDF3;SYNCRIP;DDX6;EIF4ENIF1;EIF2AK3;LARP1;PUM1;DHX36;LSM14A;CNOT8;TPR;EIF2AK4;YBX1;EIF2AK2;DDX3X;DAPK1;CNOT1;CPEB1;CNOT10;RBM4
prerank,circulatory system development (GO:0072359),-0.44941374371531495,-1.7618257840214597,0.0,0.10256026075317216,0.979,35/118,12.91%,AKAP13;CACNA1C;FBN1;COL3A1;NXN;TGFBR1;PLCE1;PKD1;NTRK3;PDLIM5;GLI2;FOXC1;ADAP2;KAT2B;SH3PXD2B;BCOR;OSR1;TGFBR2;PCSK5;MICAL2;RBP4;MEF2A;HSPG2;CXADR;PDLIM7;FOXC2;ECE1;NCOA6;KDM6A;ID2;MEF2C;PDLIM2;FN1;FBXW7;PKD2
prerank,synapse organization (GO:0050808),0.44589956584061746,1.7610156473496787,0.0,0.07489268236635353,0.992,40/125,12.61%,SPOCK2;DNM3;DSCAM;KIRREL3;GRM5;ADGRL3;NRXN1;PTPRD;LRRC4C;LRFN5;CTNND2;NLGN1;GPM6A;DNER;ANK3;CDH2;SHANK3;SNCA;UNC13A;PPFIA3;PCDHB6;NRXN2;ELFN1;NRCAM;WNT7B;ARHGAP39;RAB39B;CACNB2;LRRC4B;SHANK2;NTNG1;APBB2;CACNB4;F2R;PPFIA2;PPFIA4;DVL1;CNTN2;SNCB;DCTN1
prerank,positive regulation of DNA replication (GO:0045740),-0.6733858492912936,-1.7593314676705312,0.005494505494505495,0.10396470771950041,0.982,10/16,26.04%,EGFR;GLI2;DHX9;BRPF3;GLI1;CTC1;PCNA;STN1;ATAD5;EGF
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.6134165205952227,-1.7593283746995725,0.0019230769230769232,0.10226036824868893,0.982,9/24,9.09%,ROCK2;ERRFI1;FOXC1;ROCK1;NUMA1;HOXA7;SRSF6;RUNX1;MED1
prerank,cellular defense response (GO:0006968),-0.5429937228732071,-1.7586412096510309,0.0,0.1013019644084731,0.982,12/40,19.41%,ZNF148;DCDC2;CCR9;LBP;ITGB1;LSP1;VEZF1;BECN1;TCIRG1;CX3CR1;LGALS3BP;NCF2
prerank,embryonic skeletal system development (GO:0048706),-0.5656911354673658,-1.7585787990460209,0.0,0.09975066250007843,0.982,13/35,9.37%,SULF1;COL1A1;PDGFRA;OSR1;HOXB3;PCSK5;RBP4;SULF2;DYNC2I1;HOXC4;HOXA3;WNT9A;HOXB4
prerank,cell differentiation in hindbrain (GO:0021533),0.7264549886369591,1.7550007822960312,0.002173913043478261,0.07867680588876523,0.994,7/11,20.07%,PROX1;GRID2;CEND1;LHX1;KNDC1;FAIM2;CBLN1
prerank,regulation of dendrite extension (GO:1903859),0.6662086286252019,1.7548755148614525,0.0,0.07773725820724485,0.994,7/18,10.85%,SYT1;RIMS1;RIMS2;CPNE9;UNC13A;RNF157;SYT2
prerank,negative regulation of cell differentiation (GO:0045596),-0.4247155280420349,-1.7534618123397627,0.0,0.10468117568332472,0.984,51/181,17.45%,RANBP3L;EGFR;COL5A2;SMAD3;TGFBR1;CRIM1;EFEMP1;ADAMTS12;COL5A1;LDLRAD4;SMAD6;ABCA1;BMP5;ITGAV;BMP7;TMEM64;BMP4;OSR1;JAG1;ENPP1;YAP1;ZBTB16;SKI;ADGRV1;REST;WNT9A;CTR9;IGF2;NBR1;RUNX1T1;MED1;NR1H3;LIMD1;ID2;IL17RD;HES1;RB1;EIF2AK4;NELFB;SUFU;TRPM4;TRIB2;ANKRD26;RORA;ANP32B;PTCH1;VASN;PDCD4;TRIO;TWIST2;HNRNPU
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.6183261123642703,-1.75279272723618,0.0037735849056603774,0.10385791451754631,0.986,11/22,15.15%,ROCK2;IGF1;IL6ST;ROCK1;SLC9A1;MEF2A;CAMK2D;SMAD4;PARP1;LMCD1;P2RX4
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6766829827746056,1.7524572170705892,0.006564551422319475,0.07873955614546009,0.996,9/15,17.22%,GRM5;GRM7;GRM1;GRM8;HOMER1;HOMER2;GRM3;HOMER3;GRIK3
prerank,cellular response to BMP stimulus (GO:0071773),-0.48517354133269414,-1.7524060480794397,0.0,0.1027170302587482,0.986,26/66,21.58%,BMP6;TGFBR3;SMAD3;BMPR1A;ADAMTS12;SMAD6;DDX5;BMP5;BMP7;BMP4;RGMB;SMAD2;RGMA;SMAD4;SLC33A1;SMURF1;ACVR1;ZFYVE16;TGFB3;PDCD4;RUNX2;BMP2;MEGF8;SMAD9;SMAD1;TMEM100
prerank,positive regulation of dendrite extension (GO:1903861),0.6702548917290035,1.7518102293613265,0.002197802197802198,0.07827382857371366,0.996,7/17,10.85%,SYT1;RIMS1;RIMS2;CPNE9;UNC13A;RNF157;SYT2
prerank,neurotransmitter transport (GO:0006836),0.48651128813889455,1.7502951014350976,0.0,0.07839354855982089,0.996,29/73,15.69%,NRXN1;PTPRN2;SYT1;RIMS1;SYN2;GABRA2;SNAP25;LIN7A;SLC17A6;SLC18A3;SLC1A1;UNC13A;HSPA8;PPFIA3;SLC1A2;NRXN2;SNPH;SLC6A2;CPLX1;GAD1;PPFIA2;PPFIA4;DVL1;CHAT;PDZD11;TSPOAP1;SYN1;GLS2;GLS
prerank,mesenchymal cell differentiation (GO:0048762),-0.5176210645820178,-1.7497952359863607,0.0,0.10438090519184953,0.987,16/51,6.49%,ROCK2;RANBP3L;TGFBR3;TGFBR1;WNT4;LRP6;FBXL17;RBPJ;LIMS1;DDX5;FOXC1;BMP7;ROCK1;GSK3B;DDX17;FGFR2
prerank,positive regulation of developmental growth (GO:0048639),0.5194565419349685,1.7495191746916527,0.0,0.07819763919260712,0.996,15/49,14.15%,SYT1;RIMS1;RIMS2;CPNE9;SEMA4D;SEMA7A;UNC13A;PLCB1;RNF157;SHTN1;CDKL5;NTN1;SYT2;DLL1;INSR
prerank,sensory perception of smell (GO:0007608),0.7249092525471437,1.7473608777821192,0.008281573498964804,0.07905856321068357,0.996,3/11,7.15%,SLC24A4;ADCY3;SYT10
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.48211962101561223,-1.7452783728734613,0.0,0.10851580322428947,0.989,16/74,7.11%,PHLDB2;SMAD3;TGFBR1;DAG1;EPHA3;COL1A1;LDLRAD4;BMP5;FOXC1;DAB2;PDPN;TGFBR2;TGFB1I1;BCL9L;SMAD2;MTOR
prerank,neuropeptide signaling pathway (GO:0007218),0.49796794862760807,1.7432682213271502,0.0,0.0813195455767323,0.998,16/58,15.25%,GLRA1;NXPH2;HCRTR1;GPR149;GLRA3;SORCS3;SORCS1;ADCYAP1;HCRTR2;GLRA2;OPRM1;GRP;PNOC;SORL1;OPRK1;OPRL1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.4278328669251619,-1.7402360786181639,0.0,0.11313446289002253,0.99,46/138,18.33%,NOTCH2;TEAD1;RBPJ;THRB;NR1D2;RARB;CCN2;KAT2B;GTF2H2;NR3C2;NCOR1;TBL1X;TBL1XR1;CCNH;NR6A1;YAP1;TAF3;RARG;NR3C1;CDK7;MED17;CREBBP;MED26;AR;PPARGC1A;TAF4;TBP;MED1;TEAD3;MNAT1;NR1H3;NOTCH3;MAML2;ERCC3;TEAD2;MAML1;RORA;HDAC1;TAF8;TAF13;RXRA;GTF2B;NR4A1;NR4A2;MED27;POLR2H
prerank,regulation of dopamine secretion (GO:0014059),0.5915298621691609,1.738209602236442,0.004158004158004158,0.08457254535623572,0.998,9/25,11.77%,SYT1;SYT6;SYT7;SYT12;SYT11;SNCA;SYT10;SYT2;KCNA2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5359928066708385,-1.737115409700623,0.001941747572815534,0.11615918371079953,0.992,17/43,17.72%,IGF1;FOXP1;BMPR1A;IGFBP5;PDGFRB;BMP4;THBS1;GJA1;JUN;ID2;IL6R;MMP2;ERN1;STAT1;IL18;ADAMTS1;CCN4
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.5325407315143836,-1.736211912309369,0.0018214936247723133,0.1156795996603799,0.992,13/40,7.11%,SMAD3;TCF7L2;TGFBR1;COL1A1;FOXC1;DAB2;PDPN;JAG1;TGFBR2;TGFB1I1;BCL9L;SMAD2;MTOR
prerank,cellular transition metal ion homeostasis (GO:0046916),0.46180677751637383,1.73173962331438,0.0,0.08922948906954462,0.998,26/91,11.88%,SLC39A10;TFRC;ALAS2;TMPRSS6;MT2A;SLC40A1;ABCG2;FTH1;SLC22A17;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;SLC30A1;FTL;ISCU;FBXL5;ATP6V1A;ATP6AP1;SLC39A8;ATOX1;SLC30A5
prerank,rRNA metabolic process (GO:0016072),0.4203159814789743,1.727414763731888,0.0,0.09240689117419691,0.998,52/160,16.46%,EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPL10;RPL15;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;FBL;RPL12;RPL13;RPS15;NOL6;RPL14;RPL5;RPL21;RPS7;RPL23A;DKC1;POP5;RPL8;RPS14;DDX10;RPS2;PIH1D2;WDR75;RPL18A;RPS28;RRP1;RRP1B;DIS3L;NOP56;RPS25;MDN1;UTP15;EXOSC4
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.7206354653851876,-1.7271624053835375,0.003669724770642202,0.12661732574066717,0.995,9/11,25.39%,PUM2;WTIP;STAT3;DHX9;PUM1;LIMD1;AJUBA;XPO5;FXR1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.4967667862676107,-1.726531199069299,0.0021231422505307855,0.1258935109548852,0.995,17/56,16.01%,BMP6;TGFBR1;BMPR1A;LDLRAD4;SMAD6;RBPMS;BMP5;BMP7;DAB2;BMP4;TWSG1;PMEPA1;SMAD4;BMPER;EMILIN1;ACVR1;TGFB3
prerank,response to cadmium ion (GO:0046686),0.5771480159758954,1.7204377151375605,0.006276150627615063,0.09793109833608614,0.998,10/26,7.85%,MT2A;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;AKT1
prerank,cellular response to cadmium ion (GO:0071276),0.5841527523414781,1.720403518138878,0.008456659619450317,0.09681824494590334,0.998,10/24,7.85%,MT2A;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;AKT1
prerank,cell projection assembly (GO:0030031),-0.6023903592477287,-1.7184150432964844,0.00558659217877095,0.13562571716586402,0.997,6/22,11.17%,PARVA;RHOQ;GSN;RHOJ;CDC42;NCKAP1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.7228447389174344,1.7178701448156044,0.008602150537634409,0.09834486651538597,0.999,6/12,4.76%,SYT1;RIMS1;SYT7;RIMS2;RIMS3;UNC13A
prerank,melanocyte differentiation (GO:0030318),-0.7250825589649157,-1.7149957783177832,0.0,0.13946581928338936,0.998,5/11,14.58%,LRMDA;ENPP1;KIT;MEF2C;USP13
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.4417378861467525,-1.714902367258828,0.0,0.1377873192129767,0.998,38/112,16.01%,COL1A2;TGFBR3;COL3A1;SMAD3;TGFBR1;APPL2;SOX5;BMPR1A;WNT4;ZMIZ1;SMAD6;LIMS1;WWOX;TGFBR2;CLEC3B;NR3C1;ITGB1;SMAD2;SKI;TWSG1;ITGB5;PTPRK;JUN;RHOA;ADAM9;SMAD4;ARHGEF18;MEF2C;ZYX;APPL1;PARD3;SOX6;PDE3A;PRKCZ;SMURF1;ACVR1;LRRC32;TGFB3
prerank,glucose import (GO:0046323),0.6773312940128502,1.7139440449659467,0.008583690987124463,0.10127097484041701,0.999,3/13,1.71%,SLC2A1;SLC2A3;RAB4B
prerank,negative regulation of secretion by cell (GO:1903531),0.529124352024397,1.7132155998020366,0.004008016032064128,0.10078431258618464,0.999,9/38,5.94%,GRM7;IL1RAPL1;SYT11;RHBDF2;SNCA;TRH;IL12A;NOTCH1;SLC30A1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.673717640216087,-1.7112400214848318,0.0055147058823529415,0.1423032294625071,0.998,6/15,3.86%,LRP6;ANKRD11;GLI2;FOXC1;EDA;WNT6
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.7000360058606595,1.7081402291130319,0.008849557522123894,0.104575200962753,0.999,6/12,8.37%,PROM1;PODXL;MYO1E;MAGI2;CD24;BASP1
prerank,positive regulation of secretion (GO:0051047),0.7068546083554205,1.706224561118468,0.011086474501108648,0.10539958627535585,0.999,5/11,16.44%,TRH;XBP1;ACSL3;NPR1;GPLD1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5148518982904848,1.7037324051276068,0.0,0.10670319534499126,0.999,11/41,6.44%,SLC24A2;GRIN1;GRIN2A;RYR2;HTR2C;CACNA2D1;RYR3;GRIN2B;GRIN2D;SLC8A1;TRPM2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.7276740696832225,-1.702378641152621,0.0057361376673040155,0.15480437431834163,0.999,5/11,10.63%,PDK1;MAP3K5;CYP1B1;PRKCD;PRODH
prerank,regulation of microtubule depolymerization (GO:0031114),0.5818480480364886,1.7019872739677455,0.006109979633401222,0.10743783864900239,1.0,14/25,19.98%,NAV3;MAP1B;FGF13;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;CAMSAP3;CLASP2;TTBK2;TRPV4;CLASP1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5823786183549592,1.7014074802827424,0.004366812227074236,0.10689579659122472,1.0,8/24,4.59%,DSCAM;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,positive regulation of nervous system development (GO:0051962),0.5147102656968457,1.700233823978288,0.008247422680412371,0.10696872053781563,1.0,10/42,9.74%,NRXN1;PTPRD;IL1RAPL1;EPHB1;MME;NLGN1;GRID2;CLSTN3;LRRC4B;OPRM1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.6420826967913321,-1.6991090271807499,0.011278195488721804,0.15846334501892856,0.999,8/16,11.60%,ROCK2;IGF1;IL6ST;ROCK1;SLC9A1;MEF2A;CAMK2D;PARP1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.4238295035520957,-1.6967592819793285,0.0,0.16054336471049716,0.999,42/128,17.16%,BMP6;COL1A2;TGFBR3;COL3A1;SMAD3;TGFBR1;APPL2;BMPR1A;ZMIZ1;SMAD6;DDX5;SMURF2;BMP5;BMP7;BMP4;TGFBR2;RGMB;TGFB1I1;ITGB1;SMAD2;SKI;TWSG1;ITGB5;RGMA;PTPRK;JUN;RHOA;ADAM9;SMAD4;ARHGEF18;ZYX;APPL1;SLC33A1;PARD3;PRKCZ;SMURF1;ACVR1;ZFYVE16;LRRC32;TGFB3;PDCD4;RUNX2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.46374681228425874,1.696282698388425,0.0021321961620469083,0.11005252822473492,1.0,25/75,11.69%,DCC;CTNNA2;ACTB;SPTBN4;MAPK8IP2;ADGRB1;MAP1B;ANK3;MAP2;APBB1;PAX2;MFSD2A;DSCAML1;NRCAM;ZDHHC17;SHTN1;PLPPR4;NTNG2;NTNG1;TAOK2;CELSR2;BRSK2;CNTN4;SLITRK5;DVL1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5256075553811599,1.694052319389715,0.0039603960396039604,0.11138719982092347,1.0,12/41,7.94%,KCNJ3;KCNJ6;KCNN2;ANK3;AKAP6;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNJ10;GNG2;KCNN3
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.6762324650291707,-1.6925075493216266,0.009259259259259259,0.16581876524792646,0.999,3/13,3.21%,RHOQ;OPA1;LRRK2
prerank,regulation of neurotransmitter secretion (GO:0046928),0.5447127649182605,1.6919434688254804,0.004282655246252677,0.11252897258188123,1.0,9/32,5.94%,CAMK2A;RIMS1;RIMS2;SYT11;MCTP1;PREPL;RIMS3;KCNMB4;SLC30A1
prerank,inorganic cation transmembrane transport (GO:0098662),0.3905237261433783,1.6917393269505847,0.0,0.11155587560014298,1.0,66/268,12.06%,KCND2;SLC6A6;HCN1;SLC24A4;SLC24A2;CACNA1A;TRPC5;SCN1A;KCNH7;SLC6A17;ASIC2;SLC40A1;KCNQ3;KCNC2;KCNN2;UCP2;KCNH5;SLC39A2;ASIC4;KCNH8;RYR3;GAS6;SLC8A1;KCNJ11;KCNN1;ASIC1;SCN4B;KCNK13;KCNK10;SLC30A1;HCN2;TRPM2;KCNJ10;KCND3;KCNH1;KCNC3;SLC6A2;SLC6A5;ATP1A3;KCNQ5;KCNK9;SLC6A8;KCNAB1;SLC30A3;KCNN3;KCNC1;SLC25A14;LRRC55;KCNK1;SCN3A;ATP6V1F;MCOLN2;SLC25A27;SLC12A3;ATP6V1A;SLC36A1;KCNQ2;SLC39A8;ATP1A4;ATP1A1;P2RX7;ATP5F1B;KCNA2;SLC30A5;SCN2A;TRPC1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.6506088339180898,-1.691710814006423,0.01073345259391771,0.16503010248175973,0.999,7/16,10.31%,RBFOX2;DDX5;DDX17;PPARGC1B;TRIP4;AR;TADA3
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.6546834621574312,-1.6913909415929642,0.01090909090909091,0.16371563287933538,0.999,11/15,27.76%,WNT5B;GPC3;RSPO3;RNF213;DACT1;CSNK1E;CSNK1D;SFRP4;SPEF1;ZNRF3;DAAM2
prerank,protein K63-linked ubiquitination (GO:0070534),-0.5070247558088544,-1.6896188130203318,0.0038314176245210726,0.1648407558489272,0.999,19/41,22.61%,RNF152;UBE2N;UBE2E2;PRKN;WWP2;RNF115;TRAF3IP2;RNF8;TRAF2;TRIM5;UBE2B;TRAF3;HECTD1;BFAR;UBE2S;TRAF6;ARIH2;TRAF5;UBE2V2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.41725318164239217,-1.6895324813793418,0.0,0.16298545152551885,0.999,57/152,22.69%,RNF220;WLS;SULF1;LRRK1;EGFR;NFKB1;COL1A1;SMURF2;LGR4;PTK7;TNKS2;LRRK2;WNT5B;TBL1X;TBL1XR1;GPC3;RNF146;SULF2;RSPO3;AXIN1;UBR5;SKI;LYPD6;ADGRA2;FGFR2;ZEB2;XIAP;DACT1;CSNK1E;JUP;WNK1;RSPO2;USP47;PSMF1;PPM1A;TRPM4;PSMB2;UBE2B;DDX3X;ZBED3;CSNK2A1;PRDM15;SALL1;USP34;VCP;BMP2;CSNK1D;SFRP4;CDC73;TERT;PSMC1;DKK2;GID8;SPIN1;PLEKHA4;PSMA3;PSMB6
prerank,DNA conformation change (GO:0071103),-0.6503007708877654,-1.6879267492133965,0.0037105751391465678,0.16360860457246565,0.999,6/17,17.63%,ABL1;TOP1;HMGB1;HAT1;ERCC3;TOP2B
prerank,positive regulation of DNA binding (GO:0043388),-0.5473560241576907,-1.6876998610430143,0.004016064257028112,0.1621247063636199,0.999,18/31,26.04%,IGF1;FOXC1;PRKN;NIBAN2;HMGB1;SKI;CEBPG;NGF;HES1;RB1;TXN;TRAF6;PARK7;H1-0;NME1;TWIST1;EDF1;EGF
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.45538545727426255,-1.6867397945519615,0.0,0.1622566674663928,0.999,16/74,7.88%,EYA2;IGF1;EYA1;TCF7L2;TGFBR1;BMP5;EYA4;ITGAV;CFLAR;BMP4;BIRC6;GSK3B;THBS1;SH3RF1;BCL2;AR
prerank,androgen receptor signaling pathway (GO:0030521),-0.7167093701728934,-1.6865740854889637,0.0057251908396946565,0.16078119385691958,0.999,7/11,19.03%,ZMIZ1;DDX5;DDX17;AR;PMEPA1;KDM3A;RNF14
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.6443818723615262,-1.6864614778162141,0.011560693641618497,0.15917984436411872,0.999,4/15,3.00%,UST;DSE;DCN;BGN
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.35144011324795815,-1.685712401997229,0.0,0.15867290357280187,0.999,214/807,17.49%,BMP6;FOXP2;PRDM6;FOXP1;FHL2;NR2F2;AEBP1;SMAD3;GLI3;TCF7L2;RBFOX2;FOXD1;NFKB1;PRDM5;KANK2;ZNF148;WNT4;HDAC8;RBPJ;THRB;PHF21A;MIDEAS;LIMS1;DDX5;ZNF423;SMURF2;GLIS3;GLI2;FOXP4;NR1D2;ZHX2;MDFIC;ATXN1;ZFHX3;WWOX;MDM4;RARB;FOXC1;ZEB1;PER3;BMP7;ZMYM5;DAB2;ZIC2;BMP4;EP300;FOXO3;HDAC4;DICER1;PRKN;BCOR;KAT6B;NCOR1;DKK3;CUX1;OSR1;WWC2;MXI1;BTRC;TBL1X;WWP2;BRD7;FOXN3;TBL1XR1;KCNIP3;FRK;NR6A1;RREB1;VGLL4;NIBAN2;NFIX;FLNA;YAP1;EZH1;RCOR1;TAF3;KHDRBS1;RARG;MEF2A;RCOR3;ZKSCAN3;HMGB1;DLG1;NR3C1;LCOR;SMARCC2;CBX5;SMAD2;ZBTB16;ATP8B1;SBNO2;LBH;SKI;SNX6;DCAF1;CREBBP;HOXA7;TFDP2;STAT3;JDP2;NSD1;FGFR2;NAB1;SHC1;L3MBTL3;DNMT3A;FOXC2;WWP1;SKIL;CHD8;REST;SCMH1;BCL7A;RUNX1;GTF2IRD1;AR;CTR9;FOXK1;IGF2;PTPRK;SP2;MBD2;ZEB2;IMPACT;CBFA2T2;ZBTB1;SP100;RUNX1T1;DACT1;UBE2I;MED1;BTAF1;MIER1;CHD3;PRMT2;JUN;NR1H3;HCFC1;PCGF2;PARP9;LIMD1;MPHOSPH8;SMAD4;GLIS2;ID2;ATF7IP;USP47;BCLAF1;MEF2C;WWC1;NIPBL;RTF1;PARP1;PBXIP1;TLE1;FNIP1;PCGF6;HES1;RB1;ARID5B;TPR;ZNF692;PIAS4;BHLHE41;TCF3;KDM1B;SOX13;PPM1A;PATZ1;SUFU;IRF1;KAT8;EHMT1;CGGBP1;TSHZ3;TCERG1;HINFP;USP2;VEGFA;MCPH1;STAT1;CBX7;ZNF318;CBFA2T3;SCML4;CNOT2;HDAC1;RXRA;PRDM2;SFPQ;PTCH1;MNT;L3MBTL2;JARID2;ATOH8;NOP53;TRPS1;KDM2A;PHC2;EPC1;SALL1;FOXK2;LOXL3;CITED2;PDCD4;CNOT1;HEYL;ZFP37;TBX2;RUNX2;TWIST2;NR4A2;HNRNPU;ZMYND15
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7154117345149801,-1.684717059187493,0.009140767824497258,0.15855208606393628,0.999,5/11,9.13%,MLLT3;DAB2;WNT5B;RSPO3;CSNK1E
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.35892652438263545,-1.6846308041908937,0.0,0.1569751799119803,0.999,143/572,16.19%,BMP6;FOXP2;PRDM6;FOXP1;FHL2;NR2F2;AEBP1;SMAD3;GLI3;TCF7L2;NFKB1;PRDM5;KANK2;ZNF148;HDAC8;RBPJ;THRB;PHF21A;DDX5;SMURF2;GLIS3;GLI2;FOXP4;NR1D2;ZHX2;ATXN1;ZFHX3;WWOX;MDM4;RARB;FOXC1;ZEB1;PER3;ZMYM5;DAB2;BMP4;EP300;FOXO3;HDAC4;DICER1;PRKN;BCOR;NCOR1;CUX1;OSR1;WWC2;MXI1;NFIB;TBL1X;WWP2;TBL1XR1;KCNIP3;FRK;NR6A1;RREB1;NFIX;YAP1;EZH1;TAF3;RARG;MEF2A;ZKSCAN3;HMGB1;DLG1;NR3C1;LCOR;CBX5;SMAD2;ZBTB16;SKI;DCAF1;CREBBP;HOXA7;STAT3;JDP2;NSD1;FGFR2;DNMT3A;FOXC2;SKIL;CHD8;REST;RUNX1;GTF2IRD1;AR;CTR9;IGF2;SP2;MBD2;ZEB2;IMPACT;ZBTB1;SP100;DACT1;UBE2I;MED1;MIER1;CHD3;BAG3;JUN;NR1H3;HCFC1;PCGF2;PARP9;SMAD4;GLIS2;ID2;MEF2C;WWC1;NIPBL;RTF1;NFATC4;PARP1;FNIP1;HES1;RB1;ARID5B;TPR;ZNF692;BHLHE41;TCF3;KDM1B;SOX13;PPM1A;SUFU;CGGBP1;TCERG1;USP2;VEGFA;MCPH1;STAT1;CBX7;CNOT2;HDAC1;RXRA;PRDM2;SFPQ;PTCH1;MNT;NOP53;TRPS1;EPC1;SALL1
prerank,ganglioside biosynthetic process (GO:0001574),0.6505463610293767,1.6839287666931395,0.008333333333333333,0.11878797942238503,1.0,6/15,11.67%,ST6GALNAC3;ST8SIA4;B4GALNT1;B4GALT6;ST8SIA6;ST8SIA3
prerank,negative regulation of cell development (GO:0010721),-0.584283476699823,-1.6831029287986898,0.0,0.15791306275334024,0.999,6/25,7.41%,FBN1;IGF1;APPL2;PCM1;GSK3B;REST
prerank,camera-type eye development (GO:0043010),-0.583845139467294,-1.6830154515742186,0.0,0.15641365954658548,0.999,9/25,10.15%,CACNA1C;FBN1;EFEMP1;LAMA1;SHROOM2;SKI;RAB3GAP1;NES;CYP1B1
prerank,RNA destabilization (GO:0050779),-0.6160358544372628,-1.6810226966422162,0.016885553470919325,0.15862699884185985,0.999,6/18,7.74%,ROCK2;CELF1;FTO;ROCK1;YTHDF3;PUM1
prerank,histone modification (GO:0016570),-0.4307960453215648,-1.6808014235670792,0.0,0.15724929379459596,0.999,37/109,20.12%,EYA2;EYA1;PRDM5;MIDEAS;UBE2N;EYA4;EP300;HDAC4;KAT6B;HLCS;TBL1X;TBL1XR1;RCOR1;HUWE1;RCOR3;BAZ2A;CREBBP;UFL1;NSD1;NSD3;TRRAP;ENY2;MIER1;PRMT2;PRKCD;KAT8;EHMT1;UBE2B;HDAC1;ATXN7;BAZ1B;TAF6L;MSL3;PRMT8;PARK7;CDK2;NTMT1
prerank,cellular response to drug (GO:0035690),0.5703058451572769,1.6801444536978223,0.004273504273504274,0.1217225979559331,1.0,5/25,3.85%,TFRC;PDE4B;ACER2;PPM1F;GAS6
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.5026306329417908,-1.6794433847616024,0.0055762081784386614,0.15781824660672594,0.999,21/45,26.91%,EGFR;EFEMP1;PLCE1;SLC30A10;GAREM1;SHC1;BRAF;PDPK1;PLCG1;KIF16B;REPS2;NCK2;GAB1;HBEGF;PTPN11;DGKD;AAMP;PIK3R1;SHC3;EGF;SOS1
prerank,positive regulation of proteolysis (GO:0045862),-0.47989589710202935,-1.679403457357141,0.003898635477582846,0.156308263002137,0.999,21/55,23.13%,CCBE1;CYFIP2;BTRC;CTSC;CTSH;SNX9;WDR48;ASPH;NRDC;ADAM9;RCN3;OGT;APOE;ADRA2A;ATP5IF1;FBXW11;TANK;FGFR4;TBC1D10A;PERP;HDAC2
prerank,rRNA processing (GO:0006364),0.4042244609551001,1.6756659640008986,0.0,0.12559770953202384,1.0,56/172,16.46%,TSR3;EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPL10;RPL15;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;TFB1M;FBL;RPL12;RPL13;RPS15;NOL6;RPL14;RPL5;ERI1;NHP2;RPL21;NOP2;RPS7;RPL23A;DKC1;POP5;RPL8;RPS14;DDX10;RPS2;PIH1D2;WDR75;RPL18A;RPS28;RRP1;RRP1B;NOP56;RPS25;MDN1;UTP15;EXOSC4
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.5983011491552122,1.6739020165388983,0.008602150537634409,0.12652716099374087,1.0,7/20,4.59%,SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,potassium ion transmembrane transport (GO:0071805),0.4175269332571699,1.6733543568951739,0.0,0.12597563183272198,1.0,35/135,11.77%,KCND2;HCN1;SLC24A4;SLC24A2;KCNH7;KCNJ3;KCNQ3;KCNC2;KCNJ6;KCNN2;KCNH5;KCNH8;KCNJ11;SLC12A6;KCNN1;KCNK13;KCNK10;HCN2;KCNJ10;KCND3;KCNH1;KCNC3;ATP1A3;KCNQ5;KCNK9;KCNAB1;KCNN3;KCNC1;LRRC55;KCNK1;SLC12A3;KCNQ2;ATP1A4;ATP1A1;KCNA2
prerank,maturation of 5.8S rRNA (GO:0000460),-0.6356576061513647,-1.6727988911158451,0.0058823529411764705,0.16565730974778695,0.999,9/17,16.75%,NSA2;LAS1L;MPHOSPH6;URB1;PRKDC;EXOSC10;MAK16;MTREX;WDR12
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.3361128085163281,-1.6723530161224662,0.0,0.16472405800367199,0.999,431/1668,18.73%,ZBTB20;NFIA;BMP6;PBX1;FOXP2;PRDM6;IGF1;AUTS2;FOXP1;FHL2;HLF;EGFR;NR2F2;AEBP1;ZIC4;PKNOX2;NFAT5;ZIC1;PID1;RHOQ;SMAD3;GLI3;TCF4;TCF7L2;ZBTB7C;MAF;SOX5;TEAD1;BMPR1A;FOXD1;PRRX1;NFKB1;CREB3L2;TRAK1;PRDM5;HOXB6;CDK8;KANK2;ZNF148;ZKSCAN2;HIVEP2;PKD1;HDAC8;LRP6;RBPJ;ZMIZ1;THRB;CCNL2;INO80;PHF21A;MIDEAS;SMAD6;DDX5;DCN;SMURF2;GLIS3;HOXC6;GLI2;ZNF462;FOXP4;NR1D2;ZHX2;ATXN1;ZFHX3;WWOX;MDM4;BMP5;RARB;BRWD1;FOXC1;ZEB1;PER3;FGF1;KAT2B;KLF9;ZMYM5;PIAS1;DAB2;ZIC2;BMP4;EP300;PPP1R12A;FOXO3;CREB5;HDAC4;GTF2H2;DICER1;ARID1B;PRKN;BCOR;NR3C2;KAT6B;ABL1;NCOR1;PPM1D;CUX1;OSR1;WWC2;TNRC6B;ARNT;TFEB;CCNT2;JAG1;CCNL1;MXI1;MEOX2;HOXB3;NFIB;KDM7A;TBL1X;ELF1;WWP2;BRD7;RBBP8;TBL1XR1;KCNIP3;FRK;CCNH;KIT;SSBP3;NR6A1;RREB1;KMT2C;BCLAF3;NFIX;CCNT1;TNRC6A;TBK1;YAP1;MED15;SLC9A1;EZH1;GMEB1;RCOR1;TAF3;RARG;MEF2A;ANXA4;DDX17;BAZ1A;PPARGC1B;KMT2D;RCOR3;ZKSCAN3;HMGB1;DLG1;NR3C1;CDK7;SS18;KLF3;BCL9L;LCOR;ZNF182;SMARCC2;MOV10;HOXA5;BCAS3;CBX5;SMAD2;PRRX2;ZBTB16;FUS;SBNO2;TBX15;PLSCR1;GABPB2;MED17;SKI;PBX3;DCAF1;ZIC5;TEF;CREBBP;HOXA7;TFDP2;STAT3;PHF8;JDP2;NSD1;HOXC8;MED26;FGFR2;FHOD1;MED12;DNMT3A;ENY2;FOXC2;ELF4;HOXC4;SKIL;HIVEP3;CHD8;DHX9;HOXA3;CAMK2D;KDM5B;AKAP8L;REST;VEZF1;HDGFL2;MYSM1;CEBPG;HOXB5;ZBTB37;RUNX1;GTF2IRD1;AR;CRTC3;ZBTB8A;CTR9;ZFX;PRPF6;DHX36;RGMA;PPARGC1A;FOXK1;ZNF496;SAFB2;IGF2;NCOA6;CDC5L;SP2;MBD2;NFYC;ZEB2;SETD3;SSU72;IMPACT;MAFG;ZBTB1;PIAS3;SP100;NCOA1;SP140;DACT1;UBE2I;MED1;CCNK;CDK13;JUP;CHD4;HNRNPK;CHD2;HOXB4;ATF2;MIER1;PHF2;CHD3;WASL;TEAD3;ZNF467;RFX2;UBP1;MNAT1;ZNF569;JUN;NR1H3;GABPA;TADA3;SSBP2;HCFC1;PCGF2;THAP3;HIF1A;CREBRF;PARP9;SENP1;SMAD4;GLIS2;MAVS;CALCOCO1;ID2;MED21;ZBTB24;MAML2;CRTC1;BCLAF1;RAD21;MEF2C;ZBED4;DCAF6;WWC1;NIPBL;ZXDC;RTF1;NFATC4;PARP1;VGLL3;FNIP1;NRF1;TEAD2;PCGF6;FBXL19;HES1;RB1;TBX18;TFCP2;IRF9;ARID5B;TPR;ZNF692;PIAS4;EPC2;BHLHE41;TCF3;TCF7L1;ZBTB34;KDM1B;MLLT10;PKD2;SOX13;PPM1A;PATZ1;SUFU;HTATSF1;MAML1;IRF1;CCN1;ATF6;KAT8;SOX6;YBX1;CGGBP1;OGT;SIX5;GLI1;TSHZ3;TCERG1;ZFP3;CRLF3;KDM3B;HINFP;USP2;VEGFA;MKX;MED8;ZSCAN18;PRKDC;MCPH1;CC2D1B;STAT1;CBX7;RORA;APOE;CIAO1;KDM3A;CNOT2;ZNF367;ZNF18;ACVR1;DDX3X;HDAC1;ZNF697;ZBED3;HOXB9;CARF;NCK1;HOXC5;RXRA;EFCAB7;ZKSCAN1;KLF15;PRDM2;SFPQ;PTCH1;MNT;BBX;NCK2;TNRC6C;ABHD14B;ATOH8;IKZF2;PRDM15;NOP53;TGFB3;TRPS1;KDM2A;ZNF112;FOXL1;EPC1;SALL1;PTOV1;FOXK2;TNIP2;KLF6;IL18;ARRB1;BRD3;CITED2;MYBL1;MED13L;NR4A1;SIX1;CNOT1;CAMTA2;NFYB;HEYL;ZFP37;SERPINE1;TLR4;TBX2;SMARCD2;RUNX2;TWIST2;PRKD1;STAT5A;NR4A2;CRTC2;HNRNPU;PHIP;BCL2L12;BAZ1B;MED27;TAF6L;NFIC;LPIN2;CC2D1A;STAT5B;POU6F2;SOD2;ZFHX4;ZKSCAN7;TFCP2L1;TRAF6;ZNF436;LPIN3;NFATC3;BAZ2B;HSBP1;WNT5A;BMP2
prerank,response to histamine (GO:0034776),0.6998944075815251,1.668975579137237,0.017278617710583154,0.13023491482096425,1.0,4/10,8.68%,GABRB3;GABRB1;GABRB2;GABRG2
prerank,nuclear migration (GO:0007097),-0.671783312180789,-1.668629427498896,0.014842300556586271,0.16926901994100046,0.999,8/13,18.52%,SYNE2;PCM1;SYNE3;CLMN;DOCK7;DYNC1H1;TMEM201;FBXW11
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.6128410328235002,-1.6679305269653175,0.005813953488372093,0.16891959174777457,0.999,6/21,8.78%,ROCK2;ERRFI1;BMP4;ROCK1;RUNX1;MAFG
prerank,long-term synaptic potentiation (GO:0060291),0.5895924958166271,1.6659090222742523,0.017130620985010708,0.13268584798400707,1.0,7/21,9.00%,MPP2;SLC24A2;GRIN2A;GRIN2B;GRIN2D;NPTN;SHANK2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.49777632604005273,-1.6658147973733533,0.008456659619450317,0.17086530908365494,0.999,8/45,2.60%,BMP6;TGFBR1;BMPR1A;RBPMS;BMP5;BMP7;DAB2;BMP4
prerank,positive regulation of wound healing (GO:0090303),-0.519489960721458,-1.6656765339491053,0.003883495145631068,0.1694873498604817,0.999,11/36,7.19%,ST3GAL4;MYLK;PLPP3;VTN;RREB1;ITGB1;THBS1;ARFGEF1;FOXC2;MTOR;ANXA1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.5948726221128536,1.6654340402248455,0.011904761904761904,0.1320639526146115,1.0,11/20,17.06%,TMEM35A;CLU;BBS10;PFDN6;HSP90AB1;CCT2;HSPD1;HOPX;NDUFAF1;PTGES3;HSP90AA1
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.4004291200128515,-1.6635233079266087,0.0,0.1713909993399048,0.999,82/166,30.67%,NOTCH2;TEAD1;RBPJ;THRB;NR1D2;RARB;CCN2;KAT2B;GTF2H2;NR3C2;NCOR1;TBL1X;TBL1XR1;CCNH;NR6A1;YAP1;TAF3;RARG;NR3C1;CDK7;MED17;CREBBP;MED26;AR;PPARGC1A;CAVIN1;NCOA6;TAF4;TBP;TAF1D;MED1;TEAD3;MNAT1;NR1H3;BRF1;NOTCH3;MAML2;ERCC3;TEAD2;MAML1;RORA;HDAC1;TAF8;TAF13;RXRA;GTF2B;NR4A1;NR4A2;MED27;POLR2H;TAF12;TAF9B;TAF2;GTF2F1;POLR2K;GTF3C1;TBPL1;GTF2H1;NR2F1;POLR2E;POLR3H;PPARA;NR2C1;GTF2E2;TAF1C;TAF7;ESR1;GTF2H4;HDAC3;THRA;POLR1G;POLR2D;BRF2;RRN3;TAF1A;CDK9;POLR1C;POLRMT;GTF2A1;SNW1;HDAC10;NR5A2
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.5049094677918838,-1.6632626329756803,0.005802707930367505,0.17021182451375347,0.999,20/43,18.73%,BMP6;IGF1;BMPR1A;WNT4;BMP7;IL6ST;BMP4;YAP1;MEF2C;IL6R;CCN1;ATRAID;ACVR1;SUCO;RUNX2;PRKD1;FBN2;CCN4;NPNT;BMP2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.43253162968005215,-1.6625753896757127,0.0019646365422396855,0.1699579906495924,0.999,40/95,19.60%,GPC6;UST;DSE;ST3GAL4;ANGPT1;DCN;B4GALT1;SDC2;CEMIP;BGN;FMOD;HS3ST3A1;GPC4;GPC3;EXT1;HSPG2;OGN;GLCE;HS2ST1;SLC10A7;NDST1;ABCC5;PRELP;CHST15;ST3GAL3;NDST2;LUM;HEXA;PXYLP1;CHST11;SDC4;HS6ST1;CHPF2;XYLT2;CHSY1;OMD;GCNT2;CHST12;B4GALT5;B4GALT7
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.38195965026360046,-1.6608782931773005,0.0,0.17100796828561,0.999,65/248,15.12%,RNF220;BICC1;WLS;MLLT3;LRRK1;EGFR;GLI3;TCF7L2;IGFBP2;RBMS3;NFKB1;COL1A1;LRP6;SMURF2;LGR4;PTK7;TNKS2;DAB2;TMEM64;STK3;PRKN;DKK3;LRRK2;CSNK1A1;BTRC;TBL1X;TBL1XR1;GSK3B;GPC3;RNF146;IGFBP6;AXIN1;UBR5;LYPD6;ADGRA2;FGFR2;CHD8;IGFBP4;ZEB2;XIAP;DACT1;CSNK1E;JUP;WNK1;LIMD1;TLE4;LZTS2;USP47;TLE1;PSMF1;CUL3;FZD7;SOX13;PPM1A;TRPM4;GLI1;PSMB2;UBAC2;UBE2B;APOE;LATS1;DDX3X;HDAC1;EMD;ZBED3
prerank,metal ion transport (GO:0030001),0.4415462168646564,1.6598910785997383,0.00211864406779661,0.13736049153829938,1.0,31/86,18.99%,CAMK2A;CACNA1A;TRPC5;CACNA1B;RAMP2;RYR2;SLC39A2;CACNA2D1;RYR3;SLC8A1;SLC30A1;CACNA1E;TRPM2;TPT1;CACNG3;NIPA1;GRIN3A;CACNG8;SLC39A8;SLC30A5;TRPC1;NIPAL3;PSEN1;ATP2B2;SLC3A2;NIPAL4;CALCRL;MMGT1;FYN;MAGT1;ATP2C1
prerank,retinoid metabolic process (GO:0001523),-0.4519921519449594,-1.659481686006693,0.0,0.17206049144448557,1.0,16/71,11.11%,GPC6;ALDH1A1;ALDH1A2;LRP1;RBP1;SDC2;CYP26B1;GPC4;RBP4;GPC3;HSPG2;ABCA4;DHRS3;AKR1B1;CYP1B1;NAPEPLD
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.47819352836127743,-1.6590310344191055,0.0037593984962406013,0.17143236449287264,1.0,24/55,22.98%,GPC6;DCN;SDC2;CEMIP;BGN;FMOD;GPC4;GPC3;GNS;SLC9A1;HSPG2;OGN;PRELP;CEMIP2;GUSB;LUM;HEXA;SDC4;GALNS;OMD;FGF2;GPC1;CHP1;CSPG4
prerank,histone lysine demethylation (GO:0070076),-0.5669769491442487,-1.6548182583008013,0.016605166051660517,0.1769884825712076,1.0,10/25,16.10%,KDM7A;KDM4B;PHF8;KDM5B;KDM6A;PHF2;KDM1B;KDM3B;KDM3A;KDM2A
prerank,axon guidance (GO:0007411),0.3879636024053493,1.6544771072240267,0.0,0.14273985280152934,1.0,61/201,12.35%,DSCAM;BSG;NRXN3;NRXN1;DCC;EPHA6;SEMA3C;TMEFF1;SPTBN4;EPHB1;PLXNB3;DAB1;SEMA6A;CXCL12;UNC5C;SPTB;EPHA5;SEMA4A;SEMA4F;SHANK3;CNTN6;ROBO4;SEMA6D;SEMA4D;DOK6;SEMA7A;EFNB3;TNR;RPS6KA5;NOTCH1;DSCAML1;UNC5D;NCAM1;NPTN;SLIT3;SLIT1;ENAH;RAP1GAP;PRKCQ;LHX1;VSTM2L;UNC5B;ROBO2;EFNA2;SPTBN5;EPHA10;PLXNA4;RELN;TUBB3;ROBO3;FEZ1;NTN1;PTPRM;CHN1;CNTN4;SPTBN1;DOK5;DOK2;CNTN2;RET;EPHA1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.36140848198000575,-1.653610835278718,0.0,0.17780217560034625,1.0,177/476,24.26%,IGF1;MLLT3;EGFR;NR2F2;ZIC1;SMAD3;GLI3;TCF4;TGFBR1;TEAD1;NFKB1;CREB3L2;COL1A1;WNT4;LRP6;ZMIZ1;ZNF423;GLI2;NR1D2;MDFIC;ZFHX3;FOXC1;BMP7;TRIM44;IL31RA;ZIC2;BMP4;EP300;FOXO3;CREB5;HDAC4;ARID1B;KAT6B;TFEB;BTRC;NFIB;TBL1X;ELF1;BRD7;TBL1XR1;RREB1;NIBAN2;CREBL2;YAP1;RGMB;ZKSCAN3;TGFB1I1;SMARCC2;SMAD2;ZBTB16;AXIN1;LBH;MED17;CDH1;FZD2;CREBBP;TRIP4;STAT3;PHF8;NSD1;NSD3;MED12;SHC1;ENY2;FOXC2;ELF4;HIVEP3;CHD8;REST;MAP3K5;HNRNPD;RUNX1;AR;PPARGC1A;FOXK1;ZNF496;NCOA6;SETD3;SP100;NCOA1;MAP2K1;MED1;PRMT2;JUN;NR1H3;TADA3;HCFC1;HIF1A;PARP9;SMAD4;GLIS2;CALCOCO1;ID2;ATF7IP;MEF2C;ZXDC;TEAD2;HES1;TCF3;FZD7;PPM1A;IRF1;KAT8;DTX3L;GLI1;BICRA;MMS19;ING5;CRLF3;BRCA2;PITHD1;NAA15;HINFP;STAT1;RORA;ZNF318;APOE;KDM3A;ILF2;ACVR1;HDAC1;RXRA;MAP2K7;ATOH8;TGFB3;ARHGEF11;AFAP1L2;EPC1;SALL1;FOXK2;KLF6;CITED2;MYBL1;SIX1;RNF20;RUNX2;PICALM;PHIP;INPP5K;FBXW11;NEK4;WNT5A;BMP2;FZD1;RNF14;INHBA;KARS1;ING1;PML;MED16;CDKN1C;SPP1;NOS1;NFYA;ZIC3;XRCC6;DVL3;KMT2A;NIF3L1;WAC;SPIN1;MAP3K12;FGF2;GATA6;MYRF;CAND2;CD80;HDAC2;TFAP4;RNF6;MAFB;SMARCD3;MED13;DYRK1B;MED14;CXXC1;GTF2H1
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.5219557752684405,-1.6528371621516338,0.003968253968253968,0.17777695708456107,1.0,9/38,11.75%,BMP6;SASH1;ANKRD17;PUM2;PLSCR1;DHX9;PUM1;DDX60;RIOK3
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.6797347684204789,-1.652787094765692,0.007518796992481203,0.1732694274752648,1.0,9/12,24.71%,NSMCE2;ANAPC5;ANAPC7;ANAPC4;RB1;CUL3;CDC27;ANAPC11;CDC16
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.6797347684204789,-1.652787094765692,0.007518796992481203,0.1732694274752648,1.0,9/12,24.71%,NSMCE2;ANAPC5;ANAPC7;ANAPC4;RB1;CUL3;CDC27;ANAPC11;CDC16
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.6797347684204789,-1.652787094765692,0.007518796992481203,0.1732694274752648,1.0,9/12,24.71%,NSMCE2;ANAPC5;ANAPC7;ANAPC4;RB1;CUL3;CDC27;ANAPC11;CDC16
prerank,cytosolic transport (GO:0016482),-0.4258098176123484,-1.6521838934112874,0.0,0.17304144683025377,1.0,51/108,26.37%,DENND2A;VTI1A;VPS13A;ERC1;GBF1;EEA1;TMEM87A;SNX6;VTI1B;STX16;CORO7;MON2;CCDC91;KIF16B;GOSR1;WDR91;VPS54;STX5;BECN1;VPS13C;DOP1B;PIK3C3;DENND5A;TMEM87B;ANKRD27;EHD3;HEATR5A;GOSR2;LAMP1;TBC1D17;ANKFY1;HEATR5B;SNF8;CLN5;TBC1D10A;WDR81;STX8;VPS26B;BET1L;RGP1;TBC1D23;SPAG9;AP2A1;PTPN23;RAB9A;BAIAP3;MYO1D;PHETA1;RAB7A;RAB5A;TBC1D10B
prerank,diterpenoid metabolic process (GO:0016101),-0.46499395403667093,-1.6510707446661215,0.003683241252302026,0.17346728762934546,1.0,12/55,7.89%,GPC6;ALDH1A1;LRP1;RBP1;SDC2;GPC4;RBP4;GPC3;HSPG2;ABCA4;DHRS3;AKR1B1
prerank,mRNA metabolic process (GO:0016071),-0.43450921562874156,-1.6508785876852419,0.0,0.17226963968935152,1.0,50/90,33.41%,SON;DDX5;CELF1;DIS3L2;HNRNPR;PCF11;U2AF2;AKAP8L;CPSF3;PCBP2;PPARGC1A;PRPF3;SLBP;SF3A1;USP39;SCAF11;SF3A3;TCERG1;ERN1;SRSF1;SFPQ;PRKACA;CSTF3;SNRPF;RNASE4;CNOT10;SRSF7;GEMIN2;SRSF11;SRSF2;HSF1;NUDT21;NONO;DHX15;PRMT9;KIN;PCBP3;LSM11;NCBP2;PRPF8;LSM6;ZFP36L2;PRPF18;SF3A2;TBRG4;SF3B4;NUDT16;NUDT16L1;HSPA1A;HNRNPA2B1
prerank,embryonic organ morphogenesis (GO:0048562),-0.507316414502017,-1.6492413112588376,0.001953125,0.17382579442035276,1.0,21/42,20.30%,FBN1;EFEMP1;PDGFRA;HOXB3;RBP4;RARG;MFAP5;FGFR2;DYNC2I1;HOXC4;HOXA3;HOXB4;ID2;NIPBL;HES1;ACVR1;HOXB9;SIX1;FBN2;MEGF8;RBPMS2
prerank,contractile actin filament bundle assembly (GO:0030038),-0.6519025980655501,-1.6492015575565055,0.009689922480620155,0.17106708125703338,1.0,9/15,16.42%,PHACTR1;SORBS1;ITGB1;ITGB5;TNFAIP1;RHOA;ZYX;CUL3;ARRB1
prerank,stress fiber assembly (GO:0043149),-0.6519025980655501,-1.6492015575565055,0.009689922480620155,0.17106708125703338,1.0,9/15,16.42%,PHACTR1;SORBS1;ITGB1;ITGB5;TNFAIP1;RHOA;ZYX;CUL3;ARRB1
prerank,nervous system development (GO:0007399),0.3629185721603096,1.6486165746124606,0.0,0.14841181463666964,1.0,103/429,14.62%,SPOCK2;PAX8;DNM3;DSCAM;KIRREL3;ADGRL3;ST8SIA4;NELL1;NAV3;SPOCK1;RBFOX3;TRPC5;NRXN1;LSAMP;MYT1L;LY6H;ERBB4;SLC2A1;MAL;MBP;LRCH4;PROX1;ASIC2;EPHB1;FGF12;NLGN1;CHRM3;GPM6A;SH3GL2;SEMA6A;PCDH1;GPM6B;NRG1;TENM1;SH3GL3;ADGRB1;DOC2A;DNER;MOBP;AHI1;CDH2;SEMA4F;MPZ;SHANK3;GRIK1;CNTN6;FGF13;ADAM22;APBA2;ADAM23;MOG;EFNB3;RBFOX1;NAB2;PCDHB6;NPAS2;GJB1;DSCAML1;NRXN2;CYP26C1;NRCAM;ARHGAP26;NFASC;LHX1;FGF5;SRRM4;NINJ1;MTF1;ROBO2;IL1RAPL2;ACVR1C;SHANK2;RELN;DCHS1;FEZ1;DPF3;SMPD1;KCNQ2;HAP1;CNTN4;PCDHA4;APC;NRGN;DVL1;MBD5;NPTX1;SCN2A;KALRN;DPYSL2;SH3GL1;VCAN;DCTN1;SERF1A;DPYSL5;PTPRZ1;HPCAL4;HAPLN3;DCX;STMN3;NHEJ1;PPT1;LGI1;HAPLN4
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.5928507391009943,-1.646582994868695,0.013232514177693762,0.17430348423182046,1.0,9/20,19.85%,IGF1;FOXC1;EP300;NIBAN2;RB1;GTF2B;TRAF6;PARK7;H1-0
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.5964934594673454,-1.6465471985172524,0.0136986301369863,0.17298521516713092,1.0,10/19,30.74%,IRS1;ABHD5;ABCD2;PRKCD;AKT2;DAGLB;TWIST1;PNPLA2;PPARA;ANGPTL3
prerank,ethanol metabolic process (GO:0006067),-0.6932470240727282,-1.6456431778573588,0.01717557251908397,0.17334062294323418,1.0,3/12,10.33%,ALDH1A1;ALDH2;SULT1A1
prerank,embryonic digit morphogenesis (GO:0042733),-0.618772301911237,-1.6448795368843978,0.009345794392523364,0.17346555537296676,1.0,9/18,17.12%,GLI3;OSR1;WDPCP;CREBBP;ECE1;MAP3K20;HDAC1;SALL1;TBX2
prerank,endoderm formation (GO:0001706),-0.5235891163395405,-1.6446580271870386,0.005649717514124294,0.17258448893296982,1.0,14/35,15.66%,COL8A1;COL12A1;ITGAV;VTN;COL6A1;ITGB5;LAMA3;SETD2;MMP14;FN1;MMP2;DUSP1;ITGA5;ITGA4
prerank,protein autoubiquitination (GO:0051865),-0.4591776062064871,-1.6434664066175964,0.002,0.1734882175346392,1.0,25/61,20.68%,RNF220;PRKN;WWP2;RNF115;RNF146;UHRF2;RNF213;SH3RF1;RNF8;RNFT1;DDB2;TRAF2;CUL3;DTX3L;SH3RF2;UBE2B;ERCC8;RNF181;SH3RF3;BFAR;TRAF6;LRSAM1;UBE2D3;NFX1;RNF11
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.5343844356785307,-1.6432448413256049,0.010771992818671455,0.17253814831140757,1.0,9/32,10.53%,ZBTB20;IGF1;PID1;PRKAA2;ARNT;NUPR1;PFKFB4;PPARGC1A;HIF1A
prerank,GTP metabolic process (GO:0046039),-0.6272637731349371,-1.642961984262807,0.014787430683918669,0.17157533247952594,1.0,3/15,3.21%,RHOQ;OPA1;LRRK2
prerank,adherens junction organization (GO:0034332),0.4866295901350228,1.639392621431487,0.010101010101010102,0.15954457993809867,1.0,19/48,14.01%,CDH12;CDH8;ACTB;CADM1;CADM2;CDH19;CDH20;CDH7;RAMP2;CDH18;CDH2;CDH10;DCHS1;CADM3;SMAD7;NECTIN1;TJP1;CTNND1;JAM3
prerank,negative regulation of metabolic process (GO:0009892),-0.483815943520432,-1.637610703517138,0.007736943907156673,0.1797142354053138,1.0,21/54,20.31%,ALDH1A1;RBPJ;ZNF423;LGR4;NPR3;DOCK7;ADAMTS5;FOXC2;LAMA4;NRDC;NR1H3;RB1;ACOT11;LNPEP;CCDC3;TLR4;PLCL1;ABHD6;MAP2K6;TLE3;FIS1
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.41285494671451095,-1.6344832767810111,0.0,0.18401764897748651,1.0,43/132,18.42%,ZBTB20;IGF1;RNF152;DCN;FOXO3;ROCK1;PRKAA2;ARNT;TFEB;LRRK2;GSK3B;VGLL4;IRS1;HMGB1;TPCN1;MOV10;SNX9;RC3H1;UFL1;PFKFB4;TRIM8;ZC3HAV1;ZSWIM8;ABHD5;ABCD2;DACT1;UPF1;NRDC;PRKCD;HIF1A;ADAM9;CNOT8;TRIM5;ATF6;DTX3L;APOE;DAPK1;ADRA2A;CNOT1;PRXL2C;PRKD1;PRKAA1;PTPN1
prerank,retrograde axonal transport (GO:0008090),0.6281246725984215,1.633504532446935,0.008403361344537815,0.1664761639891199,1.0,6/16,11.55%,DLG2;TMEM108;KIF1A;DST;HAP1;ACTR10
prerank,regulation of biosynthetic process (GO:0009889),0.6804427606611654,1.6333774529901555,0.017964071856287425,0.1652074826660668,1.0,3/11,10.48%,THRSP;SNCA;MID1IP1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.32887734763214477,-1.6333732054497214,0.0,0.1847579319820001,1.0,424/1646,18.73%,ZBTB20;NFIA;PBX1;FOXP2;IGF1;BNC2;MLLT3;FOXP1;DENND4A;HLF;EGFR;NR2F2;ZIC4;PKNOX2;NFAT5;ZIC1;SMAD3;GLI3;TCF4;TCF7L2;TGFBR1;ZBTB7C;MAF;RBFOX2;EFEMP1;SOX5;TEAD1;FOXD1;PRRX1;NFKB1;CREB3L2;TRAK1;PRDM5;HOXB6;COL1A1;ZNF148;ZKSCAN2;HIVEP2;WNT4;LRP6;RBPJ;ZMIZ1;CCNL2;MIDEAS;SMAD6;LIMS1;DDX5;ZNF423;SMURF2;GLIS3;HOXC6;GLI2;FOXP4;NR1D2;ZHX2;MDFIC;ATXN1;ZFHX3;MDM4;BRWD1;FOXC1;ZEB1;KLF9;BMP7;TRIM44;PIAS1;IL31RA;ZIC2;BMP4;EP300;FOXO3;CREB5;HDAC4;ERC1;GTF2H2;ARID1B;BCOR;NR3C2;KAT6B;ABL1;NCOR1;DKK3;CUX1;OSR1;WWC2;ARNT;TFEB;CCNT2;CCNL1;MXI1;MEOX2;HOXB3;BTRC;NFIB;KDM7A;TBL1X;ELF1;WWP2;BRD7;FOXN3;RBBP8;TBL1XR1;SETD5;CCNH;KIT;NR6A1;RREB1;VGLL4;NIBAN2;NFIX;CCNT1;GON4L;WTIP;CREBL2;YAP1;RGMB;GMEB1;RCOR1;KHDRBS1;MEF2A;ANXA4;DDX17;BAZ1A;PPARGC1B;CDK16;KMT2D;RCOR3;ZKSCAN3;HMGB1;TGFB1I1;BAZ2A;NR3C1;KLF3;SRSF10;LCOR;ZNF182;SMARCC2;HOXA5;CBX5;SMAD2;PRRX2;ZBTB16;AXIN1;FUS;ATP8B1;SBNO2;TBX15;LBH;MED17;SNX6;CDH1;PBX3;FZD2;ZIC5;TEF;CREBBP;HOXA7;TFDP2;TRIP4;STAT3;PHF8;JDP2;NSD1;HOXC8;NSD3;TRRAP;MED26;MED12;NAB1;SHC1;L3MBTL3;ENY2;FOXC2;ELF4;HOXC4;WWP1;HIVEP3;CHD8;DHX9;HOXA3;CAMK2D;KDM5B;REST;VEZF1;POFUT1;MAP3K5;HDGFL2;CEBPG;SCMH1;HOXB5;ZBTB37;HNRNPD;BCL7A;RUNX1;GTF2IRD1;AR;ZBTB8A;CTR9;ZFX;DHX36;PPARGC1A;FOXK1;ZNF496;SAFB2;IGF2;PTPRK;NCOA6;CDC5L;SP2;MBD2;NFYC;ZEB2;SETD3;CBFA2T2;MAFG;ZBTB1;PIAS3;SP100;NCOA1;SP140;RUNX1T1;MAP2K1;UBE2I;MED1;CCNK;CHD4;HNRNPK;CHD2;BTAF1;HOXB4;ATF2;PHF2;CHD3;ZFAT;TEAD3;ZNF467;RFX2;UBP1;PRMT2;MNAT1;ZNF569;JUN;NR1H3;GABPA;TADA3;SSBP2;HCFC1;HIF1A;CREBRF;PARP9;LIMD1;MPHOSPH8;SMAD4;GLIS2;TULP3;CALCOCO1;ID2;MED21;ATF7IP;GPBP1L1;ZBTB24;CDK11B;USP47;BCLAF1;RAD21;MEF2C;WWC1;NIPBL;ZXDC;NFATC4;PBXIP1;TLE1;VGLL3;NRF1;TEAD2;PCGF6;FBXL19;HES1;RB1;SPTY2D1;TBX18;TFCP2;IRF9;ARID5B;ZNF692;PIAS4;EPC2;BHLHE41;TCF3;TCF7L1;CRABP2;ZBTB34;FZD7;SOX13;PPM1A;PATZ1;SUFU;HTATSF1;IRF1;ATF6;KAT8;EHMT1;SOX6;YBX1;OGT;DTX3L;SIX5;GLI1;TSHZ3;BICRA;CCAR1;MMS19;ZFP3;ING5;PHF1;CRLF3;KDM3B;BRCA2;PITHD1;NAA15;HINFP;VEGFA;MKX;MED8;ZSCAN18;CC2D1B;STAT1;RORA;ZNF318;CBFA2T3;USP13;APOE;CIAO1;CHD7;KDM3A;TAF5L;SCML4;ILF2;CNOT2;ZNF367;ZNF18;ACVR1;HDAC1;ZNF697;HOXB9;CARF;HOXC5;RXRA;ZKSCAN1;KLF15;PRDM2;SFPQ;VSX1;MNT;BBX;L3MBTL2;JARID2;MAP2K7;ATOH8;IKZF2;PRDM15;TGFB3;TRPS1;KDM2A;PHC2;ARHGEF11;AFAP1L2;ZNF112;FOXL1;EPC1;SALL1;FOXK2;KLF6;LOXL3;ARRB1;PRMT5;BRD3;CITED2;MYBL1;PDCD4;GLRX2;MED13L;NR4A1;ATXN1L;SIX1;CAMTA2;NFYB;HEYL;RNF20;ZFP37;TBX2;SMARCD2;RUNX2;TWIST2;PICALM;STAT5A;NR4A2;ZMYND15;PHIP;DAP;BAZ1B;MED27;TAF6L;NFIC;CC2D1A;MSL3;STAT5B;POU6F2;SOD2;ZFHX4;HMG20A;INPP5K;ZKSCAN7;RHOH;TFCP2L1;TRAF6;ZNF436;NFATC3;FBXW11;RRP8;BAZ2B;NEK4;WNT5A;BMP2
prerank,regulation of protein sumoylation (GO:0033233),-0.6119964363374546,-1.6329173094110496,0.021739130434782608,0.1840857141900078,1.0,12/17,29.41%,ZMIZ1;PIAS1;HDAC4;SAE1;PIAS3;PIAS4;PARK7;GNL3L;GNL3;MUL1;EGR1;UBA2
prerank,negative regulation of axon extension (GO:0030517),0.5321331915168375,1.6326883858037708,0.008733624454148471,0.16482035827948208,1.0,9/30,4.59%,SEMA3C;MAG;SEMA6A;SEMA4A;SEMA4F;MAP2;SEMA6D;SEMA4D;SEMA7A
prerank,neural crest cell development (GO:0014032),0.493164534771724,1.632128151477057,0.00641025641025641,0.16409485850314184,1.0,11/44,6.08%,ERBB4;SEMA3C;SEMA6A;NRG1;SEMA4A;CDH2;SEMA4F;SEMA6D;SEMA4D;SEMA7A;CYP26C1
prerank,neutral amino acid transport (GO:0015804),0.5417019054314441,1.6297260918986207,0.015053763440860216,0.16639320602264193,1.0,7/28,9.70%,SLC7A5;SLC6A6;SLC6A17;SLC1A1;SLC7A8;SLC43A2;SLC36A1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.7072970925601781,-1.6268534242043813,0.020036429872495445,0.19391446791297395,1.0,6/10,19.34%,GRB10;ARNT;VTN;HIF1A;ITGA5;ITGB3
prerank,skeletal system morphogenesis (GO:0048705),-0.49592791564805877,-1.6265407551269715,0.011342155009451797,0.19311573952614502,1.0,13/42,9.37%,TGFBR1;PDGFRA;LRP6;ANKRD11;WWOX;HOXB3;CYP26B1;SKI;FGFR2;DYNC2I1;HOXC4;HOXA3;HOXB4
prerank,regulation of ossification (GO:0030278),-0.5138520563527508,-1.6260333005936147,0.009487666034155597,0.19273387043101323,1.0,16/36,19.29%,PTN;LRP6;RBPJ;SMAD6;BMP4;ENPP1;ZBTB16;NBR1;MEF2C;BMP2K;ACVR1;ECM1;CHSY1;WNT5A;BMP2;PTPN11
prerank,integrin-mediated signaling pathway (GO:0007229),-0.4496608058567788,-1.6252336473709688,0.003816793893129771,0.19283691281940388,1.0,26/73,17.27%,ITGBL1;COL3A1;PTN;PLPP3;FBLN1;ITGAV;DAB2;ABL1;ITGA10;ITGB1;FYB1;ITGA11;NRP1;ITGB5;CDC42;LAMA3;ITGB8;ADAM9;FN1;ZYX;CUL3;TEC;ITGA5;DOCK1;ADAMTS1;PRKD1
prerank,protein export from nucleus (GO:0006611),-0.5538492251294928,-1.6249739334996043,0.013232514177693762,0.19186749991979202,1.0,14/27,23.60%,RANBP3L;PKD1;XPO4;STYX;DUSP16;NUP42;NUP214;TPR;SMURF1;RANBP3;DESI1;CHP1;XPO5;XPO1
prerank,regulation of protein export from nucleus (GO:0046825),-0.5653703012669188,-1.6247852848475073,0.01338432122370937,0.19100467298560186,1.0,13/23,19.65%,TCF7L2;XPO4;PTPN14;GSK3B;RAPGEF3;SP100;BAG3;TPR;YWHAE;EMD;ANP32B;PARK7;IFI27
prerank,regulation of monocyte differentiation (GO:0045655),-0.6446858055297291,-1.6238209879871466,0.011009174311926606,0.19136074023795818,1.0,4/14,6.13%,FOXP1;IL34;ACIN1;HOXA7
prerank,neuron development (GO:0048666),0.3988973085280883,1.6230397617091994,0.0,0.1742330112218706,1.0,37/141,11.10%,CNTNAP2;GPRIN1;MYT1L;FRY;PLP1;TMEM108;NLGN1;TENM2;GPM6A;SH3GL2;GPM6B;PBX2;TENM1;EPHA5;STMN1;MAP2;NTRK2;TENM4;STX3;TGFB2;ALK;PPP1R9A;TENM3;GPRIN3;SRRM4;STMN4;ADCYAP1;BICDL1;RASGRF1;CAMSAP1;RAB35;B4GALT6;STMN2;ATP8A2;PTPRM;MICALL2;CNTN4
prerank,regulation of interleukin-4 production (GO:0032673),0.5904345618251395,1.6215288589843784,0.01616161616161616,0.17500373695829444,1.0,3/21,6.58%,LEF1;SLC7A5;PRKCQ
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6512063350113022,1.621134124676269,0.023454157782515993,0.17418535576806357,1.0,5/13,13.50%,TMSB4X;HEY1;PER2;SIN3A;PSEN1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.5734088932040382,-1.6203563275713968,0.016822429906542057,0.19631364368567497,1.0,7/23,10.53%,ZBTB20;IGF1;NFKB1;PRKAA2;ARNT;PFKFB4;HIF1A
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5198846982958771,-1.6200832276806554,0.00927643784786642,0.19536354247716436,1.0,15/34,21.43%,DOCK5;LIMS1;ABL1;RREB1;FLNA;NRP1;S100A10;CDC42;CARMIL1;DOCK1;MYADM;MYOC;TRIOBP;P4HB;CRKL
prerank,sensory perception of chemical stimulus (GO:0007606),0.6282967752105058,1.6189570246021596,0.020491803278688523,0.17584557619206273,1.0,5/15,12.99%,SLC24A4;ADCY3;SYT10;GNAL;CD36
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.4310062221476838,-1.6181818869962712,0.005893909626719057,0.1975533248081528,1.0,30/87,16.01%,COL1A2;TGFBR3;COL3A1;SMAD3;TGFBR1;APPL2;BMPR1A;ZMIZ1;SMAD6;FMOD;TGFBR2;ITGB1;SMAD2;SKI;TWSG1;ITGB5;PTPRK;JUN;RHOA;ADAM9;SMAD4;ARHGEF18;ZYX;APPL1;PARD3;PRKCZ;SMURF1;ACVR1;LRRC32;TGFB3
prerank,calcium ion transport into cytosol (GO:0060402),0.5719424330344026,1.618179538141691,0.014957264957264958,0.17540686388501478,1.0,10/21,11.38%,GRIN1;GRIN2A;RYR2;CACNA2D1;GRIN2B;GRIN2D;SLC8A1;TRPM2;ADRA1A;JPH3
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.6937710370362298,-1.6174682971787813,0.02099236641221374,0.19763471796154708,1.0,3/11,7.83%,HMGB1;TWSG1;RUNX1
prerank,Golgi to endosome transport (GO:0006895),-0.6236147143089549,-1.6163973728987455,0.019305019305019305,0.19841927842719903,1.0,8/16,14.20%,VPS13A;GBF1;CORO7;MON2;KIF16B;WIPI1;VPS13C;DOP1B
prerank,cartilage development (GO:0051216),-0.47166435622614655,-1.6150069800292257,0.00998003992015968,0.19966762119871365,1.0,15/49,11.26%,SULF1;SOX5;CREB3L2;PKD1;BMP4;OSR1;WNT5B;NFIB;SULF2;SLC39A14;ZBTB16;RUNX1;CCN3;ITGB8;MEF2C
prerank,negative regulation of immune system process (GO:0002683),-0.615257480331594,-1.6148552349154168,0.014953271028037384,0.19861508233265052,1.0,4/16,14.90%,COL3A1;HOXA7;LYN;IL17D
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.6520184329662096,-1.6147389320786565,0.026262626262626262,0.1975210448531188,1.0,7/13,18.73%,NFKB1;BMP5;DKK3;REST;ERLIN1;APOE;BMP2
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5868642860662818,1.614199789123812,0.018947368421052633,0.17950694172838766,1.0,4/18,16.03%,NAV3;CD34;HOMER2;HOMER3
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.5170303289253187,1.613903060830338,0.0099601593625498,0.17861540675396648,1.0,15/32,16.86%,NAV3;STMN1;FGF13;MAP2;SNCA;TUBB4A;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;FKBP4;CAMSAP3;CLASP2
prerank,calcium ion import into cytosol (GO:1902656),0.6308179498065939,1.6137554383537223,0.018711018711018712,0.1773799842776842,1.0,4/15,6.44%,SLC24A2;CACNA2D1;SLC8A1;TRPM2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.5065105309026445,-1.6135617968819536,0.007905138339920948,0.1982225296902952,1.0,17/37,25.98%,APPL2;STAT3;ABCD2;IL17RA;HIF1A;APPL1;APOD;IL17D;PDCD4;TLR4;CHID1;ADCY7;TICAM1;NLRC3;SIRPA;MAPK14;PPARA
prerank,cellular response to misfolded protein (GO:0071218),-0.579354922824268,-1.6134522963533968,0.024,0.19723158709843877,1.0,14/20,32.56%,UGGT2;KLHL15;DNAJB14;POMT2;CUL3;AUP1;DERL1;VCP;TOR1A;DNAJC18;BAG6;RNF126;UFD1;UBE2W
prerank,pharyngeal system development (GO:0060037),-0.6314772323927325,-1.6122087188745104,0.01953125,0.19821356735802592,1.0,5/15,2.60%,TGFBR1;BMPR1A;BMP5;BMP7;BMP4
prerank,calcium ion import across plasma membrane (GO:0098703),0.6437580486952972,1.6108117622655866,0.019189765458422176,0.18042042111519074,1.0,4/14,6.44%,SLC24A2;CACNA2D1;SLC8A1;TRPM2
prerank,mesonephric tubule development (GO:0072164),-0.6222410084429069,-1.6104577020273054,0.0260707635009311,0.1999941455771399,1.0,10/15,17.89%,PKD1;FOXC1;BMP7;BMP4;OSR1;FGFR2;PKD2;SALL1;SIX1;NPNT
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4916672678579525,-1.6098252385827918,0.009633911368015413,0.19986313296292385,1.0,15/39,13.93%,RBPJ;ZMIZ1;KAT2B;IL6ST;EP300;ROBO1;JAG1;TSPAN5;YAP1;CREBBP;STAT3;CCN3;MAML2;MAML1;BMP2K
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.5682026344355201,-1.6095705093920678,0.013232514177693762,0.19912355312929877,1.0,7/22,9.09%,NOTCH2;KLF9;STXBP4;FGFR2;SRSF6;PTPRK;MED1
prerank,regulation of acrosome reaction (GO:0060046),0.6859295075351437,1.6087612235249906,0.027659574468085105,0.18221380320145775,1.0,2/10,5.73%,GLRA1;PLCB1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.48944829931983325,-1.6083102568203356,0.009784735812133072,0.20029584902408898,1.0,19/46,19.97%,ALDH1A1;RBPJ;ZNF423;LGR4;NPR3;DOCK7;ADAMTS5;FOXC2;LAMA4;NRDC;NR1H3;RB1;ACOT11;LNPEP;TLR4;PLCL1;ABHD6;MAP2K6;TLE3
prerank,regulation of BMP signaling pathway (GO:0030510),-0.4444797933758524,-1.6068245572854005,0.006,0.20207842253815933,1.0,20/73,10.86%,FSTL1;SULF1;CRIM1;BMPR1A;FOXD1;RBPJ;SMAD6;ZNF423;SMURF2;NBL1;BMP4;NUMA1;HTRA3;SMAD2;SKI;TWSG1;SKIL;XIAP;SMAD4;BMPER
prerank,embryonic digestive tract development (GO:0048566),-0.5954275447515485,-1.606678566686215,0.019342359767891684,0.20106943465277533,1.0,11/18,20.75%,GLI3;PDGFRA;GLI2;RARB;PCSK5;FGFR2;ID2;NIPBL;SALL1;RBPMS2;PKDCC
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.393597031381526,1.6063011879407643,0.0019646365422396855,0.18461131729453142,1.0,54/168,14.50%,EXOSC5;RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;HELZ2;RPL10;RPL15;RPL10A;RPS24;PPP2R1A;RPL27A;RPS17;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL12;RPL13;CNOT6L;RPS15;SMG8;PABPC1;RPL14;RPL5;ERI1;RPS4X;RPL21;RPS7;RPL23A;MAGOHB;MAGOH;RPL8;RPS3;RPS14;RPS2;ATM;RPS5;RPL18A;RPS28
prerank,regulation of dendrite development (GO:0050773),0.5083057756183968,1.605405526192197,0.018218623481781375,0.18446364523077027,1.0,14/37,10.02%,ADGRB3;DCC;CSMD3;LRP8;HECW1;TNIK;MFSD2A;SEMA4D;ALK;HECW2;CDKL5;ZDHHC15;LZTS1;DAB2IP
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.6218804735338673,-1.6036253176956101,0.016574585635359115,0.2049594202117984,1.0,9/15,15.26%,TCF7L2;XPO4;GSK3B;RAPGEF3;BAG3;TPR;YWHAE;EMD;ANP32B
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.5665898206990682,1.6029834482151086,0.014112903225806451,0.18665634079138582,1.0,12/21,19.98%,NAV3;FGF13;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;CAMSAP3;CLASP2;TTBK2;CLASP1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.446893534097765,-1.602753739016957,0.0,0.20537157137601258,1.0,22/63,20.15%,IGF1;TCF7L2;TGFBR1;WWOX;ITGAV;CFLAR;BMP4;BIRC6;DEPTOR;THBS1;PAK2;SH3RF1;AR;SP100;TRAF2;STX4;LTBR;ACVR1;PHIP;BCL2L12;PARK7;PML
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.5581621676661792,-1.6021430011684539,0.018108651911468814,0.2051983346859584,1.0,8/25,5.49%,SULF1;BMPR1A;FOXD1;RBPJ;ZNF423;BMP4;NUMA1;SMAD2
prerank,regulation of neurotransmitter transport (GO:0051588),0.6098689315190063,1.6012631581717731,0.01956521739130435,0.1877665371559628,1.0,5/16,10.59%,CAMK2A;RIMS1;MCTP1;KCNMB4;CPLX1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6884137360458686,-1.6005962212412006,0.014545454545454545,0.20720277240421472,1.0,6/11,18.73%,EFNB2;FRS2;MEF2C;FZD7;SOX6;BMP2
prerank,organelle disassembly (GO:1903008),-0.5187296652327953,-1.600031624514781,0.01764705882352941,0.20704950643321376,1.0,16/33,22.87%,GBF1;UFL1;DENR;UBA5;TEX264;RB1CC1;ULK2;STX5;GFM2;ATG2A;MRRF;ATG2B;VCP;KIF9;ZFAND1;PLK5
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.6478172404268947,-1.5987553544298057,0.02626641651031895,0.2081385636838668,1.0,7/13,19.31%,IRAK2;PIK3AP1;PIK3C3;PIK3R4;TNIP2;TRAF6;IRAK1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.5874124139486981,-1.5986762673213526,0.0210727969348659,0.20700658247905104,1.0,10/19,13.59%,TGFBR3;TGFBR1;BMPR1A;RBPJ;VGLL4;RBP4;FGFR2;RUNX1;MEF2C;GLI1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5339121037371575,1.5983689582260572,0.01583710407239819,0.19065717567326457,1.0,11/27,13.98%,CTNNA2;IL1RAPL1;MBOAT1;HOMER1;AKT1;NTNG2;NTNG1;BRSK2;CCDC88A;PSEN1;EFHC2
prerank,response to amyloid-beta (GO:1904645),0.4798212161705086,1.5976747924747072,0.014925373134328358,0.19038019775393908,1.0,9/44,3.78%,IGF1R;GRM5;CACNA1A;GRIN1;CACNA1B;MMP12;GRIN2A;CACNA2D1;MMP13
prerank,regulation of DNA repair (GO:0006282),-0.4862306056221409,-1.5960416507623503,0.015655577299412915,0.21079772188696874,1.0,11/44,7.78%,EYA2;EYA1;EGFR;UBE2N;EYA4;TRIP12;UBR5;DHX9;BRCC3;CEBPG;RNF8
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.5322897300011254,-1.5959124032507266,0.013133208255159476,0.209826302445547,1.0,11/29,18.04%,PKD1;PIAS1;IL31RA;GHR;STAT3;CTR9;FER;PKD2;STAT1;STAT5A;STAT5B
prerank,regulation of autophagy (GO:0010506),-0.3780651841480026,-1.5952922332144823,0.0,0.2097606254645964,1.0,72/216,23.17%,PRKAG2;ITPR1;RNF152;LEPR;DCN;EIF4G3;EP300;FOXO3;ROCK1;ATP6V1B2;PRKN;ABL1;PRKAA2;TFEB;LRRK2;NUPR1;GSK3B;RPTOR;ZKSCAN3;HMGB1;TPCN1;ATP6V0D1;DNM1L;SNX6;UBQLN1;UFL1;STAT3;BCL2;MTOR;TRIM8;TPCN2;PIP4K2C;FOXK1;VDAC1;PTPN22;EIF4E;USP33;RB1CC1;ABL2;PRKAB2;TRIM5;FBXW7;MTMR3;ATF6;KAT8;KLHL22;GFAP;ERN1;CTSA;USP13;DAPK1;FOXK2;RUBCN;PRKD1;PRKACA;DAPK2;DAP;PRKAA1;RMC1;GPR137B;EIF4G1;PLEKHF1;ORMDL3;PRKAG3;BNIP3;BMF;PRKAB1;VPS26B;DCAF12;TICAM1;ATP6V1G2;DAPL1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5216686574334088,-1.5942936424287832,0.0150093808630394,0.21058470725363806,1.0,10/31,9.37%,TGFBR1;PDGFRA;OSR1;TGFBR2;HOXB3;FGFR2;DYNC2I1;HOXC4;HOXA3;HOXB4
prerank,cellular response to metal ion (GO:0071248),0.4030872778434176,1.5932995373975374,0.008264462809917356,0.19576475581053635,1.0,28/123,7.85%,DLG2;SYT1;MT2A;ADCY8;SYT6;NLGN1;SYT7;GLRA1;SYT12;SYT11;ANK3;RYR3;SNCA;CPNE9;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;TRPM2;CPNE8;KCNH1;CPNE1;SYT10;AKT1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.35880251387067713,-1.5928963018720033,0.0,0.2121367999438577,1.0,126/327,25.79%,NFIA;BNC2;DENND4A;TGFBR1;EFEMP1;ZMIZ1;ZNF423;NR1D2;ATXN1;ZFHX3;FOXC1;EP300;ERC1;KAT6B;ABL1;WWC2;TFEB;FOXN3;RREB1;GON4L;WTIP;CREBL2;PPARGC1B;KMT2D;BAZ2A;NR3C1;SRSF10;PRRX2;FUS;SBNO2;CREBBP;TRIP4;STAT3;NSD1;NSD3;TRRAP;NAB1;REST;POFUT1;HNRNPD;GTF2IRD1;CTR9;PPARGC1A;IGF2;NFYC;ATF2;CHD3;ZFAT;SSBP2;HCFC1;HIF1A;LIMD1;TULP3;GPBP1L1;CDK11B;MEF2C;WWC1;TEAD2;RB1;SPTY2D1;COPS2;TCF3;TCF7L1;CRABP2;FZD7;SOX13;PATZ1;SUFU;SOX6;YBX1;CCAR1;PHF1;BRCA2;HINFP;RORA;USP13;CHD7;TAF5L;PRDM2;SFPQ;VSX1;FOXK2;PRMT5;MYBL1;GLRX2;ATXN1L;SIX1;NFYB;RNF20;ZFP37;TAF6L;MSL3;POU6F2;HMG20A;RHOH;BMP2;RNF14;AJUBA;NFX1;PML;NFYA;PPP2CA;NIF3L1;EZH2;SPIN1;ZNF205;IRF2;DRAP1;TRAPPC2;NFXL1;CCAR2;RNF6;MAFB;CXXC1;ZNF35;NONO;LDB1;MZF1;SOX11;RPS6KA4;NFKB2;ACTR5;EDF1;DVL2;OGG1;ZNF219
prerank,modification-dependent protein catabolic process (GO:0019941),-0.372413958395885,-1.592537212129748,0.0,0.21174058452893738,1.0,94/193,31.61%,FBXL7;SMURF2;RNF43;PRKN;SPSB1;BIRC6;ARIH1;BTRC;TRIP12;KLHL15;RNF146;RNF217;RBBP6;RC3H1;RNF213;UBQLN1;OS9;RNF19A;UBE4B;ASB2;UBE2H;FBXL4;ANAPC5;RNF8;FBXO10;ANAPC7;UBE2K;UBE2I;ANAPC4;ANAPC16;NUB1;NTAN1;USP33;UBE2R2;UBR3;PSMF1;WDR91;TRIM25;CUL3;DTX3L;CDC26;TRPC4AP;UBE2B;SMURF1;FBXO45;TOPORS;UBR4;UBE2E1;CDC27;ARRB1;FEM1A;BFAR;RNF20;UBE2S;FBXO22;SYVN1;MYLIP;SPSB4;AREL1;RNF14;RNF11;WDR81;TTC3;ANAPC11;ARIH2;FBXW4;RNF144A;RNF6;SIAH2;BAG6;FBXL14;CDC16;ANAPC1;CNOT4;UBQLN4;ZNRF3;FBXO11;UBE3C;PSMD13;SPSB2;LONP1;KCTD6;CDC34;FZR1;RBX1;MIB1;UBA52;RNF126;ADRM1;HERPUD1;UBA1;UFD1;RNF130;UBE2L3
prerank,anterior/posterior pattern specification (GO:0009952),-0.4617623257682365,-1.5916740175043693,0.005747126436781609,0.2121606132482817,1.0,18/53,15.24%,WLS;TGFBR1;HOXB6;HOXC6;HOXB3;PCSK5;HOXA5;SMAD2;SKI;HOXA7;HOXC4;HOXA3;HOXB5;HOXB4;HES1;BHLHE41;HOXB9;HOXC5
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.4820048731884106,-1.5914409160407734,0.007707129094412331,0.21134479881696389,1.0,15/44,11.08%,ROCK2;CELF1;FTO;ROCK1;TNRC6B;YTHDF3;TNRC6A;EIF4ENIF1;MOV10;RC3H1;ZC3HAV1;PUM1;DHX36;UPF1;CNOT8
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.5512829940701749,-1.5914253621649697,0.023076923076923078,0.2101507140396464,1.0,11/24,21.94%,TGFBR1;EFEMP1;SOX5;ADAMTS12;ZBTB16;WNT9A;SOX6;TRPS1;PTPN11;PKDCC;PTHLH
prerank,regulation of synapse assembly (GO:0051963),0.4690604945339853,1.5912274669166948,0.010638297872340425,0.19761333613785656,1.0,15/46,9.32%,NRXN1;PTPRD;LRFN5;IL1RAPL1;EPHB1;NLGN1;GRID2;SNCA;TLR2;SLIT1;ROBO2;CLSTN3;LRRC4B;IL1RAPL2;LHFPL4
prerank,limb development (GO:0060173),-0.5328126412297767,-1.5909802811016618,0.013307984790874524,0.20972069803619353,1.0,16/28,27.86%,SMOC1;GLI3;KAT2B;PCSK5;MAP3K20;RSPO2;CHD7;PTCH1;SALL1;IQCE;MEGF8;LRP4;COMP;ZNRF3;KREMEN1;IFT122
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.5444009583223385,-1.5902116545884493,0.015296367112810707,0.2099678468424988,1.0,7/24,5.79%,PHLDB2;ARHGAP6;CGNL1;ARHGAP28;ARAP1;WASF2;PAK2
prerank,supramolecular fiber organization (GO:0097435),-0.35422801978045265,-1.587689606536248,0.0,0.21352812190395057,1.0,99/333,20.00%,COL1A2;COL3A1;COL4A5;COL5A2;ADAMTS2;TGFBR1;CGNL1;COL5A1;COL8A1;COL4A6;TNXB;COL1A1;GSN;COL12A1;COL22A1;TPM1;COL4A3;PCM1;MPRIP;MYO1B;LOXL1;VIM;COL6A3;PRKN;COL4A4;FIGN;COL25A1;COL6A1;COL23A1;SHROOM2;TSPAN5;COL8A2;FBLN5;SNCAIP;FAT1;COL26A1;PLOD2;DLG1;HSPG2;SLK;RND3;SHROOM3;COL6A2;VPS4B;TMOD3;CORO7;TUBGCP6;INPPL1;CDC42;TUBGCP2;ARHGAP17;FIGNL2;COL15A1;LAMA3;NCSTN;COL13A1;CYP1B1;GGA3;COL5A3;CLIP4;TPM3;RHOA;COL18A1;P4HA2;COL27A1;RHOBTB2;MYO1F;EFEMP2;KATNA1;LUM;GFAP;LOX;EMILIN1;ZBED3;WHAMM;CARMIL1;COL9A2;MYH11;TSPAN15;LOXL3;DYNC1H1;RHOBTB1;IAPP;DPT;RHOH;MAP7D3;TRIOBP;COL14A1;RHOC;COL20A1;LMOD1;AVIL;MFAP4;B4GALT7;TPM2;TUBGCP4;NCKAP5L;ADAMTS14;MARCKS
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.6721893218071335,-1.5871856111517546,0.01834862385321101,0.21334571436128524,1.0,5/12,9.10%,ELF1;RC3H1;LYN;RUNX1;PTPN22
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.35983740992803254,1.5870057536886828,0.0,0.20265274044517495,1.0,82/306,14.50%,PAX8;ALAS2;CHEK1;RPS6;RPS19;RPS20;RPL38;RPL29;PTMA;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;RPL10;RPL15;HOXD3;RPL10A;TBRG1;RPS24;EEF1B2;FUT9;RPL27A;RPS17;RPS6KB2;RPS8;RPA3;RPS16;RPS27A;RPLP1;XAB2;RPL41;RPLP0;RPL30;RPL7A;TUFM;ING4;MRPS18A;RPL12;MRPL13;RPL13;EEF1D;MRPS7;RPS15;PIF1;MRPS14;POLR2J;POLR2B;RPL14;SET;EIF4EBP2;BCL3;FARSB;RPL5;RPS4X;RPL21;RPS7;POLR2I;THAP1;RPL23A;EEF1A2;MCM3;RPL8;MED20;RNASEH2A;BRIP1;MRPL36;MRPL23;RPS3;RPS14;POLD1;RPS2;ATM;RPS5;EEF1A1;POLR3A;RPL18A;RPS28
prerank,positive regulation of glycolytic process (GO:0045821),-0.5856966364325557,-1.5867570835528575,0.019642857142857142,0.21171149626476457,1.0,6/20,10.53%,ZBTB20;IGF1;PRKAA2;ARNT;PFKFB4;HIF1A
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5856966364325557,-1.5867570835528575,0.019642857142857142,0.21171149626476457,1.0,6/20,10.53%,ZBTB20;IGF1;PRKAA2;ARNT;PFKFB4;HIF1A
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.6157157020129338,-1.585310351596229,0.02247191011235955,0.2133205106298926,1.0,10/16,15.47%,DDX5;DDX17;HNRNPM;DHX9;SRSF6;CDK13;SLU7;RSRC1;SRSF1;SFPQ
prerank,neuronal action potential (GO:0019228),0.5598723534751585,1.5850649232213476,0.02301255230125523,0.20416653389673375,1.0,11/22,18.35%,SCN1A;ANK3;KCNMB2;KCNMB3;KCNMB4;SCN3A;KCNA2;SCN2A;CACNA1I;SCN8A;KCNA1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.5273787844838888,-1.5842511745452093,0.005940594059405941,0.21406659816525753,1.0,8/27,5.79%,PHLDB2;ARHGAP6;CGNL1;ARHGAP28;PRKN;ARAP1;WASF2;PAK2
prerank,limb morphogenesis (GO:0035108),-0.5726351171836142,-1.5842485684814527,0.01618705035971223,0.21291612732080722,1.0,10/20,22.00%,GLI3;LRP6;PCSK5;CYP26B1;SKI;NIPBL;PTCH1;IQCE;MEGF8;FBXW4
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.5243620098402595,-1.5840712494815932,0.018442622950819672,0.21206111660062632,1.0,8/29,7.79%,SMAD3;DICER1;PUM2;ZC3H7A;SMAD2;PUS10;PUM1;TUT4
prerank,skin development (GO:0043588),-0.44120275932253394,-1.5831229586084408,0.011857707509881422,0.2126547931649133,1.0,16/65,12.15%,COL1A2;COL3A1;COL5A2;ERRFI1;COL5A1;COL1A1;PKD1;JAG1;BCR;ANXA1;CLIC4;TXNIP;MED1;COL5A3;ADAM9;UGCG
prerank,ribosome biogenesis (GO:0042254),0.38084114824377086,1.5824489645702704,0.0,0.2070478616119878,1.0,54/187,16.46%,EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPF2;RPS27;RPL7;RPL10;RPL15;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;FBL;RPL12;RPL13;RPS15;NOL6;RPL14;RPL5;RPL21;RPS7;RPL23A;DKC1;POP5;RPL8;MRPL36;RPS14;DDX10;URB2;RPS2;PIH1D2;WDR75;RPL18A;RPS28;RRP1;RRP1B;NOP56;RPS25;MDN1;UTP15;EXOSC4
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.4780955311335607,-1.582292888851553,0.015779092702169626,0.21312757658371248,1.0,17/46,17.72%,IGF1;FOXP1;TCF7L2;IGFBP5;PDGFRB;BMP4;ELN;IGFBP3;OGN;THBS1;ID2;IL6R;APOD;PRKDC;STAT1;IL18;CCN4
prerank,intracellular cholesterol transport (GO:0032367),-0.6275152771490542,-1.5813529263083308,0.021352313167259787,0.21379788041604827,1.0,5/15,11.76%,LRP6;ABCA1;LDLR;RELCH;NPC2
prerank,energy reserve metabolic process (GO:0006112),-0.5821143045827677,-1.580120404048172,0.030534351145038167,0.21473182759358547,1.0,7/19,8.97%,PRKAG2;PID1;LEPR;PHKB;GSK3B;GFPT1;PHKA1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.37644396825448784,-1.5796102070283422,0.0,0.21457869743435434,1.0,77/186,29.63%,BICC1;TRABD2B;MLLT3;NXN;GLI3;TCF7L2;LRP1;IGFBP2;RBMS3;LRP6;WWOX;GRB10;RNF43;DAB2;TMEM64;STK3;PRKN;DKK3;CSNK1A1;GSK3B;VGLL4;IGFBP6;AXIN1;RNF213;CHD8;IGFBP4;DACT1;LIMD1;TLE4;LZTS2;TLE1;PSMF1;CUL3;SOX13;GLI1;PSMB2;UBAC2;APOE;LATS1;HDAC1;EMD;INVS;DACT3;WNT5A;BMP2;SFRP4;MDFI;TLE3;PSMC1;DKK2;FRZB;DVL3;PSMA3;PSMB6;PSMA4;SIAH2;LRP4;ZNRF3;DVL2;TPBG;LMBR1L;NKD2;KREMEN1;PSME1;PSMD13;MCC;CXXC4;SDHAF2;PSMB9;RBX1;PSMB10;PSMA5;RUVBL2;TSKU;HIC1;MAD2L2;CAV1
prerank,positive regulation of glucose import (GO:0046326),-0.5751417847757957,-1.5787985368419826,0.015810276679841896,0.2149380527963855,1.0,6/21,4.70%,IGF1;SORBS1;RHOQ;OSBPL8;CREBL2;IRS1
prerank,regulation of bone mineralization (GO:0030500),-0.45261117293034525,-1.578796823516218,0.007547169811320755,0.21381858377140434,1.0,23/55,18.73%,BMP6;BMPR1A;PTN;WNT4;BMP7;BMP4;BCOR;OSR1;ENPP1;ADGRV1;NBR1;KL;MEF2C;ATP2B1;TRPM4;CCN1;ATRAID;BMP2K;ACVR1;TGFB3;ECM1;FBN2;BMP2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.338967537136077,-1.5784625124269607,0.0,0.2132532976513549,1.0,132/497,17.68%,SAMD4A;FOXP2;FOXP1;NR2F2;GLI3;TCF7L2;RBFOX2;FOXD1;PRDM5;ZNF148;WNT4;RBPJ;MIDEAS;LIMS1;IGFBP5;ZNF423;SMURF2;NR1D2;ZHX2;MDFIC;ATXN1;ZEB1;BMP7;ZIC2;BMP4;HDAC4;BCOR;KAT6B;NCOR1;DKK3;ENPP1;BTRC;WWP2;BRD7;FOXN3;GSK3B;VGLL4;NIBAN2;SYNCRIP;RCOR1;KHDRBS1;DDX6;RCOR3;ZKSCAN3;NR3C1;SMARCC2;EIF4ENIF1;EIF2AK1;CBX5;SMAD2;ZBTB16;ATP8B1;SBNO2;LBH;SNX6;HOXA7;TFDP2;NAB1;SHC1;L3MBTL3;EIF2AK3;WWP1;CHD8;LARP1;REST;SCMH1;BCL7A;PDS5A;DHX36;FOXK1;PTPRK;MBD2;CBFA2T2;RUNX1T1;UBE2I;BTAF1;PRMT2;SELENOS;JUN;LSM14A;LIMD1;MPHOSPH8;SMAD4;GLIS2;ID2;ATF7IP;CNOT8;USP47;BCLAF1;NIPBL;PBXIP1;TLE1;PCGF6;HES1;RB1;ARID5B;PIAS4;BHLHE41;SOX13;PATZ1;IRF1;KAT8;EHMT1;YBX1;TSHZ3;EIF2AK2;HINFP;ZNF318;CBFA2T3;SCML4;DDX3X;HDAC1;SFPQ;L3MBTL2;JARID2;ATOH8;PHC2;DAPK1;EPC1;SALL1;FOXK2;LOXL3;CITED2;PDCD4;CNOT1;HEYL;TBX2;RUNX2;TWIST2;ZMYND15;S100A11;DAP
prerank,Golgi localization (GO:0051645),-0.6749812546689613,-1.577700970367022,0.01818181818181818,0.21367526717642182,1.0,6/11,19.11%,UVRAG;ARHGAP21;CDC42;ARCN1;TBCCD1;COPG1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6982850862529633,-1.577556476316899,0.03577817531305903,0.21280528791679149,1.0,6/10,18.42%,GHR;STAT3;LYN;STAT5A;STAT5B;PTPN1
prerank,RNA biosynthetic process (GO:0032774),-0.5072796409808256,-1.5767093389994946,0.009505703422053232,0.21329809339799552,1.0,16/31,28.13%,NCOA6;TAF4;TBP;BRF1;TTF1;TAF13;GTF2B;PRMT5;HELB;PRIM2;POLA2;TAF12;TERT;TBPL1;TAF7;BRF2
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.5463834705151606,-1.5767088670414258,0.01818181818181818,0.21221536195942703,1.0,17/23,35.69%,OS9;SELENOS;SURF4;FAF2;AUP1;DERL1;SYVN1;VCP;SEC16A;PREB;LMAN1;SEL1L;DERL2;HERPUD1;UFD1;SEC13;TMEM129
prerank,negative regulation of cell junction assembly (GO:1901889),-0.5481329501730507,-1.575200901570529,0.019193857965451054,0.21388413041064486,1.0,6/25,5.45%,PHLDB2;ROCK2;ARHGAP6;ROCK1;THBS1;BCAS3
prerank,atrial septum development (GO:0003283),-0.6369295354603114,-1.5744409346595738,0.03136531365313653,0.21416077194056055,1.0,3/13,2.11%,NOTCH2;ANK2;MDM4
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.32298315460723426,-1.572955572238306,0.0,0.21584477500612265,1.0,288/1082,18.73%,NFIA;BMP6;PBX1;IGF1;AUTS2;MLLT3;HLF;EGFR;NR2F2;NFAT5;ZIC1;PID1;RHOQ;SMAD3;GLI3;TCF4;TCF7L2;TGFBR1;TEAD1;BMPR1A;NFKB1;CREB3L2;COL1A1;CDK8;PKD1;WNT4;HDAC8;LRP6;RBPJ;ZMIZ1;THRB;INO80;DCN;ZNF423;GLIS3;GLI2;ZNF462;NR1D2;MDFIC;ZFHX3;WWOX;BMP5;RARB;FOXC1;FGF1;KAT2B;BMP7;TRIM44;DAB2;IL31RA;ZIC2;BMP4;EP300;PPP1R12A;FOXO3;CREB5;HDAC4;ARID1B;PRKN;KAT6B;ABL1;OSR1;ARNT;TFEB;CCNT2;JAG1;MEOX2;HOXB3;BTRC;NFIB;TBL1X;ELF1;BRD7;TBL1XR1;SSBP3;RREB1;KMT2C;BCLAF3;NIBAN2;NFIX;CCNT1;RPTOR;TBK1;CREBL2;YAP1;RGMB;SLC9A1;RARG;MEF2A;DDX17;PPARGC1B;KMT2D;ZKSCAN3;HMGB1;TGFB1I1;NR3C1;CDK7;SS18;BCL9L;SMARCC2;HOXA5;BCAS3;SMAD2;ZBTB16;AXIN1;SBNO2;PLSCR1;LBH;GABPB2;MED17;SKI;CDH1;FZD2;SCAF8;CREBBP;HOXA7;TFDP2;TRIP4;STAT3;PHF8;NSD1;NSD3;FGFR2;FHOD1;MED12;SHC1;ENY2;FOXC2;ELF4;EIF2AK3;HOXC4;HIVEP3;CHD8;DHX9;MTOR;AKAP8L;REST;VEZF1;MAP3K5;MYSM1;CEBPG;HNRNPD;RUNX1;AR;CRTC3;PRPF6;DHX36;RGMA;PPARGC1A;FOXK1;ZNF496;IGF2;NCOA6;CDC5L;ZEB2;SETD3;SP100;NCOA1;MAP2K1;MED1;CCNK;JUP;HOXB4;ATF2;WASL;UBP1;PRMT2;JUN;NR1H3;GABPA;TADA3;SSBP2;HCFC1;THAP3;HIF1A;CREBRF;PARP9;SENP1;SMAD4;GLIS2;MAVS;CALCOCO1;ID2;MED21;ATF7IP;MAML2;CRTC1;BCLAF1;MEF2C;ZBED4;DCAF6;ZXDC;PARP1;NRF1;TEAD2;WDR43;HES1;TFCP2;TCF3;KDM1B;FZD7;MLLT10;PKD2;PPM1A;MAML1;IRF1;CCN1;ATF6;KAT8;YBX1;OGT;DTX3L;GLI1;BICRA;TCERG1;MMS19;ING5;CRLF3;BRCA2;PITHD1;NAA15;HINFP;VEGFA;PRKDC;STAT1;RORA;ZNF318;APOE;KDM3A;ILF2;ACVR1;DDX3X;HDAC1;ZBED3;NCK1;RXRA;EFCAB7;KLF15;PRDM2;SFPQ;NCK2;ABHD14B;MAP2K7;ATOH8;PRDM15;TGFB3;ARHGEF11;AFAP1L2;EPC1;SALL1;PTOV1;FOXK2;TNIP2;KLF6;IL18;ARRB1;CITED2;MYBL1;ICE1;NR4A1;SIX1;CAMTA2;NFYB;HEYL;RNF20;SERPINE1;TLR4;SMARCD2;RUNX2;PICALM;PRKD1;NR4A2;CRTC2;HNRNPU;PHIP;BCL2L12;TAF6L;NFIC;LPIN2;STAT5B;INPP5K;TRAF6;LPIN3;NFATC3;FBXW11;NEK4;WNT5A;BMP2
prerank,positive regulation of cellular senescence (GO:2000774),0.6652266322046229,1.5726326754793296,0.0389908256880734,0.2220368510301814,1.0,5/10,18.79%,SIRT1;HMGA2;YPEL3;B2M;EEF1E1
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.6020526873903758,-1.57240267795474,0.03571428571428571,0.21581881446677342,1.0,7/17,9.09%,ATP1A2;BMP7;BMP4;NR3C1;TFPI;AR;MED1
prerank,keratan sulfate catabolic process (GO:0042340),-0.6798909151646668,-1.5719584063459702,0.020072992700729927,0.21565761803155797,1.0,8/11,18.86%,FMOD;GNS;OGN;PRELP;LUM;HEXA;GALNS;OMD
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.550476430722259,1.5715280593823058,0.031446540880503145,0.22247724282588857,1.0,9/20,20.93%,LY6H;CHRM3;GRK2;PLCB1;CHRM2;GNAQ;LY6G6D;RGS10;CDK5R1
prerank,cardiac conduction system development (GO:0003161),-0.5555289888648587,-1.5693419443146712,0.021653543307086614,0.2195720839665224,1.0,11/24,22.22%,NOTCH2;BMPR1A;GJB6;BMP4;GJA1;SMAD4;TBX18;MAML1;CACNA1G;SMAD1;GATA6
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5825699106163894,-1.569331601411182,0.026156941649899398,0.21850158346371204,1.0,12/18,32.05%,ANKRD17;PUM2;PUM1;DDX60;NOP53;SEC14L1;GPATCH3;DHX58;BIRC3;C1QBP;UFD1;ZCCHC3
prerank,Ras protein signal transduction (GO:0007265),-0.3879006293801044,-1.5687460321829019,0.0,0.21857346038860997,1.0,47/137,22.75%,ROCK2;COL1A2;PLD1;IGF1;ARHGAP29;ARHGAP6;PLCE1;KSR1;ROCK1;PDPN;RREB1;SHOC2;RAP1B;CTNNAL1;MRAS;SHC1;RAPGEF3;BRK1;CDC42EP5;JUN;RHOA;NCKAP1;RB1;AGTR1;RALA;SETDB1;ARHGDIB;USP50;RAPGEF2;WASF1;GNB1;ARHGEF11;FARP2;ADRA2A;PRKD1;ARHGEF1;CDC42EP4;RHOH;RASSF1;PARK7;CDK2;RTKN;RAPGEF1;CRKL;FGF2;RIT1;CDC42EP1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.589908200537769,-1.5686598187041927,0.017578125,0.2176510627820481,1.0,7/17,6.93%,IGF1;DOCK5;IGFBP5;PDGFRB;VTN;DOCK7;NRP1
prerank,protein localization to cell surface (GO:0034394),-0.5212337729863642,-1.568083116966583,0.023032629558541268,0.21764587220611037,1.0,10/26,14.92%,ANK2;VCL;ANGPT1;FBLN5;FLNA;PIGK;PTPRK;GGA3;USP4;SMURF1
prerank,regulation of B cell proliferation (GO:0030888),0.47857020774398557,1.5671681830739521,0.011160714285714286,0.22844046478679988,1.0,11/44,15.15%,TFRC;TIRAP;MIF;IL7;VAV3;TNFSF13B;TNFRSF21;CD40;ATM;NFATC2;CD38
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.5813410986039689,-1.566090535843329,0.028985507246376812,0.2203296318030442,1.0,8/18,22.01%,SETD7;KMT2D;SETD3;SETD2;EHMT1;ASH1L;KMT2A;PRDM9
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6675777366015418,1.564527061211519,0.042316258351893093,0.23147547727307247,1.0,4/10,9.37%,KDR;TLR2;CCL2;NAMPT
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.5780460009162216,-1.5638688794465248,0.034545454545454546,0.2234716732144679,1.0,8/18,16.00%,SMAD3;LTBP1;ITGAV;ITGB8;HIF1A;SMAD4;FN1;LRRC32
prerank,ribosomal small subunit biogenesis (GO:0042274),0.48396023806785443,1.5632274489306424,0.015317286652078774,0.23228084505827237,1.0,14/39,15.57%,TSR3;RPS6;RPS19;RPS27;RPS24;RPS17;RPS16;MRPS7;RPS15;RPS7;RPS14;RPS5;RPS28;RPS25
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.6380627092836668,-1.5629699047740064,0.025179856115107913,0.22403383029368115,1.0,10/13,31.01%,SAE1;SENP6;UBA5;UBA7;DESI1;DESI2;NAE1;UBA2;ATG10;UBA1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5556328447166243,-1.5617260156586423,0.028142589118198873,0.2242385220616315,1.0,4/21,7.00%,EYA2;EYA1;EYA4;BCL2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5556328447166243,-1.5617260156586423,0.028142589118198873,0.2242385220616315,1.0,4/21,7.00%,EYA2;EYA1;EYA4;BCL2
prerank,negative regulation of cartilage development (GO:0061037),-0.6443041984121599,-1.561267032198382,0.026515151515151516,0.224057294715519,1.0,4/13,7.81%,TGFBR1;EFEMP1;ADAMTS12;WNT9A
prerank,cell-cell junction assembly (GO:0007043),0.4453834576171107,1.5611087864735775,0.006172839506172839,0.23417768203881673,1.0,16/63,7.09%,CLDN5;CDH12;CDH8;ACTB;CTNND2;CDH19;CDH20;CDH7;RAMP2;CDH18;CDH2;CDH10;GJB1;WDR1;EPB41L3;CNTNAP1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.6344273447369817,-1.56090410668426,0.027522935779816515,0.22364977399356956,1.0,3/13,5.83%,ERRFI1;CBLB;SNX6
prerank,regulation of synapse maturation (GO:0090128),0.6637952109519281,1.559956654985474,0.05806451612903226,0.2346607794636393,1.0,4/10,10.02%,ARHGEF15;NRXN1;RELN;DAB2IP
prerank,cell proliferation in forebrain (GO:0021846),-0.6768419076910892,-1.558153964349449,0.04085603112840467,0.227878669399782,1.0,4/10,14.55%,PCM1;DOCK7;NUMBL;NUMB
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.4194660006051653,-1.5578433613126998,0.007952286282306162,0.2274902855070865,1.0,37/80,26.37%,DENND2A;VTI1A;ERC1;GBF1;TMEM87A;SGSM2;SNX6;VTI1B;STX16;GOSR1;VPS54;STX5;SURF4;DENND5A;TMEM87B;EHD3;HEATR5A;GOSR2;SNX8;TBC1D17;ANKFY1;HEATR5B;CLN5;TBC1D10A;VPS26B;BET1L;RGP1;TBC1D23;SPAG9;LMAN1;SNX12;RAB9A;BAIAP3;PHETA1;RAB7B;RAB7A;TBC1D10B
prerank,spliceosomal complex assembly (GO:0000245),-0.46333161089793673,-1.5577611128092805,0.009596928982725527,0.22663935944555755,1.0,15/46,14.48%,CELF2;CELF1;LUC7L2;SRSF10;SF3B1;SRSF6;PRPF6;SF3A1;YTHDC1;USP39;SCAF11;SF3A3;DDX23;RBM5;SRSF1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6410791536708587,1.5566584811396926,0.05045871559633028,0.2389976628700855,1.0,4/12,8.62%,SPTBN4;EPHB1;HSP90AB1;B4GALT6
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.3926703379764259,-1.5561959047372789,0.001968503937007874,0.2286401864022938,1.0,34/129,15.12%,RNF220;WLS;LRRK1;EGFR;NFKB1;COL1A1;SMURF2;LGR4;PTK7;TNKS2;LRRK2;TBL1X;TBL1XR1;GPC3;RNF146;AXIN1;UBR5;LYPD6;ADGRA2;FGFR2;ZEB2;XIAP;DACT1;CSNK1E;JUP;WNK1;USP47;PSMF1;PPM1A;TRPM4;PSMB2;UBE2B;DDX3X;ZBED3
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5971524732474619,-1.5560350553384128,0.025974025974025976,0.22789502106085033,1.0,9/16,25.98%,APPL2;ABCD2;APOD;PDCD4;CHID1;ADCY7;NLRC3;SIRPA;PPARA
prerank,brain morphogenesis (GO:0048854),0.6538079828225323,1.555680208028704,0.03296703296703297,0.23907267568354454,1.0,4/12,10.15%,CTNNA2;SHANK3;PAX2;SPEF2
prerank,regulation of protein import into nucleus (GO:0042306),-0.4944034504641074,-1.554298505572717,0.036328871892925434,0.2301694464771202,1.0,15/36,15.31%,ZIC1;SMAD3;MDFIC;BMP4;FLNA;UBR5;CDH1;JUP;BAG3;PRKCD;MAVS;TPR;SUFU;APOD;EFCAB7
prerank,positive regulation of tissue remodeling (GO:0034105),-0.6777619350244157,-1.5526990726262082,0.0260707635009311,0.23238559713961193,1.0,2/10,2.67%,ROCK2;ROCK1
prerank,autophagy of nucleus (GO:0044804),-0.584664656439768,-1.551502209091349,0.03377110694183865,0.23373485878655842,1.0,12/16,33.40%,RB1CC1;ULK2;WIPI1;ATG2A;ATG9A;WDR45B;ATG2B;ATG5;WIPI2;ATG3;ATG12;WDR45
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4780666037458725,1.550365626527254,0.017582417582417582,0.2468221948056332,1.0,10/39,7.14%,FGF12;HECW1;NETO1;FGF14;ANK3;FGF13;WNK2;SCN4B;HECW2;GLRX
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.44178801145517077,-1.549713426717589,0.009784735812133072,0.23610191364244792,1.0,15/61,8.19%,EYA2;EYA1;EGFR;UBE2N;EYA4;PDGFRB;HMGB1;USP7;NBN;DHX9;BRCC3;CEBPG;RNF8;DHX36;WRN
prerank,cellular glucan metabolic process (GO:0006073),-0.6641908984133515,-1.548943729028112,0.04283054003724395,0.2365778633192337,1.0,5/11,14.62%,PRKAG2;PHKB;GSK3B;PHKA1;PYGM
prerank,ceramide biosynthetic process (GO:0046513),0.47478706830561435,1.5485832651958396,0.017057569296375266,0.24878046875958643,1.0,10/40,11.67%,ST6GALNAC3;ST8SIA4;SGMS1;FA2H;DEGS2;B4GALNT1;B4GALT6;SMPD1;ST8SIA6;ST8SIA3
prerank,positive regulation of cell division (GO:0051781),-0.4816366258578826,-1.5485510549102612,0.01893939393939394,0.2363779039458401,1.0,11/38,14.94%,SVIL;FGF1;CDC14A;CSPP1;FGFR2;CDC42;RHOA;GIPC1;CUL3;CDC25B;CDC14B
prerank,ganglioside metabolic process (GO:0001573),0.5532615888036104,1.547286860709844,0.05393258426966292,0.24953348598680533,1.0,6/20,11.67%,ST6GALNAC3;ST8SIA4;B4GALNT1;NEU2;ST8SIA6;ST8SIA3
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.5440361554624222,-1.5472859662114022,0.03564727954971857,0.23792256297907033,1.0,17/23,28.35%,GLI3;ENPP1;BTRC;GPC3;GLIS2;TULP3;HERC4;SUFU;PTCH1;GPR161;VCP;MEGF8;KIF7;MGRN1;IFT122;PTCH2;KCTD6
prerank,regulation of hemopoiesis (GO:1903706),-0.6724001523939371,-1.5469087491665539,0.03409090909090909,0.23760835519082954,1.0,5/10,14.90%,PTN;CREBBP;MYSM1;RUNX1;IL17D
prerank,P-body assembly (GO:0033962),-0.6297464763875137,-1.5462915440509333,0.02952029520295203,0.23784492135812735,1.0,7/12,16.89%,DDX6;EIF4ENIF1;RC3H1;LSM14A;LIMD1;EDC3;DYNC1H1
prerank,sodium ion transport (GO:0006814),0.4130494899900144,1.5459111643283576,0.01279317697228145,0.2507243916052828,1.0,19/85,9.16%,SLC6A6;HCN1;SLC24A4;SLC24A2;SCN1A;SLC6A17;ASIC2;ASIC4;FGF13;SLC8A1;ASIC1;SCN4B;HCN2;SLC6A2;SLC6A5;SLC6A8;KCNK1;SCN3A;SLC12A3
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.5440965734007487,-1.5457320176845863,0.017578125,0.23790793941053304,1.0,12/21,28.30%,SAMD4A;PAN3;TUT4;CNOT8;PAN2;CNOT2;CNOT1;CNOT10;CNOT4;PNLDC1;TNKS1BP1;PARN
prerank,detection of calcium ion (GO:0005513),0.617783795775738,1.5447743632259452,0.032467532467532464,0.25099964454603896,1.0,8/13,13.93%,SYT1;RYR2;KCNMB2;KCNMB3;KCNMB4;CALM1;CALM2;CALM3
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.6240758462183815,-1.5441290160411856,0.0347985347985348,0.2403141554412698,1.0,5/13,8.09%,LRRK2;NUPR1;SEC22B;CHMP4B;CHMP4A
prerank,response to sterol (GO:0036314),-0.6660529824596163,-1.5430678034910632,0.030249110320284697,0.24127259104785634,1.0,4/11,14.47%,TGFBR1;TGFBR2;SMAD2;RORA
prerank,positive regulation of cell differentiation (GO:0045597),-0.3586843981376846,-1.542592173197581,0.0,0.241166142869042,1.0,74/237,17.89%,BMP6;RANBP3L;IGF1;SMAD3;TCF4;TGFBR1;SOX5;BMPR1A;PTN;NFKB1;COL1A1;WNT4;BOC;NBL1;MEDAG;FOXC1;ZEB1;CCN2;BMP7;CDON;DAB2;TMEM64;IL6ST;BMP4;CTNNA1;PDPN;ABL1;TGFBR2;RIPOR2;CREBL2;YAP1;IGFBP3;MEF2A;TGFB1I1;BCL9L;HOXA5;SMAD2;ZBTB16;MTOR;REST;AR;CDC42;DHX36;GJA1;IMPACT;HOXB4;NGF;RHOA;SMAD4;ID2;MEF2C;AGTR1;TCF3;IL6R;TRPM4;CCN1;SOX6;ATRAID;WDFY2;RAPGEF2;BLOC1S5;ACVR1;GLIPR2;TGFB3;IL18;CMKLR1;SUCO;HEYL;RUNX2;PRKD1;FBN2;CCN4;SYAP1;NPNT
prerank,central nervous system myelination (GO:0022010),0.6654487733732679,1.5409200871367832,0.023504273504273504,0.2564106364191366,1.0,5/11,8.62%,PLP1;TENM4;CLU;CNTNAP1;B4GALT6
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.5371262155337425,-1.540885399803825,0.011049723756906077,0.2434558928437463,1.0,11/24,26.67%,AUTS2;PLCE1;WASF2;BRK1;CDC42;NCKAP1;ARPC2;AVIL;PIK3R1;TWF2;ACTR2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.5274841094063255,1.5407832582247554,0.03164556962025317,0.2549810451471701,1.0,11/24,19.08%,LIG3;RPA3;RPS27A;UBC;POLK;UBB;POLD1;RFC4;POLD3;RFC5;RFC2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.33685538475089827,-1.5407334043622167,0.0,0.24271043569828488,1.0,118/417,18.73%,FOXP2;FOXP1;NR2F2;GLI3;TCF7L2;RBFOX2;FOXD1;PRDM5;ZNF148;WNT4;RBPJ;MIDEAS;LIMS1;ZNF423;SMURF2;NR1D2;ZHX2;MDFIC;ATXN1;ZEB1;BMP7;ZIC2;BMP4;HDAC4;BCOR;KAT6B;NCOR1;DKK3;BTRC;WWP2;BRD7;FOXN3;VGLL4;NIBAN2;EIF4A2;RCOR1;KHDRBS1;RCOR3;ZKSCAN3;NR3C1;SMARCC2;CBX5;SMAD2;ZBTB16;ATP8B1;SBNO2;LBH;SNX6;HOXA7;TFDP2;NAB1;SHC1;L3MBTL3;WWP1;CHD8;REST;SCMH1;BCL7A;FOXK1;PTPRK;MBD2;CBFA2T2;RUNX1T1;UBE2I;BTAF1;PRMT2;JUN;LIMD1;MPHOSPH8;SMAD4;GLIS2;ID2;ATF7IP;USP47;BCLAF1;NIPBL;PBXIP1;TLE1;PCGF6;HES1;RB1;ARID5B;PIAS4;COPS2;BHLHE41;SOX13;PATZ1;IRF1;KAT8;EHMT1;TSHZ3;HINFP;ZNF318;CBFA2T3;SCML4;HDAC1;SFPQ;L3MBTL2;JARID2;ATOH8;PHC2;EPC1;SALL1;FOXK2;LOXL3;CITED2;PDCD4;HEYL;TBX2;RUNX2;TWIST2;ZMYND15;DAP;INPP5K;TRAF6;FBXW11;WNT5A;BMP2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.32045680715204755,-1.5399480258076403,0.0,0.24320181426703305,1.0,214/834,17.91%,NFIA;BMP6;PBX1;IGF1;AUTS2;HLF;EGFR;NR2F2;NFAT5;PID1;RHOQ;SMAD3;GLI3;TCF4;TCF7L2;TEAD1;BMPR1A;NFKB1;CDK8;PKD1;HDAC8;LRP6;RBPJ;ZMIZ1;THRB;INO80;DCN;GLIS3;GLI2;ZNF462;NR1D2;ZFHX3;WWOX;BMP5;RARB;FOXC1;FGF1;KAT2B;DAB2;BMP4;EP300;PPP1R12A;FOXO3;HDAC4;PRKN;KAT6B;ABL1;OSR1;ARNT;TFEB;CCNT2;JAG1;MEOX2;HOXB3;NFIB;TBL1X;ELF1;TBL1XR1;MICAL2;SSBP3;RREB1;KMT2C;BCLAF3;NFIX;CCNT1;TBK1;YAP1;SLC9A1;RARG;MEF2A;DDX17;PPARGC1B;KMT2D;HMGB1;NR3C1;CDK7;SS18;BCL9L;HOXA5;BCAS3;SMAD2;SBNO2;PLSCR1;GABPB2;MED17;SKI;CREBBP;HOXA7;TFDP2;STAT3;FGFR2;FHOD1;MED12;FOXC2;ELF4;HOXC4;CHD8;DHX9;AKAP8L;REST;VEZF1;MYSM1;CEBPG;RUNX1;AR;CRTC3;PRPF6;DHX36;RGMA;PPARGC1A;IGF2;NCOA6;CDC5L;ZEB2;SETD3;GCN1;NCOA1;MED1;CCNK;CDK13;JUP;HOXB4;ATF2;WASL;UBP1;JUN;NR1H3;GABPA;SSBP2;NOTCH3;HCFC1;THAP3;HIF1A;CREBRF;SENP1;SMAD4;GLIS2;MAVS;CALCOCO1;MED21;MAML2;CRTC1;BCLAF1;MEF2C;ZBED4;DCAF6;WWC1;PARP1;NRF1;HES1;TFCP2;TCF3;KDM1B;MLLT10;PKD2;MAML1;IRF1;CCN1;ATF6;KAT8;YBX1;OGT;GLI1;TCERG1;CRLF3;HINFP;VEGFA;PRKDC;STAT1;RORA;ACVR1;DDX3X;HDAC1;ZBED3;NCK1;RXRA;EFCAB7;KLF15;PRDM2;SFPQ;NCK2;PLXND1;ABHD14B;ATOH8;PRDM15;TGFB3;EPC1;SALL1;PTOV1;FOXK2;TNIP2;KLF6;IL18;ARRB1;CITED2;MYBL1;NR4A1;SIX1;CAMTA2;NFYB;HEYL;SERPINE1;TLR4;SMARCD2;RUNX2;PRKD1;NR4A2;CRTC2;HNRNPU;PHIP;BCL2L12;TAF6L;NFIC;LPIN2
prerank,cellular response to leucine (GO:0071233),-0.6876396579064753,-1.5386389414218842,0.026,0.24373530282806877,1.0,6/10,13.74%,UBR2;RPTOR;MTOR;SESN1;UBR1;KLHL22
prerank,response to leucine (GO:0043201),-0.6876396579064753,-1.5386389414218842,0.026,0.24373530282806877,1.0,6/10,13.74%,UBR2;RPTOR;MTOR;SESN1;UBR1;KLHL22
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5604866449767523,1.5380337863335802,0.026373626373626374,0.25865842725283456,1.0,5/19,7.34%,GRM5;RYR2;KDR;TRPM2;PTPRJ
prerank,regulation of myoblast differentiation (GO:0045661),-0.499986125594201,-1.5378838218935809,0.023715415019762844,0.2442961801340237,1.0,7/32,6.18%,RANBP3L;BOC;BMP4;FLOT2;RIPOR2;IGFBP3;TRIP4
prerank,divalent inorganic cation homeostasis (GO:0072507),0.5316863182916193,1.5376907518402678,0.030042918454935622,0.25768138900341814,1.0,6/25,7.48%,TMTC2;GRIN1;ANK3;SNCA;SLC8A1;CIB2
prerank,positive regulation of telomerase activity (GO:0051973),0.4985821749510078,1.5374086169373962,0.026804123711340205,0.2565263685580731,1.0,15/33,19.09%,PRKCQ;KLF4;HSP90AB1;CCT2;DKC1;CCT4;PARM1;PTGES3;XRCC5;CTNNB1;HSP90AA1;NAF1;MAPK3;NVL;TCP1
prerank,positive regulation of cell communication (GO:0010647),0.512329190919165,1.5373125012865332,0.02079002079002079,0.2550722815712096,1.0,10/28,8.31%,SYT1;RIMS1;RIMS2;ANK3;RIMS3;GRIK2;KCTD13;HOMER1;CLSTN3;NMB
prerank,metal ion homeostasis (GO:0055065),0.47085975099048877,1.5370183326518272,0.022044088176352707,0.2541607091464006,1.0,9/40,9.16%,TMTC2;GRIN1;ANK3;SNCA;SLC8A1;SLC12A6;SLC7A8;CIB2;SLC12A3
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.36728023982844593,-1.536809780576674,0.0,0.24539507508536448,1.0,53/182,17.80%,SLC24A3;ROCK2;NOTCH2;IGF1;FOXP1;BMPR1A;RBMS3;NFKB1;ZNF148;WNT4;CELF1;BMP4;DICER1;ROBO1;PRKN;SMO;PRKAA2;TNRC6B;WWP2;FLOT2;DLG4;TNRC6A;YAP1;MOV10;ANXA7;REST;PARP10;RUNX1;LDLR;MAP2K1;PTPN22;ITGB8;HIF1A;PARP9;PARP14;ID2;MEF2C;RB1;SETDB1;FBXW7;APOBEC1;HINFP;VEGFA;EMILIN1;APOE;HDAC1;CCDC3;TNRC6C;ATOH8;CITED2;PICALM;PRKAA1;MYADM
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.6564256677544829,-1.5361623947866474,0.03213610586011342,0.2456964499057804,1.0,7/12,19.65%,BMP4;PTPN14;KHDRBS1;NUP214;TPR;RBM4;IFI27
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.463583454122836,1.5351618697124503,0.01984126984126984,0.25604775618605513,1.0,12/44,7.94%,KCNJ3;KCNJ6;KCNN2;AKAP6;WNK2;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNJ10;GNG2;KCNN3
prerank,positive regulation of cytokinesis (GO:0032467),-0.49706632221041397,-1.5336055228045733,0.02389705882352941,0.2495405794593039,1.0,9/32,14.94%,SVIL;CDC14A;CSPP1;CDC42;RHOA;GIPC1;CUL3;CDC25B;CDC14B
prerank,neuron projection morphogenesis (GO:0048812),0.3806026650034955,1.533603031846247,0.006160164271047228,0.25742295431073736,1.0,40/137,12.36%,NYAP2;CNTNAP2;DCC;CTNNA2;ACTB;SPTBN4;EPHB1;CTNND2;NLGN1;MAPK8IP2;GPM6A;ADGRB1;MAP1B;ANK3;SHANK3;MAP2;APBB1;PAX2;TNIK;PAK1;DSCAML1;NRCAM;EPB41L3;CNTNAP1;CPNE1;ZDHHC17;UBB;SHTN1;PLPPR4;NTNG2;NTNG1;TAOK2;DAB2IP;CELSR2;BRSK2;CNTN4;SLITRK5;DVL1;SRGAP2;DOCK10
prerank,negative regulation of ossification (GO:0030279),-0.5245303413231864,-1.5335203876618335,0.028142589118198873,0.24874544940729745,1.0,8/23,18.16%,RBPJ;SMAD6;BCOR;ENPP1;MEF2C;TRPM4;ECM1;CHSY1
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.5262429476458427,-1.5331934603839572,0.013565891472868217,0.24837800931380732,1.0,12/24,22.81%,IGF1;SORBS1;ENPP1;GSK3B;IRS1;IGF2;SELENOS;PPP1R3B;INPP5K;PPP1R3C;AKT2;PPP1R3F
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.44206392760393554,-1.5324367927775575,0.015779092702169626,0.2488231585295741,1.0,13/53,11.24%,EYA2;EYA1;EGFR;DDX5;UBE2N;EYA4;PLA2R1;DHX9;BRCC3;CEBPG;RNF8;PRKCD;BCLAF1
prerank,peroxisome organization (GO:0007031),-0.5270084357331575,-1.5311330797353089,0.029143897996357013,0.2502846579255086,1.0,18/25,37.68%,ABCD3;DNM1L;ABCD2;LONP2;ABCD4;PEX6;PEX7;SEC16B;FIS1;ACOT8;PEX11B;PEX10;PEX11A;PEX16;PLAAT3;PEX19;PEX11G;PEX12
prerank,protein stabilization (GO:0050821),-0.3664463493254886,-1.5307288612630805,0.0,0.2500557242229337,1.0,70/168,25.33%,IGF1;PARVA;ANK2;PLPP3;MDM4;PER3;TRIM44;EP300;STK3;PRKN;TBL1X;FLOT2;CCNH;FLNA;CREBL2;COA8;USP7;CDK7;CCT6A;STXBP4;EPHA4;PPARGC1A;LAMP2;USP33;BAG3;PRKCD;HCFC1;RPL11;COG3;ATF7IP;COG7;TELO2;PEX6;CCT8;FBXW7;RASSF2;UBE2B;NAA15;USP2;RAB21;USP13;TRIM39;CCT5;PDCL3;ZBED3;NOP53;TNIP2;LAMP1;ZSWIM7;SYVN1;MORC3;ATP1B3;PARK7;SUGT1;WDR81;SEC16A;DVL3;PIK3R1;TAF9B;WFS1;RABL3;CHP1;HIP1R;BAG5;BAG6;NAA16;STX12;IRGM;PHB2;USP9X
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.44564607969792075,-1.5294566062062251,0.013182674199623353,0.25159193650140105,1.0,13/51,11.37%,FSTL1;FBN1;CRIM1;BMPR1A;SMAD6;SMURF2;NBL1;HTRA3;SKI;SKIL;SMAD4;BMPER;GREM2
prerank,defense response to Gram-positive bacterium (GO:0050830),0.47271146684053594,1.5291709143101178,0.02301255230125523,0.26419035915676564,1.0,11/40,16.04%,PGLYRP1;TIRAP;MBL2;IL12A;TLR2;PPP1R11;GBP4;DROSHA;DEFA6;STAB2;RNASE3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.5265781028531026,-1.5284765307683814,0.03294573643410853,0.2526119372038876,1.0,7/26,7.42%,IGF1;SORBS1;RHOQ;OSBPL8;CREBL2;IRS1;BRAF
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.5860289956397331,-1.5280086405436446,0.05956678700361011,0.25164298525784795,1.0,4/16,5.45%,PHLDB2;ARHGAP6;THBS1;BCAS3
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.5860289956397331,-1.5280086405436446,0.05956678700361011,0.25164298525784795,1.0,4/16,5.45%,PHLDB2;ARHGAP6;THBS1;BCAS3
prerank,receptor clustering (GO:0043113),0.5175059767236843,1.5269634417078766,0.022988505747126436,0.26667666612496416,1.0,7/27,6.01%,DLG2;NRXN1;LRRC7;NLGN1;MAGI2;THY1;NRXN2
prerank,Notch signaling pathway (GO:0007219),-0.44005862466676704,-1.5257424364433485,0.011320754716981131,0.2550969275859474,1.0,22/59,17.00%,PBX1;NOTCH2;GMDS;RBPJ;ZNF423;KAT2B;EP300;JAG1;CREBBP;DTX4;POFUT1;NCSTN;NOTCH3;MAML2;WWC1;HES1;MAML1;YBX1;DTX3L;STAT1;PLXND1;HEYL
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.42636467900670216,1.5255406577444006,0.006329113924050633,0.26778496538014906,1.0,13/63,15.15%,TFRC;TIRAP;SLC7A1;MIF;IL7;VAV3;FGF10;IL12A;TNFSF13B;AIF1;CD40;NFATC2;CD38
prerank,protein localization to synapse (GO:0035418),0.6216945711391169,1.5248294696223381,0.04219409282700422,0.2675926064431344,1.0,5/12,8.96%,NRXN1;PCLO;NLGN1;NRXN2;ZDHHC15
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.5862170540506322,-1.5241625914155639,0.03578528827037773,0.2573523648736875,1.0,5/16,11.26%,RANBP3L;BOC;RIPOR2;IGFBP3;MEF2C
prerank,regulation of neuron projection development (GO:0010975),0.37049461262514405,1.5240264407592001,0.0,0.26752577163613184,1.0,56/163,16.59%,SPOCK1;DCC;CTNNA2;RIT2;CSMD3;LRRC4C;LRRC7;MINAR1;MAG;IL1RAPL1;PLXNB3;S100A9;ITGA6;MBOAT1;MAGI2;CDH2;SHANK3;TOX;KIF1A;MFSD2A;NTRK2;SCARF1;FUT9;PAK1;NPTN;PLPPR5;TENM3;ITM2C;AKT1;NDNF;SCARB2;CDKL5;STMN2;ZDHHC15;RTN4R;NTNG2;NTNG1;RELN;DAB2IP;CHN1;BRSK2;PPFIA2;CCDC88A;RET;PSEN1;EFHC2;PRAG1;KNDC1;CIB1;PAK3;RTN4RL1;FKBP4;STX1B;RAP1A;CRMP1;RAB29
prerank,positive regulation of protein sumoylation (GO:0033235),-0.6660719328301185,-1.5233356624200902,0.03522504892367906,0.2581130787146244,1.0,5/10,12.39%,PIAS1;HDAC4;SAE1;PIAS3;PIAS4
prerank,regulation of sodium ion transport (GO:0002028),0.4884129163540717,1.5227172248956569,0.024017467248908297,0.26831714130817763,1.0,9/34,5.65%,NKAIN2;SPTBN4;FGF12;NKAIN1;NKAIN3;CNKSR3;ANK3;WNK2;SCN4B
prerank,sodium ion transmembrane transport (GO:0035725),0.41053681112235857,1.521863724089652,0.008888888888888889,0.26833110716493425,1.0,22/84,12.05%,SLC6A6;HCN1;SLC24A4;SLC24A2;SCN1A;SLC6A17;ASIC2;ASIC4;SLC8A1;ASIC1;SCN4B;HCN2;SLC6A2;SLC6A5;ATP1A3;SLC6A8;KCNK1;SCN3A;SLC12A3;ATP1A4;ATP1A1;SCN2A
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.5841576156006163,1.52134150575959,0.036885245901639344,0.26772105650339995,1.0,3/16,9.47%,KLRC1;IL12A;CYRIB
prerank,negative regulation of gene expression (GO:0010629),-0.3436345144564421,-1.521054766202433,0.0,0.26167878235178144,1.0,79/302,17.80%,SLC24A3;SAMD4A;ROCK2;NOTCH2;IGF1;FOXP1;BMPR1A;RBMS3;NFKB1;ZNF148;WNT4;IGFBP5;CELF1;LGR4;DIS3L2;KAT2B;BMP4;DICER1;ROBO1;PRKN;SMO;NCOR1;PPM1D;PRKAA2;TNRC6B;WWP2;FLOT2;TNRC6A;YAP1;SYNCRIP;DDX6;EIF4ENIF1;MOV10;TWSG1;DNMT3A;EIF2AK3;ANXA7;LARP1;REST;PARP10;PTBP3;RUNX1;DHX36;MAP2K1;PTPN22;LSM14A;ITGB8;HIF1A;PARP9;PARP14;MPHOSPH8;ID2;CNOT8;MEF2C;ATP2B1;RB1;SETDB1;FBXW7;YBX1;PHF1;EIF2AK2;ERN1;HINFP;VEGFA;EMILIN1;APOE;DDX3X;HDAC1;CCDC3;JARID2;TNRC6C;ATOH8;DAPK1;EPC1;CITED2;CNOT1;PICALM;PRKAA1;MYADM
prerank,negative regulation of autophagy (GO:0010507),-0.44048973762029453,-1.5198923403007807,0.008064516129032258,0.26309321955293197,1.0,27/54,28.53%,LEPR;EIF4G3;SMG1;LRRK2;NUPR1;ZKSCAN3;STAT3;BCL2;MTOR;FOXK1;PTPN22;EIF4E;SNRNP70;KLHL22;CTSA;FOXK2;RUBCN;DAP;EIF4G1;NRBP2;BMF;DAPL1;WDR6;RRAGA;HGF;MET;MT3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.6048578702924967,-1.5198918602143505,0.03488372093023256,0.26206551166405334,1.0,4/14,7.81%,TGFBR1;EFEMP1;ADAMTS12;WNT9A
prerank,positive regulation of autophagy (GO:0010508),-0.4089027081517911,-1.519513977760729,0.007920792079207921,0.2618190578936286,1.0,32/81,25.04%,RNF152;DCN;FOXO3;ROCK1;PRKN;PRKAA2;TFEB;LRRK2;GSK3B;TBK1;HMGB1;TPCN1;UFL1;TRIM8;LARP1;SESN1;PAFAH1B2;TRIM5;EIF2AK4;ATF6;DAPK1;PRKD1;PRKAA1;PARK7;PLEKHF1;ORMDL3;BNIP3;WAC;TICAM1;TRIM68;IRGM;PHB2
prerank,muscle contraction (GO:0006936),-0.3824927437947721,-1.518649525663083,0.00202020202020202,0.262750659017807,1.0,21/126,8.42%,CALD1;ROCK2;SORBS1;VCL;TPM1;MYLK;VIM;ROCK1;PABPN1;TLN1;SNTA1;MYOF;TMOD3;SNTB1;EDNRA;ITGB5;TPCN2;SSPN;ASPH;SMTN;ACTN2
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5851487928905937,-1.518196203774502,0.027131782945736434,0.262595353463796,1.0,4/16,9.88%,PRKAG2;APPL2;PPARGC1A;LONP2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.6179170886049699,1.5171731659149146,0.0472972972972973,0.27417180383456347,1.0,5/13,6.84%,SHISA6;GRIK2;SHISA8;PPFIA3;SHISA7
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.6114472679506637,-1.517074050451324,0.044326241134751775,0.263878373942761,1.0,7/14,21.62%,GHR;STAT3;LYN;STAT5A;STAT5B;PTPN1;PIK3R1
prerank,cellular response to calcium ion (GO:0071277),0.4280308282661423,1.516330867430891,0.018329938900203666,0.27435855389753594,1.0,14/67,7.15%,SYT1;ADCY8;SYT6;NLGN1;SYT7;SYT12;SYT11;RYR3;CPNE9;TRPM2;CPNE8;KCNH1;CPNE1;SYT10
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.4433943690727555,1.51457979159653,0.017057569296375266,0.2744390533259525,1.0,27/56,21.57%,NDUFC1;NDUFA1;NDUFAF5;NDUFA2;TIMM21;NDUFC2;DMAC2;NDUFA3;NDUFA13;TMEM126A;DMAC1;NDUFB2;NDUFAF1;ECSIT;BCS1L;NDUFB9;NDUFA7;NDUFAB1;NDUFAF6;NDUFA12;NDUFB8;OXA1L;NDUFB4;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.4433943690727555,1.51457979159653,0.017057569296375266,0.2744390533259525,1.0,27/56,21.57%,NDUFC1;NDUFA1;NDUFAF5;NDUFA2;TIMM21;NDUFC2;DMAC2;NDUFA3;NDUFA13;TMEM126A;DMAC1;NDUFB2;NDUFAF1;ECSIT;BCS1L;NDUFB9;NDUFA7;NDUFAB1;NDUFAF6;NDUFA12;NDUFB8;OXA1L;NDUFB4;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5816593059082891,-1.5139214317840477,0.047957371225577264,0.26946923479875773,1.0,7/16,9.92%,PDGFRA;PDGFRB;ABL1;PLAT;NRP1;FER;PDGFC
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.5707889941567021,-1.5132677784614739,0.04954128440366973,0.26992139013992344,1.0,7/18,17.45%,KLF9;NR3C1;ANXA1;REST;PCK2;FAM107A;HNRNPU
prerank,regulation of metal ion transport (GO:0010959),-0.5827294878822487,-1.5119697597171209,0.047058823529411764,0.2715917609391974,1.0,8/16,13.25%,STIM1;ANK2;DLG1;SLC30A10;IL16;BCL2;CAMK2G;SRI
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.5839717122376793,-1.511454670908461,0.03143418467583497,0.27161776050385766,1.0,6/16,13.44%,SOX5;PTN;FOXC1;DHX36;HOXB4;SOX6
prerank,epithelial cell migration (GO:0010631),-0.47350076776813466,-1.5114010192413312,0.03148148148148148,0.27070055972247276,1.0,15/37,15.86%,FSTL1;KANK2;ROCK1;ABL1;KIT;DPP4;ADGRA2;NRP1;ZEB2;CYP1B1;RHOA;GIPC1;FAP;STAT1;PLXND1
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.5839654223787863,-1.5112056455577974,0.035269709543568464,0.2700452512003937,1.0,8/16,19.13%,LRP1;ROCK1;APOE;HDAC1;IFNGR1;HMGCR;CYP51A1;ABCA7
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.6159736246240486,-1.5108332804724154,0.026415094339622643,0.2698182529756871,1.0,6/13,16.81%,IL6ST;JAK1;STAT3;TYK2;STAT1;OAS2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.4186149919594956,-1.5095430531657676,0.011342155009451797,0.2715111277297607,1.0,24/67,21.54%,DOCK5;PLEKHA2;LIMS1;ECM2;ABL1;RREB1;GSK3B;FLNA;VIT;NRP1;S100A10;CDC42;RSU1;JUP;FN1;CARMIL1;DOCK1;MYADM;NPNT;MYOC;TRIOBP;P4HB;CRKL;CDK6
prerank,chordate embryonic development (GO:0043009),-0.43162747412367736,-1.5085069292753932,0.01953125,0.27268268794953504,1.0,21/55,18.73%,SULF1;ALDH1A2;TGFBR1;COL1A1;PKD1;BMP5;BMP7;PCSK5;RBP4;SULF2;FGFR2;IGF2;DACT1;PKD2;HINFP;VEGFA;CHD7;PTCH1;TGFB3;WNT5A;BMP2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5526205906253238,-1.5083498055398423,0.04133858267716536,0.2719812657627746,1.0,8/21,17.21%,IGF1;BMPR1A;IGFBP5;GJA1;JUN;MMP2;ERN1;ADAMTS1
prerank,Wnt signaling pathway (GO:0016055),-0.396335848525626,-1.5078954983669866,0.011342155009451797,0.2717812116269568,1.0,18/92,5.97%,WLS;NXN;TCF7L2;WNT4;LRP6;PLPP3;LRRK2;CSNK1A1;BTRC;WNT5B;GPC4;WNT6;GSK3B;RYK;RARG;BCL9L;AXIN1;FZD2
prerank,ureteric bud development (GO:0001657),-0.5689285414828076,-1.5076138579714569,0.0433996383363472,0.27142513094009607,1.0,11/17,18.73%,FOXC1;BMP7;BMP4;OSR1;GPC3;FGFR2;PKD2;SALL1;SIX1;NPNT;BMP2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.4376261360335874,-1.5061105963365964,0.023593466424682397,0.27358674778163034,1.0,19/51,16.01%,ROCK2;LPAR1;TGFBR1;TPM1;CCN2;ABL1;PPM1E;ARHGEF10L;FHOD1;NRP1;RAPGEF3;S100A10;CDC42;SYNPO2;RHOA;SYNPO;SORBS3;CARMIL1;TGFB3
prerank,smooth muscle contraction (GO:0006939),-0.6040483008093047,-1.5054996301454997,0.03667953667953668,0.2738346963658188,1.0,8/14,15.99%,ROCK2;MYLK;ROCK1;EDNRA;TPCN2;SMTN;BDKRB2;MYH11
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.3332297903474198,-1.5044477792051585,0.0,0.27490733785521954,1.0,131/366,25.79%,NFIA;BNC2;DENND4A;TGFBR1;EFEMP1;ANKRD17;ZNF423;NR1D2;ATXN1;ZFHX3;FOXC1;EP300;FOXO3;ERC1;KAT6B;ABL1;WWC2;TFEB;FOXN3;RREB1;GON4L;WTIP;CREBL2;PPARGC1B;KMT2D;BAZ2A;NR3C1;SRSF10;RBBP6;PRRX2;FUS;SBNO2;CREBBP;TRIP4;STAT3;NSD1;NSD3;TRRAP;NAB1;REST;POFUT1;HNRNPD;GTF2IRD1;CTR9;PPARGC1A;IGF2;NFYC;GEMIN5;ATF2;EIF4E;CHD3;ZFAT;SSBP2;HCFC1;HIF1A;LIMD1;TULP3;GPBP1L1;CDK11B;MEF2C;WWC1;TEAD2;RB1;SPTY2D1;TCF3;TCF7L1;CRABP2;FZD7;SOX13;PATZ1;SUFU;SOX6;YBX1;CCAR1;PHF1;ESCO1;BRCA2;HINFP;RORA;USP13;CHD7;TAF5L;PRDM2;SFPQ;VSX1;FOXK2;PRMT5;MYBL1;GLRX2;ATXN1L;SIX1;NFYB;RNF20;ZFP37;TAF6L;MSL3;POU6F2;HMG20A;RHOH;BMP2;RNF14;AJUBA;NFX1;EIF2B4;PML;NFYA;PPP2CA;EZH2;SPIN1;ZNF205;IRF2;DRAP1;RABL3;TRAPPC2;NFXL1;CCAR2;RNF6;MAFB;CXXC1;ZNF35;NONO;LDB1;MZF1;SOX11;RPS6KA4;NFKB2;ACTR5;EDF1;DVL2;OGG1;ZNF219
prerank,mitochondrion distribution (GO:0048311),-0.6133120077770433,-1.5039390277621323,0.031598513011152414,0.2749762438924149,1.0,5/12,13.39%,TRAK1;LRRK2;MEF2A;DNM1L;ARMC1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.6464256634189717,1.5036231192495457,0.05908096280087528,0.2947014010964188,1.0,5/10,13.93%,PDE4B;CACNA2D1;CACNB2;CALM1;CALM3
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.481973687997626,-1.5026627212428836,0.023575638506876228,0.27674585324958856,1.0,16/33,26.95%,APPL2;PKD1;INO80;STXBP4;MN1;ID2;APPL1;FBXW7;GLI1;TRIM39;CDC73;EZH2;PLK5;PHB2;TCIM;PSME1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.5617927494542441,1.5019492396506933,0.05625,0.2963411762048344,1.0,7/16,11.67%,ST6GALNAC3;ST8SIA4;B4GALNT1;ST8SIA1;B4GALT6;ST8SIA6;ST8SIA3
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.6066537427888425,-1.501243510180718,0.0499001996007984,0.2788408917842754,1.0,5/14,4.75%,LRP1;BMPR1A;TPM1;IGFBP5;IGFBP3
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5870000665550998,-1.5001699835527877,0.054945054945054944,0.279986840705411,1.0,6/14,24.80%,DHX9;DHX36;YBX3;CPEB1;PKM;UNK
prerank,cellular response to glucose starvation (GO:0042149),-0.4672697864454778,-1.50004066799853,0.019891500904159132,0.27929713285183383,1.0,21/41,26.18%,PRKAG2;FOXO3;PRKAA2;EIF2AK3;SESN1;IMPACT;BRSK1;SIK1;MTMR3;BECN1;PIK3C3;PIK3R4;PRKAA1;RRP8;PRKAG3;SIK2;TBL2;ATG14;SZT2;NUAK1;KPTN
prerank,regulation of feeding behavior (GO:0060259),-0.6418082898154399,-1.4995398149383572,0.044859813084112146,0.2793576603751638,1.0,4/11,12.61%,LEPR;AGRP;STAT3;EIF2AK4
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.5062590611360794,-1.4995163682856103,0.04519774011299435,0.27841766787992717,1.0,11/28,15.31%,ZIC1;SMAD3;FLNA;UBR5;CDH1;JUP;BAG3;PRKCD;MAVS;TPR;EFCAB7
prerank,sphingolipid metabolic process (GO:0006665),0.3895126129456106,1.4986453053016662,0.01050420168067227,0.3014278300331161,1.0,36/108,18.82%,ST6GALNAC3;GAL3ST1;SGMS1;FA2H;ACER2;DEGS2;CERT1;B4GALNT1;ENPP2;ORMDL1;ORMDL2;NEU2;SPNS2;PPP2R1A;ELOVL7;SGPP2;ELOVL4;TECR;ARSA;SERINC1;SMPD1;GLA;HACD3;CPTP;HACD1;PPT1;PPM1L;SAMD8;PRKD3;GALC;KDSR;GLB1;HEXB;SGPP1;SPTLC2;NEU1
prerank,membrane depolarization (GO:0051899),0.47686785873984505,1.4978011812414533,0.02880658436213992,0.30141069768265594,1.0,11/32,15.88%,CACNA1A;SCN1A;CACNA1B;CACNG2;CACNA1E;SCN3A;CACNB4;P2RX7;SCN2A;CACNA1I;SCN8A
prerank,urogenital system development (GO:0001655),0.6328762608973084,1.4976790847858035,0.058577405857740586,0.2999788663837771,1.0,4/11,6.67%,PAX8;AMH;PAX2;LHX1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.5463716072683988,-1.4967057576769451,0.057034220532319393,0.28328705456352654,1.0,6/19,15.89%,ENPP1;TPST1;SLC35B3;SLC26A2;SULT1A1;ABHD14B
prerank,negative regulation of phosphorylation (GO:0042326),-0.39684215915332477,-1.4948724608348856,0.010183299389002037,0.2861653846133478,1.0,41/85,27.18%,PTPN13;PID1;LRP6;NTRK3;PLPP3;FBLN1;BMP7;BMP4;ROCK1;HDAC4;PRKN;NCOR1;LRRK2;NUPR1;IBTK;IGFBP3;LYN;IMPACT;ANKLE2;FKBP8;PRKDC;CBFA2T3;ZBED3;HNRNPU;MYADM;INPP5K;PARK7;INHBA;CDKN1C;CRKL;CDK5RAP3;ATG14;CHP1;PRKRIP1;SLIT2;SIRPA;PPARA;WARS1;CACTIN;PPP1R15B;TESK1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.4403299463866563,-1.494041450849218,0.01717557251908397,0.28692330308113134,1.0,23/54,21.57%,RNF152;UBE2E2;PRKN;RNF115;RNF146;UBR5;UBE2H;RNF8;UBE2K;RNF216;UBE2R2;CUL3;DTX3L;UBE2B;FBXO38;TOPORS;UBE2E1;BFAR;SYVN1;UBE2D3;IFI27;TTC3;ARIH2
prerank,activin receptor signaling pathway (GO:0032924),-0.5656366454169687,-1.4921778999660502,0.0513347022587269,0.29013493891411557,1.0,5/15,19.46%,SMAD3;TGFBR1;SMAD2;ACVR1;INHBA
prerank,protein O-linked glycosylation via serine (GO:0018242),0.6486744765522208,1.491629212418532,0.059957173447537475,0.3109184253610441,1.0,7/10,16.88%,GALNT13;MGAT5B;GALNT3;GALNT2;POGLUT1;GALNT16;GALNT4
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5452841925397266,1.490702080045674,0.05353319057815846,0.31105903117739964,1.0,6/19,11.89%,SLCO1C1;PAX8;KLF4;PDGFB;MAPK8;KLF2
prerank,negative regulation of cholesterol transport (GO:0032375),-0.6457784240106068,-1.4893933133453565,0.06358381502890173,0.29530611423938224,1.0,1/10,1.20%,NFKB1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4949757713158999,-1.4893554645859486,0.02321083172147002,0.2943840427830999,1.0,13/28,18.42%,PID1;APPL2;GRB10;TNS2;ENPP1;IRS1;PIP4K2C;PTPN2;PRKCD;PRKCZ;NCK1;INPP5K;PTPN1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5211244320481847,1.488986362771086,0.04631578947368421,0.31290276267804323,1.0,3/23,4.98%,CADM1;KLRC1;IL12A
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.5304921681019795,-1.4882983981122535,0.043222003929273084,0.29567537675819944,1.0,11/21,25.08%,MED17;MED12;DHX36;MED1;JUN;BCLAF1;MED16;MED13;MED14;PAXIP1;TWIST1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.5228781691294557,-1.488125733239267,0.0390625,0.2950004907591334,1.0,4/23,7.33%,ATP1A2;ANK2;DIAPH1;CAMK2D
prerank,neutrophil migration (GO:1990266),0.42288927261940534,1.4880862875495884,0.010548523206751054,0.3130526128799594,1.0,7/58,8.57%,BSG;PDE4B;S100A9;S100A8;TGFB2;PECAM1;CCL2
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.39660687449532794,-1.4877971895332474,0.008,0.29467783221855665,1.0,15/85,7.45%,BMP6;TGFBR3;IGF1;EGFR;TCF7L2;ANGPT1;LIMS1;BMP5;FGF1;BMP4;OSR1;NUPR1;YAP1;FGFR2;SRSF6
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.5543210169128562,-1.4877900766121595,0.03874538745387454,0.2936808873965055,1.0,12/17,31.10%,HM13;OS9;SELENOS;FAF2;AUP1;DERL1;SYVN1;VCP;SEL1L;DERL2;HERPUD1;UFD1
prerank,ceramide transport (GO:0035627),0.6173468665307561,1.487635135955855,0.06680161943319839,0.3123276537144808,1.0,5/12,12.46%,PLTP;CERT1;ABCB4;PLEKHA3;CPTP
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.514680023548918,-1.4868803747987223,0.03696498054474708,0.2947376781096707,1.0,18/26,41.87%,ERRFI1;CBLB;SNX6;SHC1;FBXW7;NCK2;ADRA2A;HBEGF;EGF;APP;GPRC5A;ZGPAT;ADAM17;CBL;TSG101;SOCS4;CHMP6;BTC
prerank,positive regulation of protein import (GO:1904591),-0.4901030378715467,-1.4866334357480586,0.045454545454545456,0.29423706591459414,1.0,11/30,15.31%,ZIC1;SMAD3;FLNA;UBR5;CDH1;JUP;BAG3;PRKCD;MAVS;TPR;EFCAB7
prerank,positive regulation of binding (GO:0051099),-0.396838421815637,-1.486241780349582,0.011787819253438114,0.29412709588269603,1.0,26/84,14.69%,IGF1;TCF7L2;LRP1;PKD1;FOXC1;BMP4;STK3;PRKN;LRRK2;VTN;GSK3B;MARK3;HMGB1;SKI;DHX9;CEBPG;DACT1;NGF;USP33;PARP9;RPL11;HES1;DTX3L;TXN;RAPGEF2;APOE
prerank,signal peptide processing (GO:0006465),-0.6302556664744083,-1.4861265685822496,0.055762081784386616,0.2933706154986295,1.0,8/11,26.87%,PCSK5;HM13;SEC11C;SEC11A;SPPL3;CLN5;PARL;SPCS3
prerank,regulation of telomere maintenance (GO:0032204),-0.5074595871066121,-1.4859597292119349,0.048507462686567165,0.29268734267164226,1.0,16/26,28.10%,SMG6;HDAC8;SMG1;USP7;NBN;YLPM1;HNRNPD;DHX36;UPF1;MRE11;TERF2;PML;ERCC1;PPP1R10;ATRX;GNL3
prerank,regulation of focal adhesion assembly (GO:0051893),-0.4315729131379631,-1.485012741780882,0.02631578947368421,0.29361792570745626,1.0,15/54,7.83%,PHLDB2;ROCK2;ARHGAP6;EPHA3;VCL;LIMS1;ROCK1;ABL1;SLC9A1;SLK;THBS1;BCAS3;MAP4K4;NRP1;S100A10
prerank,regulation of gene expression (GO:0010468),-0.3065540310042345,-1.4832155391444402,0.0,0.29652027993507724,1.0,215/903,17.06%,NFIA;BMP6;SLC24A3;ROCK2;NOTCH2;PRDM6;IGF1;BNC2;FOXP1;DENND4A;PID1;AHNAK;AFDN;SMAD3;TGFBR1;EFEMP1;ANK2;BMPR1A;FOXD1;SON;RBMS3;NFKB1;PRDM5;ZNF148;GSN;ANGPT1;WNT4;RBPJ;CLK1;NTRK3;LIMS1;ZNF423;CELF1;ZNF462;NR1D2;ATXN1;ZFHX3;HNRNPH1;FOXC1;FGF1;AFF3;BMP7;TRIM44;BMP4;EP300;ROCK1;HDAC4;ERC1;DICER1;ROBO1;PRKN;KAT6B;SMO;ABL1;OSR1;PRKAA2;WWC2;TNRC6B;TFEB;PABPN1;MBNL2;WWP2;FOXN3;FLOT2;WNT6;RREB1;GSK3B;PUM2;GON4L;ZC3H7A;WTIP;TNRC6A;CREBL2;YAP1;PPARGC1B;KMT2D;BAZ2A;NR3C1;CTSH;SRSF10;MOV10;HOXA5;PRRX2;FUS;UBR5;SBNO2;PLSCR1;RC3H1;CDH1;AFF1;CREBBP;TRIP4;STAT3;NSD1;NSD3;TRRAP;MED26;DTNBP1;ZUP1;NAB1;EIF2AK3;LYN;ANXA7;MTOR;F3;LARP1;REST;BRAF;PARP10;POFUT1;PTBP3;HNRNPD;PUM1;RUNX1;GTF2IRD1;AR;CTR9;DHX36;PCBP2;PPARGC1A;FUBP1;GJA1;IGF2;NFYC;KDM6A;MAP2K1;MED1;PTPN22;HNRNPK;CLK2;ATF2;CHD3;NGF;ZFAT;GABPA;TADA3;ITGB8;SSBP2;HCFC1;HIF1A;PARP9;LIMD1;PARP14;TULP3;RPL11;CALCOCO1;YTHDC1;ID2;AFF4;CLK3;GPBP1L1;CDK11B;MEF2C;WWC1;NFKBIZ;TRIM5;TLE1;TEAD2;RB1;SPTY2D1;ADAM19;TRIM11;SNRNP70;FN1;TCF3;TCF7L1;YBX3;CRABP2;SETDB1;FZD7;FBXW7;SOX13;PATZ1;ADNP2;SUFU;SOX6;YBX1;CGGBP1;ATRAID;CCAR1;PHF1;BRCA2;HINFP;VEGFA;RORA;EMILIN1;USP13;APOE;CHD7;TAF5L;TRIM39;DDX3X;HDAC1;PDCL3;PRDM2;SFPQ;CCDC3;VSX1;TNRC6C;ATOH8;TRAF3;FOXK2;EPHX2;PRMT5;IFNGR1;CITED2;MYBL1;GLRX2;ATXN1L;SIX1;NFYB;PIK3CD;RNF20;ZFP37;TLR4
prerank,cation transport (GO:0006812),0.35631697142838176,1.4824035626086909,0.004056795131845842,0.32141600902079726,1.0,30/167,9.70%,SLC6A6;GRIN1;SCN1A;SLC6A17;KCNJ3;SLC7A1;KCNJ6;KCNN2;FGF13;KCNMB2;KCNMB3;SLC1A1;SLC8A1;KCNN1;ASIC1;SCN4B;KCNMB4;TRPM2;KCNJ10;KCND3;KCNH1;KCNK9;SLC7A8;KCNAB1;KCNC1;KCNK1;SCN3A;SLC66A1;SLC12A3;SLC36A1
prerank,cellular response to leucine starvation (GO:1990253),-0.6441541502973366,-1.4823531050759615,0.0690978886756238,0.2973168510917648,1.0,6/10,21.11%,MTOR;GCN1;SESN1;IMPACT;EIF2AK4;LARS1
prerank,neuron projection development (GO:0031175),0.3570928290988908,1.4822271361532693,0.004219409282700422,0.32003688667509345,1.0,38/168,11.10%,NYAP2;CNTNAP2;GPRIN1;FRY;PLP1;GRM7;TMEM108;EPHB1;CTNND2;NLGN1;GPM6A;SH3GL2;GPM6B;SHANK3;STMN1;MAP2;TNIK;STX3;OMG;PAK1;PPP1R9A;GPRIN3;EPB41L3;CNTNAP1;STMN4;ADCYAP1;BICDL1;RASGRF1;UBB;SHTN1;CAMSAP1;RAB35;STMN2;TAOK2;DAB2IP;PTPRM;MICALL2;CNTN4
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.6468600316298152,-1.4821672624976692,0.05390334572490706,0.29670861641620233,1.0,5/10,20.19%,SETD7;SETD3;SETD2;EHMT1;KMT5A
prerank,negative regulation of lipid catabolic process (GO:0050995),0.5536938491258485,1.4819797835947084,0.05919661733615222,0.31884180933874734,1.0,6/17,16.44%,HCAR2;MFSD2A;ALK;AKT1;SORL1;GPLD1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.38213004694896163,1.481668012714801,0.00398406374501992,0.31782363026000615,1.0,19/107,6.14%,SLC39A10;SLC24A4;SLC24A2;MT2A;CXCL12;RYR2;HTR2C;SLC8A1;ATP2B3;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;SLC30A1;NPTN
prerank,cellular response to interleukin-6 (GO:0071354),-0.5027461142597222,-1.4801390382140494,0.042801556420233464,0.30024570264662487,1.0,13/26,14.43%,PID1;NFKB1;IL6ST;PTGIS;JAK1;YAP1;SBNO2;STAT3;CTR9;FER;SMAD4;IL6R;STAT1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.5460130417246513,1.479706711562884,0.045951859956236324,0.3204636154920108,1.0,8/18,20.93%,CHRM3;GRK2;PLCB1;OPRM1;CHRM2;GNAQ;RGS10;CDK5R1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5709838379980132,1.4790693629939495,0.04893617021276596,0.32006828506022783,1.0,6/15,13.66%,KCNJ3;KCNN2;KCND3;ATP1A1;KCNJ8;ATP1B1
prerank,regulation of peptide hormone secretion (GO:0090276),0.41013084190075577,1.4790429436443215,0.014925373134328358,0.3184339722746487,1.0,11/67,6.38%,PAX8;CACNA1A;SLC2A1;MTNR1B;SYT7;KCNC2;SNAP25;HADH;HTR2C;KCNJ11;CACNA1E
prerank,histone ubiquitination (GO:0016574),-0.5283475621031893,-1.4788764078292231,0.0437375745526839,0.3019842880117386,1.0,11/21,21.87%,UBE2N;UBR2;HUWE1;RNF8;CTR9;DTX3L;UBE2B;UBE2E1;RNF20;CDC73;WAC
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.6214862069691995,-1.478274889553206,0.051756007393715345,0.3022083009238254,1.0,5/11,18.89%,LRP6;RYK;NR4A2;WNT5A;FZD1
prerank,regulation of glycolytic process (GO:0006110),-0.4123947365340777,-1.4782588441146285,0.01717557251908397,0.3012369619272425,1.0,17/68,14.51%,ZBTB20;PRKAG2;IGF1;EP300;HDAC4;NCOR1;PRKAA2;ARNT;NUPR1;RANBP2;PFKFB4;NUP42;HIF1A;NUP214;TPR;OGT;CBFA2T3
prerank,heme catabolic process (GO:0042167),0.5809517025412356,1.4777028980808096,0.06708595387840671,0.3178816740229923,1.0,2/14,9.62%,ABCG2;SLCO2B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.5809517025412356,1.4777028980808096,0.06708595387840671,0.3178816740229923,1.0,2/14,9.62%,ABCG2;SLCO2B1
prerank,positive regulation of signal transduction (GO:0009967),-0.34393516091466547,-1.4776107914701186,0.0,0.30164861669270854,1.0,67/238,16.51%,BMP6;WLS;SULF1;IGF1;SASH1;SORBS1;TGFBR1;RBPJ;ZMIZ1;NTRK3;LIMS1;GRB10;ITGAV;FGF1;KAT2B;AXL;TRIM44;IL6ST;EP300;CCBE1;PTGIS;ROBO1;SMO;ARNT;JAG1;LRRK2;VTN;TSPAN5;NLGN2;DLG4;DCDC2;FLNA;TTC23;YAP1;IRS1;SULF2;RSPO3;SLC39A14;SKI;CREBBP;STAT3;FGFR2;NRP1;F3;IGF2;DACT1;MN1;RSPO2;CCN3;HIF1A;EVC;MAML2;ARMC9;PKD2;MAML1;GLI1;TPD52L1;BMP2K;ING5;ERN1;PRKCZ;TRIM39;ITGA5;CSNK2A1;SALL1;LOXL3;CITED2
prerank,positive regulation of ossification (GO:0045778),-0.4539049099462239,-1.4775795846626063,0.027079303675048357,0.30074744728738134,1.0,22/39,21.31%,BMP6;BMPR1A;PTN;WNT4;BMP7;BMP4;OSR1;ZBTB16;ADGRV1;KL;MEF2C;ATP2B1;CCN1;ATRAID;ACVR1;TGFB3;FBN2;WNT5A;BMP2;PTPN11;PKDCC;TMEM119
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.4458882089433196,-1.4774465869734443,0.02962962962962963,0.30004917200498926,1.0,12/43,11.45%,SMAD3;TEAD1;DDX5;BMP4;FOXO3;NFIB;NR3C1;STAT3;REST;JUN;HIF1A;NFATC4
prerank,inositol lipid-mediated signaling (GO:0048017),-0.44431891299292187,-1.4774012452399699,0.028409090909090908,0.2991821180425669,1.0,18/50,17.22%,IGF1;GAB2;PLCE1;PDGFRA;PI4KA;ADAP2;PDGFRB;PLCD3;IRS1;NGF;PLCB3;PLCD1;RHOA;PITPNM2;OGT;PIK3C3;PIK3CD;PLCL1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.5705627814032381,-1.4767212547076742,0.040145985401459854,0.2996027669616111,1.0,11/15,31.10%,OS9;SELENOS;FAF2;AUP1;DERL1;SYVN1;VCP;SEL1L;DERL2;HERPUD1;UFD1
prerank,positive regulation of dendritic spine development (GO:0060999),0.529787160745487,1.476424761601994,0.045081967213114756,0.3190295173934852,1.0,5/20,13.50%,LRP8;NLGN1;SHANK3;RELN;PSEN1
prerank,RNA metabolic process (GO:0016070),-0.37178630435363375,-1.47576168624892,0.008421052631578947,0.30083954038325134,1.0,39/127,19.82%,RBMS1;CELF2;RBFOX2;TENT2;RBPMS;ATXN1;HNRNPH1;FTO;RBM39;DICER1;PABPN1;HNRNPR;WTAP;SYNCRIP;DDX17;RBMS2;RBM6;HNRNPM;DHX9;HNRNPD;HNRNPUL1;DHX36;PCBP2;HNRNPK;DUSP11;XRN2;ALKBH1;RBM5;APOBEC1;PAPOLG;DDX3X;MTREX;RNGTT;HNRNPU;POLR2H;HNRNPA3;RNASE4;RBM4;SIDT2
prerank,organelle organization (GO:0006996),-0.3259559447207751,-1.4755691604681938,0.0,0.3003253681525292,1.0,141/388,25.26%,ARHGAP10;MICAL3;PLCE1;TPM1;OPA1;BRWD1;DIAPH1;PRKN;GBF1;LRRK2;FBXW8;SYNE3;RAB30;NUMA1;CSNK1A1;ATL3;MICAL2;ABCD3;PACSIN2;WDPCP;ODF2;YTHDF3;WTIP;HPS3;HUWE1;UBXN2B;DNM1L;CXADR;BCAS3;GOLGB1;ATP8B1;SEC23IP;VPS4B;VPS13D;ARFGEF1;AFG1L;RAB3GAP1;EIF2AK3;ARHGAP21;OBSL1;CDC42;CHMP4B;CHMP4A;PPARGC1A;ABCD2;MARK4;USP6NL;MTX3;CHMP5;ATP8B2;RANBP10;WASL;SEC31A;PALLD;LONP2;ATL2;TBC1D20;GABPA;CHMP3;FAM161A;HCFC1;LIMD1;RHOT1;COG3;COG7;STX4;PARP1;ZMYM4;NRF1;YME1L1;ABCD4;PEX6;FGD1;PKD2;VPS13C;SIRT5;SURF4;ZMYM3;CAPZB;NECTIN2;DOP1B;APOE;FGD4;TTC17;RANBP9;FAF2;STOML2;ZFYVE16;MARK1;AUP1;PRKD1;TMED3;MIA3;PHIP;MICAL1;ATXN7;TJAP1;TMED4;CSNK1D;SMPD4;PARK7;TMED5;AJUBA;TMCC1;PEX7;PLEKHF1;SEC16B;SIPA1L3;CNN2;TERT;SPRYD3;KIF9;PYROXD2;TRIP11;DES;WDR81;SEC16A;KIFAP3;CUL7;MAST2;TOR1A;SSBP1;SIRT4;STX17;PLEKHM2;PPID;COG4;PI4K2B;ARMC2;VAPA;RHOT2;LMAN1;SAR1B;SPTSSB;BAG5;SIRT3;CENPT;KIF3A;PHB2;BSCL2;CLUH
prerank,negative regulation of ion transport (GO:0043271),0.5193448292506577,1.4754770119313867,0.04375,0.31930919386987816,1.0,5/24,4.10%,CD33;GPM6B;SYT11;SNCA;WNK2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.4237800710397096,-1.4752792450748982,0.01761252446183953,0.30000077238419814,1.0,26/58,26.74%,UBE2N;UVRAG;HMGB1;NBN;NSMCE2;BRCC3;RNF8;SMC5;HERC2;XRCC4;POLM;PAXX;PIAS4;PRKDC;ERCC8;MRE11;KDM2A;DCLRE1A;XRCC6;SMARCAL1;UBE2V2;ERCC1;PAXIP1;ZBTB7A;IFFO1;ABRAXAS1
prerank,lipid modification (GO:0030258),0.4610061416095247,1.4749379489809173,0.03333333333333333,0.31874206778525904,1.0,10/37,8.81%,DGKI;PLPPR1;MBOAT1;DGKH;PLPPR5;CYP2E1;SGPP2;DGKB;PLPPR4;PLPP4
prerank,defense response to bacterium (GO:0042742),0.38560082276454666,1.4748027831872266,0.007736943907156673,0.3174495080422802,1.0,21/105,14.60%,PGLYRP1;TIRAP;MBL2;RPS19;S100A9;S100A8;ADGRB1;ISG15;IL12A;TLR2;RPL30;EPX;NOD1;SLPI;PPP1R11;GBP4;DROSHA;LCN2;LPO;DEFA6;STAB2
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.4106288956113232,-1.4736376822859814,0.022018348623853212,0.3025129768504291,1.0,34/68,29.48%,GTF2H2;PABPN1;CCNH;WDR33;PCF11;CDK7;SCAF8;CPSF3;CAVIN1;TBP;SSU72;TAF1D;MNAT1;SLBP;ERCC3;TTF1;PRMT5;CSTF3;POLR2H;SNRPF;CPSF4;CSTF1;NUDT21;POLR2K;GTF2H1;POLR2E;CPSF1;LSM11;NCBP2;TAF1C;GTF2H4;POLR1G;TAF1A;POLR1C
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.48516633863004943,-1.473027762346955,0.03838771593090211,0.302814376242427,1.0,10/30,10.64%,FSTL1;TGFBR3;SMAD3;SMURF2;NREP;DKK3;SMAD2;TWSG1;XIAP;SMAD4
prerank,ncRNA processing (GO:0034470),0.34993017840650803,1.4714807684602664,0.0,0.3228853742889089,1.0,57/200,16.46%,EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPL10;RPL15;LIN28B;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;FBL;RPL12;RPL13;RPS15;NOL6;RPL14;RPL5;INTS2;RPP30;RPL21;RPS7;RPL23A;DKC1;POP5;RPL8;DROSHA;RPS14;DDX10;RPS2;PIH1D2;WDR75;RPL18A;RPS28;RRP1;RRP1B;NOP56;INTS11;RPS25;INTS10;MDN1;UTP15;EXOSC4
prerank,epidermis development (GO:0008544),-0.42455967244214354,-1.471161835929977,0.026052104208416832,0.30604363235951343,1.0,16/56,24.66%,SVEP1;CCN2;FLOT2;FGFR2;LAMA3;ATP2A2;EMP1;UGCG;CRABP2;YBX1;GLI1;HDAC1;PTHLH;GATA6;HDAC2;LAMC2
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.6458047848857394,-1.4704173728340355,0.054901960784313725,0.3067449197608466,1.0,7/10,29.63%,ERRFI1;ENPP1;IMPACT;MVP;CHP1;TESK1;CAV1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.47337897958203473,-1.470029662573719,0.04408817635270541,0.3066372493812322,1.0,6/32,7.11%,ZBTB20;PRKAG2;SORBS1;PRKAA2;CREBL2;MTOR
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.47522960078318627,1.4699871352490594,0.044897959183673466,0.32432524583582806,1.0,7/31,7.15%,SYT1;SYT6;SYT7;DOC2A;SYT12;SYT11;SYT10
prerank,receptor signaling pathway via STAT (GO:0097696),-0.5054823878876418,-1.4698532035389649,0.06554307116104868,0.3060378479572807,1.0,10/25,18.04%,PKD1;PIAS1;IL31RA;GHR;STAT3;CTR9;PKD2;STAT1;STAT5A;STAT5B
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.44262028794572095,-1.469838788324702,0.0299625468164794,0.30511866660095177,1.0,13/44,8.05%,ROCK2;LPAR1;TGFBR1;TPM1;CCN2;ABL1;PPM1E;ARHGEF10L;FHOD1;NRP1;RAPGEF3;S100A10;CDC42
prerank,"transcription, DNA-templated (GO:0006351)",-0.3433729700779785,-1.4695894487150616,0.004032258064516129,0.30468342905283424,1.0,89/207,29.58%,MLLT3;MAF;SOX5;NFKB1;THRB;DDX5;GLIS3;FOXO3;GTF2H2;CCNT2;CCNH;RREB1;NFIX;CCNT1;CREBL2;TAF3;MEF2A;BAZ2A;CDK7;CTR9;NCOA6;TAF4;TBP;CCNK;MNAT1;BRF1;AFF4;RTF1;PARP1;ERCC3;IRF9;COPS2;NELFB;TTF1;MMS19;TAF5L;TAF13;TOPORS;MNT;SNAPC3;PIR;EPC1;GTF2B;PRMT5;RNGTT;PMF1;NR4A2;NFIC;POLR2H;GTF3C4;NFX1;CDC73;MED16;NFYA;TAF12;TRIP11;TAF9B;RPAP1;TAF2;DRAP1;GTF2F1;HSF1;EAF2;POLR2K;GTF3C1;TBPL1;GTF2H1;POLR2E;CTDP1;POLR3H;NCBP2;GTF3C6;GTF2E2;TAF1C;TAF7;ZBTB7B;GTF2H4;NFKBIB;THRA;NELFA;NELFE;POLR2D;BRF2;MRPL12;TAF1A;CDK9;E2F1;POLR1C;POLRMT
prerank,mRNA splice site selection (GO:0006376),-0.4807206423519897,-1.4693417788095886,0.031192660550458717,0.30427676400424664,1.0,12/30,14.48%,CELF2;CELF1;LUC7L2;PRPF39;SFSWAP;SRSF10;SRSF6;SLU7;SF3A1;YTHDC1;SF3A3;SRSF1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.4963772368636402,-1.468375210891306,0.042884990253411304,0.3054862759845138,1.0,15/27,24.85%,UBE2E2;PRKN;UBE2H;ANAPC5;ANAPC7;ANAPC4;CDC26;UBE2B;CDC27;UBE2S;UBE2D3;ANAPC11;ANAPC13;CDC16;ANAPC1
prerank,oligodendrocyte development (GO:0014003),0.5640200137849126,1.4680707135396587,0.06276150627615062,0.32667276292848135,1.0,6/15,8.86%,PLP1;CNTNAP1;NSUN5;EIF2B3;B4GALT6;TPPP
prerank,canonical Wnt signaling pathway (GO:0060070),-0.409932827232995,-1.467562218009999,0.02330097087378641,0.30642020874976755,1.0,16/68,9.13%,TCF7L2;WNT4;LRP6;PLPP3;LRRK2;CSNK1A1;WNT5B;WNT6;GSK3B;RYK;RARG;BCL9L;AXIN1;FZD2;WNT9A;CSNK1E
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.5010536003797056,-1.46755719566002,0.057803468208092484,0.30548836178185934,1.0,9/26,17.00%,FOXP1;KANK2;DAB2;NCOR1;STRN3;CNOT2;HDAC1;CNOT1;HEYL
prerank,regulation of secretion by cell (GO:1903530),0.428136813277747,1.4675005700755168,0.0273109243697479,0.32625636346390613,1.0,11/54,5.92%,CAMK2A;SYT1;RIMS1;RIMS2;SCG5;MCTP1;RAB3C;LGI3;RHBDF2;STXBP5L;KCNMB4
prerank,positive regulation of bone mineralization (GO:0030501),-0.4624126542151964,-1.46745145593151,0.034482758620689655,0.30479949789522115,1.0,19/35,21.31%,BMP6;BMPR1A;PTN;WNT4;BMP7;BMP4;OSR1;ADGRV1;KL;MEF2C;ATP2B1;CCN1;ATRAID;ACVR1;TGFB3;FBN2;BMP2;PKDCC;TMEM119
prerank,negative regulation of cellular protein localization (GO:1903828),-0.4793810605730169,-1.467016267215468,0.02697495183044316,0.3048863336511894,1.0,11/34,17.26%,ROCK2;CTNNA1;GSK3B;RIPOR2;UBXN2B;ACTN2;LEPROTL1;LEPROT;ILRUN;LATS1;PICALM
prerank,hemopoiesis (GO:0030097),0.387465663600522,1.4652414796613997,0.013944223107569721,0.3294683205725071,1.0,18/87,9.11%,FLT1;KIRREL3;MECOM;KITLG;TEK;TIRAP;CSF1R;ARMC6;FST;TOX;KDR;FLT3;TGFB2;TAL1;RTKN2;MELK;CD34;TPO
prerank,response to purine-containing compound (GO:0014074),0.539681789010112,1.4645947045988434,0.06496519721577726,0.32927228093586974,1.0,6/17,13.39%,RYR2;KCNJ11;TRPM2;P2RY1;P2RX7;VGF
prerank,clathrin coat assembly (GO:0048268),0.5588684532180739,1.4628514176154852,0.07214428857715431,0.3315766758551877,1.0,6/15,14.43%,NSG2;HIP1;FCHO1;CALY;SGIP1;CLTB
prerank,ribosomal small subunit assembly (GO:0000028),0.5580656188544737,1.4626196414134254,0.07625272331154684,0.33046884801098186,1.0,8/16,16.84%,RPS19;RPS27;MRPS7;RPS15;RPS14;RPS5;RPS28;XRCC5
prerank,intraciliary retrograde transport (GO:0035721),-0.6079184251230897,-1.4626023878940544,0.05928853754940711,0.31365442490234907,1.0,9/12,33.72%,IFT43;DYNC2I1;DYNC2LI1;DYNC2I2;IFT140;TTC21B;IFT122;WDR35;DYNC2H1
prerank,myelination (GO:0042552),0.4395629446967301,1.4619260469431854,0.030864197530864196,0.3302515963353354,1.0,17/46,16.94%,GAL3ST1;MAL;MBP;PLP1;MPZ;CMTM8;NFASC;EPB41L3;CNTNAP1;B4GALT6;TPPP;TNFRSF21;SCN2A;MAL2;SCN8A;PLLP;HES5
prerank,muscle cell differentiation (GO:0042692),0.46676445418996737,1.4618747819057318,0.04276985743380855,0.32873264701018523,1.0,8/32,11.98%,MRTFA;SYNE1;SGCZ;TMEM204;MRTFB;NINJ1;NRAP;MEGF10
prerank,regulation of histone modification (GO:0031056),-0.5765623485986693,-1.461745988764898,0.04798464491362764,0.3145746557132208,1.0,5/13,8.43%,UBE2N;SETD5;MTHFR;AKAP8L;IGF2
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.41451311157675175,-1.4607585983192093,0.025896414342629483,0.31576336568852187,1.0,25/62,25.02%,KAT2B;EP300;TNRC6B;KMT2C;TNRC6A;KMT2D;THBS1;MOV10;HOXA5;ZBTB16;CREBBP;LYN;RUNX1;CTR9;MEF2C;HSPA9;HDAC1;TNRC6C;CDC73;CDK6;KMT2A;AGO1;MAFB;KMT2E;CNOT4
prerank,muscle cell migration (GO:0014812),-0.6357483508144774,-1.4598085204144335,0.07750472589792061,0.31685501537747646,1.0,7/10,20.96%,ROCK1;PLAT;CCN3;DDR1;SIX1;ITGB3;AAMP
prerank,histone H2A ubiquitination (GO:0033522),-0.5494818681655589,-1.4596241798708933,0.062264150943396226,0.31626981377543556,1.0,6/17,14.23%,UBR2;BCOR;RNF8;DDB2;DTX3L;UBE2B
prerank,action potential (GO:0001508),0.4373313386680537,1.4594961092934713,0.029350104821802937,0.33243744209538073,1.0,13/44,16.49%,KCND2;SCN1A;ANK3;AKAP6;KCNMB2;KCNMB3;KCNMB4;SCN3A;KCNA2;SCN2A;CACNA1I;SCN8A;GNAQ
prerank,myoblast differentiation (GO:0045445),-0.5767766917577984,-1.459480057906599,0.06375227686703097,0.31567025930924475,1.0,8/14,14.32%,IGF1;TCF7L2;DDX5;JAG1;DDX17;REST;RB1;HINFP
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.45808433940637305,1.4594076191551055,0.03497942386831276,0.3310248148708512,1.0,19/38,21.57%,NDUFC1;NDUFA4;NDUFA1;NDUFA2;NDUFC2;NDUFA3;NDUFA13;NDUFB2;NDUFAF1;NDUFB9;NDUFA7;NDUFAB1;NDUFA12;NDUFB8;NDUFB4;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,epidermal cell differentiation (GO:0009913),-0.447363618123154,-1.459282567142466,0.04460966542750929,0.3151099231749833,1.0,15/41,23.13%,JAG1;BCR;ANXA1;CLIC4;TXNIP;MED1;ADAM9;ERCC3;UGCG;GLI1;HDAC1;WNT5A;WNT16;GATA6;HDAC2
prerank,artery morphogenesis (GO:0048844),-0.4898495260294374,-1.4582855141444828,0.0497131931166348,0.31649242439283337,1.0,11/30,14.35%,LRP1;TGFBR1;BMPR1A;PDGFRB;BMP4;JAG1;NRP1;ADAMTS9;HES1;PKD2;VEGFA
prerank,peptidyl-lysine modification (GO:0018205),-0.3769275864583862,-1.4576221992897649,0.006,0.31695650233541894,1.0,30/99,16.34%,EYA1;KAT2B;LOXL1;PIAS1;EP300;HDAC4;PLOD2;SAE1;RANBP2;SENP3;SENP7;NSMCE2;NNAT;P3H3;NUP42;SENP6;PIAS3;UBE2I;NUP214;SENP1;SENP5;TPR;PIAS4;TRPM4;SIRT5;LOX;ESCO1;METTL21A;TOPORS;LOXL3
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.5218705038149654,-1.456431484314173,0.045627376425855515,0.3187455204796637,1.0,6/20,11.17%,ROCK2;RHOQ;ROCK1;DLG1;FHOD1;NCKAP1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.4832807054809669,1.456288111315771,0.05485232067510549,0.3360891847008768,1.0,11/28,20.01%,FGF10;THY1;IL12A;PRKCQ;CCL2;CYRIB;HSPD1;SH3KBP1;NCKAP1L;NOD2;CD47
prerank,barbed-end actin filament capping (GO:0051016),-0.5386335533385994,-1.4555711940952358,0.05565529622980251,0.31890448256960946,1.0,10/18,25.67%,ADD3;GSN;SVIL;CAPZA1;CAPZB;TRIOBP;AVIL;VILL;TWF2;TWF1
prerank,actin filament capping (GO:0051693),-0.5386335533385994,-1.4555711940952358,0.05565529622980251,0.31890448256960946,1.0,10/18,25.67%,ADD3;GSN;SVIL;CAPZA1;CAPZB;TRIOBP;AVIL;VILL;TWF2;TWF1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5083638323464711,-1.455039869935203,0.06099815157116451,0.31911801020429814,1.0,9/24,10.64%,PARVA;BMPR1A;SMAD6;BMP4;ROBO1;TGFBR2;FGFR2;NRP1;SMAD4
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5028067478630645,-1.4548817327778802,0.06601941747572816,0.31854859682037445,1.0,9/22,20.04%,TIMP3;ROCK1;SNX9;PTPN3;NRDC;ADAM9;APOE;ADRA2A;TIMP2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.6156637797126767,-1.4540539474939442,0.041749502982107355,0.3194821682529371,1.0,7/11,24.33%,UGGT2;POMT2;AUP1;DERL1;VCP;TOR1A;BAG6
prerank,vesicle coating (GO:0006901),-0.40945173307007354,-1.4539935648555948,0.029850746268656716,0.3168696250706615,1.0,25/61,24.48%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;CUL3;STX5;GOSR2;NAPA;CSNK1D;SEC16B;SEC16A;F5;NSF;TRAPPC2;PREB;LMAN1;SAR1B;USO1;MCFD2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.40945173307007354,-1.4539935648555948,0.029850746268656716,0.3168696250706615,1.0,25/61,24.48%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;CUL3;STX5;GOSR2;NAPA;CSNK1D;SEC16B;SEC16A;F5;NSF;TRAPPC2;PREB;LMAN1;SAR1B;USO1;MCFD2
prerank,COPII vesicle coating (GO:0048208),-0.40945173307007354,-1.4539935648555948,0.029850746268656716,0.3168696250706615,1.0,25/61,24.48%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;CUL3;STX5;GOSR2;NAPA;CSNK1D;SEC16B;SEC16A;F5;NSF;TRAPPC2;PREB;LMAN1;SAR1B;USO1;MCFD2
prerank,transport along microtubule (GO:0010970),-0.6017448389250117,-1.4536661334281902,0.06481481481481481,0.3166863777055794,1.0,9/13,29.95%,ARHGAP21;CDC42;SPG11;BAG3;COPG2;COPG1;CLIP3;APP;APBA1
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.3879995915265504,-1.4535647328439494,0.024096385542168676,0.3159897853426578,1.0,35/87,25.67%,ROCK2;NOTCH2;RHOQ;LRP1;EPHA3;PDGFRA;PDGFRB;ROCK1;ABL1;RND3;MTOR;RAPGEF3;ARHGAP17;IQGAP2;SEMA3E;RHOA;PRKCD;ABL2;RHOBTB2;RICTOR;ARHGDIB;ARHGAP18;FAM107A;RHOBTB1;RHOH;RHOC;CDK10;BAIAP2;TAOK1;F11R;HIP1R;ARHGAP35;ARHGAP44;TWF2;TWF1
prerank,response to cholesterol (GO:0070723),-0.5557819982510082,-1.453244433428655,0.06284658040665435,0.3157656660705254,1.0,6/17,5.49%,TGFBR1;LRP6;SMO;TGFBR2;GRAMD1C;SMAD2
prerank,hexose transmembrane transport (GO:0008645),0.5100906423015913,1.4532099225424036,0.08641975308641975,0.3411768194222186,1.0,3/21,2.70%,SLC2A1;SLC2A3;SLC2A5
prerank,organic anion transport (GO:0015711),0.39977799586905155,1.4529792027130715,0.018518518518518517,0.34011628622831624,1.0,16/76,12.46%,SLCO1C1;SLC4A1;CA4;SLCO4C1;AQP9;ABCG2;SLC35A1;SLC52A2;SLC25A42;CA2;SLCO5A1;SLC52A3;SLCO2B1;SLC39A8;ABCC4;CPTP
prerank,response to interleukin-4 (GO:0070670),0.6247884984419296,1.452189252655493,0.08482142857142858,0.3402584661666071,1.0,3/10,13.35%,LEF1;TCF7;XBP1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.3216981592422438,-1.4518119886296654,0.0,0.3181205558866616,1.0,139/341,29.07%,FBXL7;FBXL17;SMURF2;RNF43;PRKN;SPSB1;BIRC6;RAD23B;ARIH1;BTRC;TBL1X;WWP2;RNF115;TRIP12;TBL1XR1;KLHL15;RNF146;HUWE1;UBXN2B;RNF217;TGFB1I1;RBBP6;RC3H1;RNF213;VPS4B;UBQLN1;OS9;RNF19A;WWP1;UBE4B;ASB2;UBE2H;FBXL4;ANAPC5;ZSWIM8;RNF8;FBXO10;PCBP2;ANAPC7;UBE2K;MAEA;UBE2I;ANAPC4;ANAPC16;NUB1;TNFAIP1;RNF216;NTAN1;USP33;SPOPL;VPS37C;UBE2R2;GID4;KCTD5;UBR3;PSMF1;FBXL19;WDR91;TRIM25;CUL3;FBXW7;NHLRC3;DTX3L;PSMB2;KLHL22;CDC26;TRPC4AP;UBE2B;SMURF1;FBXO45;TOPORS;ERCC8;UBR4;UBE2E1;CDC27;ARRB1;FEM1A;BFAR;RNF20;UBE2S;FBXO22;SYVN1;PPP2R5C;FBXW5;FBXW11;VCP;MYLIP;SPSB4;AREL1;RNF14;UBE2D3;IFI27;PML;COP1;PSMC1;RNF11;SHARPIN;WDR81;KCTD17;TTC3;GID8;ANAPC11;ARIH2;APPBP2;FBXW4;PSMA3;PSMB6;RMND5A;ARMC8;RNF144A;RNF6;PSMA4;SIAH2;BAG6;PTPN23;FBXL14;CDC16;ANAPC1;CNOT4;UBQLN4;USP9X;ZNRF3;FBXO11;UBE3C;PSME1;PSMD13;SPSB2;PCNP;KCTD6;CDC34;FZR1;PSMB9;RBX1;PSMB10;PSMA5;KBTBD7;MIB1;SPSB3;VPS28
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.5402915487045015,-1.4513411081858447,0.05860805860805861,0.3183064228944465,1.0,5/18,9.06%,EGFR;DDX5;BMP4;NCOR1;MAP2K1
prerank,sterol metabolic process (GO:0016125),-0.41321472153274524,-1.4502132658043914,0.019646365422396856,0.31977952977517027,1.0,21/60,26.16%,PRKAG2;ABCA1;CYP7B1;CYP26B1;CYP27A1;SOAT1;INSIG2;OSBPL5;CYP1B1;APOE;RXRA;HMGCR;SQLE;CYP51A1;FDX1;SC5D;LBR;ARV1;GBA2;SCAP;CLN8
prerank,kidney development (GO:0001822),-0.4081597559085143,-1.4494352953737266,0.02895752895752896,0.320547857165095,1.0,16/65,5.88%,SULF1;TGFBR1;KANK2;PKD1;WNT4;GLI2;FOXC1;BMP7;BMP4;OSR1;PCSK5;ARL3;SULF2;CTSH;ZBTB16;PYGO1
prerank,positive regulation of organelle organization (GO:0010638),-0.48166953203599955,-1.4486312726342598,0.0367504835589942,0.3215343208642875,1.0,15/32,27.06%,UVRAG;ATL3;GSK3B;ANXA2;RAB3GAP1;STX18;ANXA1;PPARGC1A;SURF4;SORBS3;AKT2;LMAN1;IRGM;HTRA2;ADRB2
prerank,negative regulation of signal transduction (GO:0009968),-0.33017184164924274,-1.4472116614240618,0.0,0.3238699076540519,1.0,72/249,19.73%,TRABD2B;SULF1;EGFR;NXN;PID1;GLI3;LRP1;ADAMTS12;KANK2;IGFBP5;DCN;LGR4;WWOX;BMP5;GRB10;RNF43;DKK3;LRRK2;TNS2;ENPP1;BTRC;CYP26B1;WWP2;VGLL4;NIBAN2;GPC3;IRAK3;IRS1;IGFBP3;SULF2;THBS1;ASAH2;LYN;BCL2;PIP4K2C;DACT1;PTPN12;LEPROT;PTPN2;PRKCD;NOTCH3;GLIS2;TULP3;MMP14;HERC4;TLE1;RB1;APPL1;FBXW7;SUFU;APOD;OTUD4;EMILIN1;PRKCZ;ACVR1;NCK1;CSNK2A1;PTCH1;TSPAN15;ARRB1;CNOT1;NR4A2;LRRC14;CX3CR1;INPP5K;PTPN1;DACT3;VCP;BMP2;SFRP4;MDFI;MEGF8
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.44125248616637963,-1.4470201154920508,0.029644268774703556,0.32333638086469385,1.0,10/40,10.45%,EGFR;LPAR1;ARHGAP6;PDGFRA;NTRK3;PDGFRB;KIT;EDNRA;PLCG1;ABL2
prerank,phospholipid transport (GO:0015914),0.4208530295017416,1.4469147221246434,0.03171247357293869,0.35020743324321996,1.0,18/52,15.12%,PLTP;TMEM30A;ATP8A1;ATP11A;ATP10A;MFSD2A;ATP10B;PITPNM1;PRELID3A;SCARB2;ATP11C;ATP8A2;ABCB4;PRELID2;CPTP;SCARB1;ATP11B;SCP2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.45905427976389873,-1.44690677612535,0.036511156186612576,0.3227022294415982,1.0,14/37,18.12%,IGF1;BMPR1A;TPM1;IGFBP5;GJA1;JUN;MEF2C;MMP2;EFEMP2;ERN1;TGFB3;PDCD4;ADAMTS1;SOD2
prerank,epithelial cell-cell adhesion (GO:0090136),-0.6062299657603931,-1.4467667979599446,0.07518796992481203,0.3220682974063261,1.0,5/11,9.85%,VCL;KIT;ITGB5;JUP;CCN3
prerank,polarized epithelial cell differentiation (GO:0030859),-0.5824560058482819,-1.4465891484466287,0.05162523900573614,0.3215575698241988,1.0,6/13,21.80%,MYO9A;RAB10;CDC42;RHOA;SCRIB;MSN
prerank,COPII-coated vesicle budding (GO:0090114),-0.40005455351642044,-1.4459886608688681,0.02394106813996317,0.32205404507578944,1.0,31/68,27.71%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;SEC23B;CUL3;STX5;GOSR2;MIA3;NAPA;CSNK1D;SEC16B;SEC16A;F5;NSF;TRAPPC2;VAPA;PREB;LMAN1;SAR1B;USO1;MCFD2;SCAP;SEC24A;TMED2
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3999287266016457,1.445811542121228,0.026476578411405296,0.35115538941894203,1.0,20/75,14.38%,SLC39A10;SLC24A2;KCNJ3;KCNJ6;CACNA2D1;SLC8A1;KCNJ11;SLC12A6;HCN2;TRPM2;KCNJ10;ATP1A3;KCNK9;SLC12A3;SLC39A8;ATP1A4;ATP1A1;KCNJ8;ATP1B1;ATP2B4
prerank,modified amino acid transport (GO:0072337),-0.5715485430345697,-1.4450190917443286,0.06801470588235294,0.3232650564713297,1.0,6/15,19.26%,SLC6A13;SLC16A12;PDPN;SLC5A6;CTNS;MGST1
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.4443606039398965,-1.444363230678914,0.044573643410852716,0.32387601613953587,1.0,20/40,21.31%,BMP6;BMPR1A;PTN;WNT4;BMP7;BMP4;OSR1;WNT6;ADGRV1;KL;MEF2C;ATP2B1;CCN1;ATRAID;ACVR1;TGFB3;FBN2;BMP2;PKDCC;TMEM119
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3991330508809009,-1.4440428914797636,0.016728624535315983,0.32376040722807065,1.0,28/67,21.65%,ROCK2;SULF1;ITGAV;AXL;ROCK1;CYFIP2;WASF2;SHB;PAK2;NRP1;BRK1;CDC42;VAV2;RHOA;NCKAP1;ABI1;VEGFA;VEGFD;NCK1;CYBA;NCK2;DOCK1;PRKD1;ITGB3;NCF2;AAMP;PIK3R1;BAIAP2
prerank,cardiac muscle tissue development (GO:0048738),-0.42909983152355585,-1.4434635853809399,0.025341130604288498,0.3241961704705476,1.0,14/50,13.06%,AKAP13;NOTCH2;BMPR1A;GJB6;BMP5;BMP7;BMP4;RBP4;GJA1;ADAMTS9;SMAD4;TBX18;SIK1;MAML1
prerank,transition metal ion transport (GO:0000041),0.45809405145486737,1.4430405522524026,0.043121149897330596,0.3557037464029453,1.0,10/35,12.06%,TFRC;TRPC5;FTH1;SLC39A2;SLC30A1;MELTF;SLC39A8;ATOX1;SLC30A5;TRPC1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.5086536282435882,-1.442969968935991,0.0670391061452514,0.3243876201152719,1.0,6/23,5.49%,TGFBR3;SMAD3;SMURF2;NREP;DKK3;SMAD2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.38922925188165247,-1.4424631347462988,0.02459016393442623,0.3245617196058716,1.0,41/76,35.15%,ANGPT1;PIAS1;HDAC4;LRRK2;HUWE1;SAE1;AXIN1;WDR48;UBQLN1;PIAS3;XIAP;PIAS4;CUL3;FBXW7;FANCI;SPRTN;DERL1;FAM107A;TRAF6;DCUN1D3;TANK;TBC1D7;CDK5RAP3;SENP2;SPHK1;WFS1;PAXIP1;FBXO4;HDAC3;GNL3;MUL1;DCUN1D5;UBA2;CAV1;BIRC3;UBE2L3;DCUN1D4;BRCA1;PSMD10;CENPX;RIPK2
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.5042489050273233,-1.4421494707105684,0.06958250497017893,0.3242276625491466,1.0,4/22,7.11%,ZBTB20;SORBS1;CREBL2;MTOR
prerank,establishment of epithelial cell polarity (GO:0090162),-0.5368548486427311,-1.4421022750739367,0.05805243445692884,0.3234414821111273,1.0,7/19,21.80%,MYO9A;CYTH3;CDC42;RHOA;PARD3;SIPA1L3;MSN
prerank,protein modification by small protein conjugation (GO:0032446),-0.3221757282695955,-1.4415610995899175,0.002008032128514056,0.32367817259630094,1.0,114/361,21.87%,RNF220;PDZRN3;FBXL7;EYA1;RNF152;FBXL17;SMURF2;UBE2N;RNF43;UBR2;TRIM44;PIAS1;PRKN;SPSB1;BIRC6;FBXW8;ARIH1;KLHL13;BTRC;WWP2;HUWE1;SAE1;USP7;UHRF2;RANBP2;RNF213;OS9;UFL1;DTX4;NSMCE2;WWP1;ASB2;UBE2H;ZSWIM8;RNF8;NUP42;CTR9;UBA5;FBXO10;ANAPC7;UBE2K;HLTF;PIAS3;UBE2I;VCPIP1;ANAPC16;NUB1;TNFAIP1;LZTR1;HERC2;SELENOS;UBR1;RNF103-CHMP3;HIF1A;NUP214;UBE2R2;RFWD3;RTF1;TRIM5;UBR3;TRIM11;TPR;PIAS4;CUL3;FBXW7;TRPM4;DTX3L;TRPC4AP;UBE2B;PRKDC;TRIM39;SMURF1;CUL2;FBXO45;TOPORS;MSL2;UBE2E1;CDC27;ARRB1;RNF181;RNF20;DERL1;ASB5;UBA7;UBE2S;KLHL18;SYVN1;SDE2;FBXW5;FBXW11;VCP;DCUN1D3;MYLIP;SPSB4;EIPR1;AREL1;RNF14;UBE2D3;NFX1;PCNA;NUP98;CDC73;DTX2;TRIM63;HIF3A;NAE1;ANAPC11;CUL1;CUL7;CDK5RAP3;ARIH2;DET1;NUP43;WAC
prerank,cellular response to interleukin-4 (GO:0071353),0.6295646626614377,1.440518182725881,0.08991228070175439,0.35977615971947385,1.0,3/10,13.35%,LEF1;TCF7;XBP1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.48398578411368276,-1.4404578989261911,0.06679389312977099,0.32530672915435627,1.0,13/25,28.55%,RNF8;CDK13;WDR43;NELFB;TCERG1;HNRNPU;CDC73;EAF2;LDB1;RECQL5;NELFA;NELFE;ZMYND11
prerank,dendritic spine organization (GO:0097061),0.48233467341505537,1.4401575001901394,0.053830227743271224,0.35896809200488544,1.0,4/26,3.17%,IGF1R;EPHB1;CTNND2;SHANK3
prerank,positive regulation of potassium ion transport (GO:0043268),0.4583090333871229,1.4400105626827862,0.04426559356136821,0.3575891724510059,1.0,11/38,7.94%,KCNJ3;KCNJ6;KCNN2;AKAP6;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNJ10;GNG2;KCNN3
prerank,phosphate ion homeostasis (GO:0055062),-0.6245163077470188,-1.4398590677017191,0.074487895716946,0.32578474379970035,1.0,3/10,20.32%,ENPP1;SFRP4;FGFR4
prerank,regulation of cellular localization (GO:0060341),-0.43411482390718403,-1.4397850393032232,0.03474903474903475,0.32509586012961755,1.0,16/46,11.60%,ADCY5;GSN;PARD6G;PRKN;LRRK2;NUMA1;CDK16;STXBP4;LYN;CAMK2D;CSNK1E;FER;BRSK1;WWC1;GOSR1;PARP1
prerank,regulation of cellular component movement (GO:0051270),-0.429194132022488,-1.439539084844985,0.03441682600382409,0.32476255635360063,1.0,15/49,10.45%,ROCK2;TGFBR3;EGFR;TGFBR1;DIAPH1;ROCK1;PDPN;ABL1;ARAP1;CD9;LYN;ZSWIM8;SP100;RHOA;ABL2
prerank,regulation of RNA metabolic process (GO:0051252),-0.41060983779692845,-1.4394689734284032,0.03232323232323232,0.3240769165800139,1.0,14/59,12.23%,AHNAK;SON;CLK1;CELF1;HNRNPH1;MBNL2;FUS;RC3H1;PTBP3;PCBP2;MED1;CLK2;CLK3;SNRNP70
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.6265994031272736,-1.438033787536424,0.07352941176470588,0.3265926206024598,1.0,3/11,3.17%,BMPR1A;BMP4;JAG1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.41034789507191854,-1.437901269982333,0.038834951456310676,0.32600412919817334,1.0,11/61,6.87%,AKAP13;NOTCH2;IGF1;COL3A1;AUTS2;LPAR1;ROBO1;SHOC2;SHC1;MAP4K4;LYN
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5375895992849133,-1.43784179981218,0.07977736549165121,0.32527951492555623,1.0,5/17,10.80%,PRKAG2;NCOR1;PRKAA2;PANK2;PRKAB2
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.4959451521287188,1.437572790760436,0.06832298136645963,0.3616082752989288,1.0,6/24,7.40%,PRKAR2B;PDE2A;PDE11A;PEX5L;RNF157;APLNR
prerank,T cell differentiation (GO:0030217),-0.4486832838990715,-1.4369419142301223,0.03696498054474708,0.3263989547133704,1.0,15/40,25.84%,GLI3;LEPR;KIT;ANXA1;PTPN22;PTPN2;SOX13;CHD7;PIK3CD;RHOH;RABL3;GPR89B;GPR89A;FCER1G;LMBR1L
prerank,RNA processing (GO:0006396),-0.34427885092906907,-1.436686663864149,0.006122448979591836,0.32608638272685486,1.0,70/176,26.93%,RBMS1;CELF2;SON;TENT2;RBPMS;CELF1;ATXN1;HNRNPH1;RBM39;DICER1;PABPN1;HNRNPR;SYNCRIP;DDX17;RBMS2;RBM6;FUS;U2AF2;AKAP8L;SF3B1;HNRNPD;TUT4;HNRNPUL1;PRPF6;PPARGC1A;RNPC3;TSEN2;SLU7;HNRNPK;PRPF3;SF3A1;USP39;SCAF11;DUSP11;XRN2;SF3A3;ZCRB1;RSRC1;DDX23;RBM5;TCERG1;APOBEC1;SRSF1;SFPQ;RNGTT;PRKACA;HNRNPU;CSTF3;SNRPF;ZMAT5;RBM4;SRSF7;GEMIN2;SRSF11;SRRM1;PPP2CA;USB1;SRSF2;LUC7L3;NUDT21;CCAR2;SMU1;NONO;DHX15;PABPC4;PRMT9;KIN;NCBP2;PRPF8;LSM6
prerank,neural crest cell migration (GO:0001755),0.4503473053952626,1.4365998138433451,0.04338394793926247,0.36223538318682524,1.0,8/36,4.59%,ERBB4;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.41103460125760727,1.4365460027017178,0.03285420944558522,0.360735601321813,1.0,17/57,15.57%,RPS6;RPS19;RPL38;RPL35A;RPF2;RPL7;RPS24;RPS17;RPS16;RPS15;RPL14;RPL5;RPS7;MRPL36;URB2;RPS28;RPS25
prerank,positive regulation of protein binding (GO:0032092),-0.410748968208916,-1.436194646562011,0.03143418467583497,0.32636888099703704,1.0,23/56,21.03%,TCF7L2;LRP1;PKD1;BMP4;STK3;PRKN;ABL1;LRRK2;VTN;GSK3B;MARK3;DACT1;PPP2CB;USP33;RPL11;DTX3L;RAPGEF2;APOE;DERL1;BMP2;TERT;SPPL3;PPP2CA
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.5450642953337153,-1.4360663958856685,0.09073359073359073,0.32572295955951275,1.0,10/17,28.91%,CCNT1;CTR9;ZC3H3;RNF20;CPEB1;HSF1;NUDT21;NCBP2;NELFE;CDK9
prerank,sensory perception of taste (GO:0050909),0.6297426831425204,1.4358110164974203,0.06567796610169492,0.36076474569202194,1.0,3/10,12.99%,ASIC2;ASIC1;CD36
prerank,negative regulation of proteolysis (GO:0045861),-0.4572809712717195,-1.4352361524107624,0.052123552123552123,0.32678887976229576,1.0,8/34,7.63%,TIMP3;DNAJC1;ROCK1;LRRK2;PLAT;GAS1;PTPN3;EPHA4
prerank,negative regulation of vascular permeability (GO:0043116),0.5967346166316839,1.4346916891406785,0.07268722466960352,0.36160981709302253,1.0,5/12,7.34%,CLDN5;SH3GL2;RAMP2;PDE2A;PTPRJ
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.5011245996787663,-1.4345932005979982,0.061930783242258654,0.32738817931952996,1.0,4/22,7.58%,CACNA1C;STIM1;ADGRV1;CACNA1D
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5437855824270159,-1.4343423438794864,0.0583804143126177,0.32708331907743443,1.0,3/17,3.63%,BMP6;SASH1;CD55
prerank,mitotic cytokinetic process (GO:1902410),-0.5128804640691693,-1.4338825049658703,0.07540394973070018,0.3272479820406978,1.0,7/20,10.38%,VPS4B;KLHDC8B;CHMP4B;CHMP4A;CHMP5;CHMP3;RHOA
prerank,neuron migration (GO:0001764),0.4207959187574318,1.4331083272574334,0.060674157303370786,0.3634147097833568,1.0,13/48,9.48%,ADGRL3;SPOCK1;GPM6A;DNER;MAP1B;FGF13;NTRK2;ASTN1;NRCAM;NDNF;CDKL5;RELN;ASTN2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.5130419614874606,-1.432402160884723,0.05421686746987952,0.3298010249806349,1.0,8/21,19.17%,OPA1;PRKN;LRRK2;EIF2AK3;SELENOS;NCK1;SYVN1;PARK7
prerank,cell-cell junction organization (GO:0045216),0.38903865458224973,1.4321837805287299,0.024390243902439025,0.3639043841939429,1.0,21/79,12.41%,CLDN5;CDH12;CDH8;CADM1;CSF1R;CADM2;CTNND2;CDH19;CDH20;CDH7;CDH18;CDH2;CDH10;OCLN;TGFB2;DCHS1;CADM3;F2R;NECTIN1;MARVELD2;TJP1
prerank,mRNA processing (GO:0006397),-0.3243413336397582,-1.4317537569356669,0.00404040404040404,0.3304017249614929,1.0,114/287,28.12%,SRRM2;SON;DDX5;CELF1;HNRNPH1;GTF2H2;PABPN1;HNRNPR;CCNH;WDR33;PCF11;SYNCRIP;CASC3;IK;CDK7;SRSF10;RBM6;DDX46;FUS;U2AF2;HNRNPM;DHX9;AKAP8L;SF3B1;CPSF3;SRSF6;HNRNPD;HNRNPUL1;PRPF6;RBM10;PCBP2;PPARGC1A;RNPC3;DDX42;CDC5L;PRCC;SLU7;GEMIN5;HNRNPK;RPRD2;PRPF3;MNAT1;SF3A1;SF3B6;YTHDC1;USP39;SCAF11;ERCC3;SF3A3;SNRNP70;ZCRB1;RSRC1;DNAJC8;CWC22;DDX23;YBX1;RBM5;TCERG1;CCAR1;ERN1;SRSF1;CWF19L1;GEMIN7;SFPQ;EFTUD2;SNU13;MTREX;PPIH;RNGTT;UBL5;PRPF40B;PPWD1;PRKACA;HNRNPU;WBP11;CSTF3;POLR2H;SNRPF;ZMAT5;HNRNPA3;RBM4;SRSF7;GEMIN2;SRSF11;UPF3B;SRRM1;SRSF2;GTF2F1;CPSF4;CSTF1;DDX41;NUDT21;POLR2K;SMU1;GTF2H1;PRPF38A;NONO;DHX15;POLR2E;PRMT9;KIN;CPSF1;NCBP2;CRNKL1;PRPF8;RBM19;LSM6;CACTIN;RBM22;GTF2H4;ISY1;SUGP1;HNRNPL;POLR2D
prerank,glycerolipid metabolic process (GO:0046486),0.6128972301523679,1.4317230882439695,0.07236842105263158,0.363385608438704,1.0,6/11,18.36%,GAL3ST1;PGP;DGKB;PIP5K1A;PNPLA3;DGKG
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.40137786367749617,-1.4314713816979554,0.03353057199211045,0.33014757676178513,1.0,18/66,15.91%,SULF1;TGFBR3;NR2F2;KLF9;ROBO1;NFIB;SPARC;NUPR1;THBS1;FGFR2;PTPRK;MED1;FBXW7;BRCA2;STAT1;APOE;DUSP10;ATOH8
prerank,regulation of actin filament-based process (GO:0032970),-0.3996009781774892,-1.4309946648585072,0.028112449799196786,0.3303793186562152,1.0,29/70,25.66%,ROCK2;RHOQ;LRP1;EPHA3;PDGFRB;ROCK1;ABL1;RND3;MTOR;ARHGAP17;IQGAP2;RHOA;PRKCD;RHOBTB2;RICTOR;ARHGAP18;FAM107A;RHOBTB1;RHOH;RHOC;CDK10;CNN2;BAIAP2;TAOK1;F11R;HIP1R;ARHGAP35;ARHGAP44;TWF2
prerank,establishment of skin barrier (GO:0061436),0.5551865563149576,1.4302250698511811,0.08297872340425531,0.3635954885446166,1.0,3/15,3.30%,HRNR;FA2H;STMN1
prerank,regulation of water loss via skin (GO:0033561),0.5551865563149576,1.4302250698511811,0.08297872340425531,0.3635954885446166,1.0,3/15,3.30%,HRNR;FA2H;STMN1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.3947334825599504,-1.4301881614230094,0.023032629558541268,0.33133181151467367,1.0,24/76,19.96%,UACA;EGFR;SASH1;NFAT5;LIMS1;BMP7;TRIM44;EP300;NR3C2;DLG1;PTPN22;CCN3;RHOA;PPM1A;RASSF2;EIF2AK2;DDX3X;C1QTNF3;PDCD4;TLR4;TRAF6;IFI35;IRAK1;TRIP6
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.3947436158845653,-1.430105240983742,0.032,0.3306744705307175,1.0,25/66,20.20%,EGFR;APPL2;KANK2;PKD1;INO80;ANKRD17;FHL1;UBE2E2;BRD7;RPTOR;DLG1;ANXA1;DACT1;PRMT2;ID2;RB1;APPL1;PKD2;DDX3X;CCND3;ADAMTS1;FAM107A;DCUN1D3;EIF4G1;CDC73
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.34683805680958313,-1.429928616536924,0.013916500994035786,0.33023961891320264,1.0,70/173,24.95%,ANK2;SEC24D;VTI1A;GBF1;CD55;ATL3;PROS1;CTSC;GOLGB1;TFG;VTI1B;SEC23A;VAMP7;SEC22B;KDELR1;COPB1;BCAP29;COPZ2;DCTN5;ARFGAP1;ARFGAP3;SEC31A;ARCN1;ATL2;TBC1D20;COG3;COG7;GOSR1;CAPZA1;CNIH4;DYNC1LI1;TRAPPC6B;CUL3;KDELR3;STX5;CAPZB;COPB2;WHAMM;COPG2;GOSR2;DYNC1H1;TMED3;VAMP4;MIA3;NAPA;TMED4;COPG1;TMED5;SEC16B;NRBP2;MPPE1;TRIP11;COPE;SEC16A;STX17;COG4;BET1L;F5;ERGIC1;NSF;TRAPPC2;VAPA;ACTR1A;PREB;LMAN1;SAR1B;USO1;HYOU1;MCFD2;TEX261
prerank,lamellipodium organization (GO:0097581),-0.4816720977089982,-1.4292977834071297,0.039603960396039604,0.33076929230813773,1.0,11/29,16.40%,VCL;KIT;ITGB1;ABLIM3;ARFIP2;P2RY12;CTTN;WASF1;WHAMM;CARMIL1;ARHGEF6
prerank,stem cell differentiation (GO:0048863),-0.436916537315291,-1.4291803400744933,0.027613412228796843,0.33019409910277825,1.0,12/39,12.71%,MLLT3;LRP6;FBXL17;OSR1;KIT;UFL1;FGFR2;PUM1;HOXB4;SETD2;MEF2C;NELFB
prerank,epithelial cell morphogenesis (GO:0003382),-0.5384476415268773,-1.4288206176707472,0.07254901960784314,0.3301564112096209,1.0,8/17,27.78%,COL22A1;COL15A1;COL18A1;RILPL2;RILPL1;SIPA1L3;DACT2;MET
prerank,response to calcium ion (GO:0051592),0.37502169809585284,1.4279489275683293,0.026970954356846474,0.367028329538902,1.0,30/102,16.61%,SYT1;ADCY8;SYT6;NLGN1;SYT7;SYT12;SYT11;RYR2;RYR3;CPNE9;KCNMB2;KCNMB3;KCNMB4;TRPM2;CPNE8;KCNH1;CPNE1;SYT10;HOMER1;SMPD1;SYT2;CALM1;TRPC1;CALM2;CALM3;PPP3CA;HPCA;CPNE7;GPLD1;KCNMA1
prerank,response to cytokine (GO:0034097),-0.35162806620317805,-1.4275218509507703,0.00796812749003984,0.33231812026032304,1.0,29/141,10.55%,PTPN13;DPYSL3;COL3A1;TIMP3;ALDH1A2;NFAT5;PID1;SMAD3;AFF3;IL6ST;HDAC4;PTPN14;TBK1;IRAK3;PTPN9;PLSCR1;STAT3;ASAH2;BCL2;IRAK2;ANXA1;SP100;NUB1;SETD2;PTPN12;CXCL16;PTPN2;RHOA;ADAM9
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.34797063537458583,-1.4271168327408958,0.00816326530612245,0.33240146916803265,1.0,66/161,29.63%,BICC1;MLLT3;GLI3;TCF7L2;IGFBP2;RBMS3;LRP6;DAB2;TMEM64;STK3;PRKN;DKK3;CSNK1A1;GSK3B;IGFBP6;AXIN1;CHD8;IGFBP4;DACT1;LIMD1;TLE4;LZTS2;TLE1;PSMF1;TBX18;CUL3;SOX13;GLI1;PSMB2;UBAC2;APOE;LATS1;HDAC1;EMD;INVS;DACT3;WNT5A;BMP2;SFRP4;TLE3;PSMC1;DKK2;FRZB;DVL3;PSMA3;PSMB6;PSMA4;SIAH2;LRP4;ZNRF3;DVL2;TPBG;LMBR1L;NKD2;KREMEN1;PSME1;PSMD13;MCC;SDHAF2;PSMB9;RBX1;PSMB10;PSMA5;RUVBL2;MAD2L2;CAV1
prerank,protein monoubiquitination (GO:0006513),-0.45083732627320455,-1.427032612529958,0.05555555555555555,0.3317710088329267,1.0,21/36,32.56%,PRKN;HUWE1;CTR9;UBE2R2;TRIM25;CUL3;DTX3L;KLHL22;UBE2B;TOPORS;UBE2E1;RNF20;UBE2D3;CDC73;WAC;MGRN1;OBI1;RBX1;RNF126;KBTBD8;UBE2W
prerank,negative chemotaxis (GO:0050919),0.45441832454846276,1.4269989381689234,0.05714285714285714,0.3676664982246659,1.0,10/33,6.32%,SEMA3C;SEMA6A;UNC5C;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A;SLIT3;SLIT1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.6061605383971612,-1.4269264015688012,0.07532956685499058,0.33115268634920236,1.0,3/11,3.19%,TGFBR3;TGFBR1;TGFBR2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.4908777291969747,-1.4261917602132308,0.06903353057199212,0.33197796701807064,1.0,14/25,24.33%,NGLY1;FBXL17;UGGT2;KLHL15;YME1L1;POMT2;CUL3;CLPP;AUP1;DERL1;VCP;ZYG11B;TOR1A;BAG6
prerank,keratinocyte differentiation (GO:0030216),-0.47500145089037993,-1.4261450265832207,0.05947955390334572,0.33124619556546475,1.0,8/29,12.15%,JAG1;BCR;ANXA1;CLIC4;TXNIP;MED1;ADAM9;UGCG
prerank,epithelial structure maintenance (GO:0010669),-0.6161483709319351,-1.426075075507219,0.07734806629834254,0.33061600248912043,1.0,3/11,12.82%,RBP4;CXADR;STRAP
prerank,positive regulation of cation channel activity (GO:2001259),0.44206855547071583,1.4252671952822358,0.06170212765957447,0.37003217746116784,1.0,13/40,15.49%,TMSB4X;ANK3;SHANK3;AKAP6;ATPSCKMT;LRRC55;CCL2;RELN;HAP1;CALM1;CALM2;CALM3;NLGN3
prerank,positive regulation of DNA repair (GO:0045739),-0.4309703694479904,-1.4249009136986828,0.025341130604288498,0.3324784331387373,1.0,11/46,7.78%,EYA2;EYA1;EGFR;UBE2N;EYA4;SPIDR;HMGB1;DHX9;BRCC3;CEBPG;RNF8
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.3642350649372184,-1.4246657567399545,0.021739130434782608,0.3322085524161155,1.0,51/107,31.36%,ITPR1;CREB3L2;PRKN;GSK3B;THBS1;UBQLN1;OS9;UFL1;EIF2AK3;BCL2;MAP3K5;UBA5;AIFM1;SELENOS;JUN;TRAF2;ERLEC1;TMEM259;MBTPS2;RCN3;ATP2A2;ATF6;ERP44;ERN1;MBTPS1;NCK1;DERL1;SYVN1;VCP;TMTC3;ATP2A3;P4HB;SEC16A;CDK5RAP3;PIK3R1;WFS1;EIF2B5;HYOU1;BAG6;QRICH1;ATF6B;PPP1R15B;SEL1L;USP19;CCDC47;BAK1;UFM1;ATG10;HERPUD1;BCL2L11;CEBPB
prerank,neutrophil chemotaxis (GO:0030593),0.41132804375697524,1.4246383765013975,0.027253668763102725,0.3698809027489674,1.0,13/53,20.59%,BSG;PDE4B;S100A9;S100A8;TGFB2;CCL2;EDN1;CCL25;PPIA;NCKAP1L;CKLF;CCL13;CCL19
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.5543995630819634,-1.4219786438689461,0.08333333333333333,0.3372271775406338,1.0,7/15,22.55%,STAT3;IL17RA;HIF1A;APPL1;IL17D;TLR4;TICAM1
prerank,regulation of cation transmembrane transport (GO:1904062),0.4694794867161195,1.4215482712945149,0.06396588486140725,0.3752913947932973,1.0,8/29,7.66%,DPP10;KCNIP4;FGF12;KCNN2;KCNIP1;DPP6;HOMER1;KCNAB1
prerank,epithelial to mesenchymal transition (GO:0001837),-0.42894876982709107,-1.42152271416943,0.05471698113207547,0.3374699084353786,1.0,11/47,4.83%,ROCK2;TGFBR3;TGFBR1;WNT4;RBPJ;LIMS1;DDX5;BMP7;ROCK1;GSK3B;DDX17
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.5601289340650639,-1.4200605728751214,0.062385321100917435,0.3398071004984748,1.0,9/15,31.61%,NR3C1;ANXA1;REST;FAM107A;HNRNPU;ZFP36L2;GPER1;BCL2L11;UBE2L3
prerank,connective tissue development (GO:0061448),-0.4497668776860976,-1.4200484848416932,0.0622568093385214,0.33899850770250517,1.0,11/35,13.44%,SULF1;SOX5;CREB3L2;PKD1;SH3PXD2B;SULF2;ZBTB16;PGRMC2;ITGB8;ARID5B;SOX6
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.5479185868529461,-1.419645072095057,0.08061420345489444,0.33904261532568747,1.0,5/17,3.17%,NOTCH2;BMPR1A;RBPJ;BMP4;JAG1
prerank,zinc ion transmembrane transport (GO:0071577),0.5034223035262992,1.4195252289316627,0.06378600823045268,0.37838588180241817,1.0,7/22,11.88%,SLC39A10;SLC39A2;SLC30A1;TRPM2;SLC30A3;SLC39A8;SLC30A5
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.41631005561584117,-1.4194591518550186,0.036036036036036036,0.33858898448069363,1.0,16/50,19.96%,EGFR;SASH1;NFAT5;LIMS1;TRIM44;EP300;NR3C2;RHOA;EIF2AK2;DDX3X;PDCD4;TLR4;TRAF6;IFI35;IRAK1;TRIP6
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4268178075519813,-1.4183619668183787,0.04428044280442804,0.3401199013265476,1.0,24/47,30.86%,DOCK5;LIMS1;FBLN1;PDPN;ABL1;RREB1;FLNA;NRP1;S100A10;CDC42;CARMIL1;DOCK1;MYADM;MYOC;TRIOBP;P4HB;CRKL;KANK1;AP1AR;TESK1;FERMT2;EFNA5;CALR;C1QBP
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.4825564721122955,-1.4182354618021065,0.05827067669172932,0.33954714819096443,1.0,11/26,19.29%,EGFR;FOXC1;GAREM1;PDPK1;MED1;PLCG1;PTPN12;SYAP1;STAT5B;INPP5K;PTPN11
prerank,protein polyubiquitination (GO:0000209),-0.32043058689102977,-1.4181358225482052,0.006012024048096192,0.3389049678015974,1.0,119/297,28.97%,FBXL7;RNF152;SASH1;FBXL17;PELI2;SMURF2;UBE2N;TNKS2;UBR2;UBE2E2;PRKN;SPSB1;FBXW8;ARIH1;BTRC;WWP2;RNF115;TRIP12;RNF146;HUWE1;RNF217;RBBP6;UBR5;RC3H1;RNF213;RNF19A;WWP1;BCL2;UBE4B;UBE2H;FBXL4;ANAPC5;TRAF3IP2;RNF8;FBXL12;FBXO10;ANAPC7;UBE2K;DDB2;ANAPC4;RNF216;TRAF2;UBE2R2;TRIM5;PSMF1;FBXL19;FBXL18;CUL3;NPEPPS;FBXO30;FBXW7;NHLRC3;DTX3L;PSMB2;CDC26;UBE2B;SMURF1;FBXO38;LNPEP;TOPORS;ERCC8;TRAF3;UBE2E1;CDC27;HECTD1;BFAR;RNF20;UBE2S;FBXO22;HERC6;SYVN1;FBXW5;TRAF6;FBXW11;MYLIP;AREL1;RNF14;LRSAM1;UBE2D3;IFI27;TPP2;PSMC1;SHARPIN;TTC3;ANAPC11;CUL1;ARIH2;FBXW4;TRAF5;UBE2V2;PSMA3;PSMB6;RMND5A;ANKRD39;RNF144A;RNF6;ANAPC13;PSMA4;SIAH2;FBXL14;CDC16;ANAPC1;TRIM68;FBXO4;FBXW9;FBXO11;UBE3C;SHPRH;PSME1;PSMD13;MUL1;CDC34;FBXL3;FZR1;PSMB9;RBX1;PSMB10;PSMA5;KBTBD7
prerank,reticulophagy (GO:0061709),-0.5922976320769684,-1.4168267949845925,0.0830188679245283,0.341075175352065,1.0,7/12,17.30%,UFL1;UBA5;TEX264;RB1CC1;ULK2;ATG2A;ATG2B
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6162583749296374,-1.41670281427274,0.07330827067669173,0.3405387573906356,1.0,5/10,25.94%,ABCA1;APOE;PRKACA;ABCA7;ZDHHC8
prerank,anterior/posterior axis specification (GO:0009948),-0.5545284719728478,-1.4136051305641142,0.06319702602230483,0.3467290363038661,1.0,2/15,5.76%,WLS;SKI
prerank,regulation of RNA splicing (GO:0043484),-0.3920728977199948,-1.4132310238861927,0.03333333333333333,0.3467336889767137,1.0,19/69,14.29%,AHNAK;SON;CLK1;CELF1;HNRNPH1;RBM39;MBNL2;KHDRBS1;SRSF10;FUS;U2AF2;PTBP3;HNRNPK;CLK2;YTHDC1;CLK3;SNRNP70;CWC22;ERN1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.4486872446956584,-1.4116569542696147,0.07894736842105263,0.3495834307231289,1.0,12/35,10.45%,NOTCH2;PDGFRA;NTRK3;ABL1;BAIAP2L1;BCAS3;NRP1;RAPGEF3;CDC42;IQGAP2;SEMA3E;ABL2
prerank,regulation of cellular catabolic process (GO:0031329),-0.3931701870681357,-1.4115179554633706,0.04065040650406504,0.3490659534152715,1.0,20/62,17.77%,ITPR1;EP300;ROCK1;PRKN;ABL1;LRRK2;NUPR1;RPTOR;TPCN2;PIP4K2C;LONP2;USP33;ABL2;WDR91;MTMR3;KAT8;USP13;DAPK1;DAPK2;RMC1
prerank,monocyte chemotaxis (GO:0002548),0.45770448242482215,1.411065454648733,0.05714285714285714,0.39719268263672286,1.0,8/32,20.59%,FLT1;RPS19;CCL2;PDGFB;CCL25;PTPRO;CCL13;CCL19
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.474137316626457,-1.4109015814250794,0.052941176470588235,0.34953076378109127,1.0,11/27,19.24%,DICER1;PCF11;ZC3H12C;NYNRIN;CPSF3;XRN1;KHNYN;ERN1;ZC3H12B;CSTF3;RNASE4
prerank,spindle assembly (GO:0051225),-0.394701646177009,-1.4090738982713942,0.0375234521575985,0.35293714806787835,1.0,34/67,30.19%,INO80;NCOR1;NUMA1;FLNA;PIBF1;CEP63;SPICE1;TUBGCP6;TUBGCP2;STAG1;LSM14A;RHOA;RAB11A;ABRAXAS2;MAPRE1;TOGARAM1;MAP9;RCC1;STAG2;CSNK1D;TUBGCP4;NEK6;SMC1A;HAUS7;HAUS8;BCCIP;NEK7;ABRAXAS1;HDAC3;HAUS3;KIF11;MZT1;HAUS4;HAUS5
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.36391792185599264,-1.4089584648388918,0.026,0.35236734066713343,1.0,29/104,15.00%,SMAD3;TGFBR1;CRIM1;BMPR1A;LDLRAD4;SMAD6;SMURF2;NBL1;TGFBR2;HTRA3;TGFB1I1;BCL9L;SMAD2;SKI;SNX6;SKIL;PDPK1;PMEPA1;CCN3;SMAD4;BMPER;CD109;IL17RD;STRAP;PPM1A;ASPN;EMILIN1;SMURF1;ACVR1
prerank,aminoglycan catabolic process (GO:0006026),-0.47659825528764493,-1.4086994595592877,0.05576923076923077,0.3521047787765009,1.0,6/28,5.04%,GPC6;SDC2;GPC4;GPC3;GNS;HSPG2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.45988488314633275,1.4085421263843085,0.06,0.401638011969817,1.0,9/30,19.07%,MIF;CXCL12;SIRT1;CLU;TPT1;RPS3;THOC1;MDM2;THOC5
prerank,regulation of dendrite morphogenesis (GO:0048814),0.46066999471858006,1.4074685288582245,0.059957173447537475,0.40264073683499774,1.0,9/32,9.80%,ADGRB3;PTPRD;IL1RAPL1;HECW1;TNIK;SEMA4D;HECW2;CDKL5;LZTS1
prerank,mitochondrial genome maintenance (GO:0000002),-0.6008578704575519,-1.4069068824699318,0.08921933085501858,0.3553205670650177,1.0,4/11,19.00%,OPA1;MEF2A;PARP1;MGME1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.5131954303273132,-1.4056320986267392,0.07262569832402235,0.3574743397020209,1.0,6/18,6.49%,ROCK2;ROCK1;RIPOR2;BCAS3;RAP1B;ARFGEF1
prerank,phosphorylation (GO:0016310),-0.3108263985224942,-1.4048757206603169,0.0,0.35829359764665,1.0,129/384,22.06%,PRKAG2;ROCK2;GRK5;TGFBR1;BMPR1A;EPHA7;CDK8;TLK1;PI4KA;PDK1;STK3;ROCK1;FAM20A;ABL1;BIRC6;PRKAA2;TGFBR2;LRRK2;JAK1;CSNK1A1;FRK;GK5;TOP1;GSK3B;STK17B;CCNT1;RYK;TBK1;NRK;IRAK3;MARK3;IGFBP3;CDK16;BCR;CDK7;DGKA;PAK2;STAT3;NADK;TAOK3;MAP4K4;EIF2AK3;LYN;MTOR;CAMK2D;BRAF;MAP3K5;MERTK;GRK4;PDPK1;DCLK1;MARK4;WNK4;GRK3;MAP2K1;HIPK1;CSNK1E;CDK13;CLK2;WNK1;MAP3K20;FER;BRSK1;PANK2;PRKCD;LIMD1;DMPK;FAM20C;CLK3;CDK11B;MKNK2;SIK1;COPS2;EIF2AK4;MAML1;PGK1;GMFB;TBCK;TRIB2;TEC;COPS8;MAPK6;TYK2;BMP2K;EIF2AK2;ERN1;PRKDC;PRKCZ;LATS1;CDC25B;ACVR1;GRK6;CSNK2A1;PIK3R4;DAPK1;MARK1;SIK3;PIK3CD;PRKD1;PRKACA;IKBKE;DAPK2;PRKAA1;PXK;MORC3;MAP3K1;NEK4;BMP2;CSNK1D;IRAK1;SHPK;CDK2;FASTK;CDK10;NRBP2;GNPTG;BCKDK;PRKAG3;DGKD;NEK6;SIK2;PRKAB1;CDK6;MAST2;MKNK1;MAP3K12;SPHK1;TAOK1;PPP4R1
prerank,positive regulation of sodium ion transport (GO:0010765),0.5708076387405157,1.4046887760042086,0.10583153347732181,0.40784732957352343,1.0,3/12,5.65%,CNKSR3;ANK3;SCN4B
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.5279533847496297,1.4041762602201526,0.08035714285714286,0.40745716302396895,1.0,2/16,6.16%,CLDN5;CLDN14
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.4469590989379518,1.4033218298421708,0.06779661016949153,0.407874824843532,1.0,8/32,12.06%,GRIN1;AKAP6;SNCA;THY1;APLNR;F2R;P2RX7;TRPC1
prerank,histone H3-K36 demethylation (GO:0070544),-0.6221300534665465,-1.402660115013839,0.07992565055762081,0.36273761454405234,1.0,4/10,16.10%,KDM7A;KDM4B;PHF8;KDM2A
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3591540137806845,-1.402316445483218,0.015625,0.3627631802183419,1.0,43/100,25.32%,FHIT;ARAF;PIAS1;DAB2;PRKN;LRRK2;RAD23B;ARIH1;CSNK1A1;GSK3B;RNF217;USP7;UFL1;RNF19A;CSNK1E;NUB1;RPL11;GIPC1;OGT;TRIB2;SH3RF2;CBFA2T3;TRIM39;NOP53;HECTD1;FBXO22;VCP;RNF14;CSNK1D;PARK7;COP1;DESI1;ZYG11B;ARIH2;DET1;WAC;CCAR2;RNF144A;XPO1;BAG5;BAG6;EIF3H;UBQLN4
prerank,aminoglycan metabolic process (GO:0006022),0.6075949077477238,1.4020956727908458,0.10515021459227468,0.4090543254354216,1.0,3/10,5.50%,B3GAT1;CHST9;B3GAT2
prerank,filopodium assembly (GO:0046847),0.5363531861856128,1.4017679500134446,0.08705357142857142,0.40818522769850835,1.0,5/16,12.16%,DNM3;FGD5;SPATA13;FGD3;SRGAP2
prerank,wound healing (GO:0042060),-0.39281480986994277,-1.4011588635934304,0.026052104208416832,0.36471261503456587,1.0,12/62,5.58%,IGF1;COL3A1;SMAD3;TGFBR1;PDGFRA;TPM1;DCBLD2;FGF1;CFLAR;ANXA6;MYOF;FUT10
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.4982341829562338,-1.4011358797711344,0.07784431137724551,0.36393458916321086,1.0,5/21,5.97%,LRP6;CSNK1A1;GSK3B;AXIN1;FZD2
prerank,positive regulation of chemokine production (GO:0032722),0.4235130316216379,1.399972591781939,0.05714285714285714,0.41063179218686235,1.0,8/44,9.84%,TIRAP;MBP;IL17F;CSF1R;IL7;TLR2;ADCYAP1;AIF1
prerank,cell part morphogenesis (GO:0032990),-0.5758040455213468,-1.399972403389691,0.1017274472168906,0.36591374361273893,1.0,7/13,28.33%,PID1;PACSIN2;DNM1L;WASF1;FIS1;MYH14;SUPV3L1
prerank,base conversion or substitution editing (GO:0016553),0.5732691358764881,1.3994367210350054,0.1010989010989011,0.41028021860079134,1.0,1/11,0.14%,ADARB2
prerank,postsynaptic membrane organization (GO:0001941),0.5290252713081831,1.3992712804127188,0.1032258064516129,0.40902100916048606,1.0,6/17,9.32%,NRXN1;NLGN1;SHANK3;NRXN2;SHISA7;LHFPL4
prerank,regulation of response to stress (GO:0080134),0.6032178931376925,1.3986531362671568,0.1108695652173913,0.40879736164466846,1.0,5/10,19.58%,ADCY8;MLC1;OPRM1;STOX1;SLC38A2
prerank,sensory perception of pain (GO:0019233),0.4948607604742731,1.3977187050853435,0.0970464135021097,0.4093318672114242,1.0,8/21,15.25%,MME;CCL2;OPRM1;RETREG1;P2RX7;KCNA2;OPRK1;OPRL1
prerank,regulation of endothelial cell migration (GO:0010594),-0.3726297112906408,-1.396917027180135,0.03824091778202677,0.3722212100340136,1.0,21/85,12.02%,ROCK2;FOXP1;NR2F2;SASH1;PTN;ANGPT1;DCN;FGF1;BMP4;ABL1;SPARC;RHOJ;THBS1;BCAS3;FOXC2;NRP1;SP100;GLUL;ADAMTS9;BMPER;ANXA3
prerank,positive regulation of biosynthetic process (GO:0009891),-0.43614674995745034,-1.396755198130882,0.06627680311890838,0.37172870146145615,1.0,14/40,17.06%,ZBTB20;SORBS1;WNT4;VIM;BMP4;SLC5A3;CREBL2;MTOR;RUNX1;APOE;CYBA;TGFB3;SUCO;TLR4
prerank,heart trabecula morphogenesis (GO:0061384),-0.5118724295991067,-1.3959483009134905,0.07992202729044834,0.372609831993641,1.0,7/18,4.38%,TGFBR3;TGFBR1;BMPR1A;RBPJ;BMP5;BMP7;RBP4
prerank,negative regulation of chemotaxis (GO:0050922),0.45574678501728166,1.3958429138505468,0.06318082788671024,0.412319084279773,1.0,10/31,9.84%,SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A;NOTCH1;ROBO2;AIF1
prerank,negative regulation of histone acetylation (GO:0035067),0.585594482484558,1.395322864226542,0.09791666666666667,0.4119487980938166,1.0,4/11,13.03%,SIRT1;SNCA;SET;SIN3A
prerank,glycine transport (GO:0015816),0.6141401749911556,1.3952111322743568,0.10087719298245613,0.41056928378675506,1.0,4/10,9.70%,SLC6A17;SLC6A5;SLC7A8;SLC36A1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5963280064200105,-1.3952101923224778,0.0782122905027933,0.37350061147951613,1.0,4/11,9.06%,EGFR;DDX5;BMP4;MAP2K1
prerank,regulation of activated T cell proliferation (GO:0046006),-0.4597295368018179,-1.3949941492506854,0.07183364839319471,0.3731863716766837,1.0,5/30,8.43%,IGF1;IGFBP2;HMGB1;RC3H1;IGF2
prerank,cyclooxygenase pathway (GO:0019371),-0.6068936958994764,-1.3948934298234164,0.08846153846153847,0.37258153662278004,1.0,4/10,10.82%,PTGDS;PTGIS;PTGS1;PTGES
prerank,regulation of defense response to virus by host (GO:0050691),-0.4600325770556364,-1.3941606850974446,0.07789855072463768,0.37344720417996147,1.0,11/30,17.47%,TRIM44;DHX9;TRAF3IP2;PTPN22;RNF216;PARP9;MAVS;EIF2AK4;DTX3L;STAT1;ZDHHC1
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.4400869795874567,-1.393195888069692,0.04296875,0.37493922869629537,1.0,16/35,25.45%,FOXO3;ARNT;HOXA5;STAT3;LYN;MED1;HIF1A;HSPA9;PRKDC;STAT1;STAT5B;INHBA;CDK6;MAFB;LDB1;MAPK14
prerank,lipid translocation (GO:0034204),0.4907680302493106,1.3922135630012518,0.0957683741648107,0.4160065968601795,1.0,8/21,11.06%,TMEM30A;ATP8A1;ATP11A;ATP10A;ATP10B;ATP11C;ATP8A2;ABCB4
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.47218705537108036,-1.391609348994444,0.08272058823529412,0.3778638182940827,1.0,4/26,7.00%,EYA2;EYA1;EYA4;BCL2
prerank,skeletal muscle organ development (GO:0060538),-0.4674478813456354,-1.391526848430722,0.08301158301158301,0.3771835340978493,1.0,6/26,11.26%,LARGE1;SVIL;CFLAR;DISP1;IGSF8;MEF2C
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.4799011159076315,-1.3904435408952525,0.07222222222222222,0.37888899624762656,1.0,12/26,20.48%,ANK2;FHL1;WWP2;DLG1;ITGB1;CACNA1D;ACTN2;VAMP2;YWHAE;AKAP9;ATP1B3;CAB39
prerank,lipid droplet formation (GO:0140042),-0.6055948787181135,-1.3900963098418775,0.08545454545454545,0.3788959985801391,1.0,7/10,30.87%,ZFYVE1;AUP1;SQLE;CDS2;BSCL2;PLA2G4C;FITM2
prerank,regulation of organelle assembly (GO:1902115),-0.3884980251272002,-1.3893621559042748,0.042801556420233464,0.37975717716180185,1.0,32/72,27.67%,GSN;TBC1D16;ALMS1;DCDC2;SPICE1;STX18;TBC1D19;TBC1D24;SENP6;ATXN2L;USP6NL;TBC1D2B;TBC1D20;IFT88;MTMR3;TBC1D22B;DYNC2LI1;CEP295;CEP76;NPRL3;ATG5;TBC1D17;RABGAP1;KIF9;TBC1D10A;MSN;IFT140;RAB5A;TBC1D10B;RABEP2;ATG3;TBC1D9B
prerank,sensory perception (GO:0007600),0.4134958477901388,1.388798330218883,0.0440251572327044,0.422558390033976,1.0,15/45,19.16%,PCDH15;MME;GNAL;CCL2;OPRM1;RETREG1;TTC8;P2RX7;KCNA2;PNOC;OPRK1;OPRL1;NTSR2;TMEM150C;ADORA2A
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.48521514660478904,-1.3885045263247342,0.0836734693877551,0.3800506417186383,1.0,8/23,10.84%,DAB2;EP300;TGFB1I1;THBS1;CREBBP;ZEB2;SMAD4;GIPC1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.48521514660478904,-1.3885045263247342,0.0836734693877551,0.3800506417186383,1.0,8/23,10.84%,DAB2;EP300;TGFB1I1;THBS1;CREBBP;ZEB2;SMAD4;GIPC1
prerank,regulation of gastrulation (GO:0010470),-0.5576007225263555,-1.3884338749674685,0.0847145488029466,0.3793425886996121,1.0,3/14,3.07%,PHLDB2;DAG1;OSR1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5619343873351907,-1.3879105413598523,0.09760589318600368,0.3797132126132304,1.0,4/14,16.63%,IRAK3;PIBF1;THBS1;CMKLR1
prerank,melanosome organization (GO:0032438),-0.46161961840368393,-1.3874527331555115,0.0823293172690763,0.3799493715324571,1.0,6/26,18.79%,KIF13A;SHROOM2;DTNBP1;AP3B1;BLOC1S5;HPS1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.6039878760173146,-1.3865763025492506,0.07865168539325842,0.3811624365012461,1.0,5/10,16.51%,IMPACT;BAG3;JUN;NCK1;CITED2
prerank,regulation of autophagosome assembly (GO:2000785),-0.4357373596497585,-1.3863539462365504,0.06566604127579738,0.380881311127122,1.0,12/33,19.13%,LRRK2;NUPR1;RAB3GAP1;SEC22B;CHMP4B;CHMP4A;PIP4K2C;IFT88;MTMR3;NPRL3;FEZ2;LRSAM1
prerank,response to amino acid (GO:0043200),0.4477252567056326,1.38534747248631,0.08456659619450317,0.42973787396120217,1.0,6/31,9.58%,GRIN1;IPO5;GLRA1;GLRA3;MEAK7;GLRA2
prerank,rRNA pseudouridine synthesis (GO:0031118),0.595102135154883,1.3849457544807442,0.11358574610244988,0.42904582495142446,1.0,5/10,17.38%,TSR3;RPUSD1;NHP2;DKC1;NAF1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.48178343080574226,-1.3846728478625416,0.08458646616541353,0.3840394496245983,1.0,16/24,35.45%,SEC24D;SEC23A;SEC31A;MFSD6;TAP2;SAR1B;TAPBPL;TAP1;FCER1G;ERAP1;SEC24A;CALR;SEC24C;IDE;SEC13;TAPBP
prerank,regulation of lamellipodium assembly (GO:0010591),-0.44749771601136734,-1.3835764587898598,0.06457564575645756,0.3858040781065142,1.0,15/34,26.67%,AUTS2;PLCE1;WASF2;BRK1;CDC42;FER;NCKAP1;ARPC2;CAPZB;AVIL;PIK3R1;SLIT2;TWF2;TWF1;ACTR2
prerank,regulation of neuron migration (GO:2001222),0.4656094250050371,1.383287595331916,0.07883817427385892,0.43143534284779644,1.0,11/26,14.06%,CAMK2A;CTNNA2;SEMA6A;SHTN1;NEXMIF;NTNG2;NTNG1;ARHGEF2;DAB2IP;SRGAP2;ADGRG1
prerank,positive regulation of gene expression (GO:0010628),-0.3011210152324751,-1.382769031580653,0.0,0.3868752973156048,1.0,78/442,10.81%,BMP6;SLC24A3;SAMD4A;ROCK2;PLD1;IGF1;EGFR;PID1;AFDN;SMAD3;TGFBR1;ANK2;FOXD1;RBMS3;GSN;ANGPT1;RBPJ;NTRK3;LIMS1;DDX5;CELF1;FGF1;KAT2B;VIM;BMP7;BMP4;EP300;ROCK1;ROBO1;PRKN;SMO;OSR1;TNRC6B;ZCCHC4;WNT6;GSK3B;PLA2R1;YTHDF3;TNRC6A;YAP1;CTSH;THBS1;MOV10;HOXA5;UBR5;PLSCR1;STAT3;U2AF2;MED26;DTNBP1;EIF2AK3;MTOR;F3;SF3B1;BRAF;HNRNPD;AR;DHX36;PPARGC1A;FUBP1;GJA1;TBP;TAF1D;MAP2K1;MED1;PTPN22;PLXNB2;ATF2;PHF2;NGF;GABPA;TADA3;ITGB8;HCFC1;HIF1A;RPL11;CALCOCO1;ID2
prerank,positive regulation of cell cycle process (GO:0090068),-0.36713658367115887,-1.3825795272629913,0.030303030303030304,0.38646349462120505,1.0,23/91,17.57%,IGF1;INO80;SVIL;PDGFRB;CDC14A;NUMA1;CSPP1;UBXN2B;PLSCR1;CDC42;IGF2;MAP3K20;RHOA;GIPC1;RAD21;DYNC1LI1;TPR;CUL3;CDC25B;CDC14B;CEP295;DYNC1H1;PHIP
prerank,regulation of cartilage development (GO:0061035),-0.5162125439598992,-1.3824904306914951,0.08082706766917293,0.385828582488505,1.0,8/18,21.94%,SOX5;BMP4;ZBTB16;SOX6;TRPS1;BMP2;TAPT1;PTHLH
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.4586086477288167,-1.3824856124611653,0.06432748538011696,0.3850033440425775,1.0,8/29,14.69%,ZBTB20;SORBS1;CREBL2;MTOR;LDLR;NR1H3;SLC27A1;APOE
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.4852960711457586,-1.3824471276597001,0.08023483365949119,0.38424681459385346,1.0,6/23,8.28%,PRKAG2;CEMIP;BMP7;RPTOR;AXIN1;UBE2K
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.5753395198190395,-1.382056931777894,0.09315589353612168,0.3844029631942965,1.0,6/12,25.98%,IRS1;PPARGC1A;ABCD2;AKT2;TWIST1;PPARA
prerank,negative regulation of type I interferon production (GO:0032480),-0.4308935455953007,-1.3819999269797494,0.07750472589792061,0.38369251902234147,1.0,24/40,37.42%,TAX1BP1;TBK1;PTPRS;PCBP2;RNF216;MAVS;TRIM25;ILRUN;IKBKE;UBA7;NLRX1;NLRC3;SIRPA;GPATCH3;CACTIN;DHX58;TNFAIP3;IFIH1;UFD1;OTUD5;PYCARD;PIN1;TRAF3IP1;NLRC5
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5922243562980133,-1.3819248580132368,0.11359404096834265,0.38302138056310114,1.0,4/11,10.16%,LRRK2;USP7;MAP2K1;CHMP3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.3170790318222185,-1.3816001182743267,0.00398406374501992,0.3829881546844387,1.0,71/259,18.45%,PARVA;VCL;GSN;PKD1;MYLK;PCM1;ASAP1;GBF1;BBS9;CDC14A;KIT;WDPCP;DCDC2;FLNA;NUDCD3;CYS1;ARL3;PIBF1;IFT43;ITGB1;ATP6V0D1;PDE6D;ARL13B;RAP1B;CFAP44;IFT81;CEP162;DYNC2I1;MAP4K4;ABLIM3;NRP1;PCNT;EHD2;ACTN2;RFX2;RAB3IP;FAM161A;IFT88;RPGR;RP2;EXOC2;IFT80;ARFIP2;EMP1;RAB11A;CC2D2A;POC1B;FGD1;ARMC9;P2RY12;SNX10;RILPL2;EMP3;RAPGEF2;FGD4;CDC14B;EHD3;DZIP1L;WHAMM;CCDC57;CARMIL1;ARHGEF6;FXYD5;CCDC66;TCTN1;PTPDC1;WDR11;DYNC2I2;INPP5K;CPLANE1;EHD4
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4802358248450917,1.3814963217928622,0.08438818565400844,0.43418813427564146,1.0,5/22,10.36%,SLA2;THY1;PTPRJ;GPS2;LPXN
prerank,regulation of chromatin organization (GO:1902275),-0.5567037892144135,-1.381213636364528,0.10018552875695733,0.383065828484705,1.0,4/14,8.43%,MLLT3;TLK1;SETD5;IGF2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.38741168292783923,-1.3801482439215285,0.045364891518737675,0.3847392325173223,1.0,29/62,28.91%,MLLT3;GTF2H2;CCNT2;CCNH;CCNT1;CDK7;CTR9;CCNK;CDK13;SETD2;MNAT1;AFF4;RTF1;ERCC3;NELFB;POLR2H;CDC73;GTF2F1;EAF2;POLR2K;GTF2H1;POLR2E;CTDP1;NCBP2;GTF2H4;NELFA;NELFE;POLR2D;CDK9
prerank,water transport (GO:0006833),0.5547032210443532,1.3796580261649705,0.11016949152542373,0.43721714851118465,1.0,4/12,16.16%,AQP9;AQP11;AQP4;CFTR
prerank,microtubule polymerization or depolymerization (GO:0031109),0.4781807955204005,1.379554187376874,0.09465020576131687,0.4358254647997199,1.0,9/24,19.68%,STMN1;FGF13;STMN4;TPPP;STMN2;STMN3;TPPP3;KIF18A;TRPV4
prerank,response to ATP (GO:0033198),0.5012227261195237,1.379226021575417,0.1006423982869379,0.4349771959735583,1.0,5/18,11.32%,RYR3;KCNJ11;P2RY1;CIB2;P2RX7
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.5217252797161092,-1.3791849456092002,0.10112359550561797,0.3861976897807269,1.0,12/16,41.24%,PDS5A;RAD21;NIPBL;RB1;PDS5B;SMC1A;BOD1;POGZ;MAU2;REC8;SGO1;DSCC1
prerank,positive regulation of locomotion (GO:0040017),0.4645015305636121,1.3790533114799886,0.1,0.433686633281634,1.0,7/27,10.53%,SPOCK2;CSF1R;PPM1F;STX3;AIF1;NTN1;PDGFB
prerank,angiogenesis involved in wound healing (GO:0060055),0.5783745678110581,1.3787960359674887,0.10062893081761007,0.4327412330051529,1.0,4/11,9.30%,KDR;NDNF;CD34;ADIPOR2
prerank,hippo signaling (GO:0035329),-0.4745700276909838,-1.3773219099948562,0.07894736842105263,0.38997097760135363,1.0,10/26,14.99%,TEAD1;STK3;YAP1;AMOTL2;TEAD3;WWC1;TEAD2;MOB1B;LATS1;YWHAE
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5268144848154593,1.3773054777263838,0.10736842105263159,0.43469198075132043,1.0,4/16,13.09%,CXCL12;CLU;TPT1;RPS3
prerank,cellular protein modification process (GO:0006464),-0.28431165677011816,-1.3768682177880083,0.0,0.3901632340903224,1.0,300/982,22.69%,UST;PTPN13;PRKAG2;FSTL1;CP;ROCK2;FBN1;COL3A1;FBXL7;GRK5;TGFBR1;LARGE1;BMPR1A;ST3GAL4;CDK8;NGLY1;TLK1;LTBP1;IGFBP5;PDK1;SDC2;ARAF;B3GALT1;TNKS2;UBE2E2;LOXL1;BMP4;PPP1R12A;STK3;ROCK1;FAM20A;ABL1;PPM1D;SPSB1;BIRC6;PRKAA2;PPM1E;PTPN14;TGFBR2;LRRK2;FBXW8;HLCS;JAK1;CSNK1A1;KLHL13;BTRC;WWP2;FRK;GSK3B;STK17B;CCNT1;RYK;TBK1;GPC3;NRK;PLOD2;IRAK3;ASB3;MARK3;IGFBP3;PLAT;CDK16;BCR;PTPN9;CDK7;PTPRS;PIGK;THBS1;STT3A;ZBTB16;FUT10;PAK2;PTPN21;UFL1;DUSP16;TAOK3;WDTC1;ITIH2;MAP4K4;EIF2AK3;LYN;MTOR;ASB2;OGA;ANXA1;PTPN3;FBXL4;CAMK2D;ZC3HAV1;BRAF;OBSL1;PARP10;MAP3K5;MERTK;GRK4;PDPK1;FBXL12;FBXO10;DCLK1;ASB13;PTPRK;IGFBP4;SETD3;MARK4;DDB2;KTN1;WNK4;GRK3;MAP2K1;UBE2I;PTPN22;DAPP1;HIPK1;CSNK1E;CDK13;PPP2CB;NUB1;PMM2;PPP4R2;CLK2;WNK1;MAP3K20;PPM1H;TNC;FER;PTPN12;EGLN3;BRSK1;MAN2A1;PRKCD;ABL2;HIF1A;PARP9;DMPK;GGCX;PARP14;DCAF10;COG3;ST3GAL3;DNAJC3;FAM20C;CLK3;COG7;CDK11B;DUSP11;SERPIND1;DCAF6;WIPI1;YES1;LGALS1;PARP1;PPM1M;PSMF1;FBXL19;PPP2R5E;RAB11A;FBXL18;UGCG;MKNK2;LRRC41;FN1;SIK1;CUL3;COPS2;EIF2AK4;FBXO30;FBXW7;MTMR3;PPM1A;MAML1;DCAF8;MXRA8;GMFB;SIRT5;TBCK;CCN1;WSB2;TRIB2;TEC;COPS8;PSMB2;PARP4;KLHL22;MAPK6;LOX;TYK2;BMP2K;EIF2AK2;PIK3C3;DUSP1;ERN1;PRKDC;MSLN;PPP2R5D;PRKCZ;APOE;LATS1;CDC25B;CDC14B;CUL2;ACVR1;MBTPS1;ERCC8;GRK6;PPP1CB;IGFBP7;CSNK2A1;DUSP10;PIK3R4;KLHL11;DCAF4;DAPK1;MARK1;MANBA;UBE2E1;FEM1A;SIK3;WDR45B;UBL5;PIK3CD;ASB5;PIGS;PRKD1;PRKACA;IKBKE;UBA7;DAPK2;UBE2S;MAN2A2;MIA3;FBXO22;PRKAA1;ATG5;PXK;RPN1;PPP2R5C;RABGGTB;MORC3;FBXW5;PTPN1;FBXW11;RCN1;MAP3K1;DCUN1D3;NEK4;CHM;BMP2;SPSB4;GCNT2;TRIOBP;CSNK1D;ABCA7;UBE2D3;PARK7;GPAA1;IRAK1;CDK2;B4GALT5;FASTK;B4GALT7;CDK10;PPP2R1B;COP1;NRBP2;SPP1;P4HB;BCKDK;PSMC1;PRKAG3;PIGH;HIF3A;WIPI2;PARP6;PPP2CA;CHML;AKT2;NAE1;NEK6;PTPRA;SIK2;CUL1;PRKAB1;CUL7;CDK6;MAST2;MKNK1;SUMF1;SIRT4;MAP3K12;FBXW4;TAOK1;PPP4R1;DUSP7;WFS1;F5;LAMB2;LAMC1;BTBD1;PSMA3;PSMB6
prerank,central nervous system development (GO:0007417),0.3187399882606259,1.3768526176003457,0.00980392156862745,0.4342296037374045,1.0,57/250,14.62%,PAX8;ADGRL3;CNTNAP2;SPOCK1;GRIN1;SLC6A17;SLC2A1;MAL;MBP;PROX1;ASIC2;SH3GL2;PBX2;GRIN2A;SH3GL3;DNER;AHI1;CDH2;GRIK1;CNTN6;GRIN2B;MFSD2A;ADAM22;ADAM23;GRIN2D;AATK;MOG;PITPNM1;NPAS2;DSCAML1;CYP26C1;NRCAM;MTF1;ROBO2;IL1RAPL2;TPPP;UBE3A;ADGRL2;RELN;PHGDH;FOXJ1;HAP1;CNTN4;NPTX1;SH3GL1;VCAN;ITGAM;PTPRZ1;HPCAL4;HAPLN3;DLL1;ADGRG1;DCX;NHEJ1;PPT1;LSR;HAPLN4
prerank,regulation of protein autophosphorylation (GO:0031952),-0.4354994432648789,-1.3767735141292894,0.0779467680608365,0.3895774845024071,1.0,16/36,22.51%,ERRFI1;EPHA7;ENPP1;NBN;IMPACT;PDGFC;PPP2R5E;MOB1B;RASSF2;VEGFA;PPP2R5D;DDX3X;MRE11;PPP2R5C;MVP;CHP1
prerank,response to axon injury (GO:0048678),-0.5095300577369614,-1.376471613600801,0.09284332688588008,0.38949514908892946,1.0,5/18,15.15%,DPYSL3;NREP;P2RY12;APOD;P2RX4
prerank,regulation of membrane depolarization (GO:0003254),-0.5144583222221516,-1.3762876641605581,0.10207939508506617,0.3890833191972228,1.0,4/18,7.33%,FHL1;LRRK2;PTPN3;CAMK2D
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.4338586097106467,-1.3761982615696675,0.07034220532319392,0.3884428411204139,1.0,15/34,26.46%,IGF1;PDGFRB;NSMCE2;ANAPC5;ANAPC7;IGF2;ANAPC4;RB1;CUL3;CDC27;PHIP;ANAPC11;CDC16;EGF;EDN3
prerank,lipoprotein biosynthetic process (GO:0042158),-0.5886030970849395,-1.3750640179199727,0.10693069306930693,0.3904604339574264,1.0,8/11,33.40%,WIPI1;UGCG;PIK3C3;APOE;WDR45B;WIPI2;ATG10;WDR45
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.47490519895295713,-1.3746435734393208,0.08555133079847908,0.39062904034801493,1.0,14/26,29.48%,KMT5B;SETD5;KMT2D;CTR9;SETD3;SETD2;KMT5C;OGT;EEF2KMT;KMT2A;PRDM9;TET2;TET3;ANTKMT
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.4074512345429526,-1.3743524115681822,0.033797216699801194,0.3904799408859083,1.0,19/47,21.68%,MEDAG;BMP7;TMEM64;RREB1;CREBL2;ZBTB16;ID2;NAPEPLD;SOX13;TRPM4;WDFY2;CMKLR1;SIX1;HNRNPU;SYAP1;METRNL;BMP2;FRZB;CCDC71L
prerank,positive regulation of macroautophagy (GO:0016239),-0.40780630359483766,-1.3740521721761658,0.061420345489443376,0.3904218488691172,1.0,12/48,11.12%,DCN;PRKAA2;UVRAG;TBK1;VPS13D;RAB3GAP1;LARP1;PIP4K2C;VDAC1;SESN1;BAG3;PAFAH1B2
prerank,regulation of vasculogenesis (GO:2001212),0.5477738332868222,1.373411063148793,0.09979633401221996,0.44092068465453804,1.0,4/14,8.85%,HEY1;KDR;CD34;RIN2
prerank,response to molecule of bacterial origin (GO:0002237),0.38247771539154296,1.3732618292862369,0.045081967213114756,0.439664766030639,1.0,19/69,15.29%,TIRAP;S100A9;S100A8;SNCA;NOS3;IL12A;CD24;HNRNPA0;IFNAR1;TRIM6;CYRIB;SLPI;GGT7;F2R;GGT1;TAB2;PELI1;MAPKAPK2;GCH1
prerank,gene expression (GO:0010467),0.3072985651312207,1.3729675736866263,0.0056925996204933585,0.4387532150970508,1.0,90/348,14.50%,PAX8;ADARB2;BICD1;LMF2;RPS6;RPS19;RPS20;RPL38;RPL29;PTMA;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;NUP210;RPL10;RPL15;HOXD3;NXT1;RPL10A;RPS24;RPL27A;RPS17;RPS6KB2;RPS8;RPS16;RPS27A;RPLP1;DHX38;XAB2;RPL41;RPLP0;RPL30;RPL7A;RBM15B;MRPS18A;GLE1;RPL12;MRPL13;RPL13;TSPAN17;MRPS7;RPS15;ALYREF;NUP62;MRPS14;POLR2J;POLR2B;RPL14;EIF4EBP2;BCL3;FARSB;RPL5;RPS4X;TSPAN14;RPL21;RPS7;POLR2I;THAP1;RPL23A;DKC1;EEF1A2;HSPD1;MAGOHB;MAGOH;RPL8;MED20;DROSHA;NUP205;MRPL36;MRPL23;RPS3;SORL1;RPS14;GALNT2;TASP1;CPSF2;DDX20;RPS2;RPS5;EEF1A1;POLR3A;RPL18A;THOC1;RPS28
prerank,response to amino acid starvation (GO:1990928),-0.3769332732661679,-1.3723443045590782,0.060263653483992465,0.39380116875865884,1.0,25/72,23.17%,RNF152;ATP6V1B2;TFEB;RPTOR;ATP6V0D1;EIF2AK3;MTOR;LARP1;MAP3K5;GCN1;SESN1;IMPACT;ATF2;WDR59;EIF2AK4;CASTOR2;EIF2AK2;PRKD1;NPRL3;TCIRG1;DAP;LARS1;SZT2;ATP6V1G2;DAPL1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5845860020908726,1.3721926266390208,0.12300683371298406,0.4389470526038025,1.0,3/10,6.14%,NETO1;SHANK3;NPTN
prerank,regulation of transferase activity (GO:0051338),-0.5176619201922663,-1.3715474805603711,0.09615384615384616,0.3949288248106044,1.0,12/17,34.09%,SMG6;NABP2;PARP4;FEM1A;PPP1R3F;SPTSSB;BAG5;LDB1;LDB2;JMJD8;PINX1;FEM1B
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.604382365254129,-1.3715237834795726,0.11776061776061776,0.3941482814597873,1.0,4/10,18.89%,LRP6;RYK;WNT5A;FZD1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.38123636773722513,1.3714252236411122,0.04025423728813559,0.4391806398696879,1.0,15/75,7.63%,CAMK2A;MRAP2;RGS12;GIT1;GNG4;METAP2;YWHAB;RGS20;PLCB1;RGS5;KCTD8;GUCA1B;RGS11;RNF157;ADCYAP1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.578658241975966,1.3712051907626188,0.1326530612244898,0.43806116192258887,1.0,3/10,13.93%,GPR35;CALM1;CALM3
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4617274179507552,-1.3701977053114938,0.07572815533980583,0.3967044455821929,1.0,12/27,18.42%,PID1;GRB10;TNS2;ENPP1;IRS1;PIP4K2C;PTPN2;PRKCD;PRKCZ;NCK1;INPP5K;PTPN1
prerank,granulocyte chemotaxis (GO:0071621),0.39819991990282455,1.3700208463448669,0.04148471615720524,0.4394265260549513,1.0,14/55,20.59%,BSG;PDE4B;S100A9;S100A8;TGFB2;CCL2;SCG2;EDN1;CCL25;PPIA;NCKAP1L;CKLF;CCL13;CCL19
prerank,activation of phospholipase C activity (GO:0007202),-0.4450095402397077,-1.3697135054134082,0.0854368932038835,0.3969966734793794,1.0,6/29,13.62%,EGFR;LPAR1;ARHGAP6;EDNRA;PLCG1;P2RY12
prerank,aorta morphogenesis (GO:0035909),-0.525962092364085,-1.3694681547596284,0.1016949152542373,0.3967298799822638,1.0,6/17,3.17%,LRP1;BMPR1A;RBPJ;MYLK;PDGFRB;JAG1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.37034174794720515,-1.368880226331561,0.04375,0.39724844550518884,1.0,24/77,19.17%,IGF1;TCF7L2;TGFBR1;OPA1;ITGAV;CFLAR;BMP4;PRKN;BIRC6;THBS1;SH3RF1;ASAH2;BCL2;AR;ACAA2;RB1;ACVR1;DDX3X;CSNK2A1;NR4A2;PHIP;CX3CR1;TMEM14A;PARK7
prerank,cilium organization (GO:0044782),-0.3206458191689143,-1.368759337270606,0.007722007722007722,0.3967699163548636,1.0,58/209,19.76%,PARVA;GSN;PKD1;PCM1;ASAP1;GBF1;BBS9;CDC14A;WDPCP;DCDC2;ODF2;FLNA;NUDCD3;CYS1;ARL3;PIBF1;IFT43;ATP6V0D1;PDE6D;ARL13B;CFAP44;IFT81;CEP162;DYNC2I1;ABLIM3;PCNT;EHD2;MARK4;RFX2;RAB3IP;FAM161A;IFT88;RPGR;RP2;EXOC2;IFT80;RAB11A;CC2D2A;POC1B;ARMC9;PKD2;SNX10;RILPL2;TTC17;CDC14B;EHD3;DZIP1L;CCDC57;CCDC66;TCTN1;PTPDC1;WDR11;DYNC2I2;CPLANE1;EHD4;RILPL1;AVIL;CEP89
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.4754045644621915,1.3685385264484449,0.07505070993914807,0.44162859045739,1.0,5/24,8.19%,MIF;CXCL12;SIRT1;CLU;TPT1
prerank,protein ubiquitination (GO:0016567),-0.29627416543426355,-1.3678546760934926,0.002066115702479339,0.39809928248304444,1.0,157/471,25.68%,RNF220;PDZRN3;FBXL7;RNF152;SASH1;FBXL17;PELI2;SMURF2;UBE2N;RNF43;TNKS2;UBR2;UBE2E2;TRIM44;PRKN;SPSB1;BIRC6;FBXW8;ARIH1;KLHL13;BTRC;WWP2;RNF115;TRIP12;RNF146;HUWE1;RNF217;USP7;UHRF2;RBBP6;UBR5;RC3H1;RNF213;OS9;SH3RF1;DTX4;RNF19A;WWP1;BCL2;UBE4B;ASB2;UBE2H;FBXL4;ZSWIM8;RNF8;CTR9;FBXL12;FBXO10;ANAPC7;UBE2K;HLTF;RNFT1;DDB2;VCPIP1;ANAPC16;NUB1;TNFAIP1;LZTR1;HERC2;SELENOS;UBR1;RNF103-CHMP3;TRAF2;HIF1A;UBE2R2;RFWD3;RTF1;TRIM5;UBR3;PSMF1;FBXL19;FBXL18;TRIM11;TRIM25;CUL3;NPEPPS;FBXO30;FBXW7;NHLRC3;DTX3L;SH3RF2;PSMB2;KLHL22;TRPC4AP;UBE2B;PRKDC;TRIM39;SMURF1;CUL2;FBXO45;LNPEP;TOPORS;ERCC8;MSL2;UBE2E1;CDC27;ARRB1;RNF181;SH3RF3;BFAR;RNF20;DERL1;ASB5;UBE2S;KLHL18;FBXO22;HERC6;SYVN1;SDE2;FBXW5;TRAF6;FBXW11;VCP;MYLIP;SPSB4;EIPR1;AREL1;RNF14;LRSAM1;UBE2D3;TPP2;NFX1;PCNA;CDC73;DTX2;PSMC1;TRIM63;HIF3A;RNF11;ANAPC11;CUL1;CUL7;ARIH2;DET1;WAC;FBXW4;UBE2V2;CAND2;PSMA3;PSMB6;RMND5A;ARRDC4;RNF144A;RNF6;PSMA4;SIAH2;TRIM47;FBXL14;CDC16;TRIM68;CNOT4;USP9X;FBXO4;MGRN1;ZNRF3;FBXW9;FBXO11
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.49824900146892537,-1.3678214757644247,0.0782122905027933,0.39735789839935154,1.0,8/20,19.15%,GSN;PLA2R1;THBS1;PLCG1;PIAS4;ITGA4;PDCD4;SFRP4
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.5594577957074841,-1.3676284473334912,0.11969111969111969,0.3970047820412262,1.0,4/13,15.89%,ENPP1;TPST1;SULT1A1;ABHD14B
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5652310648801658,-1.3673301286288717,0.10458715596330276,0.39691755914643867,1.0,5/12,14.21%,RESF1;MPHOSPH8;ATF7IP;SETDB1;APOBEC1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5528695479531511,-1.3666254138011942,0.11923076923076924,0.39790827514321603,1.0,7/13,10.80%,BMP7;BMP4;NR3C2;NR3C1;AR;MED1;CALCOCO1
prerank,V(D)J recombination (GO:0033151),-0.5921115624742826,-1.366457308887797,0.10909090909090909,0.39747085473502597,1.0,5/11,14.38%,HMGB1;DCAF1;XRCC4;TCF3;PRKDC
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.5632696544621006,-1.3664088083659391,0.1125703564727955,0.39676510489160244,1.0,3/12,2.76%,ANK2;DIAPH1;ANXA6
prerank,positive regulation of signaling (GO:0023056),0.4282080398584304,1.366030277685138,0.06584362139917696,0.44629325302446304,1.0,10/37,8.31%,SYT1;RIMS1;RIMS2;RIMS3;SNCA;GRIK2;KCTD13;HOMER1;CLSTN3;NMB
prerank,regulation of interferon-alpha production (GO:0032647),-0.4855767690530014,-1.3656381656037093,0.10037174721189591,0.3978642074837779,1.0,9/23,17.06%,TBK1;PTPRS;DHX9;DHX36;SETD2;MAVS;STAT1;DDX3X;TLR4
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.5389639685463449,-1.365081208315371,0.11131386861313869,0.3984862335446723,1.0,10/14,37.04%,FUS;WDR48;PARP1;MMS19;ARID2;ACTR2;FANCB;TIMELESS;ERCC6;MRNIP
prerank,regulation of coagulation (GO:0050818),0.5686030531229711,1.365065108562429,0.12875536480686695,0.4470965788230274,1.0,3/11,11.41%,HS3ST5;F2R;PROC
prerank,negative regulation of macroautophagy (GO:0016242),-0.46287619733039886,-1.3649207213811028,0.07532956685499058,0.39808505594692156,1.0,10/26,20.19%,SMG1;LRRK2;NUPR1;MTOR;SEC22B;CHMP4B;CHMP4A;RUBCN;FEZ2;NRBP2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.3423717427593379,-1.3649003091774936,0.01717557251908397,0.39734999384925246,1.0,21/122,9.33%,SAMD4A;PLD1;IGF1;EGFR;SORBS1;NFKB1;GLI2;VIM;PDGFRB;ZCCHC4;YTHDF3;IRS1;THBS1;DHX9;MTOR;SLC6A9;HNRNPD;BRPF3;AR;IGF2;PLXNB2
prerank,maintenance of blood-brain barrier (GO:0035633),0.4503246777807547,1.3643176035728635,0.06976744186046512,0.4474364577651204,1.0,9/30,7.46%,CLDN5;ACTB;MBP;MFSD2A;JAM2;SLC1A1;OCLN;ESAM;PECAM1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.37025113903927054,-1.3635916350306887,0.047619047619047616,0.3997759352549933,1.0,28/76,21.59%,PIAS1;DAB2;PRKN;LRRK2;ARIH1;CSNK1A1;GSK3B;RNF217;AXIN1;RNF19A;CSNK1E;NUB1;FBXW7;TRIB2;SH3RF2;CBFA2T3;SMURF1;NOP53;HECTD1;FBXO22;VCP;RNF14;CSNK1D;COP1;ZYG11B;CDK5RAP3;ARIH2;DET1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.5623682188890317,-1.3635723988867334,0.11976047904191617,0.3990308111761413,1.0,8/12,35.18%,TNKS2;PARP10;PARP1;PARP6;PARP12;PARP2;PARP3;TIPARP
prerank,positive regulation of response to wounding (GO:1903036),-0.46843191097332965,-1.36351476439861,0.09380863039399624,0.3983318764384897,1.0,6/24,7.19%,PTN;MYLK;VTN;ITGB1;ARFGEF1;ANXA1
prerank,regulation of histone methylation (GO:0031060),-0.5462277064682843,-1.3633364263165582,0.12,0.39799250930056146,1.0,8/13,35.78%,NSD1;MTHFR;CTR9;JARID2;PIH1D1;NNMT;TTLL12;AASS
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.3261799021765715,-1.362867293659117,0.011904761904761904,0.3983355185307833,1.0,49/166,22.51%,SAMD4A;PLD1;IGF1;EGFR;SORBS1;SMAD3;GLI2;VIM;PDGFRB;ARNT;ZCCHC4;YTHDF3;IRS1;THBS1;DHX9;MTOR;SLC6A9;HNRNPD;BRPF3;PPARGC1A;IGF2;ZEB2;LDLR;PLXNB2;NR1H3;PTPN2;HIF1A;GIPC1;APPL1;PKD2;GLI1;SLC27A1;PRKDC;CTC1;DDX3X;P2RX4;TLR4;UPF3A;PARK7;PCNA;UPF3B;FGFR4;STN1;ASS1;AKT2;PYM1;ZNF205;FGF2;CHP1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.5181946454305282,-1.3622537683164266,0.1266294227188082,0.39906109486690744,1.0,11/16,33.21%,AUTS2;BCOR;CTR9;SMAD4;PIH1D1;KMT2A;PAXIP1;KDM1A;WDR5;SNW1;BRCA1
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.585290821130434,-1.3617243758160373,0.11218568665377177,0.39944819414480376,1.0,3/10,9.37%,MLLT3;UFL1;HOXB4
prerank,histone H2B ubiquitination (GO:0033523),-0.592116207651122,-1.3614644980776178,0.09195402298850575,0.3993183270337164,1.0,7/10,21.87%,RNF8;CTR9;DTX3L;UBE2E1;RNF20;CDC73;WAC
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.54430501250223,-1.3614123293840212,0.09829867674858223,0.39865087816558736,1.0,6/14,25.83%,MOXD1;DAGLA;NOS1;SLC5A7;DAGLB;SLC22A2
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.4076811764966648,-1.3605205344063813,0.07034220532319392,0.4001152745293052,1.0,20/48,21.49%,DOCK5;LIMS1;ABL1;CUX1;FBXW8;RREB1;FLNA;NRP1;OBSL1;S100A10;CDC42;PRKDC;CARMIL1;DOCK1;MYADM;MYOC;TRIOBP;P4HB;CRKL;CUL7
prerank,DNA methylation (GO:0006306),-0.4773137313244929,-1.3604479025736447,0.10869565217391304,0.399515003100165,1.0,6/23,13.43%,PPM1D;BAZ2A;DNMT3A;ATF7IP;N6AMT1;EHMT1
prerank,calcium ion homeostasis (GO:0055074),0.35573054576117885,1.3603754525208978,0.037422037422037424,0.45571996029948625,1.0,14/95,8.19%,TMTC2;SLC24A4;SLC24A2;GRIN1;CXCL12;RYR2;HTR2C;SNCA;SLC8A1;ATP2B3;SLC30A1;NPTN;CIB2;TPT1
prerank,positive regulation of lipid localization (GO:1905954),-0.5732221838561813,-1.360188259072173,0.11131386861313869,0.3993176967793472,1.0,2/11,1.20%,LRP1;NFKB1
prerank,organelle assembly (GO:0070925),-0.2999681616463016,-1.3599871428686676,0.0,0.3990012314893362,1.0,146/384,29.07%,PARVA;GSN;PKD1;INO80;PCM1;ASAP1;SH3PXD2B;GBF1;BBS9;NCOR1;CDC14A;WDPCP;DCDC2;PRRC2C;YTHDF3;FLNA;NUDCD3;CYS1;ARL3;UBXN2B;DDX6;PIBF1;CEP63;IFT43;ATP6V0D1;EIF4ENIF1;PDE6D;ARL13B;CFAP44;IFT81;RC3H1;VPS4B;TMOD3;UBQLN1;CEP162;DYNC2I1;ABLIM3;ZFYVE1;PCNT;TUBGCP6;EHD2;CHMP4B;CHMP4A;ATXN2L;TUBGCP2;CHMP5;UBAP2L;RFX2;RAB3IP;RB1CC1;CSDE1;CHMP3;VPS37C;LSM14A;FAM161A;IFT88;RPGR;RP2;LIMD1;EXOC2;ULK2;IFT80;WIPI1;ATP2A2;RAB11A;CC2D2A;POC1B;ARMC9;BECN1;MAPRE1;SNX10;ATG2A;RILPL2;SYNPO;PIK3C3;EDC3;CDC14B;EHD3;DZIP1L;DDX3X;RCC1;CCDC57;ATG9A;FARP2;WDR45B;DYNC1H1;AUP1;CCDC66;TCTN1;ATG2B;PTPDC1;WDR11;ATG5;SQLE;DYNC2I2;CPLANE1;EHD4;AMBRA1;HPS1;RILPL1;CSNK1D;LMOD1;AVIL;TUBGCP4;CEP89;SNF8;CDS2;WIPI2;GALNT11;TRAPPC14;NEK6;HAUS7;ATG14;HAUS8;MAP1LC3A;HYLS1;SSX2IP;RAB8A;PTPN23;CENPT;KIF3A;STX12;TTLL3;IRGM;BSCL2;IFT140;RAB7A;BBS4;NEK7;ACTR2;B9D1;MRPL22;DHX37;HDAC3;STX7;ATG3;POGZ;IFT122;BBS2;HAUS3;EXOC8;PLA2G4C;CEP41;CFAP43;EHD1;VPS28
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.5034688884063487,-1.35964888144232,0.0912621359223301,0.39909206346087184,1.0,11/19,39.17%,PRKN;DNM1L;VDAC1;FBXW7;PARK7;HTRA2;USP36;HTT;SREBF1;FZD5;HAX1
prerank,MAPK cascade (GO:0000165),0.31195059313477325,1.3592530443374737,0.006072874493927126,0.45698057063987424,1.0,55/295,11.18%,CAMK2A;DLG2;GRIN1;KITLG;TEK;RIT2;ERBB4;MBP;LRRC7;SPTBN4;RASGRP3;NRG2;NRG1;SPTB;DUSP6;SHANK3;RASAL3;FGF13;YWHAB;IL2RG;TNIK;GRIN2B;FGF10;KDR;PSMA1;FRS3;FLT3;LYPLA1;PEBP1;RASGEF1A;PAK1;PRKG2;NCAM1;PRKCQ;IL5;FGF5;RPS27A;UBC;RASGRF1;PSMD12;UBB;SPTBN5;PSMA6;GOLGA7;CCL2;WDR83;PSMB3;TAOK2;DAB2IP;SHC2;PDGFB;MEN1;SCG2;CALM1;SPTBN1
prerank,phospholipid homeostasis (GO:0055091),-0.5798102250019354,-1.3582913331852953,0.11796733212341198,0.4014781712225568,1.0,3/11,11.32%,ABCA1;TLCD2;RCN3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.5372430826138772,-1.3581266122721722,0.11196911196911197,0.4010728250089276,1.0,7/14,23.67%,OPA1;PRKN;LRRK2;SELENOS;SYVN1;PARK7;TMBIM6
prerank,cellular response to amyloid-beta (GO:1904646),0.42553600892572796,1.3576080129000836,0.0824524312896406,0.4594733854937755,1.0,6/35,3.52%,IGF1R;GRM5;CACNA1A;GRIN1;GRIN2A;CACNA2D1
prerank,ribosome assembly (GO:0042255),0.4032968886596007,1.3566285644991565,0.05701754385964912,0.46037109561176026,1.0,15/47,17.33%,RPS19;RPF2;RPS27;RPL10;RPLP0;MRPS7;RPS15;RPL5;NOP2;RPL23A;RPS14;RPS5;RPS28;MDN1;PPAN
prerank,nucleotide metabolic process (GO:0009117),-0.47009472042824996,-1.3566170988079587,0.09514563106796116,0.4039286840869294,1.0,8/23,14.73%,FHIT;NMNAT2;NUDT5;ME1;ENPP3;CTPS2;NMNAT3;NMNAT1
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.3508535455751779,-1.356136339035612,0.032388663967611336,0.40429326742732424,1.0,37/102,21.65%,SORBS1;RHOQ;ADCY9;NFKB1;ADCY5;KAT2B;ENPP1;IRS1;SLC39A14;SLC30A10;INSIG2;RAB10;ADCY1;RAB12;ADCY6;PDPK1;VAMP2;FER;SELENOS;PRKCD;PARP1;DENND4C;PCK2;PRKDC;NR4A1;CPEB1;PRKACA;NR4A2;SYAP1;LPIN2;INPP5K;LPIN3;PKM;AKT2;ADCY7;PIK3R1;USF1
prerank,response to reactive oxygen species (GO:0000302),-0.391901188046746,-1.3557452269116441,0.0888468809073724,0.4043937940018739,1.0,17/54,18.12%,EGFR;PDGFRA;TPM1;COA8;PTPRK;FER;JUN;HIF1A;ADAM9;APTX;PKD2;ERCC6L2;APOD;TXNRD2;APOE;GLRX2;SOD2
prerank,histone H3-K9 demethylation (GO:0033169),-0.5758505550930914,-1.355369942893406,0.12144212523719165,0.40453800204488705,1.0,7/11,27.02%,KDM7A;KDM4B;PHF8;KDM3B;KDM3A;KDM1A;JMJD1C
prerank,cellular response to organonitrogen compound (GO:0071417),0.3586403499225355,1.3553260794837552,0.03205128205128205,0.46207080755110985,1.0,17/99,9.58%,GABRB3;HCN1;GABRB1;ACTB;IPO5;AQP9;GLRA1;AKAP6;PDE2A;RYR3;GABRB2;HCN2;TRPM2;P2RY1;CIB2;GABRG2;GLRA2
prerank,glycogen biosynthetic process (GO:0005978),0.5447110089827902,1.3551975563735132,0.14541387024608501,0.45910804608537065,1.0,4/12,17.04%,PGM2L1;GYS1;PER2;GBE1
prerank,glucan biosynthetic process (GO:0009250),0.5447110089827902,1.3551975563735132,0.14541387024608501,0.45910804608537065,1.0,4/12,17.04%,PGM2L1;GYS1;PER2;GBE1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5855941057287709,-1.355139967512545,0.09073724007561437,0.40430891160464777,1.0,4/11,18.69%,TGFBR2;FGFR2;STAT1;WNT5A
prerank,regulation of type I interferon production (GO:0032479),-0.3608620315774442,-1.3550382496360212,0.050880626223091974,0.4037479781746207,1.0,45/84,34.58%,NFKB1;EP300;TAX1BP1;TBK1;CREBBP;DTX4;DHX9;DHX36;PCBP2;PTPN22;RNF216;MAVS;TRIM25;IRF1;ILRUN;PRKDC;NLRP4;MRE11;TRAF3;IKBKE;UBA7;POLR2H;IRAK1;XRCC6;NLRX1;DDX41;POLR2K;POLR3D;POLR2E;NFKB2;POLR3H;GPATCH3;DHX58;CGAS;POLR3E;POLR1C;TNFAIP3;IFIH1;DHX33;UFD1;POLA1;IRF5;OTUD5;IRF8;MYD88
prerank,negative regulation of neuron projection development (GO:0010977),0.39150778346150744,1.3548728288811436,0.06896551724137931,0.458293990421191,1.0,22/56,16.59%,SPOCK1;DCC;MINAR1;MAG;NLGN1;MCF2;THY1;EFNB3;OMG;LINGO1;ITM2C;STMN2;RTN4R;PRAG1;CIB1;RTN4RL1;RTN4;GDI1;FKBP4;STX1B;CRMP1;RAB29
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.5632582761712448,-1.3548101558682566,0.12849162011173185,0.40350055124642,1.0,6/13,22.07%,HMGB1;PDPK1;IGF2;PLCG1;ITGA4;FGF2
prerank,peptide catabolic process (GO:0043171),-0.4807452520895046,-1.3548085404590968,0.08935361216730038,0.4027223876683674,1.0,8/23,17.69%,CPQ;XPNPEP1;CTSH;ECE1;ANPEP;NPEPPS;LNPEP;CHAC2
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.4723433386967094,-1.354314467283431,0.09345794392523364,0.4031532908057349,1.0,13/26,31.95%,IRAK3;TRAFD1;MAPKBP1;PCBP2;ILRUN;CARD16;NLRC3;CACTIN;DHX58;MUL1;TNFAIP3;C1QBP;TYRO3
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.40854924137528315,-1.3537922548081907,0.08349900596421471,0.40371551786320087,1.0,16/43,19.29%,PID1;SORBS1;GRB10;TNS2;ENPP1;IRS1;PIP4K2C;IGF2;PTPN2;PRKCD;OGT;PRKCZ;NCK1;INPP5K;PTPN1;PTPN11
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.4457441732269398,1.3536978995866205,0.0872210953346856,0.45977642612014596,1.0,6/30,4.51%,FLT1;CSF1R;ARMC6;FST;KDR;FLT3
prerank,female gonad development (GO:0008585),-0.5086529211695272,-1.3529796791473683,0.10371819960861056,0.4048248046903856,1.0,12/19,37.89%,NR2F2;KIT;VEGFA;INHBA;EIF2B4;EIF2B5;INHA;INHBB;CEBPB;ANG;COL9A3;LHCGR
prerank,cellular response to lipid (GO:0071396),-0.3251043574872938,-1.352796409164385,0.021912350597609563,0.40445434765257315,1.0,51/191,20.29%,ATP1A2;ROCK2;EGFR;PID1;NFKB1;EPHA3;ADCY5;PTK7;VIM;AXL;PABPN1;WNT5B;WNT6;IRS1;LBP;HMGB1;NR3C1;LCOR;TFPI;SBNO2;ADCY1;LYN;ADCY6;WNT9A;AR;CTR9;MED1;CHMP5;UPF1;SELENOS;NR1H3;RHOA;ABL2;ADAM9;MEF2C;FZD7;ADNP2;RORA;TNIP2;PDCD4;SERPINE1;TLR4;CX3CR1;TRAF6;WNT5A;MGST1;IRAK1;SHPK;CARD16;CDC73;SPP1
prerank,response to metal ion (GO:0010038),0.3757981856727566,1.3527625603105704,0.06198347107438017,0.4605486465371137,1.0,18/67,14.34%,MT2A;AQP9;KHK;SNCA;MT1A;MT1X;HOMER1;ATP5F1D;MTF1;SLC30A3;CALM1;SLC30A5;TRPC1;SNCB;CALM2;CALM3;PPP3CA;NDRG1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.3298622709692154,-1.3523992552874902,0.015655577299412915,0.40463698718799984,1.0,54/151,21.99%,BMP6;EGFR;SMAD3;TGFBR1;APPL2;SOX5;BMPR1A;ADAMTS12;WNT4;NTRK3;LIMS1;WWOX;FOXC1;BMP7;BMP4;TGFBR2;CLEC3B;NR3C1;GAREM1;SHC1;NRP1;GAS1;ANXA1;PDPK1;MED1;PLCG1;PTPN12;SMAD4;MEF2C;APPL1;CPNE3;SOX6;PDE3A;ERN1;VEGFA;RAPGEF2;ACVR1;EMD;ACAP2;NR4A1;RUNX2;PRKD1;SYAP1;STAT5B;INPP5K;WNT5A;BMP2;PTPN11;RAPGEF1;NOS1;SMAD9;CRKL;TMEM100;SPHK1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4701891103827128,1.3520960125355275,0.1087866108786611,0.4605959629008853,1.0,7/22,8.94%,TMEM108;SH3GL2;MAGI2;NTRK2;AKT1;RAB35;STMN2
prerank,embryonic organ development (GO:0048568),-0.3780519399361856,-1.3516499580444026,0.04040404040404041,0.4055766028703972,1.0,18/61,11.84%,PBX1;GLI3;TEAD1;BMPR1A;RBPJ;GLI2;RARB;TGFBR2;PCSK5;KIT;RBP4;PBX3;FGFR2;TEAD3;COL13A1;NES;ERCC3;TEAD2
prerank,phospholipid catabolic process (GO:0009395),0.456103724478973,1.3515856706948193,0.1154639175257732,0.4603037548332723,1.0,8/24,19.36%,GPCPD1;ENPP2;SMPDL3A;SMPD1;PLA2G4E;PNPLA6;PLBD2;PRDX6
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.506406743125386,1.3515855743211205,0.10845986984815618,0.4587054779067679,1.0,4/17,10.90%,ANK3;AKAP6;KCNAB1;RNF207
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.47098263453401606,-1.351525569396343,0.10989010989010989,0.40508874228389563,1.0,9/24,17.47%,TRIM44;TRAF3IP2;PTPN22;PARP9;MAVS;EIF2AK4;DTX3L;STAT1;ZDHHC1
prerank,relaxation of muscle (GO:0090075),-0.5522627559654856,-1.351353595074194,0.13001912045889102,0.4047342048249727,1.0,4/13,7.48%,ATP1A2;GSN;CAMK2D;KCNJ2
prerank,regulation of interleukin-2 production (GO:0032663),0.4088145098884286,1.3511776535994464,0.07083333333333333,0.45810689494801726,1.0,8/43,13.09%,NAV3;PDE4B;IL17F;CD34;HOMER2;SPTBN1;PDE4D;RPS3
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5131235633206717,-1.351173870802662,0.10486891385767791,0.40442399953599023,1.0,4/18,8.43%,IGF1;IGFBP2;HMGB1;IGF2
prerank,histone H3-K4 trimethylation (GO:0080182),-0.5720021412818121,-1.3507751178124965,0.1171003717472119,0.40458012551375877,1.0,7/11,28.79%,KMT2D;CTR9;OGT;KMT2A;PRDM9;TET2;TET3
prerank,carnitine metabolic process (GO:0009437),-0.5475718020454495,-1.3507540776066689,0.10556621880998081,0.4038657115867321,1.0,6/12,19.02%,ACADM;CPT1C;TMLHE;CPT2;BBOX1;CPT1A
prerank,stress granule assembly (GO:0034063),-0.4964747440568821,-1.3496408089309333,0.09786476868327403,0.40571167133064273,1.0,9/20,16.89%,PRRC2C;YTHDF3;DDX6;ATXN2L;UBAP2L;CSDE1;LSM14A;DDX3X;DYNC1H1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.5022495867238614,-1.3493865411800336,0.12593984962406016,0.40552096107654706,1.0,9/18,14.43%,IL6ST;JAK1;YAP1;STAT3;CTR9;FER;SMAD4;IL6R;STAT1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.37515699589183055,1.348361649912838,0.06625258799171843,0.46359572165780627,1.0,31/69,21.57%,NDUFC1;SDHC;NDUFA4;NDUFA1;COX4I1;COX6A1;NDUFA2;NDUFC2;NDUFA3;NDUFA13;COX6B1;NDUFB2;COX7C;NDUFAF1;UQCRH;NDUFB9;UQCC3;COA6;NDUFA7;NDUFAB1;NDUFA12;COX10;NDUFB8;NDUFB4;COX8A;NDUFA10;NDUFS3;UQCRC2;NDUFA6;COX5B;NDUFB7
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.4720256652385942,-1.3482914687184913,0.11218568665377177,0.40746666078145455,1.0,9/24,19.34%,GRB10;ARNT;VTN;NIBAN2;HIF1A;EMILIN1;ITGA5;PTPN1;ITGB3
prerank,histone deacetylation (GO:0016575),-0.41594481694414764,-1.3480992005309589,0.08349514563106795,0.4071704755028665,1.0,11/43,9.47%,PRDM5;HDAC8;MIDEAS;HDAC4;TBL1X;TBL1XR1;RCOR1;RCOR3;BAZ2A;REST;MIER1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.4155944051759409,1.347713263695466,0.08456659619450317,0.4636834296875168,1.0,6/41,4.20%,GRM5;LRP8;CSF1R;DOCK3;GAS6;NTRK2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3627152508344012,-1.3475961781141523,0.05040322580645161,0.4075384869303544,1.0,31/80,24.78%,PLPP3;GBF1;UVRAG;STX18;SEC22B;KDELR1;COPB1;COPZ2;ARFGAP1;ARFGAP3;ARCN1;COG3;COG7;RINT1;KDELR3;SURF4;COPB2;KIF1C;COPG2;TMED3;NAPA;COPG1;RER1;COPE;KIFAP3;COG4;ERGIC1;NSF;KIF3A;ATP9A;KIF23
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.48581315409237924,-1.3469489573666447,0.08023483365949119,0.408246069762908,1.0,6/21,5.22%,ROCK2;EPHA3;VCL;ROCK1;SLC9A1;SLK
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3363813072518474,1.3467184531993666,0.034408602150537634,0.46464601553679186,1.0,26/124,11.10%,CNTNAP2;GPRIN1;FRY;PLP1;CSF1R;TMEM108;NLGN1;GPM6A;SH3GL2;GPM6B;STMN1;MAP2;STX3;PPP1R9A;GPRIN3;STMN4;ADCYAP1;BICDL1;IQCG;RASGRF1;CAMSAP1;RAB35;STMN2;PTPRM;MICALL2;CNTN4
prerank,ceramide metabolic process (GO:0006672),0.4003786726316454,1.3461469046220458,0.08102345415778252,0.46447022417101175,1.0,8/49,5.89%,ST6GALNAC3;SGMS1;FA2H;ACER2;DEGS2;ORMDL1;ORMDL2;PPP2R1A
prerank,regulation of secretion (GO:0051046),0.5448147268340193,1.346119781256926,0.12577319587628866,0.4629523099695241,1.0,6/13,16.44%,NRG1;FGF10;MYO6;OPRK1;ACSL3;GPLD1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.38541491653228865,-1.3460143165484644,0.07768924302788845,0.40982069476196115,1.0,26/56,25.04%,EGFR;ANKRD17;UBE2E2;RPTOR;VPS4B;NSMCE2;RAD51B;ANXA1;ANAPC5;ANAPC7;ANAPC4;RB1;RAB11A;CUL3;CDC25B;DDX3X;CCND3;CDC27;ADAMTS1;KLHL18;EIF4G1;ANAPC11;RAD51C;KMT2E;CDC16;PHB2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5536085039641012,1.3459835892372727,0.12304250559284116,0.4617720000161087,1.0,3/12,4.66%,SMS;DDC;TRH
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.38379962587395616,-1.345334481724541,0.06722689075630252,0.41063904558022934,1.0,25/57,32.18%,DCN;MCU;PRKN;GSK3B;DNM1L;DDHD1;FAM162A;PPARGC1A;RALA;PARK7;FIS1;BNIP3;BMF;ZNF205;HIP1R;HTRA2;PDCD5;MUL1;CHCHD10;GPER1;BAK1;PLAUR;PPIF;BCL2L11;HTT
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.2999836062894291,-1.3441470928269401,0.007984031936127744,0.4125423948387697,1.0,65/348,10.86%,BMP6;SLC24A3;ROCK2;IGF1;PID1;AFDN;SMAD3;TGFBR1;ANK2;FOXD1;RBMS3;GSN;ANGPT1;RBPJ;NTRK3;LIMS1;CELF1;FGF1;BMP7;BMP4;ROCK1;ROBO1;PRKN;SMO;OSR1;TNRC6B;WNT6;GSK3B;TNRC6A;YAP1;RESF1;CTSH;MOV10;HOXA5;UBR5;PLSCR1;ANXA2;STAT3;MED26;DTNBP1;EIF2AK3;MTOR;F3;BRAF;ECE1;AR;DHX36;PPARGC1A;FUBP1;GJA1;MAP2K1;MED1;PTPN22;ATF2;NGF;GABPA;TADA3;ITGB8;HCFC1;HIF1A;MPHOSPH8;RPL11;CALCOCO1;ID2;ATF7IP
prerank,regulation of protein processing (GO:0070613),-0.4752003478571476,-1.3436019801260117,0.10077519379844961,0.41308943304085854,1.0,4/21,7.83%,CCBE1;LRRK2;GAS1;RUNX1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.43939169716290255,-1.3435870554786276,0.11213235294117647,0.41235835747360505,1.0,11/29,16.87%,KANK2;YAP1;KMT2D;STRN3;AXIN1;UFL1;RUNX1;UBA5;LATS1;CNOT2;CNOT1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.44787433123668663,-1.3433983947105785,0.09633911368015415,0.412017835381052,1.0,4/30,2.79%,AKAP13;COL3A1;LPAR1;ROBO1
prerank,microtubule anchoring at centrosome (GO:0034454),-0.58381450943946,-1.3432183775638822,0.1348747591522158,0.4116829713420508,1.0,3/10,4.72%,PCM1;NIN;NINL
prerank,cellular component maintenance (GO:0043954),0.5525935246365935,1.3427950045736299,0.12688172043010754,0.46832436606550026,1.0,1/12,0.12%,IGF1R
prerank,regulation of tau-protein kinase activity (GO:1902947),0.5893255397912166,1.3420973122263322,0.14736842105263157,0.46862888583239165,1.0,5/10,17.06%,NAB2;CLU;HSP90AB1;SORL1;HSP90AA1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5029397589360715,-1.3418115531921133,0.126232741617357,0.4143660116616084,1.0,7/18,19.94%,LBP;THBS1;NECTIN2;TNIP2;TLR4;WNT5A;KARS1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.5244232457828545,-1.341612246242693,0.10940499040307101,0.41408941839757424,1.0,6/15,16.85%,TGFBR1;PDGFRA;TGFBR2;FGFR2;NIPBL;SIX1
prerank,negative regulation of protein processing (GO:0010955),-0.5598049901172271,-1.3405699571606766,0.13051823416506717,0.4158175606899776,1.0,5/12,24.34%,LRRK2;THBS1;GAS1;SERPINE1;SNX12
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.5268250639339237,-1.34047907333884,0.11798839458413926,0.41527730480266883,1.0,4/15,12.33%,LARGE1;OGA;RENBP;MGAT3
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5811042846136325,-1.3404579145329243,0.13152804642166344,0.41458428670447584,1.0,8/11,35.18%,PARP10;PARP9;PARP14;PARP4;PARP6;PARP12;PARP3;TIPARP
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.4900702882812085,1.3404532033021768,0.09090909090909091,0.4714172719973862,1.0,5/18,3.38%,RIMS1;NLGN1;RIMS2;PREPL;RIMS3
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.3516891569031815,-1.3402964738703051,0.04933586337760911,0.41419184170877865,1.0,28/92,17.27%,ROCK2;FOXP1;DOCK5;SASH1;ANGPT1;FGF1;BMP4;ABL1;SPARC;RREB1;CTSH;THBS1;BCAS3;FOXC2;MAP4K4;NRP1;MTOR;PLCG1;HIF1A;ADAM9;ANXA3;RAB11A;VEGFA;GLIPR2;ATOH8;PIK3CD;DOCK1;PRKD1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5940245039791274,-1.3401438236182635,0.12633451957295375,0.4138030004929803,1.0,3/10,9.06%,LYN;NBR1;MAP2K1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.5100006647937643,-1.3399524102707276,0.11324376199616124,0.4134871047569767,1.0,5/16,19.31%,NFAT5;ST3GAL4;RHOA;TRAF6;IRAK1
prerank,actin crosslink formation (GO:0051764),-0.5664165769930788,-1.3398700913863926,0.11545988258317025,0.4129343614540998,1.0,7/12,27.03%,DPYSL3;BAIAP2L1;FLNA;GAS2;BAIAP2;GAS2L3;GAS2L1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5306514095985628,1.3397420138396423,0.14757709251101322,0.47166970561047294,1.0,6/13,19.16%,KDR;TLR2;CCL2;NAMPT;EDN1;NOD2
prerank,regulation of chromosome segregation (GO:0051983),-0.5133342864672576,-1.3393100235805,0.1340782122905028,0.4135131349484115,1.0,6/16,15.57%,NUMA1;PUM2;SMC6;PUM1;SMC5;CSNK2A1
prerank,aorta development (GO:0035904),-0.5508268314640983,-1.3392330896089806,0.1111111111111111,0.41292354344143434,1.0,9/14,17.12%,LRP1;PDGFRB;ROBO1;JAG1;ADAMTS9;PKD2;EFEMP2;HECTD1;TBX2
prerank,endomembrane system organization (GO:0010256),-0.3203726763642149,-1.3385369725679823,0.027613412228796843,0.41380150439699814,1.0,63/178,25.84%,GBF1;LRRK2;FBXW8;RAB30;CSNK1A1;A4GALT;ATL3;HUWE1;UBXN2B;DNM1L;MYOF;BCAS3;GOLGB1;ATP8B1;SEC23IP;RAB22A;ARFGEF1;EIF2AK3;ARHGAP21;OBSL1;CDC42;USP6NL;TLCD2;ATP8B2;SEC31A;ATL2;TBC1D20;DMPK;COG3;COG7;SURF4;SNX10;USP50;DOP1B;PRKD1;TMED3;MIA3;TJAP1;TMED4;CSNK1D;SMPD4;TMED5;TMCC1;PLEKHF1;SEC16B;TRIP11;SEC16A;CUL7;TOR1A;STX17;PLEKHM2;COG4;ALS2;PI4K2B;VAPA;WASHC4;LMAN1;SPTSSB;BAG5;SUN2;PHETA1;ARFGEF2;NUP93
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.34622819385256465,-1.3384969769406243,0.04308797127468582,0.41313834152685,1.0,29/101,20.20%,NFKB1;VIM;AXL;PABPN1;LBP;HMGB1;SBNO2;LYN;CTR9;PTPN22;CHMP5;UPF1;SELENOS;NR1H3;RHOA;ADAM9;MEF2C;TNIP2;IL18;PDCD4;SERPINE1;TLR4;CX3CR1;TRAF6;WNT5A;IRAK1;SHPK;CARD16;CDC73
prerank,histone lysine methylation (GO:0034968),-0.4363650366195711,-1.3381911838102236,0.09584086799276673,0.4131744043837852,1.0,17/33,33.19%,PRDM5;KMT2D;SMYD3;SETD3;KDM6A;N6AMT1;SETDB1;KMT2A;EZH2;PRDM9;CXXC1;PAXIP1;SMYD1;WDR5;SETDB2;DPY30;WDR5B
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3329519158843743,1.337950524233565,0.04251012145748988,0.4747301191029962,1.0,20/138,6.64%,FLT1;PTPRG;IGF1R;TEK;MPZL1;PTPRD;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;PTPRT;AHI1;KDR;NTRK2;FLT3;SRMS;ALK;GUCA1B
prerank,endochondral bone morphogenesis (GO:0060350),-0.5724888454699222,-1.3375446873640848,0.134765625,0.4138631150810317,1.0,5/11,11.26%,FOXC1;BMP4;INPPL1;COL13A1;MEF2C
prerank,nuclear export (GO:0051168),-0.3645708373341452,-1.3373856909496706,0.05421686746987952,0.4135601941688571,1.0,27/80,23.82%,RANBP3L;PKD1;ATXN1;XPO4;CASC3;U2AF2;SRSF6;NUP42;PHAX;SLU7;EIF4E;NUP214;TPR;SRSF1;SMURF1;NXF1;RANBP3;SRSF7;SRSF11;DESI1;UPF3B;SRRM1;SRSF2;CHP1;XPO5;XPO1;WASHC4
prerank,negative regulation of transposition (GO:0010529),-0.5209756401373298,-1.337368087381651,0.12154696132596685,0.41286383111346,1.0,4/16,16.54%,UBR2;MOV10;TUT4;MYBL1
prerank,positive regulation of B cell activation (GO:0050871),0.3992417340832762,1.337071406758259,0.08061002178649238,0.47548260545513044,1.0,15/50,19.16%,TFRC;TIRAP;MIF;IL7;VAV3;TNFSF13B;SHLD3;CD40;XBP1;SH3KBP1;NFATC2;CD38;BTK;NCKAP1L;NOD2
prerank,myoblast fusion (GO:0007520),0.5484027048649507,1.3368121639193324,0.1337579617834395,0.4746419584318002,1.0,4/12,6.78%,ADGRB3;ADAM12;JAM2;KCNH1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5620124848677008,-1.336762707405222,0.11531190926275993,0.41361539308864537,1.0,4/12,8.43%,IGF1;SORBS1;IRS1;IGF2
prerank,defense response to fungus (GO:0050832),0.5080003262051845,1.3362745224599393,0.13518886679920478,0.47444420297151746,1.0,3/17,11.76%,S100A9;S100A8;BCL10
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.4364140612762323,-1.3362351819672575,0.10978043912175649,0.4142516476749198,1.0,16/30,25.57%,FOXP1;DDX5;DAB2;EP300;NCOR1;AR;SAFB2;PRMT2;HDAC1;HEYL;RNF14;PARK7;RNF6;TRIM68;KDM1A;ZBTB7A
prerank,tRNA methylation (GO:0030488),-0.4320855708178024,-1.3361729000250417,0.11089494163424124,0.41364686546475377,1.0,20/34,32.96%,NSUN6;METTL2A;METTL2B;NSUN2;METTL1;THUMPD3;TRMT1L;FTSJ1;DALRD3;LCMT2;GTPBP3;WDR6;TRMT1;MTO1;TRMT44;TRMT10C;TRMT61B;TYW3;ALKBH8;TRMT12
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.37765163975161226,-1.3353421317178296,0.05102040816326531,0.41496048668033336,1.0,15/64,10.38%,ROCK2;PLEKHA2;EPHA3;VCL;ROCK1;JAG1;GSK3B;SLC9A1;SLK;THBS1;HOXA7;MAP4K4;JUP;SEMA3E;RHOA
prerank,DNA geometric change (GO:0032392),-0.46727493394696507,-1.3343222616706454,0.10301953818827708,0.41662241988567095,1.0,10/24,16.69%,HMGB1;NBN;DHX9;ANXA1;DHX36;WRN;MCM9;ASCC3;MRE11;ZRANB3
prerank,macroautophagy (GO:0016236),-0.3328302795414183,-1.3333517030063806,0.03653846153846154,0.41821938262040503,1.0,39/118,22.27%,PRKAG2;PRKN;PRKAA2;UVRAG;VPS4B;UBQLN1;VTI1B;VAMP7;ZFYVE1;LIX1L;CHMP4B;CHMP4A;NBR1;VDAC1;LAMP2;RB1CC1;CHMP3;VPS37C;VPS39;PRKAB2;WIPI1;MTMR3;BECN1;ILRUN;PIK3C3;CSNK2A1;PIK3R4;TCIRG1;PRKAA1;ATG5;VCP;AMBRA1;SNF8;PRKAG3;WIPI2;TOMM7;PRKAB1;STX17;ATG14
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.4610943946717328,-1.3324147204287191,0.10805860805860806,0.4197917369338855,1.0,7/25,10.16%,VPS4B;CHMP4B;CHMP4A;CHMP5;LEPROTL1;LEPROT;CHMP3
prerank,phospholipid translocation (GO:0045332),0.43790876247724025,1.3323982106779113,0.10570824524312897,0.4830917296592193,1.0,10/28,11.32%,TMEM30A;ATP8A1;ATP11A;ATP10A;MFSD2A;ATP10B;ATP11C;ATP8A2;ABCB4;P2RX7
prerank,negative regulation of growth (GO:0045926),0.3375058922791254,1.3320070849609424,0.031055900621118012,0.48255617493178155,1.0,37/121,17.56%,MT2A;MINAR1;GNG4;SIRT1;APBB1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;NOTCH1;TGFB2;SCGB3A1;PPP2R1A;SLIT3;WFDC1;PTPRJ;ACVRL1;ING4;TMPRSS4;APBB2;SOX17;NDUFA13;BMPR2;SMARCA2;PPT1;CDKN1A;RTN4;CDKN1B;NPR1;DNAJB2;PNPT1;CDKN2AIP;RERG
prerank,neurotransmitter uptake (GO:0001504),-0.5567026196370723,-1.331183130981858,0.15846994535519127,0.4219787552091468,1.0,3/12,8.96%,ATP1A2;SLC1A3;GLUL
prerank,positive regulation of interferon-gamma production (GO:0032729),0.3935420223578843,1.3311176032530154,0.0826271186440678,0.48332251944875176,1.0,7/48,12.78%,SLC7A5;PDE4B;ISG15;IL12A;CYRIB;HSPD1;PDE4D
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.5010423588775891,-1.3309515700862247,0.120817843866171,0.42184315705891695,1.0,7/18,18.73%,SMAD3;PDPN;RUNX1;RB1;EFEMP2;EMILIN1;BMP2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.34039960783353496,1.3294819640369397,0.03968253968253968,0.48605348415231187,1.0,18/110,9.23%,ADGRL4;ADGRL3;ADGRB3;ADCY3;ADCY8;RAMP2;ADGRB1;ADRB1;S1PR5;GPR101;LGR5;GNG2;ADCYAP1;GPR26;GNAL;ADRA1D;ADRA1A;ADGRL2
prerank,protein-containing complex assembly (GO:0065003),-0.30502766139389864,-1.3294272498108424,0.009398496240601503,0.424726985640916,1.0,92/259,24.07%,FBXL7;AFDN;TCF7L2;TEAD1;SEC24D;OPA1;MCU;MDM4;EP300;SH3PXD2B;LRRK2;CSNK1A1;TRAPPC9;DLG4;GSK3B;YAP1;SLC9A1;KMT2D;CTSC;BCL9L;DNM1L;AXIN1;SNX9;TFG;SEC23IP;DNAJB14;PYGO1;CREBBP;TRRAP;SEC23A;DHX9;SEC22B;PPARGC1A;TUBGCP2;VAMP2;GEMIN5;WASL;SEC31A;MNAT1;TBC1D20;TRAF2;TLE4;TLE1;CAPZA1;TEAD2;HES1;TRAPPC6B;WIPF1;FN1;CUL3;GSDMD;TCF7L1;CDC123;STX5;PARD3;WASF1;REPS2;HDAC1;RANBP9;STOML2;FARP2;GOSR2;PPIH;PICALM;NAPA;CSNK1D;GPAA1;TUBGCP4;SEC16B;TLE3;PML;CDC73;TERT;CLDN1;FANCC;SEC16A;CUL1;KIFAP3;KMT2A;DET1;PPID;F5;LAMC1;CAND2;NSF;TRAPPC2;HSF1;PREB;TFAP4;LMAN1;SAR1B;USO1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.4744094488173314,-1.3293320176502912,0.11363636363636363,0.4241917679521156,1.0,8/22,26.88%,ROCK2;ROCK1;GSK3B;BOD1L1;PTPA;CRY2;MASTL;BOD1
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.4412087817542628,-1.329182684441359,0.11069418386491557,0.42381709240587845,1.0,18/30,29.48%,GTF2H2;CCNH;CDK7;CAVIN1;TBP;TAF1D;MNAT1;ERCC3;TTF1;POLR2H;POLR2K;GTF2H1;POLR2E;TAF1C;GTF2H4;POLR1G;TAF1A;POLR1C
prerank,relaxation of cardiac muscle (GO:0055119),-0.5450217901576256,-1.3290887718431734,0.1484375,0.42328951095420425,1.0,4/13,7.48%,ATP1A2;GSN;CAMK2D;KCNJ2
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.4079365372215404,-1.328899122908952,0.09611829944547134,0.42295100902751537,1.0,8/41,6.49%,TGFBR3;BMPR1A;TPM1;RBPJ;BMP4;JAG1;TGFBR2;FGFR2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.4260408588701396,-1.3287374169027957,0.08912655971479501,0.42260330482663344,1.0,14/32,20.74%,PHLDB2;ARHGAP6;JAG1;THBS1;BCAS3;HOXA7;MAP4K4;SEMA3E;APOD;RASA1;SERPINE1;FAM107A;MYOC;NF2
prerank,mammary gland epithelium development (GO:0061180),0.5204629201517407,1.3286951907863347,0.1297539149888143,0.486448884864554,1.0,5/14,7.85%,ERBB4;CSF1R;IRF6;WNT7B;AKT1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3632063760867735,1.3286898461660912,0.06477732793522267,0.4848797393103092,1.0,19/72,11.42%,NAV3;KANK3;SHANK3;STMN1;FGF13;MAP2;SNCA;PFDN5;HSPA8;CLU;PFDN6;TUBB4A;CAMSAP1;STMN2;CYRIB;ARHGEF2;MID1IP1;CORO1A;APC
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.4382906333728672,1.3284114825568811,0.10738255033557047,0.484035579225477,1.0,11/28,16.86%,MAP1B;STMN1;MAP2;MAPRE3;STMN4;CAMSAP1;STMN2;STMN3;FKBP4;CAMSAP3;CLASP2
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.3090129572095858,-1.3282762532391486,0.014492753623188406,0.4229264358146127,1.0,94/241,28.12%,SRRM2;DDX5;HNRNPH1;PABPN1;HNRNPR;WDR33;PCF11;SYNCRIP;CASC3;IK;SRSF10;RBM6;DDX46;FUS;U2AF2;HNRNPM;DHX9;SF3B1;CPSF3;SRSF6;HNRNPD;HNRNPUL1;PRPF6;RBM10;PCBP2;RNPC3;DDX42;CDC5L;PRCC;SLU7;GEMIN5;HNRNPK;PRPF3;SF3A1;SF3B6;YTHDC1;USP39;SF3A3;SNRNP70;ZCRB1;RSRC1;DNAJC8;CWC22;DDX23;YBX1;RBM5;CCAR1;SRSF1;CWF19L1;GEMIN7;SFPQ;EFTUD2;SNU13;MTREX;PPIH;UBL5;PRPF40B;PPWD1;HNRNPU;WBP11;CSTF3;POLR2H;SNRPF;ZMAT5;HNRNPA3;RBM4;SRSF7;SRSF11;UPF3B;SRRM1;SRSF2;GTF2F1;CPSF4;CSTF1;DDX41;NUDT21;POLR2K;SMU1;PRPF38A;NONO;DHX15;POLR2E;CPSF1;NCBP2;CRNKL1;PRPF8;RBM19;LSM6;CACTIN;RBM22;ISY1;SUGP1;HNRNPL;POLR2D
prerank,positive regulation of reproductive process (GO:2000243),0.4369794060229991,1.3282582194060661,0.1160337552742616,0.48291945708698014,1.0,6/31,9.28%,GLRA1;PGAM4;PLCB1;TACR1;CFAP69;TACR3
prerank,activation of protein kinase activity (GO:0032147),-0.3428065633591478,-1.3282505426897404,0.05168986083499006,0.42227369289272315,1.0,38/106,19.34%,IGF1;ADCY9;ADCY5;ANGPT1;NTRK3;FGF1;STK3;GHR;ABL1;TGFBR2;OSBPL8;NRK;MAPKAP1;PIBF1;AXIN1;PAK2;ADCY1;TAOK3;MAP4K4;MTOR;ADCY6;PDPK1;PRRC1;TRAF2;PRKCD;CARD14;RICTOR;COPS8;TXN;VEGFA;ADRA2A;IL18;PRKACA;TRAF6;WNT5A;PARK7;IRAK1;ITGB3
prerank,aerobic electron transport chain (GO:0019646),0.36947738443675576,1.3279989261989285,0.07317073170731707,0.4820869912405869,1.0,30/68,21.57%,NDUFC1;SDHC;NDUFA4;NDUFA1;COX4I1;COX6A1;NDUFA2;NDUFC2;NDUFA3;NDUFA13;COX6B1;NDUFB2;COX7C;NDUFAF1;UQCRH;NDUFB9;UQCC3;NDUFA7;NDUFAB1;NDUFA12;COX10;NDUFB8;NDUFB4;COX8A;NDUFA10;NDUFS3;UQCRC2;NDUFA6;COX5B;NDUFB7
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.5231489871460547,-1.3273693049814175,0.13214990138067062,0.4237098157572551,1.0,10/15,22.07%,FGF1;JAK1;PDPK1;BMPER;VEGFA;ITGA5;PKM;S100A1;SMAD1;FGF2
prerank,renal system development (GO:0072001),-0.3933737287535405,-1.3268390434678756,0.08190476190476191,0.4242582708886502,1.0,20/52,16.85%,SULF1;TGFBR1;PKD1;WNT4;GLI2;FOXC1;BMP4;PCSK5;RBP4;ARL3;SULF2;PYGO1;IFT88;AGTR1;TBX18;VEGFA;STAT1;GREB1L;SALL1;SIX1
prerank,selective autophagy (GO:0061912),-0.38591191720374246,-1.326603415511114,0.07952286282306163,0.4240801337005467,1.0,22/56,19.17%,UBE2N;VIM;PRKN;ARL13B;UBQLN1;UFL1;PCNT;UBA5;NBR1;TEX264;RB1CC1;IFT88;ULK2;DYNC1LI1;BECN1;ATG2A;DYNC1H1;AUP1;ATG2B;ATG5;AMBRA1;PARK7
prerank,regulation of steroid metabolic process (GO:0019218),-0.4615974990802641,-1.3261216442624641,0.12352941176470589,0.42454179010080645,1.0,13/23,40.61%,PANK2;RORA;APOE;EPHX2;ARV1;ACADVL;ASAH1;STAR;NR1H4;ACADL;FMO5;RORC;ABCG1
prerank,regulation of telomerase activity (GO:0051972),0.40641359513695513,1.3259889175250155,0.09650924024640657,0.48593524084178547,1.0,19/45,19.09%,PRKCQ;KLF4;TERF1;HSP90AB1;PIF1;MEN1;CCT2;DKC1;CCT4;ATM;PARM1;PTGES3;XRCC5;CTNNB1;HSP90AA1;NAF1;MAPK3;NVL;TCP1
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.43013136929332707,-1.325615361517386,0.09532710280373832,0.4249669758174714,1.0,11/32,21.62%,AUTS2;PLCE1;RREB1;WASF2;BRK1;CDC42;NCKAP1;ARPC2;CARMIL1;AVIL;PIK3R1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.3457808986577598,-1.3253473483347942,0.046370967741935484,0.42487046507061327,1.0,30/101,23.13%,SAMD4A;PLD1;VIM;CYFIP2;BTRC;ZCCHC4;VGLL4;YTHDF3;THBS1;MTOR;HNRNPD;ASPH;DACT1;PLXNB2;NR1H3;AGTR1;OGT;PRKDC;DDX3X;UPF3A;FBXW11;INHBA;EIF4G1;UPF3B;FGFR4;TBC1D10A;PYM1;MSN;PERP;HDAC2
prerank,cellular response to amino acid starvation (GO:0034198),-0.36620127938044345,-1.3253408297580656,0.0761904761904762,0.4241568042219449,1.0,24/71,23.17%,RNF152;ATP6V1B2;TFEB;RPTOR;ATP6V0D1;EIF2AK3;MTOR;MAP3K5;GCN1;SESN1;IMPACT;ATF2;WDR59;EIF2AK4;CASTOR2;EIF2AK2;PRKD1;NPRL3;TCIRG1;DAP;LARS1;SZT2;ATP6V1G2;DAPL1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5281136416358418,1.3247122049245832,0.15132924335378323,0.48774001466376893,1.0,5/12,8.94%,STMN1;MAP2;SNCA;TUBB4A;STMN2
prerank,response to interleukin-6 (GO:0070741),-0.5765625617977197,-1.3244449315876925,0.1261595547309833,0.42556224804986115,1.0,4/10,5.66%,PID1;NFKB1;PTGIS;SBNO2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.585709280452982,-1.324439612250323,0.12761904761904763,0.4248457714065553,1.0,3/10,14.43%,TGFBR2;FGFR2;STAT1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.38083696066898065,1.3241544308739945,0.07214428857715431,0.4877971552478023,1.0,12/53,20.02%,MTNR1B;CHRM3;HTR2C;MTNR1A;CCL2;OPRM1;CNR1;CHRM2;CALCRL;HTR1B;AGT;HTR4
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.4397340376277845,1.323938962185396,0.10970464135021098,0.4868070104546863,1.0,5/29,9.84%,CXCL12;GAS6;JAM2;IL12A;AIF1
prerank,negative regulation of viral transcription (GO:0032897),0.5265943322385701,1.3234180966871374,0.13417190775681342,0.48670444817892766,1.0,4/13,10.96%,TRIM13;TRIM62;IFITM3;MID2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.5506908283273724,-1.323239517730341,0.15717092337917485,0.4271117831296237,1.0,7/12,21.72%,INSIG2;OS9;KDELR1;KDELR3;GPAA1;RER1;TAPT1
prerank,intracellular lipid transport (GO:0032365),-0.4666500377508364,-1.323224647100678,0.12357414448669202,0.4264255678158483,1.0,9/21,14.11%,PRKAG2;PRKAA2;ABCD3;ABCD2;CPT2;PRKAB2;NPC2;ABCD4;PLEKHA8
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.4930592051422186,-1.3229862228717002,0.12825278810408922,0.42624038802738046,1.0,9/18,21.31%,HDAC4;CCN3;FRS2;BHLHE41;FZD7;SOX6;HDAC1;BMP2;TMEM119
prerank,aortic valve morphogenesis (GO:0003180),-0.432601881345426,-1.3229076242551132,0.10036496350364964,0.42571179586260716,1.0,7/30,3.17%,ROCK2;SMAD6;BMP4;ROCK1;ROBO1;ELN;JAG1
prerank,endothelial cell migration (GO:0043542),-0.4200796954577295,-1.322507558423668,0.09751434034416825,0.42590221996085015,1.0,14/37,16.73%,FSTL1;ABL1;DPP4;ADGRA2;NRP1;CCN3;CYP1B1;RHOA;GIPC1;FAP;VEGFA;STAT1;PLXND1;NR4A1
prerank,respiratory tube development (GO:0030323),-0.44073837106539626,-1.322297622733831,0.10594795539033457,0.4256361751725502,1.0,10/28,16.34%,GLI2;FGF1;BMP4;PDPN;PCSK5;RBP4;FGFR2;CCDC39;VEGFA;LOXL3
prerank,protein sumoylation (GO:0016925),-0.39082041838993664,-1.3215550637963922,0.07293666026871401,0.4266959169262201,1.0,13/49,15.33%,EYA1;PIAS1;SAE1;RANBP2;NSMCE2;NUP42;PIAS3;UBE2I;NUP214;TPR;PIAS4;TRPM4;TOPORS
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.3689340731166171,-1.3213940145303242,0.07768924302788845,0.4263972685742714,1.0,29/64,28.91%,MLLT3;GTF2H2;CCNT2;CCNH;CCNT1;CDK7;CTR9;CCNK;CDK13;SETD2;MNAT1;AFF4;RTF1;ERCC3;NELFB;POLR2H;CDC73;GTF2F1;EAF2;POLR2K;GTF2H1;POLR2E;CTDP1;NCBP2;GTF2H4;NELFA;NELFE;POLR2D;CDK9
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.3467874306432073,-1.3213393838329786,0.043121149897330596,0.4258247076520616,1.0,30/88,18.39%,VPS13A;MYO1B;DNAJC6;GBF1;CCDC93;ARL3;GOLGB1;RAB10;OSBPL5;DTNBP1;VAMP7;CORO7;AP4E1;PUM1;MON2;VAMP2;ACBD3;RP2;KIF16B;EXOC2;STX4;SCAMP2;ARF1;AP4S1;VPS13C;DOP1B;ARRB1;TXNDC5;SNAP23;NAPA
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.4813779228501213,-1.321286894348163,0.11775043936731107,0.42521200449514995,1.0,5/20,7.33%,ATP1A2;CACNA1C;ANK2;SLC9A1;CAMK2D
prerank,regulation of DNA replication (GO:0006275),-0.3879642016910181,-1.3207905572038092,0.09814814814814815,0.4257253432698247,1.0,19/49,26.95%,EGFR;ANKRD17;GLI2;RBBP6;DHX9;BRPF3;PDS5A;GLI1;ESCO1;CTC1;S100A11;CDAN1;PCNA;STN1;PPP2CA;ATR;ATAD5;EGF;OBI1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.45814014474618037,1.3206598646330303,0.11618257261410789,0.49221986540930596,1.0,3/23,3.85%,CD33;GIT1;GAS6
prerank,ERAD pathway (GO:0036503),-0.35248645538439133,-1.3197956278338328,0.0781563126252505,0.42740497808053035,1.0,36/83,28.87%,PRKN;UGGT2;ECPAS;DNAJB14;UBQLN1;OS9;UBE4B;JKAMP;EDEM1;FAM8A1;SELENOS;RNF103-CHMP3;ERLEC1;MAN1B1;RCN3;ERLIN1;RHBDD2;POMT2;TRIM25;USP13;FAF2;AUP1;DERL1;SYVN1;GET4;VCP;UBXN4;TOR1A;WFS1;DNAJC18;BAG6;TMUB2;SEL1L;USP19;DERL2;CCDC47
prerank,sulfur compound catabolic process (GO:0044273),-0.4135887067841741,-1.3197336720836885,0.09532374100719425,0.4268385519941144,1.0,14/38,24.43%,DCN;BGN;FMOD;GNS;OGN;PRELP;LUM;HEXA;GALNS;CHAC2;OMD;TXN2;CSPG4;GGT5
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.5412846468903469,-1.3193317279284689,0.12022900763358779,0.4270262159056978,1.0,4/13,8.43%,IGF1;SORBS1;IRS1;IGF2
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.430135601606852,-1.319310617296603,0.12373225152129817,0.4263609961019101,1.0,11/31,17.19%,RANBP3L;CRIM1;SMAD6;TMEM64;SKI;NBR1;LIMD1;SUFU;TRPM4;PTCH1;TWIST2
prerank,regulation of microtubule polymerization (GO:0031113),0.4051809185116758,1.3191845776088362,0.08836206896551724,0.4943959473293134,1.0,12/40,13.09%,NAV3;STMN1;MAP2;SNCA;OCLN;PAK1;MAPRE3;TUBB4A;CAMSAP1;STMN2;DCTN1;RPS3
prerank,negative regulation of developmental process (GO:0051093),0.36338175183650995,1.3190708332576697,0.06947368421052631,0.49317001500918617,1.0,17/69,13.89%,TFRC;ARHGEF15;DCC;OMA1;MIF;HEY1;SPRY3;GAS6;THY1;NOS3;NOTCH1;FOXJ1;GRIN3A;WDR77;VAT1;HOPX;DLL1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.48742938349547665,1.3189978969831095,0.16155419222903886,0.4918062511029344,1.0,3/17,7.34%,SLA2;THY1;PTPRJ
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.573685080974042,-1.3189897595438065,0.15682656826568267,0.42639214951017007,1.0,4/10,13.46%,USP7;SELENOS;ZNF692;OGT
prerank,regulation of mitochondrial fission (GO:0090140),-0.4485525504064423,-1.318412657407065,0.10980392156862745,0.42709838003700856,1.0,6/24,6.70%,DCN;MCU;PRKN;LRRK2;DNM1L;DDHD1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.29652193888470413,-1.318324569675089,0.013861386138613862,0.4266043760367131,1.0,131/314,29.88%,FBXL7;FBXL17;SMURF2;UBR2;PRKN;SPSB1;RAD23B;BTRC;TBL1X;WWP2;TBL1XR1;ECPAS;KLHL15;HUWE1;UBXN2B;DNAJB14;UBQLN1;OS9;WWP1;UBE4B;FBXL4;ANAPC5;ZSWIM8;FBXL12;PCBP2;ANAPC7;JKAMP;UBE2K;EDEM1;MAEA;ANAPC4;ANAPC16;TNFAIP1;RNF216;FAM8A1;SELENOS;UBR1;RNF103-CHMP3;SPOPL;MAN1B1;GID4;ERLIN1;RHBDD2;KCTD5;UBR3;PSMF1;FBXL19;RB1;FBXL18;AMN1;TRIM25;CUL3;FBXW7;NHLRC3;PSMB2;KLHL22;CDC26;UBE2B;SMURF1;CUL2;FBXO38;FBXO45;TOPORS;ERCC8;FAF2;UBE2E1;CDC27;ARRB1;FEM1A;BFAR;AUP1;DERL1;UBE2S;SYVN1;PPP2R5C;FBXW5;FBXW11;VCP;SPSB4;AREL1;UBE2D3;CDK2;IFI27;PML;COP1;PSMC1;UBXN4;SHARPIN;KCTD17;GID8;ANAPC11;CUL1;ECRG4;APPBP2;FBXW4;WFS1;DCAF12;PSMA3;PSMB6;RMND5A;ARMC8;DNAJC18;PSMA4;SIAH2;BAG6;FBXL14;CDC16;ANAPC1;FBXO4;TMUB2;PSME1;PSMD13;SPSB2;PCNP;SEL1L;USP19;CDC34;FBXL3;DERL2;FZR1;PSMB9;RBX1;PSMB10;PSMA5;KBTBD7;SPSB3;LTN1;UBA52;FBXL8;NFE2L2;ZFAND2B
prerank,cellular response to starvation (GO:0009267),-0.3254625616774349,-1.3183026395131388,0.033707865168539325,0.4259344013608161,1.0,50/147,23.17%,PRKAG2;RNF152;FOXO3;ATP6V1B2;PRKAA2;TFEB;LRRK2;RPTOR;ATP6V0D1;EIF2AK3;MTOR;ZFYVE1;MAP3K5;WRN;GCN1;LAMP2;SESN1;IMPACT;ATF2;BRSK1;USP33;WIPI1;FNIP1;WDR59;SIK1;EIF2AK4;CASTOR2;MTMR3;BECN1;EIF2AK2;PIK3C3;PIK3R4;WDR45B;PRKD1;NPRL3;TCIRG1;DAP;PRKAA1;ATG5;RRP8;PRKAG3;WIPI2;LARS1;SIK2;TBL2;ATG14;SZT2;ATP6V1G2;MAP1LC3A;DAPL1
prerank,intestinal lipid absorption (GO:0098856),-0.5690289075791563,-1.3173532899279243,0.1266294227188082,0.42755992054425707,1.0,3/11,12.15%,LIMA1;LDLR;UGCG
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.4781975866885793,-1.3166098534416997,0.13092979127134724,0.4286568676798321,1.0,8/18,21.13%,DCN;MCU;PRKN;DNM1L;DDHD1;RALA;FIS1;BNIP3
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.5175251631419878,-1.3165648257944509,0.1371841155234657,0.42811053369726243,1.0,8/15,25.61%,STXBP4;CUL3;GLI1;KLHL18;CDC73;EZH2;PHB2;ATAD5
prerank,smooth muscle cell differentiation (GO:0051145),0.5573334462291527,1.3163577726834121,0.13695652173913042,0.4972176462641908,1.0,5/12,7.40%,MRTFA;HEY1;TMEM204;MRTFB;APLNR
prerank,negative regulation of hippo signaling (GO:0035331),-0.560950189562953,-1.3162915935547495,0.12430426716141002,0.42812080169532146,1.0,9/12,25.45%,WWC2;VGLL4;WTIP;MARK3;LIMD1;WWC1;AJUBA;DLG5;MAPK14
prerank,embryonic appendage morphogenesis (GO:0035113),-0.5474190729875366,-1.3162302422913383,0.15384615384615385,0.42758693258267894,1.0,6/12,22.00%,LRP6;CYP26B1;SKI;PTCH1;MEGF8;FBXW4
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.4052899206575123,-1.3155833861671402,0.095703125,0.4283796236060248,1.0,20/38,32.75%,PRKN;LRRK2;HUWE1;SAE1;ABLIM3;LEPROT;NPEPPS;FBXW7;UBL5;ATP5IF1;UBE2D3;TOMM7;ARIH2;PARL;LMAN1;HTRA2;USP36;RNF31;UBE2L3;SREBF1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.5233302944613113,-1.3153791798443708,0.14339622641509434,0.42816115764194,1.0,4/13,8.96%,DDO;ASPA;GLUD1;GLUL
prerank,oligosaccharide metabolic process (GO:0009311),0.3980832487891887,1.3142275489392783,0.08842105263157894,0.5012968631898516,1.0,11/46,12.38%,ST6GALNAC3;ST8SIA4;ST3GAL6;NEU2;ST8SIA1;FUT9;B3GALT5;GLA;ST8SIA6;ST8SIA3;ST6GAL2
prerank,generation of neurons (GO:0048699),0.3122820428592656,1.3142094018700492,0.02240325865580448,0.4998009486131257,1.0,43/190,16.94%,ADGRL3;SPOCK1;MYT1L;PTPRD;IRX2;IL1RAPL1;GPM6A;HEY1;DNER;MAP1B;FGF13;NTRK2;ASTN1;NEUROD6;TGFB2;FUT9;TAFA1;NRCAM;SNPH;LHX1;WNT7B;ITM2C;NDNF;CDKL5;RELN;RNF112;ASTN2;BRSK2;FZD4;PER2;BHLHE40;HES6;POMGNT2;CIT;DLL1;DCX;ATP2B2;ELP3;ACSL3;LMX1B;DDIT4;CTNNB1;HES5
prerank,histone methylation (GO:0016571),-0.4465317630610299,-1.314156531004555,0.12754158964879853,0.4304304873751522,1.0,11/26,21.86%,CREBBP;NSD1;NSD3;SMYD3;PRMT2;N6AMT1;EHMT1;PRMT5;PRMT8;NTMT1;EZH2
prerank,mesenchymal to epithelial transition (GO:0060231),0.5568488600892596,1.313788408224167,0.1574279379157428,0.4993102544624044,1.0,3/10,8.37%,PAX8;PAX2;BASP1
prerank,regulation of mast cell degranulation (GO:0043304),-0.5324631701049438,-1.3137071175486246,0.1200750469043152,0.43088604035386757,1.0,10/14,39.08%,GAB2;LYN;FER;CD84;CD300A;SYK;SPHK2;FES;FGR;STXBP2
prerank,dicarboxylic acid transport (GO:0006835),-0.45228881481276334,-1.3135839587804532,0.12884615384615383,0.4304471356705425,1.0,7/28,10.84%,SLC1A3;SLC13A3;PDPN;SLC26A7;GJA1;SLC22A6;GIPC1
prerank,sodium-independent organic anion transport (GO:0043252),0.5682731697075056,1.3134199769900268,0.17194570135746606,0.49875216526125077,1.0,4/10,9.62%,SLCO1C1;SLCO4C1;SLCO5A1;SLCO2B1
prerank,fatty acid elongation (GO:0030497),0.5193342715018726,1.3134057598434294,0.17827868852459017,0.4972559734764076,1.0,5/13,13.93%,ELOVL7;ELOVL4;TECR;HACD3;HACD1
prerank,lung development (GO:0030324),-0.4224500289014035,-1.3133182640089038,0.096045197740113,0.43039921481360255,1.0,12/33,16.34%,ERRFI1;PKD1;GLI2;FGF1;BMP4;PDPN;RBP4;FGFR2;RCN3;CCDC39;VEGFA;LOXL3
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.508920592855876,-1.3132053879517445,0.14128440366972478,0.42996252904882537,1.0,3/16,0.97%,ATP1A2;CACNA1C;ANK2
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3942332653466261,1.3130574994892874,0.1074561403508772,0.4966279222857419,1.0,9/47,13.14%,SPOCK2;SPOCK1;SPOCK3;BIN1;TIMP1;AKT1;SERPINB8;TIMP4;SORL1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.3170641523350589,-1.3128484448492512,0.033203125,0.43012225179157415,1.0,46/158,23.10%,WLS;AKAP13;ROR1;LPAR1;PELI2;ANKRD17;UBE2N;CFLAR;MAP3K3;PRKN;FLNA;TBK1;TFG;ALPK1;TRIM8;TRAF3IP2;DHX36;GJA1;MIER1;TRAF2;RHOA;ZDHHC13;MAVS;LGALS1;TRIM5;TRIM25;PPM1A;LTBR;ECM1;TNIP2;PRKD1;IKBKE;MAP3K14;CC2D1A;TRAF6;TMED4;RHOC;IRAK1;CARD16;SHARPIN;NEK6;CXXC5;TICAM1;TRAF5;GPR89A;VAPA
prerank,actin filament organization (GO:0007015),-0.3229137125493098,-1.3127987256845033,0.032818532818532815,0.42955821040476605,1.0,43/151,20.93%,DPYSL3;CGNL1;GSN;TPM1;SVIL;MCU;MPRIP;MYO1B;BAIAP2L1;SHROOM2;FAT1;FLNA;DLG1;RND3;SHROOM3;TMOD3;FHOD1;CORO7;INPPL1;CDC42;ARHGAP17;WASL;TPM3;RHOA;ABI1;RHOBTB2;MYO1F;ZBED3;WHAMM;CARMIL1;EFS;RHOBTB1;RHOH;TRIOBP;RHOC;LMOD1;AVIL;GAS2;TPM2;MARCKS;VILL;PLS1;ARHGAP12
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.42884734831870097,-1.3125637643387054,0.09380863039399624,0.42944079326488926,1.0,15/33,26.57%,PABPN1;WDR33;PCF11;SCAF8;CPSF3;SSU72;SLBP;CSTF3;SNRPF;CPSF4;CSTF1;NUDT21;CPSF1;LSM11;NCBP2
prerank,camera-type eye morphogenesis (GO:0048593),-0.5860901341810272,-1.3124049334807901,0.14563106796116504,0.42909498686570485,1.0,5/10,17.12%,LRP6;SHROOM2;SKI;VEGFA;TBX2
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.4379106332272883,-1.3118741468630106,0.13577981651376148,0.42974450623180677,1.0,8/27,18.02%,KAT2B;EP300;KAT6B;CREBBP;TRRAP;KAT8;TAF6L;MSL3
prerank,positive regulation of phospholipase activity (GO:0010518),-0.45838127177152155,-1.3114313554728112,0.13617886178861788,0.43011791226786,1.0,9/22,12.08%,PDGFRA;NTRK3;PDGFRB;KIT;FGFR2;PDPK1;PLCG1;ABL2;AGTR1
prerank,regulation of cell communication (GO:0010646),-0.4165523738400735,-1.3110101082297267,0.11156186612576065,0.43037724159286644,1.0,16/35,18.47%,GRK5;ANK2;CXADR;ANXA1;CAMK2D;GRK4;GRK3;TBX18;UGCG;CDC42SE2;SRI;GRK6;IGFBP7;GLRX2;PTPN1;MGLL
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.328625548565415,-1.3101344489353302,0.04408817635270541,0.4318104391332338,1.0,43/140,19.12%,AKAP13;ARHGAP29;ARHGAP10;ARHGAP6;RHOQ;CGNL1;PLCE1;ARHGAP28;ITGAV;ARHGAP20;TIAM2;ARHGEF17;ARAP1;RHOJ;MYO9A;INPP5B;BCR;ARHGAP24;GMIP;ARHGAP21;PLEKHG2;CDC42;VAV2;ARHGAP17;TRIP10;RHOA;RHOT1;ARHGEF12;ARHGEF18;SOS2;ARHGAP32;FGD1;ARHGDIB;FGD4;ARHGAP18;NGEF;ARHGEF11;ARHGEF6;TRIO;ARHGEF1;RHOH;ARHGAP15;RHOC
prerank,transcription by RNA polymerase I (GO:0006360),-0.42391628495287376,-1.309816340882229,0.12355212355212356,0.43189840700292415,1.0,19/34,29.48%,GTF2H2;CCNH;CDK7;CAVIN1;TBP;TAF1D;MNAT1;ERCC3;TTF1;POLR2H;POLR2K;GTF2H1;POLR2E;TAF1C;GTF2H4;POLR1G;RRN3;TAF1A;POLR1C
prerank,regulation of Notch signaling pathway (GO:0008593),-0.35971702660971155,-1.3097124009009071,0.07317073170731707,0.4314301340685271,1.0,23/76,16.42%,EGFR;RBPJ;ZMIZ1;KAT2B;IL6ST;EP300;JAG1;WWP2;TSPAN5;NIBAN2;YAP1;CREBBP;STAT3;POFUT1;CCN3;NOTCH3;MAML2;MMP14;FBXW7;MAML1;BMP2K;TSPAN15;ARRB1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.49652409450072865,-1.3092853898564887,0.14444444444444443,0.4318434872218645,1.0,7/16,16.43%,KMT5B;SHLD2;PARP9;KMT5C;DTX3L;PRKDC;SMCHD1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.35308344372884193,-1.3086771540183106,0.07114624505928854,0.4326521823287469,1.0,13/79,6.91%,SULF1;CRIM1;BMPR1A;ADAMTS12;SMAD6;SMURF2;NBL1;HTRA3;NIBAN2;SULF2;THBS1;SKI;SKIL
prerank,negative regulation of protein depolymerization (GO:1901880),0.4490651982910203,1.308418913104916,0.123046875,0.5071658408858527,1.0,12/24,19.98%,NAV3;FGF13;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;CAMSAP3;CLASP2;TTBK2;CLASP1
prerank,platelet degranulation (GO:0002576),-0.33218240007511834,-1.30841725903128,0.05511811023622047,0.4326056083000321,1.0,36/118,19.36%,IGF1;TIMP3;VCL;PHACTR2;SERPING1;SPARC;PROS1;TLN1;FLNA;NHLRC2;CLEC3B;ANXA5;THBS1;CD9;VTI1B;ISLR;LYN;STXBP1;BRPF3;ACTN2;IGF2;LAMP2;TEX264;CD109;GTPBP2;FN1;VEGFA;VEGFD;TGFB3;ECM1;SERPINE1;SYTL4;TMX3;CHID1;ITGB3;LGALS3BP
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.3715092567140168,-1.3081616325078897,0.08216432865731463,0.4325535067735077,1.0,24/52,35.53%,ME2;MTHFR;MTHFD2L;D2HGDH;ADHFE1;ME1;MDH1;DLST;ALDH1L1;SDHA;ALDH18A1;NIT2;ASS1;ACOT8;DGLUCY;ME3;GCLC;GOT1;SLC25A32;GOT2;MDH2;IDH2;SLC19A1;SDHAF3
prerank,catecholamine biosynthetic process (GO:0042423),0.5533428747891185,1.3081077874992075,0.1559633027522936,0.5064372174273887,1.0,3/11,5.71%,DDC;SNCA;TGFB2
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.488947117152036,-1.3075126630817857,0.13559322033898305,0.4333855568264627,1.0,8/19,17.06%,TBK1;DHX9;DHX36;SETD2;MAVS;STAT1;DDX3X;TLR4
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.5525214115582837,-1.3072441889109452,0.13924050632911392,0.4333059822651075,1.0,5/11,12.77%,RESF1;MPHOSPH8;ATF7IP;TPR;SETDB1
prerank,negative regulation of locomotion (GO:0040013),0.5439860339094088,1.3071829827474835,0.175,0.5074680643743328,1.0,2/12,0.68%,SPOCK3;FRMD5
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5333438637681909,-1.3063709634900345,0.14341846758349705,0.4347235506732446,1.0,9/13,27.62%,BMP7;RREB1;NAPEPLD;SOX13;SIX1;HNRNPU;METRNL;ZBTB7B;PIM1
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.36236561022908115,-1.3061859916701546,0.08846153846153847,0.4344560029639413,1.0,18/72,16.42%,AKAP13;COL3A1;LPAR1;KANK2;ABCA1;ROBO1;ABL1;RIPOR2;BCR;NRP1;TNFAIP1;ABL2;ARHGEF18;CUL3;ARHGDIB;APOE;GPR4;ARRB1
prerank,retina homeostasis (GO:0001895),0.4497119361082865,1.306097793255136,0.13473684210526315,0.5085904412383435,1.0,3/23,8.66%,POTEF;ACTB;HSPB1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.542621017317533,-1.3059353102905449,0.16322701688555347,0.43435634711491194,1.0,7/12,27.96%,RNF8;NELFB;TCERG1;HNRNPU;RECQL5;NELFA;NELFE
prerank,homocysteine metabolic process (GO:0050667),-0.5526419706184624,-1.3054680798973677,0.1660377358490566,0.434845436886613,1.0,3/11,7.23%,MMUT;NOX4;MTHFR
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.5301107792462797,1.3051490904152414,0.17708333333333334,0.5095420820647297,1.0,4/13,9.26%,ADCY8;SHANK3;SHISA7;RELN
prerank,negative regulation of lipid storage (GO:0010888),-0.4923290931810395,-1.3046988865692368,0.13539651837524178,0.4360346286125714,1.0,6/19,10.19%,ABCA1;ITGAV;OSBPL8;ABHD5;NR1H3;PTPN2
prerank,regulation of nervous system process (GO:0031644),0.49142987014653305,1.3044543237483008,0.15137614678899083,0.5097889854642175,1.0,5/18,4.87%,DLGAP1;TMEM108;HTR2C;NOS3;DLGAP2
prerank,protein heterooligomerization (GO:0051291),0.4941224019602482,1.3043115435094859,0.13664596273291926,0.5086027094204665,1.0,5/17,13.79%,GRIN1;KCNC2;GRIN2B;FARSB;MAT2A
prerank,electron transport chain (GO:0022900),0.5062952586756845,1.3042999463109657,0.14132762312633834,0.5071149215868225,1.0,6/15,13.74%,CYB561;NDOR1;ENOX2;ETFDH;ETFB;ETFA
prerank,visual system development (GO:0150063),-0.40898497669327877,-1.3039201856764444,0.09262759924385633,0.43726678917899797,1.0,7/37,9.12%,PBX1;SMOC1;FOXC1;SH3PXD2B;RBP4;PBX3;HIPK1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.4063821295879998,-1.3038189409782988,0.10848126232741617,0.43684813800352623,1.0,16/37,27.70%,PRKAG2;CEMIP;BMP7;RPTOR;AXIN1;UBE2K;PARD3;INPP5K;EIF4G1;CAB39;SPRED2;SPHK1;IRGM;EGF;TNKS1BP1;APP
prerank,phospholipid biosynthetic process (GO:0008654),0.4125551532217261,1.3035744892481744,0.11752577319587629,0.5073926631097392,1.0,15/36,19.24%,SGMS1;MBOAT1;CPNE1;MVD;GPAM;CRLS1;FADS1;DHDDS;FAR1;IDI1;PIP5K1A;SAMD8;CPNE7;FDPS;PCYT2
prerank,regulation of B cell apoptotic process (GO:0002902),-0.5436751973642249,-1.303554769635563,0.14258555133079848,0.43677903897653636,1.0,3/12,11.77%,FOXP1;LYN;FNIP1
prerank,protein deacetylation (GO:0006476),-0.40522185725954973,-1.3034197486001005,0.11487758945386065,0.43642939464904695,1.0,9/41,5.04%,PRDM5;MIDEAS;HDAC4;TBL1X;TBL1XR1;FLNA;RCOR1;RCOR3;BAZ2A
prerank,regulation of lamellipodium organization (GO:1902743),-0.5263821332086047,-1.3032630329187,0.156140350877193,0.43611982660535203,1.0,7/14,25.67%,PDPN;CDC42;FER;CAPZB;CARMIL1;TWF2;TWF1
prerank,primary alcohol metabolic process (GO:0034308),-0.4427777084910483,-1.3032213826905203,0.12007874015748031,0.43557211453730227,1.0,5/25,11.11%,IGF1;RBP4;DHRS3;CYP1B1;NAPEPLD
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.47469967518483597,1.3030544975914118,0.12340425531914893,0.5073362567218468,1.0,5/19,9.26%,LRP8;PTPRD;IL1RAPL1;CDKL5;RELN
prerank,cellular response to ATP (GO:0071318),0.5095018826742511,1.3028884023873457,0.13695652173913042,0.506259930814889,1.0,4/14,11.32%,RYR3;P2RY1;CIB2;P2RX7
prerank,protein secretion (GO:0009306),-0.37460848617681236,-1.302399243368638,0.09505703422053231,0.4368823290034962,1.0,17/56,19.17%,WLS;ABCA1;STEAP3;TANGO6;PCSK5;CYB5R4;RAB10;ANXA1;RAB12;CAMK2G;ARFGAP3;RCN3;MON1A;COPG2;MIA3;COPG1;PARK7
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.5663238850664483,-1.301965306530627,0.15738963531669867,0.43712599109387634,1.0,3/10,2.50%,LRP6;BMP5;BMP7
prerank,regulation of neuroinflammatory response (GO:0150077),-0.4799995490118655,-1.3006815198527077,0.14979757085020243,0.4392581084128751,1.0,3/19,6.07%,IGF1;NUPR1;DAGLA
prerank,primary miRNA processing (GO:0031053),-0.5751290947008003,-1.2999710956633215,0.14711359404096835,0.440296799638023,1.0,3/10,6.91%,SMAD3;SMAD2;PUS10
prerank,ovarian follicle development (GO:0001541),-0.5285904100612481,-1.2989542805149843,0.1401151631477927,0.44207532873087363,1.0,10/13,37.89%,KIT;VEGFA;INHBA;EIF2B4;EIF2B5;INHA;INHBB;CEBPB;ANG;LHCGR
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.5241492583271703,1.2984185885309136,0.16985138004246284,0.5166893016756863,1.0,6/13,16.69%,ELOVL7;ELOVL4;TECR;HACD3;HACD1;TECRL
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5194337429595469,-1.2981897641738598,0.14285714285714285,0.4432662325770714,1.0,5/13,16.87%,TNRC6B;TNRC6A;EIF4ENIF1;TNRC6C;CNOT1
prerank,cellular response to oxidative stress (GO:0034599),-0.3299508303647725,-1.2980880852195056,0.058823529411764705,0.4428252638734131,1.0,44/118,26.06%,EGFR;PDGFRA;TPM1;FOXO3;ABL1;PRKAA2;ARNT;LRRK2;PLA2R1;NOX4;PPARGC1A;PTPRK;FER;SELENOS;JUN;PRKCD;HIF1A;STX4;PARP1;SOD3;MGAT3;PKD2;ADNP2;ERCC6L2;TXNRD2;CYBA;GPX8;DAPK1;PRKD1;PRKAA1;SOD2;PARK7;NCF2;PRDX2;FANCC;WNT16;ZFAND1;GPX7;NUDT2;GSR;CCS;SLC25A24;HTRA2;MAPK9
prerank,activation of protein kinase B activity (GO:0032148),-0.4300768085711927,-1.29751609801198,0.12375249500998003,0.44346761969404747,1.0,13/29,19.17%,IGF1;NTRK3;FGF1;OSBPL8;MAPKAP1;MTOR;PDPK1;RICTOR;TXN;ADRA2A;IL18;WNT5A;PARK7
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.48018014944721493,-1.2972814112769397,0.15356489945155394,0.44336220728109027,1.0,6/20,15.24%,WNT4;EP300;NCOR1;CLK2;SIK1;C1QTNF3
prerank,regulation of RNA export from nucleus (GO:0046831),-0.5609198383897693,-1.296750037598384,0.12897196261682242,0.4440145450261165,1.0,6/11,16.74%,KHDRBS1;DHX9;AKAP8L;SETD2;TPR;NSUN2
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.3112014191432658,-1.2966294785073953,0.036290322580645164,0.44361886746457524,1.0,36/150,15.84%,PTPN13;PRKAG2;PID1;ERRFI1;LDLRAD4;LRP6;NTRK3;SMAD6;PLPP3;FBLN1;PRKN;PPM1E;LRRK2;ENPP1;IBTK;DEPTOR;IGFBP3;PAK2;DTNBP1;LYN;PDPK1;IMPACT;PMEPA1;PRKCD;DNAJC3;RB1;FKBP8;RASSF2;PARD3;TRIB2;PRKDC;EMILIN1;PRKCZ;ZBED3;NCK1;NCK2
prerank,mitochondrion morphogenesis (GO:0070584),-0.5535433128994712,-1.2966019401110913,0.17009345794392525,0.4430206110637134,1.0,6/11,28.33%,PID1;DNM1L;WASF1;FIS1;MYH14;SUPV3L1
prerank,regulation of translation (GO:0006417),-0.3148242295274755,-1.2961886444087127,0.049800796812749,0.44329986236411195,1.0,46/173,20.28%,SAMD4A;PLD1;IGFBP5;EIF4G3;VIM;FOXO3;ZCCHC4;YTHDF3;SYNCRIP;EIF4A2;DDX6;THBS1;EIF4ENIF1;EIF2AK3;DHX9;MTOR;LARP1;HNRNPD;DHX36;IMPACT;GEMIN5;PLXNB2;EIF4E;UPF1;CSDE1;LSM14A;NSUN3;CNOT8;ALKBH1;EIF2AK4;YBX1;EIF2AK2;PRKDC;DDX3X;DAPK1;CNOT1;UPF3A;SHFL;PAIP1;MIF4GD;MTG2;CNOT10;RBM4;EIF4G1;EIF2B4;UPF3B
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.4885429005341859,-1.2953523507281564,0.15939278937381404,0.44455237815467696,1.0,8/18,31.65%,KAT2B;NCOR1;PTBP3;TERT;TMBIM6;ESR1;ZC3H10;NUDT16
prerank,arachidonic acid secretion (GO:0050482),-0.569578523394152,-1.2952029681927002,0.16205533596837945,0.44356104311050987,1.0,3/10,15.25%,ANXA1;PNPLA8;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.569578523394152,-1.2952029681927002,0.16205533596837945,0.44356104311050987,1.0,3/10,15.25%,ANXA1;PNPLA8;BDKRB2
prerank,lamellipodium assembly (GO:0030032),-0.4411321127365237,-1.295127777706869,0.11685823754789272,0.44309381524361247,1.0,9/26,16.40%,VCL;KIT;ITGB1;ABLIM3;ARFIP2;P2RY12;WHAMM;CARMIL1;ARHGEF6
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3232372709649866,-1.2943808270564836,0.033797216699801194,0.4441984180573417,1.0,45/136,23.53%,TCF7L2;PKD1;BMP7;PTGIS;HDAC4;TAX1BP1;BTRC;WWP2;NUPR1;FLNA;IRAK3;TAF3;ANXA4;USP7;UFL1;IRAK2;PARP10;CEBPG;SP100;PRMT2;CYP1B1;GLIS2;ID2;HES1;RB1;SIK1;EIF2AK4;PKD2;SUFU;PTCH1;TRAF3;ARRB1;CMKLR1;HEYL;DAP;LRRC14;SFRP4;IRAK1;MDFI;CDK5RAP3;WFS1;CHP1;HDAC2;COMMD7;NLRC3
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5340915580510299,1.2943213799355737,0.15955056179775282,0.5263844189026254,1.0,2/12,1.00%,DSCAM;PROM1
prerank,regulation of telomere capping (GO:1904353),-0.4628342201852999,-1.2941183194803108,0.13226452905811623,0.4441799079630533,1.0,8/23,19.75%,SMG6;TNKS2;USP7;NBN;HNRNPD;NABP2;MAP2K7;TERF2
prerank,regulation of ion transmembrane transport (GO:0034765),0.42089811852148945,1.2940612006838443,0.12943632567849686,0.525632109088574,1.0,8/33,12.95%,KCNJ3;CHRM3;KCNJ6;AKAP6;KCNJ11;KCNJ10;P2RX7;KCNJ8
prerank,regulation of dendritic spine development (GO:0060998),0.4763347848389087,1.2939082060607878,0.14132762312633834,0.5244619231300931,1.0,6/19,13.50%,NLGN1;SHANK3;KIF1A;GRIN3A;PPFIA2;PSEN1
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.4062822906964094,-1.2932720818239263,0.1145631067961165,0.4455455711209625,1.0,6/39,7.63%,TCF7L2;MCU;NLGN2;RBP4;GLUD1;NNAT
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.32895636267735096,-1.2921011874936494,0.05454545454545454,0.4478260746212611,1.0,19/113,7.45%,BMP6;NOTCH2;IGF1;EGFR;TCF7L2;TGFBR1;PTN;BMP5;FGF1;BMP4;OSR1;ARNT;RREB1;YAP1;STXBP4;FGFR2;NRP1;F3;SRSF6
prerank,cellular response to nitrogen compound (GO:1901699),-0.4617665512464909,-1.2912222546709613,0.14629629629629629,0.44923052091869214,1.0,10/20,33.31%,ROCK2;SPIDR;DDI2;RIOK3;HSF1;PDE12;ATRX;TIMELESS;NR1H4;EPG5
prerank,protein localization to organelle (GO:0033365),-0.3219025162150872,-1.2909593937489516,0.07056451612903226,0.4492367651140179,1.0,38/133,19.13%,ANK2;COL1A1;ZNF423;TRAM2;BMP7;BMP4;GBF1;BBS9;LRRK2;LMNA;PACSIN2;CNTLN;ARL3;DHX9;OBSL1;DCP1A;VAMP2;LAMP2;TULP3;RPL11;COG3;COG7;RAB11A;STX5;YBX1;SNX10;UBAC2;YWHAE;DDX3X;EMD;TOPORS;SIX1;LAMP1;AUP1;GBP2;GET4;CSNK1D;ABCA7
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5262757616379021,1.2906170451505095,0.17173913043478262,0.5316801336604008,1.0,3/11,7.62%,ITM2A;NECAB2;ITM2C
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.4122386417561186,1.2899620698855627,0.13617021276595745,0.5320109933019449,1.0,8/34,10.02%,FLT1;SEMA6A;RAMP2;KDR;MT1G;NOTCH1;HSPB1;DAB2IP
prerank,cellular response to peptide (GO:1901653),0.36674250072904774,1.289392821252965,0.0859538784067086,0.5320013993137215,1.0,14/56,13.50%,IGF1R;GRM5;CACNA1A;GRIN1;GRIN2A;RPL23;CACNA2D1;ATP1A3;DDX11;NOD1;ARHGEF2;CD36;XBP1;PSEN1
prerank,cellular iron ion homeostasis (GO:0006879),0.3742515260956969,1.289195982284438,0.1022964509394572,0.5309814449002208,1.0,12/55,10.73%,TFRC;ALAS2;TMPRSS6;SLC40A1;ABCG2;FTH1;SLC22A17;FTL;ISCU;FBXL5;ATP6V1A;ATP6AP1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.562483190644497,1.2890928081199158,0.16515837104072398,0.529726277132904,1.0,5/10,12.78%,PDE2A;PDE11A;RNF157;APLNR;PDE4D
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.2874028434889647,-1.2883384234339545,0.015717092337917484,0.45499814080951806,1.0,152/336,33.30%,FOXP1;INO80;SETD7;RNF169;UBE2E2;ABL1;KMT5B;RBBP8;UVRAG;TRIP12;YAP1;SPIDR;CEP63;SMC6;CBX1;RBBP6;CBX5;UBR5;STXBP4;NBN;WDR48;UFL1;TRRAP;TAOK3;LYN;BCL2;RAD51B;RNF8;PDS5A;WRN;NCOA6;DDB2;ZBTB1;XIAP;VCPIP1;CSNK1E;CCNK;ATF2;SMC5;UPF1;BRSK1;HERC2;MNAT1;RFWD3;MCM9;USP47;NIPBL;SUSD6;RAD51D;PARP1;ERCC3;PDS5B;PAXX;WDR76;ALKBH1;NABP2;SLF1;APTX;KMT5C;CASP2;STK33;DTX3L;PARP4;MMS19;PHF1;UBE2B;HINFP;PRKDC;MSH3;FBXO45;TOPORS;ERCC8;BOD1L1;NOP53;MRE11;MTREX;SPRTN;ZRANB3;HELB;IKBKE;UBA7;BAZ1B;VCP;NEK4;ZDHHC16;TANK;PARK7;MSH6;MAP2K6;PML;RPAIN;FANCC;SMC1A;SIRT4;WAC;TAOK1;SMARCAL1;ATR;NSMCE4A;PLK5;MACROD1;RAD51C;ERCC1;AATF;BRAT1;USP28;GTF2H1;MASTL;POLE2;UBQLN4;MAPK14;RECQL5;OGG1;KIN;HTRA2;BCL2L2;ENDOV;SHPRH;GTF2H4;ZBTB4;RAD54L;POLH;TIMELESS;CGAS;SAMHD1;IGHMBP2;NUDT1;BAK1;DCUN1D5;E2F1;HIC1;MGMT;GNL1;FANCG;BCL2L11;ZBTB38;UBA1;FAAP20;BATF;PARP2;PARP3;ALKBH8;RMI2;TNFRSF1B;PSME4;PNKP;RAD9A;RAD51;POLA1;TIGAR;BRCA1;PCLAF
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.37333550070937344,1.2883349193420863,0.08829568788501027,0.5303923064027467,1.0,15/57,15.85%,RGS1;ADCY3;ADCY8;GRM7;CHRM3;GRM8;PDE2A;MTNR1A;GNAL;OPRM1;ADCY4;OPRK1;CHRM2;OPRL1;GNAI1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.48051268018909893,-1.2879071174180874,0.1559633027522936,0.4553168535842967,1.0,12/17,33.13%,PID1;HDAC4;NCOR1;NUPR1;PARP1;CBFA2T3;FIS1;PPARA;PDE12;MLXIPL;PPIF;TIGAR
prerank,stem cell development (GO:0048864),0.49632121110242367,1.2878084171667474,0.1419068736141907,0.5302268947215185,1.0,3/16,6.08%,NRG1;CDH2;CYP26C1
prerank,regulation of fat cell differentiation (GO:0045598),-0.3537920933414157,-1.287608772984908,0.09633911368015415,0.4553264283252825,1.0,21/74,18.73%,SMAD3;MEDAG;FTO;TMEM64;ENPP1;CREBL2;YAP1;ZBTB16;RUNX1T1;ID2;TRPM4;TRIB2;ANKRD26;WDFY2;RORA;TAF8;CMKLR1;TRIO;SYAP1;WNT5A;BMP2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.2945271927534687,-1.2870933859625522,0.02766798418972332,0.4559443057374094,1.0,102/264,28.12%,SRRM2;DDX5;HNRNPH1;PABPN1;HNRNPR;WDR33;PCF11;SYNCRIP;CASC3;DDX17;IK;SRSF10;RBM6;DDX46;FUS;U2AF2;HNRNPM;DHX9;SF3B1;CPSF3;SRSF6;HNRNPD;HNRNPUL1;PRPF6;RBM10;PCBP2;RNPC3;DDX42;CDC5L;PRCC;CDK13;SLU7;GEMIN5;HNRNPK;PRPF3;SF3A1;SF3B6;YTHDC1;USP39;SCAF11;SF3A3;SNRNP70;ZCRB1;TGS1;RSRC1;DNAJC8;CWC22;STRAP;DDX23;YBX1;RBM5;CCAR1;COIL;SRSF1;CWF19L1;GEMIN7;SFPQ;EFTUD2;SNU13;MTREX;PRMT5;PPIH;UBL5;PRPF40B;PPWD1;HNRNPU;WBP11;CSTF3;POLR2H;SNRPF;ZMAT5;HNRNPA3;RBM4;SRSF7;GEMIN2;SRSF11;UPF3B;SRRM1;SRSF2;GTF2F1;CPSF4;CSTF1;DDX41;NUDT21;POLR2K;SMU1;PRPF38A;NONO;DHX15;POLR2E;CPSF1;NCBP2;CRNKL1;PRPF8;RBM19;LSM6;CACTIN;RBM22;ISY1;SUGP1;HNRNPL;POLR2D
prerank,heart contraction (GO:0060047),0.3939858222625892,1.2870467350432633,0.12025316455696203,0.5309170158141268,1.0,9/41,10.37%,SGCZ;RYR2;GPX1;MYH6;SLC8A1;GRK2;SCN4B;TCAP;SGCG
prerank,dopamine metabolic process (GO:0042417),-0.47375207930910646,-1.2867265975661182,0.16165413533834586,0.4561465093891772,1.0,4/18,8.39%,MOXD1;PRKN;SNCAIP;COMT
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3469272041162881,-1.286704901169921,0.07648183556405354,0.45551459133884536,1.0,15/85,7.58%,EYA1;ROR1;PIEZO2;COL1A1;COL4A3;CEMIP;CDC14A;TBL1X;GSDME;DCDC2;RIPOR2;EML2;ADGRV1;ATP6V0A4;CACNA1D
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.5212348990279141,-1.286526116246999,0.17383177570093458,0.4552404859315707,1.0,7/13,27.96%,RNF8;NELFB;TCERG1;HNRNPU;RECQL5;NELFA;NELFE
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.494900460632013,-1.2862118501479023,0.1663619744058501,0.4553031482442413,1.0,4/17,2.67%,ROCK2;VCL;PPP1R12A;ROCK1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5477600628959509,1.2859012757278119,0.17040358744394618,0.5324913534035881,1.0,4/10,20.09%,ANK3;KCNAB1;KCNRG;SUMO1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.5354427412750681,-1.285713048440946,0.15283018867924528,0.4558352611889098,1.0,5/11,26.27%,GFPT1;RENBP;UAP1;UAP1L1;PGM3
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.532265913221237,-1.2855796846340852,0.16266173752310537,0.4554508340314128,1.0,3/12,2.98%,FOXP1;DAB2;NCOR1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.47093757760657806,-1.2853671040803651,0.1475095785440613,0.45531575041053807,1.0,8/18,30.53%,VGLL4;CTSC;DACT1;APOE;ATP5IF1;MSN;CD81;RDX
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.4564813815744453,-1.2851907921641614,0.1328125,0.4550580249428651,1.0,11/19,35.78%,DDO;ASPA;DLST;ALDH7A1;PIPOX;PHYKPL;GOT1;GCDH;HYKK;GOT2;AASS
prerank,positive regulation of lyase activity (GO:0051349),-0.5061239044210527,-1.2842176562608039,0.16184971098265896,0.4567878723189105,1.0,7/14,22.23%,CACNA1C;STIM1;CACNA1D;PARK7;NOS1;FXN;ORAI1
prerank,regulation of lipid metabolic process (GO:0019216),-0.3426248128194474,-1.2833879854746124,0.0661625708884688,0.45807273438649354,1.0,36/88,26.09%,PRKAG2;CHD9;NR1D2;NCOR1;TBL1X;TBL1XR1;CREBBP;NCOA6;NFYC;NCOA1;MED1;PANK2;ID2;NPC2;TGS1;MBOAT7;LACTB;C1QTNF2;RORA;RXRA;CCDC3;NFYB;HMGCR;SQLE;CYP51A1;ABCA7;FGFR4;NFYA;FDFT1;SC5D;SMARCD3;MVK;EDF1;BBS4;PPARA;ZFP69
prerank,regulation of cellular metabolic process (GO:0031323),-0.3897203924018118,-1.2833791571758384,0.10881801125703565,0.45742359762931456,1.0,10/45,12.78%,PID1;PRKN;TBC1D16;MKLN1;PANK2;CYP1B1;KIF16B;NPC2;ARF1;MBOAT7
prerank,regulation of stem cell proliferation (GO:0072091),-0.4859617933083279,-1.2825054261608198,0.1579961464354528,0.4588645137919476,1.0,8/17,25.54%,FBLN1;YAP1;GJA1;EIF2AK2;HNRNPU;TERT;SOX11;KDM1A
prerank,actin filament depolymerization (GO:0030042),-0.5481050084657773,-1.2821564678711894,0.16757741347905283,0.4590204912816536,1.0,3/11,3.88%,MICAL3;GSN;MICAL2
prerank,positive regulation of cell aging (GO:0090343),0.5327273013741458,1.2817014006238185,0.1917808219178082,0.5426192754182757,1.0,3/11,4.86%,SIRT1;HMGA2;YPEL3
prerank,regulation of macrophage differentiation (GO:0045649),-0.49308951140870366,-1.2816812661960282,0.1641509433962264,0.4595924184023934,1.0,6/15,23.72%,IL34;PTPN2;ID2;INHBA;HSF1;PRKCA
prerank,motor neuron axon guidance (GO:0008045),0.4978490038523333,1.2813851271478331,0.16891891891891891,0.5419382720664079,1.0,5/15,10.61%,TMEFF1;SLIT1;LHX1;NTN1;CHN1
prerank,retinoic acid metabolic process (GO:0042573),-0.4999888939306178,-1.2810883537554183,0.14396887159533073,0.4604201545756954,1.0,2/14,3.47%,ALDH1A2;CYP26B1
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5273476190560942,-1.2806707331925975,0.16764132553606237,0.4608268090145324,1.0,4/13,12.33%,LARGE1;OGA;RENBP;MGAT3
prerank,post-translational protein modification (GO:0043687),-0.2856528947522924,-1.2806216521695422,0.018947368421052633,0.46027994582400195,1.0,123/332,29.24%,FSTL1;CP;FBN1;FBXL7;LTBP1;IGFBP5;SDC2;BMP4;SPSB1;FBXW8;KLHL13;BTRC;GPC3;ASB3;IGFBP3;STT3A;ZBTB16;WDTC1;ITIH2;ASB2;FBXL4;OBSL1;FBXL12;FBXO10;ASB13;IGFBP4;DDB2;KTN1;NUB1;TNC;HIF1A;DCAF10;DNAJC3;FAM20C;SERPIND1;DCAF6;LGALS1;PSMF1;FBXL19;RAB11A;FBXL18;LRRC41;FN1;CUL3;COPS2;FBXO30;FBXW7;DCAF8;MXRA8;CCN1;WSB2;COPS8;PSMB2;KLHL22;ESCO1;MSLN;APOE;CUL2;MBTPS1;ERCC8;IGFBP7;KLHL11;DCAF4;FEM1A;ASB5;MIA3;FBXO22;ATG5;RABGGTB;FBXW5;FBXW11;RCN1;DCUN1D3;CHM;SPSB4;COP1;SPP1;P4HB;PSMC1;HIF3A;CHML;NAE1;CUL1;CUL7;SUMF1;FBXW4;WFS1;F5;LAMB2;LAMC1;BTBD1;PSMA3;PSMB6;PSMA4;RAB8A;FBXL14;CALU;PNPLA2;FBXO4;FBXW9;RAB5A;FBXO11;KCTD7;CCDC8;PSME1;PSMD13;SPSB2;EVA1A;APP;MGAT4A;GPS1;KCTD6;FBXL3;PSMB9;RBX1;PSMB10;ICMT;PSMA5;KBTBD7;SPSB3;ASB6;WDR5;PENK
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.4307609916701225,-1.2805359802819756,0.14727272727272728,0.4597883710607937,1.0,4/26,4.57%,IGF1;FHL2;GSK3B;SLC9A1
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.5148273127995106,-1.2804297294147895,0.18032786885245902,0.45937778800341933,1.0,11/14,35.20%,SEC24D;SEC23A;SEC31A;TBC1D20;SEC23B;MIA3;SCAP;SEC24A;SEC24C;SEC31B;SEC13
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.30561659682260234,-1.2800769654921322,0.03725490196078431,0.45960224752575507,1.0,39/170,15.45%,ROCK2;PRDM6;IGF1;FOXP1;PRDM5;ZNF462;AFF3;TRIM44;TFEB;TBC1D16;CDH1;AFF1;ZUP1;MKLN1;REST;HNRNPD;PCBP2;FUBP1;KDM6A;LDLR;HNRNPK;HIF1A;KIF16B;AFF4;NFKBIZ;TRIM5;TRIM11;ARF1;YBX3;MTMR3;ADNP2;YBX1;CGGBP1;ATRAID;HINFP;APOE;TRIM39;PRDM2;RASA1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5547201872734284,1.279990169927485,0.16302186878727634,0.5443555801994221,1.0,4/11,22.25%,KLRC1;SMAD7;HFE;CEACAM1
prerank,negative regulation of blood coagulation (GO:0030195),-0.4006308723110279,-1.279760167773477,0.134765625,0.45976224584433245,1.0,6/38,7.29%,PDGFRA;SERPING1;VTN;PLAT;TFPI;F3
prerank,regulation of MAPK cascade (GO:0043408),-0.3124304295758392,-1.2793758207481105,0.04703476482617587,0.46007332718167226,1.0,30/157,9.06%,ROCK2;TGFBR3;IGF1;EGFR;ROR1;LPAR1;DAG1;EPHA7;NTRK3;PELI2;KSR1;STK3;ROCK1;ADRA1B;KIT;GSDME;STYX;RYK;NRK;HMGB1;LBH;PAK2;TAOK3;FGFR2;SHC1;MAP4K4;LYN;IGF2;NBR1;MAP2K1
prerank,mitotic recombination (GO:0006312),-0.4911685808512225,-1.2789683493364772,0.1636029411764706,0.46038522906629303,1.0,6/15,15.88%,SMC6;NSMCE2;SMC5;RAD51D;MSH3;DMC1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.3986570866638319,-1.2789172325190599,0.13307240704500978,0.45984624409174407,1.0,23/37,36.68%,PCM1;IFT43;IFT81;DYNC2I1;IFT88;IFT80;DYNC2LI1;DYNLRB1;DYNC2I2;TRIP11;KIFAP3;IFT27;SSX2IP;KIF3A;IFT140;TTC21B;IFT122;WDR35;IFT74;DYNC2H1;IFT52;CEP131;TRAF3IP1
prerank,protein phosphorylation (GO:0006468),-0.2774716333888772,-1.278846355941629,0.012219959266802444,0.4593362471175413,1.0,152/478,22.06%,PRKAG2;ROCK2;TGFBR3;GRK5;EGFR;TGFBR1;EFEMP1;BMPR1A;EPHA3;CDK8;PDGFRA;PKD1;TLK1;PDK1;PDGFRB;BMP4;STK3;ROCK1;FAM20A;ERC1;SMG1;MAP3K3;CAMK1D;ABL1;BIRC6;PRKAA2;TGFBR2;LRRK2;JAK1;CSNK1A1;FRK;CCNH;KIT;TOP1;GSK3B;STK17B;CCNT1;RYK;TBK1;NRK;IRAK3;MARK3;IGFBP3;CDK16;BCR;CDK7;SLK;EIF2AK1;SMAD2;PAK2;TAOK3;EEF2K;FGFR2;MAP4K4;EIF2AK3;LYN;MTOR;CAMK2D;BRAF;MAP3K5;MERTK;GRK4;EPHA4;PDPK1;DCLK1;MARK4;WNK4;GRK3;MAP2K1;HIPK1;CSNK1E;CDK13;CLK2;WNK1;MAP3K20;FER;BRSK1;PRKCD;ABL2;DMPK;ULK2;FAM20C;CLK3;CDK11B;ABI1;MKNK2;SIK1;COPS2;EIF2AK4;MAML1;STK33;RICTOR;GMFB;TBCK;TRIB2;TEC;COPS8;EPHA8;MAPK6;TYK2;BMP2K;EIF2AK2;ERN1;PRKDC;PRKCZ;LATS1;CDC25B;ACVR1;GRK6;CSNK2A1;DDR1;PIK3R4;DAPK1;MARK1;SIK3;PIK3CD;TLR4;PRKD1;PRKACA;IKBKE;DAPK2;BAZ1B;PRKAA1;PXK;MORC3;STK16;MAP3K1;NEK4;BMP2;MUSK;CSNK1D;IRAK1;CDK2;FASTK;CDK10;MAP2K6;NRBP2;FGFR4;BCKDK;CAB39;PRKAG3;PKDCC;AKT2;NEK6;SIK2;PRKAB1;CDK6;MAST2;MKNK1;MAP3K12;TAOK1;PPP4R1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.5367360511675172,-1.2786995763928968,0.1790744466800805,0.4590348943771889,1.0,5/11,20.35%,PRKN;UBQLN1;REST;PARK7;P4HB
prerank,negative regulation of RNA splicing (GO:0033119),-0.46527742169864955,-1.2783591647363948,0.15065913370998116,0.4591891993323433,1.0,5/19,7.55%,SFSWAP;SRSF10;U2AF2;SRSF6;PTBP3
prerank,regulation of small molecule metabolic process (GO:0062012),-0.4148162180266161,-1.2782413339838754,0.13214285714285715,0.4587796556940008,1.0,15/28,33.18%,PDK1;PRKN;FOXK1;PANK2;RORA;APOE;FOXK2;EPHX2;BCKDK;ARV1;PPARA;ACADVL;PDK3;PDK4;NR1H4
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.4474912514904783,1.2782110371719577,0.16740088105726872,0.5477797504338551,1.0,6/24,10.81%,TEK;RAMP2;GAS6;KDR;NDNF;SCG2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.48480630404231434,-1.2779445899705326,0.16226415094339622,0.45881965961108684,1.0,6/17,8.05%,NTRK3;ABL1;BAIAP2L1;BCAS3;NRP1;CDC42
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.5311267482034655,-1.27765093303706,0.1875,0.45881869133751324,1.0,3/12,17.06%,RBP4;STRAP;TLR4
prerank,response to UV (GO:0009411),-0.3310745354455523,-1.2774230664814643,0.07436399217221135,0.45875482681393775,1.0,35/95,24.12%,EGFR;INO80;SCARA3;EP300;GTF2H2;CREBBP;UBE4B;DHX36;WRN;PTPRK;DDB2;ZBTB1;BRSK1;PRKCD;USP47;PARP1;ERCC3;EIF2AK4;REV1;UBE2B;ERCC8;MAP2K7;SPRTN;ZRANB3;SDE2;DCUN1D3;MSH6;MFAP4;PCNA;BMF;USF1;ATR;CCAR2;PRIMPOL;USP28
prerank,polyol metabolic process (GO:0019751),-0.3772772614599522,-1.2774132084580183,0.11969111969111969,0.4581343486413986,1.0,11/46,10.23%,PLCE1;SLC5A3;NUDT4;PLCD3;INPP5B;INPP5A;ISYNA1;INPPL1;PLCG1;PLCB3;PLCD1
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5658858762093419,-1.2769742294224082,0.16483516483516483,0.4585683140607743,1.0,3/10,13.30%,GLI3;BMP4;IRF1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.4902718280868794,-1.2766231368098953,0.15009746588693956,0.45879114772539054,1.0,8/17,14.65%,FCHSD2;WASF2;BRK1;NCKAP1;ARFIP2;ARF1;GMFB;WASF1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.4146108752988188,-1.2760851755510865,0.12994350282485875,0.45944606884644235,1.0,11/31,12.66%,BOC;CDON;CTNNA1;ABL1;MEF2A;FGFR2;CDC42;IGF2;ID2;MEF2C;TCF3
prerank,respiratory system development (GO:0060541),-0.413641932489988,-1.2749995811468222,0.15180265654648956,0.4615473647095169,1.0,12/32,16.43%,GLI2;FGF1;BMP4;PDPN;DISP1;RBP4;FGFR2;CCDC39;VEGFA;CHD7;LOXL3;SMCHD1
prerank,regulation of cell motility (GO:2000145),0.3224531508691019,1.2746122581628814,0.06224899598393574,0.5561751119627482,1.0,23/121,10.17%,SPOCK2;SPOCK3;FRMD5;ERBB4;CSF1R;PLXNB3;TMSB4X;NRG2;NRG1;TMSB10;ROBO4;FGF10;ENPP2;MEAK7;PKN1;FGF5;AKT1;SGK3;PLXNA4;SST;CYRIB;SPATA13;NTN1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.48075930958143065,-1.2741673019763586,0.1539961013645224,0.4630123211493847,1.0,5/17,7.58%,ATP1A2;CACNA1C;ANK2;KCNJ2;CACNA1D
prerank,positive regulation of type I interferon production (GO:0032481),-0.3474670579783526,-1.2738198410597972,0.08610567514677103,0.4631922623797656,1.0,34/73,31.20%,NFKB1;EP300;TBK1;CREBBP;DHX9;DHX36;PTPN22;SETD2;MAVS;RIOK3;IRF1;PRKDC;STAT1;DDX3X;MRE11;OAS2;TLR4;POLR2H;PTPN11;IRAK1;XRCC6;DDX41;POLR2K;POLR3D;POLR2E;NFKB2;POLR3H;DHX58;CGAS;POLR3E;POLR1C;IFIH1;DHX33;TLR3
prerank,regulation of cilium assembly (GO:1902017),-0.3620958500006368,-1.2736536669870622,0.0945945945945946,0.4629380580142325,1.0,30/62,27.67%,TBC1D16;DCDC2;YAP1;TBC1D19;TBC1D24;MARK4;USP6NL;TBC1D2B;TBC1D20;IFT88;ODF2L;TBC1D22B;DYNC2LI1;ATG5;TBC1D17;CDK10;TBC1D7;RABGAP1;TBC1D10A;KCTD17;TAPT1;TCHP;ARHGAP35;IFT140;BBS4;TBC1D10B;TESK1;RABEP2;ATG3;TBC1D9B
prerank,fluid transport (GO:0042044),0.5138259402799922,1.2733959855734354,0.18503118503118504,0.5580305516859098,1.0,3/12,12.16%,AQP9;AQP11;AQP4
prerank,sulfation (GO:0051923),-0.5438757956073129,-1.2733320710565657,0.1947069943289225,0.4630437470575519,1.0,2/11,10.33%,UST;SULT1A1
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.45851027823186485,-1.2726789667551455,0.164969450101833,0.4639737452098422,1.0,14/20,43.09%,MBTPS2;APOE;MBTPS1;EPHX2;LPCAT3;ARV1;ACADVL;SREBF1;NR1H4;RAN;ACADL;FMO5;LDLRAP1;KPNB1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.49889463107535187,-1.2724814713442318,0.1878453038674033,0.46379148223695915,1.0,4/14,7.45%,SFSWAP;SRSF10;U2AF2;SRSF6
prerank,regulation of T cell mediated immunity (GO:0002709),-0.55952828122693,-1.2722797818598741,0.18352059925093633,0.4635829900838157,1.0,3/10,13.02%,HMGB1;ZBTB1;TRPM4
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.4381105180277069,-1.2722706948011242,0.15526802218114602,0.4629478243649588,1.0,4/25,7.24%,ERRFI1;CBLB;SNX6;SLC6A9
prerank,regulation of embryonic development (GO:0045995),-0.4075997339521622,-1.2718985472139992,0.13653846153846153,0.4632310901554847,1.0,9/34,15.12%,PHLDB2;DAG1;TRIP12;NIBAN2;WDPCP;DHX36;NIPBL;EHMT1;ZBED3
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.548741223317802,1.2718423317131065,0.1941544885177453,0.5607552933222664,1.0,3/11,10.90%,AKAP6;LRRC55;RNF207
prerank,DNA methylation or demethylation (GO:0044728),-0.47195498359481514,-1.2716447526730128,0.17073170731707318,0.46254709712614744,1.0,8/19,28.63%,PPM1D;BAZ2A;DNMT3A;ATF7IP;EHMT1;KMT2E;ATRX;DMAP1
prerank,DNA alkylation (GO:0006305),-0.47195498359481514,-1.2716447526730128,0.17073170731707318,0.46254709712614744,1.0,8/19,28.63%,PPM1D;BAZ2A;DNMT3A;ATF7IP;EHMT1;KMT2E;ATRX;DMAP1
prerank,DNA recombination (GO:0006310),-0.4007861752238945,-1.2716154814379246,0.13549618320610687,0.4619584113105864,1.0,23/37,39.50%,HMGB1;RAD51B;WRN;RAD21;RAD51D;MSH3;DMC1;MRE11;RPAIN;RAD51C;ERCC1;RECQL5;RAD54L;SUPV3L1;IGHMBP2;HDAC10;RAD51;LIG4;GEN1;MSH2;XRCC3;RAD52;EXO1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5098333989869857,1.271267926138226,0.17965367965367965,0.5608552967944335,1.0,6/13,13.93%,ANK3;SLC8A1;CALM1;PDE4D;CALM2;CALM3
prerank,regulation of exocytosis (GO:0017157),0.3834427966441531,1.2711966802297956,0.1290983606557377,0.5594946117022844,1.0,11/46,10.93%,SYT1;IL1RAPL1;CADPS;RIMS2;RAB3C;LGI3;SNCA;STXBP5L;CPLX1;ATP6AP1;HAP1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.5038529307374362,-1.270923418866546,0.1487279843444227,0.46304695190193257,1.0,10/14,33.21%,AUTS2;CTR9;SMAD4;KMT2A;PRDM9;PAXIP1;KMT2E;WDR5;SNW1;BRCA1
prerank,response to estradiol (GO:0032355),-0.4043235285673219,-1.270906929707248,0.1410488245931284,0.46242941747966454,1.0,5/31,7.19%,EGFR;LCOR;STRN3;STAT3;ANXA1
prerank,sulfur compound biosynthetic process (GO:0044272),-0.328849155538986,-1.2706527316583038,0.07047619047619047,0.4624069363754582,1.0,29/104,19.51%,UST;DSE;ST3GAL4;ANGPT1;DCN;B4GALT1;BGN;FMOD;SLC35B3;OGN;GLCE;SLC26A2;SLC10A7;PRELP;CHST15;TPK1;ST3GAL3;AKR1A1;GGTA1;LUM;CHST11;CHPF2;CHAC2;CHSY1;GSTT1;OMD;CHST12;MGST1;B4GALT5
prerank,homotypic cell-cell adhesion (GO:0034109),-0.39642296191059645,-1.2704574741315713,0.10609037328094302,0.46224917994249437,1.0,11/39,15.46%,VCL;PDGFRA;PLPP3;MEGF11;TLN1;FLNA;STXBP1;FN1;GNAS;P2RY12;FIBP
prerank,positive regulation of interleukin-4 production (GO:0032753),0.4887519913568702,1.2700604146551193,0.18200836820083682,0.5611279817095322,1.0,2/17,6.58%,SLC7A5;PRKCQ
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3369010282349829,-1.2697649418882972,0.07992202729044834,0.46330821267995936,1.0,30/85,21.59%,PIAS1;DAB2;PRKN;LRRK2;ARIH1;CSNK1A1;NUPR1;GSK3B;RNF217;RNF19A;RNFT1;CSNK1E;NUB1;TMEM259;FBXW7;TRIB2;SH3RF2;CBFA2T3;USP13;NOP53;HECTD1;FBXO22;VCP;RNF14;CSNK1D;TMTC3;COP1;ZYG11B;ARIH2;DET1
prerank,central nervous system neuron development (GO:0021954),0.4855743351199213,1.2696216150137236,0.18763326226012794,0.5607813477814181,1.0,4/15,8.62%,MAP2;NTRK2;HSP90AB1;B4GALT6
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.5210164872318349,-1.2688323268020194,0.17938931297709923,0.4649502541456476,1.0,7/12,33.23%,CLCN2;MBTPS2;MBTPS1;H6PD;LPCAT3;SREBF1;RAN
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.43805726377248705,-1.2683365716656259,0.16173570019723865,0.4655046135380594,1.0,7/25,13.05%,CCNT2;SETD5;CCNT1;SCAF8;CCNK;WDR43;HTATSF1
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.4006737066033109,-1.2683337299350896,0.13320463320463322,0.46486910362362455,1.0,5/37,3.86%,NFKB1;ITGAV;PRKN;NCOR1;DLG4
prerank,regulation of protein localization to membrane (GO:1905475),-0.43079048631727895,-1.2679996472756834,0.14205607476635515,0.46505816902491526,1.0,10/28,12.69%,GPC6;GSN;SLC5A3;PRKN;GPC4;GPC3;VTI1B;AR;MMP14;APPL1
prerank,cellular response to heat (GO:0034605),-0.4012128902013562,-1.2675488402287765,0.1306930693069307,0.46550697157987414,1.0,16/35,28.12%,FGF1;THBS1;DHX36;SLU7;BAG3;TPR;YWHAE;PRKACA;ANO1;VCP;HSBP1;ZFAND1;HSF1;HTRA2;TCIM;POLR2D
prerank,histone H3-K4 methylation (GO:0051568),-0.43424397510411644,-1.2674465197370026,0.16477272727272727,0.46509801609204693,1.0,14/26,33.19%,KMT2C;KMT2D;CTR9;KDM6A;OGT;KMT2A;PRDM9;CXXC1;PAXIP1;TET2;TET3;WDR5;DPY30;WDR5B
prerank,thyroid hormone generation (GO:0006590),-0.5408804059433996,-1.2669963218053466,0.19848771266540643,0.4655128857525735,1.0,2/10,11.09%,CPQ;SLC5A5
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.4130885285388002,-1.2668556840821759,0.13690476190476192,0.4651767674950255,1.0,15/30,31.61%,HUWE1;SAE1;ABLIM3;LEPROT;NPEPPS;FBXW7;UBL5;UBE2D3;TOMM7;ARIH2;HTRA2;PDCD5;USP36;RNF31;UBE2L3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5001995864529762,1.2667007794530438,0.17303370786516853,0.5675336152484375,1.0,4/13,13.14%,TMEM30A;SAR1A;BRSK2;SORL1
prerank,regulation of cytokinesis (GO:0032465),-0.34557010611055294,-1.2666695267785224,0.1033210332103321,0.46495063691170424,1.0,19/78,15.68%,KIF13A;SVIL;BIRC6;CDC14A;KLHL13;UVRAG;CSPP1;CDC42;SETD2;RHOA;GIPC1;RAB11A;CUL3;BECN1;PIK3C3;MAP9;CDC25B;CDC14B;PIK3R4
prerank,bile acid and bile salt transport (GO:0015721),0.4350822713935586,1.2665791984701358,0.1643835616438356,0.5662953103519032,1.0,4/24,11.08%,SLCO1C1;NCOA2;SLCO2B1;ABCC4
prerank,regulated exocytosis (GO:0045055),0.3080384159990608,1.2665516407961195,0.05976095617529881,0.5648280658131114,1.0,37/173,12.99%,SYT1;PCYOX1L;RIMS1;PCLO;SYT6;STEAP2;SYT7;TMSB4X;RIMS2;SYT12;SYT11;SNAP25;RIMS3;SNCA;GAS6;PCDH7;FERMT3;TGFB2;WDR1;CLU;SYT10;PECAM1;ITIH3;TIMP1;SELENOP;CYRIB;SCG3;PDGFB;CPLX1;SYT2;ABCC4;CALM1;ITGA2B;TUBA4A;ACTN4;VWF;CD36
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.38036924446900755,-1.2656847749724964,0.12770137524557956,0.46669867254766584,1.0,8/43,10.19%,EGFR;ERRFI1;CBLB;RNF115;SNX6;PTPN3;CDC42;PTPN2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.5020469585586018,-1.2654070023239945,0.17318435754189945,0.46672433930875606,1.0,6/14,18.43%,FOXC1;NRP1;VEGFA;VEGFD;PIK3CD;GAB1
prerank,synaptic vesicle endocytosis (GO:0048488),0.4050535236461363,1.265216853641343,0.14919354838709678,0.5670284845949156,1.0,14/33,19.04%,DNM3;SYT1;NLGN1;SNCA;SNAP91;AMPH;SYT2;SNCB;NLGN3;PACSIN1;DNM1;GAK;SYNJ1;SYT5
prerank,midbody abscission (GO:0061952),-0.4752441300891628,-1.2646617696565643,0.15730337078651685,0.46794478121053884,1.0,5/17,10.16%,VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3
prerank,iron ion homeostasis (GO:0055072),0.359176020914233,1.2645504237168361,0.11405295315682282,0.5673544461413129,1.0,12/58,10.73%,TFRC;ALAS2;TMPRSS6;SLC40A1;ABCG2;FTH1;SLC22A17;FTL;ISCU;FBXL5;ATP6V1A;ATP6AP1
prerank,positive regulation of protein secretion (GO:0050714),-0.34965574693025314,-1.264511675606349,0.09845559845559845,0.46767725872950444,1.0,12/69,10.55%,BMP6;WLS;IGF1;TCF7L2;MCU;NLGN2;RBP4;DNM1L;GLUD1;NNAT;UNC13B;ADAM9
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4832841713413535,1.264265855368472,0.174496644295302,0.5666555414955957,1.0,4/16,10.38%,MRAP2;NECAB2;GRP;PDE6H
prerank,response to steroid hormone (GO:0048545),-0.4120574561933923,-1.263874269304414,0.15458015267175573,0.46860852871766234,1.0,8/31,10.12%,ATP1A2;YAP1;NR3C1;THBS1;TFPI;AR;MED1;NR1H3
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.4144018443519835,-1.2638104270543236,0.1586998087954111,0.4681180128379753,1.0,18/32,29.48%,GTF2H2;CCNH;CDK7;CAVIN1;TBP;TAF1D;MNAT1;ERCC3;POLR2H;POLR2K;GTF2H1;POLR2E;TAF1C;GTF2H4;POLR1G;RRN3;TAF1A;POLR1C
prerank,osteoclast differentiation (GO:0030316),-0.44310749221537044,-1.2637727361527338,0.1726078799249531,0.4675723908376883,1.0,7/22,16.21%,FOXP1;GAB2;SBNO2;ANXA2;SNX10;GLO1;FARP2
prerank,cellular response to dsRNA (GO:0071359),-0.4861089804972596,-1.2636443424731911,0.1935483870967742,0.467216645788694,1.0,11/15,38.87%,DHX9;MAVS;RIOK3;PDE12;MUL1;CGAS;CAV1;IFIH1;ZCCHC3;NPM1;FLOT1
prerank,keratan sulfate metabolic process (GO:0042339),-0.4122109778977697,-1.263278867317493,0.14925373134328357,0.4675115277301754,1.0,12/31,19.51%,ST3GAL4;B4GALT1;FMOD;GNS;OGN;PRELP;ST3GAL3;LUM;HEXA;GALNS;OMD;B4GALT5
prerank,vascular process in circulatory system (GO:0003018),-0.5070116823445947,-1.2627994492581271,0.18809980806142035,0.4673114666054406,1.0,4/13,12.08%,ROCK2;ROCK1;ADCY6;AGTR1
prerank,regulation of tube diameter (GO:0035296),-0.5070116823445947,-1.2627994492581271,0.18809980806142035,0.4673114666054406,1.0,4/13,12.08%,ROCK2;ROCK1;ADCY6;AGTR1
prerank,regulation of signal transduction (GO:0009966),-0.3007101366541738,-1.262489234681821,0.05521472392638037,0.46743846492439944,1.0,56/190,18.47%,SULF1;GRK5;ZIC1;PLCE1;IGFBP2;FBXL17;IGFBP5;MDFIC;LRRK2;ELF1;CD55;DCDC2;IGFBP3;RSPO3;IGFBP6;AXIN1;PLSCR1;IFT81;CREBBP;DTNBP1;FGFR2;GAS1;IRAK2;POFUT1;GRK4;DHRS3;RUNX1;IGFBP4;SP100;GRK3;USP33;PTPN2;TULP3;TRIM5;UGCG;CDC42SE2;CASTOR2;TCF7L1;OGT;GLI1;RORA;ACVR1;NCK1;GRK6;IGFBP7;PTCH1;NCK2;FOXL1;TSPAN15;GLRX2;RIC8B;PRKD1;WDR11;SLC8A3;PTPN1;MGLL
prerank,neuron differentiation (GO:0030182),0.3076368222980016,1.2623981438290404,0.050100200400801605,0.5704524526400457,1.0,36/165,16.92%,PHOX2A;SPOCK1;MYT1L;PTPRD;IRX2;IL1RAPL1;TENM2;PBX2;TENM1;EPHA5;NTRK2;TENM4;NEUROD6;TGFB2;FUT9;ALK;TENM3;SNPH;LHX1;WNT7B;ITM2C;ERCC2;RNF112;ATP8A2;BRSK2;FZD4;XBP1;RORB;ATP2B2;PPT1;ACSL3;SOX4;LMX1B;PBX4;DDIT4;CTNNB1
prerank,regulation of potassium ion transport (GO:0043266),0.4123499247592561,1.2619762893851476,0.14669421487603307,0.5701116262531999,1.0,7/31,7.66%,DPP10;KCNIP4;KCNN2;ANK3;KCNIP1;DPP6;KCNAB1
prerank,sprouting angiogenesis (GO:0002040),-0.3732872513484137,-1.260760978558617,0.12403100775193798,0.47108708290894297,1.0,18/51,17.55%,PARVA;ANGPT1;EFNB2;BMP4;CCBE1;ROBO1;RSPO3;THBS1;RNF213;ADGRA2;NRP1;RECK;SEMA3E;BMPER;VEGFA;VEGFD;NR4A1;MIA3
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.47454666638328813,-1.2603997463870964,0.17164179104477612,0.47132846913602094,1.0,7/18,26.46%,PTN;CAMK1D;LYN;IL6R;SLC8B1;SLIT2;EDN3
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.5023312830654583,1.2602377022798057,0.20842105263157895,0.573585229331391,1.0,3/12,6.67%,PAX8;PAX2;LHX1
prerank,activation of GTPase activity (GO:0090630),-0.33289687239976806,-1.2598080556820581,0.09369024856596558,0.47215303286639393,1.0,28/89,21.47%,ARHGAP29;ARHGAP42;SIPA1L1;NTRK3;TIAM2;TBC1D16;DOCK7;BCR;SGSM2;ARHGAP24;BCAS3;GMIP;USP6NL;TBC1D2B;TBC1D8B;TBCK;GRTP1;TBC1D22B;TBC1D9;NGEF;TBC1D17;RALGAPB;TBC1D7;SIPA1L3;RABGAP1;TBC1D10A;RALGAPA2;SCRIB
prerank,microtubule depolymerization (GO:0007019),0.4727821354105078,1.2593535290300752,0.17555555555555555,0.5745279232967471,1.0,6/17,18.42%,STMN1;STMN4;STMN2;KIF19;STMN3;KIF18A
prerank,modulation by symbiont of host process (GO:0044003),0.5370355391163069,1.2593406064644277,0.19047619047619047,0.5730277275743623,1.0,6/10,19.01%,TLR2;RPS27A;UBC;UBB;B2M;HGS
prerank,nucleic acid metabolic process (GO:0090304),-0.35069374193939573,-1.2592469099531804,0.10970464135021098,0.4728909591920809,1.0,33/69,33.41%,RBFOX2;HNRNPH1;ENPP1;HNRNPR;WTAP;HNRNPM;HNRNPD;PCBP2;WRN;HNRNPK;DUSP11;XRN2;MMS19;HNRNPU;POLR2H;HNRNPA3;GTF2F1;DNASE2;POLR2K;POLR2E;RECQL5;NCBP2;PDE12;DNASE1L1;HNRNPL;POLR2D;KPNA2;LSM1;WDR74;PCBP1;RBMX;RAN;HNRNPA2B1
prerank,myelination in peripheral nervous system (GO:0022011),-0.5057958083740539,-1.2592103270579225,0.1865671641791045,0.47235579596453187,1.0,7/13,23.40%,DICER1;SKI;PARD3;LGI4;MYOC;ADGRG6;PRX
prerank,potassium ion import across plasma membrane (GO:1990573),0.39109556732290646,1.2592069150430358,0.13664596273291926,0.5718626673404347,1.0,13/41,13.66%,KCNJ3;KCNJ6;KCNJ11;SLC12A6;HCN2;KCNJ10;ATP1A3;KCNK9;SLC12A3;ATP1A4;ATP1A1;KCNJ8;ATP1B1
prerank,negative regulation of organelle assembly (GO:1902116),-0.402186564953396,-1.2589047790600068,0.13320079522862824,0.4724734534281287,1.0,13/35,22.31%,KAT2B;LRRK2;NUPR1;YAP1;SEC22B;CHMP4B;CHMP4A;SMAD4;ODF2L;FEZ2;CDK10;TBC1D7;TCHP
prerank,sensory perception of sound (GO:0007605),-0.3392609160038413,-1.2585566114904068,0.10039370078740158,0.47276374110096814,1.0,15/88,7.58%,EYA1;ROR1;COL1A1;COL4A3;CEMIP;CDC14A;TBL1X;KIT;GSDME;DCDC2;RIPOR2;EML2;ADGRV1;ATP6V0A4;CACNA1D
prerank,regulation of response to interferon-gamma (GO:0060330),-0.4979274817122193,-1.2580841357360943,0.1879432624113475,0.473302026780981,1.0,6/14,16.45%,PIAS1;JAK1;PTPN2;PARP9;STAT1;IFNGR1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.5194182401667311,-1.2574271266228043,0.1791044776119403,0.4736204960976629,1.0,2/12,4.06%,FHL2;GSK3B
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.5194182401667311,-1.2574271266228043,0.1791044776119403,0.4736204960976629,1.0,2/12,4.06%,FHL2;GSK3B
prerank,carbohydrate derivative transport (GO:1901264),0.46760799506905004,1.2573335970702404,0.1752136752136752,0.5756861774576469,1.0,7/18,18.73%,PLTP;MFSD2A;SLC15A3;CPTP;SCARB1;SLC15A2;VLDLR
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4427805278366805,-1.2573198060119049,0.16085271317829458,0.47323539880118487,1.0,6/22,13.79%,CCNT2;CCNT1;SCAF8;CCNK;CDK13;TCERG1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.45948082683877145,-1.2572362463110034,0.16888045540796964,0.4728213750783785,1.0,7/20,13.97%,WNT4;BMP5;WDTC1;ERLIN1;SIK1;FBXW7;SLC27A1
prerank,negative regulation of cell migration (GO:0030336),-0.31184088492648626,-1.2571794525187623,0.06573705179282868,0.472342336579026,1.0,24/137,8.47%,PHLDB2;SULF1;DPYSL3;COL3A1;AFDN;LRP1;DAG1;BMPR1A;VCL;LDLRAD4;TPM1;IGFBP5;FOXO3;ROBO1;JAG1;PODN;IGFBP3;CDH1;HOXA7;CLIC4;EPHA4;RECK;GJA1;PTPRK
prerank,intracellular protein transport (GO:0006886),-0.2844934994407825,-1.2569754319191784,0.029288702928870293,0.47221511304358754,1.0,109/304,26.38%,WLS;RANBP3L;APPL2;TRAK1;PKD1;TLK1;KIF13A;KIF13B;XPO4;TBC1D16;SGSM2;EIF4ENIF1;SNX9;FUT10;SEC23IP;SNX6;STAT3;STX16;RAB22A;VPS26C;STXBP1;SIL1;AP4E1;AP3B1;NUP42;LAMP2;USP6NL;COPZ2;SLU7;ARFGAP3;SEC31A;ARCN1;HERC2;TBC1D2B;BAG3;TBC1D8B;GGA3;RPGR;NUP214;IPO13;RPL11;GIPC1;COG7;STX4;ARFIP2;TPR;ARF1;APPL1;AP4S1;STX5;TBCK;SURF4;COPB2;GRTP1;CTTN;TBC1D22B;RAB21;TBC1D9;CTSA;DNAJC27;FAM91A1;COX18;SMURF1;SNX8;FAM53C;TMED3;WDR11;TBC1D17;NAPA;RANBP3;TMED4;TMED5;SNF8;DESI1;RABGAP1;TBC1D10A;RPAIN;AKT2;SEC16A;RAB24;IFT27;GGA2;STX17;STX8;IPO9;VPS26B;RABL3;CHP1;XPO5;TNPO3;NSF;ARL5A;PREB;XPO1;AP2A1;LMAN1;SAR1B;PPP1R10;USO1;SYK;STX12;PHB2;VPS45;RAB7A;RAB5A;NUP93;STX1A;TBC1D10B;CLIP3
prerank,lymphocyte differentiation (GO:0030098),-0.34892176900587724,-1.2569154812515688,0.11244979919678715,0.47175383727901815,1.0,21/68,22.74%,PBX1;LEPR;AXL;HDAC4;KIT;ITGB1;DCAF1;CEBPG;PTPN22;PTPN2;TCF3;CHD7;ITGA4;KLF6;PIK3CD;BLNK;RHOH;RABL3;VCAM1;GPR89B;GPR89A
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.498041666296621,1.256789091572185,0.17234468937875752,0.57567698722555,1.0,3/14,6.84%,TIRAP;HNRNPC;HNRNPA0
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.48925717025952387,-1.2567694497758286,0.18681318681318682,0.47150386593897864,1.0,6/15,20.32%,LRP1;PDPN;DPP4;FAP;DDR1;FGFR4
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.4133083296055702,-1.256756770625714,0.16853932584269662,0.4709194787101691,1.0,14/29,20.39%,TCF7L2;EP300;KMT2D;BCL9L;PYGO1;CREBBP;TRRAP;TLE4;TLE1;TCF7L1;HDAC1;TLE3;CDC73;TERT
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.4786990039296657,1.2565408128413496,0.16849015317286653,0.5748617347564194,1.0,2/16,4.98%,CADM1;IL12A
prerank,negative regulation of bone mineralization (GO:0030502),-0.5167149163646585,-1.256136215201241,0.187984496124031,0.471795566401617,1.0,7/13,33.03%,BCOR;ENPP1;TRPM4;ECM1;RFLNA;GREM1;SRGN
prerank,regulation of proteolysis (GO:0030162),-0.36818240370382305,-1.2557709002872943,0.12815533980582525,0.47204156919089896,1.0,21/48,31.88%,DNAJC1;CYFIP2;BTRC;PLAT;ASPH;SPOPL;OGT;TRAF3;FBXW11;FGFR4;TBC1D10A;PARL;PERP;HDAC2;BAG6;CLN8;BAK1;PLAUR;CAV1;LTBP4;CLN6
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.3895832390168261,1.255462150885361,0.13097713097713098,0.5764460300147699,1.0,8/35,4.59%,SEMA3C;PLXNB3;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,negative regulation of inclusion body assembly (GO:0090084),0.536191404496265,1.2553334105735015,0.18951612903225806,0.5753393733499627,1.0,4/10,16.65%,SACS;DNAJA4;SORL1;DNAJB2
prerank,digestive tract morphogenesis (GO:0048546),-0.4972472150782816,-1.2552413289249973,0.19092627599243855,0.47277196543720257,1.0,8/14,26.51%,PDGFRA;FGFR2;ID2;NIPBL;GLI1;RBPMS2;SOX11;EPHB3
prerank,positive regulation of nervous system process (GO:0031646),0.4519770354470745,1.2542579708734722,0.16632443531827515,0.5769307169161909,1.0,5/18,8.86%,RIMS1;RIMS2;TENM4;ATPSCKMT;TPPP
prerank,mitochondrial protein processing (GO:0034982),0.5285805625833728,1.2542447633485294,0.1965065502183406,0.5754556488696166,1.0,3/11,8.11%,OMA1;PMPCA;ATP23
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.47078924803545324,1.2530518094322702,0.17286652078774617,0.5773256169404171,1.0,2/17,4.98%,CADM1;IL12A
prerank,positive regulation of neuron projection development (GO:0010976),0.3373728958216125,1.253006484011789,0.08964143426294821,0.5759973565203229,1.0,21/85,10.02%,RIT2;LRP8;LRRC7;PLXNB3;S100A9;ITGA6;MAGI2;TOX;NTRK2;SCARF1;FUT9;ALK;NPTN;PLPPR5;TENM3;NDNF;SCARB2;STMN2;ZDHHC15;RELN;DAB2IP
prerank,fat cell differentiation (GO:0045444),-0.3648416275945289,-1.2529688989807701,0.1245136186770428,0.4775547972515883,1.0,24/57,27.91%,PID1;TCF7L2;SMAD6;EP300;BBS9;WNT5B;OSBPL8;OSBPL11;PPARGC1A;MED1;FAM120B;C1QTNF3;NR4A1;NR4A2;METRNL;AKT2;SENP2;MAFB;BSCL2;ZBTB7A;BBS4;CLIP3;ERAP1;BBS2
prerank,positive regulation of cartilage development (GO:0061036),-0.47303927344418206,-1.252927000528916,0.18482490272373542,0.47704409639466316,1.0,7/17,21.72%,SOX5;BMP4;ZBTB16;SOX6;BMP2;PKDCC;TAPT1
prerank,cilium assembly (GO:0060271),-0.281147760683214,-1.2525077068765471,0.037037037037037035,0.47737517273804686,1.0,84/296,21.60%,PARVA;GSN;PKD1;PCM1;ASAP1;GBF1;BBS9;CDC14A;ALMS1;WDPCP;DCDC2;ODF2;FLNA;NUDCD3;CYS1;ARL3;NINL;PIBF1;CEP63;IFT43;ATP6V0D1;PDE6D;ARL13B;CEP135;CFAP44;IFT81;CEP162;DYNC2I1;ABLIM3;PCNT;SPATA6;EHD2;MARK4;CSNK1E;RFX2;RAB3IP;FAM161A;IFT88;RPGR;RP2;EXOC2;IFT80;RAB11A;CC2D2A;POC1B;ARMC9;MAPRE1;C2CD3;TOGARAM1;CCDC39;SNX10;RILPL2;CDC14B;EHD3;YWHAE;DZIP1L;DYNC2LI1;AKAP9;CCDC57;DYNC1H1;CEP76;CCDC66;PRKACA;TCTN1;PTPDC1;WDR11;CFAP74;DYNLRB1;DYNC2I2;CEP57;CPLANE1;EHD4;RILPL1;CSNK1D;GORAB;AVIL;CEP89;TRIP11;NPHP1;GALNT11;TRAPPC14;KIFAP3;IFT27;HAUS7
prerank,regulation of macroautophagy (GO:0016241),-0.32271412892697365,-1.2520043640583793,0.09716599190283401,0.4780032689964349,1.0,17/105,11.12%,PRKAG2;DCN;SMG1;ATP6V1B2;PRKAA2;LRRK2;RPTOR;TBK1;ATP6V0D1;SNX6;UBQLN1;MTOR;LARP1;SESN1;RB1CC1;PRKAB2;PAFAH1B2
prerank,catecholamine metabolic process (GO:0006584),-0.5017417396267831,-1.2519914350910237,0.2049808429118774,0.477410308550438,1.0,3/14,8.39%,PRKN;SNCAIP;COMT
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.5360358197388002,-1.25185847905573,0.19699812382739212,0.47714230523327267,1.0,6/11,24.47%,DAB2;PRKN;RAB21;EIPR1;MSN;PTPN23
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3339892159369585,-1.2518221262607778,0.10789980732177264,0.47662772916769414,1.0,19/86,15.52%,BMP6;IGF1;EGFR;EPHA7;ANGPT1;GHR;ABL1;VTN;PAK2;NRP1;IGF2;PRKCD;IL6R;TEC;VEGFA;PRKCZ;ACVR1;PDCL3;ITGA5
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.5196291664273353,1.2516937612812298,0.19957537154989385,0.578203621040876,1.0,4/11,16.46%,EXOSC5;FBL;DKC1;EXOSC4
prerank,actomyosin structure organization (GO:0031032),-0.33811917613170905,-1.2512435961509212,0.08969465648854962,0.47741250913819194,1.0,16/75,12.51%,ROCK2;PHACTR1;SORBS1;FRMD6;TPM1;EPB41L5;EPB41L2;ROCK1;ITGB1;TMOD3;ITGB5;ACTN2;TNFAIP1;RHOA;ZYX;CUL3
prerank,mitochondrion localization (GO:0051646),-0.45523871485674366,-1.2502782490330593,0.16666666666666666,0.47919872476546976,1.0,9/19,28.11%,TRAK1;LRRK2;MEF2A;NECTIN2;ZBED3;MARK1;BRAT1;MFN2;MUL1
prerank,serine family amino acid biosynthetic process (GO:0009070),0.5058806843837849,1.249772947766089,0.19402985074626866,0.5822048563141414,1.0,7/12,20.35%,SEPHS2;PHGDH;MTHFD1;GGT1;SEPHS1;SERINC3;SRR
prerank,regulation of actin filament polymerization (GO:0030833),-0.3452397343438894,-1.2494297275267392,0.11650485436893204,0.4806662746288821,1.0,35/69,30.22%,FCHSD2;ARHGAP28;BAIAP2L1;SNX9;ARFGEF1;PLEKHG2;VASP;FER;CDC42EP5;PRKCD;NCKAP1;CTTN;LATS1;NCK1;ARHGAP18;RASA1;NCK2;CARMIL1;MYADM;CDC42EP4;LMOD1;BAIAP2;CDC42EP1;HIP1R;SLIT2;GBA2;ABITRAM;KANK1;TWF2;TWF1;SSH3;SSH2;KANK4;PFN2;ARF6
prerank,negative regulation of protein modification process (GO:0031400),-0.3387459053491291,-1.2493277733784582,0.1062992125984252,0.4802420515587285,1.0,13/79,4.75%,PTPN13;PID1;LRP6;NTRK3;PLPP3;FBLN1;PRKN;PRKAA2;LRRK2;IBTK;GSK3B;SNTA1;IGFBP3
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.3614821033330375,-1.2491850547995618,0.15257731958762888,0.47998168200318114,1.0,23/52,28.30%,SAMD4A;PAN3;DDX6;RC3H1;TUT4;DCP1A;CNOT8;DCP1B;EDC3;EXOSC9;PAN2;CNOT2;CNOT1;CNOT10;EXOSC3;CNOT4;LSM6;PNLDC1;PDE12;TNKS1BP1;DIS3;POLR2D;PARN
prerank,aortic valve development (GO:0003176),-0.39849249053243835,-1.2489727513483944,0.16453382084095064,0.47986766421498606,1.0,7/34,3.17%,ROCK2;SMAD6;BMP4;ROCK1;ROBO1;ELN;JAG1
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.3729500980823738,-1.2487811601157928,0.12641509433962264,0.4797631289543786,1.0,17/44,22.75%,GSN;FCHSD2;BAIAP2L1;SNX9;VASP;FER;CDC42EP5;NCKAP1;CTTN;NCK1;WHAMM;NCK2;CARMIL1;CDC42EP4;LMOD1;BAIAP2;CDC42EP1
prerank,regulation of cell-cell adhesion (GO:0022407),0.38395309230698704,1.2485802247954323,0.1402805611222445,0.5841628079318707,1.0,10/39,12.00%,PTPRG;PTPRR;PODXL;MAGI1;FERMT3;FUT9;TENM3;CELSR2;MEGF10;SMAD7
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.44167303297761473,1.248545253781202,0.16738197424892703,0.5827612650489908,1.0,5/23,11.60%,KIF1A;HOOK1;MAP6D1;MYO10;CCDC88A
prerank,calcium ion transmembrane transport (GO:0070588),0.33367177059254777,1.248457398265989,0.10526315789473684,0.5815195220591073,1.0,17/86,8.51%,SLC24A4;SLC24A2;CACNA1A;GRIN1;TRPC5;GRIN2A;CACNA2D1;RYR3;GRIN2B;GAS6;GRIN2D;SLC8A1;ATP2B3;SLC25A23;TRPM2;PMPCA;MCOLN2
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.49218537118435096,1.2483266688328658,0.19873150105708245,0.5803977917022021,1.0,1/15,0.33%,PLTP
prerank,regulation of exosomal secretion (GO:1903541),-0.46362451708825647,-1.2482603869894544,0.1839080459770115,0.4804588113533681,1.0,8/19,25.59%,PRKN;VPS4B;CHMP3;SDC4;SNF8;ATP9A;RAB7A;SDC1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.3632897300124435,-1.2481217484747427,0.1377952755905512,0.4801811695792187,1.0,9/52,5.16%,EGFR;SORBS1;LRP1;EPHA3;EPB41L2;NUMA1;PTPN9;DLG1;ITGB1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4989965963723964,-1.2474384357376038,0.19305019305019305,0.4812254241769438,1.0,4/14,10.29%,ANKRD17;PUM2;PUM1;DDX60
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.5381234609747458,-1.2467192723027096,0.2045028142589118,0.48240413436518476,1.0,3/10,10.38%,MYO9A;CDC42;RHOA
prerank,positive regulation of calcium ion transport (GO:0051928),0.38448972168883894,1.246531957223264,0.14344262295081966,0.5841600724124004,1.0,8/36,11.32%,CAMK2A;GRIN1;CXCL12;CACNB2;CCL2;PDGFB;F2R;P2RX7
prerank,regulation of interleukin-17 production (GO:0032660),0.40131323760099263,1.2461636017979274,0.17540322580645162,0.5837702319070036,1.0,4/31,11.97%,SLC7A5;IL12A;PRKCQ;RFTN1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5252414323921153,1.2459160799293043,0.2219730941704036,0.5829393220242254,1.0,3/10,8.99%,PODXL;FERMT3;SKAP1
prerank,gas transport (GO:0015669),0.5415353756731831,1.2458965787293033,0.20945945945945946,0.5815039734775451,1.0,2/10,9.20%,CA2;MB
prerank,ion transport (GO:0006811),0.3250341949811271,1.2452948420145082,0.08641975308641975,0.5816928637115565,1.0,20/111,11.07%,SLC24A4;SLC24A2;GRIN1;SLC4A1;GABRB1;GLRA1;KCNN2;AQP11;SLC17A6;SLC15A3;SLC1A1;SLC8A1;SLC12A6;KCNN1;SLC1A2;KCNN3;SLC12A3;SLC36A1;VDAC2;ATP1A4
prerank,regulation of DNA metabolic process (GO:0051052),-0.3733314136370098,-1.245184590542072,0.13450292397660818,0.48555197302556713,1.0,10/44,12.75%,SMG6;HDAC8;UBE2N;SMG1;NBN;YLPM1;HNRNPD;UPF1;MPHOSPH8;KDM1B
prerank,positive regulation of macrophage activation (GO:0043032),-0.47591214669608606,-1.245174938797396,0.1987704918032787,0.48494705328215265,1.0,6/17,19.94%,LBP;THBS1;TNIP2;TLR4;WNT5A;KARS1
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.3469823999446907,-1.2447894629066585,0.13688212927756654,0.48523919841307056,1.0,23/66,21.62%,ZIC1;SMAD3;FLNA;YAP1;UBR5;CCT6A;CDH1;EIF2AK3;JUP;BAG3;PRKCD;PARP9;MAVS;TPR;CCT8;DTX3L;CCT5;EFCAB7;PARK7;TERT;ORMDL3;CDK5RAP3;PIK3R1
prerank,neuron remodeling (GO:0016322),0.5256398871273642,1.2444226368391529,0.21145374449339208,0.582732212915151,1.0,2/10,5.08%,ADGRB3;SCARF1
prerank,regulation of trophoblast cell migration (GO:1901163),-0.49584234674455907,-1.2443420469978737,0.17938931297709923,0.4857610160045044,1.0,5/14,14.35%,SMURF2;YTHDF3;GJA1;ARHGDIB;VEGFA
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.3367315546348189,1.2428729254950928,0.12578616352201258,0.5854389461502806,1.0,36/87,21.57%,OMA1;NDUFC1;CHCHD4;NDUFA1;NDUFAF5;NDUFA2;TIMM21;NDUFC2;COA5;DMAC2;FASTKD3;COX16;NDUFA3;NDUFA13;TMEM126A;DMAC1;NDUFB2;NDUFAF1;COX17;ECSIT;BCS1L;NDUFB9;UQCC3;NDUFA7;NDUFAB1;NDUFAF6;NDUFA12;NDUFB8;COA3;OXA1L;NDUFB4;NDUFA10;NDUFS3;SCO1;NDUFA6;NDUFB7
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.4077087863504081,1.242812892099388,0.17364016736401675,0.5841489546811419,1.0,10/30,14.43%,DACH1;HNRNPC;TERF1;ACVRL1;TEN1;PIF1;MEN1;BMPR2;TINF2;CDKN1A
prerank,pyroptosis (GO:0070269),-0.48402744985725155,-1.2425704751298723,0.20161290322580644,0.48948355498454055,1.0,4/15,18.88%,GSDME;DHX9;GSDMD;APIP
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5405002352058598,1.2424558834045683,0.19658119658119658,0.5836291133097504,1.0,3/10,10.21%,SIRT1;SNCA;SET
prerank,protein localization to cilium (GO:0061512),-0.3994554111754862,-1.2420063425365628,0.17032967032967034,0.49019673162394806,1.0,17/32,33.48%,ZNF423;BBS9;ARL3;TULP3;SNX10;TCTN1;INVS;CSNK1D;IFT140;TTC21B;BBS4;IFT122;RABEP1;EHD1;TULP1;WDR35;TMEM107
prerank,hepaticobiliary system development (GO:0061008),-0.4469097973995963,-1.2419651858296208,0.1724137931034483,0.48967130278834026,1.0,8/20,16.51%,TGFBR3;WNT4;CEBPG;PHF2;NIPBL;ARID5B;PKD2;CITED2
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.45214558568310925,-1.2417960307851277,0.17921146953405018,0.4888699635223218,1.0,8/20,24.39%,ACADSB;IVD;HIBCH;MCCC2;ALDH6A1;BCKDK;HIBADH;AUH
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.45214558568310925,-1.2417960307851277,0.17921146953405018,0.4888699635223218,1.0,8/20,24.39%,ACADSB;IVD;HIBCH;MCCC2;ALDH6A1;BCKDK;HIBADH;AUH
prerank,negative regulation of cell population proliferation (GO:0008285),-0.2738292722349914,-1.2415601606076914,0.03054989816700611,0.48882359559045685,1.0,100/351,20.76%,TGFBR3;ALDH1A2;ZBTB7C;APPL2;KANK2;SMAD6;IGFBP5;CELF1;COL4A3;FBLN1;MDM4;BMP5;DIS3L2;KAT2B;BMP4;PDPN;PPM1D;PTPN14;TNS2;PODN;BRD7;FRK;NUPR1;LMNA;GSDME;CLMN;VGLL4;NIBAN2;RBP4;IGFBP3;RARG;TGFB1I1;OGN;IGFBP6;SKI;SPEG;TMEM127;NOX4;LYN;TES;REST;PARP10;P3H3;WNT9A;AR;PTPRK;MAP2K1;BTG3;MN1;NGF;CCN3;CYP1B1;PTPN2;COL18A1;ABI1;HES1;PDS5B;PKD2;IRF1;FKTN;COPS8;ATRAID;RBM5;FAP;CD164;APOD;ING5;EIF2AK2;ROR2;CBFA2T3;RAPGEF2;EMD;IGFBP7;DUSP10;MNT;PLXNB1;NCK2;TGFB3;ADAMTS1;S100A11;ARID2;SOD2;PPP2R5C;FGFBP1;MORC3;IFI35;WNT5A;BMP2;SFRP4;INHBA;B4GALT7;CDK10;PBRM1;PML;CDC73;IFIT3;CDKN1C;NME1;NF2;ZBTB49
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.41621592502207455,-1.2414041873094226,0.17726396917148363,0.48855497448898294,1.0,13/29,22.83%,VTI1A;VTI1B;COPB1;COPZ2;COG3;GOSR1;COPB2;COPG2;GOSR2;NAPA;COPG1;COPE;NSF
prerank,secretory granule organization (GO:0033363),-0.5305250803341921,-1.2413972518008685,0.21739130434782608,0.4879493942812445,1.0,2/10,6.46%,ABCA1;DTNBP1
prerank,liver development (GO:0001889),-0.39919961861395087,-1.2413739302591813,0.1601642710472279,0.4874007919978939,1.0,12/32,21.53%,TGFBR3;WNT4;ANXA1;CEBPG;PHF2;ARID5B;PKD2;PCK2;CCDC39;CITED2;ZIC3;CDK5RAP3
prerank,dendritic spine morphogenesis (GO:0060997),0.4779897935939257,1.2408347034303608,0.19583333333333333,0.586635821422476,1.0,3/15,3.17%,EPHB1;CTNND2;SHANK3
prerank,protein localization to centrosome (GO:0071539),-0.4639619934028458,-1.2406023711341254,0.19850187265917604,0.48869616996561205,1.0,7/17,13.79%,PCM1;NUDCD3;PIBF1;GOLGB1;CCDC14;C2CD3;SNX10
prerank,response to nutrient levels (GO:0031667),-0.46421627707114665,-1.2403624627101588,0.17407407407407408,0.4886951601681844,1.0,7/17,22.14%,PRKAA2;RPTOR;MTOR;FAM107A;PRKAA1;EIF4G1;KCNB1
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.34981654698599796,-1.2402207603767346,0.12625250501002003,0.48840598928004997,1.0,30/63,28.53%,TIMP3;LEPR;EIF4G3;ROCK1;NUPR1;ZKSCAN3;STAT3;BCL2;MTOR;PTPN3;FOXK1;PTPN22;EIF4E;ATRAID;KLHL22;FOXK2;RUBCN;DAP;EIF4G1;TIMP2;BMF;CDK5RAP3;RGP1;DAPL1;WDR6;RRAGA;HGF;MET;RIC1;MT3
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.3254386932235606,-1.2399312845566925,0.10743801652892562,0.48858130780928694,1.0,22/88,19.39%,SAMD4A;NFKB1;IGFBP5;DNAJC1;SYNCRIP;PLAT;DDX6;EIF4ENIF1;EIF2AK3;LARP1;DHX36;LSM14A;CNOT8;YBX1;ATRAID;EIF2AK2;APOE;DDX3X;DAPK1;CNOT1;CNOT10;RBM4
prerank,diol metabolic process (GO:0034311),0.4508937139315377,1.2393156837309396,0.19271948608137046,0.5895564802307672,1.0,9/19,18.03%,DEGS2;NOS3;PRKG2;SGPP2;AKT1;CALM1;GCH1;HSP90AA1;SGPP1
prerank,neuron projection regeneration (GO:0031102),-0.5347159145826412,-1.2391600185764156,0.2049808429118774,0.48980468173746816,1.0,2/10,1.86%,PTN;NREP
prerank,regulation of axonogenesis (GO:0050770),0.36213994508041325,1.2389456147794473,0.1351931330472103,0.5891688197257188,1.0,16/51,11.03%,LRRC4C;MAG;PLXNB3;MCF2;CDH2;NTRK2;THY1;EFNB3;OMG;PAK1;LINGO1;ROBO2;PLXNA4;RTN4R;CHN1;BRSK2
prerank,dendritic cell differentiation (GO:0097028),0.42638251248713654,1.2382975720223548,0.19196428571428573,0.5896472019344503,1.0,5/22,7.21%,GAS6;CAMK4;FLT3;TRPM2;BATF2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.4588037460498043,-1.2382318124918879,0.16766467065868262,0.49144000324170845,1.0,10/17,33.23%,FGF1;MBTPS2;ERLIN1;APOE;MBTPS1;PRKAA1;LPCAT3;SCAP;SREBF1;RAN
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.4016286367142549,-1.2381583530407057,0.1755424063116371,0.4910240575763581,1.0,5/31,1.51%,TGFBR3;TGFBR1;BMPR1A;TPM1;RBPJ
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5300532465025121,1.2376744930879284,0.2156398104265403,0.589866580980041,1.0,3/10,11.95%,DLGAP1;DLGAP2;NPTX1
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.4841195582952941,-1.2375226662390728,0.2011173184357542,0.49192376703034496,1.0,10/16,23.10%,ANK2;GBF1;LRRK2;BCAP29;UBAC2;MIA3;SEC16B;SEC16A;TAPT1;VAPA
prerank,positive regulation of axon extension (GO:0045773),0.43658828013579676,1.2374992656090873,0.16923076923076924,0.5889045349486578,1.0,5/22,10.17%,DSCAM;SEMA7A;SHTN1;CDKL5;NTN1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.4194419311292931,-1.237364888365883,0.17533718689788053,0.4916638564507086,1.0,6/26,11.36%,PRKAG2;PRKAA2;WDTC1;NR1H3;PRKAB2;ERLIN1
prerank,visual perception (GO:0007601),-0.3320406304068483,-1.2367209952886908,0.11798839458413926,0.49263601594607725,1.0,20/84,18.21%,EFEMP1;COL1A1;OPA1;EYA4;ZIC2;SLC4A10;MYO9A;EML2;ADGRV1;DHRS3;PITPNA;RPGR;RP2;COL18A1;ATF6;IMPG2;OAT;ATXN7;POU6F2;RABGGTB
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.4552997715152749,-1.2367017033077574,0.19962686567164178,0.49208021877464336,1.0,7/19,16.91%,WNT4;VIM;BMP4;RUNX1;EMILIN1;TGFB3;SUCO
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.4465596827712679,-1.236649346460568,0.1776937618147448,0.4915833804973505,1.0,10/20,21.47%,RBPJ;EP300;HIF1A;SMAD4;VEGFA;CARF;RUNX2;BMP2;SMAD9;SMAD1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.4632599919760335,-1.2366315135039214,0.19083969465648856,0.49101551940504856,1.0,9/18,33.12%,GSK3B;ACAA2;TMEM14A;ZNF205;HIP1R;MUL1;CHCHD10;BAK1;HSPA1A
prerank,modulation by host of viral genome replication (GO:0044827),-0.5015512596211278,-1.236371971188913,0.2018867924528302,0.49108823708358157,1.0,6/13,23.10%,PRKN;CCNK;TBC1D20;EIF2AK4;IFI27;VAPA
prerank,vasculature development (GO:0001944),-0.4724506363644378,-1.2362347923813077,0.19553072625698323,0.49084305437115183,1.0,3/16,2.55%,ERRFI1;PDGFRA;PDGFRB
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.4659818990493204,-1.2359125139433422,0.1791907514450867,0.4910406800103011,1.0,12/18,34.76%,ABL1;POR;ABL2;AGTR1;RFK;PARK7;FXN;SIRT3;EDN3;GDNF;ATP7A;PDP2
prerank,positive regulation of neuron migration (GO:2001224),0.519316227149275,1.2356176700547652,0.21914893617021278,0.592849956060723,1.0,4/11,10.02%,SEMA6A;SHTN1;ARHGEF2;DAB2IP
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5393996002870781,-1.2355578519265908,0.22621184919210055,0.4913375947782537,1.0,4/10,16.23%,ATP1A2;VDAC1;YWHAE;ADRA2A
prerank,negative regulation of neurogenesis (GO:0050768),0.39752713696443526,1.2350323727951291,0.1649048625792812,0.5930851287541168,1.0,12/34,14.95%,MAG;MCF2;THY1;EFNB3;OMG;NOTCH1;LINGO1;RTN4R;SORL1;B2M;RTN4;GDI1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.43114702416391887,1.2350318224786918,0.18025751072961374,0.591635368410609,1.0,8/23,15.81%,FAR2;ELOVL7;DGAT2;TECR;ACOT7;HACD1;FAR1;ACSL3
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.4761174907968675,-1.2347205751803132,0.20072992700729927,0.4927446229286101,1.0,5/16,9.99%,CHMP4B;CHMP4A;CHMP5;LEPROTL1;LEPROT
prerank,regulation of gluconeogenesis (GO:0006111),-0.42393529018290743,-1.2346616337533036,0.17578125,0.49228637384839474,1.0,10/27,15.24%,EP300;USP7;PPARGC1A;CLK2;SELENOS;PTPN2;ZNF692;SIK1;OGT;C1QTNF3
prerank,telomere maintenance via recombination (GO:0000722),-0.514415280878322,-1.2344247308039755,0.20934579439252338,0.4922926709595869,1.0,4/11,11.57%,SMC6;NSMCE2;SMC5;RAD51D
prerank,response to peptide hormone (GO:0043434),-0.3745553636630144,-1.233961435057592,0.16666666666666666,0.49285233046808163,1.0,13/43,18.04%,ROCK2;TGFBR3;IGFBP5;ROCK1;IRS1;STAT3;ANXA1;OGT;SLC27A1;STAT1;ZBED3;STAT5A;STAT5B
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.5385691464211902,-1.2339027022972913,0.22986247544204322,0.4923898008904745,1.0,6/10,26.57%,DHX36;CPEB1;CDC73;HSF1;NUDT21;NCBP2
prerank,negative regulation of reproductive process (GO:2000242),-0.46771836139031875,-1.233684122677059,0.20038910505836577,0.4923362307366766,1.0,5/17,14.28%,SULF1;IGF1;GJA1;ARHGDIB;DUSP1
prerank,Golgi ribbon formation (GO:0090161),-0.5042882819560567,-1.2335218876954848,0.17836812144212524,0.4921402265532621,1.0,6/13,20.77%,VTI1A;STX16;PRMT5;VAMP4;TMED5;TRIP11
prerank,regulation of fibrinolysis (GO:0051917),-0.4993409778326926,-1.2333942502903557,0.21161048689138576,0.4918328224200188,1.0,4/13,21.65%,THBS1;FAP;SERPINE1;USF1
prerank,regulation of spindle assembly (GO:0090169),-0.4249576233325377,-1.2327178478010081,0.16634799235181644,0.49287723229328584,1.0,10/25,20.81%,NUMA1;VPS4B;SENP6;CHMP4B;CHMP5;CHMP3;TPR;DYNC1H1;HNRNPU;EML3
prerank,establishment of spindle orientation (GO:0051294),-0.4060686655266542,-1.2321521505550501,0.16945996275605213,0.4937219755536148,1.0,6/28,8.55%,NUMA1;MAP4;UBXN2B;ITGB1;GJA1;NDEL1
prerank,cellular response to organic substance (GO:0071310),-0.30732302726202276,-1.2321419220152938,0.09109311740890688,0.4931473985335711,1.0,24/116,10.38%,PTPN13;DPYSL3;NFAT5;PID1;SMAD3;TGFBR1;BMPR1A;IGFBP5;GHR;PTPN14;TGFBR2;LRRK2;TBK1;CLEC3B;PTPN9;STAT3;ASAH2;SHC1;RAMP1;NCOA1;PTPN12;CYP1B1;PTPN2;RHOA
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.47720891269593424,-1.2321162692316179,0.1947069943289225,0.4926045818577524,1.0,7/16,13.59%,TGFBR3;IGF1;BMPR1A;RBPJ;FGFR2;MEF2C;GLI1
prerank,ephrin receptor signaling pathway (GO:0048013),0.33245777646302416,1.2320483770394794,0.1194331983805668,0.598838706696978,1.0,23/82,14.57%,GRIN1;ANKS1B;ACTB;EPHA6;EPHB1;GIT1;EPHA5;VAV3;AP2M1;GRIN2B;EFNB3;PSENEN;PAK1;EFNA2;EPHA10;AP2B1;CHN1;KALRN;EPHA1;PSEN1;HRAS;PAK3;ARHGEF7
prerank,negative regulation of wound healing (GO:0061045),-0.4128997741713849,-1.2317671659770575,0.15828677839851024,0.4929035792646958,1.0,7/28,17.05%,PHLDB2;VTN;TFPI;SLC12A2;CD109;APOE;SERPINE1
prerank,regulation of insulin secretion (GO:0050796),-0.32018988335738624,-1.2317521599394088,0.07539682539682539,0.4923392956195794,1.0,18/101,7.63%,ITPR1;CACNA1C;TCF7L2;ITPR2;ADCY5;MCU;PRKN;NLGN2;RBP4;IRS1;CDK16;DPP4;STXBP4;GLUD1;REST;RAPGEF3;CACNA1D;NNAT
prerank,regulation of monooxygenase activity (GO:0032768),0.43317264265294997,1.2316428864015139,0.19017094017094016,0.59854793255061,1.0,9/23,18.18%,NOSTRIN;SNCA;NOS3;LYPLA1;AKT1;CALM1;HSP90AA1;DDAH1;NOSIP
prerank,brain development (GO:0007420),0.31117724741012337,1.2314463010068393,0.07468879668049792,0.5976385045434679,1.0,26/136,11.10%,ADGRL3;CNTNAP2;GRIN1;CTNNA2;SLC6A17;PROX1;PBX2;GRIN2A;CDH2;SHANK3;PAX2;GRIN2B;MFSD2A;GRIN2D;AATK;PITPNM1;DSCAML1;ROBO2;UBE3A;ADGRL2;RELN;PHGDH;FOXJ1;SPEF2;HAP1;CNTN4
prerank,antibacterial humoral response (GO:0019731),0.4601615792392685,1.2313029418994852,0.19213973799126638,0.5965932578276064,1.0,4/16,21.01%,SLPI;DEFA6;RNASE3;RNASE7
prerank,RNA stabilization (GO:0043489),-0.3941311157059559,-1.2309071246923795,0.15860735009671179,0.49374287295389674,1.0,11/33,18.35%,TENT2;EIF4ENIF1;FUS;LARP1;DHX36;PHAX;YBX1;NSUN2;HNRNPU;TENT5A;PAIP1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.33618866145375165,1.2305158270806826,0.1165644171779141,0.5974521798918433,1.0,19/76,15.25%,GRM5;GRM1;HTR2C;TACR1;GPR35;P2RY1;HOMER1;GPR17;ADRA1D;ADRA1A;TRHR;OPRM1;F2RL2;F2R;GRPR;OPRK1;CCKBR;CHRM2;OPRL1
prerank,regulation of presynapse assembly (GO:1905606),0.4549218639086678,1.2304478613069525,0.20495495495495494,0.5947693255141732,1.0,6/18,8.35%,PTPRD;LRFN5;IL1RAPL1;SNCA;LRRC4B;IL1RAPL2
prerank,regulation of presynapse organization (GO:0099174),0.4549218639086678,1.2304478613069525,0.20495495495495494,0.5947693255141732,1.0,6/18,8.35%,PTPRD;LRFN5;IL1RAPL1;SNCA;LRRC4B;IL1RAPL2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.42679129513544617,-1.2302903432097902,0.1830188679245283,0.49459051315440694,1.0,10/25,15.50%,CACNA1C;ANK2;DLG1;CXADR;CAMK2D;JUP;ATP2A2;TBX18;TRPM4;AKAP9
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5236435422093664,-1.2298756627093066,0.21062618595825428,0.49500064170933555,1.0,2/11,5.31%,BMPR1A;THBS1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.43743578093445573,-1.2296647330013757,0.19128787878787878,0.4949174242148329,1.0,8/23,15.24%,EP300;HDAC4;NCOR1;NUPR1;CLK2;SIK1;CBFA2T3;C1QTNF3
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.5217335376443772,-1.22950724752296,0.20348837209302326,0.4946709640169133,1.0,5/11,25.98%,COA8;SLC30A10;ABCD2;PARK7;PPARA
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.4172146226345782,-1.2293305501947847,0.19428571428571428,0.4945339280142756,1.0,14/25,31.16%,SRSF10;SF3B1;PRPF6;SLU7;PRPF3;SCAF11;SF3A3;DDX23;GEMIN2;SRRM1;PRPF8;MPHOSPH10;LSM1;SF3B4
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.4745160896819067,-1.2287718591591166,0.20784313725490197,0.49533547598513117,1.0,5/15,13.57%,EGFR;RBPJ;FER;PTPN12;RHBDF1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.4909632123514753,-1.2287305068604555,0.21372549019607842,0.4948465481905476,1.0,3/13,7.12%,IGF1;SOAT1;RAMP1
prerank,regulation of microtubule-based process (GO:0032886),-0.3843493104707151,-1.227951820231315,0.17790262172284643,0.49608098418155777,1.0,6/36,4.06%,PHLDB2;EPHA3;DIAPH1;ROCK1;PRKAA2;GSK3B
prerank,regulation of heart contraction (GO:0008016),-0.32370257085905724,-1.2275675866973825,0.10276679841897234,0.49639325625568415,1.0,26/90,21.29%,ATP1A2;ITPR1;CELF2;STIM1;ANK2;ITPR2;TPM1;TMEM65;ASB3;CAMK2D;ASPH;DMPK;ATP2A2;ATP2B1;SRI;P2RX4;TBX2;PRKACA;NPR2;SLC8A3;ATP1B3;ATP2A3;NOS1;S100A1;DES;AHCYL1
prerank,mRNA polyadenylation (GO:0006378),-0.4187073985651737,-1.2272181412457248,0.19011406844106463,0.4960118260956382,1.0,10/26,21.29%,TENT2;WDR33;PCF11;SCAF8;CPSF3;SSU72;PAPOLG;CSTF3;CDC73;AHCYL1
prerank,RNA polyadenylation (GO:0043631),-0.4187073985651737,-1.2272181412457248,0.19011406844106463,0.4960118260956382,1.0,10/26,21.29%,TENT2;WDR33;PCF11;SCAF8;CPSF3;SSU72;PAPOLG;CSTF3;CDC73;AHCYL1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.369700112406367,-1.2268030751145433,0.14396887159533073,0.49643950487156185,1.0,13/47,15.24%,ROCK2;NFKB1;WNT4;EP300;PTGIS;WDTC1;CLK2;ERLIN1;SIK1;FBXW7;SLC27A1;RAPGEF2;C1QTNF3
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.512645860815186,-1.2255758516884872,0.2058287795992714,0.4988433203633058,1.0,2/12,0.79%,NOTCH2;DOCK11
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.3274419950773751,-1.2254392785149006,0.11937377690802348,0.49860503704108033,1.0,17/80,17.26%,SAMD4A;ROCK2;PLD1;VIM;ZCCHC4;YTHDF3;THBS1;MTOR;EPHA4;HNRNPD;PLXNB2;PRKCD;PRKDC;DDX3X;IFNGR1;UPF3A;PICALM
prerank,ameboidal-type cell migration (GO:0001667),0.35387681206295996,1.2248755857280136,0.1722689075630252,0.6095834300823684,1.0,10/51,7.85%,ERBB4;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A;PKN1;AKT1
prerank,regulation of intracellular signal transduction (GO:1902531),-0.2701799875446558,-1.2248707185431476,0.038135593220338986,0.49936203729324985,1.0,121/420,20.93%,AKAP13;PTPN13;PRKAG2;ARHGAP29;EGFR;ARHGAP10;ARHGAP6;RHOQ;NTRK3;ZFAND6;ARHGAP28;ARAF;MDM4;ITGAV;FGF1;ARHGAP20;EP300;STK3;TIAM2;PRKAA2;WWC2;ARHGEF17;LRRK2;ARAP1;BRD7;RBBP8;RHOJ;MYO9A;AKAP12;NRK;TAF3;MAPKAP1;INPP5B;BCR;DLG1;USP7;ARHGAP24;LBH;PAK2;NBN;UFL1;TMBIM4;TMEM127;TAOK3;GMIP;MAP4K4;LYN;ARHGAP21;MTOR;PLEKHG2;PDPK1;CDC42;PIP4K2C;WRN;VAV2;TTI1;TAF4;TBP;ARHGAP17;XIAP;PTPN22;HIPK1;CHD4;CHD3;TRIP10;TRAF2;RHOA;RPL11;RHOT1;PRKAB2;ARHGEF12;ARHGEF18;RCN3;WWC1;SOS2;TELO2;ARHGAP32;CASTOR2;FGD1;RASSF2;RICTOR;TBCK;EHMT1;ARHGDIB;ING5;USP2;VEGFA;FGD4;HDAC1;TAF13;ARHGAP18;CSNK2A1;NGEF;NOP53;MRE11;TRAF3;ARHGEF11;ARHGEF6;PRMT5;TTC5;CMKLR1;TRIO;DAPK2;ARHGEF1;PRKAA1;PPP2R5C;RHOH;TRAF6;WNT5A;ARHGAP15;MYOC;RHOC;CDK2;MAP2K6;PML;KMT5A;TAF12;PRKAG3;GPAT3;NF2;ARHGAP12
prerank,positive regulation of ERAD pathway (GO:1904294),-0.4813762413204979,-1.2248166241329308,0.21626617375231053,0.4988876862240525,1.0,8/13,30.91%,UBQLN1;RNFT1;TMEM259;USP13;BAG6;CAV1;NFE2L2;HERPUD1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.5291777386342004,-1.2247471946194088,0.21696252465483234,0.498479394284423,1.0,3/10,7.00%,DCN;LRRK2;BCL2
prerank,autophagosome assembly (GO:0000045),-0.35506767797638833,-1.2247134993195674,0.14800759013282733,0.49795786548582405,1.0,24/52,27.49%,UBXN2B;UBQLN1;RB1CC1;ULK2;WIPI1;ATP2A2;BECN1;ATG2A;PIK3C3;SMURF1;ATG9A;WDR45B;ATG2B;ATG5;AMBRA1;WIPI2;STX17;ATG14;MAP1LC3A;STX12;IRGM;RAB7A;MFN2;ATG3
prerank,ribosomal large subunit assembly (GO:0000027),0.4154560417262929,1.2243057080003552,0.19047619047619047,0.609702609945763,1.0,9/24,19.21%,RPF2;RPL10;RPLP0;RPL5;NOP2;RPL23A;MDN1;PPAN;RPL3
prerank,T cell activation (GO:0042110),-0.33849506271822477,-1.2242809828860746,0.13253012048192772,0.4983980057614993,1.0,19/69,23.53%,LEPR;KIF13B;KIT;CXADR;DPP4;PTPN22;PTPN2;EIF2AK4;CHD7;NCK1;NCK2;PIK3CD;CTPS1;RHOH;SCRIB;MSN;GPR89B;GPR89A;NLRC3
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.497905121132696,-1.2242713220813528,0.222007722007722,0.49783701477107684,1.0,5/13,26.27%,GFPT1;RENBP;UAP1;UAP1L1;PGM3
prerank,erythrocyte development (GO:0048821),0.5295269916767824,1.2235287408631141,0.22532188841201717,0.610552084069056,1.0,1/10,0.30%,ALAS2
prerank,cellular protein metabolic process (GO:0044267),0.26979021301878287,1.223302205265322,0.03804347826086957,0.6097843722217163,1.0,88/396,14.50%,ST8SIA4;RPS6;CHRM3;RPS19;OMA1;TMEM132A;RPS20;RPL38;RPL29;ST3GAL6;LCMT1;CDH2;RPL23;RPL17;RPL35A;RPL37;PHEX;QPCT;GAS6;SLC35A1;RPS27;PDIA6;RPL7;MRPS12;RPS12;RPS21;RPL10;RPL15;RPL10A;PSENEN;RPS24;RPL27A;RPS17;AMELX;RPS6KB2;RPS8;RPS16;RPS27A;RPLP1;RPL41;MELTF;RPLP0;RPL30;RPL7A;TIMP1;ATP23;MRPS18A;MSRB2;RPL12;MRPL13;RPL13;FBXL2;MRPS7;RPS15;FDX2;DAB2IP;MRPS14;RPL14;EIF4EBP2;SCG3;FARSB;VWA1;MEN1;SCG2;RPL5;PROC;RPS4X;RPL21;RPS7;SERP1;RPL23A;EEF1A2;CSNK1G3;RABGGTA;SPARCL1;VCAN;RPL8;MRPL36;MRPL23;RPS3;RPS14;VGF;PSEN1;RPS2;RPS5;EEF1A1;RPL18A;RPS28
prerank,protein localization to membrane (GO:0072657),0.29514612336875967,1.2230176117898284,0.08333333333333333,0.6091616472703392,1.0,30/187,9.24%,BSG;DLG2;DPP10;EFR3B;NRXN1;LRRC7;MRAP2;SPTBN4;KCNIP4;NLGN1;RAMP2;MAGI2;ANK3;RAB3C;SHANK3;FGF13;TNIK;LIN7A;MAP7;GAS6;THY1;NRXN2;DPP6;ZDHHC22;EPB41L3;P2RY1;CACNB2;ZDHHC15;TSPAN17;RAB40B
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3273480844794775,-1.2228935870900162,0.12361623616236163,0.5006098583103572,1.0,20/80,13.62%,DPYSL3;AUTS2;DOCK11;RHOQ;PLCE1;ARAP1;RIPOR2;WASF2;BCAS3;NRP1;BRK1;CDC42;NDEL1;MARK4;WASL;CDC42EP5;NCKAP1;RALA;ARPC2;P2RY12
prerank,cellular response to alkaloid (GO:0071312),0.4525094406333525,1.2226655892471807,0.2148936170212766,0.6087373942839379,1.0,3/17,4.67%,RYR2;RYR3;SLC8A1
prerank,response to chemokine (GO:1990868),-0.5053440141075498,-1.222544120437224,0.20670391061452514,0.5008769205425938,1.0,6/13,14.28%,FOXC1;RIPOR2;WNK1;SLC12A2;RHOA;DUSP1
prerank,positive regulation of protein catabolic process (GO:0045732),-0.3311527978425014,-1.222281790624997,0.1124031007751938,0.5009667486405454,1.0,23/84,18.81%,SMURF2;PRKN;WWP2;GSK3B;VGLL4;GPC3;HUWE1;AXIN1;SNX9;WWP1;SEC22B;DACT1;NRDC;ADAM9;STX5;APOE;SMURF1;CSNK2A1;ADRA2A;ASB5;VCP;WNT5A;AREL1
prerank,lipid droplet organization (GO:0034389),-0.4256124346982743,-1.2220903945998285,0.19454545454545455,0.5008659683553539,1.0,10/22,30.87%,RAB3GAP1;ZFYVE1;FAF2;AUP1;SQLE;CDS2;PPID;BSCL2;PLA2G4C;FITM2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.49997769935629033,-1.2220754235181341,0.22598870056497175,0.500306771693664,1.0,7/13,17.12%,TGFBR3;BMPR1A;RBPJ;FGFR2;MEF2C;GLI1;TBX2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.507662147746767,-1.2219962458177467,0.23434343434343435,0.4999486146241707,1.0,4/12,4.54%,DOCK5;TPM1;IGFBP5;DOCK7
prerank,positive regulation of kinase activity (GO:0033674),0.3167242482078872,1.2218956992473802,0.11359026369168357,0.6096073605384849,1.0,19/107,9.26%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;MMD2;EPHB1;TIE1;EPHA5;GAS6;KDR;NTRK2;FLT3;ALK;MAPRE3;ADCYAP1;EPHA10;RELN
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.44310662381460075,-1.2218386486538115,0.22075471698113208,0.4997503335136035,1.0,8/20,24.83%,HOXA5;ZBTB16;CTR9;HSPA9;CDC73;CDK6;MAFB;LDB1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.47708232486114754,-1.221761779328214,0.19884169884169883,0.4993281760071528,1.0,5/15,16.23%,SNX9;NRDC;ADAM9;APOE;ADRA2A
prerank,mRNA catabolic process (GO:0006402),-0.36931112144826284,-1.2212835458994094,0.14763779527559054,0.49988682694026687,1.0,21/44,33.62%,DDX5;DIS3L2;RC3H1;TUT4;UPF1;XRN2;XRN1;ERN1;EXOSC9;EXOSC10;CNOT10;AGO1;LSM6;PDE12;ZFP36L2;SUPV3L1;THRAP3;NUDT16;NUDT16L1;HSPA1A;MRTO4
prerank,chromatin organization (GO:0006325),-0.3105649599775019,-1.2212479525443234,0.10133843212237094,0.49937652575673824,1.0,51/132,28.46%,HDAC8;INO80;SETD7;BRWD1;KAT2B;HDAC4;SETD5;TOP1;EZH1;BAZ1A;BAZ2A;KDM4B;SMARCC2;NUDT5;KDM5B;MYSM1;ZBTB1;KDM6A;SETD2;HCFC1;MCM3AP;RB1;TCF7L1;SETDB1;EHMT1;PHF1;HDAC1;JARID2;SMARCD2;BAZ1B;TAF6L;HMG20A;BAZ2B;BPTF;CDAN1;PBRM1;PIH1D1;EZH2;HMGN3;HDAC2;SMARCD3;FAM50A;INO80C;ZBTB7A;SNAI1;ESR1;MPND;HDAC3;ATRX;SUPV3L1;SAFB
prerank,regulation of peptidase activity (GO:0052547),-0.4463460293191579,-1.2209093730192297,0.18216318785578747,0.4995894578600621,1.0,9/19,34.46%,CTSH;NRDC;RCN3;HDAC1;ECM1;PSMA3;CAV1;FURIN;PSMB8
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.3482235748246228,-1.220707079248593,0.14822546972860126,0.49951757405451275,1.0,14/60,10.86%,TCF7L2;NFKB1;CDK8;PPM1D;TNRC6B;TNRC6A;MED15;MOV10;MED17;MED26;MED12;DHX36;MED1;ATF7IP
prerank,spinal cord development (GO:0021510),-0.5055451313136687,-1.2204124807308567,0.23518850987432674,0.4995843886272305,1.0,5/12,16.34%,PKD1;GLI2;VIT;PKD2;LOXL3
prerank,negative regulation by host of viral process (GO:0044793),-0.5359053170459933,-1.2203395727746567,0.2300380228136882,0.49916121826699544,1.0,4/10,23.10%,PRKN;CCNK;EIF2AK4;VAPA
prerank,regulation of cytoskeleton organization (GO:0051493),-0.3148125950850876,-1.2201362903871982,0.1102514506769826,0.4990914643945505,1.0,38/108,24.97%,PHLDB2;ROCK2;RHOQ;LRP1;EPHA3;DIAPH1;PDGFRB;ROCK1;ABL1;PRKAA2;GSK3B;RND3;PAK2;MTOR;CLIC4;ARHGAP17;IQGAP2;RHOA;PRKCD;RHOBTB2;RICTOR;ARHGAP18;SORBS3;PLXNB1;FAM107A;RHOBTB1;PRKAA1;RHOH;RHOC;CDK10;SPEF1;BAIAP2;TAOK1;F11R;HIP1R;ARHGAP35;NEXN;ARHGAP44
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.26169431599857607,-1.220006847806913,0.01642710472279261,0.49880651610262206,1.0,121/509,19.31%,WLS;AKAP13;ROCK2;IGF1;EGFR;ROR1;LPAR1;SASH1;NFAT5;TCF7L2;GAB2;TGFBR1;PDGFRA;ANGPT1;NTRK3;PELI2;LIMS1;ANKRD17;DCN;UBE2N;ITGAV;FGF1;KSR1;CFLAR;AXL;TRIM44;PDGFRB;EP300;ROCK1;MAP3K3;PRKN;NR3C2;NUPR1;ADRA1B;KIT;GSDME;OSBPL8;PUM2;RPTOR;FLNA;RYK;TBK1;IRS1;HMGB1;ITGB1;DNM1L;THBS1;TFG;ALPK1;ADGRV1;FGFR2;SHC1;LYN;BCL2;TRIM8;F3;TRAF3IP2;PUM1;PDPK1;DHX36;GJA1;IGF2;MIER1;PDGFC;FRS2;TRAF2;DDX60;RHOA;ZDHHC13;KL;MAVS;BCLAF1;WWC1;LGALS1;TRIM5;FNIP1;WDR59;FN1;TRIM25;PPM1A;BECN1;RICTOR;LTBR;PIK3AP1;P2RY12;TXN;EPHA8;EIF2AK2;VEGFA;ROR2;RAPGEF2;DDX3X;P2RX4;PLXNB1;ADRA2A;ECM1;TNIP2;IL18;PDCD4;PIK3CD;TLR4;PRKD1;IKBKE;MAP3K14;IAPP;CX3CR1;CC2D1A;GAB1;TRAF6;IFI35;WNT5A;BMP2;MYOC;GCNT2;TMED4;HBEGF;NRG4;RHOC;PARK7;PTPN11;IRAK1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4714449932051673,-1.2199794039001357,0.21113243761996162,0.49828368034320786,1.0,5/17,3.17%,NOTCH2;SMAD6;BMP4;ROBO1;JAG1
prerank,mitotic sister chromatid segregation (GO:0000070),-0.320505702458896,-1.219776683294344,0.10424710424710425,0.4981903930615771,1.0,25/98,15.57%,INO80;EML4;DIS3L2;PIBF1;VPS4B;PHF8;SMC4;AKAP8L;PDS5A;CHMP4B;CHMP4A;CHMP5;CHMP3;RAD21;NIPBL;RB1;RAB11A;PDS5B;CUL3;BECN1;KLHL22;NUDC;MCPH1;ZWINT;CSNK2A1
prerank,regulation of mitotic cell cycle (GO:0007346),-0.29621676367778327,-1.2195048224092813,0.07966457023060797,0.49829954952487593,1.0,68/171,28.95%,SMAD3;FOXC1;GBF1;BTRC;ASAH2;GAS1;PTPN3;OBSL1;ANAPC5;ANAPC7;MAEA;ANAPC4;CDK13;ANAPC16;BTG3;EIF4E;CDK11B;ERCC3;PSMF1;RB1;SIK1;PSMB2;TTL;CDC26;USP2;CDC25B;RCC1;TMEM8B;CCDC57;AFAP1L2;UBE2E1;CDC27;PRMT5;RNF20;TTC28;UBE2S;HNRNPU;CDK10;CDKN1C;PSMC1;NEK6;ANAPC11;CUL1;SCRIB;CUL7;CDK5RAP3;SPHK1;ANGEL2;PSMA3;PSMB6;HSF1;TFAP4;PRKCA;PSMA4;BORA;EIF4EBP1;CDC16;ANAPC1;NEK7;CCDC8;PSME1;PSMD13;APP;FZR1;PSMB9;PSMB10;CDK9;PSMA5
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.436030967206881,1.2194467106323912,0.19661733615221988,0.6151714209265123,1.0,2/19,1.76%,CD33;GIT1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.41872000090102834,1.2185506320871284,0.19874476987447698,0.6162199725508783,1.0,8/22,15.53%,RPS20;RPL23;RPL37;UBB;RPS15;RPS7;ATM;CHD5
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.3233928690353853,-1.2184087800501937,0.11798839458413926,0.5004160322035824,1.0,41/80,35.37%,ANGPT1;UBE2N;LRRK2;HUWE1;AXIN1;UBQLN1;XIAP;CUL3;FBXW7;FANCM;FANCI;TOPORS;SPRTN;DERL1;FAM107A;TRAF6;DCUN1D3;SPSB4;TBC1D7;CDK5RAP3;SENP2;SPHK1;WFS1;MAGEC2;ARRDC4;PAXIP1;FBXO4;KDM1A;HDAC3;RBX1;DCUN1D5;CAV1;PEF1;BIRC3;UBE2L3;DCUN1D4;BRCA1;PSMD10;CENPX;RIPK2;PIN1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.3609160642655168,-1.218352618261616,0.16605166051660517,0.4999555159247112,1.0,14/49,16.37%,IGF1;IL31RA;IL6ST;GHR;KIT;PIBF1;STAT3;LYN;PARP9;PARP14;HES1;IL6R;VEGFA;IL18
prerank,epithelial tube morphogenesis (GO:0060562),0.3925843093537041,1.217865988362323,0.19703389830508475,0.6167384366075715,1.0,8/32,7.45%,CSF1R;PODXL;RYR2;FGF10;CSNK2B;PAK1;LHX1;ACVRL1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5350068131901063,-1.2178452233856742,0.2085661080074488,0.5006435428009881,1.0,8/10,36.57%,RIOK3;SEC14L1;GPATCH3;DHX58;C1QBP;UFD1;TKFC;TSPAN6
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.43618605249101217,1.2175226469970604,0.19271948608137046,0.6163032350997999,1.0,6/20,15.81%,FAR2;DGAT2;SCD;FAR1;PPT1;ACSL3
prerank,positive regulation of cell growth (GO:0030307),0.3190878192033022,1.2174455389699121,0.112,0.6150897388428479,1.0,21/96,11.16%,SYT1;RIMS1;S100A9;S100A8;RIMS2;AKAP6;MFSD2A;CPNE9;SEMA4D;SEMA7A;UNC13A;TGFB2;RNF157;AKT1;RPS6KA1;SHTN1;CDKL5;H3-3A;NTN1;SYT2;CEP43
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.325036622130264,-1.2173243947723726,0.13555992141453832,0.5013683285095518,1.0,19/85,13.57%,AKAP13;NOTCH2;IGF1;DENND4A;PLCE1;KANK2;SHOC2;MAPKAP1;BCR;SHC1;LYN;ARHGAP17;LZTR1;NGF;ARFGAP1;ARHGEF18;DENND4C;OGT;ARHGDIB
prerank,negative regulation of protein metabolic process (GO:0051248),-0.3604757070371368,-1.2172209903483877,0.17073170731707318,0.5010163614060756,1.0,9/48,5.43%,EGFR;NFKB1;MDM4;ITGAV;ROCK1;FLOT2;FLNA;IRAK3;EIF2AK1
prerank,response to acidic pH (GO:0010447),-0.4899703193435415,-1.2168872398326025,0.2411214953271028,0.5011925650855884,1.0,8/13,41.21%,SLC9A1;IMPACT;GPR4;CHP1;PKD2L1;PKD1L3;LGMN;RAB11FIP5
prerank,nucleoside catabolic process (GO:0009164),-0.5325660531704357,-1.2168169743996011,0.23017408123791103,0.5007733739316199,1.0,5/11,15.13%,DERA;UPP2;NT5M;UPB1;DPYD
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.4171805385358385,-1.2163271826359585,0.18216318785578747,0.5013938210410291,1.0,10/27,20.15%,FBXL17;PER3;FBXL12;ID2;CRTC1;SIK1;USP2;PPP1CB;RBM4;PML
prerank,regulation of cell migration (GO:0030334),0.2690842354034251,1.2160248003902356,0.036893203883495145,0.6179223982896542,1.0,80/382,14.20%,CAMK2A;FLT1;CLDN5;IGF1R;PRR5L;LEF1;NAV3;LIMCH1;CTNNA2;FRMD5;SRGAP1;ERBB4;PTP4A1;SEMA3C;CSF1R;PODXL;PLXNB3;TMSB4X;SEMA6A;MIF;DACH1;ITGA6;CXCL12;TMSB10;MAGI2;SEMA4A;PTPRT;MCTP1;SEMA4F;ROBO4;PPM1F;FGF10;SEMA6D;KDR;THY1;SEMA4D;SEMA7A;FERMT3;ENPP2;MEAK7;HSPA5;NOTCH1;PAK1;FGF5;PTPRJ;ACVRL1;PECAM1;AKT1;GPNMB;SGK3;PLXNA4;SST;NTNG2;NTNG1;CYRIB;SPATA13;AIF1;PDGFB;F2R;CEP43;APC;PIK3R3;TMEFF2;SMAD7;SRGAP3;SRGAP2;RET;EPHA1;DOCK10;TJP1;BCAR1;ACTN4;SORL1;XBP1;RFFL;ATM;HRAS;CIB1;INSR;PPP3CA
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.42211145009025475,-1.2158830854075082,0.19962335216572505,0.5018903102332677,1.0,5/23,5.58%,MCU;CAMK1D;RIPOR2;DNM1L;DPP4
prerank,positive regulation of microtubule polymerization (GO:0031116),0.4036817874198554,1.215195592452404,0.2033898305084746,0.6188323991795682,1.0,11/28,21.65%,NAV3;GIT1;OCLN;PAK1;DCTN1;RPS3;MECP2;RAC1;CLASP1;CDK5R1;CDK5RAP2
prerank,mRNA 3'-end processing (GO:0031124),-0.32208212111407986,-1.2151449781825672,0.14145383104125736,0.5030330144709693,1.0,31/78,28.12%,TENT2;PABPN1;WDR33;PCF11;CASC3;SCAF8;U2AF2;CPSF3;SRSF6;SSU72;SLU7;RPRD2;SLBP;SRSF1;PAPOLG;CSTF3;SRSF7;SRSF11;CDC73;UPF3B;SRRM1;AHCYL1;SRSF2;CPSF4;CSTF1;NUDT21;CPSF1;LSM11;NCBP2;APP;POLR2D
prerank,DNA repair (GO:0006281),-0.27516373097716434,-1.2150182904132993,0.0509433962264151,0.502803816136954,1.0,132/284,34.49%,EYA1;INO80;UBE2N;FTO;GTF2H2;ABL1;KMT5B;RAD23B;RBBP8;UVRAG;WDR33;HUWE1;KDM4B;NBN;WDR48;TDP2;TRRAP;MLH1;RAD51B;APEX2;BRCC3;RNF8;PDS5A;WRN;TEX264;DDB2;ZBTB1;VCPIP1;CSNK1E;SETD2;UPF1;HERC2;MNAT1;PARP9;XRCC4;RFWD3;USP47;RAD21;ASCC3;RAD51D;PARP1;ERCC3;PDS5B;PIAS4;ALKBH1;NABP2;APTX;KMT5C;FANCE;DTX3L;ERCC6L2;PARP4;MMS19;FANCM;BRCA2;UBE2B;HINFP;PRKDC;MSH3;FANCI;ERCC8;NOP53;MRE11;SPRTN;ZRANB3;BAZ1B;DCLRE1A;VCP;MGME1;PARK7;MSH6;PCNA;POLN;RPAIN;FANCC;SMC1A;FAAP100;SMARCAL1;UBE2V2;ATR;NSMCE4A;RAD51C;ERCC1;PRIMPOL;GTF2H1;EYA3;POLE2;ACTR5;RECQL5;OGG1;SLC30A9;ENDOV;ABRAXAS1;GTF2H4;FANCB;TNKS1BP1;RAD54L;POLH;TIMELESS;IGHMBP2;NUDT1;KPNA2;MPG;MAD2L2;UBA52;MGMT;FANCD2;FANCG;POLD2;FAAP20;NSD2;PARP2;NEIL3;MDC1;RPA2;PARP3;RMI2;EXO5;EME2;PSME4;PNKP;RAD9A;RAD51;POLA1;LIG4;BRCA1;CHRNA4;ERCC6;DDB1;ACTR8;POLE;CENPX
prerank,response to muscle stretch (GO:0035994),0.4611789278916283,1.2148354668680137,0.2168421052631579,0.6183466804097492,1.0,4/15,9.67%,RYR2;CDH2;SLC8A1;TCAP
prerank,regulation of defense response (GO:0031347),-0.32770682888066627,-1.2143683929663642,0.13250517598343686,0.5038506051533137,1.0,23/76,19.48%,FOXP1;APPL2;ADAMTS12;CELF1;NR1D2;SBNO2;UFL1;ANXA1;XIAP;PTPN22;CASP12;PTGES;AGTR1;APPL1;IRF1;PIK3AP1;APOE;TRAF3;MGLL;WNT5A;AREL1;PARK7;SHPK
prerank,somite development (GO:0061053),-0.5107116093244555,-1.2140691866212598,0.2283609576427256,0.5039462773663991,1.0,4/11,16.34%,SMO;MEOX2;PTCH1;LOXL3
prerank,response to fatty acid (GO:0070542),-0.46604492022957517,-1.2140551990223423,0.22529644268774704,0.5034162809240965,1.0,3/17,4.70%,PID1;FOXO3;IRS1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5152857183171214,1.2138094998179851,0.214,0.6183145126665534,1.0,2/10,6.87%,MBP;KLF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5152857183171214,1.2138094998179851,0.214,0.6183145126665534,1.0,2/10,6.87%,MBP;KLF4
prerank,mononuclear cell differentiation (GO:1903131),0.4141830684115649,1.213595523584958,0.1869747899159664,0.61750251633151,1.0,6/24,6.44%,CSF1R;PPARG;GAS6;FLT3;MT1G;TRPM2
prerank,negative regulation of mRNA processing (GO:0050686),-0.46927915125176956,-1.2135752449317343,0.24444444444444444,0.5040112100847898,1.0,4/15,7.45%,SFSWAP;SRSF10;U2AF2;SRSF6
prerank,amino sugar biosynthetic process (GO:0046349),-0.4955579038444803,-1.2134021207540489,0.21739130434782608,0.5038618944956725,1.0,5/12,26.27%,GFPT1;RENBP;UAP1;UAP1L1;PGM3
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.4377958748517477,-1.213248692888467,0.2053742802303263,0.5036751403035717,1.0,4/19,11.45%,NFAT5;PLCE1;INPP5A;NFATC4
prerank,early endosome to late endosome transport (GO:0045022),-0.4394005357726531,-1.21290245033996,0.20909090909090908,0.5039335360187658,1.0,12/20,25.64%,EEA1;KIF16B;WDR91;BECN1;PIK3C3;ANKRD27;SNF8;WDR81;STX8;PTPN23;RAB7A;RAB5A
prerank,response to iron ion (GO:0010039),-0.5047006123055615,-1.2122281312403398,0.21595330739299612,0.5049613350885771,1.0,4/12,14.27%,BMP6;BCL2;HIF1A;ACO1
prerank,response to glucocorticoid (GO:0051384),-0.41704533431675334,-1.2114490835988243,0.20075757575757575,0.5062073277745982,1.0,11/26,31.61%,NR3C1;ANXA1;REST;ADAM9;FAM107A;HNRNPU;SLIT2;ZFP36L2;GOT1;BCL2L11;UBE2L3
prerank,photoperiodism (GO:0009648),-0.4103418420953574,-1.210620962024751,0.20637898686679174,0.5076801769311222,1.0,10/28,20.15%,FBXL17;PER3;FBXL12;ID2;CRTC1;SIK1;USP2;PPP1CB;RBM4;PML
prerank,hyaluronan catabolic process (GO:0030214),-0.45177762670494476,-1.2103932369602075,0.2058287795992714,0.5076377445448584,1.0,7/18,22.51%,CEMIP;SLC9A1;CEMIP2;GUSB;HEXA;FGF2;CHP1
prerank,membrane assembly (GO:0071709),0.3826959552752136,1.210244350826853,0.18580375782881003,0.6257978100092979,1.0,6/34,6.01%,NRXN1;PTPRD;IL1RAPL1;NLGN1;ANK3;NRXN2
prerank,substantia nigra development (GO:0021762),0.37909658467488866,1.209816607220761,0.17903930131004367,0.6257001180786503,1.0,11/37,13.93%,ACTB;MBP;PLP1;HSPA5;DYNLL1;BASP1;CALM1;COX6B1;CALM2;INA;CALM3
prerank,aggrephagy (GO:0035973),-0.41471112546236577,-1.2097946113684557,0.20445344129554655,0.5085776784040793,1.0,12/27,21.05%,UBE2N;VIM;PRKN;ARL13B;UBQLN1;PCNT;IFT88;DYNC1LI1;DYNC1H1;ATG5;PARK7;WDR81
prerank,negative regulation of developmental growth (GO:0048640),0.400365138591641,1.2096943372738163,0.1939655172413793,0.6246099258749787,1.0,9/30,15.98%,DCC;MAG;FGF13;MAP2;RTN4R;DIP2B;CDKN1A;RTN4;CDKN1B
prerank,regulation of leukocyte migration (GO:0002685),-0.46831872543801245,-1.2095675083564301,0.22568807339449543,0.5085892129474229,1.0,5/16,18.30%,HOXA7;ANXA1;VEGFA;MIA3;RHOH
prerank,regulation of axon extension (GO:0030516),0.3735891060324946,1.2089669914027885,0.19866071428571427,0.6252814981034021,1.0,12/37,15.98%,MAG;MAP2;SEMA7A;NRCAM;SHTN1;CDKL5;RTN4R;NTN1;DIP2B;SIN3A;RTN4;MACF1
prerank,protein kinase B signaling (GO:0043491),0.4338720904285796,1.2088789336948533,0.21205357142857142,0.6241231537947594,1.0,6/23,11.49%,PAX2;GAS6;KDR;AKT1;CCL2;PIK3R3
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.2653036581716475,-1.2088484260756434,0.03592814371257485,0.5098080847143345,1.0,103/390,18.43%,ROCK2;SULF1;IGF1;EGFR;ROR1;SORBS1;RHOQ;RBFOX2;COL4A6;EPHA7;SIPA1L1;EPHA3;COL1A1;PDGFRA;ANGPT1;NTRK3;EFNB2;SDC2;HNRNPH1;FLRT2;FOXC1;GRB10;ITGAV;FGF1;AXL;PDGFRB;IL31RA;ROCK1;CYFIP2;ATP6V1B2;GHR;FRK;KIT;GSK3B;SHOC2;WASF2;RYK;IRS1;PLAT;SULF2;ATP6V0D1;SLC39A14;SHB;PAK2;STAT3;HNRNPM;FGFR2;SHC1;FOXC2;EIF2AK3;LYN;NRP1;ATP6V0A4;MERTK;EPHA4;BRK1;CDC42;VAV2;IGF2;FER;NGF;WASL;NCSTN;PDGFC;FRS2;PTPN2;RHOA;KIF16B;KL;NCKAP1;YES1;NFATC4;ABI1;ANGPT2;APPL1;FLRT1;ARPC2;MMP2;EPHA8;VEGFA;ROR2;RAPGEF2;VEGFD;NCK1;BDKRB2;CYBA;RASA1;FIBP;DDR1;NGEF;NCK2;ZFYVE27;STYK1;EFS;DOCK1;PRKD1;TCIRG1;PHIP;BLNK;FGFBP1;POLR2H;CEP57;GAB1
prerank,positive regulation of developmental process (GO:0051094),-0.2947204556443753,-1.2087420966979427,0.10580912863070539,0.5095177120872318,1.0,28/164,8.40%,PHLDB2;SOX5;DAG1;BMPR1A;FOXD1;PTN;DCN;SMURF2;MCU;BMP5;CCN2;BMP7;BMP4;PRKN;KMT5B;NUMA1;DLG4;LMNA;RREB1;NIBAN2;ADGRL1;DNM1L;ZBTB16;DDHD1;REST;RAPGEF3;AR;GJA1
prerank,chromatin remodeling (GO:0006338),-0.314904786865971,-1.2078816508679602,0.1275797373358349,0.5110209669687827,1.0,40/100,27.47%,INO80;KAT2B;HDAC4;ARID1B;TOP1;EZH1;BAZ1A;BAZ2A;KDM4B;SMARCC2;NUDT5;CHD8;KDM5B;MYSM1;MBD2;ZBTB1;KDM6A;CHD4;CHD3;HCFC1;RB1;HDAC1;JARID2;SMARCD2;BAZ1B;TAF6L;BAZ2B;BPTF;PBRM1;PIH1D1;HDAC2;SMARCD3;MBD3;INO80C;ACTR5;ZBTB7A;CECR2;ESR1;MPND;ATRX
prerank,negative regulation of cellular process (GO:0048523),-0.2586129407180488,-1.2073075081714657,0.02217741935483871,0.5118505744253121,1.0,154/521,22.31%,PLXNA2;TGFBR3;ALDH1A2;SMAD3;ZBTB7C;APPL2;KANK2;ANGPT1;DCBLD2;SMAD6;CELF1;COL4A3;FBLN1;MDM4;BMP5;CCN2;FHL1;DIS3L2;UBR2;KAT2B;BMP7;BMP4;ANXA6;PDPN;PRKN;PPM1D;PTPN14;TNS2;PODN;ENPP1;BRD7;FRK;NUPR1;LMNA;GSDME;CLMN;VGLL4;NIBAN2;RIPOR2;IGFBP3;RARG;TGFB1I1;IGFBP6;PLSCR1;SKI;VPS4B;SPEG;CD9;TMEM127;NOX4;EIF2AK3;LYN;BCL2;TES;REST;SRSF6;P3H3;WNT9A;AR;CHMP4B;GJA1;PTPRK;IMPACT;SP100;TXNIP;MAP2K1;PLXNB2;BTG3;NGF;CCN3;NR1H3;CYP1B1;PTPN2;SMAD4;COL18A1;ABI1;RB1;PDS5B;PKD2;ADNP2;BECN1;CCN5;VPS13C;IRF1;CCN1;FKTN;ARHGDIB;COPS8;RBM5;CD164;ING5;CRLF3;EIF2AK2;DUSP1;ROR2;CBFA2T3;EMILIN1;RAPGEF2;DDX3X;NCK1;ANP32B;RASA1;IGFBP7;MNT;PLXNB1;NCK2;PLXND1;TGFB3;MYBL1;PDCD4;NR4A1;OSGIN2;ADAMTS1;PRKD1;MIA3;S100A11;CCN4;ARID2;ATG5;NDRG3;SOD2;PPP2R5C;FGFBP1;NME6;DACT3;DCUN1D3;IFI35;BMP2;SFRP4;PARK7;INHBA;CDK10;PBRM1;ING1;PML;CDC73;IFIT3;NOS1;NME1;SPEF1;NF2;ZBTB49;PPP2CA;FRZB;BNIP3;CDK6;TGFBI;PTHLH;LPCAT3;FGF2;WFS1;WNT16;DLG5;TCHP
prerank,chemokine-mediated signaling pathway (GO:0070098),0.3658754400797292,1.2071636169160747,0.160676532769556,0.6277674896337427,1.0,11/42,21.55%,CXCL12;GPR35;CCL2;THPO;GPR75;STK39;CIB1;CCL25;CCL13;CCL19;RBM15
prerank,response to insulin (GO:0032868),-0.3276164800783484,-1.206587312815801,0.12139917695473251,0.513019081235026,1.0,29/80,21.65%,SORBS1;RHOQ;KAT2B;ENPP1;IRS1;SLC39A14;INSIG2;RAB10;RAB12;PDPK1;VAMP2;FER;SELENOS;PARP1;DENND4C;PCK2;OGT;SLC27A1;PRKDC;ZBED3;CPEB1;SYAP1;LPIN2;INPP5K;LPIN3;PKM;AKT2;PIK3R1;USF1
prerank,cellular protein localization (GO:0034613),-0.2723342406405636,-1.2063238636574916,0.035856573705179286,0.5130867370454045,1.0,104/285,28.07%,WLS;EGFR;ANK2;VCL;ANGPT1;TLK1;KIF13A;SH3PXD2B;LRRK2;TBC1D16;FBLN5;CNTLN;FLNA;SGSM2;PIGK;SNX9;SEC23IP;SNX6;STX16;RAB22A;VPS26C;STXBP1;SIL1;AP3B1;GJA1;PTPRK;USP6NL;COPZ2;SLU7;ARFGAP3;SEC31A;ARCN1;HERC2;TBC1D2B;TBC1D8B;GGA3;RPGR;COG3;TM9SF2;COG7;STX4;WIPI1;NIPBL;ARFIP2;ARF1;STX5;USP4;TBCK;COPB2;GRTP1;TM9SF1;CTTN;TBC1D22B;RAB21;TBC1D9;CTSA;DNAJC27;FAM91A1;COX18;SMURF1;ATG9A;SNX8;WDR45B;TMED3;WDR11;TBC1D17;NAPA;WNT5A;TMED4;TMED5;RABGAP1;WIPI2;TBC1D10A;NPHP1;RAB24;IFT27;GGA2;STX17;STX8;VPS26B;RABL3;NSF;ARL5A;AP2A1;SAR1B;USO1;STX12;PRRT1;VPS45;RAB5A;BBS4;STX1A;RRAGA;TBC1D10B;MFN2;CD63;GAS8;FERMT2;STX7;TBC1D9B;TMED2;BBS2;RIC1;ARL4C
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3866483714975488,1.206136520727366,0.20292887029288703,0.6293248878075879,1.0,11/32,16.50%,AKAP6;SNCA;THY1;APLNR;HAP1;F2R;CALM1;TRPC1;CALM2;CALM3;NPSR1
prerank,recombinational repair (GO:0000725),-0.3232889552633849,-1.205959523605441,0.14587332053742802,0.5133561136818391,1.0,19/77,17.02%,INO80;UBE2N;RBBP8;SPIDR;SMC6;NBN;NSMCE2;RAD51B;WRN;SMC5;RFWD3;MCM9;RAD51D;PARP1;NABP2;BRCA2;SFPQ;MRE11;ZSWIM7
prerank,regulation of interleukin-13 production (GO:0032656),0.4881738157080352,1.2056898592718095,0.22826086956521738,0.6293102611577989,1.0,2/13,9.80%,LEF1;TNFRSF21
prerank,negative regulation of translational initiation (GO:0045947),-0.49518622265568396,-1.205275428881184,0.2361904761904762,0.514450049597314,1.0,6/13,24.64%,EIF2AK1;LARP1;TPR;EIF2AK4;RBM4;EIF4EBP1
prerank,apical protein localization (GO:0045176),0.5193905282061146,1.205192474467352,0.25,0.6292921194507627,1.0,5/10,14.01%,ACTB;MAL;INSC;VANGL2;JAM3
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.45782908229142416,1.2046727928889358,0.2222222222222222,0.6294151993537254,1.0,4/15,5.75%,IGF1R;KDR;AATK;SRMS
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.45262184313723064,-1.204607396235004,0.2136279926335175,0.5154593900582127,1.0,6/17,16.91%,WNT4;VIM;BMP4;RUNX1;TGFB3;SUCO
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.4039698456330042,-1.2046068521205011,0.20233463035019456,0.5148873439974062,1.0,4/26,5.71%,LARGE1;ST3GAL4;GK5;RRM2B
prerank,cellular response to reactive oxygen species (GO:0034614),-0.3444717207654373,-1.2042750344939337,0.16981132075471697,0.5150543576138541,1.0,14/59,13.55%,EGFR;PDGFRA;TPM1;ABL1;ANXA1;MAP3K5;PTPRK;IMPACT;FER;JUN;CYP1B1;PRKCD;PKD2;ERCC6L2
prerank,negative regulation of biosynthetic process (GO:0009890),-0.46819089012333237,-1.2038874633755112,0.218,0.5154111862063157,1.0,10/16,39.77%,COA8;SLC30A10;ABCD2;EMILIN1;PARK7;PPARA;GPER1;CIITA;SLC18A2;TRAP1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.5147266577429267,-1.2037270630054884,0.25,0.5152434734791691,1.0,2/11,13.85%,PTGIS;FAP
prerank,cell cycle G2/M phase transition (GO:0044839),-0.30196499535220983,-1.20360369200775,0.12625250501002003,0.5149575294121178,1.0,38/129,19.50%,FBXL7;FBXL17;PCM1;PPP1R12B;PPP1R12A;BTRC;ALMS1;CCNH;ODF2;NINL;KHDRBS1;CEP63;CDK7;CEP135;PHLDA1;PCNT;AKAP8L;FBXL12;CSNK1E;BRSK1;MNAT1;NES;MAPRE1;TPD52L1;LATS1;CDC25B;YWHAE;PPP1CB;AKAP9;CCDC57;DYNC1H1;CEP76;PRKACA;CEP57;FBXW11;CSNK1D;AJUBA;CDK2
prerank,cardiac atrium morphogenesis (GO:0003209),0.4513623441345804,1.203500903547236,0.2329059829059829,0.6314575362901764,1.0,4/16,5.71%,PROX1;MYH6;NOTCH1;TGFB2
prerank,regulation of actin nucleation (GO:0051125),-0.5038002104716427,-1.2033598497127544,0.22990654205607478,0.5149565498019979,1.0,4/12,15.35%,GSN;ARFIP2;ARF1;WHAMM
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.41170695654623035,-1.2033210402768588,0.21523809523809523,0.5144730053166456,1.0,9/25,19.46%,FOXO3;ARNT;STAT3;MED1;HIF1A;PRKDC;STAT1;STAT5B;INHBA
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.3797353844900745,-1.2031063745572252,0.1946564885496183,0.5144082038467561,1.0,15/33,22.07%,FGF1;JAK1;RHOJ;THBS1;PDPK1;GLUL;ADAMTS9;BMPER;CEMIP2;VEGFA;ITGA5;PKM;S100A1;SMAD1;FGF2
prerank,calcium ion transport (GO:0006816),0.30892828223829105,1.2022355897973374,0.1314655172413793,0.6337894904148805,1.0,27/113,14.63%,CAMK2A;SLC24A4;SLC24A2;CACNA1A;TRPC5;CACNA1B;RAMP2;RYR2;CACNA2D1;RYR3;GAS6;SLC8A1;CACNA1E;TRPM2;CACNB2;TPT1;CACNG3;MCOLN2;GRIN3A;CACNG8;P2RX7;TRPC1;TMCO1;PSEN1;ATP2B4;ATP2B2;CACNA1I
prerank,sodium ion export across plasma membrane (GO:0036376),-0.4968894297799942,-1.2018050283769621,0.22591943957968477,0.5170777472791541,1.0,2/13,4.57%,ATP1A2;SLC9A1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.48197356974142747,-1.2016782230398904,0.2339622641509434,0.5168346058910797,1.0,5/14,18.98%,ANK2;ACTN2;AKAP9;ATP1B3;LRRC38
prerank,B cell activation involved in immune response (GO:0002312),-0.4917080969116968,-1.2012233424129728,0.24857685009487665,0.5173604472979296,1.0,8/13,37.11%,RNF8;MSH6;EXOSC3;BATF;GPR183;LIG4;MSH2;FCGR2B
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.4003011376399126,-1.201215879243086,0.19924812030075187,0.5168010730368906,1.0,6/26,16.23%,ATP1A2;UBQLN1;PKD2;SRI;YWHAE;ADRA2A
prerank,regulation of interleukin-1 production (GO:0032652),-0.46967067539581464,-1.2008698823918909,0.24344569288389514,0.5171559860891018,1.0,3/15,7.19%,FOXP1;HMGB1;ANXA1
prerank,regulation of cellular protein localization (GO:1903827),-0.36150902662382806,-1.2007830643349038,0.17288801571709234,0.5167676872566234,1.0,18/45,22.46%,GPC6;GBF1;PRKAA2;GPC4;GPC3;SPIDR;NDEL1;VCPIP1;CSNK1E;SETD2;PARP1;CCDC66;PRKAA1;PTPN1;VCP;DVL3;TOR1A;GPC1
prerank,mesenchyme development (GO:0060485),-0.4751100166374121,-1.2003998450424171,0.2390057361376673,0.5170814547847234,1.0,5/15,12.91%,TGFBR1;BMP7;BMP4;FGFR2;PKD2
prerank,natural killer cell activation (GO:0030101),-0.42555866841118006,-1.200159758844838,0.21223709369024857,0.5171107108480812,1.0,3/23,6.81%,PBX1;AXL;ELF4
prerank,regulation of stem cell population maintenance (GO:2000036),-0.44852561721465184,-1.1994614611177907,0.2119460500963391,0.5182505522640825,1.0,7/18,17.82%,PTN;REST;WDR43;TAF5L;CNOT2;CNOT1;TAF6L
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.2807637516783823,-1.1982857137850844,0.09108910891089109,0.5204726587242893,1.0,60/208,23.10%,WLS;AKAP13;ROR1;LPAR1;PELI2;ANKRD17;ZFAND6;UBE2N;CFLAR;MAP3K3;PRKN;FLNA;TBK1;TFG;ALPK1;UFL1;MAPKBP1;TRIM8;TRAF3IP2;PDPK1;DHX36;GJA1;MIER1;TRAF2;RHOA;ZDHHC13;MAVS;LGALS1;TRIM5;TLE1;RIOK3;TRIM25;PPM1A;LTBR;STAT1;RORA;TRIM39;TRAF3;ECM1;TNIP2;PRKD1;IKBKE;MAP3K14;CC2D1A;RHOH;TRAF6;WNT5A;TANK;TMED4;RHOC;IRAK1;CARD16;SHARPIN;NEK6;CXXC5;NLRX1;TICAM1;TRAF5;GPR89A;VAPA
prerank,mitotic spindle assembly (GO:0090307),-0.37474148986812933,-1.198010314444867,0.19854280510018216,0.5205422423724227,1.0,25/42,38.32%,FLNA;PIBF1;SPICE1;STAG1;LSM14A;RHOA;RAB11A;ABRAXAS2;TOGARAM1;MAP9;STAG2;SMC1A;BCCIP;KIF23;ABRAXAS1;RACGAP1;KIF11;MZT1;PRC1;KIF2A;SMC3;MISP;TPX2;KIFC1;KIF4A
prerank,negative regulation of cell motility (GO:2000146),0.3096166606638316,1.1980081520245163,0.13496932515337423,0.6444177083891245,1.0,13/108,4.33%,CLDN5;NAV3;LIMCH1;SPOCK3;FRMD5;SRGAP1;PLXNB3;MIF;DACH1;MAGI2;PTPRT;MCTP1;THY1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3580895146809171,1.1976646211494035,0.18461538461538463,0.6439622773768766,1.0,10/46,11.33%,PTPRR;SEMA6A;CNKSR3;SPRY3;DUSP6;CAMK2N1;WNK2;DAB2IP;LMO3;DUSP26
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.44419822655632063,-1.1974745170434713,0.2309124767225326,0.5213207374092117,1.0,7/18,24.47%,DAB2;MAP2K1;CHMP3;RAB21;MSN;SNX12;PTPN23
prerank,double-strand break repair (GO:0006302),-0.29178650385229404,-1.1971952686709308,0.10912698412698413,0.5214863617086064,1.0,69/158,33.21%,EYA1;INO80;UBE2N;RBBP8;SPIDR;HMGB1;KDM4B;SMC6;NBN;TDP2;NSMCE2;RAD51B;BRCC3;RNF8;WRN;SMC5;HERC2;PARP9;XRCC4;RFWD3;MCM9;RAD21;RAD51D;PARP1;POLM;PAXX;PIAS4;NABP2;APTX;DTX3L;BRCA2;PRKDC;SFPQ;MRE11;KDM2A;ZSWIM7;BAZ1B;DCLRE1A;VCP;POLN;XRCC6;SMARCAL1;UBE2V2;RAD51C;ERCC1;PAXIP1;EYA3;ACTR5;RECQL5;IFFO1;ABRAXAS1;TNKS1BP1;SFR1;SAMHD1;KPNA2;MAD2L2;HELQ;NSD2;PARP2;ZFYVE26;MDC1;RPA2;PARP3;EME2;RNF138;RAD51;POLA1;LIG4;BRCA1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.4568569465811024,1.1967438801168993,0.21822033898305085,0.6451359541183591,1.0,5/16,14.15%,IGF1R;ETF1;GLE1;OGFOD1;INSR
prerank,transport across blood-brain barrier (GO:0150104),0.3202847204461078,1.1964687008942418,0.14495798319327732,0.6445734271237196,1.0,24/83,14.38%,SLCO1C1;TFRC;SLC7A5;SLC6A6;SLC6A17;SLC2A1;ATP8A1;SLC2A3;SLC7A1;ABCG2;MFSD2A;SLC1A1;SLC1A2;SLC7A8;SLCO2B1;ATP1A4;ABCC4;FABP5;KCNJ8;CD36;SLC27A4;SLC16A1;INSR;ATP2B4
prerank,receptor internalization (GO:0031623),0.36809558026600736,1.1958392413834762,0.18383838383838383,0.6450458084156301,1.0,6/44,4.67%,TFRC;DNM3;RAMP2;AP2M1;SNCA;GRK2
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5284759811170698,-1.1953699185757762,0.24084778420038536,0.5253677308928634,1.0,4/10,21.81%,GFPT1;PFKP;PFKM;PFKL
prerank,mesenchymal cell development (GO:0014031),0.44037584412306985,1.19505448788957,0.24086021505376345,0.6458425039813501,1.0,4/18,6.08%,NRG1;CDH2;NOTCH1;CYP26C1
prerank,embryonic hemopoiesis (GO:0035162),0.4913061504871755,1.1945204803603848,0.2686230248306998,0.6460368306040803,1.0,4/12,9.11%,KITLG;KDR;TAL1;TPO
prerank,covalent chromatin modification (GO:0016569),-0.46946926221000507,-1.1934050911089187,0.24074074074074073,0.5297626611460514,1.0,6/14,19.17%,HLCS;SETD5;UFL1;MBD2;HDAC1;PARK7
prerank,protein targeting to peroxisome (GO:0006625),-0.39642647918865936,-1.193063185610184,0.1974169741697417,0.5300941191470085,1.0,11/29,20.41%,ZFAND6;ABCD3;PXMP4;ABCD2;LONP2;PEX6;SLC25A17;PEX7;FIS1;PXMP2;PEX26
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.31460196575532734,-1.1929871549852074,0.1700404858299595,0.5296951411950352,1.0,23/84,20.51%,SAMD4A;IGF1;IGFBP5;ROCK1;SYNCRIP;DDX6;EIF4ENIF1;EIF2AK3;LARP1;DHX36;LSM14A;GGA3;CNOT8;YBX1;EIF2AK2;APOE;DDX3X;DAPK1;CNOT1;ABCA7;CNOT10;RBM4;ORMDL3
prerank,actin polymerization or depolymerization (GO:0008154),-0.3501240504852023,-1.1929848499568196,0.1627450980392157,0.5291308930657683,1.0,16/50,20.34%,ARHGAP6;MICAL3;GAS7;GSN;SVIL;DIAPH1;MICAL2;CORO7;WASL;ABI1;WASF1;TTC17;FAM107A;MICAL1;AVIL;VILL
prerank,positive regulation of protein acetylation (GO:1901985),-0.495594591623843,-1.1926526661046852,0.24427480916030533,0.5293577552842691,1.0,7/12,22.00%,PRKAA2;RAPGEF3;FAM161A;DDX3X;CEP295;PRKAA1;TAOK1
prerank,positive regulation of protein processing (GO:0010954),-0.4375367203721269,-1.1926388919582018,0.23210831721470018,0.5288233618772699,1.0,3/19,4.72%,GSN;CCBE1;CLEC3B
prerank,cytoskeleton organization (GO:0007010),-0.300650170668492,-1.192628005544186,0.14258188824662812,0.5282747171327251,1.0,40/114,21.56%,ARHGAP10;MICAL3;PLCE1;TPM1;BRWD1;DIAPH1;SYNE3;MICAL2;PACSIN2;WDPCP;WTIP;RND3;LRCH3;OBSL1;RANBP10;PALLD;RHOA;LIMD1;ZMYM4;RHOBTB2;FGD1;ZMYM3;CAPZB;NECTIN2;APOE;FGD4;RANBP9;MARK1;RHOBTB1;PHIP;MICAL1;RHOH;RHOC;AJUBA;SIPA1L3;CNN2;SPRYD3;PPP2R3C;DES;MAST2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.3516280160123987,-1.192558490437968,0.1811175337186898,0.5278772847938852,1.0,17/49,19.17%,LDLRAD4;SMAD6;EP300;GSK3B;HMGB1;CDC42;IMPACT;DACT1;PMEPA1;RIOK3;PPM1A;PRKCZ;ANKRD27;DDX3X;NOP53;IAPP;PARK7
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.3253357364244348,-1.1923596784637958,0.17485265225933203,0.5277586692763613,1.0,28/69,30.25%,CCNT2;CCNT1;INTS4;CDK7;PHAX;TBP;CCNK;RPRD2;NABP2;TAF8;TAF13;SNAPC3;GTF2B;ICE1;POLR2H;INTS6;INTS14;GTF2F1;POLR2K;SNAPC1;POLR2E;NCBP2;GTF2E2;SNAPC5;POLR2D;CDK9;INTS7;GTF2A1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.45547838849347183,-1.1921792296013287,0.21794871794871795,0.5276121587484983,1.0,6/16,16.91%,WNT4;VIM;BMP4;RUNX1;TGFB3;SUCO
prerank,regulation of complement activation (GO:0030449),-0.3667967091020102,-1.1920922727071785,0.18562874251497005,0.5272704021066673,1.0,5/40,3.77%,CFH;SERPING1;VTN;CD55;PROS1
prerank,positive regulation of cell migration (GO:0030335),-0.27526566696305793,-1.1918105967877406,0.07708333333333334,0.5273851979011636,1.0,73/253,19.23%,SYNE2;ROCK2;IGF1;EGFR;DOCK5;TGFBR1;COL1A1;PDGFRA;NTRK3;MYLK;SMURF2;SEMA3D;CEMIP;FGF1;PDGFRB;DAB2;PDPN;SMO;VTN;WNT5B;KIT;RREB1;ITGB1;CTSH;THBS1;STAT3;MAP4K4;NRP1;MTOR;F3;PLCG1;FER;SEMA3E;CXCL16;PDGFC;HIF1A;ADAM9;STX4;NIPBL;MMP14;RAB11A;FN1;MAPRE1;CPNE3;CCN1;SH3RF2;CCAR1;SEMA3B;SEMA4B;VEGFA;ROR2;RAPGEF2;NUMB;ACVR1;GLIPR2;CARMIL1;ADRA2A;PIK3CD;DOCK1;TWIST2;FAM107A;MIA3;S100A11;CCN4;MYADM;SOD2;GAB1;BMP2;MYOC;GCNT2;HBEGF;RHOC;ELP5
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.49748578031828916,-1.191690330133049,0.23583180987202926,0.5271349730418066,1.0,4/12,9.09%,THRB;KLF9;CTSH;MED1
prerank,regulation of kinase activity (GO:0043549),0.3154184290052737,1.1916159780126447,0.18016194331983806,0.6534791820469446,1.0,13/89,6.02%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3683580432569924,1.191464929249074,0.19825708061002179,0.652507002687352,1.0,7/38,10.53%,GRM5;LRP8;CSF1R;GAS6;THY1;RELN;PDGFB
prerank,pulmonary valve development (GO:0003177),-0.44590703523553266,-1.191168452603699,0.22603978300180833,0.5278459327865115,1.0,5/18,3.17%,NOTCH2;SMAD6;BMP4;ROBO1;JAG1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.45242740909295487,-1.1910718124164268,0.232,0.5275092063015883,1.0,4/16,9.65%,MOV10;RC3H1;DHX36;UPF1
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.4582310729401009,-1.19092448853357,0.23818897637795275,0.5272825352149401,1.0,8/16,18.61%,FTO;BMP7;RREB1;NAPEPLD;SOX13;SIX1;HNRNPU;METRNL
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.500460804596081,1.1902975211116138,0.25646551724137934,0.6544266002489598,1.0,4/11,13.66%,KCNJ3;KCND3;ATP1A1;ATP1B1
prerank,positive regulation of lymphocyte migration (GO:2000403),0.4827781490465064,1.1899882493161522,0.22406639004149378,0.6539061393204983,1.0,3/12,9.84%,CXCL12;JAM2;AIF1
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.32267369224429926,-1.1898727691873974,0.14512922465208747,0.5293842411143262,1.0,13/78,7.95%,EGFR;PID1;SORBS1;RHOQ;LRP1;EPHA3;DAB2;PTPN9;DLG1;ITGB1;VTI1B;AR;PDPK1
prerank,prostanoid biosynthetic process (GO:0046457),-0.46554187898698784,-1.1897246476834549,0.25390625,0.5292067998390731,1.0,6/15,12.11%,PTGDS;PTGIS;PTGS1;PLA2G4A;PTGES;PNPLA8
prerank,regulation of phospholipase activity (GO:0010517),-0.5087772827332114,-1.1897013605783409,0.2567049808429119,0.5287116477574906,1.0,3/10,7.95%,LRP1;FGFR2;PDPK1
prerank,early endosome to Golgi transport (GO:0034498),-0.5077826120034465,-1.1894962692260251,0.2644135188866799,0.5286517658057289,1.0,5/11,23.89%,STX5;SURF4;EHD3;SNX8;LMAN1
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.3688905888968299,-1.1885183772545258,0.20670391061452514,0.5303510590737854,1.0,22/39,34.09%,ABCA1;STEAP3;TANGO6;RAB10;RAB12;ARFGAP3;RCN3;MON1A;COPG2;MIA3;COPG1;RAB3D;PREB;RAB8A;TVP23B;AFM;SEL1L;PPY;MIA2;TVP23A;RAB8B;RAB15
prerank,peptide metabolic process (GO:0006518),-0.3248051942627809,-1.1884744772937632,0.17823639774859287,0.529919431691428,1.0,30/75,26.87%,CPQ;AEBP1;PCSK5;HM13;ANPEP;SEC11C;MGAT3;CPM;NPEPPS;NLN;CPXM2;LNPEP;GSTT2;GLRX2;CTNS;SEC11A;CPXM1;GSTT1;ETHE1;CARNMT1;SPPL3;CLN5;PARL;DNPEP;GSTM2;APEH;GSR;BACE2;ERAP1;SPCS3
prerank,negative regulation of defense response to virus (GO:0050687),-0.5166213598765538,-1.1884626790050004,0.25874125874125875,0.5293928145623912,1.0,8/10,40.96%,PCBP2;ILRUN;MUL1;C1QBP;TSPAN6;TRAF3IP1;TARBP2;RNF26
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.3385555330750682,-1.1884249385480363,0.16767676767676767,0.5289101726469422,1.0,18/59,17.73%,TCF7L2;NFKB1;CDK8;PPM1D;TNRC6B;TNRC6A;MED15;MOV10;MED17;MED26;MED12;MED1;JUN;BCLAF1;MED8;TNRC6C;RUNX2;MED27
prerank,substrate-dependent cell migration (GO:0006929),-0.466903254347865,-1.187987719182171,0.24571428571428572,0.529404462862248,1.0,4/14,13.80%,ITGA11;NRP1;P2RY12;EPHA8
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.2916155796362628,1.1869035882244727,0.13291139240506328,0.6614860749686094,1.0,32/149,14.15%,CAMK2A;TFRC;TIRAP;S100A9;S100A8;PRKCH;TRIM13;TRAF1;RPS6KA5;ALK;TLR2;CLU;PRKCQ;RTKN2;TRIM62;RPS27A;UBC;TRIM37;TRIM6;UBB;PSMA6;NOD1;ARHGEF2;TERF2IP;MID2;BCL10;CD40;CD36;RPS3;NFKBIA;CIB1;TAB2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.43117049346482816,-1.1867451231558674,0.25,0.5319694832828123,1.0,4/19,5.28%,MCU;CAMK1D;RIPOR2;DNM1L
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.390713268938151,-1.1866758516109315,0.20392156862745098,0.5315836627038955,1.0,17/29,35.37%,UBE2N;ABL1;AXIN1;FBXW7;DTX3L;TOPORS;FEM1A;DCUN1D3;PARK7;MAGEC2;ARRDC4;BAG5;DCUN1D5;UBE2L3;DCUN1D4;FEM1B;PIN1
prerank,regulation of cardiac conduction (GO:1903779),-0.3432032072231787,-1.1866238512303064,0.189453125,0.531160998453419,1.0,17/54,21.29%,ATP1A2;ITPR1;STIM1;ANK2;ITPR2;TMEM65;ASPH;DMPK;ATP2A2;ATP2B1;PRKACA;NPR2;SLC8A3;ATP1B3;ATP2A3;NOS1;AHCYL1
prerank,positive regulation of cyclase activity (GO:0031281),-0.47818389524084576,-1.186360510846482,0.24324324324324326,0.5312696381627171,1.0,3/14,7.58%,CACNA1C;STIM1;CACNA1D
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.49980358238921835,-1.1862987968738272,0.2413162705667276,0.5308369207759285,1.0,4/11,14.43%,IL6ST;JAK1;STAT3;STAT1
prerank,regulation of protein catabolic process (GO:0042176),-0.3130146379574493,-1.186149859386468,0.14528301886792452,0.5306240900122566,1.0,27/99,18.94%,EGFR;SMURF2;MDM4;PRKN;WWP2;GSK3B;FLNA;GPC3;IRAK3;HUWE1;AXIN1;WWP1;SEC22B;DACT1;WDR91;STX5;GFAP;CTSA;SMURF1;CSNK2A1;CENATAC;ASB5;HMGCR;VCP;WNT5A;AREL1;CYP51A1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.45555094512452965,1.1859775579050984,0.252,0.6628429774745078,1.0,4/15,12.00%,FST;MAGI2;CSNK2B;SMAD7
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.4336777093142864,-1.18556871033103,0.2277992277992278,0.5315141891333878,1.0,4/20,2.60%,TGFBR3;TGFBR1;RBPJ;BMP4
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.36339636843147993,-1.1853065730792418,0.17578125,0.5316282455871231,1.0,17/41,28.26%,ACSL1;DAGLA;PTGS1;PLA2G4A;CYP1B1;PNPLA8;EPHX1;ACOX1;MGLL;DECR2;ELOVL1;ACOT8;DAGLB;GSTM2;ELOVL5;ALOX12;PLA2G4C
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.4409435192815905,-1.185207992063066,0.25576923076923075,0.5313254447051801,1.0,7/18,14.77%,MDFIC;CTNNA1;GSK3B;SUFU;ILRUN;APOD;LATS1
prerank,regulation of chromosome organization (GO:0033044),-0.42404273749858623,-1.1850009370650876,0.2342007434944238,0.5312874413699624,1.0,7/22,12.04%,SMG6;HDAC8;SMG1;YLPM1;HNRNPD;UPF1;RB1
prerank,histone H4 deacetylation (GO:0070933),-0.5141889255528321,-1.1848406540074765,0.2631578947368421,0.5310752524820483,1.0,4/10,7.41%,HDAC8;HDAC4;RCOR1;REST
prerank,response to peptide (GO:1901652),0.3798295215953659,1.1844976921312576,0.22245762711864406,0.6658682641235606,1.0,5/33,8.03%,CACNA1A;CACNA1B;MMP12;MMP13;EIF2B3
prerank,positive regulation of viral process (GO:0048524),-0.33097347960834905,-1.184220392393347,0.186,0.532059705681947,1.0,27/60,31.95%,MDFIC;AXL;CCNT1;KPNA6;DHX9;LARP1;TBC1D20;NELFB;DDX3X;PPIH;POLR2H;PPID;GTF2F1;POLR2K;POLR2E;CTDP1;RAB7A;PPARA;PDE12;NELFA;NELFE;POLR2D;CDK9;KPNA2;ADARB1;NR5A2;TYRO3
prerank,proteoglycan metabolic process (GO:0006029),-0.4054222247135047,-1.184151473235281,0.22180451127819548,0.5316620730423385,1.0,4/26,4.80%,SULF1;IGF1;ADAMTS12;SULF2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.37745122073299636,-1.1833143742561623,0.21621621621621623,0.5331513715632591,1.0,19/33,30.47%,DDX5;EP300;AXIN1;UFL1;RUNX1;AR;UBA5;SAFB2;PRMT2;LATS1;RNF14;PARK7;RNF6;TRIM68;KDM1A;ESR1;KCTD6;UFM1;CALR
prerank,positive regulation of interleukin-17 production (GO:0032740),0.41586227151464306,1.183171378439379,0.25051334702258726,0.6685070373884495,1.0,3/22,11.97%,SLC7A5;PRKCQ;RFTN1
prerank,regulation of chemotaxis (GO:0050920),-0.3830864860918826,-1.1828630765147043,0.22574626865671643,0.5337698726130508,1.0,10/30,15.15%,PDGFRA;EFNB2;PDGFRB;THBS1;ADGRA2;ZSWIM8;PTPN2;STX4;P2RY12;P2RX4
prerank,fatty acid beta-oxidation (GO:0006635),-0.34887723811400734,-1.1826798833245689,0.19047619047619047,0.5336404071881276,1.0,21/51,24.39%,ABCD3;IVD;ACADM;ACAD10;ABCD2;ACAD11;CPT2;EHHADH;ACAA2;ABCD4;SLC25A17;BDH2;ECHDC2;ECI1;ACOX1;DECR2;AMACR;MECR;ACOT8;ACOX3;AUH
prerank,heterochromatin organization (GO:0070828),0.46375401125883964,1.182442470356566,0.221505376344086,0.6692870636361954,1.0,3/14,3.56%,MECOM;SIRT1;HMGA2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.31877271301146515,-1.1821061343156354,0.15267175572519084,0.5345106963334307,1.0,25/78,21.59%,PIAS1;DAB2;PRKN;LRRK2;ARIH1;CSNK1A1;GSK3B;RNF217;UBQLN1;RNF19A;CSNK1E;NUB1;TRIB2;SH3RF2;CBFA2T3;NOP53;HECTD1;FBXO22;VCP;RNF14;CSNK1D;COP1;ZYG11B;ARIH2;DET1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.40901608301994197,-1.1820826385712118,0.22823984526112184,0.534018669702818,1.0,12/26,31.20%,FBN1;HOXA7;PTPN2;TLR4;GPR137B;INHBA;TCTA;CDK6;MAFB;FSTL3;INHA;TLR3
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.39783736767470035,1.1817842376947327,0.20638297872340425,0.6697998950464507,1.0,11/26,21.65%,NAV3;OCLN;PAK1;STMN2;DCTN1;RPS3;TRPV4;RAC1;CLASP1;CDK5R1;CDK5RAP2
prerank,response to thyroid hormone (GO:0097066),-0.4841576589488721,-1.1817779823729926,0.25092936802973975,0.5342362212599228,1.0,4/13,9.09%,THRB;KLF9;CTSH;MED1
prerank,protein dephosphorylation (GO:0006470),-0.29630288804412747,-1.1817739082783403,0.13671875,0.5336900074434454,1.0,35/135,15.61%,EYA2;PTPN13;EYA1;EYA4;PPP1R12A;PPM1D;PPM1E;PTPN14;TNS2;BTRC;PTPN9;PTPRS;PTPN21;DUSP16;PTPN3;PTPRK;SSU72;PTPN22;DAPP1;PPP2CB;PPP4R2;PPM1H;PTPN12;PTPN2;DUSP11;PPM1M;PPP2R5E;MTMR3;PPM1A;DUSP1;PPP2R5D;CDC14B;NCK1;PPP1CB;DUSP10
prerank,regulation of defense response to virus (GO:0050688),-0.4864794887189034,-1.1817205934755872,0.2638146167557932,0.5332656472544699,1.0,5/14,16.06%,DHX9;PCBP2;RNF216;ILRUN;TRAF3
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.29665174027641916,-1.1816718218964042,0.14595660749506903,0.5328397035676573,1.0,37/128,19.50%,FBXL7;FBXL17;PCM1;PPP1R12B;PPP1R12A;BTRC;ALMS1;CCNH;ODF2;NINL;KHDRBS1;CEP63;CDK7;CEP135;PHLDA1;PCNT;FBXL12;CSNK1E;BRSK1;MNAT1;NES;MAPRE1;TPD52L1;LATS1;CDC25B;YWHAE;PPP1CB;AKAP9;CCDC57;DYNC1H1;CEP76;PRKACA;CEP57;FBXW11;CSNK1D;AJUBA;CDK2
prerank,neuromuscular process (GO:0050905),0.4365333026725355,1.1812635786119763,0.2388663967611336,0.6698746130448412,1.0,4/16,18.35%,NRXN1;DCTN1;GCH1;KCNA1
prerank,regulation of protein secretion (GO:0050708),0.29841869441964974,1.1808895701271973,0.12704918032786885,0.6695225788635716,1.0,16/119,6.38%,CD33;CACNA1A;SLC2A1;MTNR1B;SYT7;KCNC2;SNAP25;HADH;APBB1;RHBDF2;IL12A;KCNJ11;STXBP5L;APBB3;TGFB2;CACNA1E
prerank,synaptic vesicle recycling (GO:0036465),0.37844969430644154,1.1806737587410778,0.20758483033932135,0.6686563369726666,1.0,12/31,19.04%,SYT1;NLGN1;SYT7;SNCA;AMPH;SYT2;PLD2;SNCB;NLGN3;PACSIN1;SYNJ1;SYT5
prerank,regulation of DNA binding (GO:0051101),-0.35000729139887343,-1.1799974398635917,0.19160583941605838,0.5363570679545799,1.0,14/44,13.73%,IGF1;FOXC1;PRKN;SMO;HMGB1;SKI;CEBPG;SP100;NGF;JUN;HJURP;HES1;ILRUN;TXN
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3318313892941913,-1.1799043408904413,0.15760869565217392,0.5360184608089205,1.0,33/67,30.53%,PLD1;TBC1D16;DCDC2;ATP8B1;TBC1D19;TBC1D24;CDC42;USP6NL;FER;TBC1D2B;TBC1D20;IFT88;CAPZB;TBC1D22B;P2RX4;DYNC2LI1;ATG5;TBC1D17;RABGAP1;TBC1D10A;ABITRAM;FXR1;IFT140;RAB5A;TWF2;TWF1;TBC1D10B;RABEP2;ATG3;TBC1D9B;CAV1;ARF6;RDX
prerank,smooth muscle tissue development (GO:0048745),-0.5080210985373437,-1.1798262762401701,0.27697841726618705,0.5356388411343149,1.0,5/10,15.63%,MYLK;BMP4;SMO;EFEMP2;PTCH1
prerank,hyaluronan metabolic process (GO:0030212),-0.41807388644544474,-1.179069368254425,0.22889305816135083,0.5369181339873642,1.0,8/23,22.51%,CEMIP;SLC9A1;ABCC5;CEMIP2;GUSB;HEXA;FGF2;CHP1
prerank,snRNA transcription (GO:0009301),-0.3210799936951182,-1.1788919364168802,0.19094488188976377,0.5368089314465743,1.0,28/70,30.25%,CCNT2;CCNT1;INTS4;CDK7;PHAX;TBP;CCNK;RPRD2;NABP2;TAF8;TAF13;SNAPC3;GTF2B;ICE1;POLR2H;INTS6;INTS14;GTF2F1;POLR2K;SNAPC1;POLR2E;NCBP2;GTF2E2;SNAPC5;POLR2D;CDK9;INTS7;GTF2A1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.42224737666720946,-1.1787262617490077,0.2565543071161049,0.5366547022804328,1.0,3/21,0.97%,ATP1A2;CACNA1C;ANK2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.42534911642299356,-1.1779016555870678,0.2435129740518962,0.5382149005814332,1.0,5/20,10.53%,TGFBR1;ZMIZ1;PRKN;UBQLN1;HIF1A
prerank,aminoglycan biosynthetic process (GO:0006023),-0.347922185802679,-1.1776723283446142,0.1900990099009901,0.5382365173549962,1.0,18/49,19.60%,GPC6;SDC2;B3GALT1;HS3ST3A1;GPC4;GPC3;EXT1;HSPG2;HS2ST1;NDST1;NDST2;HEXA;PXYLP1;SDC4;HS6ST1;XYLT2;GCNT2;B4GALT7
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.5031584621896061,-1.177428128119468,0.275390625,0.5382519936157384,1.0,5/11,24.70%,PRKN;REST;HIF1A;PARK7;NONO
prerank,hemidesmosome assembly (GO:0031581),0.4970900285351027,1.1773684846965453,0.26411290322580644,0.6772029476866581,1.0,2/11,4.92%,ITGA6;DST
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.44702744937115835,1.1772501652302538,0.2324561403508772,0.6761392402627753,1.0,5/18,9.26%,LRP8;ADCY8;EPHA5;RPS6KA5;RELN
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5120143113788056,1.1768795513612131,0.26260504201680673,0.675719330148295,1.0,1/10,1.24%,KLRC1
prerank,regulation of cell size (GO:0008361),-0.4166636436983839,-1.1768307580614645,0.23626373626373626,0.5391724086918628,1.0,6/23,10.38%,DEPTOR;RPTOR;RARG;MTOR;VAV2;RHOA
prerank,negative regulation of DNA binding (GO:0043392),0.3964841667607406,1.1768015290618152,0.225531914893617,0.6744996311788777,1.0,7/28,13.19%,LEF1;HEY1;HMGA2;CPNE1;PER2;SIN3A;NFKBIA
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5161258276121076,-1.1766834109710085,0.2903225806451613,0.5390323691235711,1.0,6/10,26.43%,EMC2;EMC7;EMC9;EMC4;EMC10;EMC3
prerank,bone morphogenesis (GO:0060349),-0.46554430163057314,-1.1763871937272323,0.24814814814814815,0.5391891993602621,1.0,4/14,6.49%,LRP6;CYP26B1;SKI;FGFR2
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4747121986244308,-1.174977909152384,0.2650375939849624,0.5421591655434613,1.0,7/13,19.52%,PKD1;FLNA;PKD2;SUFU;LATS1;GET4;MDFI
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.4922580746150282,-1.1747430256055127,0.27307692307692305,0.5421560079548553,1.0,6/12,17.55%,NBL1;BMP5;WASL;CCN3;DUSP1;MIA3
prerank,mitochondrial membrane organization (GO:0007006),-0.3796435642627618,-1.174690802259958,0.22332015810276679,0.5417153992789081,1.0,12/32,30.72%,OPA1;BCL2;MICOS10;MTX3;RCC1L;HSPA9;BNIP3;APOO;SAMM50;MFN2;BAK1;PPIF
prerank,endocrine system development (GO:0035270),-0.42230965000127374,-1.1744600730843897,0.24029574861367836,0.5417599114316822,1.0,4/21,3.00%,TGFBR1;WNT4;GLI2;DKK3
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5008122537596147,1.1740098029471475,0.2676348547717842,0.6813916351991993,1.0,3/11,7.64%,CACNA2D1;BIN1;CACNB2
prerank,positive regulation of filopodium assembly (GO:0051491),-0.41349796633215585,-1.173859458471627,0.2426470588235294,0.5427161684484497,1.0,9/24,9.67%,DPYSL3;DOCK11;RHOQ;ARAP1;RIPOR2;BCAS3;NRP1;CDC42;WASL
prerank,regulation of leukocyte activation (GO:0002694),0.4636144476136621,1.1733089983615508,0.22707423580786026,0.6820319634523134,1.0,2/14,2.14%,CD33;MIF
prerank,regulation of response to external stimulus (GO:0032101),-0.29510964345796853,-1.1728559082375876,0.1663286004056795,0.5446128041176688,1.0,31/121,19.48%,FOXP1;APPL2;ADAMTS12;PDGFRA;EFNB2;CELF1;NR1D2;NMT2;CD55;SBNO2;ADGRA2;UFL1;ANXA1;GRK4;XIAP;PTPN22;CASP12;PTGES;TRIM5;AGTR1;APPL1;IRF1;PIK3AP1;P2RY12;P2RX4;TRAF3;MGLL;WNT5A;AREL1;PARK7;SHPK
prerank,purine nucleotide catabolic process (GO:0006195),0.47395991303440743,1.1728449870130468,0.2702702702702703,0.6819636414566526,1.0,3/13,12.70%,GPX1;NT5C;HINT1
prerank,blood vessel morphogenesis (GO:0048514),0.3377914842755064,1.1721137437198532,0.2045929018789144,0.6827422803923472,1.0,9/54,5.14%,FLT1;EGFL7;PROX1;RAMP2;CDH2;KDR;SLC1A1;TGFBR3L;ID1
prerank,vascular transport (GO:0010232),0.3151182096783165,1.1720169368400912,0.1751054852320675,0.681599108631309,1.0,12/81,4.45%,SLCO1C1;TFRC;SLC7A5;SLC6A6;SLC6A17;SLC2A1;ATP8A1;SLC2A3;SLC7A1;ABCG2;MFSD2A;SLC1A1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5158402621263755,-1.1720158513251786,0.2615658362989324,0.5461604256390232,1.0,3/10,7.83%,HMGB1;SH3RF1;RUNX1
prerank,response to UV-B (GO:0010224),0.4893423897468517,1.171902155441588,0.27765726681127983,0.6804974070558587,1.0,2/12,4.98%,MME;IL12A
prerank,regulation of immune effector process (GO:0002697),-0.35911766348309665,-1.171798988167632,0.20440881763527055,0.5461122410170506,1.0,5/41,3.77%,CFH;SERPING1;VTN;CD55;PROS1
prerank,peptidyl-lysine acetylation (GO:0018394),-0.5067863317781814,-1.1714733372483146,0.27606177606177607,0.5463640581523163,1.0,4/10,14.14%,KAT2B;EP300;CREBBP;ESCO1
prerank,regulation of osteoblast proliferation (GO:0033688),-0.4352963597790692,-1.1712542627503462,0.24953445065176907,0.546286887871389,1.0,10/17,21.31%,NPR3;FGFR2;MN1;RHOA;CCN1;ATRAID;EIF2AK2;PLXNB1;BMP2;TMEM119
prerank,vasculogenesis (GO:0001570),0.371092860093991,1.1711483557386573,0.21267893660531698,0.6814604434691951,1.0,7/32,7.40%,EGFL7;RAMP2;KDR;TGFBR3L;NOTCH1;WNT7B;APLNR
prerank,L-amino acid transport (GO:0015807),0.39202624741071657,1.1710408368293572,0.2452431289640592,0.6803503780235169,1.0,6/28,9.70%,SLC7A5;SLC7A1;SLC1A1;SLC1A2;SLC7A8;SLC36A1
prerank,regulation of autophagosome maturation (GO:1901096),-0.47407525783271354,-1.171018226818794,0.2670250896057348,0.5463156496138594,1.0,5/13,27.06%,UVRAG;RUBCN;IRGM;UBQLN4;ADRB2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.4587011677314312,-1.1708773116950204,0.2603550295857988,0.5461378176902189,1.0,4/16,11.36%,APPL2;NCOR1;WDTC1;ERLIN1
prerank,positive chemotaxis (GO:0050918),0.4401289943715906,1.170741120861349,0.24786324786324787,0.6798195066646562,1.0,6/17,10.81%,PLXNB3;FGF10;PTPRJ;GPNMB;CORO1A;SCG2
prerank,regulation of multicellular organism growth (GO:0040014),-0.45724872620547413,-1.1706715653751139,0.25824175824175827,0.5460767033663646,1.0,5/15,18.04%,IGF1;GHR;PTCH1;STAT5A;STAT5B
prerank,gland development (GO:0048732),-0.3342197078979041,-1.1700910610031467,0.1955193482688391,0.5469432504996975,1.0,17/59,16.85%,TGFBR3;TGFBR1;WNT4;GLI2;DKK3;FGFR2;ANXA1;CEBPG;ZBTB1;PHF2;HES1;ARID5B;PKD2;TGFB3;SALL1;CITED2;SIX1
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.31343222847959673,-1.1700584680163648,0.18625678119349007,0.5464744129586896,1.0,24/84,17.34%,ROCK2;FOXP1;SASH1;ANGPT1;PLPP3;FGF1;BMP4;ABL1;SPARC;HMGB1;THBS1;BCAS3;FOXC2;NRP1;PDPK1;PLCG1;HIF1A;ANXA3;VEGFA;P2RX4;ATOH8;PIK3CD;PRKD1;STAT5A
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.287056403756193,1.1691188006238267,0.14549180327868852,0.6833142156122212,1.0,31/152,16.76%,ADGRL4;ADGRL3;ADGRB3;RGS1;ADCY3;ADCY8;RAMP2;ADGRB1;GRM8;S1PR5;PDE2A;LGR5;MTNR1A;ADCYAP1;GPR26;GNAL;ADRA1D;ADGRL2;ADCY4;CNR1;OPRK1;PTGER2;ADGRG1;CHRM2;OPRL1;GNAI1;ADCYAP1R1;PTGER4;CALCRL;GNAQ;ADGRE1
prerank,cortical cytoskeleton organization (GO:0030865),-0.3559636010837174,-1.1683647178206569,0.2261904761904762,0.5501361718255328,1.0,13/41,20.52%,ROCK2;RHOQ;ROCK1;DLG1;RND3;FHOD1;RHOA;NCKAP1;RHOBTB2;RHOBTB1;RHOH;RHOC;PPP2R3C
prerank,membrane organization (GO:0061024),0.2719600485409945,1.168341880209148,0.09940357852882704,0.6842765492759783,1.0,61/227,19.28%,TFRC;DNM3;ACTB;SYT1;RIMS1;SGCZ;SH3GL2;AP2M1;ANK3;REEP1;BIN1;LPCAT2;SLC18A3;CERT1;ATP10B;HIP1;HSPA8;FNBP1L;AMPH;NAPG;FCHO1;RPS27A;UBC;DYSF;SCARB2;UBB;AP2B1;SAR1A;SUN1;SYT2;SPTBN1;LEMD2;CCDC88A;PLEKHA3;SERP1;FZD4;CNTN2;CPTP;TTPA;SGIP1;SH3KBP1;SNAP29;PPT1;NECAP1;CLTB;CHRM2;CORO1C;REEP3;CHMP2B;CFTR;RTP4;M6PR;DNM1;PDCD6IP;ARPC1A;GAK;ATP2C1;SYNJ1;HGS;OXA1L;VPS4A
prerank,neutrophil activation involved in immune response (GO:0002283),0.25863153020301155,1.1682765927498664,0.07100591715976332,0.6830299984672058,1.0,91/428,17.97%,CD33;PTPRB;PTPRN2;CD93;TMEM30A;PGLYRP1;PRG2;LRRC7;ATP8A1;DNASE1;SLCO4C1;HRNR;MME;SLC2A3;RAB4B;ATP11A;MIF;S100A9;S100A8;FTH1;SLC2A5;TOLLIP;ENPP4;SNAP25;PGAM1;QPCT;SVIP;CSNK2B;HSPA8;NME2;TLR2;DYNLL1;TRPM2;NFASC;NDUFC2;CPNE1;PTPRJ;PECAM1;BRI3;EPX;FTL;HSP90AB1;PSMD12;ARSA;GOLGA7;LAIR1;HEBP2;ALDOC;SLPI;BIN2;GGH;GLA;PDAP1;FABP5;CCT2;ACTR10;TSPAN14;CTSB;ITGAM;VAT1;CD36;LCN2;HGSNAT;PSEN1;EEF1A1;SNAP29;ATP11B;B2M;PTGES2;COTL1;IDH1;RHOF;SCAMP1;LTA4H;RNASE3;PSMA2;STK11IP;RAP1A;PSMC3;XRCC5;RAP2B;RAB31;HSP90AA1;ATP6V0A1;GLB1;TMBIM1;ARL8A;C3AR1;PPIA;HEXB;EEF2
prerank,fatty acid catabolic process (GO:0009062),-0.32722013536379735,-1.1678460046235615,0.20156555772994128,0.5508036766755676,1.0,24/67,24.39%,PCCA;ABCD3;ACADM;MMUT;ACAD10;ABCD2;ACAD11;CPT2;ABHD3;EHHADH;ACAA2;ABCD4;SLC25A17;BDH2;ECHDC2;ECI1;LPIN2;ACOX1;LPIN3;MECR;MCEE;ACOT8;ILVBL;AUH
prerank,regulation of neuroblast proliferation (GO:1902692),-0.4589211830800154,-1.1676828783353737,0.25691699604743085,0.5506868657747086,1.0,6/15,25.54%,PTN;LRRK2;VEGFA;CX3CR1;SMARCD3;KDM1A
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.30494499905737016,-1.1674480655599861,0.16023166023166024,0.550730066024642,1.0,26/94,21.39%,ITPR1;FHIT;DDX5;PDK1;ABL1;BCL2;MAP3K5;AIFM1;CYP1B1;TRAF2;PRKCD;PRODH;CUL3;CASP2;ERN1;PRKDC;CUL2;DDX3X;TOPORS;IKBKE;RRP8;MSH6;PML;ATP2A3;BNIP3;CUL1
prerank,carboxylic acid transport (GO:0046942),0.33830217799253476,1.1672599234044665,0.18962075848303392,0.6846326010853004,1.0,10/55,10.76%,SLC7A5;SLC6A6;SLC6A17;SLC7A1;AQP9;SLC1A1;SLC7A8;SLC66A1;SLC36A1;SLC16A4
prerank,plasma membrane organization (GO:0007009),-0.3251701513765368,-1.166547426196598,0.20192307692307693,0.5524384390345334,1.0,16/61,12.15%,ANK2;COL5A1;ANXA6;A4GALT;PLSCR2;PLSCR4;PACSIN2;MYOF;SNX9;PLSCR1;EHD2;CHMP4A;ABCD2;TLCD2;STX4;UGCG
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.27836120650218943,-1.1665429008163968,0.10493827160493827,0.5518907605210717,1.0,48/199,18.94%,ROCK2;ALDH1A1;EGFR;LDLRAD4;RBPJ;SMAD6;ZNF423;LGR4;BMP5;BMP4;ROCK1;ROBO1;NPR3;WWC2;NFIB;GSK3B;DOCK7;ADAMTS5;HOXA7;TWSG1;FOXC2;SRSF6;GJA1;LAMA4;NRDC;NR1H3;MEF2C;WWC1;ATP2B1;IL17RD;RB1;TBX18;ACOT11;ARHGDIB;BRCA2;IL17D;LNPEP;DUSP10;PTCH1;VASN;IFNGR1;TLR4;PLCL1;HMGCR;CHSY1;ABHD6;BMP2;CYP51A1
prerank,striated muscle tissue development (GO:0014706),-0.3782658937098885,-1.1661543707277198,0.23983739837398374,0.5523261189584716,1.0,6/29,6.00%,SVIL;BMP5;CFLAR;BMP7;RBP4;IGSF8
prerank,positive regulation of phosphorylation (GO:0042327),-0.27003268438410716,-1.1661245926390649,0.12024048096192384,0.5518176491093666,1.0,37/240,7.88%,ZBTB20;ROCK2;IGF1;EGFR;ROR1;LMO4;LEPR;EPHA7;EPHA3;PDGFRA;IL34;SLCO3A1;ANGPT1;NTRK3;PELI2;FGF1;AXL;PDGFRB;DAB2;BMP4;FAM20A;ABL1;PRKAA2;ARNT;LRRK2;KIT;RYK;THBS1;AXIN1;NBN;FGFR2;LYN;PFKFB4;NRP1;MERTK;EPHA4;AR
prerank,Golgi to lysosome transport (GO:0090160),-0.4876771498627837,-1.1659847597218833,0.27636363636363637,0.5516198493333665,1.0,4/11,18.53%,CCDC91;EHD3;LAMP1;ANKFY1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.483413472201206,-1.165691178952032,0.2796934865900383,0.5517839419124252,1.0,5/12,17.07%,DPYSL3;CTPS2;ALDH6A1;DPYD;CTPS1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.4023436972691986,1.1655604140833766,0.22792607802874743,0.6884144890717475,1.0,6/23,16.13%,CHEK1;BUB1;WEE2;NABP1;CHFR;PLK2
prerank,protein localization to cell-cell junction (GO:0150105),-0.4665602275118556,-1.1645429479062561,0.2628458498023715,0.5540482323087812,1.0,5/15,10.96%,CGNL1;MPP7;JAK1;PAK2;ARHGEF18
prerank,heart process (GO:0003015),0.45806646808678997,1.1643907168141423,0.28603603603603606,0.6906109227082432,1.0,3/14,10.37%,SGCZ;GPX1;SGCG
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.4639597324172981,-1.1635554068347056,0.2783882783882784,0.5559626189798809,1.0,5/14,22.91%,ANXA1;NFKBIZ;PRKCZ;IL18;CD80
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.4177190586071954,-1.1632705315719283,0.26765799256505574,0.556127818668753,1.0,4/21,7.58%,ANK2;FLNA;SNTA1;CACNA1D
prerank,phosphatidylcholine metabolic process (GO:0046470),0.31811653024167247,1.1628746531154497,0.1988071570576541,0.6937643626935894,1.0,11/70,9.15%,MBOAT1;MFSD2A;LPCAT2;PCYT1B;CHKA;ENPP2;CSNK2B;PLAAT1;TMEM86B;SLC44A5;PLA2G12A
prerank,methylguanosine-cap decapping (GO:0110156),-0.5098050632522829,-1.1627885816229016,0.29672447013487474,0.5567601832706518,1.0,3/10,14.49%,DCP1A;DCP1B;EDC3
prerank,DNA double-strand break processing (GO:0000729),-0.435298108705717,-1.1623878397960175,0.2678227360308285,0.5571790083482885,1.0,3/18,5.92%,UBE2N;RBBP8;NBN
prerank,lipid phosphorylation (GO:0046834),0.5018517571033345,1.1623745418725744,0.28297872340425534,0.6938204336934626,1.0,3/10,7.33%,DGKI;DGKH;DGKB
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.42889075348679556,-1.1623277724812417,0.26811594202898553,0.5567757990880857,1.0,2/19,0.80%,BMP6;AFDN
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.4512927029453612,-1.1619118026177095,0.2722117202268431,0.557289119939092,1.0,3/15,2.86%,IGF1;OPA1;PRKN
prerank,neuron maturation (GO:0042551),0.43541606455136206,1.1618104491156445,0.28199566160520606,0.6940761694512004,1.0,4/18,8.62%,ADGRB3;SCARF1;SRRM4;B4GALT6
prerank,peptidyl-proline modification (GO:0018208),-0.4002813404157687,-1.161804196178839,0.2756052141527002,0.556993602984928,1.0,11/25,30.72%,FKBP5;FKBP10;FKBP7;PPIH;PPWD1;NKTR;NTMT1;PPID;PPIC;PPIL1;PPIF
prerank,Notch signaling involved in heart development (GO:0061314),-0.4976769496935555,-1.1617067847702003,0.2947976878612717,0.5566822235375789,1.0,3/11,3.17%,NOTCH2;RBPJ;JAG1
prerank,positive regulation of GTPase activity (GO:0043547),-0.27428210239944995,-1.1617021216595733,0.11948529411764706,0.556144962778599,1.0,56/188,22.53%,ARHGAP29;ARHGAP42;DOCK11;AFDN;ASAP3;SIPA1L1;NTRK3;LIMS1;TIAM2;ARAP1;TBC1D16;GSK3B;DOCK7;BCR;SGSM2;ARHGAP24;ITGB1;BCAS3;SNX9;MMUT;RAB3GAP1;GMIP;MAP4K4;RAPGEF3;S100A10;ZC3H15;RSU1;NDEL1;USP6NL;TBC1D2B;TBC1D20;TBC1D8B;TBCK;GRTP1;TBC1D22B;TBC1D9;RAPGEF2;NGEF;PLXNB1;RAB11FIP2;PICALM;TBC1D17;RALGAPB;TBC1D7;SIPA1L3;RAPGEF1;RABGAP1;TBC1D10A;RALGAPA2;LARS1;DVL3;SCRIB;EZH2;ARHGAP27;F11R;ALS2
prerank,positive regulation of translation (GO:0045727),-0.3033684276500672,-1.1616208203196836,0.16699801192842942,0.5558068954944657,1.0,26/94,23.96%,SAMD4A;PLD1;VIM;ZCCHC4;YTHDF3;KHDRBS1;THBS1;DHX9;MTOR;LARP1;HNRNPD;DHX36;PLXNB2;RCC1L;YBX3;CDC123;PRKDC;DDX3X;UPF3A;PKM;RMND1;UPF3B;PYM1;RPUSD4;EIF2B5;JMJD4
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5199666355000196,-1.1607799373355314,0.2980599647266314,0.5573551925583886,1.0,3/10,7.33%,ATP1A2;OSR1;CAMK2D
prerank,import into cell (GO:0098657),-0.35758417281333216,-1.1606278472741163,0.22135922330097088,0.5571780725083266,1.0,12/41,13.97%,ATP1A2;SLC6A13;SLC1A3;SLC47A1;SLC5A3;SLC39A14;SLC12A7;LRRC8D;GLUL;SLC5A6;SLC22A4;SLC27A1
prerank,negative regulation of cell growth (GO:0030308),0.29381165930442277,1.160440626698221,0.15517241379310345,0.6968609159441135,1.0,30/121,17.56%,DCC;MINAR1;MAG;GNG4;FGF13;SIRT1;MAP2;APBB1;TGFB2;SCGB3A1;PPP2R1A;SLIT3;WFDC1;PTPRJ;ACVRL1;RTN4R;APBB2;SOX17;DIP2B;NDUFA13;BMPR2;SMARCA2;PPT1;CDKN1A;RTN4;CDKN1B;NPR1;DNAJB2;CDKN2AIP;RERG
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.3435408240874136,-1.160130208431835,0.19715447154471544,0.5579025535331759,1.0,13/49,15.88%,KAT2B;EP300;TNRC6B;KMT2C;TNRC6A;KMT2D;THBS1;MOV10;RUNX1;MEF2C;PITHD1;HDAC1;TNRC6C
prerank,positive regulation of ruffle assembly (GO:1900029),0.46303242456944765,1.160100906876632,0.25820568927789933,0.6965461444407574,1.0,4/13,13.92%,NLGN1;FAM98A;HRAS;PFN1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.3154072361494976,-1.1600371501345643,0.17849898580121704,0.5576096324244272,1.0,24/72,26.77%,RBFOX2;HNRNPH1;FLRT2;FGF1;SHOC2;HNRNPM;FGFR2;FRS2;KIF16B;KL;FLRT1;FIBP;FGFBP1;POLR2H;CEP57;PTPN11;FGFR4;SPRED2;FGF2;GTF2F1;POLR2K;POLR2E;NCBP2;FGFRL1
prerank,response to alcohol (GO:0097305),0.3807868942166871,1.159954284564793,0.22608695652173913,0.6955348857634729,1.0,5/27,6.31%,GRIN1;GLRA1;GRIN2A;GRIN2B;SLIT3
prerank,regulation of plasminogen activation (GO:0010755),-0.48707998902676763,-1.1596974525101817,0.2783109404990403,0.5578749436178044,1.0,4/12,17.05%,CLEC3B;THBS1;RUNX1;SERPINE1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.36385803471554373,1.1592955912508656,0.2345415778251599,0.6960300587080158,1.0,18/38,24.51%,MAGI2;SIRT1;PHLPP1;TRIB3;PTPRJ;AKT1;CIB1;PPP2R5B;PDCD6;ARRB2;HYAL2;RACK1;EPHA2;DDIT3;PHLDA3;FLCN;PIK3CB;THEM4
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.38130079519696325,1.158967997535698,0.23870967741935484,0.6955982467557502,1.0,4/29,12.62%,CADM1;IL12A;CYRIB;ITGAM
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.4829454339256133,-1.158947187200941,0.2786885245901639,0.5592189934475374,1.0,3/13,7.83%,GLI3;TGFBR2;RUNX1
prerank,fatty acid transmembrane transport (GO:1902001),-0.42489142484882303,-1.1589000234451832,0.25763358778625955,0.5587975638947179,1.0,8/19,13.97%,PRKAG2;PRKAA2;ABCD3;ABCD2;CPT2;PRKAB2;ABCD4;SLC27A1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3896493873982839,-1.1588198504113225,0.23946360153256704,0.5584746693332323,1.0,10/27,20.30%,AHNAK;ANK2;JPH1;CAMK2D;SELENON;YWHAE;ADRA2A;CACNB1;PRKACA;NOS1
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.48855192031916456,-1.1586904865748175,0.28909090909090907,0.5582569936335742,1.0,4/11,23.72%,IL34;ID2;HSF1;PRKCA
prerank,regulation of humoral immune response (GO:0002920),-0.34640872624955993,-1.1577772078655997,0.22762645914396887,0.5599855073645574,1.0,5/44,3.77%,CFH;SERPING1;VTN;CD55;PROS1
prerank,replicative senescence (GO:0090399),0.4761283437189221,1.1575303155510785,0.26931106471816285,0.6986374213539189,1.0,2/12,1.61%,CHEK1;MME
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.3986157874015915,-1.157408094483393,0.2571428571428571,0.5603907697768985,1.0,3/24,3.75%,EPHA7;FOXO3;NUPR1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.3829007903085815,1.1573596683494416,0.23949579831932774,0.6977775139995708,1.0,7/31,11.20%,LRP8;NLGN1;SHANK3;KIF1A;ZDHHC15;RELN;PPFIA2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.43809096163394035,-1.1573078505663617,0.27151051625239003,0.5600838032698127,1.0,4/17,5.28%,MCU;CAMK1D;RIPOR2;DNM1L
prerank,amino acid import (GO:0043090),0.40843642150245807,1.1569898281463205,0.24,0.6975126731224945,1.0,6/21,9.70%,SLC7A5;SLC6A6;SLC7A1;SLC1A1;SLC7A8;SLC36A1
prerank,regulation of centrosome duplication (GO:0010824),-0.38236743939223583,-1.1568608647266108,0.23674242424242425,0.5606363505047218,1.0,19/29,36.09%,ALMS1;SPICE1;VPS4B;CHMP4B;CHMP5;CHMP3;CENATAC;CEP295;CEP76;FBXW5;NAT10;STIL;CCNF;CEP295NL;CHMP1B;CHMP1A;GEN1;NPM1;CEP131
prerank,positive regulation of double-strand break repair (GO:2000781),-0.3562984139242972,-1.1568596269970302,0.24339622641509434,0.5600961401792293,1.0,14/39,17.73%,KMT5B;SPIDR;FUS;WDR48;SHLD2;PARP9;PARP1;SLF1;KMT5C;DTX3L;MMS19;PRKDC;SMCHD1;ARID2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.3811755885987915,-1.1563712684343836,0.2418426103646833,0.5607504261642509,1.0,12/31,21.54%,KANK2;FHL1;BRD7;DLG1;DACT1;PRMT2;RB1;PKD2;FAM107A;DCUN1D3;CDC73;CDK6
prerank,regulation of glucose metabolic process (GO:0010906),-0.3635550901595437,-1.155964382578624,0.2198852772466539,0.5612187707381351,1.0,12/34,21.11%,PDK1;PRKN;IRS1;USP7;FOXK1;SELENOS;ZNF692;OGT;RORA;FOXK2;BCKDK;AKT2
prerank,regulation of programmed cell death (GO:0043067),0.2807372209328994,1.1550827681520404,0.1515748031496063,0.7019928389389687,1.0,37/161,16.42%,PAX8;MECOM;LRP8;OMA1;HTATIP2;LCMT1;SIRT1;ACER2;PAX2;FLT3;HIP1;NME2;ALK;CLU;PHLPP1;AKT1;TPT1;NUP62;TRIM24;BCL3;APEX1;RABGGTA;CTSB;TNFRSF25;BCAR1;ANP32A;ACTN4;RPS3;ATM;MADD;USP42;NDRG1;RTN4;GLS2;FANK1;RAF1;MAGED1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.3894108776832159,-1.154403011771301,0.246,0.5645101073108628,1.0,8/26,17.84%,APPL2;LGR4;FLOT2;IRAK3;APPL1;IRF1;OTUD4;LRRC14
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.46584290530350786,1.1543536702447854,0.2968421052631579,0.7029149298182533,1.0,3/12,9.89%,ACTB;AHI1;VANGL2
prerank,neutrophil activation (GO:0042119),0.46965747927029344,1.1540156171631195,0.2788671023965142,0.7025237626128727,1.0,2/12,6.71%,DNASE1;PREX1
prerank,protein destabilization (GO:0031648),-0.3704827453306065,-1.153305928796524,0.2391713747645951,0.5667525418177685,1.0,12/32,21.97%,GSN;EP300;PRKN;BTRC;CTSH;CREBBP;GGA3;CUL3;DERL1;FBXW11;CDC73;SENP2
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.2947346764117583,-1.1532045100551849,0.17300380228136883,0.5665036468665258,1.0,45/110,24.23%,TRABD2B;GSN;ABCA1;MPP7;EP300;GSK3B;SPIDR;STXBP1;BRK1;CDC42;IMPACT;TRAF2;HCFC1;ATF7IP;HJURP;RIOK3;FNIP1;RB1;SLF1;GFAP;EIF2AK2;VEGFA;PRKCZ;APOE;LATS1;DDX3X;NOP53;FARP2;ICE1;IAPP;NAPA;VCP;RHOC;PARK7;AJUBA;PTPN11;KIF9;FBLIM1;BMF;PIH1D1;HSF1;PREB;SAR1B;GNL3L;SYK
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.46988183471455525,-1.1530309095832265,0.2744721689059501,0.566372506400316,1.0,2/14,3.07%,ZEB1;OSR1
prerank,protein-containing complex disassembly (GO:0032984),-0.33342830028906245,-1.1528264171476081,0.22310756972111553,0.5663174287264653,1.0,12/54,10.16%,LRP6;CSNK1A1;UVRAG;GSK3B;AXIN1;FZD2;UBQLN1;VTI1B;VAMP7;LIX1L;LAMP2;CHMP3
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.41264157832613524,-1.1525762163087785,0.2613430127041742,0.5664185204111711,1.0,10/21,26.97%,SMO;DCDC2;TTC23;EVC;ARMC9;GLI1;PDCL;DLG5;KIF7;GAS8
prerank,regulation of cell population proliferation (GO:0042127),-0.24222592233220164,-1.1525658661639644,0.04771784232365145,0.5658957661794303,1.0,176/691,21.54%,BMP6;IGF1;GRK5;EGFR;ALDH1A2;TCF7L2;GAB2;TGFBR1;ZBTB7C;RBFOX2;BMPR1A;PTN;KANK2;PDGFRA;IL34;NTRK3;EFNB2;SMAD6;LIMS1;CELF1;COL4A3;MDM4;BMP5;ITGAV;FGF1;DIS3L2;KSR1;KAT2B;PDGFRB;PIAS1;IL31RA;IL6ST;BMP4;HDAC4;PDPN;ELN;PPM1D;BIRC6;NPR3;PTPN14;JAG1;TGFBR2;TNS2;PODN;BRD7;FRK;NUPR1;KIT;LMNA;GSDME;CLMN;NIBAN2;YAP1;IRS1;IGFBP3;RARG;KMT2D;TGFB1I1;CTSH;IL13RA1;IGFBP6;THBS1;DPP4;SKI;GAREM1;SPEG;UFL1;STAT3;TMEM127;FGFR2;SHC1;NOX4;LYN;BCL2;TES;REST;P3H3;WNT9A;RUNX1;AR;ACER3;IGF2;PTPRK;XIAP;MAP2K1;CDK13;JUP;BTG3;FER;NGF;EGLN3;PDGFC;JUN;CYP1B1;PTPN2;RHOA;COL18A1;ID2;CNOT8;STX4;ABI1;HES1;AGTR1;PDS5B;FN1;CUL3;IL6R;PKD2;CDC123;TRPM4;IRF1;FKTN;GLI1;COPS8;RBM5;CCAR1;CD164;ING5;EIF2AK2;VEGFA;PRKDC;STAT1;ROR2;CBFA2T3;RAPGEF2;VEGFD;CIAO1;CDC25B;HDAC1;IGFBP7;CSNK2A1;MNT;NCK2;TGFB3;ADRA2A;SIX1;TBX2;ADAMTS1;STAT5A;TCIRG1;PHIP;S100A11;ARID2;DHPS;SQLE;STAT5B;CACUL1;PTGFR;SOD2;PPP2R5C;FGFBP1;IFI35;BMP2;GCNT2;HBEGF;SFRP4;INHBA;CDK2;CDK10;PBRM1;PML;CDC73;IFIT3;FGFR4;NME1;NF2;ZBTB49;FRZB;AKT2;XRCC6;GID8;TRAPPC14;ECRG4;FXN;CRKL;CDK6
prerank,sensory organ development (GO:0007423),-0.33509203185956665,-1.152194240429191,0.22429906542056074,0.5662948507817592,1.0,9/51,9.12%,PBX1;SMOC1;FOXC1;SH3PXD2B;SHROOM2;RBP4;PBX3;ECE1;HIPK1
prerank,muscle tissue morphogenesis (GO:0060415),-0.44476331961840115,-1.1521781060584135,0.2918287937743191,0.5657903839528942,1.0,3/16,2.60%,TGFBR3;MYLK;BMP4
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.49919160161679066,-1.1514830977310553,0.2959558823529412,0.5663854624969336,1.0,3/10,12.42%,FTO;ASCC3;ALKBH1
prerank,DNA dealkylation (GO:0035510),-0.49919160161679066,-1.1514830977310553,0.2959558823529412,0.5663854624969336,1.0,3/10,12.42%,FTO;ASCC3;ALKBH1
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.39972639926262077,-1.1513201915301436,0.26763110307414106,0.5662166498741853,1.0,5/23,8.55%,NUMA1;UBXN2B;ITGB1;GJA1;NDEL1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3632677826885152,1.151170707157556,0.24842105263157896,0.7097092849429504,1.0,11/34,13.93%,PDE4B;RYR2;SLC8A1;ADRA1A;RNF207;CALM1;SMAD7;PDE4D;CALM2;ATP1B1;CALM3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.3135390927161856,-1.1509001312133793,0.19681908548707752,0.5666978631320609,1.0,13/75,5.41%,ROCK2;SULF1;WNT4;DCN;COL4A3;FOXC1;ROCK1;SPARC;NIBAN2;HSPG2;THBS2;THBS1;HOXA5
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.41794678508312955,1.1502767921344288,0.2616033755274262,0.7110536247937702,1.0,2/18,8.75%,CAMK2A;HEBP2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.37717390838994164,-1.1501918290617192,0.27552986512524086,0.5679775496066951,1.0,7/29,9.66%,NOTCH2;IGF1;ITGAV;SHOC2;SHC1;LYN;NGF
prerank,regulation of macrophage chemotaxis (GO:0010758),0.41187380571879134,1.150185780560399,0.27253218884120173,0.7099250299168745,1.0,3/21,4.94%,CSF1R;MIF;MTUS1
prerank,myofibril assembly (GO:0030239),-0.34963141315508783,-1.149889787274762,0.22727272727272727,0.5681626457271952,1.0,7/42,8.42%,PDGFRA;TPM1;CFLAR;PDGFRB;TMOD3;OBSL1;ACTN2
prerank,presynapse organization (GO:0099172),0.502244939412402,1.149673838967435,0.3123644251626898,0.7100023023058512,1.0,4/10,15.49%,LRRTM3;NLGN1;DVL1;NLGN3
prerank,regulation of cell morphogenesis (GO:0022604),-0.3775373678275583,-1.1493772982088115,0.25493716337522443,0.5688781631642044,1.0,9/30,13.54%,PDPN;SPARC;MYO9A;WTIP;BCL9L;MOV10;ZMYM4;ZMYM3;CAPZB
prerank,positive regulation of translational initiation (GO:0045948),-0.4279964786345727,-1.1493368616776054,0.274582560296846,0.5684318561558628,1.0,6/18,15.01%,YTHDF3;KHDRBS1;MTOR;LARP1;CDC123;DDX3X
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.36366887112321417,-1.1489261219290356,0.28544423440453687,0.5689778621615118,1.0,16/33,26.30%,EGFR;ANKRD17;UBE2E2;RPTOR;STXBP4;ANXA1;GLI1;DDX3X;CCND3;ADAMTS1;EIF4G1;CDC73;EZH2;KMT2E;PHB2;LSM11
prerank,regulation of developmental growth (GO:0048638),-0.3843055896875585,-1.1482542057088738,0.2740740740740741,0.5700996858025218,1.0,12/29,18.99%,IGF1;GHR;ABL1;GSK3B;NIPBL;CTTN;APOE;LATS1;SIX1;STAT5A;STAT5B;MUSK
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.31953619107661624,1.1480208754957273,0.22012578616352202,0.7136762148307411,1.0,12/72,7.83%,FLT1;IGF1R;TEK;SIRT1;KDR;NTRK2;SEMA4D;FLT3;TGFB2;PIK3R5;UNC5B;EPO
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.36535333782149904,1.147761372221087,0.25149700598802394,0.7130704890464625,1.0,9/35,14.41%,FAR2;HPGD;GGT7;SCD;GGT1;HMGCLL1;BDH1;FAR1;PPT1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.44669065211955494,1.147696478975924,0.2854077253218884,0.7118496710974169,1.0,2/14,3.32%,PRKAR2B;SIRT1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.5040672151050462,-1.1475421254984493,0.2933579335793358,0.5713258049751008,1.0,5/10,24.29%,BMP5;HOXA7;EMILIN1;CD300A;SLIT2
prerank,regulation of cholesterol efflux (GO:0010874),0.3845904610237065,1.146852411532537,0.24686192468619247,0.7129345268901672,1.0,5/30,8.64%,PLTP;SIRT1;PPARG;NAXE;GPS2
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4909280045042175,1.1468337911459912,0.30526315789473685,0.7115970307607278,1.0,3/10,5.76%,B3GAT1;B3GAT2;CSGALNACT1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.36933025178656587,-1.1468022736285564,0.2631578947368421,0.5726842012840353,1.0,13/33,22.87%,KANK2;FHL1;BRD7;DLG1;DACT1;PRMT2;RB1;PKD2;FAM107A;DCUN1D3;CDC73;CDK6;PLK5
prerank,amide transport (GO:0042886),0.3842044011356652,1.1463312087919342,0.2612244897959184,0.711769809921586,1.0,4/26,4.45%,PLTP;ABCG2;AQP11;CERT1
prerank,positive regulation of cellular component movement (GO:0051272),0.3936284346442572,1.1460925677491947,0.2751677852348993,0.7111364616040964,1.0,6/24,12.95%,SPOCK2;CSF1R;RPS19;ETS1;NTN1;ACTN4
prerank,glycerophospholipid metabolic process (GO:0006650),0.31338291488340586,1.1458493477646639,0.21314741035856574,0.7104869745513468,1.0,22/75,19.36%,GPCPD1;CSF1R;PGP;PLCB1;DGKH;PLAAT1;CPNE1;PIGM;SERINC1;CRLS1;FAR1;PIP5K1A;PIGW;CPNE7;GPLD1;PLA2G4E;PNPLA3;PNPLA6;PIGG;SYNJ1;ACP6;PRDX6
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.38874791131071273,-1.1458138597384038,0.25440313111545987,0.5745609875546495,1.0,4/24,3.96%,ITPR1;ITPR2;ANXA6;IBTK
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3609879179443503,-1.145635527804692,0.25793650793650796,0.5744516629153911,1.0,15/36,24.73%,FHIT;USP7;RPL11;GIPC1;PSMF1;OGT;TRIM39;NOP53;PSME3IP1;PARK7;WAC;CCAR2;BAG5;BAG6;EIF3H
prerank,membrane lipid biosynthetic process (GO:0046467),0.32856816100209313,1.1451901141088474,0.22839506172839505,0.7111472456288116,1.0,18/58,18.32%,SGMS1;FA2H;ACER2;DEGS2;CERT1;SPNS2;ELOVL7;SGPP2;ELOVL4;HACD3;ST8SIA6;HACD1;PPM1L;SAMD8;PRKD3;KDSR;SGPP1;SPTLC2
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3908963477497392,1.144831968826379,0.28451882845188287,0.7108882726771317,1.0,10/27,17.37%,TIRAP;TLR2;RPS27A;UBC;UBB;HSPD1;CD36;TAB2;BTK;TNIP1
prerank,mitotic cell cycle phase transition (GO:0044772),-0.2680930370029518,-1.1444818554680698,0.162426614481409,0.5768578616468638,1.0,69/203,24.93%,FBXL7;FBXL17;PCM1;PPP1R12B;PPP1R12A;BTRC;ALMS1;CCNH;ODF2;NINL;KHDRBS1;CEP63;CDK7;CEP135;PHF8;PHLDA1;PCNT;FBXL12;CHMP4B;ANAPC7;CSNK1E;EIF4E;BRSK1;MNAT1;NES;RB1;CUL3;MAPRE1;TPD52L1;CRLF3;HINFP;LATS1;CDC25B;CUL2;YWHAE;ACVR1;CCND3;RCC1;PPP1CB;AKAP9;CCDC57;CDC27;NASP;DYNC1H1;CEP76;PRKACA;UBE2S;CACUL1;CEP57;FBXW11;CSNK1D;AJUBA;INHBA;CDK2;CUL1;CDK6;HAUS7;TAF2;HAUS8;ACTR1A;BORA;DBF4;CCNJ;MASTL;CCNE2;EIF4EBP1;CDC16;ANAPC1;CTDP1
prerank,cellular response to estradiol stimulus (GO:0071392),-0.42085295835859315,-1.1444494151526203,0.29963235294117646,0.5763859685695006,1.0,2/18,5.24%,EGFR;LCOR
prerank,cellular component assembly (GO:0022607),-0.2620984918584949,-1.1441420373765765,0.13518886679920478,0.5765600576344838,1.0,68/253,21.65%,CALD1;DPYSL3;PARVA;PAWR;RHOQ;TEAD1;GSN;LIMS1;MDM4;MYO1B;LIMA1;BAIAP2L1;SHROOM2;NLGN2;RHOJ;DLG4;MYO9A;YTHDF3;FLNA;YAP1;DNM1L;SNX9;CREBBP;CDC42;PPARGC1A;TUBGCP2;VAMP2;VASP;TLCD2;VCPIP1;GEMIN5;WASL;MNAT1;FLNC;TRAF2;RHOA;NCKAP1;RAD21;CAPZA1;TEAD2;HES1;WIPF1;PARD3;TOGARAM1;WASF1;REPS2;RANBP9;ZFYVE27;PPIH;FAM107A;PICALM;MICAL1;CFAP74;RHOH;WNT5A;FZD1;GPAA1;CDAN1;TUBGCP4;PML;SPEF1;PLS1;FBLIM1;FANCC;KIFAP3;KMT2A;DET1;BAIAP2
prerank,glycerolipid catabolic process (GO:0046503),0.41880437709940666,1.1441269233930034,0.27125506072874495,0.7116115275648931,1.0,2/19,1.98%,GPCPD1;ABHD2
prerank,cellular response to hormone stimulus (GO:0032870),-0.3151229314821779,-1.1438853026479057,0.20224719101123595,0.5766685823337433,1.0,15/69,11.26%,ATP1A2;THRB;KLF9;GHR;NR3C1;CTSH;BCAS3;TFPI;STAT3;RAMP1;AR;NCOA1;MED1;SLC5A5;MEF2C
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.37325482327335385,1.143784122455893,0.24312896405919662,0.7112895274490254,1.0,5/29,6.86%,RPS19;RPP40;RPS21;RPS8;RPS16
prerank,calcium ion import (GO:0070509),0.38035032486958154,1.1437210383538903,0.257847533632287,0.7100805048360443,1.0,6/28,7.64%,CACNA1A;CACNA1B;SLC8A1;SLC25A23;CACNA1E;CACNB2
prerank,neutrophil degranulation (GO:0043312),0.2539248968707094,1.143680238000293,0.09741550695825049,0.7088178829629282,1.0,90/425,17.97%,CD33;PTPRB;PTPRN2;CD93;TMEM30A;PGLYRP1;PRG2;LRRC7;ATP8A1;SLCO4C1;HRNR;MME;SLC2A3;RAB4B;ATP11A;MIF;S100A9;S100A8;FTH1;SLC2A5;TOLLIP;ENPP4;SNAP25;PGAM1;QPCT;SVIP;CSNK2B;HSPA8;NME2;TLR2;DYNLL1;TRPM2;NFASC;NDUFC2;CPNE1;PTPRJ;PECAM1;BRI3;EPX;FTL;HSP90AB1;PSMD12;ARSA;GOLGA7;LAIR1;HEBP2;ALDOC;SLPI;BIN2;GGH;GLA;PDAP1;FABP5;CCT2;ACTR10;TSPAN14;CTSB;ITGAM;VAT1;CD36;LCN2;HGSNAT;PSEN1;EEF1A1;SNAP29;ATP11B;B2M;PTGES2;COTL1;IDH1;RHOF;SCAMP1;LTA4H;RNASE3;PSMA2;STK11IP;RAP1A;PSMC3;XRCC5;RAP2B;RAB31;HSP90AA1;ATP6V0A1;GLB1;TMBIM1;ARL8A;C3AR1;PPIA;HEXB;EEF2
prerank,inositol phosphate metabolic process (GO:0043647),-0.3383478850910915,-1.1436220911620065,0.25193798449612403,0.5767870152323796,1.0,10/46,10.23%,PLCE1;NUDT4;PLCD3;INPP5B;INPP5A;ISYNA1;INPPL1;PLCG1;PLCB3;PLCD1
prerank,amino acid import across plasma membrane (GO:0089718),0.3937637709330194,1.1434487374342073,0.2536082474226804,0.708141872072988,1.0,8/24,9.70%,SLC7A5;SLC6A6;SLC7A1;SLC1A1;SLC1A2;SLC6A5;SLC7A8;SLC36A1
prerank,regulation of lipid storage (GO:0010883),-0.40319175728299117,-1.1433286833875265,0.2656826568265683,0.5769400260153482,1.0,7/22,19.34%,NFKB1;FTO;ITGAV;PTPN2;FBXW7;IKBKE;ITGB3
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3186274236593275,-1.1431100642129024,0.23046875,0.576883015552233,1.0,19/65,17.02%,FOXP1;GAB2;IL31RA;BMP4;EP300;TGFBR2;KIT;SBNO2;RUNX1;CDC42;PARP1;SNX10;GLO1;VEGFA;CBFA2T3;RXRA;PIR;FARP2;PIK3CD
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.40199953352801765,-1.1429305402524088,0.2783109404990403,0.5767880151207159,1.0,5/23,10.81%,TGFBR3;TPM1;FGFR2;ADAMTS9;ID2
prerank,positive regulation of vacuole organization (GO:0044090),-0.49600848905854195,-1.1422953741095685,0.3069679849340866,0.5778104102031026,1.0,4/10,19.13%,ANXA2;RAB3GAP1;PIP4K2C;LRSAM1
prerank,acylglycerol biosynthetic process (GO:0046463),-0.3973091355858307,-1.1422431867518743,0.2660377358490566,0.5773881428913196,1.0,8/23,20.62%,AGMO;PLCE1;GPAT4;PLA2G4A;MOGAT3;LPIN2;LPIN3;GPAT3
prerank,peptide cross-linking (GO:0018149),-0.3936904948521135,-1.1421900191931658,0.27360308285163776,0.5769800768108436,1.0,4/25,12.32%,COL3A1;THBS1;ANXA1;FN1
prerank,regulation of vasoconstriction (GO:0019229),0.37784930090795465,1.1421019814660298,0.27104722792607805,0.7108650019821405,1.0,8/27,12.80%,CHRM3;KCNMB2;KCNMB4;ADRA1D;ADRA1A;F2R;PER2;BMPR2
prerank,regulation of hydrolase activity (GO:0051336),0.3122560203354693,1.142087722859753,0.1892430278884462,0.7095441186211862,1.0,16/71,12.35%,CAMK2A;PLXNB3;EPHA5;VAV3;CHN2;NTRK2;PRKG1;RAP1GAP;SCARB2;PLXNA4;FGD5;CFAP100;DAB2IP;CHN1;FGD3;EPHA1
prerank,regulation of calcium ion import (GO:0090279),0.4047638546952579,1.1419306773686009,0.2712215320910973,0.708686445859197,1.0,7/21,18.32%,CXCL12;SLC30A1;CCL2;PLPP4;PDGFB;CTNNB1;FYN
prerank,positive regulation of vascular permeability (GO:0043117),-0.4780965061547333,-1.1410412002861055,0.3088235294117647,0.5792932122194826,1.0,2/12,1.39%,BMP6;ANGPT1
prerank,negative regulation of cell adhesion (GO:0007162),0.3129854299325061,1.1408588402913733,0.242914979757085,0.7105269598079906,1.0,13/72,10.36%,DSCAM;SPOCK1;PODXL;PLXNB3;SEMA6A;ACER2;ADAM22;SEMA4D;NOTCH1;ACVRL1;PLXNA4;NEXMIF;LPXN
prerank,positive regulation of response to external stimulus (GO:0032103),-0.2816076467104531,-1.1399879767314443,0.17221135029354206,0.5813655769381718,1.0,30/128,19.13%,BMP6;SASH1;PTN;ANKRD17;PDGFRB;PUM2;THBS1;PLSCR1;IL16;DHX9;PUM1;IL17RA;DDX60;NAPEPLD;STX4;NFKBIZ;RIOK3;AGTR1;P2RY12;CYBA;GPR4;IL18;FEM1A;PDCD4;SERPINE1;TLR4;CCN4;IFI35;WNT5A;LRSAM1
prerank,intracellular sterol transport (GO:0032366),-0.47081801100085613,-1.1398586426900552,0.32379248658318427,0.5811242935692703,1.0,3/13,11.76%,ABCA1;RELCH;NPC2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.46624729154781175,1.1395799666751245,0.3036876355748373,0.713117003773129,1.0,2/12,2.63%,GRIN1;ADGRB1
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.29185651154866576,-1.1393596144057592,0.2084942084942085,0.5818708456189924,1.0,23/95,17.02%,INO80;UBE2N;RBBP8;SPIDR;SMC6;NBN;NSMCE2;RAD51B;WRN;SMC5;RFWD3;MCM9;RAD21;NIPBL;RAD51D;PARP1;NABP2;FANCM;BRCA2;MCM6;SFPQ;MRE11;ZSWIM7
prerank,regulation of protein binding (GO:0043393),-0.2893137807947049,-1.1392862395755188,0.19175257731958764,0.5815172156868603,1.0,38/114,23.94%,TCF7L2;LRP1;PKD1;DAB2;BMP4;STK3;ROCK1;HDAC4;PRKN;LRRK2;VTN;GSK3B;STYX;MARK3;IFIT2;DACT1;CSNK1E;USP33;NES;PRKCD;RPL11;DTX3L;RAPGEF2;PSME3IP1;DERL1;PRKACA;PRMT8;BMP2;PARK7;CARD16;TERT;SPPL3;PPP2CA;BTBD1;GTF2F1;HIP1R;TMBIM6;GNL3L
prerank,embryonic axis specification (GO:0000578),-0.44423562300556846,-1.1389718732943421,0.2964352720450281,0.5817686811214573,1.0,6/15,29.74%,SMAD6;SMAD2;PTCH1;CXXC4;COBL;STIL
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.30932946376701775,-1.138719388316251,0.21755027422303475,0.5818587191000061,1.0,24/76,19.37%,NTRK3;FCHSD2;ABL1;BAIAP2L1;NUMA1;BCAS3;SNX9;NRP1;CDC42;VASP;FER;CDC42EP5;SYNPO2;NES;NCKAP1;CTTN;SYNPO;NCK1;SORBS3;NCK2;CARMIL1;DYNC1H1;CDC42EP4;LMOD1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3281011446102171,1.1384843450433455,0.2328159645232816,0.7152688801374184,1.0,11/52,8.23%,KHDRBS2;RBFOX3;NOVA2;CELF5;RBFOX1;CELF4;RBM11;KHDRBS3;SRRM4;SRSF12;RBM15B
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.4107143502395869,-1.1383098843618038,0.2823529411764706,0.5823068035967723,1.0,4/20,7.74%,DICER1;PUM2;ZC3H7A;PUM1
prerank,negative regulation of synaptic transmission (GO:0050805),0.4009675865118289,1.1381839110350147,0.27253218884120173,0.7148735457507795,1.0,4/23,9.00%,SLC24A2;SYT11;SLC30A1;SHANK2
prerank,regulation of primary metabolic process (GO:0080090),-0.28780761097460017,-1.1380843388064472,0.18846153846153846,0.5823507452666118,1.0,48/126,29.41%,ROCK2;CHD9;NR1D2;NCOR1;TBL1X;TBL1XR1;CREBBP;NCOA6;NFYC;NCOA1;LDLR;MED1;PRKAB2;ID2;PSMF1;TGS1;LACTB;PSMB2;C1QTNF2;APOE;RXRA;NFYB;HMGCR;SQLE;CYP51A1;ABCA7;FGFR4;NFYA;PSMC1;PRKAB1;FDFT1;SC5D;PSMA3;PSMB6;SMARCD3;PSMA4;MVK;EDF1;BBS4;PPARA;ZFP69;PSME1;PSMD13;HDAC3;PSMB9;PSMB10;PSMA5;PLPP1
prerank,cellular response to cAMP (GO:0071320),0.37963608109097535,1.1379334103391618,0.2531914893617021,0.7142279595554343,1.0,5/30,6.33%,HCN1;AQP9;AKAP6;PDE2A;HCN2
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.4617267360234172,1.1375900610112122,0.29504504504504503,0.7139354152320118,1.0,3/13,8.05%,TMEM35A;STX3;HSP90AB1
prerank,positive regulation of transferase activity (GO:0051347),0.28017003304044497,1.137467492590462,0.18700787401574803,0.7129291191840177,1.0,43/142,19.09%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK;PRKCQ;KLF4;TRIB3;HSP90AB1;EPHA10;SERINC1;CCT2;DKC1;RET;EPHA1;SORL1;CCT4;RPS2;PARM1;INSR;DBI;RFC4;DCUN1D2;DDR2;PTGES3;XRCC5;CTNNB1;RFC5;HSP90AA1;NAF1;MAPK3;NVL;FGFR3;RFC2;TCP1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.45637903812705477,-1.1373712866703936,0.3082706766917293,0.5836244371173898,1.0,6/14,15.83%,ADK;GMPS;PPAT;ATIC;RFK;PAICS
prerank,regulation of blood circulation (GO:1903522),-0.3593736131769657,-1.1367334803710771,0.24775583482944344,0.5846966939918868,1.0,11/34,21.02%,CELF2;TPM1;CAMK2D;ECE1;DMPK;AGTR1;SRI;BDKRB2;TBX2;S100A1;DES
prerank,positive regulation of neutrophil migration (GO:1902624),-0.42403695633755323,-1.1365436191346068,0.2737642585551331,0.5846476921244493,1.0,4/18,5.28%,MCU;CAMK1D;RIPOR2;DNM1L
prerank,ERBB2 signaling pathway (GO:0038128),0.3720163289185695,1.1359994693166746,0.27345309381237526,0.7160817699461544,1.0,5/31,6.79%,ERBB4;PTPRR;NRG2;NRG1;PTPN18
prerank,cellular potassium ion homeostasis (GO:0030007),-0.46721839755263034,-1.1356934326008281,0.30198915009041594,0.5863197282864538,1.0,3/13,9.43%,ATP1A2;KCNJ2;SLC12A2
prerank,endoplasmic reticulum organization (GO:0007029),-0.31306681323678015,-1.1355311018862175,0.232421875,0.5861689531684684,1.0,25/72,23.93%,TRAM2;LRRK2;ATL3;DNM1L;RAB10;EIF2AK3;STX18;VAMP2;VCPIP1;SEC31A;ATL2;STX5;DOP1B;EMD;ZBED3;MIA3;GET4;SMPD4;TMCC1;SEC16B;SEC16A;LPCAT3;VAPA;LMAN1;SPTSSB
prerank,cellular response to alcohol (GO:0097306),-0.3527468496200462,-1.1354495505500923,0.2524084778420039,0.5858179233622174,1.0,12/42,9.16%,ADCY5;LRP6;KLF9;CTNNA1;SMO;SPIDR;GRAMD1C;CDH1;ADCY1;LARP1;ADCY6;JUP
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.48727480508006193,1.1353678273279384,0.3163265306122449,0.7166431683127428,1.0,3/10,10.02%,SEMA6A;IL12A;DAB2IP
prerank,sulfate transport (GO:0008272),-0.4537788033344445,-1.1352398376497383,0.3141263940520446,0.585815400660374,1.0,3/14,6.73%,SLC13A4;SLC26A7;SLC26A2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3619230894461804,1.1351278107645992,0.2768595041322314,0.7160570794228133,1.0,4/33,7.85%,IGF1R;NYAP2;PIK3R5;AKT1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.46328798291434126,-1.1350686337573288,0.30755064456721914,0.585686405856114,1.0,8/13,27.44%,ABCA1;ITGB1;CD9;LDLR;SYK;FCER1G;LPL;CD81
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.36548849348540635,-1.1349223733118121,0.24277456647398843,0.5855400687502079,1.0,11/33,19.46%,FOXO3;ARNT;HOXA5;STAT3;MED1;HIF1A;PITHD1;PRKDC;STAT1;STAT5B;INHBA
prerank,proton transmembrane transport (GO:1902600),0.356412153310928,1.1347191736203663,0.2408256880733945,0.7159516477994547,1.0,14/36,17.93%,UCP2;ATP1A3;SLC25A14;ATP6V1F;SLC25A27;ATP6V1A;SLC36A1;ATP1A4;ATP1A1;ATP5F1B;DMAC2L;ATP5MF;NNT;ATP6V0E2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.46074155506648456,1.1343290914675759,0.2995689655172414,0.7157811539091457,1.0,2/13,3.32%,MIF;SIRT1
prerank,nitric oxide mediated signal transduction (GO:0007263),0.4338998461155089,1.1341158251295496,0.28695652173913044,0.7150678245844003,1.0,6/16,19.96%,KCNC2;NOS3;NDNF;CD36;DDAH1;AGT
prerank,positive regulation of viral life cycle (GO:1903902),-0.4028833866268148,-1.134014119904497,0.29571984435797666,0.5872887506100586,1.0,5/22,12.22%,AXL;KPNA6;CHMP3;LGALS1;TRIM11
prerank,protein tetramerization (GO:0051262),0.3212693409074109,1.1338130797149262,0.23935091277890466,0.7146876805927553,1.0,15/67,15.69%,HCN1;GRIN1;RYR3;GRIN2B;SNCA;TRPM2;KCNC3;HOMER1;HPRT1;KCNC1;FARSB;AQP4;GOLGA2;B2M;GLS
prerank,long-chain fatty acid transport (GO:0015909),-0.37208030916227164,-1.1335569053702919,0.2792452830188679,0.5879100331226715,1.0,10/30,14.69%,PRKAG2;ACSL1;PRKAA2;ABCD3;ABCD2;CPT2;PRKAB2;ABCD4;SLC27A1;APOE
prerank,response to interleukin-1 (GO:0070555),-0.3135534630644208,-1.1335464372088118,0.2480916030534351,0.5874037434094669,1.0,15/73,19.31%,ADAMTS12;NFKB1;PTGIS;HDAC4;IRAK3;RC3H1;IRAK2;ANXA1;UPF1;HIF1A;GBP3;GBP2;TRAF6;TANK;IRAK1
prerank,neutrophil mediated immunity (GO:0002446),0.2512821024611189,1.1330829520799903,0.10039370078740158,0.7156285413205263,1.0,90/432,17.97%,CD33;PTPRB;PTPRN2;CD93;TMEM30A;PGLYRP1;PRG2;LRRC7;ATP8A1;SLCO4C1;HRNR;MME;SLC2A3;RAB4B;ATP11A;MIF;S100A9;S100A8;FTH1;SLC2A5;TOLLIP;ENPP4;SNAP25;PGAM1;QPCT;SVIP;CSNK2B;HSPA8;NME2;TLR2;DYNLL1;TRPM2;NFASC;NDUFC2;CPNE1;PTPRJ;PECAM1;BRI3;EPX;FTL;HSP90AB1;PSMD12;ARSA;GOLGA7;LAIR1;HEBP2;ALDOC;SLPI;BIN2;GGH;GLA;PDAP1;FABP5;CCT2;ACTR10;TSPAN14;CTSB;ITGAM;VAT1;CD36;LCN2;HGSNAT;PSEN1;EEF1A1;SNAP29;ATP11B;B2M;PTGES2;COTL1;IDH1;RHOF;SCAMP1;LTA4H;RNASE3;PSMA2;STK11IP;RAP1A;PSMC3;XRCC5;RAP2B;RAB31;HSP90AA1;ATP6V0A1;GLB1;TMBIM1;ARL8A;C3AR1;PPIA;HEXB;EEF2
prerank,necroptotic process (GO:0070266),-0.43406661651697753,-1.133073064633112,0.29853479853479853,0.5880073559324547,1.0,8/16,32.08%,DNM1L;TLR4;TRPM7;MLKL;TICAM1;TLR3;ITPK1;LY96
prerank,cellular response to insulin stimulus (GO:0032869),-0.2845045635442388,-1.1329682812315967,0.20235756385068762,0.587700966835224,1.0,41/124,21.65%,SORBS1;RHOQ;GRB10;KAT2B;ATP6V1B2;ENPP1;GSK3B;IRS1;ATP6V0D1;SLC39A14;INSIG2;RAB10;SHC1;FOXC2;ATP6V0A4;RAB12;PDPK1;IGF2;VAMP2;FER;SELENOS;PTPN2;PARP1;DENND4C;APPL1;PCK2;SLC27A1;PRKDC;CPEB1;TCIRG1;PHIP;SYAP1;LPIN2;INPP5K;GAB1;LPIN3;PKM;AKT2;PIK3R1;USF1;BAIAP2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.40249750150880786,-1.132824409199703,0.2845691382765531,0.5874902078200899,1.0,7/23,18.66%,UACA;BMP7;CCN3;PPM1A;DDX3X;C1QTNF3;IFI35
prerank,sphingolipid biosynthetic process (GO:0030148),0.31585719952574143,1.1321579297760864,0.23858921161825727,0.7170871290015819,1.0,22/71,18.32%,SGMS1;FA2H;ACER2;DEGS2;CERT1;ST8SIA1;SPNS2;ELOVL7;SGPP2;ELOVL4;B4GALT6;SMPD1;HACD3;ST8SIA3;HACD1;PPM1L;SAMD8;PRKD3;TLCD3B;KDSR;SGPP1;SPTLC2
prerank,positive regulation of catabolic process (GO:0009896),-0.31901041833185556,-1.1321001955799799,0.22095238095238096,0.5888148023433718,1.0,18/65,20.21%,SMURF2;PRKN;WWP2;GSK3B;GPC3;HUWE1;AXIN1;WWP1;SEC22B;DACT1;STX5;SMURF1;CSNK2A1;ASB5;VCP;WNT5A;AREL1;SNF8
prerank,nitrogen compound transport (GO:0071705),0.28094366345138205,1.1318754510595699,0.1852589641434263,0.7166463946104941,1.0,18/141,9.70%,SLC7A5;SLC6A6;LRP1B;TMEM30A;SLC7A1;AQP9;RAMP2;ABCG2;SLC15A3;CERT1;SLC52A2;SLC6A2;SLC7A8;SLC6A8;SLC52A3;SCARB2;SLC43A2;SLC36A1
prerank,regulation of microtubule nucleation (GO:0010968),0.48272317471903126,1.1318635909816481,0.3139784946236559,0.7153437602079268,1.0,5/10,19.34%,GIT1;PAK1;DCTN1;ARHGEF7;MECP2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4080967541837361,1.1313269195266533,0.2827868852459016,0.7143417363457555,1.0,7/19,17.45%,TERF1;TERF2IP;POLR2J;POLR2B;POLR2I;TINF2;POLR2G
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4080967541837361,1.1313269195266533,0.2827868852459016,0.7143417363457555,1.0,7/19,17.45%,TERF1;TERF2IP;POLR2J;POLR2B;POLR2I;TINF2;POLR2G
prerank,lipid homeostasis (GO:0055088),-0.33305025527473137,-1.1312852277181584,0.25430210325047803,0.5903191197847274,1.0,15/57,17.97%,ZBTB20;RBP1;ABCA1;NR1D2;PRKAA2;ABHD5;TLCD2;NR1H3;RCN3;PNPLA8;FBXW7;APOE;DDX3X;PRKAA1;ACOX1
prerank,carnitine shuttle (GO:0006853),-0.47908993204113914,-1.1312041335036598,0.32575757575757575,0.5900030181796131,1.0,4/11,10.80%,PRKAG2;PRKAA2;CPT2;PRKAB2
prerank,negative regulation of protein polymerization (GO:0032272),0.37158479942193695,1.1309269308412184,0.27872340425531916,0.714257516657012,1.0,7/27,9.47%,KANK3;STMN1;MAP2;SNCA;TUBB4A;STMN2;CYRIB
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.4649915412549509,-1.1306729068539139,0.3042671614100185,0.5908785651082354,1.0,3/13,14.01%,DCN;BGN;HEXA
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.382760842664361,-1.1306336797565923,0.3007518796992481,0.5904417914951148,1.0,9/26,19.51%,ST3GAL4;B4GALT1;FMOD;OGN;PRELP;ST3GAL3;LUM;OMD;B4GALT5
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.40492105637435594,1.1305338435398093,0.3147410358565737,0.7141575450163522,1.0,3/22,9.46%,SLC7A5;TRIM6;TRIL
prerank,histone H4-K16 acetylation (GO:0043984),-0.4108965567074068,-1.130515623095461,0.28820116054158607,0.5901796942017556,1.0,9/19,23.29%,KANSL2;HCFC1;KAT8;OGT;MSL2;MSL3;KANSL3;KMT2A;JADE2
prerank,protein localization to phagophore assembly site (GO:0034497),-0.481285065132838,-1.129801322034758,0.3173996175908222,0.5913827511912592,1.0,7/11,33.40%,WIPI1;ATG9A;WDR45B;WIPI2;STX17;MFN2;WDR45
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.38787469541794944,-1.1297362874272687,0.2746615087040619,0.59101179801419,1.0,9/24,18.08%,PKD1;CTSC;EPHA4;NUB1;RHBDF1;APOE;LATS1;PRKACA;ATP5IF1
prerank,negative regulation of cell projection organization (GO:0031345),0.3353394131727921,1.1293882599930023,0.23412698412698413,0.7161888922191894,1.0,20/48,19.92%,SPOCK1;DCC;MINAR1;MAG;SPRY3;GRIN2B;ITM2C;STMN2;RTN4R;PRAG1;CIB1;RTN4RL1;FKBP4;STX1B;CRMP1;RAB29;FYN;GAK;TRPV4;PTPRO
prerank,regulation of neuron projection arborization (GO:0150011),0.4376417096894795,1.1292691714772425,0.3031674208144796,0.7152360883279143,1.0,7/15,11.96%,SPRY3;MFSD2A;GRIP1;NTNG2;NTNG1;DVL1;FZD4
prerank,T cell mediated immunity (GO:0002456),-0.4486118204957803,-1.1287776952775088,0.3156934306569343,0.5928209855366522,1.0,3/13,5.18%,JAG1;CD55;CTSH
prerank,protein autophosphorylation (GO:0046777),0.2792382679705121,1.1285749924227797,0.1970649895178197,0.7160381458959894,1.0,23/157,9.28%,CAMK2A;FLT1;IGF1R;TEK;ERBB4;CSF1R;EPHB1;HTATIP2;TNIK;MEX3B;WNK2;KDR;CAMK4;NTRK2;FLT3;AATK;SRMS;PAK1;ALK;MELK;AKT1;CDKL5;TAOK2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.4799925125657982,-1.1285490832927028,0.312621359223301,0.5923197292743829,1.0,3/11,5.95%,INPP5B;SYNJ2;INPP5A
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.4799925125657982,-1.1285490832927028,0.312621359223301,0.5923197292743829,1.0,3/11,5.95%,INPP5B;SYNJ2;INPP5A
prerank,cellular response to cytokine stimulus (GO:0071345),-0.2465120863194277,-1.1282499412403673,0.11041666666666666,0.5925307532309818,1.0,96/416,19.48%,PTPN13;COL1A2;DPYSL3;NFAT5;PID1;SMAD3;GAB2;ADAMTS12;LEPR;NFKB1;IL34;ZFAND6;FOXC1;GRB10;ZEB1;VIM;AXL;IL31RA;IL6ST;FOXO3;PTGIS;GHR;PTPN14;JAK1;KIT;GSDME;GSK3B;RIPOR2;TBK1;SYNCRIP;IRAK3;LBP;PTPN9;ITGB1;IL13RA1;SBNO2;RC3H1;STAT3;ASAH2;SHC1;IL16;DHX9;BCL2;IRAK2;ANXA1;F3;INPPL1;UBE2K;WNK1;SLC12A2;FER;UPF1;PTPN12;PTPN2;RHOA;ABL2;HIF1A;STX4;CNTFR;GREM2;TPR;FN1;NUMBL;YBX3;IL6R;IRF1;MMP2;TEC;TYK2;GBP3;DUSP1;VEGFA;STAT1;RORA;DAPK1;IL18;IFNGR1;PIK3CD;TLR4;GBP2;PRKACA;STAT5A;NPR2;HNRNPU;GBP7;NPNT;STAT5B;INPP5K;TRAF6;WNT5A;TANK;SMPD4;GBP6;PTPN11;IRAK1;SHPK
prerank,cell differentiation in spinal cord (GO:0021515),0.4844179057966857,1.1282437762020776,0.30751708428246016,0.7157095156221711,1.0,2/10,6.67%,MDGA2;LHX1
prerank,negative regulation of cellular component organization (GO:0051129),-0.30828672227349374,-1.1276024720847542,0.2388663967611336,0.5936549370884304,1.0,23/74,19.75%,BMP6;EPHA3;EP300;GSK3B;IRAK3;RAPGEF3;AR;CDC42;IMPACT;WASL;RIOK3;FAP;VEGFA;PRKCZ;DDX3X;CARMIL1;NOP53;RUBCN;PRKD1;IAPP;LRSAM1;ABCA7;TERF2
prerank,negative regulation of catalytic activity (GO:0043086),0.3926076329889832,1.127521924312606,0.3044397463002114,0.7165902484237983,1.0,4/24,7.83%,CAMK2A;SIRT1;NOTCH1;TIMP1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.43631719905173516,-1.1273720551733257,0.3211538461538462,0.5937025390462009,1.0,7/16,31.73%,VAMP7;CEBPG;VAMP2;PLEKHM2;KIF5B;RAET1E;ULBP1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.42152390829577785,-1.1272813306759053,0.3055555555555556,0.5933652510028038,1.0,9/18,33.91%,PABPN1;ENY2;MCM3AP;DDX19B;NXF1;NUP93;THOC2;DDX25;NUP133
prerank,secondary palate development (GO:0062009),-0.456961245957739,-1.127084848405256,0.29423076923076924,0.5933484145882464,1.0,8/14,18.69%,TGFBR3;TGFBR2;SMAD2;SMAD4;CHD7;LRRC32;TGFB3;WNT5A
prerank,peroxisomal membrane transport (GO:0015919),-0.37634281865050845,-1.1269376767890185,0.2687385740402194,0.5931938892537064,1.0,10/27,20.41%,ABCD3;PXMP4;ABCD2;ABCD4;PEX6;SLC25A17;PEX7;FIS1;PXMP2;PEX26
prerank,organonitrogen compound catabolic process (GO:1901565),-0.3215576199205225,-1.1268508249442821,0.24649298597194388,0.5928762490852931,1.0,18/57,26.87%,CPQ;MTOR;ANPEP;RENBP;PLA2G4A;PDXDC1;GGACT;PNPLA8;NPEPPS;LNPEP;LRSAM1;BCKDK;CLN5;SMPD2;TXN2;CLPX;CLN8;ERAP1
prerank,monosaccharide transmembrane transport (GO:0015749),-0.42646529790757826,-1.1266300730003236,0.30057803468208094,0.5928813794027082,1.0,2/16,6.56%,SLC5A3;SLC2A12
prerank,regulation of fibroblast proliferation (GO:0048145),-0.3344728010323883,-1.1266121135233704,0.26032315978456017,0.5923896912839755,1.0,17/45,23.53%,IGF1;PDGFRA;SKI;DHX9;PARP10;PDGFC;S100A6;FN1;EMD;MORC3;WNT5A;B4GALT7;CDC73;CDK6;SPHK1;CD300A;NLRC3
prerank,positive regulation of vasculogenesis (GO:2001214),0.48244278063726054,1.1264449814480226,0.32577319587628867,0.7184166454780846,1.0,4/10,16.37%,KDR;CD34;RIN2;RAP1A
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.46106474689731125,-1.1262131540512867,0.31204379562043794,0.5928390815959423,1.0,4/13,6.74%,CBLB;KPNA4;RANBP2;KPNA6
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3125147215042473,1.1261677290223107,0.22857142857142856,0.7179182496164154,1.0,9/67,5.75%,FLT1;IGF1R;TEK;ERBB4;CSF1R;KDR;FLT3;AATK;SRMS
prerank,programmed necrotic cell death (GO:0097300),-0.41883468258994994,-1.125900865637982,0.29908256880733947,0.593079871394043,1.0,9/18,32.08%,DNM1L;TLR4;TRPM7;MLKL;TICAM1;PPIF;TLR3;ITPK1;LY96
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.32846319712749283,-1.1257546411396604,0.2556701030927835,0.5928911071289505,1.0,14/55,14.88%,TGFBR1;WWOX;NUPR1;GSDME;DNM1L;PAK2;BCL2;TRAF2;BCLAF1;BECN1;LTBR;TPD52L1;ING5;TRIM39
prerank,histone mRNA catabolic process (GO:0071044),-0.44168494141987114,-1.1252524181048198,0.322265625,0.5936189570440066,1.0,5/15,15.81%,TENT2;TUT4;UPF1;XRN1;EXOSC10
prerank,proteasomal protein catabolic process (GO:0010498),-0.26730783541091907,-1.1252518466304613,0.19008264462809918,0.5930860854488145,1.0,79/201,30.15%,FBXL17;SMURF2;PRKN;SPSB1;RAD23B;BTRC;TBL1X;WWP2;TBL1XR1;HUWE1;UBXN2B;WWP1;UBE4B;DDI2;ZSWIM8;PCBP2;UBE2K;MAEA;TNFAIP1;RNF216;SPOPL;ERLEC1;GID4;RCN3;KCTD5;PSMF1;FBXL19;CUL3;FBXW7;NHLRC3;PSMB2;KLHL22;UBE2B;SMURF1;FBXO45;TOPORS;ERCC8;ARRB1;BFAR;DERL1;SYVN1;PPP2R5C;FBXW5;FBXW11;VCP;SPSB4;AREL1;UBE2D3;IFI27;PML;COP1;PSMC1;SHARPIN;KCTD17;GID8;APPBP2;PSMA3;PSMB6;RMND5A;ARMC8;PSMA4;SIAH2;BAG6;PSME1;PSMD13;SPSB2;PCNP;SEL1L;CDC34;PSMB9;CCDC47;RBX1;PSMB10;PSMA5;KBTBD7;SPSB3;NFE2L2;ZFAND2B;RNF126
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.36947053280577125,-1.1248798964804487,0.294,0.5934944150649248,1.0,14/30,24.73%,FHIT;STYX;USP7;RPL11;GIPC1;OGT;TRIM39;NOP53;PARK7;WAC;CCAR2;BAG5;BAG6;EIF3H
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.3389816274824179,-1.124755270245294,0.26990291262135924,0.5932483761745247,1.0,10/45,16.68%,EGFR;NFKB1;DDX5;BMP4;U2AF2;MAP2K1;WDR43;DIMT1;ERN1;BUD23
prerank,regulation of cell cycle (GO:0051726),-0.25579984230149816,-1.124663156143088,0.15060240963855423,0.5929495109708933,1.0,75/271,21.54%,NOTCH2;GRK5;SMAD3;TCF7L2;TGFBR1;SON;PKD1;LRP6;FBXL17;ANKRD17;KAT2B;BMP7;BMP4;EP300;GBF1;ABL1;CDC14A;NUPR1;CDK7;THBS1;UHRF2;NBN;STAT3;ASAH2;FGFR2;PUM1;FBXL12;PTPRK;MAEA;XIAP;PRCC;MAP2K1;MAP3K20;JUN;HCFC1;ID2;CDK11B;RB1;SIK1;PKD2;CDC123;IRF1;FAP;CRLF3;CDC26;DUSP1;ERN1;CDC14B;TMEM8B;WHAMM;CSNK2A1;NOP53;AFAP1L2;CITED2;PDCD4;NR4A1;WDR12;RNF20;TTC28;PRKACA;HNRNPU;RRP8;DCUN1D3;BMP2;RASSF1;INHBA;CDK10;MAP2K6;PML;NF2;ZBTB49;AKT2;NEK6;CDK5RAP3;CDK6
prerank,negative regulation of cell communication (GO:0010648),0.39881215607182363,1.1244448469935457,0.3104166666666667,0.7218322250742092,1.0,4/21,11.12%,GLRA1;SRMS;OPRM1;UBASH3B
prerank,negative regulation of programmed cell death (GO:0043069),-0.25033632951568197,-1.1242194318072003,0.13429752066115702,0.5935250397334756,1.0,50/355,10.11%,FSTL1;NOTCH2;IGF1;GRK5;FHL2;EGFR;ARHGAP10;SON;NFKB1;KANK2;ANGPT1;SMAD6;OPA1;ZFAND6;ARAF;CFLAR;AXL;DAB2;IL31RA;IL6ST;BMP4;ERC1;PDPN;TAX1BP1;BIRC6;OSR1;PRKAA2;NUPR1;GSK3B;NIBAN2;FLNA;ANXA5;ANXA4;CTSH;THBS1;PAK2;SH3RF1;TMBIM4;SHC1;MAP4K4;BCL2;ANXA1;BRAF;VDAC1;XIAP;MED1;HNRNPK;NGF;BAG3;ANKLE2
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.41389737552981753,-1.1242072485163404,0.2964352720450281,0.5930169651754094,1.0,7/19,20.81%,VPS4B;CHMP4B;CHMP5;CHMP3;TPR;HNRNPU;EML3
prerank,regulation of macrophage cytokine production (GO:0010935),0.4560836020219261,1.1241545541043036,0.2725274725274725,0.7213739676798224,1.0,3/13,5.71%,SIRT1;SEMA7A;TGFB2
prerank,regulation of cilium movement (GO:0003352),-0.49587666910690065,-1.1240373140135733,0.30560578661844484,0.5929156665470926,1.0,9/10,46.50%,CCDC39;DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.41450223892345656,1.123898300613651,0.31092436974789917,0.7208155712625822,1.0,5/19,6.00%,HS6ST3;HS3ST5;HS6ST2;CSGALNACT1;NDST4
prerank,neural tube development (GO:0021915),-0.4402377796965223,-1.1238963194944536,0.3108108108108108,0.592749794977002,1.0,6/15,15.63%,ALDH1A2;PKD1;ARL13B;DACT1;PKD2;PTCH1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.45131516071945577,1.1236929196551144,0.3,0.720094606216348,1.0,2/13,2.97%,USP44;LCMT1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.4532530752582203,1.1234403719769206,0.3133047210300429,0.7195333918980078,1.0,2/13,4.14%,RPP40;RPS21
prerank,positive regulation of cell projection organization (GO:0031346),0.28445657585151163,1.1232365844253767,0.222,0.7188686727334127,1.0,27/115,12.30%,RIT2;PTPRD;LRRC7;IL1RAPL1;PLXNB3;S100A9;ITGA6;MAGI2;TOX;GRIP1;NTRK2;SCARF1;FUT9;NPTN;PLPPR5;TENM3;ROBO2;NDNF;SCARB2;PLXNA4;CDKL5;STMN2;RELN;DAB2IP;DVL1;FZD4;RET
prerank,metal ion export (GO:0070839),-0.3704942269353437,-1.1231186369758648,0.2859744990892532,0.5941931333147803,1.0,4/31,6.12%,ATP1A2;KCNT2;SLC9A1;KCNK5
prerank,negative regulation of glycolytic process (GO:0045820),-0.49126659641578263,-1.1225693713899034,0.34558823529411764,0.5945100457540577,1.0,3/10,3.75%,HDAC4;NCOR1;NUPR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.49126659641578263,-1.1225693713899034,0.34558823529411764,0.5945100457540577,1.0,3/10,3.75%,HDAC4;NCOR1;NUPR1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3509652529340563,-1.1221338904435219,0.27735849056603773,0.5951535918322043,1.0,10/36,15.61%,PRKN;NCOR1;DLG1;TAOK3;DACT1;PTPN22;FKTN;SH3RF2;DUSP1;DUSP10
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.404910944524326,1.1217553943465937,0.3029045643153527,0.7221109474307595,1.0,2/21,2.22%,SLC39A10;PRKCH
prerank,epithelial cell differentiation (GO:0030855),-0.30251067239098406,-1.1214589272573126,0.2361904761904762,0.596254655523578,1.0,30/88,23.13%,FSTL1;MAF;DAB2;BMP4;JAG1;ANXA4;RAB10;FGFR2;ANXA7;ANXA1;CNN3;VDAC1;FZD7;PCK2;PGK1;GLI1;SCUBE1;VEGFA;LATS1;HDAC1;BDH2;SIX1;TAGLN;CPT1A;PCNA;AKT2;PIH1D1;SCRIB;GATA6;HDAC2
prerank,regulation of phospholipase C activity (GO:1900274),-0.4333883641251815,-1.1212375566916821,0.34750462107208874,0.5962471986936922,1.0,7/15,10.45%,PDGFRA;NTRK3;PDGFRB;ABL1;KIT;PLCG1;ABL2
prerank,error-prone translesion synthesis (GO:0042276),0.39931445189931847,1.1203113439415533,0.3107822410147992,0.7253131617413489,1.0,9/21,19.08%,RPA3;RPS27A;UBC;POLK;UBB;RFC4;RFC5;POLI;RFC2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.32495919297856846,-1.1200953574383128,0.26666666666666666,0.5985184428593546,1.0,8/52,7.95%,EGFR;SORBS1;LRP1;EPHA3;PTPN9;DLG1;ITGB1;PDPK1
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.456448389177863,-1.1198904819574087,0.3359683794466403,0.5985079400993808,1.0,5/13,29.49%,GAB2;STX4;LAMP1;SYK;SPHK2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.30953339412611824,-1.1198035412741574,0.23715415019762845,0.5981983809587438,1.0,27/69,28.58%,ECPAS;DNAJB14;UBQLN1;OS9;UBE4B;JKAMP;EDEM1;FAM8A1;SELENOS;RNF103-CHMP3;MAN1B1;ERLIN1;RHBDD2;TRIM25;FAF2;AUP1;DERL1;SYVN1;VCP;UBXN4;WFS1;DNAJC18;BAG6;TMUB2;SEL1L;USP19;DERL2
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.45959219525143946,-1.1196721060634307,0.3390804597701149,0.5979882713046162,1.0,7/12,32.05%,DHX9;MAVS;MUL1;CGAS;CAV1;IFIH1;ZCCHC3
prerank,positive regulation of histone modification (GO:0031058),-0.36449230160791996,-1.1195779463841438,0.29835390946502055,0.597728074293982,1.0,15/33,29.92%,UBE2N;BRD7;AKAP8L;PPARGC1A;NIPBL;ARRB1;SAP30BP;NOS1;PAXIP1;RPS6KA4;KDM1A;ZBTB7B;CDK9;RUVBL2;GLYR1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.45080471801494115,-1.1194359558830766,0.3241758241758242,0.5970180723084287,1.0,6/13,18.04%,JAK1;IL15RA;STAT3;SHC1;STAT5A;STAT5B
prerank,cellular response to interleukin-15 (GO:0071350),-0.45080471801494115,-1.1194359558830766,0.3241758241758242,0.5970180723084287,1.0,6/13,18.04%,JAK1;IL15RA;STAT3;SHC1;STAT5A;STAT5B
prerank,negative regulation of apoptotic process (GO:0043066),-0.24399003283663237,-1.1192587594226762,0.10721649484536082,0.596952331127202,1.0,103/444,19.31%,FSTL1;NOTCH2;IGF1;GRK5;FHL2;EGFR;ARHGAP10;SON;NFKB1;ANGPT1;SMAD6;OPA1;ZFAND6;ARAF;CFLAR;AXL;DAB2;IL31RA;IL6ST;BMP4;ERC1;PDPN;PRKN;TAX1BP1;BIRC6;OSR1;PRKAA2;NUPR1;GSK3B;NIBAN2;FLNA;YAP1;ANXA5;ANXA4;ITGB1;CTSH;THBS1;SLC30A10;PAK2;SNX6;RNF213;SH3RF1;TMBIM4;ASAH2;SHC1;MAP4K4;BCL2;ANXA1;BRAF;MERTK;PPARGC1A;VDAC1;MAEA;XIAP;MED1;HNRNPK;NGF;BAG3;ANKLE2;PRKCD;DNAJC3;USP47;MEF2C;NFATC4;TLE1;FNIP1;YME1L1;HSPA9;RB1;CASP2;CARD14;SH3RF2;GLO1;NAA15;VEGFA;PRKDC;APOE;YWHAE;DDX3X;HDAC1;TOPORS;RASA1;SFPQ;ITGA5;CSNK2A1;TGFB3;MRE11;CITED2;TXNDC5;SIX1;BFAR;NR4A2;PHIP;PRKAA1;CX3CR1;SOD2;TRAF6;WNT5A;TMEM14A;AREL1;APIP;PARK7;IRAK1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2988112909460771,-1.1191495388483994,0.2409867172675522,0.5966929147035632,1.0,21/84,13.84%,CELF2;RBFOX2;SON;DDX5;CELF1;RBM39;MBNL2;SFSWAP;WTAP;KHDRBS1;DDX17;SRSF10;U2AF2;REST;SRSF6;HNRNPK;DAZAP1;YTHDC1;CWC22;RBM5;NSRP1
prerank,lung epithelium development (GO:0060428),-0.49957317980991717,-1.1188705304862645,0.35714285714285715,0.5968368946468817,1.0,3/10,2.60%,ERRFI1;PKD1;BMP4
prerank,positive regulation of viral transcription (GO:0050434),-0.37550100034348405,-1.11879960037348,0.2925430210325048,0.5964807875376188,1.0,13/25,28.91%,MDFIC;CCNT1;DHX9;NELFB;POLR2H;GTF2F1;POLR2K;POLR2E;CTDP1;NELFA;NELFE;POLR2D;CDK9
prerank,negative regulation of complement activation (GO:0045916),-0.4841677109750786,-1.1186588358370886,0.3463035019455253,0.5963185862860918,1.0,3/10,13.91%,SERPING1;CD55;CR1L
prerank,mRNA export from nucleus (GO:0006406),-0.2908854077652626,-1.1186577728696,0.22612085769980506,0.5957975874935482,1.0,36/102,26.80%,SMG6;SMG1;PABPN1;WDR33;CASC3;RANBP2;U2AF2;ENY2;CPSF3;SRSF6;NUP42;SLU7;SMG7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;NUP98;SRSF11;UPF3B;SRRM1;NUP43;SRSF2;CPSF4;NUP160;NUP93;CPSF1;NCBP2;FYTTD1
prerank,heart morphogenesis (GO:0003007),-0.3272007112779197,-1.1184922940238224,0.2419047619047619,0.5957051026088034,1.0,14/50,19.73%,TGFBR3;TGFBR1;BMPR1A;FLRT2;MDM4;NIPBL;HES1;VEGFA;CHD7;ACVR1;HEYL;TBX2;BMP2;MEGF8
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.3366318517664161,1.1182305289979382,0.2689243027888446,0.730153470897779,1.0,9/44,7.93%,PAX2;SNCA;GAS6;GPX1;ARL6IP1;KLF4;BEX3;AKT1;RPS6KA1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.4839802043244087,-1.1182277337113344,0.31411530815109345,0.5958493171514021,1.0,4/10,20.75%,SOX5;ZBTB16;SOX6;PKDCC
prerank,positive regulation of ATPase activity (GO:0032781),0.3351377467870607,1.1180983898076637,0.27467811158798283,0.729274876493743,1.0,11/41,17.60%,DNAJC9;RYR2;DNAL4;FGF10;DYNLL1;VMP1;ATP1B1;PFN1;DYNLL2;DNAJB2;AHSA1
prerank,hexose metabolic process (GO:0019318),0.34871270053684905,1.1177615401736871,0.2926829268292683,0.7289435447591192,1.0,7/39,10.88%,OMA1;KHK;KCNJ11;SLC37A4;PMM1;ALDOC;GDPGP1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.4197875684405786,-1.1177427791380492,0.3346456692913386,0.596445118304294,1.0,6/18,12.11%,PTGDS;PTGIS;PTGS1;PLA2G4A;PTGES;PNPLA8
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.39684259487880946,-1.1176823701954206,0.31299212598425197,0.5960828998032938,1.0,4/21,3.37%,ROCK2;ROCK1;BCOR;ENPP1
prerank,polyol biosynthetic process (GO:0046173),-0.42739980142647777,-1.1175585291949686,0.3081395348837209,0.5958616174814066,1.0,7/16,25.96%,CYP27A1;ISYNA1;ACER3;ITPKC;FGF2;CYP2R1;IP6K2
prerank,cellular response to ketone (GO:1901655),-0.35425277228765745,-1.1172775558238102,0.2862453531598513,0.5960394585623412,1.0,8/35,7.88%,ROCK2;ADCY5;KLF9;NR3C1;ADCY1;LARP1;ADCY6;AR
prerank,cellular protein-containing complex assembly (GO:0034622),0.27486694787847693,1.117056883293494,0.206,0.7297646004994729,1.0,34/159,15.16%,NSG2;MAPK8IP2;OMA1;DNAAF3;NRG1;RPL38;ANLN;PDE4DIP;AP2M1;TMEM35A;COX7A1;BIN1;SNCA;HIP1;CSNK2B;CHCHD4;CLU;BBS10;PFDN6;FCHO1;HSP90AB1;DNAAF2;MID1IP1;CCT2;CALY;HSPD1;HOPX;NUP205;HIGD1A;SGIP1;HIGD1B;CLTB;RTN4;NDUFAF1
prerank,fatty acid biosynthetic process (GO:0006633),0.3169178744898427,1.1164655096498755,0.26337448559670784,0.7301968651542726,1.0,16/63,17.76%,ABHD2;ELOVL7;CYP2E1;ELOVL4;TECR;HPGD;HACD3;SCD;ACOT7;FADS1;XBP1;HACD1;LTA4H;TECRL;NDUFAB1;LIAS
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.40006952101190424,-1.1163449987596779,0.3055555555555556,0.5978022481059194,1.0,5/20,12.87%,ITGAV;GSK3B;BCL2;APPL1;CASP2
prerank,glycogen metabolic process (GO:0005977),-0.3805113173713507,-1.1163067516993765,0.2900763358778626,0.5973623668346336,1.0,6/27,9.38%,PRKAG2;PHKB;GSK3B;PYGB;PHKA1;AGL
prerank,T cell differentiation in thymus (GO:0033077),-0.4502907904615452,-1.116184654607156,0.3339622641509434,0.5971252063067918,1.0,1/14,0.85%,GLI3
prerank,glial cell development (GO:0021782),0.3819687119247835,1.116113489622367,0.3022222222222222,0.7299935873236922,1.0,8/25,16.94%,S100A9;TLR2;NSUN5;EIF2B3;TPPP;DLL1;SOX4;HES5
prerank,apoptotic cell clearance (GO:0043277),-0.37035783279389567,-1.1160906322691924,0.29541284403669726,0.5968501718741737,1.0,11/30,19.34%,LRP1;ITGAV;HMGB1;THBS1;ANXA1;NR1H3;RHOBTB2;TXNDC5;RHOBTB1;RHOH;ITGB3
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.40772507447637524,-1.1160811385247589,0.30842911877394635,0.5963585031898548,1.0,3/20,2.56%,PID1;RHOQ;DAB2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.3347956519899108,-1.1160151623207464,0.27087198515769945,0.5960195346810305,1.0,25/42,34.10%,KLHL15;SPIDR;FUS;WDR48;PPP4C;PPP4R2;SETD2;SHLD2;PARP1;MMS19;SMCHD1;HELB;ARID2;UBQLN4;KDM1A;ACTR2;FANCB;TIMELESS;CGAS;MAD2L2;RPA2;RMI2;RAD51;PARPBP;ERCC6
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.3195750910093129,-1.1157183295260151,0.26679841897233203,0.5962446665865222,1.0,13/59,10.39%,ROCK2;TGFBR1;ROCK1;TGFBR2;LRRK2;GSK3B;TBK1;CAMK2D;PDPK1;MAP2K1;HIPK1;WNK1;PRKCD
prerank,positive regulation of neuron death (GO:1901216),-0.33328702929944126,-1.1157030464195166,0.29174664107485604,0.5957795490848529,1.0,7/46,7.50%,EPHA7;EFNB2;FOXO3;NUPR1;GSK3B;REST;MAP3K5
prerank,regulation of cellular amide metabolic process (GO:0034248),0.35418960889691303,1.1156869054938494,0.2746331236897275,0.7299369722644118,1.0,4/32,4.78%,GRM5;PGAM1;RPL10;NANOS3
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.3320619118209438,-1.1152791408579872,0.27533460803059273,0.5963403724673743,1.0,13/46,20.82%,PLD1;GNPAT;DGKA;AGPAT4;DDHD1;ABHD5;GPAT4;PLA2G4A;SLC27A1;GPD1L;LPCAT1;GPAT3;DGKD
prerank,membrane depolarization during action potential (GO:0086010),-0.37531109468990353,-1.115112163786365,0.29377431906614787,0.5962270007997921,1.0,5/26,7.58%,ATP1A2;CACNA1C;SCN7A;KCNJ2;CACNA1D
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3984385825509119,-1.1149978581281161,0.2958801498127341,0.5959770338150441,1.0,2/22,1.49%,ALDH1A2;RBP1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3473811755908214,-1.114900049907543,0.28515625,0.5957233880810704,1.0,13/39,14.77%,ROCK2;ROCK1;SNCAIP;RAP1B;PARP10;TRAF2;HCFC1;HJURP;SPTY2D1;GFAP;RAPGEF2;APOE;LATS1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.39191404040355327,-1.1148460787434886,0.2918149466192171,0.595340811920802,1.0,8/23,16.45%,PIAS1;JAK1;NR1H3;PTPN2;PARP9;PARP14;STAT1;IFNGR1
prerank,multivesicular body organization (GO:0036257),-0.35537621327098695,-1.1146924352576406,0.29174311926605506,0.5952112534976444,1.0,7/31,12.04%,VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3;VPS37C;RAB11A
prerank,positive regulation of phospholipid transport (GO:2001140),0.481140534995532,1.1146920280675878,0.34328358208955223,0.7316273602919311,1.0,3/10,14.84%,TMEM30A;ABCB4;DBI
prerank,cellular amide metabolic process (GO:0043603),-0.28914752936747,-1.1144845311733171,0.23700623700623702,0.5952213131505608,1.0,29/102,23.28%,AEBP1;PCCA;PLPP3;HLCS;ASAH2;MCCC2;MTHFR;GPAT4;MTHFD2L;PANK2;ACSF2;SLC5A6;NAPEPLD;ACSL6;CPM;NLN;ACOT11;CPXM2;ACOT9;ALDH1L1;CPXM1;NIT1;ORMDL3;PPP2CA;SMPD2;ACOT8;DNPEP;ACOT6;ST6GAL1
prerank,positive regulation of telomere maintenance (GO:0032206),-0.3659086378003209,-1.1142699932485842,0.27054108216432865,0.5952395481320828,1.0,13/31,28.10%,TNKS2;NBN;HNRNPD;DHX36;NABP2;MAP2K7;MRE11;PML;ERCC1;PPP1R10;NEK7;ATRX;GNL3
prerank,autophagy of peroxisome (GO:0030242),-0.463788919284173,-1.1141504748545572,0.3436928702010969,0.5950193461965116,1.0,4/12,15.68%,NBR1;RB1CC1;PIK3C3;PIK3R4
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.3567039331289062,-1.1141191941443283,0.2859778597785978,0.5945817682876748,1.0,7/33,10.53%,SMAD3;TEAD1;FOXO3;NR3C1;STAT3;JUN;HIF1A
prerank,epithelium development (GO:0060429),-0.2876015097178306,-1.113879636905916,0.2199630314232902,0.594648513110741,1.0,30/107,19.02%,ALDH1A2;DAG1;ERRFI1;VCL;KANK2;PKD1;WNT4;SMO;OSR1;MEOX2;ANXA4;FGFR2;ANXA7;CNN3;VDAC1;DACT1;RCN3;PKD2;PGK1;VEGFA;STAT1;BDH2;PTCH1;SALL1;LOXL3;SIX1;TBX2;TAGLN;BMP2;CPT1A
prerank,membrane repolarization (GO:0086009),-0.43901422315404276,-1.1136821018490168,0.34177215189873417,0.5945947165152444,1.0,2/15,7.48%,ATP1A2;KCNJ2
prerank,regulation of mitochondrion organization (GO:0010821),-0.33427690265394383,-1.113607505735292,0.27613412228796846,0.5942687541624264,1.0,10/47,12.86%,PID1;EP300;PRKN;LRRK2;GSK3B;DNM1L;PPARGC1A;VDAC1;RHOT1;FBXW7
prerank,cellular response to glucose stimulus (GO:0071333),0.3660519940021776,1.1135638718619918,0.2823779193205945,0.7337774188253371,1.0,5/30,3.85%,IGF1R;PTPRN2;ADCY8;PAX2;GAS6
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.44829677665962664,-1.1131708889571503,0.30694980694980695,0.5948073090580173,1.0,7/13,31.76%,LRRK2;TXN;PARK7;HGF;MET;NFE2L2;PDE8A
prerank,negative regulation of TOR signaling (GO:0032007),-0.34768645096202083,-1.112648064151588,0.31401869158878504,0.5956503270059348,1.0,12/36,19.92%,RNF152;UBR2;PRKAA2;DEPTOR;TMEM127;SESN1;UBR1;FNIP1;CASTOR2;NPRL3;PRKAA1;TBC1D7
prerank,RNA interference (GO:0016246),-0.42159749680241987,-1.1124529971112316,0.321011673151751,0.5955928068448888,1.0,3/17,6.99%,CELF1;DICER1;DHX9
prerank,macrophage chemotaxis (GO:0048246),0.48032579635942296,1.1115821541808348,0.3295711060948081,0.7385189902198641,1.0,3/10,18.53%,CCL2;EDNRB;CKLF
prerank,C-terminal protein amino acid modification (GO:0018410),0.4710691516818599,1.1115769886269742,0.30628803245436104,0.7372410752174053,1.0,2/11,2.97%,AGBL4;LCMT1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.42750954732895263,-1.1112319887339575,0.3055028462998102,0.5980921681745522,1.0,3/17,3.80%,AKAP13;ADCY9;ADRA1B
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.4430894497268363,-1.1111089945966168,0.3531746031746032,0.5978651311784166,1.0,6/13,19.29%,SORBS1;IRS1;IGF2;PRKCZ;ECHDC3;PTPN11
prerank,muscle cell development (GO:0055001),0.3606932615438129,1.1110936834836336,0.3022312373225152,0.7373906006022942,1.0,9/30,11.98%,SGCZ;RAMP2;BIN1;MYH6;SLC8A1;DYSF;NRAP;TCAP;MEGF10
prerank,calcium-mediated signaling (GO:0019722),-0.2884639642271095,-1.1110891277006407,0.2335907335907336,0.5974051516021921,1.0,24/93,18.07%,CACNA1C;EGFR;ANK2;PLCE1;MCU;LRRK2;NUDT4;SLC9A1;CCR9;ADGRL1;EIF2AK3;TPCN2;PDPK1;PLCG1;DMPK;ATP2A2;AGTR1;TRPM4;P2RY12;P2RX4;PRKACA;PRKAA1;CX3CR1;PTGFR
prerank,phosphatidic acid metabolic process (GO:0046473),-0.32827629837910854,-1.110986044296547,0.2585551330798479,0.5971284059356173,1.0,13/48,20.82%,PLD1;GNPAT;DGKA;AGPAT4;DDHD1;ABHD5;GPAT4;PLA2G4A;SLC27A1;GPD1L;LPCAT1;GPAT3;DGKD
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.3554474224347773,-1.110789567453187,0.299625468164794,0.5971336758593777,1.0,17/34,32.08%,LGR4;IRAK3;PTPRS;LYN;OTUD4;TLR4;LRRC14;CD300A;TICAM1;RAB7B;CACTIN;GRAMD4;NLRP2B;TNFAIP3;TLR3;TYRO3;LY96
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.40137693658221846,-1.1106220215036469,0.304029304029304,0.5970620332612577,1.0,8/20,30.72%,FKBP5;PPIH;PPWD1;NKTR;PPID;PPIC;PPIL1;PPIF
prerank,regulation of Golgi organization (GO:1903358),-0.4178424292380417,-1.1104574245780876,0.3401869158878505,0.5969884903423308,1.0,7/17,15.50%,STX18;USP6NL;MAP2K1;STX5;ARMH3;EHD3;AKAP9
prerank,regulation of mRNA processing (GO:0050684),-0.3601875931505056,-1.109753590488466,0.30895795246800734,0.598283853937519,1.0,11/32,12.79%,SON;RBM39;PABPN1;KHDRBS1;SRSF10;DHX9;SAFB2;HNRNPK;YTHDC1;CDK11B;CWC22
prerank,histone deubiquitination (GO:0016578),-0.4174527010986468,-1.1097052710917696,0.3132075471698113,0.5979005493212565,1.0,4/18,7.33%,USP7;TRRAP;ENY2;BRCC3
prerank,peptidyl-methionine modification (GO:0018206),0.44027617869438374,1.1095972153800022,0.32510288065843623,0.740658208987734,1.0,3/12,15.37%,METAP2;NAA30;NAA60
prerank,regulation of protein localization to nucleus (GO:1900180),-0.33917450666238647,-1.1093738458693998,0.30095238095238097,0.598195578692676,1.0,14/43,21.53%,BMP4;CTNNA1;GSK3B;YAP1;EIF2AK3;GLUL;PARP9;TPR;DTX3L;ILRUN;LATS1;PARK7;ORMDL3;CDK5RAP3
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.2741843371133556,-1.1092437690502754,0.2015810276679842,0.5980195569469334,1.0,44/144,22.76%,ZIC1;SMAD3;TCF7L2;CEMIP;PCM1;XPO4;GSK3B;FLNA;HUWE1;SAE1;BCAS3;UBR5;CDH1;TFDP2;ABLIM3;BCL2;PCNT;RAPGEF3;VAMP2;JUP;LEPROT;BAG3;PRKCD;MAVS;TPR;NPEPPS;FBXW7;YWHAE;EMD;ANP32B;EFCAB7;ICE1;UBL5;UBE2D3;SEC16B;FIS1;TOMM7;AKT2;SEC16A;ARIH2;PIK3R1;KCNB1;CHP1;ZFAND1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.4682128632575321,-1.1092076268526672,0.3141263940520446,0.5971141545229203,1.0,4/11,23.52%,TNRC6A;TNRC6C;RBM4;AGO1
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.4682128632575321,-1.1092076268526672,0.3141263940520446,0.5971141545229203,1.0,4/11,23.52%,TNRC6A;TNRC6C;RBM4;AGO1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.40130252095396346,-1.1090337429853887,0.3069679849340866,0.5970309518617961,1.0,5/20,13.40%,ST3GAL4;B4GALT1;B3GALT1;ST3GAL3;ST6GALNAC5
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.4281655919219748,1.1090070462059092,0.32891832229580575,0.7410812152559069,1.0,3/15,6.67%,PAX8;PAX2;LHX1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.3217759665063895,-1.1088930080845707,0.2835538752362949,0.5968454608489553,1.0,14/57,14.35%,IGF1;IL31RA;IL6ST;GHR;KIT;PIBF1;STAT3;LYN;PTPN2;PARP9;PARP14;HES1;IL6R;VEGFA
prerank,regulation of extracellular matrix organization (GO:1903053),-0.44120335744991146,-1.1086650249716183,0.35580524344569286,0.596881021175516,1.0,7/15,15.64%,AEBP1;LRP1;RUNX1;RB1;EFEMP2;FAP;DDR1
prerank,negative regulation of peptidase activity (GO:0010466),0.33563916513166464,1.1085193854964888,0.291220556745182,0.7413546907150015,1.0,7/47,12.13%,SPOCK2;SPOCK1;SPOCK3;TIMP1;AKT1;SERPINB8;TIMP4
prerank,multivesicular body assembly (GO:0036258),-0.35674954473670284,-1.1079252337636398,0.31954887218045114,0.5981997365674909,1.0,7/30,12.04%,VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3;VPS37C;RAB11A
prerank,cellular response to fatty acid (GO:0071398),-0.4652639640201959,-1.1075881985757694,0.32509505703422054,0.5985506241027054,1.0,2/12,4.70%,PID1;IRS1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4852325736557234,-1.1073630320296317,0.3622350674373796,0.5986126837015757,1.0,6/10,31.96%,LRRK2;TXN;PARK7;NFE2L2;PDE8A;STK26
prerank,protein modification by small protein removal (GO:0070646),-0.25641513604717003,-1.1071700936784825,0.20318725099601595,0.5986166399054853,1.0,100/252,31.10%,SMAD3;TGFBR1;INO80;SMURF2;MDM4;USP24;KAT2B;EP300;PRKN;RAD23B;USP7;SMAD2;SENP3;WDR48;SENP7;TRRAP;BRCC3;MYSM1;AR;SENP6;FOXK1;DDB2;VCPIP1;USP33;TRAF2;TADA3;RHOA;HCFC1;HIF1A;SENP1;SMAD4;RHOT1;USP47;WDR20;SENP5;PSMF1;COPS2;KDM1B;USP46;USP11;ABRAXAS2;BECN1;USP4;USP12;OGT;USP35;COPS8;PSMB2;USP50;USP2;OTUD4;USP13;TRAF3;FOXK2;TNIP2;USP34;ATXN7;TRAF6;VCP;DESI1;DESI2;PSMC1;SMAD1;TAF9B;TOR1A;SENP2;CLSPN;PSMA3;PSMB6;USP18;OTUD1;USP28;PSMA4;SIAH2;INO80D;INO80C;USP9X;ACTR5;ABRAXAS1;MBD6;PSME1;ADRB2;PSMD13;ESR1;USP19;GPS1;RCE1;PSMB9;PSMB10;PSMA5;FOXO4;UBA52;TNFAIP3;IFIH1;USP36;INO80B;ADRM1;COPS5;BIRC3;UFD1
prerank,linoleic acid metabolic process (GO:0043651),-0.42006737806659505,-1.1071207868238893,0.31103074141048825,0.5982608973571186,1.0,6/17,27.17%,ACSL1;PNPLA8;ELOVL1;GSTM2;ELOVL5;ALOX12
prerank,cellular response to sterol (GO:0036315),-0.4454149893779683,-1.1070237433162464,0.32765151515151514,0.597963653471422,1.0,6/13,15.63%,LRP6;SMO;GRAMD1C;INSIG2;RORA;PTCH1
prerank,regulation of JNK cascade (GO:0046328),0.289743850378806,1.1068843909773374,0.22505307855626328,0.7450982843392899,1.0,23/101,14.49%,IGF1R;MECOM;TIRAP;EPHB1;MAPK8IP2;MAP4K2;TRAF1;PLCB1;TNFRSF19;PHLPP1;WNT7B;ANKRD6;GPS2;MAPK8IP1;TAOK2;DAB2IP;MEN1;HIPK2;PJA2;DUSP15;MAP3K11;HRAS;MFHAS1
prerank,small GTPase mediated signal transduction (GO:0007264),-0.2829756158608938,-1.1068365209128965,0.24596774193548387,0.5979362247273314,1.0,35/103,25.45%,PLD1;IGF1;PLCE1;KSR1;TIAM2;RREB1;SHOC2;ARL3;BCR;MRAS;SHC1;JUN;ARHGEF18;ARFIP2;RB1;ARHGAP32;RALA;SETDB1;USP50;RAPGEF2;ARHGAP18;GNB1;ADRA2A;PRKD1;RASSF1;PARK7;CDK2;CRKL;FGF2;RIT1;CHP1;USP28;SIAH2;SHC3;MAPK14
prerank,regulation of protein kinase A signaling (GO:0010738),0.3990374842424208,1.1065472379976355,0.3188405797101449,0.7447778014392854,1.0,3/20,3.22%,PRKAR2B;MIF;AKAP6
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.2906886391423119,-1.1065293187936704,0.24603174603174602,0.5982078322273356,1.0,34/96,26.80%,SMG6;SMG1;WDR33;CASC3;RANBP2;U2AF2;CPSF3;SRSF6;NUP42;SLU7;SMG7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;NUP98;SRSF11;UPF3B;SRRM1;NUP43;SRSF2;CPSF4;NUP160;NUP93;CPSF1;NCBP2;FYTTD1
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.29863021861565814,-1.1064748918454221,0.27613412228796846,0.5978356981415581,1.0,31/88,25.59%,TRABD2B;SMAD3;MPP7;BMP7;GSK3B;SPIDR;VPS4B;STX18;BRK1;SYNPO2;FNIP1;TPR;SLF1;SYNPO;VEGFA;EMILIN1;SDC4;ICE1;VCP;RHOC;PARK7;AJUBA;SNF8;BMF;PIH1D1;ERCC1;PRKCA;GNL3L;SYK;RAB7A;SDC1
prerank,RNA export from nucleus (GO:0006405),-0.28826389888407056,-1.1064414553777542,0.2565130260521042,0.5974243876447801,1.0,35/100,26.80%,SMG6;SMG1;WDR33;CASC3;RANBP2;U2AF2;CPSF3;SRSF6;NUP42;SLU7;SMG7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;NUP98;SRSF11;UPF3B;SRRM1;NUP43;SRSF2;XPO5;CPSF4;NUP160;NUP93;CPSF1;NCBP2;FYTTD1
prerank,ventricular septum morphogenesis (GO:0060412),-0.3740603418435837,-1.106344812087592,0.3176691729323308,0.5971758086334538,1.0,6/27,3.19%,TGFBR3;TGFBR1;BMPR1A;BMP4;ROBO1;TGFBR2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.392585886974914,-1.1062875426282617,0.3093385214007782,0.5968382470116386,1.0,9/22,27.07%,MED17;MED12;DHX36;MED1;MED16;MED13;MED14;PAXIP1;ESR1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.40342921685505717,-1.105580387647797,0.3269230769230769,0.598028672451861,1.0,7/20,22.55%,LBP;LYN;PTPN22;IL18;TLR4;IRAK1;TICAM1
prerank,regulation of cell projection organization (GO:0031344),0.44200889063196963,1.1055738443509056,0.3489795918367347,0.7464790505051004,1.0,4/13,9.17%,MFSD2A;SEMA4D;NTNG2;NTNG1
prerank,ion homeostasis (GO:0050801),0.36100235010086984,1.10546646424348,0.2976939203354298,0.7455472038720837,1.0,5/30,7.90%,SLC4A1;KLHL3;WNK2;UNC80;SLC30A3
prerank,erythrocyte differentiation (GO:0030218),-0.33426789805716267,-1.1052128085343909,0.3182674199623352,0.598438667688296,1.0,15/44,19.46%,TGFBR3;KIT;ACIN1;UFL1;LYN;CEBPG;UBA5;MED1;PTPN2;ID2;HSPA9;VEGFA;SLC25A38;ATP5IF1;INHBA
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.4819861590487402,1.104903107259543,0.3235294117647059,0.745991630114335,1.0,6/10,16.43%,ISG15;RPS27A;UBC;UBB;CHFR;NEDD8
prerank,striated muscle cell development (GO:0055002),0.42940205071510806,1.1047918086600395,0.33544303797468356,0.7450597432577065,1.0,3/14,8.10%,MYH6;PGM5;TMOD1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.4328503527403112,-1.1042548221435018,0.3574144486692015,0.6003688972695218,1.0,4/15,9.09%,FOXC1;BMP4;NUMA1;MED1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.40750661549115164,-1.1041983923742906,0.327683615819209,0.5999931724582745,1.0,11/18,37.11%,RNFT1;TMEM259;ERN1;USP13;NCK1;PIK3R1;BAG6;BAK1;BCL2L11;RNF185;FCGR2B
prerank,thymus development (GO:0048538),-0.44900520284018003,-1.1037271055198932,0.33468559837728196,0.6005835102317229,1.0,6/13,26.51%,TGFBR1;ZBTB1;HES1;SIX1;FOXE1;EPHB3
prerank,response to UV-A (GO:0070141),0.4364672732973154,1.1036343140005498,0.33072407045009783,0.7472859570944939,1.0,4/14,7.85%,MME;CCND1;TIMP1;AKT1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.25993593997239994,1.1032513681561693,0.2075098814229249,0.7471164856636394,1.0,35/214,11.33%,TEK;ERBB4;TIRAP;PTPRR;CSF1R;EPHB1;NECAB2;SEMA6A;MIF;CNKSR3;SPRY3;DUSP6;HTR2C;CAMK2N1;GAS6;FGF10;WNK2;KDR;NTRK2;SEMA7A;NOTCH1;P2RY1;ZDHHC17;ADCYAP1;GPNMB;CCL2;ADRA1A;THPO;OPRM1;DAB2IP;LMO3;PDGFB;ATP6AP1;F2R;DUSP26
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.4722479104537649,1.1031942351463262,0.3444676409185804,0.7460103849444127,1.0,5/10,19.23%,RUVBL1;PIH1D2;ZNHIT6;NAF1;NUFIP1
prerank,protein oxidation (GO:0018158),-0.47639135235788266,-1.1030660683490479,0.34501845018450183,0.6016670456970767,1.0,5/11,21.64%,LOXL1;LOX;LOXL3;TMX3;SUMF1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.33755906847780204,-1.1030105327397606,0.30495049504950494,0.6013109297272158,1.0,7/39,10.19%,EGFR;ERRFI1;RNF115;PTPN3;CDC42;PTPN12;PTPN2
prerank,regulation of endopeptidase activity (GO:0052548),0.31839534960363364,1.1026149822137656,0.2894168466522678,0.7464665158934234,1.0,7/59,9.96%,SPOCK2;SPOCK1;SPOCK3;PSENEN;TIMP1;AKT1;SERPINB8
prerank,ERBB signaling pathway (GO:0038127),-0.3118595306698989,-1.1024104452534336,0.2865853658536585,0.6022973402305684,1.0,22/64,21.62%,EGFR;EFEMP1;PLCE1;SLC30A10;GAREM1;SHC1;BRAF;PDPK1;PLCG1;PTPN12;KIF16B;CPNE3;REPS2;NCK2;GAB1;HBEGF;NRG4;PTPN11;MVP;DGKD;AAMP;PIK3R1
prerank,ncRNA transcription (GO:0098781),-0.4485569966275832,-1.10213273534485,0.3314814814814815,0.6024894525888159,1.0,9/13,38.65%,CAVIN1;BRF1;SNAPC3;SPIN1;GTF3C1;POLR1G;GTF3A;ANG;SNAPC2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.41864418850389373,1.1019101872144503,0.32589285714285715,0.7473554995260872,1.0,6/17,13.93%,CD33;MAGI2;HSP90AB1;CALM1;CALM2;CALM3
prerank,superoxide metabolic process (GO:0006801),-0.36102363622381856,-1.101851811400594,0.312015503875969,0.6027127695661576,1.0,12/29,28.53%,SH3PXD2B;CYB5R4;NOX4;SH3PXD2A;SOD3;CYBA;SOD2;NCF2;PRDX2;CCS;ALOX12;MT3
prerank,cardiac muscle contraction (GO:0060048),-0.34939763384329126,-1.1016079985331104,0.29734848484848486,0.6028333531284064,1.0,3/34,1.48%,ATP1A2;GSN;TPM1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.3837610809796266,-1.1015424716427615,0.33840304182509506,0.602495447024244,1.0,8/24,12.66%,BOC;CDON;CTNNA1;ABL1;MEF2A;CDC42;MEF2C;TCF3
prerank,plasma membrane invagination (GO:0099024),-0.36602880446817354,-1.1010914104870466,0.3253968253968254,0.6030739228116372,1.0,6/29,10.38%,GULP1;GSN;SNX9;VAMP7;CDC42;RHOA
prerank,regulation of innate immune response (GO:0045088),-0.30984665698712965,-1.100805048760818,0.28598848368522073,0.6033451121747281,1.0,27/57,32.26%,APPL2;IRAK3;TRAFD1;PLSCR1;DHX9;XIAP;PTPN22;PARP9;RIOK3;APPL1;IRF1;PTPN1;IFI35;PTPN11;USP18;NLRC3;POLR3D;ERAP1;CACTIN;DHX58;MUL1;SAMHD1;TNFAIP3;BIRC3;TYRO3;TKFC;PTPN6
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.30845689756704353,-1.1007416126474092,0.2881679389312977,0.6029938855592397,1.0,17/68,23.20%,RHOQ;OPA1;LRRK2;ENPP1;TPST1;AMPD3;GPAT4;ACSF2;SULT1A1;ACSL6;ACOT11;ABHD14B;ACOT9;AMPD2;ACOT8;PTHLH;ACOT6
prerank,glycoprotein catabolic process (GO:0006516),-0.4198063945304869,-1.100585297666288,0.3443830570902394,0.6028873111843925,1.0,5/17,9.50%,ADAMTS12;NGLY1;OGA;EDEM1;ADAMTS9
prerank,protein kinase A signaling (GO:0010737),-0.4541718383692591,-1.1004188277505966,0.3742911153119093,0.602805397454467,1.0,10/12,52.97%,PRKACA;MYOM1;RDX;TTN;TCP11X2;TCP11;PRKACB;RAB13;LCP1;GAL
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.45324394715037447,-1.1002221729627477,0.3230174081237911,0.6027970136850267,1.0,9/14,31.13%,UPP2;NT5M;UPB1;DPYD;DHODH;NT5C1A;UMPS;CAD;ERH
prerank,presynaptic endocytosis (GO:0140238),0.3767359447631575,1.0999271249753617,0.3213572854291417,0.7520333721454387,1.0,10/24,19.04%,SYT1;NLGN1;SNCA;AMPH;SYT2;SNCB;NLGN3;PACSIN1;SYNJ1;SYT5
prerank,cellular response to increased oxygen levels (GO:0036295),0.4534106675784078,1.0998244805577568,0.32142857142857145,0.7510603679941434,1.0,4/11,15.05%,ATP6V1A;ATP6AP1;FOXO1;TMEM199
prerank,nucleosome organization (GO:0034728),-0.3173933274038331,-1.0994588328657433,0.2848605577689243,0.6042035188584817,1.0,27/55,36.22%,INO80;KAT6B;SMARCC2;RNF8;SETD2;MCM3AP;SPTY2D1;ANP32B;ANP32E;NASP;SMARCD2;ARID2;BPTF;H1-0;PRDM9;NAP1L4;SMARCD3;NAP1L1;ACTR6;ATRX;DMAP1;NAP1L2;CHAF1A;NAP1L3;NPM1;SMARCA4;ARID1A
prerank,SNARE complex assembly (GO:0035493),-0.471806001546594,-1.099098095060416,0.33984375,0.6046209483197185,1.0,4/10,17.41%,UVRAG;STXBP1;VAMP2;VAMP4
prerank,regulation of cell differentiation (GO:0045595),-0.26612635915245664,-1.098644929779354,0.2361111111111111,0.6052563605316975,1.0,33/148,17.28%,PHLDB2;SMOC1;TGFBR1;DAG1;EPHA3;DDX5;NREP;NR1D2;ZFHX3;CCN2;ROCK1;FLOT2;DDX17;CREBBP;TRIP4;FGFR2;REST;RUNX1;AR;ST7;IGF2;NGF;ID2;SIK1;CDK5RAP1;EIF2AK2;TAF8;ANP32B;TRPS1;NSUN2;SIX1;RUNX2;PRKACA
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.24861808219687073,-1.0986019973157315,0.1864406779661017,0.604865591375906,1.0,78/308,19.51%,SMAD3;LRP1;TGFBR1;APPL2;SOX5;BMPR1A;FOXD1;PTN;LEPR;COL1A1;ABCA1;SMURF2;FOXC1;GRB10;DAB2;BMP4;ROCK1;ACSL1;GHR;PDPN;SMO;TGFBR2;KMT5B;NUMA1;ALMS1;ADRA1B;RREB1;NIBAN2;PLA2R1;PPARGC1B;LBP;TGFB1I1;BCL9L;SMAD2;ZBTB16;VAMP7;MTOR;REST;PPARGC1A;GJA1;MED1;CPT2;PDGFC;SHLD2;SMAD4;PRKAB2;GNAS;KMT5C;TRPM4;EHMT1;SOX6;OGT;SLC27A1;EIF2AK2;VEGFA;APOE;KDM3A;ACVR1;ZBED3;C1QTNF3;GLIPR2;TGFB3;ADRA2A;IL18;CMKLR1;SIX1;DYNC1H1;PIK3CD;SERPINE1;TRPV2;INPP5K;WNT5A;BMP2;GCNT2;ABCA7;PTPN11;INHBA;B4GALT5
prerank,arachidonic acid metabolic process (GO:0019369),-0.35056335446616543,-1.098593359812403,0.2934131736526946,0.6043984692375169,1.0,18/35,32.81%,PTGDS;PTGIS;DAGLA;PTGS1;PLA2G4A;CYP1B1;PTGES;PNPLA8;EPHX1;EPHX2;MGLL;DAGLB;CYP2U1;ALOX12;PLA2G4C;TBXAS1;CYP2S1;CBR1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3678455122971864,-1.0985607915239195,0.3106796116504854,0.6039895657132651,1.0,8/29,11.64%,GTF2H2;RAD23B;CCNH;CDK7;DDB2;MNAT1;PARP1;ERCC3
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.36793116410772086,1.0984001118873907,0.31717171717171716,0.7540344501373396,1.0,6/27,10.98%,GRM1;HTR2C;GPR35;GPR17;F2RL2;F2R
prerank,cobalamin metabolic process (GO:0009235),-0.40316065734262363,-1.0980843088228243,0.3235867446393762,0.6047372572030556,1.0,4/17,16.18%,TCN2;MMUT;ABCD4;CUBN
prerank,glycosphingolipid metabolic process (GO:0006687),0.3340817547828256,1.0980482617481446,0.3225152129817444,0.7538366268270178,1.0,18/42,21.64%,ST6GALNAC3;B4GALNT1;NEU2;ST8SIA1;ARSA;B4GALT6;SMPD1;GLA;ST8SIA3;CPTP;GALC;GLB1;HEXB;NEU1;PSAP;NEU4;ESYT2;SUMF2
prerank,organic hydroxy compound transport (GO:0015850),0.347970312707437,1.097870772428454,0.30648330058939094,0.7531158782162742,1.0,6/36,13.94%,SLCO1C1;AQP9;NCOA2;SLCO2B1;ABCC4;SLC16A1
prerank,cellular amino acid catabolic process (GO:0009063),-0.2882116567663504,-1.0972475722273625,0.25646123260437376,0.6062984364579805,1.0,24/87,25.05%,DDO;ABAT;ASPA;ACADSB;IVD;HIBCH;GLUD1;MCCC2;GLUL;PRODH;ALDH6A1;DLST;SARDH;ALDH7A1;CARNMT1;NOS1;BCKDK;ALDH4A1;AMT;HIBADH;PIPOX;AUH;HNMT;CBS
prerank,peptidyl-threonine modification (GO:0018210),-0.30739481262745255,-1.0969623493996583,0.2975708502024291,0.6064980595271087,1.0,24/66,24.02%,ROCK2;TGFBR1;ROCK1;TGFBR2;LRRK2;GSK3B;TBK1;CAMK2D;PDPK1;MAP2K1;HIPK1;WNK1;PRKCD;PRKDC;ACVR1;CSNK2A1;PRKD1;GALNT1;CDK10;GALNT11;MAP3K12;CDC42BPG;PRKCA;DYRK1B
prerank,vasodilation (GO:0042311),0.44115764874958546,1.0965029752418654,0.3503480278422274,0.7560471353440577,1.0,4/13,16.61%,ADRB1;NOS3;KLF2;KCNMA1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.423237999515374,-1.0961239291225564,0.3296500920810313,0.6080911687581467,1.0,5/15,16.87%,TNRC6B;TNRC6A;EIF4ENIF1;TNRC6C;CNOT1
prerank,protein targeting to mitochondrion (GO:0006626),0.3229597766232402,1.0957945096649646,0.294478527607362,0.756874455728048,1.0,14/52,20.14%,GDAP1;CHCHD4;TIMM21;DNAJC15;PMPCA;PITRM1;TIMM22;HSPD1;NDUFA13;TSPO;HSP90AA1;TOMM70;TIMM10B;DNAJC19
prerank,positive regulation of calcium ion import (GO:0090280),0.4445942768374994,1.095472742326566,0.3267543859649123,0.7566276338414164,1.0,3/12,10.53%,CXCL12;CCL2;PDGFB
prerank,protein ADP-ribosylation (GO:0006471),-0.37592179175133394,-1.0949686587450482,0.333984375,0.6104963384226226,1.0,12/28,24.59%,TNKS2;ZC3HAV1;PARP10;PARP9;PARP14;PARP1;SIRT5;PARP4;PARP6;SIRT4;PARP12;SIRT3
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.4511885572428883,1.0948091310412003,0.34285714285714286,0.757516687538762,1.0,3/12,6.87%,TIRAP;MBP;KLF4
prerank,bicellular tight junction assembly (GO:0070830),0.3248360020658001,1.0945481384570581,0.289760348583878,0.7570320453254901,1.0,9/46,12.22%,CLDN5;RAMP2;OCLN;CLDN14;ESAM;PECAM1;MICALL2;APC;MARVELD2
prerank,cellular response to UV-A (GO:0071492),0.4709103752468327,1.0943034427531833,0.3425531914893617,0.7565263838551503,1.0,4/11,18.29%,MME;TIMP1;MMP1;MMP3
prerank,apoptotic DNA fragmentation (GO:0006309),-0.4254647903142327,-1.0941798139484216,0.34386617100371747,0.6119566528166352,1.0,6/16,26.99%,DICER1;HMGB1;H1-0;EXOG;DNASE2;CECR2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.3968139122146567,-1.0941794793340895,0.3178294573643411,0.611458722261048,1.0,3/20,2.56%,PID1;RHOQ;DAB2
prerank,cellular response to glucagon stimulus (GO:0071377),0.4124984666994158,1.0939429965752194,0.33405639913232105,0.7564174841503145,1.0,3/17,1.18%,PRKAR2B;ADCY3;ADCY8
prerank,glycolipid metabolic process (GO:0006664),0.32597702837339426,1.0937913722658783,0.3125,0.7556117795648446,1.0,18/47,21.64%,ST6GALNAC3;ST3GAL6;B4GALNT1;NEU2;ARSA;SMPD1;GLA;ST8SIA6;CPTP;PIGW;GALC;GLB1;HEXB;NEU1;PSAP;NEU4;ESYT2;SUMF2
prerank,TOR signaling (GO:0031929),0.3672769376981104,1.0936252866346252,0.33617021276595743,0.7548750601121119,1.0,7/26,11.60%,PRR5L;RPS6;MEAK7;RPS6KB2;AKT1;EIF4EBP2;CCDC88A
prerank,receptor metabolic process (GO:0043112),0.3212805870207129,1.0931720461535213,0.2921108742004264,0.7549587289490263,1.0,6/53,4.67%,TFRC;DNM3;RAMP2;AP2M1;SNCA;GRK2
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.26882376254236157,-1.0926692764869748,0.2542056074766355,0.6146824699976314,1.0,55/153,25.45%,ROCK2;TGFBR1;PKD1;TLK1;ROCK1;SMG1;CAMK1D;TGFBR2;LRRK2;CSNK1A1;TOP1;GSK3B;TBK1;MARK3;PAK2;EIF2AK3;MTOR;CAMK2D;PDPK1;HIPK1;CSNK1E;WNK1;BRSK1;PRKCD;DMPK;ULK2;MKNK2;RICTOR;ERN1;PRKDC;PRKCZ;LATS1;CSNK2A1;MARK1;PRKD1;PRKACA;IKBKE;MORC3;CSNK1D;CDK2;CAB39;AKT2;NEK6;MAST2;MKNK1;MAP3K12;CLSPN;ATR;PRKCA;DYRK1B;MAP3K13;MASTL;CSNK1G2;RPS6KA4;MAPK14
prerank,establishment of endothelial barrier (GO:0061028),0.3641975484618286,1.0924642182100104,0.31130063965884863,0.7558018617019122,1.0,11/29,16.91%,ROBO4;PDE2A;PPP1R16B;PECAM1;RAB1B;MARVELD2;TJP1;PDE4D;RAP1A;SOX18;RAP2B
prerank,heme biosynthetic process (GO:0006783),0.3812679811867648,1.0924178601112484,0.34024896265560167,0.7547255455122477,1.0,8/22,21.17%,ALAS2;ABCG2;CPOX;TSPO;FECH;COX10;HMBS;ABCB10
prerank,regulation of protein phosphorylation (GO:0001932),-0.2498998939725023,-1.0919739515390223,0.2286902286902287,0.615882555147309,1.0,52/256,15.12%,PTPN13;ROCK2;EGFR;PID1;PLCE1;LEPR;EPHA7;IL34;SLCO3A1;ANGPT1;LRP6;NTRK3;PELI2;PLPP3;FBLN1;FGF1;BMP7;DAB2;BMP4;FAM20A;PRKN;ABL1;LRRK2;IBTK;IGFBP3;AXIN1;NSD1;EIF2AK3;LYN;AKAP8L;IGF2;IMPACT;PLXNB2;FER;RB1CC1;MAVS;BMPER;FNIP1;PPP2R5E;FN1;CARD14;MOB1B;FKBP8;CCN1;WDFY2;VEGFA;PRKDC;VEGFD;PPP2R5D;CCND3;PDCL3;ZBED3
prerank,homologous chromosome segregation (GO:0045143),0.3857562103812273,1.0917771064204975,0.33403805496828753,0.7554161343842091,1.0,2/20,4.03%,MEI4;FMN2
prerank,regulation of urine volume (GO:0035809),-0.47384086491251676,-1.0917557345286477,0.35634328358208955,0.61585980210599,1.0,4/10,25.51%,NPR3;ADCY6;INPP5K;ADM
prerank,blood circulation (GO:0008015),-0.3203150875556493,-1.091542377786933,0.2918287937743191,0.6158901670555135,1.0,12/49,15.25%,ROCK2;COL4A3;ROCK1;ELN;SERPING1;MEOX2;MYOF;ADCY6;GUCY1A1;AGTR1;STAT1;BDKRB2
prerank,striated muscle cell differentiation (GO:0051146),-0.4203100963982093,-1.0911072841086495,0.3705103969754253,0.6164682213903208,1.0,4/16,12.38%,AKAP13;SKI;MEF2C;SIK1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2718974716527672,1.0907403260643636,0.25100401606425704,0.7573060721827358,1.0,23/140,11.38%,CACNA1A;GRIN1;ADCY8;GRM1;RYR2;HTR2C;CACNA2D1;SLC8A1;CD24;TACR1;NPTN;GPR35;P2RY1;CIB2;ACKR4;ADCYAP1;GPR17;ADRA1D;ADRA1A;F2RL2;F2R;P2RX7;JPH3
prerank,mRNA transport (GO:0051028),-0.2835725149292305,-1.0907383066423717,0.2702702702702703,0.6168873177841121,1.0,34/101,26.80%,SMG6;SMG1;WDR33;CASC3;RANBP2;U2AF2;CPSF3;SRSF6;NUP42;SLU7;SMG7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;NUP98;SRSF11;UPF3B;SRRM1;NUP43;SRSF2;CPSF4;NUP160;NUP93;CPSF1;NCBP2;FYTTD1
prerank,regulation of angiogenesis (GO:0045765),0.25942990556309936,1.0903295459184643,0.22633744855967078,0.7572852636014641,1.0,27/192,8.66%,FLT1;CLDN5;TEK;IL17F;MINAR1;ADAM12;TIE1;SEMA6A;RAMP2;HTATIP2;ADGRB1;SIRT1;HMGA2;PPARG;NAXE;TSPAN12;PPP1R16B;KDR;NOS3;TGFB2;ETS1;KLF4;APLNR;NINJ1;GPNMB;CD34;HSPB1
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.39635415320477607,-1.0901591277628238,0.3340122199592668,0.6178660670727709,1.0,3/20,3.78%,CFLAR;NUPR1;FLOT2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4740744196170404,-1.090142814386954,0.3786764705882353,0.6174031351615898,1.0,3/11,11.26%,EFNB2;DHX36;MEF2C
prerank,protein heterotetramerization (GO:0051290),0.44069260024280027,1.0900185062831118,0.3333333333333333,0.757018177219675,1.0,3/13,10.64%,GRIN1;GRIN2B;FARSB
prerank,platelet aggregation (GO:0070527),-0.35207057046478,-1.0896985423858254,0.3320610687022901,0.6179992463665144,1.0,9/33,15.46%,VCL;PDGFRA;TLN1;FLNA;STXBP1;FN1;GNAS;P2RY12;FIBP
prerank,positive regulation of insulin secretion (GO:0032024),-0.3454987699521598,-1.0895335491503795,0.31086142322097376,0.6179182477060438,1.0,8/36,13.02%,TCF7L2;MCU;NLGN2;RBP4;GLUD1;NNAT;STX4;TRPM4
prerank,regulation of blood coagulation (GO:0030193),-0.36388535361121144,-1.0894652264804487,0.3140655105973025,0.617584988473725,1.0,7/27,17.05%,ST3GAL4;VTN;THBS1;TFPI;FAP;APOE;SERPINE1
prerank,histone mRNA metabolic process (GO:0008334),-0.36657879327639115,-1.0893946366293417,0.325187969924812,0.6172647318816774,1.0,8/27,18.64%,TENT2;CPSF3;TUT4;UPF1;SLBP;XRN1;EXOSC10;SNRPF
prerank,response to cAMP (GO:0051591),0.340963031175062,1.0891504140863546,0.32914046121593293,0.7583950590616879,1.0,5/37,6.33%,HCN1;AQP9;AKAP6;PDE2A;HCN2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.4235196853119815,-1.0891137323049043,0.3697813121272366,0.6174537511615901,1.0,5/16,15.13%,DPYSL3;UPP2;NT5M;UPB1;DPYD
prerank,cell junction organization (GO:0034330),0.30359858379244675,1.0888765192485892,0.3088235294117647,0.7580695574786431,1.0,22/71,15.78%,GRM5;ACTB;CTNND2;SNCA;PPFIA3;OCLN;TGFB2;ELFN1;WNT7B;RAB39B;VMP1;APBB2;PPFIA2;PPFIA4;DVL1;MARVELD2;TJP1;SNCB;PSEN1;PAK3;NLGN3;CBLN2
prerank,positive regulation of cell motility (GO:2000147),0.25705236428641437,1.088747836618812,0.24470134874759153,0.7572405273758296,1.0,42/205,14.20%,SPOCK2;FLT1;IGF1R;LEF1;PTP4A1;SEMA3C;CSF1R;PODXL;SEMA6A;ITGA6;CXCL12;SEMA4A;SEMA4F;PPM1F;SEMA6D;KDR;SEMA4D;SEMA7A;FERMT3;HSPA5;NOTCH1;PAK1;PECAM1;GPNMB;AIF1;NTN1;PDGFB;F2R;CEP43;APC;PIK3R3;RET;EPHA1;TJP1;BCAR1;ACTN4;XBP1;ATM;HRAS;CIB1;INSR;PPP3CA
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.43249071179792403,-1.0883467422658444,0.36046511627906974,0.6189119074397551,1.0,7/13,22.51%,MDFIC;SP100;TPR;SUFU;APOD;PARK7;CHP1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.3388290297022862,1.088057925966632,0.33613445378151263,0.7581728670451885,1.0,8/39,12.28%,TEK;RAMP2;GAS6;KDR;NDNF;CCL2;SCG2;CD40
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4515936667034469,-1.0880302128370998,0.37294332723948814,0.61918539063548,1.0,2/12,5.60%,LIMA1;PLEKHH2
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.4594356982568727,-1.0879259884518,0.3411764705882353,0.6189356073344391,1.0,2/12,7.49%,GMDS;GFPT1
prerank,actin filament polymerization (GO:0030041),-0.35552511811543885,-1.0879212453602578,0.3404669260700389,0.618447464658038,1.0,9/29,17.24%,ARHGAP6;GAS7;GSN;DIAPH1;CORO7;WASL;WASF1;TTC17;FAM107A
prerank,response to lipid (GO:0033993),0.2809255476690415,1.0877740751956273,0.2813765182186235,0.7578480341689816,1.0,25/105,15.29%,TIRAP;S100A9;S100A8;ACER2;PPARG;SNCA;NOS3;IL12A;HNRNPA0;IFNAR1;TRIM6;SLPI;GGT7;F2R;SCD;FOXO1;GGT1;RXRG;CD36;TAB2;PAQR8;PELI1;HSD17B2;MAPKAPK2;GCH1
prerank,positive regulation of cellular component organization (GO:0051130),0.2798403334946574,1.0874128613781875,0.2882703777335984,0.7577344558216096,1.0,23/107,14.15%,IGF1R;TFRC;NRXN1;TMEM30A;TIRAP;NRG1;SHANK3;ATP10A;SNCA;GPX1;TGFB2;TAL1;CLU;TPPP;RELN;DAB2IP;SMPD1;ABCB4;CALY;DCTN1;RPS3;DLL1;INSR
prerank,protein glycosylation (GO:0006486),0.27545623015319964,1.0874077673031828,0.2737864077669903,0.7565163220528751,1.0,26/125,13.54%,ST8SIA4;GAL3ST1;GALNT9;MGAT5B;AQP11;ST3GAL6;EOGT;GALNT6;ST8SIA1;FUT9;ALG3;PMM1;B3GALT5;PLOD3;ALG1;MGAT4C;MPI;SLC39A8;TMEM258;ST8SIA6;ST8SIA3;B3GNT2;SERP1;ALG8;GALNT2;POMGNT2
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.3750967515202087,-1.0873915968766954,0.3403041825095057,0.6192283368628877,1.0,7/25,15.66%,PARVA;ITGAV;ITGB1;CXADR;JUP;ITGA5;ITGA4
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3945186125932273,1.0870772549887047,0.352112676056338,0.7562824344083984,1.0,7/20,10.53%,PROX1;CCND1;MAPRE3;AKT1;CCNY;HSP90AB1;PDGFB
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.42178463634330005,-1.0869560251316872,0.34790874524714827,0.6198668380816768,1.0,8/16,32.22%,KAT2B;EP300;CREBBP;NAA15;NAA16;NAA80;NAA25;NAA40
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.2759939377712248,-1.0869441249183782,0.2679245283018868,0.6193991299981815,1.0,27/121,15.52%,BMP6;IGF1;IL34;ANGPT1;IL31RA;IL6ST;GHR;ABL1;VTN;DLG4;KIT;PIBF1;PAK2;STAT3;NOX4;LYN;NRP1;EPHA4;IGF2;PARP9;PARP14;HES1;IL6R;TEC;VEGFA;ACVR1;ITGA5
prerank,regulation of TOR signaling (GO:0032006),-0.30005802456899944,-1.0868537555691524,0.2854368932038835,0.6191454149132818,1.0,19/67,21.32%,ARAF;UBR2;PRKAA2;DEPTOR;RPTOR;TMEM127;TTI1;UBR1;FNIP1;WDR59;TELO2;RICTOR;TBCK;NPRL3;PRKAA1;TBC1D7;GPAT3;LARS1;PIH1D1
prerank,fatty acid oxidation (GO:0019395),-0.31319923626693097,-1.086730353084892,0.3015267175572519,0.6189710570512482,1.0,15/57,17.97%,ABCD3;ACADM;ACAD10;PPARGC1A;ABCD2;ACAD11;CPT2;EHHADH;ACAA2;ABCD4;SLC25A17;BDH2;ECHDC2;ECI1;ACOX1
prerank,protein localization to cell junction (GO:1902414),-0.3826785496697116,-1.0866516682375407,0.3441682600382409,0.6186990798858796,1.0,5/22,5.79%,CGNL1;JAK1;NLGN2;DLG4;PAK2
prerank,negative regulation of cell cycle (GO:0045786),-0.3001037696863429,-1.0866016868224384,0.29963235294117646,0.6183268680251006,1.0,23/73,23.60%,NR2F2;SMAD3;FOXC1;BMP7;BMP4;NUPR1;GAS1;PTPN3;PTPRK;BTG3;RB1;CDK5RAP1;DUSP1;LATS1;PDCD4;NR4A1;BMP2;INHBA;CDKN1C;SCRIB;CDK6;ANGEL2;TFAP4
prerank,dendrite morphogenesis (GO:0048813),0.33769059930910755,1.0865558714238621,0.32,0.7566303121977664,1.0,10/35,12.36%,CTNNA2;EPHB1;CTNND2;MAPK8IP2;SHANK3;MAP2;TAOK2;CELSR2;DVL1;DOCK10
prerank,peptidyl-lysine methylation (GO:0018022),-0.37278193315053587,-1.0864720076057817,0.3277777777777778,0.6181516821388948,1.0,9/26,20.19%,SETD7;SMYD3;SETD3;SETD2;N6AMT1;EHMT1;METTL21A;EEF2KMT;KMT5A
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3707350807921348,1.086379599073422,0.2982832618025751,0.7559561581266514,1.0,7/25,12.06%,AKAP6;SNCA;THY1;APLNR;CACNB2;F2R;TRPC1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.41956158619002715,1.086183150243563,0.34557235421166305,0.7553433946344135,1.0,5/14,13.66%,ANK3;WNK2;GLRX;ACTN4;ATP1B1
prerank,positive regulation of chromatin organization (GO:1905269),0.4381552044157788,1.08618052979331,0.35368421052631577,0.7541287512806452,1.0,6/12,14.31%,TAL1;TERF1;H3-3A;TERF2IP;SIN3A;TINF2
prerank,autophagy of mitochondrion (GO:0000422),-0.33253129403743387,-1.0857351484651256,0.3383458646616541,0.6194682819923549,1.0,17/38,25.04%,PRKN;RB1CC1;ULK2;WIPI1;BECN1;ATG2A;ATG9A;WDR45B;ATG2B;ATG5;AMBRA1;FIS1;WIPI2;BNIP3;ATG14;MAP1LC3A;PHB2
prerank,peptidyl-tyrosine modification (GO:0018212),-0.3120090239541012,-1.0855718119134856,0.32688588007736946,0.6193843677247366,1.0,16/56,13.88%,EGFR;EFEMP1;EPHA3;PDGFRA;PDGFRB;ABL1;TPST1;KIT;FGFR2;LYN;EPHA4;FER;ABL2;ABI1;TEC;TTL
prerank,cAMP-mediated signaling (GO:0019933),0.381920328700641,1.0855493109624912,0.33137254901960783,0.754801116356786,1.0,7/24,12.78%,RIMS2;EPHA5;AKAP6;PDE2A;ADCYAP1;CAP2;PDE4D
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.45821432087483865,-1.085177462002335,0.3607843137254902,0.6198846908064749,1.0,2/11,7.19%,RC3H1;ANXA1
prerank,positive regulation of immune effector process (GO:0002699),-0.3650614479232617,-1.0850772834771296,0.3651685393258427,0.619622743882099,1.0,4/27,10.29%,APPL2;ANKRD17;LBP;DDX60
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.3697623922577691,-1.0846587769864027,0.3458646616541353,0.6201523285859674,1.0,14/26,27.70%,EIF4E;HES1;CUL3;TTL;USP2;CDC25B;CCDC57;KLHL18;SPHK1;HSF1;PRKCA;PPP1R10;EIF4EBP1;APP
prerank,microglial cell activation (GO:0001774),0.3789421152607568,1.0845784149055828,0.35020242914979755,0.7564984031475228,1.0,4/21,12.62%,SNCA;CLU;AIF1;ITGAM
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.35383098606986774,1.0845368737005423,0.3333333333333333,0.7554002975967866,1.0,10/29,17.88%,TERF1;HSP90AB1;PIF1;TERF2IP;NHP2;DKC1;TINF2;PTGES3;HSP90AA1;PPIA
prerank,superoxide anion generation (GO:0042554),-0.44043219885165297,-1.0844461099846192,0.3530534351145038,0.620137081185159,1.0,4/13,27.17%,NOX4;CYBA;NCF2;ALOX12
prerank,mitotic metaphase plate congression (GO:0007080),-0.31733685592673644,-1.0844383596026173,0.3261261261261261,0.6196651164968737,1.0,11/51,14.03%,EML4;PIBF1;VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3;RAB11A;CUL3;BECN1;NUDC
prerank,insulin secretion (GO:0030073),0.39544848181500947,1.0842306460585596,0.3367139959432049,0.7550295320460997,1.0,3/19,7.63%,PTPRN2;RIMS2;ADCYAP1
prerank,natural killer cell mediated immunity (GO:0002228),-0.4238755663307717,-1.0837161934351307,0.3474264705882353,0.620946812140871,1.0,5/15,31.73%,CEBPG;PLEKHM2;KIF5B;RAET1E;ULBP1
prerank,organic cation transport (GO:0015695),-0.3908527749586552,-1.0836118025382833,0.35797665369649806,0.6207180377913563,1.0,8/20,28.65%,SLC47A1;SLC22A5;SLC22A4;SEC14L1;SLC5A7;SLC22A2;SLC44A2;SLC25A29
prerank,mitochondrion disassembly (GO:0061726),-0.34151785613407987,-1.083570980975309,0.3259668508287293,0.6203154588460791,1.0,15/34,23.09%,PRKN;RB1CC1;ULK2;WIPI1;BECN1;ATG2A;ATG9A;WDR45B;ATG2B;ATG5;AMBRA1;FIS1;WIPI2;BNIP3;MAP1LC3A
prerank,steroid biosynthetic process (GO:0006694),-0.3092260403084507,-1.0833164253177636,0.3233082706766917,0.6204619425965553,1.0,15/56,22.80%,PRKAG2;CYP7B1;CYP27A1;INSIG2;OSBPL9;HMGCR;SQLE;CYP51A1;AMACR;DHRS11;FDFT1;SC5D;ACOT8;LBR;OSBPL3
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.31766787359811727,1.0828512110290047,0.30927835051546393,0.7578308757275206,1.0,13/54,12.28%,TMSB4X;SIRT1;PPARG;KDR;NOS3;CSNK2B;ETS1;ACVRL1;AKT1;HSPB1;PDGFB;ATP5F1B;CD40
prerank,protein localization to Golgi apparatus (GO:0034067),-0.36378568489374885,-1.0828218831322138,0.346,0.6211806267427341,1.0,6/27,13.28%,VPS13A;GBF1;VPS13D;OBSL1;COG7;VPS13C
prerank,protein homotrimerization (GO:0070207),-0.4315848782001781,-1.082068351612541,0.3738140417457306,0.6220374345763404,1.0,4/14,4.00%,CLYBL;SLC1A5;DISP1;SCARA5
prerank,protein trimerization (GO:0070206),-0.4315848782001781,-1.082068351612541,0.3738140417457306,0.6220374345763404,1.0,4/14,4.00%,CLYBL;SLC1A5;DISP1;SCARA5
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.37324695731296337,-1.0819947156783438,0.3479923518164436,0.6217404280613078,1.0,3/24,2.56%,PID1;RHOQ;DAB2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3439917355041006,1.0819069073618592,0.3081896551724138,0.7595212835368693,1.0,12/36,18.18%,NOSTRIN;NOS3;LYPLA1;AKT1;GLA;CALM1;SCARB1;ATP2B4;GCH1;HSP90AA1;DDAH1;NOSIP
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3446325500439617,1.0818517506319907,0.34309623430962344,0.7584469729539315,1.0,7/33,10.29%,PTPRG;PTPRR;ADGRB1;ACVRL1;DAB2IP;DNAJA4;PTPRM
prerank,negative regulation of immune effector process (GO:0002698),-0.44346683738999926,-1.0818166027378655,0.35887850467289717,0.6216968774432788,1.0,5/13,12.69%,CD55;RC3H1;FER;ENPP3;APPL1
prerank,establishment of protein localization to membrane (GO:0090150),-0.29753683250618923,-1.0818099417642861,0.2934131736526946,0.6212273988687816,1.0,16/66,18.71%,EGFR;AFDN;SYNE3;NACA;RAB10;RAB3GAP1;BRAF;RAB3IP;VPS37C;RAB11A;PARD3;SEC63;COX18;NECTIN3;ZDHHC1;CHM
prerank,negative regulation of interleukin-8 production (GO:0032717),0.410777997014183,1.0815039847864725,0.36585365853658536,0.7582550765570181,1.0,4/17,10.63%,CD33;TMSB4X;KLF4;BCL3
prerank,kinetochore organization (GO:0051383),-0.4351140841103087,-1.0812109716842015,0.3559322033898305,0.6222433286497577,1.0,12/13,53.23%,CENPT;POGZ;CENPE;CENPH;NDC80;CENPF;CENPA;DLGAP5;NUF2;CENPW;CENPC;CDT1
prerank,response to glucagon (GO:0033762),0.39772434152674047,1.0811932647474432,0.33403805496828753,0.7579726186930463,1.0,3/19,1.18%,PRKAR2B;ADCY3;ADCY8
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.4050560110126011,1.080526556526847,0.3792325056433409,0.7586999778391299,1.0,5/17,14.11%,PODXL;TGFB2;SKAP1;RET;CIB1
prerank,steroid hormone biosynthetic process (GO:0120178),0.3646952776368564,1.0803796979819922,0.34475374732334046,0.7579342552494577,1.0,10/29,19.32%,SRD5A2;HSD17B7;FDX2;TSPOAP1;TSPO;HSD17B2;DHCR7;STARD3NL;STARD3;SRD5A1
prerank,long-term memory (GO:0007616),0.39137809956326136,1.0801683899056846,0.33769063180827885,0.7573889992829261,1.0,4/19,12.60%,LRRN4;CAMK4;RASGRF1;PJA2
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.39894791110017486,-1.079964804327404,0.36,0.6248626882756416,1.0,3/20,3.80%,AKAP13;ADCY9;ADRA1B
prerank,"base-excision repair, gap-filling (GO:0006287)",0.34136720220985184,1.07955806475162,0.32786885245901637,0.7579401753580559,1.0,11/35,19.08%,LIG3;RPA3;UNG;APEX1;POLG;POLD1;RFC4;POLD3;RFC5;ADPRS;RFC2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.4227070885989588,-1.0794725307287856,0.3572778827977316,0.6256173056295379,1.0,6/15,23.11%,DAB2;SMAP1;WASL;BMP2K;DGKD;HIP1R
prerank,response to exogenous dsRNA (GO:0043330),-0.3915915555440028,-1.0792713207954774,0.36704119850187267,0.6256091511782879,1.0,10/18,32.05%,IRAK3;DHX9;MAVS;TICAM1;MUL1;CGAS;CAV1;IFIH1;TLR3;ZCCHC3
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.46830227048719203,-1.078436352405342,0.37640449438202245,0.6272106551859494,1.0,7/10,45.97%,FBXW7;ADRA2A;HBEGF;EGF;ADAM17;BTC;NCF1
prerank,amino acid transport (GO:0006865),0.3161922154205632,1.0775612948799351,0.30736842105263157,0.7626931034023,1.0,7/49,9.70%,SLC7A5;SLC6A6;SLC6A17;SLC7A1;SLC7A8;SLC43A2;SLC36A1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.47413699090270883,-1.0770931177209326,0.3988657844990548,0.6300518163503251,1.0,5/10,34.18%,PTPRS;NLRC3;SIRPA;CACTIN;PYCARD
prerank,regulation of cell growth (GO:0001558),0.25635410058214453,1.0765723424039146,0.26262626262626265,0.7643617294944581,1.0,41/204,14.94%,NRG3;TFRC;SPOCK1;MINAR1;S100A9;S100A8;AKAP6;GNG4;SIRT1;APBB1;OGFR;MFSD2A;PAK5;TGFB2;SCGB3A1;PPP2R1A;SLIT3;PRKCQ;WFDC1;PTPRJ;ACVRL1;MELTF;AKT1;RPS6KA1;SGK3;H3-3A;TAOK2;NET1;IL17RB;APBB2;CEP43;SOX17;NDUFA13;BMPR2;BCAR1;CIB1;SMARCA2;PPT1;CDKN1A;LGI1;RTN4
prerank,endothelial tube morphogenesis (GO:0061154),-0.47858175273490583,-1.0763351248920254,0.38420107719928187,0.6314229360160859,1.0,3/10,10.38%,RBPJ;BMP4;RHOA
prerank,regulation of wound healing (GO:0061041),-0.32744774001618193,-1.0761855664564923,0.33643122676579923,0.6313246710873095,1.0,12/42,22.07%,MYLK;VTN;ITGB1;ARFGEF1;ANXA1;SRSF6;CD109;ADRA2A;SERPINE1;HBEGF;CLDN1;FGF2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.32337543598181784,-1.0759708209101593,0.33980582524271846,0.6313650809690372,1.0,17/46,21.80%,JAK1;RAP1B;PAK2;ANXA2;CDC42;PITPNA;CAPZA1;HSPA9;ARF1;RALA;TYK2;PDCD4;AIP;SOD2;CNN2;P4HB;MSN
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4142741421852172,-1.0759655991472106,0.37725631768953066,0.6308861462617217,1.0,2/17,0.37%,ATP1A2;CACNA1C
prerank,protein localization to cell periphery (GO:1990778),0.26860550427567037,1.0756959886028254,0.29914529914529914,0.7657846333111968,1.0,21/133,9.24%,BSG;DPP10;EFR3B;MRAP2;SPTBN4;KCNIP4;RAMP2;ANK3;RAB3C;FGF13;TNIK;LIN7A;MAP7;GAS6;DPP6;ZDHHC22;EPB41L3;P2RY1;CACNB2;TSPAN17;RAB40B
prerank,regulation of hippo signaling (GO:0035330),-0.4043741596770495,-1.0755995965153915,0.3611111111111111,0.6312656364192536,1.0,12/17,27.12%,WWC2;VGLL4;WTIP;MARK3;LIMD1;WWC1;AJUBA;NF2;DLG5;SOX11;MAPK14;NEK8
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.4095633367032961,1.0749989543818435,0.38074398249452956,0.7666066374289926,1.0,8/17,21.57%,NDUFA4;COX4I1;COX6A1;COX6B1;COX7C;COX10;COX8A;COX5B
prerank,macrophage activation involved in immune response (GO:0002281),-0.4353306262162577,-1.0748328333613428,0.37524177949709864,0.6327371289936818,1.0,6/13,27.42%,LBP;SBNO2;CX3CR1;IFI35;SYK;GRN
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.388611694398546,-1.0742147498593915,0.3448905109489051,0.6338374723627803,1.0,3/19,5.31%,IL34;CAMK1D;THBS1
prerank,regulation of cell adhesion (GO:0030155),-0.26766272001314056,-1.0741404343438339,0.2809917355371901,0.6335275726300887,1.0,31/129,17.80%,PLXNA2;ROCK2;EPHA7;ANGPT1;TPM1;ZFHX3;FBLN1;ITGAV;PPP1R12A;ROCK1;ABL1;RIPOR2;LYN;EPHA4;RSU1;PLXNB2;ABL2;STX4;ARHGDIB;EPHA8;CD164;DUSP1;VEGFA;PPP1CB;RASA1;PLXNB1;PLXND1;GPR4;IL18;MIA3;MYADM
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.32379224540504903,-1.073796001005006,0.3415559772296015,0.6339334391621028,1.0,10/45,10.81%,FOXO3;PUM2;ZC3H7A;RC3H1;LARP1;PUM1;GEMIN5;EIF4E;PARP9;YTHDC1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.39665536122966244,-1.0736612438097415,0.3775700934579439,0.6337580158355343,1.0,4/20,9.43%,ATP1A2;SLC9A1;KCNJ2;SLC12A2
prerank,lipid transport (GO:0006869),0.27908973706803475,1.0732275663581927,0.30174081237911027,0.7707803666253262,1.0,21/97,13.47%,SLCO1C1;PLTP;ATP8A1;MFSD2A;NCOA2;CERT1;CHKA;PITPNM1;SPNS2;PRELID3A;SLCO2B1;ABCC4;FABP5;PLEKHA3;PRELID2;CPTP;ABCG4;CD36;TTPA;SLC27A4;SCARB1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.4169023413687782,-1.0732268297042444,0.35753176043557167,0.6343672548144649,1.0,10/16,30.55%,PRPF39;SFSWAP;DDX23;SRSF1;WBP11;NCBP2;CACTIN;RBM22;SNRNP200;PSIP1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.4715062650246763,-1.0730648600785004,0.39344262295081966,0.634261928940871,1.0,4/10,29.40%,ADGRV1;IFT88;PLS1;TSKU
prerank,histone H2A monoubiquitination (GO:0035518),-0.4076951643589379,-1.0730607307245579,0.38132295719844356,0.633782245087515,1.0,4/17,11.85%,BCOR;DDB2;PCGF2;PCGF6
prerank,negative regulation of catabolic process (GO:0009895),-0.3247469850355428,-1.0729837133182811,0.3422562141491396,0.6334692196528137,1.0,7/47,4.64%,EGFR;MDM4;HDAC4;NCOR1;NUPR1;FLNA;IRAK3
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3008697771346355,-1.0726929133391219,0.3060428849902534,0.6336420659248364,1.0,13/69,10.94%,IGF1;GAB2;PLCE1;PDGFRA;PI4KA;PDGFRB;PLCD3;IRS1;NGF;PLCB3;PLCD1;RHOA;PITPNM2
prerank,regulation of apoptotic process (GO:0042981),-0.225807047903445,-1.072299318577896,0.19017094017094016,0.634140440209736,1.0,154/676,19.31%,AKAP13;FSTL1;NOTCH2;IGF1;GRK5;FHL2;PAWR;EGFR;ARHGAP10;SON;NFKB1;ANGPT1;SMAD6;OPA1;ZFAND6;STEAP3;ARAF;CFLAR;AXL;DAB2;IL31RA;IL6ST;BMP4;FOXO3;STK3;TIAM2;ERC1;PDPN;PRKN;TAX1BP1;ABL1;BIRC6;OSR1;PRKAA2;ARHGEF17;NUPR1;GSK3B;STK17B;NIBAN2;FLNA;IGFBP3;RARG;ANXA5;ANXA4;HMGB1;ITGB1;CTSH;SLK;DNM1L;THBS1;HOXA5;PAK2;CREBBP;SH3RF1;TMBIM4;PHLDA1;SHC1;IFIT2;MAP4K4;GAS1;BCL2;ANXA1;REST;BRAF;MAP3K5;PLEKHG2;FAM162A;FBXO10;CALHM2;WRN;AIFM1;DDX42;VAV2;ACTN2;VDAC1;ADAMTSL4;UNC13B;XIAP;MED1;HNRNPK;MAP3K20;NGF;NCSTN;EGLN3;PRMT2;BAG3;JUN;ANKLE2;CYP1B1;TRAF2;DNAJC3;ARHGEF12;ARHGEF18;USP47;BCLAF1;MEF2C;LGALS1;ERCC3;SOS2;YME1L1;HSPA9;FGD1;CASP2;CARD14;RASSF2;ATF6;SH3RF2;RBM5;CCAR1;GLO1;ING5;NAA15;VEGFA;PRKDC;STAT1;LATS1;FGD4;DDX3X;HDAC1;ANP32B;TOPORS;RASA1;ANP32E;NGEF;NOP53;TGFB3;MRE11;ARHGEF11;DAPK1;PTPA;ARHGEF6;CITED2;TXNDC5;BFAR;TRIO;DAPK2;ARHGEF1;TMEM219;PHIP;IAPP;PRKAA1;RABGGTB;TRAF6;VCP;DCUN1D3;WNT5A;CHM;BMP2;TMEM14A;AREL1;APIP;SFRP4;PARK7;IRAK1
prerank,peripheral nervous system development (GO:0007422),0.3779403784198402,1.0722427321973163,0.37549407114624506,0.7725765583913194,1.0,3/23,6.65%,ASIC2;ADGRB1;NFASC
prerank,ventricular septum development (GO:0003281),-0.3400632519283232,-1.0718385245820625,0.3333333333333333,0.634829324062809,1.0,13/37,17.00%,TGFBR3;TGFBR1;BMPR1A;MDM4;ROBO1;TGFBR2;SMAD4;HES1;ACVR1;SALL1;HECTD1;CITED2;HEYL
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.4130388080538566,1.0714576923384258,0.3582089552238806,0.7738183103295189,1.0,3/15,8.66%,TMSB4X;KDR;HSPB1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.37424182716454063,-1.0712777294795894,0.35658914728682173,0.6357358432856706,1.0,7/22,11.86%,UGGT2;MAN1C1;OS9;EDEM3;EDEM1;MAN1B1;MAN1A2
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.440359074834331,1.0712738190629758,0.3669527896995708,0.7731800316569112,1.0,4/12,16.31%,SNAP25;STX3;SNAP29;STX1B
prerank,potassium ion export across plasma membrane (GO:0097623),-0.4442609827055589,-1.0711021700195833,0.3917910447761194,0.6356970585651228,1.0,2/13,6.12%,KCNT2;KCNK5
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.4249300584370684,-1.0710454784281005,0.36750483558994196,0.6353427179233564,1.0,5/15,14.39%,DICER1;ZC3H12C;NYNRIN;KHNYN;ZC3H12B
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.3678851184550809,-1.0706100737924238,0.33811475409836067,0.6359478759091507,1.0,6/23,18.26%,INPP5B;SYNJ2;MTMR12;MTMR3;SACM1L;INPP5K
prerank,positive regulation of MAPK cascade (GO:0043410),-0.24493700630943374,-1.0705281411618939,0.27920792079207923,0.6356854952391009,1.0,59/245,19.31%,ROCK2;NOTCH2;IGF1;EGFR;ROR1;LPAR1;PDGFRA;IL34;ANGPT1;NTRK3;PELI2;CCN2;FGF1;KSR1;PDGFRB;ROCK1;ROBO1;LRRK2;ADRA1B;KIT;GSDME;RYK;HMGB1;SLC30A10;GAREM1;TAOK3;FGFR2;SHC1;NRP1;BRAF;MID1;IGF2;MAP2K1;PTPN22;PDGFC;BMPER;WWC1;TRIM5;FBXW7;TPD52L1;EPHA8;EIF2AK2;VEGFA;ROR2;RAPGEF2;PRKCZ;APOE;GLIPR2;MAP2K7;ADRA2A;ARRB1;PRXL2C;IAPP;NPNT;BMP2;GCNT2;ABCA7;PTPN11;IRAK1
prerank,cellular response to chemical stress (GO:0062197),-0.2821086048964005,-1.0703327759980514,0.31752577319587627,0.6356724989538904,1.0,41/96,31.48%,FOXO3;ABL1;PRKAA2;LRRK2;NOX4;LRRC8D;PPARGC1A;SELENOS;STX4;PARP1;SOD3;MGAT3;PKD2;ADNP2;TXNRD2;DDX3X;CYBA;GPX8;PRKD1;PRKAA1;SOD2;PARK7;NCF2;PRDX2;FANCC;ZFAND1;GPX7;NUDT2;GSR;CCS;SLC25A24;HTRA2;LONP1;BRF2;MT3;CAV1;SRXN1;NFE2L2;CYCS;TXNRD1;PYCR2
prerank,cholesterol efflux (GO:0033344),-0.3852185090603561,-1.0700001686531464,0.36293436293436293,0.6359915466643011,1.0,5/20,19.13%,ABCA1;SOAT1;NPC2;APOE;ABCA7
prerank,sensory perception of light stimulus (GO:0050953),-0.2897122388630242,-1.0698451092318064,0.3373253493013972,0.6358933366091809,1.0,20/87,18.21%,EFEMP1;COL1A1;OPA1;EYA4;ZIC2;SLC4A10;MYO9A;EML2;ADGRV1;DHRS3;PITPNA;RPGR;RP2;COL18A1;ATF6;IMPG2;OAT;ATXN7;POU6F2;RABGGTB
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.2937091266141025,-1.069837372162989,0.3285123966942149,0.63542814566384,1.0,17/68,17.38%,PCCA;AOX1;HLCS;ENPP1;TCN2;MMUT;MCCC2;MTHFR;MTHFD2L;PANK2;TPK1;SLC5A6;ABCD4;RFK;PDXK;CUBN;ALDH1L1
prerank,mesonephros development (GO:0001823),-0.45913828168867155,-1.0698322763803318,0.38049713193116635,0.6349554551397814,1.0,5/11,5.54%,FGF1;BMP7;BMP4;OSR1;ZBTB16
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3758812081603433,-1.0698301489861435,0.34502923976608185,0.6344807534562347,1.0,4/21,9.06%,IGF1;ITGAV;CTSH;MAP2K1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.3688085624287104,1.0697996371558727,0.33766233766233766,0.7765742162802214,1.0,10/25,18.07%,CLU;KLF4;AKT1;HSP90AB1;KLF2;CD36;INSR;EDN1;HSP90AA1;DDAH1
prerank,regulation of cell division (GO:0051302),-0.2972695628743527,-1.069491595738952,0.33076923076923076,0.6347931140588302,1.0,15/72,15.94%,MLLT3;KIF13A;FGF1;BIRC6;KLHL13;UVRAG;CSPP1;FGFR2;TXNIP;SETD2;RAB11A;BECN1;PIK3C3;PIK3R4;PRDM15
prerank,negative regulation of cell death (GO:0060548),-0.28223899984361656,-1.0692823121778448,0.31496062992125984,0.6348227516674714,1.0,31/88,22.17%,KANK2;CCN2;BMP7;BMP4;PRKN;LRRK2;GSK3B;VPS4B;INPP5A;SRSF6;CHMP4B;CHMP4A;PPARGC1A;IMPACT;CCN3;TRAF2;ADNP2;BECN1;CCN5;CCN1;NCK1;PRKD1;CCN4;ATG5;PARK7;EIF4G1;SPEF1;BNIP3;FGF2;WFS1;WNT16
prerank,negative regulation of macrophage activation (GO:0043031),0.3967815845170528,1.0690066749015108,0.36983471074380164,0.7777456688978069,1.0,2/16,2.83%,LRFN5;SYT11
prerank,regulation of protein ubiquitination (GO:0031396),-0.2732193229690797,-1.0685427863769288,0.3031578947368421,0.6361405806962641,1.0,36/108,24.36%,NXN;SASH1;TGFBR1;ANGPT1;HDAC8;UBE2N;PRKN;LRRK2;HUWE1;AXIN1;UBQLN1;UFL1;U2AF2;XIAP;SPOPL;CUL3;FBXW7;USP4;OGT;SH3RF2;FANCI;ARRB1;SPRTN;DERL1;FAM107A;TRAF6;PARK7;TBC1D7;CDK5RAP3;SENP2;SPHK1;WFS1;CHP1;GNL3L;BAG5;PAXIP1
prerank,activation of protein kinase A activity (GO:0034199),0.40267812200014197,1.0683933375914703,0.38228941684665224,0.7783594427149393,1.0,3/16,1.18%,PRKAR2B;ADCY3;ADCY8
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.38015514855172994,-1.068203337082547,0.37057728119180633,0.636492774939073,1.0,9/22,22.16%,PPM1D;PPM1E;DUSP16;PPP2CB;PPM1A;DUSP1;DUSP10;PPP2CA;DUSP7
prerank,cGMP-mediated signaling (GO:0019934),0.42946558500846094,1.0680550590473048,0.37684210526315787,0.7781872554882919,1.0,3/13,3.44%,KCNC2;PDE2A;HTR2C
prerank,protein O-linked mannosylation (GO:0035269),-0.4002447631752375,-1.0677772200869433,0.3618181818181818,0.6370442756841866,1.0,11/18,23.49%,TMTC1;LARGE1;TMTC4;CRPPA;POMT2;FKTN;DPM1;TMTC3;POMT1;FKRP;DPM3
prerank,secondary alcohol metabolic process (GO:1902652),-0.3312284158938372,-1.0677095697935153,0.3627450980392157,0.6367462450760315,1.0,17/42,34.86%,ABCA1;CYP27A1;SOAT1;OSBPL5;APOE;RXRA;SQLE;FDX1;GBA2;SCAP;CLN8;TSKU;ANGPTL3;CLN6;LCAT;CH25H;IDH2
prerank,DNA modification (GO:0006304),0.37269997284340356,1.0675504467128474,0.3651452282157676,0.7785777591275636,1.0,6/22,16.46%,EXOSC5;TERF1;UNG;TERF2IP;TINF2;EXOSC4
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.4486853727669995,-1.067334784686305,0.3806818181818182,0.6371661042111998,1.0,5/12,17.45%,JAG1;REST;HES1;NELFB;HNRNPU
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.46261175316348446,-1.0673292549198983,0.39410681399631675,0.6366944237974044,1.0,5/10,16.77%,ZEB2;GIPC1;APPL1;RAPGEF2;CTNS
prerank,cell cycle checkpoint signaling (GO:0000075),0.43148329509905053,1.0672616783616942,0.3595744680851064,0.7782457538586933,1.0,5/12,16.13%,BUB1;WEE2;NABP1;CHFR;PLK2
prerank,positive regulation of cellular process (GO:0048522),0.22947587563188704,1.0670025191821426,0.2315369261477046,0.7778557892793688,1.0,92/565,14.30%,FLT1;CLDN5;IGF1R;LEF1;SLC6A6;CHEK1;GRIN1;KITLG;FRMD5;ERBB4;PROX1;CSF1R;RPS6;RPS19;S100A9;S100A8;IL7;CXCL12;NRG1;AQP11;CCND1;COPS9;RYR2;RPL23;AKAP6;SIRT1;ACER2;TRIM13;HMGA2;IL2RG;MFSD2A;GAS6;FGF10;KDR;NTRK2;TENM4;FLT3;IL12A;STX3;NOTCH1;TGFB2;PAK1;TAL1;ETS1;SPAG5;TLR2;MLC1;RTKN2;FGF5;PTPRJ;EPO;TIMP1;AKT1;RPS6KA1;HSP90AB1;MVD;H3-3A;TPPP;ADRA1D;CNOT6L;SHANK2;THPO;NAMPT;LIFR;AIF1;FAM98A;PDGFB;HMGN5;F2R;WDR77;CEP43;P2RX7;DUSP26;APC;RPS4X;MAPK8;NOP2;EPHA1;TJP1;AGPAT1;ACTN4;CD36;BMPR1B;XBP1;ATM;HRAS;DLL1;ADGRG1;CIB1;INSR;PPP3CA;CCKBR
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.332260130347598,-1.0669202371522466,0.3285123966942149,0.6371906608027633,1.0,16/37,24.73%,FHIT;USP7;RPL11;GIPC1;OGT;TRIM39;PDCL3;CSNK2A1;NOP53;PARK7;PML;WAC;CCAR2;BAG5;BAG6;EIF3H
prerank,axon extension (GO:0048675),-0.37371670381243915,-1.0662321466792095,0.3435804701627486,0.6383865579787139,1.0,5/23,10.76%,ALCAM;AUTS2;NRP1;SPG11;ULK2
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.37496000797375856,1.0662186161069276,0.37209302325581395,0.777695738295815,1.0,6/22,19.57%,ZDHHC22;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14;ZDHHC24
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.37496000797375856,1.0662186161069276,0.37209302325581395,0.777695738295815,1.0,6/22,19.57%,ZDHHC22;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14;ZDHHC24
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.27953978915568123,-1.0660335034345745,0.3111111111111111,0.6383951774944511,1.0,26/95,20.20%,NFKB1;VIM;AXL;PABPN1;LBP;HMGB1;SBNO2;CTR9;CHMP5;UPF1;SELENOS;NR1H3;RHOA;ADAM9;MEF2C;TNIP2;PDCD4;SERPINE1;TLR4;CX3CR1;TRAF6;WNT5A;IRAK1;SHPK;CARD16;CDC73
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.2792688820838587,1.0658199706386944,0.3168724279835391,0.7777011009808958,1.0,18/100,10.98%,FLT1;IGF1R;TEK;PIP5K1B;SIRT1;PPP1R16B;KDR;NTRK2;SEMA4D;FLT3;TGFB2;PIK3R5;UNC5B;EPO;FBXL2;DAB2IP;PDGFB;F2R
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.46272294492146754,1.0658007135784973,0.3951965065502183,0.7765595712054163,1.0,3/10,11.42%,KNSTRN;SPAG5;APC
prerank,telomere maintenance via telomerase (GO:0007004),0.3467588249440435,1.0657901269718353,0.36779324055666,0.775391071787432,1.0,9/28,17.06%,TERF1;HSP90AB1;PIF1;TERF2IP;NHP2;DKC1;TINF2;PTGES3;HSP90AA1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.423445004540789,-1.065737469245573,0.36622390891840606,0.6386603934237328,1.0,3/14,5.31%,SULF1;SULF2;THBS1
prerank,histone monoubiquitination (GO:0010390),-0.36527108340762354,-1.065665621789955,0.3629191321499014,0.6383554965374079,1.0,8/24,21.87%,BCOR;CTR9;DDB2;DTX3L;UBE2E1;RNF20;CDC73;WAC
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.4232546643437064,-1.0647606397473228,0.38361266294227186,0.6401522497333741,1.0,7/15,24.43%,PRODH;GGACT;SARDH;CHAC2;ABHD12;ALDH4A1;GGT5
prerank,muscle tissue development (GO:0060537),-0.42989909124698555,-1.0642949962824473,0.3814814814814815,0.6408022757366386,1.0,4/13,15.63%,BMP4;SMO;CSRP2;PTCH1
prerank,plasma membrane repair (GO:0001778),0.42991824125445643,1.0641643288505866,0.38181818181818183,0.7790637799672092,1.0,4/13,10.73%,SYT7;SYT11;DYSF;SMPD1
prerank,mucosal immune response (GO:0002385),0.4123187040873987,1.0640538697703426,0.37100213219616207,0.7781989616021276,1.0,15/15,58.81%,DEFA6;RNASE3;OTUD7B;PLA2G1B;RPL39;PIGR;LTF;FFAR2;DEFB1;BPIFB1;CAMP;IL4;RAB17;NOS2;IFNLR1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.423848105903195,-1.0640032599231137,0.3770491803278688,0.6410315361220085,1.0,3/15,9.43%,ATP1A2;SLC9A1;SLC12A2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.38082482412909713,-1.0639779406755776,0.38783269961977185,0.64061325101382,1.0,6/22,17.26%,ROCK2;LYN;EPHA4;RANBP9;IFNGR1;PICALM
prerank,regulation of cell killing (GO:0031341),-0.41239812717211916,-1.0633346700003008,0.37454545454545457,0.6417435634475205,1.0,6/16,18.69%,CFH;CD55;FZD7;CR1L;CYBA;WNT5A
prerank,positive regulation of T cell activation (GO:0050870),0.30146502924197294,1.0630060244965944,0.3576017130620985,0.7801760776662641,1.0,10/62,13.35%,TFRC;SLC7A1;IL7;THY1;PRKCQ;CCL2;CYRIB;AIF1;HSPD1;XBP1
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.46711798974933905,-1.062810535067255,0.3926605504587156,0.6425782682222745,1.0,4/10,25.54%,VEGFA;CX3CR1;SMARCD3;KDM1A
prerank,regulation of interferon-gamma production (GO:0032649),0.2918271109417237,1.0621836684081771,0.3216494845360825,0.7814041650643597,1.0,8/71,12.78%,SLC7A5;PDE4B;GAS6;ISG15;IL12A;CYRIB;HSPD1;PDE4D
prerank,tetrapyrrole metabolic process (GO:0033013),-0.38300516465705325,-1.061876256022945,0.3627450980392157,0.6444544061954884,1.0,4/18,16.18%,TCN2;MMUT;ABCD4;CUBN
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.3196633709260802,-1.0616143091660295,0.3371647509578544,0.64463158707285,1.0,14/44,22.80%,PRKAG2;CYP7B1;CYP27A1;INSIG2;OSBPL9;HMGCR;SQLE;PARK7;AMACR;SC5D;ACOT8;LBR;PSAT1;OSBPL3
prerank,morphogenesis of an epithelium (GO:0002009),-0.3689705117693989,-1.0614099205346241,0.3747534516765286,0.64463901599462,1.0,6/25,12.13%,DAG1;VCL;LRP6;FGFR2;LAMA3;TBX18
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.454308051092818,1.0613724120983787,0.3651452282157676,0.7814505607570534,1.0,2/10,9.06%,AP2M1;AP2B1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.454308051092818,1.0613724120983787,0.3651452282157676,0.7814505607570534,1.0,2/10,9.06%,AP2M1;AP2B1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.41218586926986833,-1.0610005259217592,0.396484375,0.6451715309394122,1.0,3/15,6.17%,PIEZO2;KIT;ADGRV1
prerank,cytoplasmic microtubule organization (GO:0031122),-0.3078360040791235,-1.0608459575000546,0.3389830508474576,0.6450308020496031,1.0,13/54,13.48%,PCM1;FIGN;NUMA1;DLG1;SLK;VPS4B;TUBGCP6;TUBGCP2;FIGNL2;CLIP4;RHOA;RAB11A;KATNA1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.3872495411109015,1.0608251935213366,0.36134453781512604,0.7819544368741225,1.0,6/21,14.31%,USP44;RPL23;UBE2C;RPL5;RPS7;GOLGA2
prerank,sodium ion import across plasma membrane (GO:0098719),-0.40437770552914004,-1.0604705428696009,0.3807763401109057,0.6454548549018171,1.0,5/17,13.02%,SLC9A1;SLC9A2;SLC12A2;SLC6A1;TRPM4
prerank,cellular response to organic cyclic compound (GO:0071407),-0.26484545725214254,-1.060413867879494,0.3142292490118577,0.6450995524578748,1.0,35/141,16.37%,ATP1A2;ROCK2;EGFR;ADCY5;IGFBP5;DIAPH1;CTNNA1;LRRK2;SPIDR;NR3C1;LCOR;TFPI;RAP1B;CDH1;ADCY1;LARP1;RAPGEF3;ADCY6;AR;IMPACT;MED1;JUP;CYP1B1;SLC5A5;MEF2C;RIOK3;PKD2;P2RY12;PDE3A;RORA;RAPGEF2;P2RX4;AKAP9;GNB1;IL18
prerank,proteasome assembly (GO:0043248),-0.4544963698009058,-1.0602308943478613,0.41825095057034223,0.6450753338880861,1.0,5/11,34.16%,PSMG1;PSMD13;ADRM1;PSMD10;OTUD6B
prerank,synaptic membrane adhesion (GO:0099560),0.4188587125272937,1.0601363439797435,0.37093275488069416,0.7827350530085484,1.0,5/14,9.17%,PTPRD;LRRC4C;LRFN5;LRRC4B;NTNG1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4717077746793559,-1.0597509955788567,0.39204545454545453,0.6458278086785574,1.0,4/10,15.13%,UPP2;NT5M;UPB1;DPYD
prerank,cholesterol transport (GO:0030301),-0.32248959498205915,-1.0596363833028664,0.36470588235294116,0.6456202122941602,1.0,8/45,14.69%,ABCA1;LIMA1;SOAT1;OSBPL5;LDLR;RELCH;NPC2;APOE
prerank,cellular response to hexose stimulus (GO:0071331),0.36968013137804123,1.059543459355878,0.3547008547008547,0.7833052089204489,1.0,5/23,3.85%,IGF1R;ADCY8;SLC2A5;PAX2;GAS6
prerank,negative regulation of angiogenesis (GO:0016525),-0.28445076738227393,-1.0591328974662921,0.33201581027667987,0.6463399536189016,1.0,16/84,9.72%,ROCK2;SULF1;DCN;COL4A3;FOXC1;ROCK1;SPARC;NIBAN2;HSPG2;THBS2;THBS1;HOXA5;ATF2;SLC12A2;ADAMTS9;SEMA3E
prerank,eosinophil migration (GO:0072677),0.4078750450979002,1.058934166301111,0.3881856540084388,0.7828778148498914,1.0,2/14,10.81%,CCL2;SCG2
prerank,eosinophil chemotaxis (GO:0048245),0.4078750450979002,1.058934166301111,0.3881856540084388,0.7828778148498914,1.0,2/14,10.81%,CCL2;SCG2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.37442939667166397,1.0585963258807065,0.3663157894736842,0.7827542909410344,1.0,4/23,3.22%,PROX1;ATP11A;NRG1;AKAP6
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.4042856665030785,-1.058208923496171,0.3821292775665399,0.6482263312638824,1.0,4/17,8.89%,FSTL1;SULF1;TWSG1;XIAP
prerank,DNA packaging (GO:0006323),-0.4057090585015056,-1.0581215514834161,0.38976377952755903,0.6479826952326887,1.0,8/16,37.19%,AIFM1;HAT1;CDAN1;H1-0;BANF1;CHAF1A;NAA10;TP53
prerank,positive regulation of cholesterol transport (GO:0032376),0.3569603518206008,1.0580951888697196,0.33264033264033266,0.7831846800070938,1.0,7/27,15.12%,PLTP;SIRT1;PPARG;GPS2;ABCB4;NFKBIA;SCP2
prerank,nucleocytoplasmic transport (GO:0006913),0.32301671047855984,1.0578944642372454,0.35135135135135137,0.7825477546397629,1.0,9/40,13.57%,GEMIN8;HTATIP2;NXT1;RBM15B;SNRPD1;SNRPD2;ANP32A;NUP205;DDX20
prerank,acidic amino acid transport (GO:0015800),-0.41010982779152,-1.0575758732605327,0.3742911153119093,0.6487684282179363,1.0,6/17,10.84%,SLC6A13;SLC1A3;LRRC8D;GJA1;SLC6A1;GIPC1
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.2996864132515917,-1.0570892035097208,0.36907216494845363,0.6495503214644607,1.0,23/65,22.22%,MDM4;BMP7;PTGIS;LMNA;UBQLN1;MTOR;FAM162A;EGLN3;HIF1A;ACAA2;NPEPPS;PGK1;VEGFA;RORA;NOP53;CPEB1;SLC8A3;CARD16;P4HB;TERT;BNIP3;TBL2;GATA6
prerank,regulation of interleukin-8 production (GO:0032677),0.2975522369301624,1.0570515041767972,0.3347022587268994,0.7839068788162283,1.0,10/69,11.76%,CD33;TIRAP;IL17F;TMSB4X;TLR2;KLF4;NOD1;BCL3;F2R;BCL10
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.3654409368985177,1.056999411407727,0.36086956521739133,0.7829208768884398,1.0,4/25,3.84%,DSCAM;MIF;ITGA6;SNCA
prerank,diacylglycerol metabolic process (GO:0046339),0.3727051777253804,1.0569310510773664,0.35913978494623655,0.7819853707202821,1.0,6/23,10.18%,DGKI;LIPE;DGKH;DGAT2;DGKB;GPAM
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.23427295298424908,-1.0566786318916603,0.2732919254658385,0.6500735144195511,1.0,78/348,19.50%,BMP6;PRKAG2;ROCK2;IGF1;EGFR;TGFBR1;BMPR1A;LEPR;IL34;SLCO3A1;ANGPT1;NTRK3;RBPMS;PELI2;CEMIP;ARAF;BMP5;FGF1;BMP7;DAB2;BMP4;FAM20A;GHR;ABL1;LRRK2;VTN;RPTOR;TBK1;CREBL2;DOCK7;AXIN1;SNX9;PAK2;NBN;TWSG1;LYN;NRP1;BRAF;RAPGEF3;UBE2K;IGF2;NGF;PDGFC;RB1CC1;SMAD4;MAVS;FNIP1;IL6R;CARD14;RASSF2;CCN1;TEC;TXN;WDFY2;VEGFA;RAPGEF2;VEGFD;LATS1;ACVR1;DDX3X;CCND3;AKAP9;ITGA5;TGFB3;MRE11;ARRB1;PRKD1;CX3CR1;CACUL1;BMP2;MTCP1;MUSK;CSNK1D;PARK7;PTPN11;ITGB3;INHBA;EIF4G1
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.3206483691450205,-1.0565775975730431,0.36730769230769234,0.6498230159657001,1.0,19/42,26.99%,INO80;ARID1B;SMARCC2;CHD8;RNF8;MBD2;CHD4;CHD3;SPTY2D1;HDAC1;ANP32E;NASP;SMARCD2;PBRM1;HDAC2;MBD3;ACTR5;ACTR6;CECR2
prerank,mitotic nuclear division (GO:0140014),-0.28975331745224997,-1.0565252542629733,0.34823091247672255,0.6494664841509875,1.0,19/71,17.43%,INO80;FLNA;PIBF1;SPICE1;KLHDC8B;SMC4;CHMP4B;NDEL1;STAG1;LSM14A;RHOA;RAB11A;ABRAXAS2;TOGARAM1;KLHL22;ZWINT;MAP9;STAG2;UBE2S
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3720146600736636,1.0563777161574999,0.3840909090909091,0.7824445375775386,1.0,8/22,13.93%,RYR2;AKAP6;VMP1;HAP1;CALM1;CALM2;ATP1B1;CALM3
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4287763883588216,1.0559630374900608,0.39065817409766457,0.7825445165115077,1.0,4/13,18.10%,SYT1;SYT10;CACNA1I;SYT4
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.44870778080660784,-1.0548549894904529,0.4076190476190476,0.6531075093938832,1.0,8/11,33.18%,WNT4;BMP5;BMP2;FGFR4;EGR1;ASAH1;STAR;NR1H4
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3836893826680187,1.0547883549492385,0.36622807017543857,0.7847949647462092,1.0,5/19,11.10%,DLG2;LRRC7;MTCL1;FOXJ1;CRB1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.4484541773809698,1.0547309876693682,0.4025423728813559,0.7838102704400672,1.0,2/10,4.17%,CHEK1;SMARCB1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.4084282431443621,1.0546339718726845,0.4057017543859649,0.7828839483258491,1.0,5/15,15.32%,REEP1;ARL6IP1;REEP2;RTN4;REEP3
prerank,ribosomal large subunit biogenesis (GO:0042273),0.3015503136801951,1.0545870659340795,0.3484251968503937,0.781844962703722,1.0,12/54,11.94%,RPL35A;RPF2;RPL7;RPL10;RPL10A;RPLP0;RPL7A;RPL14;RPL5;NHP2;NOP2;RPL23A
prerank,autophagosome organization (GO:1905037),-0.3107924742150384,-1.0543287178554313,0.35384615384615387,0.6539470143315551,1.0,20/50,25.56%,UBXN2B;UBQLN1;RB1CC1;ULK2;WIPI1;ATP2A2;BECN1;ATG2A;PIK3C3;ATG9A;WDR45B;ATG2B;ATG5;AMBRA1;WIPI2;ATG14;MAP1LC3A;STX12;IRGM;RAB7A
prerank,regulation of translational initiation (GO:0006446),-0.30181775404973793,-1.0539317559671129,0.3563218390804598,0.6544384510788841,1.0,20/63,19.50%,EIF4G3;YTHDF3;EIF4A2;KHDRBS1;EIF2AK3;LARP1;IMPACT;CSDE1;DNAJC3;TPR;ALKBH1;EIF2AK4;CDC123;DDX3X;NCK1;NCK2;PAIP1;MIF4GD;RBM4;EIF4G1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.34903488427993257,1.0538994669685127,0.3448275862068966,0.7828082806235411,1.0,5/27,5.76%,B3GAT1;CHST9;B3GAT2;CHSY3;CSGALNACT1
prerank,sulfur amino acid catabolic process (GO:0000098),-0.4583856389656038,-1.053786798459185,0.4011406844106464,0.6543129488183701,1.0,9/10,54.19%,TXN2;CBS;CTH;ADO;MPST;BLMH;MTRR;TST;GADL1
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.3586565101631365,-1.0536235043520144,0.391304347826087,0.6542547736479853,1.0,8/26,20.95%,NPR3;POR;HIF1A;APOE;PARK7;TERF2;TERT;S100A1
prerank,protein targeting to lysosome (GO:0006622),0.3814368173468134,1.0533272023173683,0.3842887473460722,0.7834047180251217,1.0,10/20,20.96%,HSPA8;CLU;SCARB2;NCOA4;SORL1;M6PR;AP3M1;HGS;VPS4A;SNX16
prerank,receptor-mediated endocytosis (GO:0006898),0.2660488982604589,1.0531614899037502,0.32238193018480493,0.7827635469695995,1.0,32/132,17.24%,TFRC;DNM3;LRP1B;TMEM108;RAMP2;AP2M1;CAV2;SNCA;GRK2;SNAP91;SCARF1;FNBP1L;FCHO1;SCARB2;AP2B1;CD163;ITGAM;CD36;SORL1;SGIP1;SCARB1;DLL1;INSR;PPT1;CLTB;STAB2;NLGN3;CALCRL;M6PR;RAB31;HSP90AA1;DNM1
prerank,negative regulation of histone methylation (GO:0031061),-0.45590243723986,-1.0525723976014458,0.4095940959409594,0.6564565901073784,1.0,7/10,35.78%,BCOR;PHF1;JARID2;KDM1A;WDR5;BRCA1;AASS
prerank,detection of mechanical stimulus (GO:0050982),-0.38733198810816405,-1.0519123906897494,0.38666666666666666,0.6576010074579529,1.0,4/19,12.91%,PIEZO2;PKD1;JUP;PKD2
prerank,cellular calcium ion homeostasis (GO:0006874),0.2612352130930595,1.0518199556417605,0.3081510934393638,0.7855628842358308,1.0,14/133,6.14%,SLC24A4;SLC24A2;TRPC5;ADCY8;CXCL12;RYR2;HTR2C;CAV2;HCRTR1;SLC8A1;ATP2B3;TMEM178A;SLC30A1;NPTN
prerank,nucleic acid-templated transcription (GO:0097659),0.3244604016411527,1.0517650324091057,0.4025695931477516,0.7845545034011989,1.0,11/42,14.23%,PAX8;PTMA;HOXD3;XAB2;POLR2J;POLR2B;BCL3;POLR2I;THAP1;MED20;POLR3A
prerank,protein transport (GO:0015031),-0.23405762108023973,-1.0516551690022071,0.26534653465346536,0.6577503152790155,1.0,114/332,28.98%,WLS;LRP1;TLK1;ABCA1;KIF13A;STEAP3;TANGO6;ATP6V1B2;TBC1D16;SGSM2;ATP6V0D1;SNX9;SEC23IP;SNX6;RAB10;STX16;RAB22A;VAMP5;VPS26C;STXBP1;ATP6V0A4;RAMP1;RAB12;SIL1;AP3B1;SLC10A7;VAMP2;LAMP2;USP6NL;TXNIP;COPZ2;SLU7;ARFGAP3;SEC31A;ARCN1;HERC2;TBC1D2B;TBC1D8B;CHMP3;GGA3;RPGR;COG7;STX4;RCN3;ARFIP2;SCAMP2;ARF1;MON1A;STX5;TBCK;COPB2;GRTP1;CTTN;TBC1D22B;RAB21;TBC1D9;CTSA;DNAJC27;FAM91A1;APOE;COPG2;SNX8;TMED3;VAMP4;TOM1;TCIRG1;MIA3;WDR11;TBC1D17;NAPA;TMED4;COPG1;LRSAM1;TMED5;RABGAP1;TBC1D10A;RAB24;IFT27;GGA2;STX17;STX8;VPS26B;RABL3;ATP6V1G2;NSF;ARL5A;RAB3D;PREB;ARRDC4;AP2A1;SAR1B;USO1;RAB8A;KIF3A;STX12;ARRDC2;TVP23B;VPS45;RAB7A;RAB5A;STX1A;TBC1D10B;AFM;STX7;SEL1L;TBC1D9B;TMED2;BBS2;RIC1;ARL4C;RUFY1;MCOLN1;EHD1;ARFIP1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3508595330437453,-1.0516484136311004,0.3645224171539961,0.6572872354731958,1.0,6/28,14.29%,ITPR1;BCL2;MAP3K5;AIFM1;TRAF2;ERN1
prerank,negative regulation of telomere maintenance (GO:0032205),-0.4139701357087604,-1.0513331406024042,0.3702290076335878,0.6575967443075021,1.0,4/15,11.60%,SMG6;TNKS2;NBN;PARP1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.3694784009058574,-1.0512398705362507,0.3808630393996248,0.657343786676232,1.0,3/23,5.83%,ERRFI1;CBLB;SNX6
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.4030839322956097,-1.0512256324889804,0.3733826247689464,0.6568881851848676,1.0,5/17,17.06%,JAG1;CD55;STAT3;IL18;TLR4
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.4173733704621313,-1.0510522656809613,0.3838951310861423,0.6568495301018877,1.0,5/14,21.80%,MYO9A;CDC42;RHOA;SCRIB;MSN
prerank,negative regulation of neuron differentiation (GO:0045665),-0.37352512447199093,-1.0509751856727547,0.38011695906432746,0.6565608253235561,1.0,6/22,12.61%,BMP7;GSK3B;REST;MED1;HES1;EIF2AK4
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.4208452475175322,-1.0505584881808983,0.3944954128440367,0.6571345591001805,1.0,8/13,27.10%,UFL1;NCK1;BFAR;PTPN1;ABCA7;WFS1;ATF6B;PPP1R15B
prerank,metanephric mesenchyme development (GO:0072075),-0.45834423529430124,-1.0503572997449997,0.40966010733452596,0.6571562709593689,1.0,5/10,16.85%,WNT4;OSR1;PKD2;STAT1;SIX1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.3674052720996218,-1.0502794545287106,0.38764044943820225,0.6568942466926442,1.0,4/24,8.20%,PID1;LEPR;GFPT1;PPARGC1A
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.4246889263938816,-1.0492314629572805,0.40313111545988256,0.6591184438866715,1.0,4/13,11.45%,BMP4;NFIB;REST;NFATC4
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.36822921398580455,-1.0490933641871052,0.40476190476190477,0.6589786453745742,1.0,9/22,23.89%,MDFIC;LRRK2;SP100;SUFU;APOD;INPP5K;PARK7;CHP1;LMAN1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.34391863013479107,-1.0485418298605431,0.37014314928425357,0.6597817760256852,1.0,10/33,18.12%,TPM1;IGFBP5;IGFBP3;OGN;MEF2C;EFEMP2;APOD;TGFB3;PDCD4;SOD2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.35139455430291233,-1.0484445817027461,0.384765625,0.6595421670851653,1.0,10/26,19.70%,EGFR;ANKRD17;UBE2E2;RPTOR;ANXA1;DDX3X;CCND3;ADAMTS1;EIF4G1;CDK10
prerank,cellular senescence (GO:0090398),-0.34943922128332994,-1.0483798692791417,0.38247011952191234,0.6592130501786488,1.0,11/27,21.40%,OPA1;SMC6;NSMCE2;MAP2K1;SMC5;PRKCD;ID2;TBX2;TERF2;PML;ECRG4
prerank,cellular response to nutrient levels (GO:0031669),-0.2959219925264644,-1.0476797126549333,0.36627906976744184,0.6604841340709168,1.0,24/62,27.65%,PRKAA2;TFEB;LRRK2;RPTOR;MTOR;ZFYVE1;WRN;LAMP2;USP33;WIPI1;FNIP1;WDR45B;FAM107A;PRKAA1;EIF4G1;WIPI2;KCNB1;ATG14;MAP1LC3A;PPARA;RRAGA;LPL;GAS2L1;VPS41
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.36463484438212607,1.0472437814105795,0.3836734693877551,0.7971065458982042,1.0,6/27,7.31%,SLC7A5;SLC7A1;SLC1A1;SLC1A2;SLC6A5;SLC7A8
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.4572356405953994,-1.0466373231372308,0.400390625,0.6626480208350991,1.0,4/10,13.99%,LRP1;PTPN12;PTPN2;APOD
prerank,cellular protein catabolic process (GO:0044257),-0.2992762958457221,-1.0462324917562384,0.37924151696606784,0.6631573922544134,1.0,20/59,26.05%,ADAMTS12;PRKN;CTSC;CTSH;AFG1L;RAB12;YME1L1;FAP;CLPP;TCIRG1;CTSF;MYLIP;BNIP3;MAGEC2;CTSL;AP2A1;CLPX;SIAH2;RAB7A;HTRA2
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.23973418863643128,-1.046208643523664,0.3136456211812627,0.6627291695923548,1.0,71/291,20.24%,ROCK2;EGFR;PID1;NFKB1;EPHA3;PDGFRA;TPM1;IGFBP5;PTK7;VIM;AXL;PABPN1;WNT5B;WNT6;RPTOR;IRS1;LBP;HMGB1;LCOR;SBNO2;RAP1B;LYN;MTOR;RAPGEF3;ADCY6;WNT9A;CTR9;DHX36;PTPRK;IMPACT;CHMP5;FER;UPF1;SELENOS;JUN;NR1H3;RHOA;PRKCD;ABL2;ADAM9;SLC5A5;MEF2C;FZD7;PKD2;ADNP2;ERCC6L2;P2RY12;PDE3A;RORA;RAPGEF2;P2RX4;AKAP9;GNB1;DAPK1;TNIP2;PDCD4;SERPINE1;TLR4;CPEB1;PRKD1;CX3CR1;INPP5K;TRAF6;VCP;WNT5A;IRAK1;SHPK;CDK2;CARD16;CDC73;RAPGEF1
prerank,chromosome organization (GO:0051276),-0.2719803173448471,-1.045991228269551,0.35856573705179284,0.6627570511635776,1.0,37/99,30.57%,TCF7L2;HDAC8;SETD7;BRWD1;ABL1;RAD23B;EZH1;MTHFR;DDB2;RFWD3;PARP1;COPS2;TCF7L1;EHMT1;COPS8;PHF1;LATS1;MSH3;HDAC1;TOP2B;HMG20A;CDAN1;MSH6;EZH2;HMGN3;HDAC2;CENPT;LDB1;FAM50A;ZBTB7A;HDAC3;GPS1;SAFB;RBX1;UBA52;HDAC10;COPS5
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3603073675268903,-1.045669646038919,0.37773359840954274,0.6630776100825138,1.0,10/24,23.67%,OPA1;PRKN;LRRK2;SELENOS;NR1H3;SYVN1;PARK7;LPCAT3;WFS1;TMBIM6
prerank,regulation of mononuclear cell migration (GO:0071675),-0.36626696381691615,-1.045561385787518,0.39655172413793105,0.6628413351641915,1.0,4/23,6.87%,IL34;BMP5;THBS1;LYN
prerank,signal transduction by p53 class mediator (GO:0072331),-0.3431553875179172,-1.0454457408673177,0.3837429111531191,0.6626166800038493,1.0,4/30,5.92%,FHIT;DDX5;MDM4;NBN
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.3747042137485553,-1.0449114501983323,0.4143968871595331,0.6634826627917735,1.0,9/21,28.53%,PRKN;COA8;SLC30A10;ABCD2;SIRT5;PARK7;AATF;PPARA;MT3
prerank,positive regulation of histone methylation (GO:0031062),-0.35276897526419904,-1.0445357755850695,0.3766990291262136,0.6639810370681252,1.0,6/24,15.87%,AUTS2;CTR9;SMAD4;OGT;PHF1;JARID2
prerank,regulation of response to biotic stimulus (GO:0002831),-0.34909741602801303,-1.0445226107043803,0.39921722113502933,0.663530163085929,1.0,9/28,16.06%,FOXP1;APPL2;CD55;XIAP;PTPN22;TRIM5;APPL1;IRF1;TRAF3
prerank,response to prostaglandin E (GO:0034695),-0.45889431892840293,-1.044515897032399,0.43399638336347196,0.6630643778267612,1.0,3/10,16.11%,TGFBR3;ADCY6;GNB1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.44445263133642776,1.0444501326627653,0.4004329004329004,0.8044206308427533,1.0,3/10,22.95%,IL12A;NCKAP1L;DDIT3
prerank,positive regulation of cellular protein localization (GO:1903829),0.2885571194001126,1.0444470529332195,0.3860759493670886,0.8032551178775756,1.0,12/69,11.60%,TFRC;BICD1;NECAB2;SYT11;TMEM35A;MEAK7;STX3;AKT1;HSP90AB1;NUP62;APC;CCDC88A
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2711432155028644,1.0442865992245152,0.3682008368200837,0.8025311750997424,1.0,24/101,14.38%,FLT1;PROX1;CSF1R;TENM1;CCND1;SIRT1;HMGA2;SNCA;FLT3;CD24;DIRAS1;PIK3R5;MAPRE3;AKT1;CCNY;DAB2IP;PDGFB;CALM1;CD40;CALM2;HRAS;CALM3;CIB1;ATP2B4
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.35797986176420105,-1.0442511077744832,0.40823970037453183,0.6632569131273215,1.0,9/24,25.45%,PPM1D;DNMT3A;MPHOSPH8;PHF1;JARID2;EPC1;EZH2;PPHLN1;CREBZF
prerank,positive regulation of cellular metabolic process (GO:0031325),0.2724294909878679,1.0440363078087562,0.36024844720496896,0.8021400950220152,1.0,19/98,16.59%,SLCO1C1;PAX8;MAGI2;AHI1;PPARG;SNCA;KLF4;IFNAR1;RAB1B;AKT1;PDGFB;AGPAT1;NFKBIA;GHITM;INSR;CDKN1A;STARD4;TBC1D5;RAB29
prerank,positive regulation of endopeptidase activity (GO:0010950),0.35869380494561004,1.0439832378564518,0.3940774487471526,0.8011557003081321,1.0,4/26,4.93%,GRIN1;MBP;GRIN2B;PSENEN
prerank,GPI anchor biosynthetic process (GO:0006506),-0.350723667482881,-1.043754283115605,0.38022813688212925,0.6640078902934851,1.0,14/30,32.02%,PIGN;PIGK;DPM1;PIGS;GPAA1;MPPE1;PIGH;PIGC;DPM3;PIGA;PIGZ;PIGP;PIGF;PIGO
prerank,regulation of stem cell differentiation (GO:2000736),-0.2779807141981146,-1.043583190851411,0.34545454545454546,0.6639259131323244,1.0,30/89,28.95%,BMPR1A;PTN;PDGFRA;ABL1;JAG1;YAP1;RUNX1;HOXB4;PSMF1;HES1;TCF3;NELFB;PSMB2;EIF2AK2;PRKDC;NSUN2;HNRNPU;PSMC1;KMT2A;PSMA3;PSMB6;NUDT21;PSMA4;LDB1;PSME1;PSMD13;ZFP36L2;PSMB9;PSMB10;PSMA5
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.43576187299540525,1.0435813703280328,0.4021505376344086,0.8012225137617232,1.0,2/12,3.32%,MIF;SIRT1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.30538841302496694,-1.043348784109321,0.3882113821138211,0.6639906466894006,1.0,20/52,24.13%,LMNA;TLN1;ATP6V0D1;SHC1;GFPT1;EDEM1;ARFGAP1;SEC31A;DNAJC3;WIPI1;KDELR3;ERN1;GOSR2;FKBP14;SYVN1;CUL7;WFS1;PREB;HYOU1;CXXC1
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.33820787966642346,-1.0431935610674956,0.3793103448275862,0.6638975988836454,1.0,9/34,18.69%,SMAD3;ENPP1;YAP1;RUNX1T1;TRIB2;ANKRD26;RORA;TRIO;WNT5A
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.42395931882438165,1.0431059845998898,0.416135881104034,0.8014913284939256,1.0,4/12,13.66%,ANK3;WNK2;GLRX;ATP1B1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4342532373285545,1.0421916356201009,0.4506024096385542,0.8030849877784828,1.0,3/11,12.82%,STMN1;PAK1;BCAR1
prerank,positive regulation of cell death (GO:0010942),-0.2993250915538213,-1.041827006083135,0.36770428015564205,0.6668812439965048,1.0,11/59,10.63%,SLC6A13;LRP1;EFNB2;CELF1;BMP4;LRRK2;GSK3B;RARG;MAP3K5;MARK4;PRODH
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.4183732221616221,-1.041699706106662,0.43366336633663366,0.6667475210899617,1.0,5/12,19.29%,SORBS1;IRS1;IGF2;PRKCZ;PTPN11
prerank,glycerophospholipid catabolic process (GO:0046475),0.34795183992487927,1.0414254656461224,0.3771551724137931,0.80419360519655,1.0,2/27,4.80%,GPCPD1;ENPP2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.4340553658208855,1.041317568613279,0.4012345679012346,0.8033606270727569,1.0,2/11,5.53%,ATF3;HSPA5
prerank,microtubule nucleation (GO:0007020),-0.3835259193204701,-1.0412412824584376,0.40148698884758366,0.6674256550338495,1.0,8/19,19.75%,TUBGCP6;TUBGCP2;NDEL1;RANBP9;AKAP9;CCDC57;CSNK1D;TUBGCP4
prerank,regulation of filopodium assembly (GO:0051489),-0.32635126157753724,-1.0406021102181942,0.39162112932604737,0.6685384202401679,1.0,12/38,13.54%,DPYSL3;DOCK11;RHOQ;ARAP1;RIPOR2;BCAS3;NRP1;CDC42;WASL;PRKCD;RALA;CAPZB
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.3232566831071765,-1.040084739223022,0.3864077669902913,0.6693018578890115,1.0,9/40,21.11%,PID1;ABL1;LRRK2;BCL2;STOML2;ATP5IF1;VCP;PARK7;AKT2
prerank,apoptotic nuclear changes (GO:0030262),-0.36369161324808236,-1.039966901817387,0.40847784200385356,0.6691453265779288,1.0,9/24,28.75%,DICER1;ACIN1;HMGB1;H1-0;CDK5RAP3;EXOG;DNASE2;CECR2;GPER1
prerank,protein K48-linked deubiquitination (GO:0071108),0.3615759701495928,1.0388884220480321,0.3760869565217391,0.8095072706954491,1.0,9/23,18.96%,OTUD7A;YOD1;OTUB2;MINDY2;MINDY1;OTUB1;USP8;OTUD7B;ATXN3
prerank,acylglycerol homeostasis (GO:0055090),-0.38108355072414823,-1.0388215850238156,0.3877159309021113,0.6714975838973459,1.0,8/20,30.74%,NR1H3;PNPLA8;RORA;APOE;IL18;LPL;MLXIPL;ANGPTL3
prerank,oxoacid metabolic process (GO:0043436),-0.35288387328586357,-1.0379101859456024,0.40925925925925927,0.673297297957093,1.0,7/27,18.72%,DDO;ENPP1;TPST1;SULT1A1;PPA1;ABHD14B;THAP4
prerank,apoptotic mitochondrial changes (GO:0008637),0.3415487860199649,1.0379099158915992,0.4064516129032258,0.8113324218162121,1.0,3/32,6.44%,CAMK2A;ERBB4;CLU
prerank,phospholipid metabolic process (GO:0006644),0.28318402955887817,1.0378845221696174,0.3628865979381443,0.8102304380234132,1.0,17/71,19.24%,PLPPR1;MBOAT1;PGP;ENPP2;PLPPR5;PLPPR4;GPAM;SMPD1;FADS1;AGPAT1;PIP5K1A;PLA2G4E;PNPLA3;PIP4K2B;PLBD2;ACP6;PCYT2
prerank,positive regulation of neuron differentiation (GO:0045666),0.3208718655443377,1.037055772794965,0.3659574468085106,0.8115162955400566,1.0,10/40,13.77%,PROX1;MMD2;BRINP1;HOXD3;NRCAM;CPNE1;BRINP3;ARHGEF2;SIN3A;BEND6
prerank,regulation of protein acetylation (GO:1901983),-0.42819362872892514,-1.0367794231091594,0.4294234592445328,0.6756440398055571,1.0,7/12,22.00%,GSK3B;RAPGEF3;FAM161A;DDX3X;CEP295;PARK7;TAOK1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3535837230211417,-1.0366830808588883,0.4038095238095238,0.6754072609023339,1.0,10/25,25.57%,IGF1;NIBAN2;NSD1;RB1;TRAF6;PARK7;H1-0;TWIST1;SOX11;ZBTB7A
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2653981612737112,-1.0366023349027396,0.3843058350100604,0.6751229493840153,1.0,22/109,15.71%,PTPN13;PLEKHA2;PI4KA;PDGFRB;INPP5B;SYNJ2;MTMR12;INPPL1;PIP4K2C;PLCG1;PLA2G4A;PLCB3;PLCD1;PITPNM2;ARF1;MBOAT7;MTMR3;SLC27A1;PLEKHA8;PIK3C3;PIK3R4;SACM1L
prerank,carbohydrate biosynthetic process (GO:0016051),-0.37163385271123794,-1.036545900515808,0.3980952380952381,0.6747801022640495,1.0,5/21,13.40%,ST3GAL4;B4GALT1;B3GALT1;ST3GAL3;ST6GALNAC5
prerank,macromolecule catabolic process (GO:0009057),-0.35842747779478334,-1.0363796137719115,0.41818181818181815,0.6746998161067475,1.0,15/26,38.04%,UVRAG;MTOR;KIF16B;BECN1;SMURF1;PIK3R4;LRSAM1;CLN5;CLPX;CLN8;CLN6;IDE;SNX25;LGMN;NEDD4
prerank,import into nucleus (GO:0051170),0.2845410209862726,1.0361269308356367,0.36472945891783565,0.8131753250688921,1.0,11/73,11.04%,IPO5;IPO4;MMP12;GEMIN8;HTATIP2;NXT1;AKT1;FAM53B;NUP62;SNRPD1;SNRPD2
prerank,triglyceride biosynthetic process (GO:0019432),-0.386542365117875,-1.0357723999606705,0.40350877192982454,0.6758036552154527,1.0,7/18,20.62%,AGMO;GPAT4;MOGAT3;PCK2;LPIN2;LPIN3;GPAT3
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.3446430060972043,-1.03551461011177,0.4087301587301587,0.6759793299598107,1.0,9/28,21.53%,PRKN;NUPR1;CTSC;AXIN1;FBXW7;SMURF1;ATP5IF1;TMTC3;CDK5RAP3
prerank,protein polymerization (GO:0051258),-0.29039452158237555,-1.0354530353038212,0.3878787878787879,0.6756470732368546,1.0,11/55,10.16%,ARHGAP6;GAS7;GSN;DIAPH1;PRKN;CORO7;CHMP4B;CHMP4A;UBE2K;WASL;CHMP3
prerank,negative regulation of signaling (GO:0023057),0.35923952159045636,1.0352023266364399,0.40301724137931033,0.8148147480199514,1.0,7/25,20.39%,GLRA1;SRMS;OPRM1;UBASH3B;OPTN;BRAP;KIF26A
prerank,regulation of intracellular protein transport (GO:0033157),-0.34094367650206847,-1.0351829514043673,0.40331491712707185,0.6758532519602148,1.0,11/32,19.65%,PCM1;BMP4;PTPN14;BCAS3;PCNT;VAMP2;NDEL1;TPR;ICE1;PTPN1;IFI27
prerank,regulation of striated muscle contraction (GO:0006942),-0.3500467983831524,-1.0351240814829032,0.3784786641929499,0.6755249627261924,1.0,8/27,20.30%,ATP1A2;ANK2;ASB3;SRI;P2RX4;PRKACA;SLC8A3;NOS1
prerank,positive regulation of vasculature development (GO:1904018),0.27482588560618587,1.0348863345474284,0.3660531697341513,0.8145750161133003,1.0,19/94,13.35%,FLT1;TEK;ADAM12;TIE1;RAMP2;SIRT1;HMGA2;KDR;NOS3;ETS1;APLNR;NINJ1;CD34;HSPB1;HIPK2;CD40;EPHA1;ANGPTL4;XBP1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.26485091625137475,-1.0346956427214364,0.37065637065637064,0.6760870785615641,1.0,22/118,11.67%,PHLDB2;PID1;DAG1;SIPA1L1;PDLIM5;SDC2;KIF13B;LRRK2;SPARC;GSK3B;WTIP;BCL9L;PAK2;RC3H1;ADGRA2;FGFR2;EPHA4;SP100;BRSK1;BMPER;MEF2C;ZMYM4
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.41280145684518976,-1.0345535152346068,0.42105263157894735,0.6759527497197736,1.0,8/15,37.58%,IQGAP2;ARPC2;WHAMM;ACTR2;ARPC5;JMY;ARPC3;ARPC4
prerank,innate immune response in mucosa (GO:0002227),0.44212904845593776,1.0338497580685155,0.4225941422594142,0.8165716040636719,1.0,10/10,55.81%,DEFA6;RNASE3;PLA2G1B;RPL39;LTF;DEFB1;BPIFB1;CAMP;IL4;NOS2
prerank,axonal transport (GO:0098930),0.3251224479540324,1.0335568580617298,0.3983739837398374,0.8162800767746755,1.0,7/36,12.61%,SYBU;TMEM108;KIF1A;DST;AP3B2;HAP1;DCTN1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.32262586727244963,1.033478074222409,0.37393162393162394,0.8153215243725225,1.0,7/36,11.96%,CAMK2A;LEF1;PLCB1;FZD6;GNG2;CALM1;FZD4
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.31259430759897583,1.033140904724353,0.4033970276008493,0.8151424494462026,1.0,9/47,11.72%,IGF1R;EPHB1;MAPK8IP2;TGFB2;PHLPP1;MAPK8IP1;TAOK2;DAB2IP;FOXO1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.41000410366332213,1.032907294407829,0.39835728952772076,0.8147219272760825,1.0,5/15,12.00%,USP44;RPL23;RPL5;RPS7;SMAD7
prerank,response to light stimulus (GO:0009416),-0.29809496748951264,-1.0327222637792832,0.427734375,0.6800174983457856,1.0,16/55,24.50%,GTF2H2;UBE4B;DDB2;BRSK1;ERCC3;REV1;UBE2B;ERCC8;MAP2K7;SPRTN;ZRANB3;MSH6;USF1;CCAR2;PRIMPOL;CRY2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.4455820234959902,1.032717751355352,0.41885964912280704,0.8141230881450604,1.0,2/11,3.32%,MIF;SIRT1
prerank,organic acid transport (GO:0015849),-0.2711263069292584,-1.032505269807492,0.3702970297029703,0.6801010835454293,1.0,13/94,8.90%,SLC7A11;SLC7A2;SLC6A13;SLC13A3;ACSL1;PDPN;SLC1A5;SLC26A7;SLC6A12;ATP8B1;LRRC8D;SLC22A6;NCOA1
prerank,glycerol metabolic process (GO:0006071),0.44602088882890356,1.0324906657116384,0.4288659793814433,0.8136533544475529,1.0,2/10,3.42%,COQ2;PGP
prerank,positive regulation of cell population proliferation (GO:0008284),-0.22404519119942415,-1.0323296889947435,0.32719836400818,0.6800294452654753,1.0,101/423,22.07%,BMP6;TGFBR3;IGF1;FOXP1;GRK5;EGFR;PID1;TCF7L2;GAB2;TGFBR1;BMPR1A;PTN;PDGFRA;IL34;RBPJ;NTRK3;EFNB2;BMP5;ITGAV;FGF1;PDGFRB;IL31RA;IL6ST;BMP4;HDAC4;MAP3K3;OSR1;TGFBR2;YAP1;IRS1;KMT2D;CTSH;IL13RA1;THBS1;DPP4;GAREM1;UFL1;FGFR2;SHC1;LYN;DHX9;BCL2;AR;ACER3;GJA1;IGF2;CDK13;FER;PDGFC;NES;S100A6;ID2;CNOT8;STX4;MEF2C;HES1;FN1;CUL3;IL6R;CDC123;TRPM4;CCN1;GLI1;CCAR1;VEGFA;STAT1;VEGFD;CIAO1;CDC25B;HDAC1;CSNK2A1;TGFB3;ADRA2A;IL18;TBX2;HNRNPU;TCIRG1;PHIP;CCN4;DHPS;CACUL1;PTGFR;WNT5A;BMP2;GCNT2;HBEGF;CDK2;RBPMS2;FGFR4;TERT;NME1;AKT2;GID8;TMEM119;FXN;CRKL;CDK6;EZH2;PTHLH;SPHK1;FGF2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3343314280115758,1.032247223205692,0.3986784140969163,0.8132052219517827,1.0,5/30,5.65%,SCN1A;FGF12;RYR2;CACNA2D1;SCN4B
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.27855682941244253,1.031812182053393,0.3987341772151899,0.8134553819729131,1.0,18/90,13.64%,IGF1R;GATM;OMA1;KSR2;UCP2;ADRB1;HADH;EPAS1;ADCYAP1;ADIPOR2;APC;FABP5;SCD;PER2;CD36;LCN2;ESRRG;EBF2
prerank,cellular response to interleukin-12 (GO:0071349),-0.306803032394784,-1.0315415126200502,0.3969171483622351,0.6815214005288752,1.0,17/48,21.80%,JAK1;RAP1B;PAK2;ANXA2;CDC42;PITPNA;CAPZA1;HSPA9;ARF1;RALA;TYK2;PDCD4;AIP;SOD2;CNN2;P4HB;MSN
prerank,primary neural tube formation (GO:0014020),-0.3402973705799174,-1.0310686251557526,0.39925373134328357,0.6822588199678911,1.0,6/30,9.33%,LMO4;LRP6;SKI;MTHFR;VASP;PLXNB2
prerank,protein mannosylation (GO:0035268),-0.3621205656924942,-1.0308530277482764,0.41397849462365593,0.6823228136453756,1.0,11/22,23.49%,TMTC1;LARGE1;TMTC4;CRPPA;POMT2;FKTN;DPM1;TMTC3;POMT1;FKRP;DPM3
prerank,tight junction assembly (GO:0120192),0.3026027928984104,1.0306031377807814,0.3717391304347826,0.8159512153801194,1.0,9/49,12.22%,CLDN5;RAMP2;OCLN;CLDN14;ESAM;PECAM1;MICALL2;APC;MARVELD2
prerank,glycolipid biosynthetic process (GO:0009247),-0.31921503038986787,-1.030470879324617,0.4030131826741996,0.6828109853569746,1.0,16/38,29.98%,LARGE1;ST3GAL4;A4GALT;PIGN;GBGT1;ST6GALNAC5;DPM1;MPPE1;PIGH;PIGC;DPM3;PIGA;ST3GAL2;PIGZ;PIGP;PIGF
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.3141901953812816,1.0302204709553844,0.4117647058823529,0.8158828859991536,1.0,7/38,7.64%,KCNJ3;CTNNA3;CACNA2D1;BIN1;SCN4B;KCND3;CACNB2
prerank,negative regulation of cell activation (GO:0050866),-0.4047466653302204,-1.0301205648564895,0.4406779661016949,0.683213163836397,1.0,4/14,14.69%,PDGFRA;LDLR;EMILIN1;APOE
prerank,protein localization to plasma membrane (GO:0072659),0.25753677041156064,1.02963090599076,0.39705882352941174,0.8165367980371481,1.0,24/129,11.73%,BSG;DPP10;EFR3B;MRAP2;SPTBN4;KCNIP4;RAMP2;ANK3;RAB3C;FGF13;TNIK;MAP7;GAS6;DPP6;ZDHHC22;EPB41L3;P2RY1;CACNB2;TSPAN17;RAB40B;SPTBN1;CCDC88A;TSPAN14;ANK1
prerank,regulation of MAP kinase activity (GO:0043405),-0.270478667066668,-1.0296249013067342,0.39223300970873787,0.684019871898641,1.0,29/92,22.47%,EGFR;IL34;FGF1;KSR1;BMP7;PDGFRB;BMP4;ROBO1;LRRK2;KIT;IRAK3;LYN;PDGFC;PRKCD;TRIB2;TPD52L1;DUSP1;VEGFA;APOE;ADRA2A;INPP5K;PTPN1;IRAK1;SNF8;CDK5RAP3;EZH2;FGF2;DUSP7;CD300A
prerank,zinc ion transport (GO:0006829),0.3737852474608217,1.029464561306649,0.4093816631130064,0.8158675366169447,1.0,6/21,11.88%,SLC39A2;SLC30A1;TRPM2;SLC30A3;SLC39A8;SLC30A5
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.25190235386686965,1.0293335074825827,0.37322515212981744,0.8151320690055581,1.0,23/151,10.98%,TEK;ERBB4;TIRAP;CSF1R;NECAB2;MIF;HTR2C;GAS6;FGF10;KDR;NTRK2;SEMA7A;NOTCH1;P2RY1;ADCYAP1;GPNMB;CCL2;ADRA1A;THPO;OPRM1;PDGFB;ATP6AP1;F2R
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.4159256177184727,-1.0288511445017163,0.42585551330798477,0.6855110884346978,1.0,2/13,4.11%,DDX5;PLA2R1
prerank,metanephros development (GO:0001656),-0.3454043247777041,-1.0281641692217842,0.4143968871595331,0.6868307973977331,1.0,10/26,16.85%,FOXD1;PKD1;BMP7;BMP4;OSR1;CTSH;NIPBL;PKD2;PTCH1;SIX1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3717971516668234,1.0280094659214771,0.42061855670103093,0.8179802825291299,1.0,6/21,10.02%,SPRY3;RASAL3;TGFB2;SPRY4;CYRIB;DAB2IP
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.34903283375420247,1.027867969970597,0.38934426229508196,0.8172706279874279,1.0,8/24,21.17%,ALAS2;ABCG2;CPOX;TSPO;FECH;COX10;HMBS;ABCB10
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.3503035323793753,1.027773939128057,0.4008810572687225,0.8164329104623164,1.0,10/26,18.07%,CLU;KLF4;AKT1;HSP90AB1;KLF2;CD36;INSR;EDN1;HSP90AA1;DDAH1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.3895755682909142,-1.0273772504836576,0.41788321167883213,0.6884130787171308,1.0,9/17,24.29%,EFNB2;ROBO1;NRP1;VEGFA;NR4A1;MIA3;FGF2;EPHB4;SLIT2
prerank,tube closure (GO:0060606),-0.33736254057130255,-1.0266850088834358,0.4022346368715084,0.6896598598990833,1.0,6/31,9.33%,LMO4;LRP6;SKI;MTHFR;VASP;PLXNB2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3917378066105802,-1.0266110619149336,0.42803030303030304,0.6893658923093574,1.0,4/16,11.60%,SMG6;TNKS2;DHX36;PARP1
prerank,regulation of postsynapse organization (GO:0099175),0.340960842947993,1.026552396210463,0.4214876033057851,0.8189587259805112,1.0,7/28,11.20%,IL1RAPL1;SHANK3;KIF1A;HOMER1;CDKL5;ZDHHC15;PPFIA2
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.27624367552320217,-1.026517720843596,0.40262172284644193,0.6891143590450829,1.0,36/91,24.76%,PLD1;ITGAV;STXBP5;ABL1;LRRK2;PACSIN2;STON2;USP7;RAB10;NRP1;GAS1;RAB12;VAMP2;MAP2K1;ARFGAP1;CHMP3;ABL2;STX4;RAB11A;RALA;RINT1;RAB21;MBTPS1;ZFYVE16;PICALM;PTPN1;STON1;SPHK1;BET1L;NSF;HIP1R;RAB3D;SYK;SNX12;RAB8A;ATP9A
prerank,negative regulation of dephosphorylation (GO:0035305),0.3767352744050681,1.0262565025380295,0.42943548387096775,0.8186774473859191,1.0,3/18,5.01%,YWHAB;PPP1R16B;ZCCHC9
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.4190939856251167,1.0258443623383278,0.42105263157894735,0.8187002541560682,1.0,1/12,0.12%,IGF1R
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2537880965387355,1.0256333401929356,0.37551020408163266,0.8182156263760617,1.0,19/151,8.66%,ALAS2;SGMS1;GSTA4;PCSK1;FA2H;ACER2;DEGS2;MFSD2A;LPCAT2;CERT1;PCYT1B;CHKA;CSNK2B;SPNS2;ELOVL7;SGPP2;ELOVL4;GSTM5;SLC44A5
prerank,miRNA metabolic process (GO:0010586),-0.36880379637807237,-1.025612935026708,0.44508670520231214,0.6908274479016486,1.0,4/20,7.79%,DIS3L2;DICER1;DDX17;TUT4
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3460203669058724,1.0255403479335983,0.39835728952772076,0.8173647712225172,1.0,7/27,12.37%,THY1;ETS1;PRKCQ;CCL2;SKAP1;CYRIB;HSPD1
prerank,B cell mediated immunity (GO:0019724),0.4283055567571038,1.0254496048045105,0.41774891774891776,0.8165140815309558,1.0,1/10,3.19%,SLA2
prerank,dephosphorylation (GO:0016311),0.255761369397528,1.0249304123180307,0.39879759519038077,0.816998791753795,1.0,31/147,15.44%,PTPRG;PTPRB;PTPRN2;PTPRD;PTPRR;PLPPR1;PTPRT;DUSP6;PGP;PPM1F;PPP2R1A;PLPPR5;PTPN18;SGPP2;PTPRJ;PLPPR4;PLPP4;NT5C;MTMR6;PTPRM;DUSP26;DUSP28;DUSP15;PTPRZ1;CTTNBP2NL;PPP3CA;PPM1L;CTDSP2;PLPP6;PDP1;FRA10AC1
prerank,lymphocyte mediated immunity (GO:0002449),-0.417379652365581,-1.0231778562533325,0.4370503597122302,0.696588085436553,1.0,2/12,3.63%,JAG1;CD55
prerank,JNK cascade (GO:0007254),0.3120704512495946,1.0229541906105268,0.40332640332640335,0.821757108029329,1.0,15/40,19.16%,MAP4K2;SH2D3C;TNFRSF19;RPS27A;UBC;UBB;GPS2;NOD1;MAPK8;MAP3K11;TAB2;MAPK10;PTGER4;ADORA2B;NOD2
prerank,glycoprotein metabolic process (GO:0009100),-0.29517481327501993,-1.0226675516831245,0.39096267190569745,0.6974221816422079,1.0,18/53,19.60%,LARGE1;ST3GAL4;NGLY1;MAN1C1;OGA;GANC;ADAMTS9;MAN2A1;MAN1B1;HIF1A;MAN1A2;ERP44;MANBA;GANAB;MAN2A2;PARK7;B4GALT5;B4GALT7
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.3036326691000195,-1.022389140824065,0.42134831460674155,0.6976651404582668,1.0,10/48,9.99%,ADCY9;ADCY5;SLC35B3;AMPD3;ADCY1;SLC26A2;ADCY6;GMPS;GUCY1A1;PANK2
prerank,positive regulation of protein kinase activity (GO:0045860),0.25040114885078896,1.0223765652728813,0.3912175648702595,0.8223155306317318,1.0,36/148,17.28%,GRM5;LRP8;CSF1R;MMD2;HMGA2;TNIK;SNCA;GAS6;PAK5;NAB2;TGFB2;PAK1;CLU;MAPRE3;ADCYAP1;HSP90AB1;RELN;TAOK2;DAB2IP;PDGFB;CALM1;CCDC88A;CALM2;CALM3;PAK6;CIB1;INSR;TAB2;CDKN1A;PAK3;DDR2;STOX1;RAP1A;XRCC5;HSP90AA1;RALB
prerank,regulation of neuron differentiation (GO:0045664),-0.2817682330043119,-1.0223568649784893,0.41841004184100417,0.6972637772412467,1.0,19/76,13.64%,TCF4;NBL1;NREP;ZFHX3;ZEB1;BMP7;ROCK1;LRRK2;REST;IMPACT;MED1;NGF;RHOA;ID2;MEF2C;HES1;EIF2AK4;TCF3;CDK5RAP1
prerank,negative regulation of protein kinase activity (GO:0006469),0.2732925336807245,1.0222089319404808,0.40118577075098816,0.8216786477223661,1.0,29/88,20.37%,PTPRB;PTPRT;CAMK2N1;PPM1F;SNCA;THY1;SLC8A1;TRIB3;AKT1;YWHAG;HSPB1;DAB2IP;UBASH3B;CEP43;DUSP26;DVL1;EPHA1;SORL1;CDKN1A;CORO1C;CDKN1B;GNAQ;PPIA;ADAR;GSKIP;SH3BP5;PTPRO;HYAL2;DBNDD2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.25113843870191743,-1.0221834901328073,0.376984126984127,0.6972512706296276,1.0,49/148,25.45%,PRKAG2;MDM4;EP300;PRKAA2;BRD7;RBBP8;TAF3;MAPKAP1;USP7;NBN;MTOR;PDPK1;WRN;TAF4;TBP;HIPK1;CHD4;CHD3;RPL11;PRKAB2;RICTOR;EHMT1;ING5;USP2;HDAC1;TAF13;CSNK2A1;NOP53;MRE11;PRMT5;TTC5;PRKAA1;PPP2R5C;CDK2;MAP2K6;PML;KMT5A;TAF12;PRKAG3;PRKAB1;CDK5RAP3;TAF9B;TAF2;ATR;HDAC2;BOP1;MBD3;NUAK1;MAPK14
prerank,regulation of receptor recycling (GO:0001919),-0.38868696751149834,-1.0219487565094831,0.4227941176470588,0.697427773721513,1.0,7/16,25.80%,TBC1D16;ANXA2;ECE1;KIF16B;SCRIB;NSF;AP1AR
prerank,negative regulation of MAPK cascade (GO:0043409),0.27443458154153455,1.0219224403758345,0.3927855711422846,0.8214179074643403,1.0,17/87,11.72%,PTPRR;SEMA6A;CNKSR3;SPRY3;DUSP6;CAMK2N1;WNK2;PEBP1;PTPRJ;SPRY4;UCHL1;DAB2IP;LMO3;SMPD1;P2RX7;DUSP26;FOXO1
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.3446533823701531,-1.021809098132076,0.41696750902527074,0.6973207398060394,1.0,6/27,12.32%,IGF1;PDGFRA;DHX9;PDGFC;S100A6;FN1
prerank,regulation of synapse organization (GO:0050807),-0.3494059520217848,-1.0218024022997971,0.4413919413919414,0.696840577739737,1.0,10/26,20.04%,PDLIM5;ABL1;SETD5;ABHD17B;EPHA4;GRIPAP1;MEF2C;SLITRK4;WNT5A;MDGA1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.3134366034568783,1.0213585145682216,0.39166666666666666,0.8219307579130132,1.0,7/39,8.80%,MBP;PODXL;PPM1F;NOTCH1;KLF4;AKT1;NEXMIF
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.38601892168442176,1.0213178892206871,0.4409937888198758,0.8209182346985983,1.0,6/17,10.53%,PROX1;CCND1;MAPRE3;AKT1;CCNY;PDGFB
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.3855202115761992,-1.0209324475731123,0.42463235294117646,0.6986033612047594,1.0,8/18,31.20%,FBN1;FBXW7;TLR4;GPR137B;TCTA;MAFB;FSTL3;TLR3
prerank,ureteric bud morphogenesis (GO:0060675),0.38918245756756553,1.0207291247181716,0.43559718969555034,0.8215513680664592,1.0,2/16,3.55%,PAX8;PAX2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.35113271819110636,-1.0197198511067795,0.4052532833020638,0.7011358694092182,1.0,8/25,30.22%,ITGAV;DLG4;PICALM;ITGB3;ANKRD13B;APP;NEU3;ARF6
prerank,neuron projection extension (GO:1990138),-0.33442585831135263,-1.019717233443373,0.40789473684210525,0.7006515444664567,1.0,8/32,12.73%,ALCAM;AUTS2;NRP1;IMPACT;SPG11;ULK2;EIF2AK4;FLRT1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.4450803439174369,-1.0194737339218547,0.44045368620037806,0.7002849103390846,1.0,5/10,29.49%,PRKCD;SMPD2;SIRT3;NSMAF;SPHK2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.4450803439174369,-1.0194737339218547,0.44045368620037806,0.7002849103390846,1.0,5/10,29.49%,PRKCD;SMPD2;SIRT3;NSMAF;SPHK2
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.29526537689036864,1.019099372939291,0.42231075697211157,0.8253845025813138,1.0,12/56,15.03%,S100A9;S100A8;TLR2;RPS27A;UBC;UBB;NOD1;BCL10;CTSB;CD36;TAB2;MAPKAPK2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.39954587272414177,1.0185278859055553,0.43451143451143454,0.8259380088633026,1.0,4/14,11.76%,SIRT1;CAMK4;SEMA7A;BCL10
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.39346735854150006,1.0182311694900033,0.4185022026431718,0.8256605438162364,1.0,1/14,1.05%,IL17F
prerank,protein hydroxylation (GO:0018126),-0.39377061276333125,-1.0176389407533128,0.4419047619047619,0.7043999641922122,1.0,4/15,9.80%,PLOD2;P3H3;ASPH;EGLN3
prerank,regulation of mRNA stability (GO:0043488),-0.24941614819238556,-1.0175815597820062,0.386317907444668,0.7040601364203994,1.0,68/145,36.28%,SAMD4A;ROCK2;CELF1;FTO;VIM;ROCK1;PUM2;YTHDF3;EIF4ENIF1;FUS;RC3H1;LARP1;HNRNPD;PUM1;DCP1A;DHX36;CSDC2;PRKCD;NUP214;XRN1;PSMF1;SERBP1;YBX1;PSMB2;EXOSC9;HNRNPU;TENT5A;PAIP1;EIF4G1;PSMC1;PSMA3;PSMB6;XPO1;PRKCA;EXOSC3;PSMA4;FXR1;PSME1;PSMD13;PDE12;PCBP4;TENT5D;DIS3;ZFP36L2;PARN;FASTKD1;PSMB9;PSMB10;PSMA5;E2F1;UBA52;TBRG4;THRAP3;YWHAZ;TNFSF13;GDNF;GIGYF2;PSME4;HSPA1A;RC3H2;PSMD10;PSMB8;EXOSC8;SLC11A1;NPM1;RBM24;ELAVL1;PSMD3
prerank,lipoprotein localization (GO:0044872),0.43352445297285097,1.0172575312158236,0.4458874458874459,0.8275326915850498,1.0,4/11,12.99%,PPARG;ZDHHC17;VMP1;CD36
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.40240863705788993,-1.0172440423731393,0.44095940959409596,0.704437429093721,1.0,2/15,3.63%,GLI3;CD55
prerank,xenobiotic transport (GO:0042908),0.38452936076135524,1.0172271280959584,0.43737166324435317,0.8264969962926356,1.0,2/17,2.33%,SLC7A5;ABCG2
prerank,positive regulation of protein deacetylation (GO:0090312),-0.39471824505586117,-1.0172018121414903,0.4199623352165725,0.7040482591371452,1.0,8/14,30.43%,AKAP8L;NIPBL;SAP30BP;FNTA;ZBTB7B;DYRK1A;NNMT;BRMS1
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.3717019687265163,-1.017200106749744,0.4290909090909091,0.7035626087045472,1.0,8/19,18.73%,BMPR1A;SMAD6;MDM4;TGFBR2;SMAD4;ACVR1;HEYL;BMP2
prerank,positive regulation of interleukin-12 production (GO:0032735),0.33398819023286513,1.01700192899628,0.410752688172043,0.8260306909517936,1.0,5/31,12.37%,TIRAP;PLCB1;TLR2;CD40;HSPD1
prerank,myelin assembly (GO:0032288),0.44649430790299177,1.0168654252673186,0.4437627811860941,0.8253108377194598,1.0,4/10,8.86%,TENM4;EPB41L3;CNTNAP1;TPPP
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.42713007937506875,-1.0165617367573014,0.4519056261343013,0.7046952138293293,1.0,3/12,22.91%,IL17D;IL18;CD80
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.2980091821388357,1.0165058979122439,0.412,0.8252506940652685,1.0,11/51,10.02%,NYAP2;CNTNAP2;GPM6A;TNIK;PAK1;EPB41L3;CNTNAP1;UBB;SHTN1;TAOK2;DAB2IP
prerank,cardiac muscle cell contraction (GO:0086003),0.3588098382618202,1.0161716282328355,0.4298056155507559,0.8250841100185109,1.0,4/19,5.65%,SCN1A;FGF12;CACNA2D1;SCN4B
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.40868566058777667,-1.015579693392081,0.4479553903345725,0.7066667653033467,1.0,6/14,27.44%,TGFBR2;CD55;PTPN22;IL18;SYK;CD81
prerank,cardiac myofibril assembly (GO:0055003),-0.4054255120139846,-1.0153677501385425,0.4261682242990654,0.7067380591712706,1.0,4/15,7.44%,PDGFRA;PDGFRB;MEF2A;OBSL1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.32108900460637135,-1.015355365253767,0.425,0.7062808327487203,1.0,13/36,17.88%,TGFBR1;DEPTOR;ASAH2;BCL2;RB1;TPD52L1;ING5;TRIM39;CSNK2A1;NR4A2;DAPK2;BCL2L12;CX3CR1
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.28994964855104893,-1.0149595316752098,0.42429906542056073,0.7067977122525855,1.0,19/54,19.60%,GPC6;SDC2;HS3ST3A1;GPC4;GPC3;GNS;EXT1;HSPG2;HS2ST1;NDST1;GUSB;NDST2;HEXA;PXYLP1;SDC4;HS6ST1;XYLT2;GCNT2;B4GALT7
prerank,negative regulation of viral process (GO:0048525),0.2899285258125882,1.0143672694531791,0.4147368421052632,0.8294118475667309,1.0,9/57,10.96%,MBL2;PROX1;TRIM13;ISG15;TRIM62;TRIM6;IFITM3;SLPI;MID2
prerank,regulation of mast cell activation (GO:0033003),-0.44793084139529193,-1.0143135525019085,0.4505703422053232,0.7079621293238736,1.0,4/10,20.59%,PLSCR1;LYN;NECTIN2;CD84
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3802215472727118,-1.0143034169823621,0.44403669724770645,0.7074951025077009,1.0,5/17,12.01%,PTN;IL34;DICER1;ID2;HES1
prerank,anion transmembrane transport (GO:0098656),0.2879575389374959,1.013254341911723,0.41598360655737704,0.8316348362565437,1.0,12/67,8.09%,SLC7A5;SLC7A1;LRRC8B;SLC35A1;SLC1A1;SLC25A42;MFSD12;SLC1A2;SLC6A5;SLC7A8;SLC6A8;SLC25A14
prerank,establishment of protein localization to organelle (GO:0072594),0.27935598186398825,1.01315636539476,0.4112903225806452,0.830781429766864,1.0,11/72,9.92%,IPO5;IPO4;MMP12;RYR2;NXT1;AKT1;ZDHHC15;TSPAN17;FAM53B;NEURL1B;NUP62
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.44769880700401166,-1.0130204085337209,0.46296296296296297,0.7102176752072235,1.0,1/10,0.93%,APPL2
prerank,protein localization to nucleus (GO:0034504),-0.2629808763327339,-1.0128088636470407,0.3920792079207921,0.7102804451534965,1.0,57/102,37.47%,APPL2;COL1A1;BMP7;BMP4;LMNA;TAF3;EIF4ENIF1;STAT3;WRN;NUP214;IPO13;RPL11;TPR;APPL1;YWHAE;TAF8;TOPORS;NOP53;FAM53C;SIX1;GBP2;HNRNPU;MORC3;ABCA7;PML;RPAIN;TOR1A;IPO9;TNPO3;PPP1R10;SYK;PHB2;ZBTB7A;NUP93;BBS4;RRS1;CHCHD10;RANBP17;TNPO2;SIX4;CALR;PINX1;ARL2;E2F3;RAN;NUP133;FAM53A;IPO11;NUP88;SEC13;MSX1;NUTF2;IPO7;TOR1AIP1;TSC2;CSE1L;SKP1
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.4306976945475434,-1.0126409143134658,0.4669260700389105,0.7101973657942408,1.0,2/12,16.37%,NUPR1;IL18
prerank,cellular component disassembly (GO:0022411),0.29604382710669425,1.0123021099027272,0.44948453608247424,0.83220509465646,1.0,6/53,7.83%,BSG;TMPRSS6;MMP12;MMP13;MMP16;TIMP1
prerank,regulation of establishment of protein localization (GO:0070201),-0.41210202977338917,-1.0122082749151953,0.4681238615664845,0.7108295423059473,1.0,3/13,16.82%,SPIDR;CEP135;CEP295
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.43450357947352714,-1.0120027209014832,0.44550669216061184,0.7108646207781961,1.0,2/10,8.81%,MTHFR;MTHFD2L
prerank,positive regulation of blood coagulation (GO:0030194),-0.37687712840737675,-1.0116833052219032,0.436399217221135,0.7112061860617157,1.0,3/17,7.29%,ST3GAL4;THBS1;F3
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.33441869493547055,1.0116014785551322,0.4339622641509434,0.833167151747671,1.0,7/31,11.73%,DLG2;LRRC7;LIN7A;WDR1;MTCL1;CRB1;ANK1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.3040322893381845,-1.0112482251204535,0.439453125,0.7118338937715023,1.0,5/40,7.97%,IGF1;OPA1;PRKN;DNM1L;FAM162A
prerank,positive regulation of cholesterol efflux (GO:0010875),0.3666161214960163,1.0112131412032102,0.43067226890756305,0.8331973743497395,1.0,4/21,8.64%,PLTP;SIRT1;PPARG;GPS2
prerank,carboxylic acid metabolic process (GO:0019752),0.3243968742284363,1.0109814575005303,0.41414141414141414,0.8327741892384315,1.0,4/33,5.76%,SLC2A1;SLC2A3;MIF;CSGALNACT1
prerank,acyl-CoA metabolic process (GO:0006637),-0.3253209662795631,-1.0109230348108125,0.4433399602385686,0.7121480578080269,1.0,11/35,23.20%,GPAT4;ACSF2;ACSL6;DLST;ACOT11;ACOT9;SUCLA2;MCEE;ACOT8;SUCLG2;ACOT6
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3393396238712225,-1.0105408235108249,0.43151969981238275,0.7126315518378802,1.0,9/27,15.50%,CACNA1C;ANK2;DLG1;CAMK2D;JUP;ATP2A2;TRPM4;SRI;AKAP9
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.35667237451766753,1.0104446979595534,0.43259557344064387,0.8332586407095821,1.0,4/22,8.99%,MBP;THY1;KLF4;SKAP1
prerank,insulin receptor signaling pathway (GO:0008286),-0.28113377508700127,-1.0100989730590044,0.4412878787878788,0.7132930410162587,1.0,14/69,10.19%,SORBS1;RHOQ;GRB10;ATP6V1B2;GSK3B;IRS1;ATP6V0D1;SLC39A14;SHC1;FOXC2;ATP6V0A4;IGF2;FER;PTPN2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.3994155452038066,-1.0099637979709997,0.4674329501915709,0.7131149817259539,1.0,6/14,27.12%,LIMS1;FLNA;LOXL3;PRKD1;CD63;SLC2A10
prerank,autophagosome maturation (GO:0097352),-0.3319871694141364,-1.0097533640394591,0.4294117647058823,0.7131769641597132,1.0,13/32,23.09%,UVRAG;UBQLN1;VTI1B;VAMP7;LIX1L;LAMP2;CHMP3;ATP2A2;VCP;WIPI2;STX17;ATG14;MAP1LC3A
prerank,cardiac muscle cell differentiation (GO:0055007),-0.36355835605212117,-1.0094140275108332,0.4419475655430712,0.7135316540669427,1.0,8/21,18.73%,AKAP13;CXADR;MEF2C;SIK1;VEGFA;ACVR1;MYH11;BMP2
prerank,megakaryocyte differentiation (GO:0030219),-0.4335455893375973,-1.0093935992513516,0.4497153700189753,0.7130808212735409,1.0,3/11,9.09%,KIT;UBA5;MED1
prerank,glucose homeostasis (GO:0042593),-0.27200878714622223,-1.0085710372983419,0.42653061224489797,0.7146120039403292,1.0,25/83,22.16%,TCF7L2;APPL2;LEPR;MCU;PRKAA2;CYB5R4;RBP4;IRS1;STAT3;LRRC8D;PPARGC1A;FOXK1;PTPN2;HIF1A;ADRA2A;FOXK2;CRTC2;PRKAA1;INPP5K;PARK7;FGFR4;PIK3R1;USF1;KCNB1;WFS1
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.24477140922799287,-1.0085351531480655,0.42217898832684825,0.7142214454533816,1.0,36/150,19.29%,EGFR;TCF7L2;GAB2;TGFBR1;PDGFRA;ANGPT1;FGF1;AXL;PDGFRB;KIT;OSBPL8;IRS1;ITGB1;THBS1;FGFR2;F3;PDPK1;IGF2;FRS2;KL;RICTOR;PIK3AP1;P2RY12;TXN;P2RX4;IL18;PIK3CD;IAPP;CX3CR1;GAB1;MYOC;GCNT2;HBEGF;NRG4;PARK7;PTPN11
prerank,myotube differentiation (GO:0014902),0.38260230720844257,1.0085211085389638,0.44893617021276594,0.8378362893627022,1.0,4/17,6.78%,ADGRB3;ADAM12;JAM2;KCNH1
prerank,endothelial cell proliferation (GO:0001935),0.37671833840370567,1.0081290156076248,0.4366812227074236,0.8379078883614722,1.0,5/17,12.80%,TEK;ACVRL1;CD34;THAP1;BMPR2
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.2860441772740206,-1.0079944767742395,0.444,0.7151266179941107,1.0,22/62,25.84%,PUM2;WTIP;TNRC6A;RANBP2;STAT3;DHX9;PUM1;NUP42;NUP214;LIMD1;TPR;POLR2H;AJUBA;EIF4G1;NUP98;NUP43;POLR2K;AGO1;NUP160;POLR2E;FXR1;NUP93
prerank,positive regulation of neurogenesis (GO:0050769),0.280525016395805,1.0078563205639206,0.42398286937901497,0.8375623496411108,1.0,11/68,9.74%,PTPRD;IL1RAPL1;MME;PLXNB3;SHANK3;NTRK2;NPTN;ROBO2;PLXNA4;CDKL5;OPRM1
prerank,cellular response to unfolded protein (GO:0034620),0.33766862903533934,1.007687940997159,0.45073375262054505,0.8369284897067485,1.0,6/26,12.37%,HSPA13;PACRG;HSPA8;HSPA5;DAB2IP;HSPD1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.34441341753406207,1.0074870635812543,0.4271047227926078,0.8363873206678335,1.0,6/24,14.11%,ANK3;MTCL1;MIEF1;ITGAM;HRAS;CIB1
prerank,renal filtration (GO:0097205),-0.4498043485548235,-1.0074194388638988,0.46886446886446886,0.7160672280811499,1.0,3/10,10.14%,SULF1;SULF2;TBC1D8B
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.36488933397964673,-1.0073560916015603,0.44488977955911824,0.7157343048647274,1.0,8/19,19.31%,ELF1;DHX9;IRAK2;RUNX1;PARP9;MAVS;WNT5A;IRAK1
prerank,regulation of mitochondrial fusion (GO:0010635),0.41738490104666387,1.0073256896393392,0.46680497925311204,0.8357007179709406,1.0,2/11,2.06%,TFRC;OMA1
prerank,negative regulation of inflammatory response (GO:0050728),0.24090188553367764,1.0071142709145715,0.428842504743833,0.8352185585157471,1.0,37/182,18.50%,TEK;PRKAR2B;ADCY3;ADCY8;LRFN5;GIT1;RPS19;RAMP2;ADRB1;PPARG;RHBDF2;KLF4;GNG2;ADCYAP1;GPR176;GPS2;POMC;CD163;CD200R1;ADCY4;PROC;GGT1;PTGER2;MFHAS1;OTULIN;ADCYAP1R1;PLK2;PTGER4;CALCRL;NPSR1;GPR45;AOAH;CYSLTR1;TNFRSF1A;FYN;ADORA2B;PRKAR1A
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.33544926018702875,-1.0071054571598437,0.44594594594594594,0.7158918294219996,1.0,14/29,36.17%,EIF4ENIF1;FUS;LARP1;YBX1;HNRNPU;TENT5A;PAIP1;TENT5D;E2F1;THRAP3;GDNF;SLC11A1;RBM24;ELAVL1
prerank,negative regulation of hemostasis (GO:1900047),-0.4080228103725006,-1.0069761168214102,0.45878136200716846,0.7157506265558812,1.0,4/12,17.05%,VTN;TFPI;APOE;SERPINE1
prerank,histone acetylation (GO:0016573),-0.2807732574022094,-1.0068964919629377,0.402834008097166,0.7154722485191898,1.0,18/69,18.02%,KAT2B;EP300;KAT6B;CREBBP;TRRAP;BRPF3;ZZZ3;HAT1;ATF2;TADA3;KAT14;KAT8;ING5;BRCA2;TAF5L;EPC1;TAF6L;MSL3
prerank,myotube cell development (GO:0014904),-0.4399186955857379,-1.0068442531407338,0.4645669291338583,0.7151146476698972,1.0,4/10,16.85%,IGF1;SKI;SELENON;SIX1
prerank,tyrosine metabolic process (GO:0006570),-0.4387117059010286,-1.006359541910211,0.47619047619047616,0.7157957244492578,1.0,7/11,55.75%,THAP4;TYR;IL4I1;FAH;HGD;DCT;IYD
prerank,cation transmembrane transport (GO:0098655),-0.3061903280670167,-1.0062263123681485,0.4504672897196262,0.7156752512704381,1.0,7/44,8.24%,ATP1A2;TRPM3;SLC7A2;TRPM6;SLC22A5;SLC6A9;SFXN2
prerank,response to X-ray (GO:0010165),-0.4079966582575376,-1.006066745306834,0.43263757115749524,0.7155857455570812,1.0,4/14,11.39%,ANXA1;BRCC3;XRCC4;NIPBL
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.30055202067590664,1.0060666453708298,0.432712215320911,0.8372058401962855,1.0,12/50,13.60%,PAX2;SNCA;GAS6;GPX1;ARL6IP1;KLF4;BEX3;AKT1;RPS6KA1;RNF34;CAAP1;RFFL
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.36737376204573735,-1.0059731685635682,0.47953216374269003,0.7153440700067637,1.0,4/18,11.97%,FLNA;PHF8;EIF2AK3;WDR43
prerank,DNA catabolic process (GO:0006308),0.41261207910643655,1.005876155607764,0.4781659388646288,0.8366440266507665,1.0,1/11,1.06%,DNASE1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3049529591658226,1.0056957211474877,0.44989339019189767,0.8360721435564761,1.0,9/46,14.84%,GDAP1;CHCHD4;TIMM21;DNAJC15;AKT1;PITRM1;TIMM22;HSPD1;TSPO
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.27892684545990387,-1.0052932257236205,0.44052044609665425,0.7166318898325419,1.0,15/70,12.78%,CYFIP2;ABL1;WASF2;LYN;BRK1;CDC42;VAV2;PLCG1;WASL;PRKCD;NCKAP1;YES1;ABI1;WIPF1;ARPC2
prerank,positive regulation of apoptotic process (GO:0043065),-0.22650486805974668,-1.005166107927079,0.4173387096774194,0.7164553575178971,1.0,68/293,18.73%,AKAP13;PAWR;TGFBR1;EPHA7;BMP4;FOXO3;STK3;TIAM2;PTGIS;ABL1;ARHGEF17;NUPR1;STK17B;IGFBP3;RARG;HMGB1;ITGB1;DNM1L;HOXA5;PHLDA1;IFIT2;REST;MAP3K5;PLEKHG2;FAM162A;CALHM2;AIFM1;VAV2;ADAMTSL4;UNC13B;MAP3K20;NGF;NCSTN;PRMT2;JUN;CYP1B1;ARHGEF12;ARHGEF18;BCLAF1;ERCC3;SOS2;SIK1;FGD1;CASP2;RASSF2;ATF6;TPD52L1;RBM5;CCAR1;FAP;ING5;LATS1;FGD4;TRIM39;DDX3X;NGEF;TGFB3;ARHGEF11;DAPK1;PTPA;ARHGEF6;TRIO;DAPK2;ARHGEF1;IAPP;TRAF6;DCUN1D3;BMP2
prerank,long-chain fatty acid import into cell (GO:0044539),0.4278170813078487,1.0050870392836637,0.45964125560538116,0.83679812495621,1.0,4/10,15.81%,SLC2A1;CD36;SLC27A4;ACSL3
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4184218659972502,-1.0048536019245675,0.46236559139784944,0.7168150417306455,1.0,3/12,10.12%,ABCA1;ITGAV;NR1H3
prerank,sodium ion homeostasis (GO:0055078),-0.3706697095521819,-1.004767783437099,0.45126353790613716,0.7165400655482209,1.0,3/21,9.43%,ATP1A2;SLC9A1;SLC12A2
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.2781629522273694,-1.0042391116704004,0.45318352059925093,0.7173747124232086,1.0,12/66,10.22%,EGFR;SASH1;IL34;FGF1;PDGFRB;ROBO1;LRRK2;KIT;TAOK3;MAP3K5;PDGFC;TRAF2
prerank,regulation of neuron death (GO:1901214),0.2713892868453087,1.0039469544076902,0.452755905511811,0.838941559549825,1.0,16/82,13.14%,DCC;EPHB1;GRID2;TRIM2;GRIN2B;SNCA;CLU;AKT1;UBB;GPNMB;CD34;GPR75;CD200R1;SNCB;ITGAM;SORL1
prerank,extracellular matrix disassembly (GO:0022617),0.29567930277865445,1.0037792722019003,0.4479166666666667,0.8383500626181765,1.0,6/53,7.83%,BSG;TMPRSS6;MMP12;MMP13;MMP16;TIMP1
prerank,regulation of intracellular transport (GO:0032386),-0.316067520885806,-1.0037016302342983,0.4450651769087523,0.718251792994117,1.0,12/38,19.39%,LRRK2;NUMA1;GAS1;NDEL1;GRIPAP1;NUP214;WWC1;RINT1;DYNC1H1;LAMP1;PTPN1;RBM4
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.4142690095027388,-1.0034456993402638,0.44696969696969696,0.7184335292962654,1.0,5/13,15.86%,PLXNA2;NRP1;PLXNB2;PLXNB1;PLXND1
prerank,skeletal muscle tissue development (GO:0007519),-0.322290188905591,-1.0032747480170503,0.4630738522954092,0.7183918476441001,1.0,6/32,11.61%,SVIL;CFLAR;SKI;IGSF8;MEF2C;SELENON
prerank,response to retinoic acid (GO:0032526),-0.28682680011884765,-1.0026375971440098,0.44664031620553357,0.7195216858095359,1.0,12/59,12.97%,EPHA3;PTK7;WNT5B;WNT6;RBP4;RARG;CTSH;LYN;WNT9A;ABL2;FZD7;ADNP2
prerank,T cell migration (GO:0072678),-0.4084333218150844,-1.0025546920038182,0.4759259259259259,0.7192596730461108,1.0,9/13,47.18%,SLC12A2;CXCL16;PIK3CD;MSN;GPR183;PIK3CG;CXCL10;MYO1G;ZAP70
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.3725388184099002,-1.0022558696196937,0.4640776699029126,0.7195222494001823,1.0,5/19,8.10%,RPTOR;CHD8;MTOR;AR;DHX36
prerank,RNA 3'-end processing (GO:0031123),-0.2791993195499811,-1.0021440501558112,0.4316831683168317,0.7193184419860122,1.0,21/69,23.32%,TENT2;PABPN1;WDR33;PCF11;CASC3;U2AF2;CPSF3;SRSF6;TUT4;SLU7;RPRD2;SRSF1;CSTF3;SRSF7;SRSF11;UPF3B;SRRM1;SRSF2;CPSF4;CSTF1;NUDT21
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.33889960894750004,-1.0020782185081534,0.45286506469500926,0.7190089193700374,1.0,5/27,7.33%,SLMAP;SNTA1;DLG1;PTPN3;CAMK2D
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.3517290737502361,-1.001752780534205,0.4533333333333333,0.7193056374803608,1.0,8/22,27.76%,SASH1;RELL1;VEGFA;BMP2;SPHK1;EMC10;MINK1;GADD45G
prerank,endothelial cell differentiation (GO:0045446),0.4036683818379582,1.001737201149008,0.44493392070484583,0.843456090162392,1.0,4/12,7.45%,PROX1;TIE1;KDR;ACVRL1
prerank,oogenesis (GO:0048477),0.3868603611482798,1.0016253056378084,0.4588744588744589,0.842648238666171,1.0,3/15,4.78%,MEI4;FMN2;NANOS3
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3036332654083123,-1.0015135429321753,0.4520547945205479,0.7194632314550747,1.0,15/44,22.47%,BMP7;BMP4;IRAK3;LYN;PTPN22;PRKCD;DUSP1;APOE;DUSP10;PDCD4;INPP5K;PTPN1;CDK5RAP3;DUSP7;CD300A
prerank,regulation of platelet activation (GO:0010543),-0.3577997097164925,-1.0014356502569375,0.4583333333333333,0.7191694619871468,1.0,9/21,25.69%,PDGFRA;LYN;PLA2G4A;TEC;APOE;TLR4;PRKCA;SYK;FCER1G
prerank,positive regulation of behavior (GO:0048520),0.42885486224569264,1.0011258043938218,0.4787234042553192,0.8430093635419246,1.0,4/10,18.44%,NLGN1;NPAS2;SGIP1;NR4A3
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.24590920684312906,-1.0009714916773114,0.4644268774703557,0.7198546594111639,1.0,13/142,5.01%,ATP1A2;CACNA1C;LPAR1;SMAD3;PLCE1;PDGFRA;ADCY5;ABL1;CD55;ADRA1B;DLG4;CCR9;HMGB1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.41415503508532614,1.0009674745708277,0.4610655737704918,0.8424041721187214,1.0,2/11,8.55%,MECOM;CD34
prerank,glial cell differentiation (GO:0010001),0.3342905867439731,1.000900307977591,0.45643153526970953,0.8415052058745345,1.0,10/28,18.80%,CDH2;PAX2;FGF10;TPPP;RELN;PTPRZ1;SOX4;HES5;SOX2;METRN
prerank,monocarboxylic acid transport (GO:0015718),-0.28868396395347684,-1.0008755287736104,0.47731755424063116,0.7196314443975613,1.0,10/51,10.69%,SLC6A13;SLC16A12;SLCO3A1;SLC6A12;SLCO2A1;SLC16A6;ATP8B1;NCOA1;SLC16A9;SLC5A6
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.40376346753309345,1.0004364336826812,0.47391304347826085,0.8417729301873389,1.0,2/13,9.47%,IL12A;CYRIB
prerank,cardiac muscle cell action potential (GO:0086001),0.3217601574951027,1.0001426855377602,0.4700665188470067,0.8415627981078783,1.0,7/30,6.69%,SCN1A;FGF12;CACNA2D1;SLC8A1;SCN4B;HCN2;KCND3
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.33853467375843543,-1.0000512817910803,0.43884892086330934,0.7212006989620469,1.0,9/28,20.32%,PRKAG2;PRKAA2;MED1;PRKAB2;SIRT5;CTNS;CX3CR1;AVIL;FGFR4
prerank,retinol metabolic process (GO:0042572),-0.3962111689107444,-0.9990480246501859,0.4649805447470817,0.7232209816936359,1.0,3/14,10.15%,RBP4;DHRS3;CYP1B1
prerank,Golgi inheritance (GO:0048313),-0.42923010709847104,-0.9987085707506858,0.4768339768339768,0.7235981353332102,1.0,3/11,13.01%,GBF1;VCPIP1;STX5
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2419258365330976,-0.9985205471333294,0.4297029702970297,0.7235605641905231,1.0,47/172,22.15%,PTPN13;PLD1;PLEKHA2;PI4KA;SYNJ2;MTMR12;GNPAT;DGKA;PLSCR1;AGPAT4;DDHD1;INPPL1;ABHD5;PIP4K2C;GPAT4;STARD7;ETNK2;PLA2G4A;ABHD3;PTDSS1;PITPNM2;ARF1;PCYT1A;MBOAT7;MTMR3;CPNE3;SLC27A1;PLEKHA8;PIK3C3;HDHD5;CSNK2A1;PIK3R4;SACM1L;TAMM41;PIK3CD;LPIN2;INPP5K;LPIN3;GPD1L;LPCAT1;CDS2;GPAT3;DGKD;PIK3R1;LPCAT3;FGF2;PLEKHA4
prerank,negative regulation of transport (GO:0051051),0.29233457002270824,0.9984547462158235,0.43568464730290457,0.8455591120075995,1.0,8/51,8.04%,NRG1;SYT11;MCTP1;PPM1F;SNCA;TLR2;DYSF;YRDC
prerank,cellular response to light stimulus (GO:0071482),-0.2784067994556068,-0.9982967805626326,0.4697855750487329,0.7236562383795723,1.0,29/66,39.02%,INO80;EP300;CREBBP;DHX36;PTPRK;ZBTB1;PRKCD;USP47;PARP1;EIF2AK4;GNB1;SDE2;PCNA;BMF;ATR;USP28;KDM1A;SAG;BAK1;RUVBL2;OPN3;PDE6A;GPR88;NPM1;TP53;TRIAP1;NEDD4;CNGB1;CDC25A
prerank,regulation of lymphocyte proliferation (GO:0050670),0.3868759748896742,0.9980885397847992,0.46120689655172414,0.8456301243327692,1.0,2/16,4.98%,FGF10;IL12A
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3374399322526547,0.9977312482854107,0.4497991967871486,0.8455748971678231,1.0,3/26,3.84%,GRIN1;ADGRB1;SNCA
prerank,DNA duplex unwinding (GO:0032508),-0.29390498775122664,-0.9977044053359633,0.4463276836158192,0.7246564253167173,1.0,23/50,30.89%,GTF2H2;RAD23B;NBN;DHX9;ANXA1;WRN;DDB2;MCM9;ASCC3;PARP1;ERCC3;MCM6;MRE11;SSBP1;GTF2H1;RECQL5;GTF2H4;MCM4;MCMDC2;SUPV3L1;RBX1;UBA52;TWNK
prerank,regulation of GTPase activity (GO:0043087),-0.2419191948215874,-0.9972734391455199,0.4543726235741445,0.7252466652467757,1.0,30/177,10.07%,PLXNA2;DOCK11;AFDN;ASAP3;SIPA1L1;EPHA3;LIMS1;LRRK2;ARAP1;GSK3B;SGSM2;ITGB1;BCAS3;SNX9;ARFGEF1;MMUT;RAB3GAP1;GMIP;MAP4K4;RAPGEF3;EPHA4;S100A10;ZC3H15;RSU1;VAV2;NDEL1;USP6NL;PLXNB2;WNK1;TBC1D20
prerank,nucleotide biosynthetic process (GO:0009165),-0.37024395013300054,-0.9970564382191072,0.44402985074626866,0.7253465914399244,1.0,10/18,27.30%,NMNAT2;RRM2B;ME1;PPAT;NMNAT3;NMNAT1;PRPSAP2;RRM1;PRPS1;PRPS1L1
prerank,positive regulation of metabolic process (GO:0009893),0.26196747679970855,0.9969764017603592,0.4789915966386555,0.8467126708201129,1.0,20/103,14.15%,IGF1R;GATM;OMA1;KSR2;UCP2;ADRB1;HADH;EPAS1;ADCYAP1;ADIPOR2;APC;FABP5;SCD;PER2;AGPAT1;CD36;LCN2;ESRRG;EBF2;INSR
prerank,renal water homeostasis (GO:0003091),0.354507822440461,0.9969476600377737,0.4572072072072072,0.8456885013618981,1.0,3/23,1.18%,PRKAR2B;ADCY3;ADCY8
prerank,mitotic spindle organization (GO:0007052),-0.24594037613055528,-0.995655598874081,0.4742857142857143,0.7283847471879566,1.0,82/153,40.15%,EML4;FLNA;MAP4;PIBF1;RANBP2;SPICE1;PCNT;NDEL1;STAG1;LSM14A;RHOA;DYNC1LI1;RAB11A;ABRAXAS2;MAPRE1;TOGARAM1;NUDC;ZWINT;MAP9;CENPP;RCC1;SKA2;PTPA;PMF1;DYNC1H1;STAG2;EFHC1;VCP;NUP98;WDR62;NEK6;SMC1A;NUP43;TAOK1;ITGB3BP;XPO1;TBCE;NUP160;BCCIP;CENPT;KIF23;SUN2;INCENP;ABRAXAS1;KIF11;MZT1;STIL;DSN1;KNL1;CENPE;CENPU;BUB1B;RAN;PRC1;KIF2A;MAD2L1;NUP133;CKAP5;AHCTF1;SMC3;TTK;MISP;SEC13;RCC2;B9D2;CENPI;DCTN6;CENPH;TPX2;SEH1L;NDC80;CENPF;KIFC1;NSL1;KIF4A;CENPN;PAFAH1B1;KNTC1;SPDL1;CENPA;TUBG2;SGO1
prerank,protein insertion into ER membrane (GO:0045048),-0.3108505834417314,-0.9956057925177598,0.46123260437375746,0.7280182157538788,1.0,17/37,30.28%,EMC2;TRAM2;EMC7;VAMP2;STX5;EMD;EMC9;GET4;EMC4;VAPA;BAG6;EMC10;STX1A;EMC3;APP;CCDC47;GET3
prerank,receptor catabolic process (GO:0032801),-0.34612828936723233,-0.995304220792329,0.4438305709023941,0.72829164966319,1.0,9/24,25.49%,RNF43;UVRAG;KIF16B;BECN1;SMURF1;PIK3R4;MYLIP;AP2A1;ZNRF3
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.32262746274936455,-0.995282935302679,0.4369747899159664,0.7278526351552086,1.0,12/32,22.38%,MAP3K3;MEOX2;RHOJ;THBS1;FOXC2;ANXA1;RHOA;VEGFA;FGFBP1;FGF2;SRPX2;TBXA2R
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.2585299068915286,-0.995111403607892,0.439918533604888,0.7278076931805902,1.0,13/98,7.95%,EGFR;SORBS1;LRP1;EPHA3;CEMIP;SLC5A3;PRKN;PTPN9;DLG1;ITGB1;TFDP2;BCL2;PDPK1
prerank,sphingolipid catabolic process (GO:0030149),0.3851347805852259,0.9949108335010403,0.450199203187251,0.8506600233683521,1.0,6/15,14.41%,ACER2;ENPP2;SMPDL3A;SMPD1;GLA;PPT1
prerank,bicarbonate transport (GO:0015701),0.3472916130985991,0.9946494534779826,0.4693446088794926,0.8503395293536083,1.0,3/25,5.87%,SLC4A1;CA4;CA2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.40839571064769964,-0.9945171838732036,0.4981060606060606,0.7288402159610099,1.0,3/12,4.72%,PCM1;NIN;NINL
prerank,carboxylic acid catabolic process (GO:0046395),-0.40963396798688867,-0.9945006077633356,0.46716697936210133,0.7283929981786615,1.0,8/12,46.25%,RENBP;BCKDK;ACOT8;PON3;NPL;IL4I1;NAGK;GNPDA1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.35562227004799213,0.9941247201295164,0.47085201793721976,0.8508410903702509,1.0,5/19,7.34%,TEK;PPM1F;KDR;THY1;PTPRJ
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.43730324641599666,-0.9938313952507102,0.49907578558225507,0.7295179743424692,1.0,6/10,47.44%,GNB1;SAG;PDE6A;CNGB1;PDE6G;PDE6B
prerank,response to muramyl dipeptide (GO:0032495),-0.41412542540414904,-0.9937396836586885,0.4600389863547758,0.7292299340449726,1.0,3/12,9.41%,VIM;PTPN22;CHMP5
prerank,cell-cell junction maintenance (GO:0045217),0.4103672873139103,0.9936739895264889,0.4860813704496788,0.8510532708418885,1.0,3/11,12.41%,CSF1R;F2R;TJP1
prerank,protein alkylation (GO:0008213),0.3444904190113881,0.9934294856725775,0.44150110375275936,0.8506833421231332,1.0,6/22,15.09%,LCMT1;EEF1AKMT1;ETF1;FAM98A;VCPKMT;METTL22
prerank,positive regulation of cell adhesion (GO:0045785),0.2717538988752566,0.9933914916145409,0.4668094218415418,0.8497018613770673,1.0,18/74,14.20%,FRMD5;CXCL12;MAGI1;PPM1F;IL12A;STX3;TGFB2;PTPRJ;NDNF;PDGFB;DUSP26;MEGF10;SMAD7;RET;ATM;ADGRG1;CIB1;PPP3CA
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.3793249427254489,-0.9925850315435782,0.4632352941176471,0.7316155835621034,1.0,9/16,22.07%,FOXD1;FGF1;BMP4;PKD2;SALL1;SIX1;NPNT;BMP2;FGF2
prerank,gliogenesis (GO:0042063),0.38620031121209486,0.9924164685621983,0.45739910313901344,0.8515670428130194,1.0,4/15,9.26%,CDH2;PAX2;TGFB2;RELN
prerank,positive regulation of histone deacetylation (GO:0031065),-0.41772740870409225,-0.992219210341608,0.49510763209393344,0.7320187133654177,1.0,5/12,18.62%,AKAP8L;NIPBL;VEGFA;PRKD1;SAP30BP
prerank,regulation of protein targeting to membrane (GO:0090313),0.33306613019536757,0.9916248942773679,0.4460580912863071,0.8527930297407484,1.0,7/28,14.95%,ANK3;MTCL1;MIEF1;ITGAM;HRAS;CIB1;GDI1
prerank,nucleotide catabolic process (GO:0009166),0.37570843833013534,0.9914714288634396,0.4639830508474576,0.8521681156688535,1.0,3/16,9.72%,NUDT3;GPX1;NT5C
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.37753394969113374,0.9913087371832803,0.4393305439330544,0.8515682058091405,1.0,5/17,13.54%,ALG3;MVD;ALG1;ALG8;DHDDS
prerank,purine nucleotide metabolic process (GO:0006163),0.3370328964647985,0.9912778186849133,0.45417515274949083,0.8505593771842523,1.0,6/24,12.56%,GART;GPX1;HPRT1;MTHFD1;NT5C;GUK1
prerank,nuclear membrane organization (GO:0071763),-0.3681254964233613,-0.9910558015874205,0.4764595103578154,0.7345075263679592,1.0,7/19,28.75%,UBXN2B;AKAP8L;CHMP4B;EMD;TOR1A;NEMP1;GPER1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.24561846380092206,0.9909179736594067,0.4744094488188976,0.8505434678612577,1.0,33/132,17.38%,RPS19;GEMIN8;RPL38;RPF2;RPS27;RPL10;CELF5;SNRPC;CELF4;XAB2;RPLP0;HSP90AB1;PRMT7;MRPS7;RPS15;LSM4;WDR77;RPL5;SNRPD1;SNRPD2;NOP2;RPL23A;RPS14;DDX20;DDX1;RPS5;RPS28;MDN1;PTGES3;XRCC5;HSP90AA1;PPAN;NAF1
prerank,protein acetylation (GO:0006473),-0.3237406807281099,-0.990299323734455,0.4552380952380952,0.7360066481453624,1.0,8/30,16.20%,KAT2B;EP300;CREBBP;HAT1;ING5;ESCO1;NAA15;GTF2B
prerank,response to glucose (GO:0009749),-0.29542519069586465,-0.989341466156338,0.48014440433212996,0.737924101161349,1.0,17/46,23.12%,ZBTB20;TCF7L2;PRKAA2;THBS1;SLC39A14;VAMP2;UNC13B;SELENOS;PCK2;ERN1;ZBED3;PRKACA;PRKAA1;EIF2B4;PFKL;KCNB1;EIF2B5
prerank,acetyl-CoA metabolic process (GO:0006084),0.3765836840360087,0.9891604760247393,0.45353982300884954,0.8545953298375137,1.0,7/15,25.12%,MVD;ACSS1;HMGCS1;PPCS;PMVK;ACAT1;DIP2A
prerank,cardiac cell development (GO:0055006),0.4109961226907448,0.9889776105361313,0.48366013071895425,0.8540743277281642,1.0,4/11,9.67%,MYH6;SLC8A1;NOTCH1;TCAP
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.3338562449564197,-0.9882473877212343,0.48823529411764705,0.7401975850567233,1.0,3/25,6.40%,ITPR1;LRRK2;TMBIM4
prerank,protein homooligomerization (GO:0051260),0.25560146585972865,0.9882029773699488,0.4547325102880658,0.8553195085237588,1.0,13/114,7.46%,MPP2;HCN1;ADCY8;KCNC2;MIF;AQP11;RYR3;GLRA3;ASIC1;SLC1A2;TRPM2;HPRT1;NINJ1
prerank,regulation of axon regeneration (GO:0048679),-0.41681099488273493,-0.9878113292357884,0.48919449901768175,0.7407968879566194,1.0,3/12,7.63%,PTN;PTPRS;EPHA4
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.42009198194860786,0.9873410045574135,0.47516198704103674,0.8568704222972315,1.0,3/11,10.63%,PTPRT;SOCS1;BCL3
prerank,rRNA transcription (GO:0009303),-0.3738827979873285,-0.9873098586128657,0.4920071047957371,0.741584284063241,1.0,9/17,34.30%,CAVIN1;BRF1;GTF3C4;SPIN1;GTF3C1;GTF3C6;POLR1G;GTF3A;ANG
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.27380783268202796,-0.9871756758448744,0.4803001876172608,0.7414244743481596,1.0,15/71,12.78%,CYFIP2;ABL1;WASF2;LYN;BRK1;CDC42;VAV2;PLCG1;WASL;PRKCD;NCKAP1;YES1;ABI1;WIPF1;ARPC2
prerank,DNA metabolic process (GO:0006259),-0.22252597777507388,-0.9868215168088261,0.50199203187251,0.7417922717230845,1.0,110/270,33.23%,TCF7L2;INO80;UBE2N;KMT5B;RBBP8;UVRAG;TOP1;HMGB1;USP7;UHRF2;NBN;TRRAP;RAD51B;PDS5A;WRN;DDB2;ZBTB1;SP100;CSNK1E;UPF1;MNAT1;RAD21;RAD51D;PARP1;ERCC3;PDS5B;ALKBH1;NABP2;KMT5C;DDX23;PARP4;MMS19;UBE2B;HINFP;PRKDC;MCM6;MSH3;CTC1;DMC1;NOP53;MRE11;GLRX2;ZRANB3;HELB;PRIM2;TOP2B;VCP;PARK7;POLE4;MSH6;CDK2;TERF2;POLA2;PCNA;STN1;TERT;RPAIN;XRCC6;FANCC;SMC1A;SMARCAL1;UBE2V2;ATR;NSMCE4A;RAD51C;DNASE2;ERCC1;PRIMPOL;GTF2H1;DBF4;CBS;POLE2;RECQL5;OGG1;ORC1;ENDOV;GTF2H4;DNASE1L1;RAD54L;LONP1;MCM4;SUPV3L1;POLH;CDC34;TIMELESS;SAMHD1;IGHMBP2;NUDT1;KPNA2;TOP1MT;MPG;UBA52;MGMT;PARG;FANCG;POLD2;PARP2;NEIL3;RPA2;PARP3;RMI2;PSME4;CDC45;PNKP;RAD9A;RAD51;POLA1;LIG4;BRCA1;RAN
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.43298703416590684,-0.986327445529832,0.5066162570888468,0.7425617422851843,1.0,5/10,27.47%,INO80;STOML2;SSBP1;DBF4;ATRX
prerank,negative regulation of JNK cascade (GO:0046329),-0.3225842615068649,-0.9857975859584602,0.502868068833652,0.7434102624257688,1.0,9/31,16.60%,PRKN;NCOR1;TAOK3;DACT1;PTPN22;FKTN;SH3RF2;DUSP10;PDCD4
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.3017616021508712,-0.9856578435185339,0.4567404426559356,0.7432308440798772,1.0,9/42,9.16%,PLEKHA2;LIMS1;ROCK1;ABL1;GSK3B;MAP4K4;NRP1;S100A10;JUP
prerank,negative regulation of binding (GO:0051100),-0.2616203488741419,-0.9854591681718201,0.5009940357852882,0.7432264749351558,1.0,16/81,10.39%,ARHGAP28;DAB2;ROCK1;SMO;LRRK2;GSK3B;STYX;IFIT2;SP100;DACT1;CSNK1E;BTAF1;USP33;JUN;NES;PRKCD
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.43199979170240144,-0.9852854551926467,0.5,0.7431547393246501,1.0,8/10,43.85%,HMGB1;ATF7IP;ESR1;THRA;TP53;PSMC2;PSMC6;PSMC5
prerank,fibrinolysis (GO:0042730),-0.40714729615128903,-0.9852104250261077,0.47601476014760147,0.74286702253434,1.0,9/13,54.44%,PLAT;SERPINE1;PLAUR;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.3028478608890965,-0.9849869663987965,0.4816955684007707,0.7429528735008598,1.0,8/41,13.46%,PRKAG2;EP300;RANBP2;NUP42;HIF1A;NUP214;TPR;OGT
prerank,mesenchyme morphogenesis (GO:0072132),0.36918297203360617,0.9846116956989396,0.45564516129032256,0.8638305288312176,1.0,5/17,7.45%,HEY1;NOS3;NOTCH1;TGFB2;ACVRL1
prerank,lipoprotein transport (GO:0042953),0.4376846538313997,0.9844743927556178,0.5033407572383074,0.8631624778289205,1.0,4/10,12.99%,PPARG;ZDHHC17;VMP1;CD36
prerank,inorganic ion transmembrane transport (GO:0098660),0.4136438971009906,0.9841860494816194,0.5,0.8629828639091042,1.0,3/12,12.95%,ASIC2;KCNJ11;KCNJ8
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3033000135219449,-0.9839605924369101,0.5039525691699605,0.7450159197640139,1.0,17/40,25.32%,ARAF;RAD23B;AXIN1;UFL1;NUB1;RPL11;FBXW7;LATS1;TRIM39;SMURF1;PDCL3;CSNK2A1;PML;DESI1;CDK5RAP3;XPO1;UBQLN4
prerank,hydrogen peroxide catabolic process (GO:0042744),0.41716897625426885,0.9838240588585667,0.46881720430107526,0.8630015694375464,1.0,5/11,23.45%,GPX1;PRDX5;PRDX1;PXDN;GPX3
prerank,positive regulation of catalytic activity (GO:0043085),-0.30693585407647883,-0.9836180734380134,0.4672727272727273,0.7454135645187883,1.0,14/37,21.76%,SLC5A3;ABL1;BCAS3;WRN;IGF2;NCSTN;ABL2;XRCC4;STX4;MSH3;MSH6;FGFR4;FXN;SSBP1
prerank,photoreceptor cell development (GO:0042461),0.3889379188859473,0.9828729080250631,0.49667405764966743,0.8648458889299988,1.0,4/14,14.10%,AHI1;MFSD2A;RORB;DCX
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.4021305143854796,0.9828382192735434,0.46325167037861914,0.8638653571596654,1.0,2/11,3.32%,HCAR2;SIRT1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3860494654760255,0.9824173019518443,0.4708333333333333,0.8640599777342806,1.0,4/14,15.82%,RPF2;RPL7;ZNHIT6;DDX18
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.34081117162308533,-0.9823691180244125,0.4820415879017013,0.748082895995814,1.0,6/24,17.05%,NBL1;HMGB1;LYN;CCN3;DUSP1;SERPINE1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.3689313455788834,0.982335300185016,0.48785425101214575,0.8632298130814363,1.0,5/18,15.41%,GINS2;LIG3;MCM3;RFC4;POLD3
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.3828432711860085,0.9823191425931286,0.4936708860759494,0.8621841670812869,1.0,7/15,19.09%,RUVBL1;NHP2;CCT2;DKC1;CCT4;NAF1;TCP1
prerank,fatty acid transport (GO:0015908),0.3605038114258041,0.9822590539960032,0.46296296296296297,0.8612737285296193,1.0,5/17,13.31%,PPARG;MFSD2A;FABP5;CD36;SLC27A4
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.25910007821787456,-0.9822072234940492,0.4720616570327553,0.7479879698780161,1.0,27/87,28.14%,RBFOX2;HNRNPH1;FLRT2;FGF1;SHOC2;HNRNPM;FGFR2;FRS2;KIF16B;KL;FLRT1;FIBP;NR4A1;FGFBP1;POLR2H;CEP57;PTPN11;FGFR4;SPRED2;FGF2;GTF2F1;POLR2K;POLR2E;NCBP2;FGFRL1;POLR2D;ZFP36L2
prerank,sterol transport (GO:0015918),-0.36184121188020746,-0.9821482701199903,0.5090180360721442,0.7476397317677179,1.0,7/19,34.32%,OSBPL5;LDLR;NPC2;ARV1;CAV1;MSR1;LCAT
prerank,regulation of interleukin-12 production (GO:0032655),-0.29782495451555874,-0.9821103118828762,0.49183303085299457,0.7472420749717978,1.0,6/47,6.96%,FOXP1;IRAK3;PIBF1;HMGB1;THBS1;IL16
prerank,protein deubiquitination (GO:0016579),-0.22828771746657836,-0.9820176576627708,0.5050301810865191,0.7470193862031483,1.0,46/242,14.58%,SMAD3;TGFBR1;INO80;SMURF2;MDM4;USP24;KAT2B;EP300;PRKN;RAD23B;USP7;SMAD2;WDR48;TRRAP;ENY2;BRCC3;MYSM1;AR;FOXK1;DDB2;VCPIP1;USP33;TRAF2;TADA3;RHOA;HCFC1;HIF1A;SMAD4;RHOT1;USP47;WDR20;PSMF1;KDM1B;USP46;USP11;ABRAXAS2;BECN1;USP4;USP12;OGT;USP35;PSMB2;USP50;USP2;OTUD4;USP13
prerank,regulation of TORC1 signaling (GO:1903432),-0.3134699115080951,-0.9817844670557169,0.4570383912248629,0.7471106332611819,1.0,12/33,26.25%,RNF152;SESN1;TELO2;CASTOR2;KLHL22;SIK3;GPR137B;LARS1;PIH1D1;SZT2;KPTN;RRAGA
prerank,response to laminar fluid shear stress (GO:0034616),-0.43300766016264475,-0.9817306446612512,0.5037593984962406,0.7467428793282963,1.0,2/10,1.69%,SMAD6;ABCA1
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.26083476124363,-0.9816664556532518,0.4990328820116054,0.7464168004585758,1.0,26/88,19.34%,SULF1;NR2F2;TGFBR1;ANGPT1;BMP4;ARNT;SPARC;THBS1;NRP1;F3;HIF1A;VEGFA;STAT1;VEGFD;APOE;PDCL3;ATOH8;ECM1;NR4A1;PIK3CD;PRKD1;STAT5A;ATP5IF1;WNT5A;BMP2;ITGB3
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.3706881198796125,0.9816080327175282,0.49290060851926976,0.8620938378325953,1.0,8/17,14.94%,BIN1;NTRK2;CLU;RTN2;HAP1;RTN1;SORL1;RTN4
prerank,C4-dicarboxylate transport (GO:0015740),0.3890946008039603,0.9813951162034439,0.46578366445916114,0.8616600763012161,1.0,3/14,8.09%,SLC1A1;SLC1A2;SLC25A14
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.3906428255980144,0.9812499731482575,0.46275395033860045,0.8610049618959791,1.0,3/13,13.14%,TMEM30A;SAR1A;SORL1
prerank,Rap protein signal transduction (GO:0032486),-0.4318540476682937,-0.9809722389773137,0.4943609022556391,0.7476228987854192,1.0,4/10,20.24%,RAP1B;RAPGEF3;RAPGEF2;RAPGEF1
prerank,regulation of protein kinase activity (GO:0045859),0.25358490941147577,0.9806840535676751,0.49903660886319845,0.8615773509311148,1.0,26/106,16.91%,MMD2;SIRT1;CAMK2N1;PPM1F;SNCA;GAS6;THY1;TRIB3;MAPRE3;ADCYAP1;AKT1;YWHAG;HSPB1;RELN;SMG8;UBASH3B;CEP43;DVL1;EPHA1;TAB2;CDKN1A;DDR2;RAP1A;GNAQ;XRCC5;RAP2B
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2727259365150035,-0.9805125732984091,0.49633699633699635,0.7482825006121436,1.0,13/72,10.22%,CFLAR;AXL;TRIM44;PIAS1;TAX1BP1;JAK1;ELF1;IRAK3;IRAK2;RUNX1;HIPK1;PTPN2;TRAF2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3596911818429702,0.9804367608558348,0.49159663865546216,0.8612667122987019,1.0,7/19,16.89%,TMEM109;SIRT1;BCL3;HIPK2;AEN;CDIP1;DDIT4
prerank,protein maturation (GO:0051604),0.2607787130811747,0.9803382672386289,0.5073375262054507,0.8604829669998695,1.0,19/95,13.50%,LMF2;MME;PCSK1;PCSK2;METAP2;PHEX;PCSK6;PSENEN;MMP16;PITRM1;PCSK7;TSPAN17;TMPRSS4;TSPAN14;HSPD1;SORL1;GALNT2;TASP1;PSEN1
prerank,focal adhesion assembly (GO:0048041),-0.35512439974977994,-0.9803356670225848,0.47162426614481406,0.7482136006458577,1.0,6/21,15.35%,SORBS1;BCR;ACTN2;PTPRK;CTTN;WHAMM
prerank,regulation of platelet aggregation (GO:0090330),-0.3753292070013304,-0.9802374173343598,0.4894837476099426,0.7479781155332487,1.0,8/17,27.17%,PDPN;CD9;LYN;PRKCD;F11R;PRKCA;SYK;ALOX12
prerank,regulation of p38MAPK cascade (GO:1900744),-0.30865335377128766,-0.9802237666443302,0.49607843137254903,0.747532211170167,1.0,12/35,27.76%,SASH1;DLG1;PTPN22;RELL1;DUSP1;VEGFA;DUSP10;BMP2;SPHK1;EMC10;MINK1;GADD45G
prerank,7-methylguanosine RNA capping (GO:0009452),-0.3187465579642057,-0.9801861085656721,0.4640151515151515,0.7466475580330354,1.0,14/31,28.12%,GTF2H2;CCNH;CDK7;MNAT1;ERCC3;RNGTT;POLR2H;GTF2F1;POLR2K;GTF2H1;POLR2E;NCBP2;GTF2H4;POLR2D
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.3187465579642057,-0.9801861085656721,0.4640151515151515,0.7466475580330354,1.0,14/31,28.12%,GTF2H2;CCNH;CDK7;MNAT1;ERCC3;RNGTT;POLR2H;GTF2F1;POLR2K;GTF2H1;POLR2E;NCBP2;GTF2H4;POLR2D
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.4022009867543673,-0.9801705884659472,0.49353049907578556,0.7461956552662223,1.0,6/13,29.17%,RNF152;SESN1;CASTOR2;SZT2;KPTN;CASTOR1
prerank,negative regulation of secretion (GO:0051048),0.42865946984579384,0.9801684225703838,0.5100806451612904,0.8599541278081182,1.0,1/10,2.44%,NRG1
prerank,defense response to tumor cell (GO:0002357),-0.4255465437494319,-0.9798777318026645,0.4893203883495146,0.7464444193486142,1.0,4/10,22.87%,RBMS3;DAPK1;PRDX2;PLK5
prerank,spliceosomal snRNP assembly (GO:0000387),0.30342745280133476,0.9795461054441621,0.4662698412698413,0.8607233293027817,1.0,11/38,14.77%,GEMIN8;SNRPC;SRSF12;PRMT7;LSM4;WDR77;SNRPD1;SNRPD2;DDX20;LSM2;CD2BP2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.3729469886230379,-0.9794313422160529,0.46502835538752363,0.747119122562014,1.0,6/16,20.42%,PDK1;PRKN;FOXK1;RORA;FOXK2;BCKDK
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.3817376238093502,0.9789966324552655,0.46444444444444444,0.8612905337536269,1.0,4/14,14.23%,GAS6;GPS2;RFFL;TRAIP
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.36250357348338275,-0.9785374001400795,0.4770992366412214,0.7489134779002542,1.0,5/20,18.44%,CD55;TRAF2;PRKCZ;IL18;TRAF6
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.26777143171979934,-0.9783549170839141,0.5048923679060665,0.7488561390767462,1.0,21/76,23.53%,BMP7;PTGIS;TAX1BP1;IRAK3;ANXA4;USP7;UFL1;IRAK2;PARP10;PRMT2;CYP1B1;TRAF3;ARRB1;CMKLR1;DAP;LRRC14;IRAK1;CDK5RAP3;CHP1;COMMD7;NLRC3
prerank,cardiac muscle cell development (GO:0055013),-0.3506184374842738,-0.978228449245654,0.4795539033457249,0.7486871210923788,1.0,5/20,7.44%,PDGFRA;PDLIM5;PDGFRB;CXADR;OBSL1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.31927200172368064,-0.978054421584498,0.47928994082840237,0.7486415562205556,1.0,9/30,18.96%,DSE;DCN;BGN;CHST15;HEXA;CHST11;CHPF2;CHSY1;CHST12
prerank,protein lipidation (GO:0006497),-0.2786310593855924,-0.9779406300986887,0.46511627906976744,0.748449034481748,1.0,26/59,33.40%,PIGN;GLUL;ZDHHC13;WIPI1;UGCG;PIK3C3;DPM1;WDR45B;ZDHHC1;ATG5;ZDHHC16;HHAT;MPPE1;PIGH;WIPI2;PIGC;DPM3;PIGA;ZDHHC8;PIGZ;PIGP;PIGF;ATG10;PIGO;ATG12;WDR45
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.22694894385801825,-0.9771134076141671,0.4896265560165975,0.7500059650581447,1.0,43/234,12.93%,ROR1;SMAD3;NFKB1;SLCO3A1;LRP6;PLPP3;UBE2N;CFLAR;ZIC2;EP300;STK3;HDAC4;ERC1;CAMK1D;SMO;EDA;FLOT2;KIT;IRAK3;PPARGC1B;FZD2;STAT3;ADCY1;DHX9;IRAK2;TRIM8;CEBPG;AR;CRTC3;PPARGC1A;JUP;ATF2;FER;TRAF2;MAVS;MBTPS2;CRTC1;TRIM5;ANXA3;ARID5B;TRIM25;TCF3;CARD14
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.42835702284772703,-0.9765380400817635,0.5113438045375218,0.7509535938504438,1.0,3/10,8.52%,IVD;ACADM;ACAD11
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.3258978223807267,0.9764617253911982,0.468682505399568,0.8676179964352632,1.0,8/26,15.49%,TIRAP;TLR2;NINJ1;PJA2;WDFY1;MFHAS1;RTN4;RSAD2
prerank,rRNA modification (GO:0000154),0.3583454154722134,0.97620939957192,0.5076923076923077,0.8672510442160356,1.0,5/21,11.97%,TSR3;TFB1M;FBL;NHP2;DKC1
prerank,potassium ion homeostasis (GO:0055075),-0.3462700853485914,-0.9761113472737695,0.47654784240150094,0.75153201906306,1.0,4/23,9.43%,ATP1A2;SLC12A7;KCNJ2;SLC12A2
prerank,regulation of protein kinase B signaling (GO:0051896),0.23060161394024967,0.9757419354197048,0.5211267605633803,0.8676037923108387,1.0,22/193,8.05%,IGF1R;KITLG;TEK;ERBB4;NRG2;NRG1;MAGI2;SIRT1;GAS6;FGF10;NTRK2;FLT3;HIP1;PHLPP1;PIK3R5;FGF5;TRIB3;CPNE1;PTPRJ;MYORG;AKT1;HSP90AB1
prerank,protein localization to chromosome (GO:0034502),-0.31421876921098113,-0.975541565303074,0.4849056603773585,0.7524559441194887,1.0,19/34,37.04%,TNKS2;XRCC4;MCM9;RAD21;RB1;SLF1;TERF2;ATR;IFFO1;BOD1;ESR1;ATRX;WAPL;PINX1;RPA2;PARP3;SLF2;MSH2;MRNIP
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.3985197927395159,-0.9752113180599374,0.4751908396946565,0.7528370099149797,1.0,3/13,8.40%,CACNA1C;ANK2;GJA1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.33010513402546515,0.9750884348760113,0.47717842323651455,0.8685127244788027,1.0,3/27,4.51%,FLT1;TEK;FLT3
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.25674237913134124,0.9745543652796769,0.4940239043824701,0.8690001711203291,1.0,13/93,8.15%,TFRC;SPTBN4;MIF;TENM1;CNKSR3;PPM1F;SNCA;GAS6;SH2D3C;PAK1;AKT1;HSP90AB1;TRIM6
prerank,icosanoid secretion (GO:0032309),-0.4095007732538055,-0.9743117199752281,0.4969818913480885,0.7545593806760085,1.0,3/12,15.25%,ANXA1;PNPLA8;BDKRB2
prerank,proteolysis (GO:0006508),-0.2250279830258123,-0.9742456352591141,0.54375,0.7542175629820265,1.0,47/252,16.50%,CPQ;TRABD2B;AEBP1;ADAMTS12;PCSK5;TBL1X;XPNPEP1;HTRA3;PLAT;HM13;CTSC;CTSH;DPP4;ADGRV1;DPP8;F3;DDI2;ECE1;SENP6;ANPEP;FBXO3;ADAMTS9;NCSTN;LONP2;SENP1;LAP3;MMP14;YME1L1;ADAM19;CPM;ADAM33;NPEPPS;CASP2;NLN;SUFU;MMP2;OGT;LACTB;FAP;CTSA;CPXM2;MBTPS1;LNPEP;ATG4D;PTCH1;CLPP;SPRTN
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.36657060008223397,-0.9740941514125845,0.5203703703703704,0.7541288839593092,1.0,2/18,7.33%,ATP1A2;CAMK2D
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.36464872730928277,0.9739533236946606,0.49899396378269617,0.869724142486172,1.0,4/17,8.66%,SIRT1;NME5;AKT1;HSPB1
prerank,positive regulation of nuclear division (GO:0051785),-0.33248911034025797,-0.9737613998884537,0.48713235294117646,0.7545484525270304,1.0,3/25,8.43%,IGF1;PDGFRB;IGF2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.4209684934784242,-0.9737028672963519,0.4980769230769231,0.7542065361182914,1.0,3/10,9.09%,FOXC1;NUMA1;MED1
prerank,establishment of mitotic spindle localization (GO:0040001),-0.32442291616410046,-0.9735809899870213,0.491588785046729,0.7540286144757454,1.0,5/28,8.55%,NUMA1;UBXN2B;ITGB1;GJA1;NDEL1
prerank,clathrin-dependent endocytosis (GO:0072583),0.3256016673610984,0.9734072122996773,0.4793388429752066,0.8702890125121792,1.0,8/26,14.43%,AP2M1;SNAP91;FNBP1L;FCHO1;AP2B1;SGIP1;DLL1;CLTB
prerank,regulation of multicellular organismal development (GO:2000026),-0.33134095956046883,-0.9732488995724226,0.49907235621521334,0.7543947381446536,1.0,7/25,16.81%,PTN;TRIP12;MYSM1;DHX36;NIPBL;EHMT1;OAS2
prerank,positive regulation of protein metabolic process (GO:0051247),-0.2518290811258784,-0.9730739086562032,0.5290697674418605,0.7543329453109762,1.0,32/110,23.28%,ROCK2;SMURF2;PRKN;WWP2;GSK3B;GPC3;HUWE1;AXIN1;WWP1;SLC6A9;SEC22B;DACT1;NR1H3;AGTR1;STX5;APOE;IL17D;SMURF1;RANBP9;CSNK2A1;IL18;ASB5;VCP;WNT5A;AREL1;INHBA;EIF4G1;SNF8;WFS1;NSF;CD80;MAPK7
prerank,regulation of JUN kinase activity (GO:0043506),-0.30968626648031755,-0.9724488671219551,0.4749536178107607,0.7554131561512037,1.0,9/33,21.31%,SASH1;TAOK3;MAP3K5;PTPN22;TRAF2;DUSP10;PDCD4;TRAF6;DVL3
prerank,glycoprotein biosynthetic process (GO:0009101),0.2685929727372938,0.9724292107988645,0.518595041322314,0.8722080135920444,1.0,17/79,14.31%,ST8SIA4;ST3GAL6;CHST9;ST8SIA1;CSGALNACT1;FUT9;ALG3;B3GALT5;ALG1;MPI;ST8SIA6;ST8SIA3;B3GNT2;SERP1;BMPR2;BMPR1B;GOLGA2
prerank,RNA splicing (GO:0008380),-0.25406738391991834,-0.9722411197799974,0.49230769230769234,0.7554521786237125,1.0,34/95,26.93%,SYNCRIP;SRSF10;FUS;SF3B1;PRPF6;PPARGC1A;RNPC3;SLU7;PRPF3;USP39;SCAF11;SF3A3;ZCRB1;RSRC1;DDX23;TCERG1;SFPQ;SNRPF;ZMAT5;SRSF7;GEMIN2;SRSF11;SRRM1;PPP2CA;USB1;SRSF2;LUC7L3;CCAR2;SMU1;NONO;DHX15;NCBP2;PRPF8;LSM6
prerank,RNA transport (GO:0050658),-0.2676410682267447,-0.9720487933379675,0.5272373540856031,0.7554492503781857,1.0,20/71,22.52%,TGFBR2;CASC3;U2AF2;SRSF6;SIDT1;SLU7;EIF4E;SLBP;NUP214;TPR;YBX1;SRSF1;NXF1;SRSF7;SIDT2;SRSF11;UPF3B;SRRM1;SRSF2;XPO5
prerank,mitochondrial fission (GO:0000266),0.3702312230007803,0.9716515180425459,0.507399577167019,0.8733552012021922,1.0,4/16,12.58%,DNM3;GDAP1;MIEF1;SLC25A46
prerank,negative regulation of cilium assembly (GO:1902018),-0.3978407723477532,-0.9712198310642359,0.4990583804143126,0.7569476971575392,1.0,7/12,27.18%,YAP1;MAP4;ODF2L;CDK10;TBC1D7;TCHP;TESK1
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.292407663460744,-0.9710947338239885,0.4887640449438202,0.7567528411679352,1.0,9/45,9.38%,SMAD3;FOXC1;BMP7;BMP4;GAS1;PTPN3;PRCC;TOM1L2;BTG3
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.35767688605534753,-0.971052320321926,0.49906191369606,0.7563734639217378,1.0,9/20,25.04%,MCU;YME1L1;LETM1;MICU1;STOML2;SLC8A3;PARL;SLC8B1;PHB2
prerank,regulation of mitotic spindle organization (GO:0060236),-0.31085458836275454,-0.9710287349438818,0.4849056603773585,0.7559656955271051,1.0,18/35,37.60%,NUMA1;VPS4B;CHMP4B;CHMP5;CHMP3;TPR;MAP9;DYNC1H1;HNRNPU;EML3;BORA;PARP3;CHMP1B;HSPA1A;TACC3;CHMP1A;TPX2;FSD1
prerank,tRNA modification (GO:0006400),-0.27080603208645443,-0.9709254816351967,0.5116731517509727,0.7557346286130165,1.0,29/62,32.96%,TRMT9B;PUS10;NSUN6;QTRT2;ALKBH1;METTL2A;METTL2B;TYW5;NSUN2;METTL1;TYW1;THUMPD3;ELP5;FTSJ1;PUS3;CDKAL1;LCMT2;GTPBP3;DTWD1;WDR6;TRMT1;DTWD2;MTO1;TRMT44;TRMT61B;TYW3;ALKBH8;PUS1;TRMT12
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.363809549459605,-0.970761518903491,0.5095785440613027,0.7556457738509412,1.0,10/16,39.05%,WRN;MCM6;SSBP1;RECQL5;MCM4;MCMDC2;TWNK;RAD51;MCM2;MCM7
prerank,iron ion transport (GO:0006826),-0.2901878434321226,-0.970463868828646,0.49521988527724664,0.7558793663811767,1.0,7/47,7.10%,CP;STEAP3;ATP6V1B2;SCARA5;ATP6V0D1;SLC39A14;ATP6V0A4
prerank,myeloid cell development (GO:0061515),-0.36444733280079666,-0.9704220342208224,0.5055970149253731,0.7554873526474295,1.0,4/18,9.09%,FOXP1;KIT;ANXA2;MED1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.26813190721675606,-0.9701905455826534,0.5160075329566854,0.7555987963755246,1.0,15/73,12.78%,CYFIP2;ABL1;WASF2;LYN;BRK1;CDC42;VAV2;PLCG1;WASL;PRKCD;NCKAP1;YES1;ABI1;WIPF1;ARPC2
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.4067957615221655,-0.9701623493789253,0.49165120593692024,0.7547099538069315,1.0,3/12,12.80%,IGF1;SLC9A1;LMCD1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.4067957615221655,-0.9701623493789253,0.49165120593692024,0.7547099538069315,1.0,3/12,12.80%,IGF1;SLC9A1;LMCD1
prerank,carbohydrate homeostasis (GO:0033500),-0.26897364887092834,-0.9699768855230344,0.5123809523809524,0.7547037393204882,1.0,9/67,6.19%,TCF7L2;APPL2;LEPR;MCU;PRKAA2;CYB5R4;RBP4;IRS1;STAT3
prerank,membrane lipid metabolic process (GO:0006643),0.3371151729806223,0.9698718628440514,0.4967462039045553,0.8774443997430934,1.0,4/22,8.78%,GAL3ST1;ST3GAL6;TECR;SERINC1
prerank,positive regulation of angiogenesis (GO:0045766),0.2516499824871794,0.9695114632046357,0.5261044176706827,0.8774311295469729,1.0,22/108,13.89%,FLT1;TEK;ADAM12;TIE1;RAMP2;SIRT1;HMGA2;KDR;NOS3;ETS1;KLF4;APLNR;NINJ1;CD34;HSPB1;HIPK2;CD40;EPHA1;TJP1;ANGPTL4;XBP1;DLL1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3765725767680671,-0.9691119699738394,0.5102040816326531,0.7563861729881917,1.0,6/15,19.04%,PCM1;PIBF1;CCDC14;C2CD3;SNX10;CSNK1D
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.35519156422912296,0.9688610703776287,0.5020746887966805,0.8781928373544832,1.0,3/19,5.68%,CLDN5;PRKCH;OCLN
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.39907695741596005,0.9687529206708935,0.5173913043478261,0.877422145280471,1.0,3/12,8.99%,FUT9;AKT1;SKAP1
prerank,synaptic vesicle transport (GO:0048489),-0.41211043084879967,-0.9687381602706244,0.503690036900369,0.7569202839260619,1.0,4/11,26.83%,TMEM230;SPG11;TOR1A;KIF5B
prerank,regulation of cell death (GO:0010941),-0.2533304920349136,-0.968515763281345,0.520242914979757,0.7570092666061817,1.0,31/94,22.51%,LRP1;CELF1;CCN2;BMP7;BMP4;PRKN;LRRK2;TBK1;VPS4B;SRSF6;CHMP4B;ACER3;IMPACT;CCN3;PRODH;ADNP2;BECN1;CCN5;CCN1;NCK1;PRKD1;CCN4;ATG5;RILPL1;PARK7;EIF4G1;SPEF1;BNIP3;FGF2;WNT16;CHP1
prerank,artery development (GO:0060840),-0.3416274214087477,-0.9685013982259048,0.5173076923076924,0.7565687531498069,1.0,8/23,16.40%,TGFBR1;ROBO1;NRP1;HES1;PKD2;EFEMP2;VEGFA;HECTD1
prerank,peptidyl-serine modification (GO:0018209),-0.2366917282317211,-0.968436445114169,0.5285171102661597,0.7562305376763294,1.0,58/166,25.45%,ROCK2;TGFBR1;PKD1;TLK1;ROCK1;SMG1;CAMK1D;TGFBR2;LRRK2;CSNK1A1;TOP1;GSK3B;TBK1;MARK3;PAK2;EIF2AK3;MTOR;CAMK2D;PDPK1;HIPK1;CSNK1E;WNK1;BRSK1;PRKCD;DMPK;ULK2;PARP1;MKNK2;POGLUT2;RICTOR;PRKDC;PRKCZ;LATS1;CSNK2A1;MARK1;PRKD1;PRKACA;IKBKE;MORC3;GALNT1;CSNK1D;CDK2;NTMT1;CAB39;AKT2;NEK6;MAST2;MKNK1;MAP3K12;CLSPN;ATR;PRKCA;DYRK1B;MAP3K13;MASTL;CSNK1G2;RPS6KA4;MAPK14
prerank,positive regulation of response to stimulus (GO:0048584),0.295824301954396,0.9684313949937041,0.5053763440860215,0.8772587975425197,1.0,11/40,18.79%,SIRT1;HMGA2;YPEL3;TGFB2;HOMER1;B2M;RSAD2;CDKN2AIP;IER5;ILK;EEF1E1
prerank,body fluid secretion (GO:0007589),0.3801973009269305,0.9681555102102151,0.4979253112033195,0.8770087698636694,1.0,2/15,6.64%,ERBB4;GUCA1B
prerank,response to growth factor (GO:0070848),-0.2947494288722537,-0.9680109950656232,0.5176470588235295,0.7568567858827551,1.0,16/41,26.05%,TGFBR1;BMPR1A;TGFBR2;SHC1;CPNE3;ACVR1;EMD;STAT5B;TBC1D7;NOS1;SPHK1;GATA6;PLK5;MAPK7;TWF2;HTRA2
prerank,protein catabolic process (GO:0030163),-0.27726773000716526,-0.967445576195641,0.5337186897880539,0.7577118081742623,1.0,19/59,26.16%,NGLY1;PRKN;MTOR;OGA;RAB12;DDI2;LAMP2;ADAMTS9;APOE;MANBA;VCP;LRSAM1;CLN5;MAGEC2;CLPX;SIAH2;BAG6;HTRA2;CLN8
prerank,ganglion development (GO:0061548),0.4028965571600569,0.9670790536213629,0.4690265486725664,0.8791269510907284,1.0,4/11,21.36%,UNC5C;TUBB3;CTNNB1;SEMA3A
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.3993517911570438,0.9668041404732184,0.5099778270509978,0.8788771853757954,1.0,2/12,1.51%,SPTBN4;EPHB1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3495725825131043,0.9667936030568715,0.4948453608247423,0.8778404298522574,1.0,3/21,7.01%,GRIN1;GRIN2B;BEX3
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.35464443558106146,-0.9666602949828855,0.4961089494163424,0.759219411872919,1.0,8/19,27.09%,GFPT1;RENBP;UAP1;PMM2;SLC35D1;UAP1L1;PGM3;NANS
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.34647937147907026,-0.9665092692512012,0.5055350553505535,0.7591066459272525,1.0,5/21,9.08%,ADCY9;ADCY5;ADCY1;ADCY6;GUCY1A1
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.42817457829486394,-0.9662296650651464,0.5036630036630036,0.7593245727498316,1.0,7/10,49.59%,PRKCZ;IL18;SPHK2;RARA;TSLP;GATA3;IL4
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.2609432583443282,-0.966192700353746,0.5234215885947047,0.7589243351937032,1.0,19/73,18.62%,SMAD3;COL4A3;CFLAR;ROBO1;EIF2AK3;F3;FAM162A;AIFM1;CASP12;NGF;EGLN3;TRAF2;SENP1;CASP2;ANP32B;BCL2L13;HSPE1;DAP;VCP
prerank,negative regulation of cellular senescence (GO:2000773),-0.3956805730481825,-0.9661578041061407,0.5207920792079208,0.7585381078142392,1.0,8/13,25.08%,MAP3K3;ZKSCAN3;SLC30A10;YBX1;TERF2;TERT;CDK6;TWIST1
prerank,respiratory chain complex IV assembly (GO:0008535),0.3477214187154008,0.9658694035423642,0.512987012987013,0.8795204421959564,1.0,11/21,20.99%,TIMM21;COA5;FASTKD3;COX16;COX17;BCS1L;COA6;COX10;COA3;OXA1L;SCO1
prerank,anion transport (GO:0006820),0.32199403674327187,0.9657075913142578,0.5073375262054507,0.8788681691343976,1.0,6/33,10.30%,SLC4A1;ABCG2;LRRC8B;SLC17A6;SLCO2B1;VDAC2
prerank,negative regulation of double-strand break repair (GO:2000780),-0.3150320017657736,-0.9657038925732221,0.5028901734104047,0.7591773858029338,1.0,19/30,34.10%,RNF169;TRIP12;KLHL15;UBR5;SHLD2;SMCHD1;HELB;HSF1;TWIST1;UBQLN4;OGG1;FANCB;CGAS;MAD2L2;RMI2;TFIP11;NUDT16L1;PARPBP;ERCC6
prerank,microtubule anchoring (GO:0034453),-0.3949966799565814,-0.9652623757023048,0.5077220077220077,0.7597619048393058,1.0,2/12,1.96%,DAG1;PCM1
prerank,monocyte differentiation (GO:0030224),0.4195876877135647,0.9652479862270494,0.4989059080962801,0.8791453249579548,1.0,3/10,5.23%,CSF1R;PPARG;MT1G
prerank,apical junction assembly (GO:0043297),-0.2845200424048074,-0.965192286583148,0.5219047619047619,0.7594582571110347,1.0,9/53,10.38%,AFDN;VCL;MPP7;PARD6G;CTNNA1;DLG1;PAK2;CLDN11;RHOA
prerank,"base-excision repair, AP site formation (GO:0006285)",0.35816241790250336,0.9651143438633771,0.5237068965517241,0.8784557549715489,1.0,4/17,14.31%,TERF1;UNG;TERF2IP;TINF2
prerank,regulation of glucose transmembrane transport (GO:0010827),0.34799162905971215,0.9650811575335724,0.47288503253796094,0.877489983281207,1.0,4/18,7.98%,SLC2A1;OCLN;TRIB3;RTN2
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.39641174619153,0.964844406025374,0.5130023640661938,0.8771084144429445,1.0,2/12,4.98%,CSF1R;IL12A
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.30166594907147365,0.964814534844683,0.48344370860927155,0.8761370441304948,1.0,6/39,5.85%,PAX8;TIE1;PAX2;FGF10;KDR;PAK1
prerank,endocardial cushion development (GO:0003197),0.3462320178350634,0.9644649598581644,0.5242105263157895,0.8760549425595202,1.0,7/21,12.80%,HEY1;NOS3;NOTCH1;TGFB2;ACVRL1;FOXF1;BMPR2
prerank,macrophage differentiation (GO:0030225),-0.3971598434247869,-0.9643862760346761,0.5176470588235295,0.7609826231297182,1.0,5/13,14.35%,IL31RA;BMP4;CDC42;PARP1;VEGFA
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.4130889795654519,0.964007667960902,0.5295454545454545,0.8762753171532515,1.0,3/11,14.49%,TIRAP;PJA2;MFHAS1
prerank,negative regulation of cell aging (GO:0090344),0.36308059822042443,0.9636972615828,0.49377593360995853,0.8760770525321457,1.0,3/16,3.56%,MIF;SIRT1;HMGA2
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.2905805073261908,0.963645224219873,0.5239085239085239,0.8751934008652323,1.0,8/41,12.41%,PODXL;MAGI1;ANK3;THY1;SKAP1;MEGF10;SMAD7;TJP1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3491448185746659,-0.9634990595749299,0.5124282982791587,0.7627219771257692,1.0,3/20,5.31%,SULF1;SULF2;THBS1
prerank,regulation of inflammatory response (GO:0050727),-0.22852691991787444,-0.9630352753748773,0.5566600397614314,0.7633663364579666,1.0,45/190,19.48%,FOXP1;ADAMTS12;CELF1;NR1D2;PTGIS;SBNO2;SNX6;DAGLA;UFL1;IL16;DHX9;ANXA1;VAMP2;XIAP;IL17RA;CASP12;CCN3;SELENOS;NR1H3;PTPN2;ENPP3;PRKCD;PTGES;NAPEPLD;NFKBIZ;RB1;AGTR1;PIK3AP1;RORA;APOE;C1QTNF3;GPR4;IL18;FEM1A;PDCD4;SERPINE1;TLR4;CCN4;MGLL;METRNL;IFI35;WNT5A;AREL1;PARK7;SHPK
prerank,plasma membrane tubulation (GO:0097320),-0.3974111443911076,-0.9629399503684787,0.5009416195856874,0.7631321541356269,1.0,5/13,15.35%,PACSIN2;SNX9;EHD2;CHMP4A;WHAMM
prerank,monoacylglycerol metabolic process (GO:0046462),-0.39635312792605676,-0.9628680972365676,0.5055970149253731,0.7628236118542683,1.0,5/13,18.47%,PLA2G4A;MOGAT3;ABHD6;ABHD12;MGLL
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.2970510571918687,-0.9626868714439444,0.5197132616487455,0.7628347743508747,1.0,21/40,35.37%,WRN;RFWD3;MCM9;FANCM;MSH3;BOD1L1;ZRANB3;PCNA;SMARCAL1;ATR;PRIMPOL;DONSON;TIPIN;ATRX;TIMELESS;CDK9;EME2;RAD51;POLE;CENPX;GEN1
prerank,positive regulation of axonogenesis (GO:0050772),0.28913251449325256,0.9622849097808657,0.5208333333333334,0.8780705661490009,1.0,9/43,10.17%,PLXNB3;NTRK2;SEMA4D;SEMA7A;ROBO2;SHTN1;PLXNA4;CDKL5;NTN1
prerank,phagosome-lysosome fusion (GO:0090385),0.4124564603958919,0.9618036164275428,0.5144124168514412,0.8784089371799294,1.0,1/10,1.83%,SYT7
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.3012496885834125,-0.9617502482877939,0.5211786372007366,0.7646957623559666,1.0,5/37,4.06%,PHLDB2;EPHA3;ROCK1;PRKAA2;GSK3B
prerank,regulation of myelination (GO:0031641),0.32586226824472503,0.9616604158749587,0.5021551724137931,0.8777559950526668,1.0,7/25,13.28%,JAM2;TENM4;TMEM98;NSUN5;TPPP;TNFRSF21;PTPRZ1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.39663147761667905,-0.9615344222019456,0.5019083969465649,0.7647564077951169,1.0,5/12,26.79%,AR;SELENOS;HDAC2;AP2A1;TAF7
prerank,epiboly involved in wound healing (GO:0090505),-0.36723210075670215,-0.9613709828470194,0.5,0.7646844262136987,1.0,8/16,23.72%,PDPN;FLNA;RHOA;CCN1;DDR1;RHOC;TOR1A;ARHGAP35
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.3683560763513031,-0.9613517710460262,0.522140221402214,0.7642471307480405,1.0,6/16,20.95%,NPR3;HIF1A;APOE;TERF2;TERT;S100A1
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.2725752018266207,-0.9612782687205559,0.5153846153846153,0.7639472297619326,1.0,23/64,28.26%,ACSL1;DAGLA;ASAH2;CPT2;PLA2G4A;CYP1B1;ACSL6;PNPLA8;EPHX1;EPHX2;ACAD9;ACOX1;MGLL;CPT1A;ACSL4;ELOVL1;ACOT8;DAGLB;GSTM2;ACSBG1;ELOVL5;ALOX12;PLA2G4C
prerank,icosanoid metabolic process (GO:0006690),-0.29659985500286656,-0.9611786645349113,0.5088757396449705,0.7637138547882963,1.0,16/40,30.11%,PTGIS;DAGLA;PTGS1;PLA2G4A;CYP1B1;PON2;PNPLA8;EPHX1;MGLL;DAGLB;ABCC10;GGT5;PON3;ALOX12;PLA2G4C;TBXAS1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.25717576210063764,-0.9611665547576496,0.5321637426900585,0.7632638706905231,1.0,37/87,35.12%,FBXL7;KANK2;FHL1;BRD7;DLG1;DACT1;PRMT2;USP47;PSMF1;RB1;PKD2;PSMB2;FAM107A;DCUN1D3;CDC73;PSMC1;CUL1;CDK6;PSMA3;PSMB6;PSMA4;AVEN;PSME1;PSMD13;ZFP36L2;PSMB9;RBX1;PSMB10;PSMA5;CDK2AP2;PINX1;PSME4;MYO16;PSMD10;CDKN2C;PSMB8;RBL2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.42779700944866467,-0.9609118353484682,0.5222222222222223,0.7634187180476859,1.0,1/10,0.08%,BMP6
prerank,regulation of cell junction assembly (GO:1901888),-0.32940092202449534,-0.9609046815916791,0.5162523900573613,0.762958350772879,1.0,7/27,11.26%,ROCK2;PDLIM5;ROCK1;SETD5;RAP1B;RUNX1;MEF2C
prerank,response to unfolded protein (GO:0006986),0.2824108621823981,0.9608869589510811,0.5190380761523046,0.8789100017736607,1.0,9/48,12.37%,HSPA13;PACRG;HSPA8;HSPA5;HSPA4L;HSP90AB1;HSPB1;DAB2IP;HSPD1
prerank,regulation of protein neddylation (GO:2000434),0.41789986027131704,0.9608040055408691,0.508695652173913,0.8780868703884483,1.0,4/10,15.72%,COPS9;EPAS1;RPL5;DCUN1D2
prerank,atrial septum morphogenesis (GO:0060413),-0.4231711313972344,-0.9607257722735162,0.5149253731343284,0.7629404443360149,1.0,1/10,0.31%,NOTCH2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.33971877111966975,0.9604253469022238,0.4922048997772829,0.8781157141035777,1.0,2/21,3.58%,PROX1;TOX
prerank,activation of adenylate cyclase activity (GO:0007190),0.30294500043683326,0.9599568493263606,0.5076252723311547,0.8784189982409899,1.0,7/35,11.30%,ADCY3;ADCY8;ADRB1;LGR5;ADCYAP1;CAP2;ADCY4
prerank,response to nitric oxide (GO:0071731),0.3879757222622755,0.9599550268388469,0.5166666666666667,0.8773760879608271,1.0,5/13,20.59%,KCNC2;FOXO1;MMP3;EGLN1;CCL19
prerank,regulation of dephosphorylation (GO:0035303),-0.3690309913770854,-0.9599516905524491,0.527831094049904,0.764411889339507,1.0,5/15,21.53%,SMG6;SMG7;MTMR3;INPP5K;CDK5RAP3
prerank,alpha-amino acid catabolic process (GO:1901606),-0.31602553207705236,-0.959907382777291,0.5180265654648957,0.7640361803157005,1.0,13/29,43.60%,DDO;ACADSB;PRODH;SARDH;ALDH4A1;CBS;KMO;GOT2;BLMH;IL4I1;FAH;HGD;HAAO
prerank,nuclear transport (GO:0051169),0.3604854859886461,0.9596636933001186,0.5231788079470199,0.8772438069570869,1.0,4/16,12.98%,NXT1;RBM15B;ANP32A;NUP205
prerank,negative regulation of response to stimulus (GO:0048585),0.2721386202487277,0.9595586228599202,0.5202312138728323,0.8765093197238577,1.0,12/60,11.12%,AQP11;MCTP1;SIRT1;HMGA2;THY1;SRMS;CLU;KLF4;CD34;GGT7;TLE5;UBASH3B
prerank,cell cycle G1/S phase transition (GO:0044843),-0.26974052529166787,-0.9595515553867595,0.5196078431372549,0.7644490792532179,1.0,23/61,24.64%,CCNH;KHDRBS1;CDK7;PHF8;EIF4E;MNAT1;RB1;CUL3;CRLF3;HINFP;LATS1;CUL2;ACVR1;RCC1;NASP;CACUL1;INHBA;CDK2;CUL1;CDK6;DBF4;CCNE2;EIF4EBP1
prerank,lytic vacuole organization (GO:0080171),-0.3145044773352278,-0.9595068581838484,0.5423387096774194,0.7640982202071053,1.0,6/32,7.43%,ABCA1;TFEB;LRRK2;ZKSCAN3;MTOR;TPCN2
prerank,synaptic vesicle membrane organization (GO:0048499),0.3626151771520419,0.9591416071447396,0.4989247311827957,0.876673181046219,1.0,4/17,16.31%,SNAP25;STX3;SNAP29;STX1B
prerank,protein-containing complex subunit organization (GO:0043933),-0.24584673286106418,-0.9586165139097113,0.5501930501930502,0.7657707653791845,1.0,35/109,22.49%,TEAD1;MDM4;DLG4;YAP1;DNM1L;SNX9;CREBBP;PPARGC1A;TUBGCP2;VAMP2;GEMIN5;WASL;MNAT1;TRAF2;CAPZA1;TEAD2;HES1;WIPF1;TPR;PARD3;WASF1;REPS2;RANBP9;PPIH;PICALM;GPAA1;TUBGCP4;NUP98;PML;FANCC;KIFAP3;KMT2A;DET1;PPID;LAMC1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.3494092917898809,-0.9582904474436035,0.5401174168297456,0.7661064753756821,1.0,3/20,1.79%,BMPR1A;NBL1;GLI2
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3609857896105165,-0.9581271481914648,0.5201535508637236,0.7660305904242847,1.0,4/18,3.19%,BMPR1A;MDM4;BMP4;TGFBR2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.2428536786838157,-0.9580474907218409,0.532803180914513,0.765755608630815,1.0,18/108,10.61%,UACA;SMAD3;GSN;COL4A3;CFLAR;ROBO1;HMGB1;EIF2AK3;F3;REST;MAP3K5;FAM162A;AIFM1;CASP12;NGF;EGLN3;TRAF2;SENP1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.3181769339176675,-0.9579690743413121,0.52465483234714,0.7654780184346283,1.0,12/25,37.19%,DNM1L;FAM162A;BNIP3;BMF;PDCD5;GPER1;PLAUR;PPIF;BCL2L11;PYCARD;BIK;TP53
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.41794087677195235,-0.957817897986718,0.5194805194805194,0.7653687693765482,1.0,4/11,6.85%,IGF1;GHR;IRS1;EIF2AK3
prerank,B cell differentiation (GO:0030183),-0.2873082412673056,-0.9572913869598697,0.5304878048780488,0.7661933785515732,1.0,12/46,18.13%,HDAC4;KIT;ITGB1;DCAF1;CEBPG;PTPN2;FNIP1;TCF3;ITGA4;KLF6;SYVN1;BLNK
prerank,neural tube closure (GO:0001843),-0.3069969894892176,-0.9571585743619188,0.5111940298507462,0.7660588009657445,1.0,6/34,9.33%,LMO4;LRP6;SKI;MTHFR;VASP;PLXNB2
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3248424237333155,-0.9568704508612178,0.5387523629489603,0.7663009475013568,1.0,8/28,17.24%,PTN;ABL1;GSK3B;ADCY1;EPHA4;EIF2AK4;APOE;FAM107A
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.3011255232483857,-0.9567731730448815,0.5103969754253308,0.7660576882231426,1.0,8/36,10.73%,AXL;TRIM44;PRKN;UBE2K;HIF1A;PARP9;PARP14;MAVS
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.3086109654676697,0.9566244909370324,0.5306930693069307,0.8828335145666908,1.0,9/35,12.99%,RIMS2;EPHA5;AKAP6;PDE2A;HTR2C;ADCYAP1;CAP2;PDE4D;CD36
prerank,regulation of epithelial cell migration (GO:0010632),-0.2796881833645831,-0.9563971413056921,0.5464895635673624,0.7664839101595977,1.0,14/51,17.03%,DOCK5;SASH1;PTN;RHOJ;RREB1;CTSH;GLUL;PLCG1;HIF1A;BMPER;RAB11A;GLIPR2;DUSP10;DOCK1
prerank,prostaglandin metabolic process (GO:0006693),-0.32949642422144026,-0.9556819302385802,0.5427435387673957,0.7678220965796299,1.0,6/26,12.11%,PTGDS;PTGIS;PTGS1;PLA2G4A;PTGES;PNPLA8
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.26141839396339217,-0.9551322714094846,0.5579567779960707,0.7687345828651914,1.0,28/73,29.49%,KAT2B;EP300;HDAC4;PPM1D;DNMT3A;SF3B1;IGF2;TBP;TAF1D;PHF2;MPHOSPH8;KDM1B;CGGBP1;PHF1;JARID2;EPC1;BAZ1B;POLR2H;EZH2;POLR2K;PPHLN1;POLR2E;CREBZF;TAF1C;POLR1G;TAF1A;POLR1C;SPHK2
prerank,positive regulation of chromosome organization (GO:2001252),-0.38002033873170604,-0.9551188996381537,0.5170454545454546,0.7682887940235873,1.0,8/15,28.10%,NBN;DHX36;RAD21;MRE11;PML;PPP1R10;ATRX;GNL3
prerank,cellular response to acid chemical (GO:0071229),0.3193545769922976,0.9550746391990269,0.5243128964059197,0.8862133922063835,1.0,9/27,21.13%,IPO5;GLRA1;GLRA2;KLF2;XBP1;CAPN2;LAMTOR2;SPAAR;RRAGD
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.35926755732901083,-0.9547399329795364,0.5447761194029851,0.7687037993527366,1.0,8/18,23.53%,SKI;PARP10;EMD;MORC3;B4GALT7;CDC73;CD300A;NLRC3
prerank,negative regulation of cellular component movement (GO:0051271),0.3784706690550449,0.9546748987521596,0.5137420718816068,0.8863680085009136,1.0,2/15,0.68%,SPOCK3;FRMD5
prerank,'de novo' posttranslational protein folding (GO:0051084),0.3121397065568457,0.9546648092539767,0.500998003992016,0.8853486273512579,1.0,10/30,21.42%,HSPA13;HSPA8;HSPA5;CHCHD4;CCT2;PTGES3;ST13;GAK;BAG1;ENTPD5
prerank,C21-steroid hormone metabolic process (GO:0008207),0.34270207204775205,0.9545124827195896,0.501010101010101,0.8847357774219231,1.0,6/20,19.29%,FDX2;TSPOAP1;TSPO;STARD3NL;HSD17B10;STARD3
prerank,Fc receptor signaling pathway (GO:0038093),-0.24540647996519177,-0.9545069936382837,0.5686653771760155,0.7688041388182907,1.0,36/110,28.95%,GAB2;NFKB1;BTRC;KIT;MAP2K4;PAK2;SHC1;LYN;PDPK1;VAV2;PLCG1;FER;JUN;PSMF1;TEC;PSMB2;MAP2K7;TRAF6;NFATC3;FBXW11;MAP3K1;PSMC1;CUL1;PIK3R1;PSMA3;PSMB6;PSMA4;SYK;FCER1G;MAPK9;SOS1;PSME1;PSMD13;PSMB9;PSMB10;PSMA5
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.4046456653701771,0.954375912676384,0.5336322869955157,0.8840945401689275,1.0,2/10,3.85%,CXCL12;GAS6
prerank,T cell activation involved in immune response (GO:0002286),-0.3964005210924252,-0.9543093759822272,0.5406427221172023,0.7688348295069162,1.0,11/12,58.41%,EIF2AK4;FCER1G;ICAM1;MDK;SLC11A1;LILRB1;LCP1;ITGAL;F2RL1;IFNK;TNFSF18
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.3351850176565679,0.9539047396035798,0.5221987315010571,0.884432490552451,1.0,4/22,10.90%,PDE4B;GPR35;CACNB2;CACNB4
prerank,glycolytic process (GO:0006096),0.3271350188190511,0.9535125964783759,0.5254237288135594,0.8845008684402171,1.0,9/28,21.43%,PGAM4;PGAM1;ALDOC;GCK;PFKFB2;GAPDHS;ENO2;LDHA;GPI
prerank,regulation of endocytosis (GO:0030100),-0.27092217593279583,-0.9532008658032068,0.5371428571428571,0.7711393928262062,1.0,19/61,20.36%,LRP1;EPHA3;DAB2;ROCK1;ABL1;PACSIN2;GPC3;STON2;ARFGAP1;ABL2;APOE;ZFYVE16;RUBCN;PICALM;PRKD1;PTPN1;LRSAM1;ABCA7;STON1
prerank,regulation of lipid catabolic process (GO:0050994),0.34908582494125234,0.9524708254112768,0.5440860215053763,0.8864604014946513,1.0,2/19,6.02%,HCAR2;ALK
prerank,positive regulation of intracellular transport (GO:0032388),-0.3000173676637652,-0.952228056470719,0.5128205128205128,0.7730946562026112,1.0,13/38,18.77%,PCM1;NUMA1;BCAS3;STX18;PCNT;EHD2;ACTN2;VAMP2;TBC1D20;TPR;ICE1;DYNC1H1;EIPR1
prerank,"wound healing, spreading of cells (GO:0044319)",-0.3325062366065201,-0.9518992745291257,0.5234375,0.7734484586849253,1.0,11/24,23.72%,COL5A1;PDPN;FLNA;ARHGAP24;RHOA;CCN1;ITGA5;DDR1;RHOC;TOR1A;ARHGAP35
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.2900197143404728,-0.9517775990386902,0.5437262357414449,0.7732542896029038,1.0,8/41,13.46%,PRKAG2;EP300;RANBP2;NUP42;HIF1A;NUP214;TPR;OGT
prerank,negative regulation of nuclear division (GO:0051784),-0.40283431681088244,-0.9515373928206525,0.49707602339181284,0.7733697100051753,1.0,3/11,9.36%,BMP7;BMP4;TOM1L2
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.3021253127400275,-0.9514063509179488,0.5380116959064327,0.7732108265810691,1.0,10/36,14.69%,NR2F2;DCN;HMGB1;THBS1;SP100;JUP;ADAMTS9;MEF2C;ANGPT2;APOE
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.3459379599054291,-0.9513206101932475,0.5155038759689923,0.7729566769011995,1.0,10/20,29.92%,PRKAA2;BRD7;PPARGC1A;ARRB1;PRKAA1;NOS1;PAXIP1;RPS6KA4;RUVBL2;GLYR1
prerank,negative regulation of protein catabolic process (GO:0042177),-0.301965847186391,-0.9509529502961499,0.5506958250497018,0.7733881335801819,1.0,16/40,24.34%,TIMP3;EGFR;MDM4;ROCK1;FLNA;IRAK3;PTPN3;SNRNP70;ATRAID;CTSA;HMGCR;CYP51A1;TIMP2;CDK5RAP3;RGP1;SNX12
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.41292200021735836,-0.950764644873871,0.5185909980430529,0.77288200429799,1.0,4/10,22.75%,CDC42;CDC42EP5;CDC42EP4;CDC42EP1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.41292200021735836,-0.950764644873871,0.5185909980430529,0.77288200429799,1.0,4/10,22.75%,CDC42;CDC42EP5;CDC42EP4;CDC42EP1
prerank,positive regulation of protein modification process (GO:0031401),-0.22737934787565856,-0.9506524367133584,0.6271186440677966,0.7726911923217356,1.0,37/203,15.03%,TRABD2B;ROCK2;EGFR;LEPR;IL34;SLCO3A1;ANGPT1;NTRK3;PELI2;UBE2N;FGF1;DAB2;BMP4;FAM20A;ABL1;LRRK2;AXIN1;RAB3GAP1;LYN;RAMP1;RAPGEF3;PPP1R7;IGF2;RB1CC1;ANKLE2;PRKCD;FAM161A;MAVS;FNIP1;CARD14;CCN1;TXN;WDFY2;VEGFA;VEGFD;DDX3X;CCND3
prerank,toll-like receptor signaling pathway (GO:0002224),0.25909864085275247,0.9505749298156011,0.5278884462151394,0.8906802169450528,1.0,16/84,15.03%,TIRAP;S100A9;S100A8;TLR2;RPS27A;UBC;UBB;TRIL;BCL10;RFTN1;CTSB;HSPD1;ITGAM;CD36;TAB2;MAPKAPK2
prerank,response to hydroxyurea (GO:0072710),-0.4167590498144651,-0.9503081869758668,0.5286506469500925,0.7730454766024133,1.0,2/11,7.30%,SPIDR;DDI2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.2883116965041579,0.9502942511634339,0.5083333333333333,0.8904926667147304,1.0,10/39,14.93%,SPOCK1;ACER2;AJAP1;NOTCH1;MELTF;SPRY4;NEXMIF;FZD4;ACTN4;CORO1C
prerank,cellular response to retinoic acid (GO:0071300),-0.29233891150283675,-0.9499645116315372,0.5285996055226825,0.7734915357875298,1.0,9/42,12.97%,EPHA3;PTK7;WNT5B;WNT6;LYN;WNT9A;ABL2;FZD7;ADNP2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.42188860640934556,-0.949830739158821,0.5257142857142857,0.773383419410827,1.0,3/10,12.75%,DNMT3A;IGF2;KDM1B
prerank,pyruvate metabolic process (GO:0006090),0.2842516167020031,0.9497438913053922,0.5319587628865979,0.8910312863941233,1.0,16/52,21.43%,BSG;PGAM4;PGAM1;ALDOC;PDHB;GCK;SLC16A1;DLAT;PFKFB2;GAPDHS;NR4A3;LDHB;ENO2;LDHA;SRR;GPI
prerank,positive regulation of JNK cascade (GO:0046330),0.26489889184369503,0.9493702812542618,0.5723830734966593,0.8910961789854254,1.0,16/70,14.49%,TIRAP;MAP4K2;TRAF1;PLCB1;TNFRSF19;WNT7B;ANKRD6;MAPK8IP1;TAOK2;DAB2IP;HIPK2;PJA2;DUSP15;MAP3K11;HRAS;MFHAS1
prerank,regulation of vasculature development (GO:1901342),0.31990163464132504,0.949075447381647,0.5446224256292906,0.8908423066768593,1.0,4/26,8.31%,HTATIP2;TSPAN12;ETS1;GPNMB
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.24369279861752308,0.9489984519577921,0.5794573643410853,0.8900217249850972,1.0,25/117,19.16%,PRKAR2B;ADCY3;ADCY8;RAMP2;ADRB1;RHBDF2;GNG2;ADCYAP1;GPR176;POMC;CD163;ADCY4;GGT1;PTGER2;ADCYAP1R1;PLK2;PTGER4;CALCRL;NPSR1;GPR45;CYSLTR1;FYN;ADORA2B;PRKAR1A;ADORA2A
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.3819303729634825,-0.9487741157470068,0.5104364326375711,0.7754973135286563,1.0,8/14,31.37%,TNKS2;NABP2;BRCA2;TERF2;TERT;ATR;ATRX;PINX1
prerank,positive regulation by host of viral transcription (GO:0043923),0.3601547614509532,0.9485412445134828,0.509719222462203,0.8903050088438965,1.0,2/15,4.17%,LEF1;SMARCB1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.33279152017858216,0.9484622455682382,0.5228215767634855,0.8895016849777623,1.0,4/22,8.88%,PSMA1;ENC1;PSMA6;PSMB3
prerank,entry into host (GO:0044409),-0.38779101890848455,-0.9482932092160116,0.537109375,0.7761896416561523,1.0,2/13,5.90%,ITGAV;CDH1
prerank,axoneme assembly (GO:0035082),0.31011893430285853,0.9482817717513763,0.5494949494949495,0.888997137403271,1.0,6/30,16.38%,SPAG16;DNAAF3;FOXJ1;DNAAF2;DCX;SPAG1
prerank,acylglycerol metabolic process (GO:0006639),0.29477383771017507,0.9480854762503601,0.5371549893842887,0.8885304868905053,1.0,5/37,7.33%,DGKI;ABHD2;DGKH;DGAT2;DGKB
prerank,regulation of lymphocyte activation (GO:0051249),-0.3912728963719516,-0.948073825166626,0.5402298850574713,0.7762444905986937,1.0,1/12,3.39%,PAG1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.24298917994357475,0.947888604130125,0.570873786407767,0.8880786742868326,1.0,25/116,19.16%,PRKAR2B;ADCY3;ADCY8;RAMP2;ADRB1;RHBDF2;GNG2;ADCYAP1;GPR176;POMC;CD163;ADCY4;GGT1;PTGER2;ADCYAP1R1;PLK2;PTGER4;CALCRL;NPSR1;GPR45;CYSLTR1;FYN;ADORA2B;PRKAR1A;ADORA2A
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.339589472872717,-0.9477910923311726,0.5130784708249497,0.7764932600494429,1.0,7/20,18.44%,NFKB1;HM13;NCSTN;ADAM9;MBTPS2;MBTPS1;TRAF6
prerank,purine nucleotide biosynthetic process (GO:0006164),0.395265641008795,0.946937863708729,0.5191011235955056,0.8896257800358178,1.0,3/12,9.32%,GART;HPRT1;MTHFD1
prerank,regulation of macrophage activation (GO:0043030),-0.3101659067791985,-0.9469288054807693,0.5153846153846153,0.7780763870269749,1.0,11/30,21.99%,IL31RA;LBP;THBS1;NR1H3;TNIP2;TLR4;WNT5A;GPR137B;SHPK;KARS1;SPHK1
prerank,T cell proliferation (GO:0042098),0.37454321459533896,0.9468527519527676,0.5,0.8888379496326372,1.0,1/13,1.00%,CADM1
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3522439775868673,-0.9467932944729817,0.5339449541284403,0.777954312050472,1.0,6/18,19.84%,NGLY1;DERA;OGA;ADAMTS9;MANBA;NAGA
prerank,negative regulation of cytokine production (GO:0001818),0.2308501021081746,0.9465850083016222,0.5833333333333334,0.8885637336285617,1.0,20/163,11.14%,CD33;LEF1;NAV3;HDAC9;TMSB4X;SYT11;GAS6;ISG15;IL12A;RPS6KA5;NPTN;KLF4;GPNMB;CD34;CD200R1;FOXJ1;TNFRSF21;HOMER2;BCL3;PPP1R11
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.41058885029920644,-0.9464867673958967,0.548689138576779,0.7781864174216454,1.0,7/10,46.25%,RENBP;ST6GAL1;NANP;GNE;NPL;NAGK;GNPDA1
prerank,negative regulation of defense response (GO:0031348),-0.25955020170871146,-0.9459984245111093,0.5901328273244781,0.7788522088404963,1.0,29/77,28.75%,PTGIS;IRAK3;TRAFD1;MAPKBP1;PCBP2;CCN3;SELENOS;NR1H3;PTPN2;ENPP3;PRKCD;RB1;ILRUN;RORA;APOE;C1QTNF3;FEM1A;METRNL;SHARPIN;LPCAT3;MAPK7;NLRC3;SIRPA;MVK;PPARA;CACTIN;DHX58;MUL1;GPER1
prerank,regulation of cholesterol transport (GO:0032374),-0.3409348367684989,-0.9459703434005934,0.5412667946257198,0.7784369003633724,1.0,2/20,1.20%,LRP1;NFKB1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2392733564379773,-0.9457591520105073,0.5886939571150097,0.7784634702072145,1.0,45/119,30.72%,PTPN13;PLEKHA2;PI4KA;SMG1;PIGN;SYNJ2;MTMR12;INPPL1;PIP4K2C;TTC7B;PITPNM2;EFR3A;ARF1;MBOAT7;MTMR3;SLC27A1;PLEKHA8;PIK3C3;DPM1;PIK3R4;SACM1L;SOCS7;PIK3CD;INPP5K;ITPKC;MPPE1;PIGH;PIK3R1;FGF2;PLEKHA4;PIGC;PI4K2B;DPM3;PIGA;RAB5A;PLEKHA1;IP6K2;PIGZ;RUFY1;PIGP;PI4KB;PIGF;CISH;PIP5K1C;SOCS3
prerank,positive regulation of macrophage migration (GO:1905523),-0.3523718310046746,-0.9456575640544418,0.5512572533849129,0.7782290912902896,1.0,5/19,16.63%,IL34;THBS1;P2RY12;P2RX4;CMKLR1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3367099442181761,-0.9453467213568928,0.5348399246704332,0.77849490356266,1.0,6/22,12.69%,APPL2;LBP;LYN;PTPN22;NR1H3;APPL1
prerank,regulation of calcium ion transport (GO:0051924),0.2738119078795732,0.945257729966412,0.54296875,0.8913354691604558,1.0,9/54,10.98%,CAMK2A;CD33;CACNA2D1;EPB41;HOMER1;CACNB2;PLPP4;HOMER2;F2R
prerank,cellular metal ion homeostasis (GO:0006875),-0.2471000349977602,-0.9449479329057995,0.5905511811023622,0.7789821209436588,1.0,16/102,13.16%,ATP1A2;SLC24A3;STIM1;ANK2;ATP13A5;SLC41A1;SLC9A1;TPCN2;KCNJ2;SLC10A7;SLC12A2;DMPK;ATP2A2;ATP2B1;ATP13A3;LETM1
prerank,cellular glucose homeostasis (GO:0001678),-0.29699518461540536,-0.9444903465721053,0.5493230174081238,0.7796435771661241,1.0,13/41,17.75%,ZBTB20;PRKAA2;SLC39A14;LRRC8D;PPARGC1A;FOXK1;UNC13B;HIF1A;PCK2;ERN1;FOXK2;PRKACA;PRKAA1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.312865160169175,0.944480496140767,0.5349794238683128,0.8925078796512003,1.0,3/29,4.51%,FLT1;TEK;FLT3
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.3668126338880057,0.9438362192653967,0.5263157894736842,0.8933178398887123,1.0,6/16,19.63%,ATP5F1D;ATP5F1B;ATP5ME;DMAC2L;ATP5MF;ATP5MG
prerank,leukocyte tethering or rolling (GO:0050901),-0.35522577185540705,-0.9436866428641385,0.5274102079395085,0.7811102576963452,1.0,5/17,22.63%,ROCK1;ITGB1;ITGA4;CX3CR1;VCAM1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.3530549887505397,0.9435548454120586,0.5291576673866091,0.8930670268763657,1.0,4/18,8.19%,TRIM13;RPS27A;UBC;UBB
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.39173157170153805,-0.94315668615626,0.5224719101123596,0.7819751460620826,1.0,4/13,14.35%,TGFBR2;NRP1;SEMA3E;VEGFA
prerank,positive regulation of embryonic development (GO:0040019),-0.3476373612701856,-0.9428406367263852,0.5343511450381679,0.7822781121316082,1.0,3/19,4.10%,WNT4;OSR1;NIBAN2
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3634725997870114,-0.9425373810918103,0.5566218809980806,0.7825520039020584,1.0,4/16,13.46%,AUTS2;ARHGAP24;ARHGAP17;OGT
prerank,regulation of amyloid-beta formation (GO:1902003),-0.2954951028550693,-0.9423890630672653,0.5783365570599613,0.7824834189346552,1.0,9/34,19.13%,ROCK2;IGF1;ROCK1;EPHA4;GGA3;APOE;IFNGR1;PICALM;ABCA7
prerank,neuron apoptotic process (GO:0051402),0.34778436163194326,0.9422723752823935,0.5366876310272537,0.8957399912622145,1.0,4/19,13.55%,TRPC5;TNFRSF21;SCN2A;CIT
prerank,protein modification process (GO:0036211),-0.25433735551227366,-0.9413348238153779,0.5622568093385214,0.7845203234381989,1.0,25/76,21.11%,ARAF;ABL1;WWP2;PLOD2;PLAT;UBE2I;PPP4R2;ABL2;GGCX;YES1;PARP1;PARP4;LOX;PRKDC;MANBA;UBL5;UBA7;UBE2S;FBXO22;RPN1;RABGGTB;UBE2D3;B4GALT7;PIGH;AKT2
prerank,interstrand cross-link repair (GO:0036297),-0.2749016532333144,-0.9409120991464676,0.581888246628131,0.7850631791340028,1.0,25/53,32.70%,WDR48;RNF8;RFWD3;MCM9;FANCE;ERCC6L2;FANCM;FANCI;DCLRE1A;VCP;MSH6;POLN;FANCC;FAAP100;ATR;ERCC1;FANCB;UBA52;FANCD2;FANCG;FAAP20;NEIL3;RPA2;EXO5;RAD51
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.42157793962519596,-0.9406854217501619,0.5562015503875969,0.7851779333838781,1.0,5/10,19.17%,PRKAA2;SETD5;KLF15;PRKAA1;PARK7
prerank,tRNA 5'-leader removal (GO:0001682),0.37787283825307905,0.9405759307281062,0.5206073752711496,0.8995704080399243,1.0,3/13,12.59%,RPP40;RPP30;POP5
prerank,positive regulation of chemotaxis (GO:0050921),0.2897057968627941,0.9404000730744516,0.5432595573440644,0.8990612623529837,1.0,8/43,10.53%,DSCAM;TMSB4X;PPM1F;KDR;STX3;HSPB1;AIF1;PDGFB
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.3727362880799331,-0.9401625251459055,0.5398886827458256,0.7859458587122223,1.0,4/14,35.10%,IL6ST;PARK7;ADAM8;OSMR
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.35623722141329517,-0.9384084771014097,0.5444234404536862,0.7892606979943078,1.0,4/17,6.19%,BRWD1;JAK1;IRS1;STAT3
prerank,cellular response to interleukin-7 (GO:0098761),-0.35623722141329517,-0.9384084771014097,0.5444234404536862,0.7892606979943078,1.0,4/17,6.19%,BRWD1;JAK1;IRS1;STAT3
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.32841143411104984,-0.9379233572328436,0.5518518518518518,0.7899512195867008,1.0,4/23,10.22%,SASH1;TAOK3;MAP3K5;TRAF2
prerank,estrogen metabolic process (GO:0008210),-0.36286218033383644,-0.9376470947841588,0.5644859813084112,0.7901105250913103,1.0,3/15,10.43%,CYP1B1;SULT1A1;HSD17B11
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.2212791852283685,-0.9372475449271253,0.6358267716535433,0.7906498914301935,1.0,29/198,10.59%,PLCE1;EPHA7;PI4KA;PLPP3;LRRK2;ENPP1;NUDT4;GK5;TOP1;PLCD3;INPP5B;PAK2;NUDT5;INPP5A;ISYNA1;STAT3;DUSP16;NADK;PFKFB4;MTOR;GFPT1;INPPL1;PLCG1;PLA2G4A;PLCB3;PANK2;ENPP3;PLCD1;LIMD1
prerank,positive regulation of immune system process (GO:0002684),0.3586939923294693,0.9371004654867611,0.5458715596330275,0.907411412167503,1.0,2/16,5.71%,HCAR2;TGFB2
prerank,regulation of mitochondrial translation (GO:0070129),-0.33472634887304903,-0.9368797439216004,0.5428571428571428,0.7910317534915556,1.0,10/21,31.70%,RCC1L;NSUN3;ALKBH1;MTG2;RMND1;RPUSD4;MPV17L2;TRMT10C;C1QBP;MRPS27
prerank,transferrin transport (GO:0033572),0.3023964107482633,0.9367662778901411,0.567287784679089,0.9073204976385452,1.0,13/33,22.78%,TFRC;ATP6V1F;ATP6V1A;ATP6AP1;ATP6V1C1;ATP6V0B;ATP6V0A1;ATP6V0E2;ATP6V1D;REP15;HFE;ATP6V1G1;ATP6V0C
prerank,organic substance transport (GO:0071702),0.234277835468592,0.9364915811548127,0.6069364161849711,0.9070581282143592,1.0,11/121,6.93%,PLTP;LRP1B;ATP8A1;AQP9;RAMP2;ABCG2;MFSD2A;CHKA;MFSD12;SPNS2;SLC6A2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.2569370309995759,0.9364487513891233,0.6200417536534447,0.9061547105923496,1.0,11/75,10.81%,EGFL7;TEK;PROX1;PLXNB3;SIRT1;PPP1R16B;KDR;APLNR;AKT1;PDGFB;SCG2
prerank,negative regulation of nervous system development (GO:0051961),0.3521690557510213,0.9363990978796506,0.5797413793103449,0.905247942297715,1.0,6/17,14.48%,NOTCH1;TLR2;SLIT1;ROBO2;SORL1;B2M
prerank,positive regulation of hormone secretion (GO:0046887),0.34483475725136586,0.9363367015333586,0.5445344129554656,0.9043909585475249,1.0,3/17,9.95%,HCAR2;NMB;GRP
prerank,cAMP biosynthetic process (GO:0006171),-0.41189034787880624,-0.9356822313274674,0.5413533834586466,0.7934567909490755,1.0,4/10,7.65%,ADCY9;ADCY5;ADCY1;ADCY6
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.41450268758029263,-0.9356492822442704,0.5620300751879699,0.7930560137342004,1.0,4/11,15.24%,EP300;CLK2;SIK1;C1QTNF3
prerank,vesicle transport along microtubule (GO:0047496),-0.326431259043291,-0.9356027275809518,0.5400763358778626,0.7926898780631675,1.0,9/23,26.83%,TRAK1;KIF13A;NDEL1;KIF1C;DYNC1H1;FBXW11;KIFAP3;KIF3A;KIF5B
prerank,negative regulation of myotube differentiation (GO:0010832),-0.3870716739341574,-0.935414654657673,0.5545286506469501,0.7926648860614028,1.0,5/12,21.31%,HDAC4;CCN3;BHLHE41;HDAC1;TMEM119
prerank,regulation of T cell proliferation (GO:0042129),0.2672976111457539,0.9349790844594938,0.5899581589958159,0.9072719465425328,1.0,5/61,9.84%,TFRC;SLC7A1;GPNMB;TNFRSF21;AIF1
prerank,positive regulation of dendrite development (GO:1900006),-0.4085992808430512,-0.934706083860943,0.5470941883767535,0.7939571494393328,1.0,3/10,2.50%,PTN;BMP5;BMP7
prerank,regulation of rRNA processing (GO:2000232),-0.3599090777106463,-0.9345839418105261,0.5753968253968254,0.7937673198320744,1.0,4/16,16.68%,KAT2B;WDR43;DIMT1;BUD23
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.3824207846191183,0.934510308281055,0.52,0.9076004447914184,1.0,3/12,6.74%,PFDN5;CLU;PFDN6
prerank,smoothened signaling pathway (GO:0007224),-0.3053430447340545,-0.9343175056671638,0.5647279549718575,0.7939227829553115,1.0,9/32,15.63%,GLI3;GLI2;SMO;ARL13B;EVC2;HIPK1;CC2D2A;GLI1;PTCH1
prerank,chemical homeostasis (GO:0048878),-0.2669023007062417,-0.9342251637120408,0.5942307692307692,0.7936757234928646,1.0,12/61,12.86%,ZBTB20;RBP1;NR1D2;SLC4A10;ABHD5;WNK4;TLCD2;WNK1;NR1H3;PNPLA8;SLC4A3;FBXW7
prerank,negative regulation of phagocytosis (GO:0050765),0.3519730406304852,0.9336135527053172,0.5605095541401274,0.9091602466224009,1.0,4/17,8.95%,SYT11;TLR2;DYSF;CD300LF
prerank,amino acid transmembrane transport (GO:0003333),0.27901388682041034,0.933590260264134,0.5850202429149798,0.9081969480625888,1.0,6/45,9.70%,SLC7A5;SLC6A6;SLC7A1;MFSD12;SLC7A8;SLC36A1
prerank,negative regulation of heart contraction (GO:0045822),-0.4029679538317882,-0.933581012222944,0.5711678832116789,0.7947253148681411,1.0,1/11,0.03%,ATP1A2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.35185935204241914,-0.9335699582124765,0.5523809523809524,0.7942711184314218,1.0,6/17,22.19%,TAOK3;LYN;MID1;EIF2AK2;TAOK1;KLHDC10
prerank,axonal transport of mitochondrion (GO:0019896),-0.39497722940275903,-0.9335653270776869,0.5415162454873647,0.7938061295486205,1.0,3/11,10.53%,TRAK1;OPA1;HIF1A
prerank,positive regulation of isotype switching (GO:0045830),0.36009995137644707,0.9334301633598044,0.5442477876106194,0.9076217076487605,1.0,3/15,12.28%,TFRC;SHLD3;CD40
prerank,amyloid-beta metabolic process (GO:0050435),0.357447535528975,0.9334118554969523,0.5361050328227571,0.9066551701077975,1.0,4/16,13.50%,MME;PSENEN;NAT8;PSEN1
prerank,protein depolymerization (GO:0051261),-0.3171316398308073,-0.9330036122184315,0.5386064030131826,0.7946690080602399,1.0,4/27,5.93%,MICAL3;GSN;MICAL2;VPS4B
prerank,positive regulation of coagulation (GO:0050820),-0.40810733337742217,-0.932963777786983,0.562862669245648,0.7938264764526944,1.0,2/10,5.31%,ST3GAL4;THBS1
prerank,positive regulation of hemostasis (GO:1900048),-0.40810733337742217,-0.932963777786983,0.562862669245648,0.7938264764526944,1.0,2/10,5.31%,ST3GAL4;THBS1
prerank,blood vessel diameter maintenance (GO:0097746),-0.29395742251907436,-0.9327885426800995,0.5386029411764706,0.7937826001263493,1.0,5/34,7.66%,ROCK2;ROCK1;EDNRA;ADCY6;ECE1
prerank,phosphatidylserine metabolic process (GO:0006658),-0.3046453286032159,-0.9325786549976451,0.5678294573643411,0.7938425902792053,1.0,10/32,23.43%,OSBPL8;PLSCR1;OSBPL5;PLA2G4A;PTDSS1;SLC27A1;PLA1A;ABHD12;LPCAT3;PTDSS2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.2548553554141692,-0.932480830127999,0.5988593155893536,0.7936032494172192,1.0,12/70,12.87%,SMAD3;ITGAV;GSK3B;BCL2;PDPK1;HIPK1;NGF;BAG3;TRAF2;APPL1;IL6R;CASP2
prerank,female gamete generation (GO:0007292),-0.31420112934808525,-0.9324616882192235,0.5553470919324578,0.7931829088300825,1.0,3/29,4.97%,DIAPH2;PTN;KMT2D
prerank,positive regulation of hydrolase activity (GO:0051345),-0.2343661250636968,-0.9323806082810803,0.6355140186915887,0.7928977146453602,1.0,24/137,11.32%,DOCK11;AFDN;ASAP3;LIMS1;ARAP1;GSK3B;SGSM2;ITGB1;CTSH;BCAS3;SNX9;MMUT;RAB3GAP1;MAP4K4;RAPGEF3;S100A10;ZC3H15;WRN;RSU1;NDEL1;USP6NL;TBC1D20;RHOA;RCN3
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.3834050923861878,-0.9320099930320261,0.5977859778597786,0.7932765422846564,1.0,9/12,37.06%,UPP2;DHODH;TK2;UMPS;CDA;CAD;UCK1;DCK;TK1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.2941601497282098,-0.9319957696152261,0.5640074211502782,0.7928543246580646,1.0,10/35,18.08%,SULF1;NR2F2;COL4A3;SPARC;THBS1;MEF2C;STAT1;APOE;ATOH8;ATP5IF1
prerank,NAD biosynthetic process (GO:0009435),-0.3404900333816609,-0.9310754955749326,0.5627450980392157,0.7946739374114873,1.0,6/20,14.73%,PTGIS;NMNAT2;PARP10;PARP9;NMNAT3;NMNAT1
prerank,organophosphate ester transport (GO:0015748),0.3129370476774401,0.9310333483158139,0.5838926174496645,0.9123377798944431,1.0,8/24,17.95%,PLTP;PITPNM1;PRELID3A;PRELID2;SCARB1;SCP2;MTTP;PITPNB
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.3170766058854669,0.9307189393006603,0.5492341356673961,0.9121702665021281,1.0,5/24,7.34%,TEK;PPM1F;KDR;THY1;PTPRJ
prerank,response to organic cyclic compound (GO:0014070),-0.27352646378647283,-0.9305327911890747,0.5996168582375478,0.7955313966027182,1.0,12/52,21.77%,IGFBP5;LRRK2;HLCS;STRN3;STAT3;ANXA1;CYP1B1;IL18;STAT5B;SPP1;FGFR4;ALPL
prerank,negative regulation of actin filament polymerization (GO:0030837),0.3241257554238928,0.9297853973655924,0.5820568927789934,0.9136974486659662,1.0,3/22,2.69%,KANK3;TMSB4X;TMSB10
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.22167144605548683,-0.9295416685873421,0.6444007858546169,0.797389451521611,1.0,46/190,19.22%,UACA;ITPR1;CGNL1;DAG1;UBR2;BMP7;PRKAA2;WWC2;VGLL4;DEPTOR;WTIP;MARK3;THBS1;TMEM127;LYN;MAPKBP1;BCL2;CCN3;UBR1;LIMD1;WWC1;TLE1;RIOK3;FNIP1;PPM1A;PDE3A;UBE2B;DUSP1;STAT1;RORA;TRIM39;DDX3X;C1QTNF3;PRDM15;NOP53;NPRL3;PRKAA1;MYADM;PPP2R5C;INPP5K;RHOH;GPD1L;IFI35;TANK;ABCA7;AJUBA
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.39473725851242436,-0.929155088979036,0.5372848948374761,0.7978839290793085,1.0,6/11,27.06%,GTF2H2;GRK3;ARRB1;ADM;SAG;ADRB2
prerank,phosphate ion transport (GO:0006817),0.35552036048591,0.9290232658574986,0.5545657015590201,0.9148463894065836,1.0,3/16,8.09%,SLC37A4;SLC37A1;SLC25A14
prerank,cellular response to hydroxyurea (GO:0072711),-0.41752319389475684,-0.9287913003091769,0.5433212996389891,0.7982739192026048,1.0,2/10,7.30%,SPIDR;DDI2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.35879176849131855,-0.928661238634418,0.5447470817120622,0.7981189768132999,1.0,10/16,33.58%,KLHL15;SHLD2;SMCHD1;HELB;UBQLN4;FANCB;CGAS;MAD2L2;RMI2;PARPBP
prerank,positive regulation of lipid transport (GO:0032370),-0.39274172838702237,-0.9284198498025168,0.5604606525911708,0.7981844021566078,1.0,3/12,20.29%,LRP1;APOE;SPP1
prerank,inositol phosphate catabolic process (GO:0071545),-0.3837964052011529,-0.928034217081465,0.566793893129771,0.798638001140168,1.0,3/12,5.95%,INPP5B;SYNJ2;INPP5A
prerank,modulation by symbiont of entry into host (GO:0052372),0.35815780997375973,0.9277752569886589,0.5794979079497908,0.9173657880797585,1.0,3/16,8.15%,HS3ST5;TRIM62;TRIM6
prerank,regulation of cell development (GO:0060284),0.2860662726839424,0.9275935847075897,0.5831622176591376,0.9168531737311291,1.0,11/36,16.94%,HDAC9;RPS19;HEY1;AKT1;FOXO1;PER2;BHLHE40;HES6;DLL1;CTNNB1;HES5
prerank,regulation of interleukin-6 production (GO:0032675),0.2452966426623364,0.9273640183135872,0.6113445378151261,0.91648633548097,1.0,15/96,13.35%,TIRAP;MBP;IL17F;SYT11;GAS6;TLR2;CD200R1;FOXJ1;ARHGEF2;AIF1;F2R;BCL10;HSPD1;POU2AF1;XBP1
prerank,positive regulation of transporter activity (GO:0032411),-0.38193383847367146,-0.9271275649812987,0.5792452830188679,0.8003692980899599,1.0,10/13,46.42%,NR1H3;RXRA;KMT2A;KCTD7;TRPC6;SGK1;SYNGR3;SGK2;PDZK1;WNK3
prerank,cell junction maintenance (GO:0034331),0.35666361107011924,0.9268674799496591,0.5524625267665952,0.9168417564445742,1.0,4/14,15.78%,CSF1R;F2R;DCTN1;CBLN2
prerank,regulation of protein dephosphorylation (GO:0035304),0.28873842587388954,0.9266559657004771,0.5775862068965517,0.9164075838684356,1.0,11/37,21.02%,YWHAB;PPP1R16B;SMPD1;CALM1;CALM2;CALM3;MFHAS1;PPIA;CAMTA1;PPP2R5A;PPP1R16A
prerank,glycogen catabolic process (GO:0005980),-0.3668098056984155,-0.9263412581504145,0.5485148514851486,0.8017898630466334,1.0,6/15,14.62%,PHKB;PYGB;PHKA1;AGL;RB1CC1;PYGM
prerank,regulation of protein kinase C signaling (GO:0090036),-0.37384025837071677,-0.9260810326446742,0.5462794918330308,0.8019299299923199,1.0,6/14,20.82%,ADGRV1;VEGFA;MYADM;GPD1L;WNT5A;DGKD
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.27373162660135925,0.9258433842157264,0.5782608695652174,0.9176271503253528,1.0,8/42,14.14%,AARS2;VARS1;VARS2;GARS1;RARS1;FARSB;AIMP2;IARS1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.3700128073185335,0.9258424163472886,0.5683760683760684,0.9166065461589248,1.0,3/13,13.52%,CSTF2T;CSTF2;CPSF2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2527258705446684,0.9257369902230203,0.6247464503042597,0.9158520356875579,1.0,20/80,16.05%,SIRT1;PAX2;PPM1F;SNCA;GAS6;GPX1;ARL6IP1;KLF4;BEX3;AKT1;RPS6KA1;ACVR1C;NOD1;F2R;BCL10;NDUFA13;TNFSF10;DELE1;SOX7;RAF1
prerank,protein-DNA complex disassembly (GO:0032986),0.34723109148608255,0.9256236063338118,0.5522388059701493,0.9151379851384709,1.0,4/16,14.94%,RPL23;SMARCB1;SET;SMARCD1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.33747077912594603,-0.9256162245478747,0.5542406311637081,0.802583719728907,1.0,7/21,23.22%,MCU;ANXA6;LETM1;MICU1;SLC8A3;FIS1;SLC8B1
prerank,peptide hormone secretion (GO:0030072),-0.3083932658427425,-0.9251497019132238,0.5834932821497121,0.8032318503643634,1.0,4/26,8.12%,CYB5R4;CDK16;ANXA1;CAMK2G
prerank,negative regulation of hydrolase activity (GO:0051346),0.27178188289678906,0.9249440631185064,0.5741525423728814,0.9160401251232878,1.0,5/49,6.42%,CAMK2A;PLXNB3;MAP2;ZCCHC9;FICD
prerank,T-helper cell differentiation (GO:0042093),0.35934277207128207,0.9245491937794945,0.5315126050420168,0.916112750910721,1.0,2/14,5.96%,LEF1;TMEM98
prerank,translational elongation (GO:0006414),0.24145514403313947,0.9242281179685609,0.6019417475728155,0.9160209513863357,1.0,37/101,24.59%,MRPS25;MRPL14;MRPS12;EEF1B2;MRPL49;TUFM;MRPS18A;MRPL13;EEF1D;MRPS7;MRPS14;MRPL45;EEF1A2;MRPL36;MRPL23;EEF1A1;MRPL54;MRPS5;EEF2;MRPS22;MRPS35;MRPS28;MRPL18;OXA1L;MRPL37;MRPL2;RACK1;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23;TSFM;MRPL17;MRPL19;MRPL15;NEMF
prerank,neuromuscular synaptic transmission (GO:0007274),-0.34879996789233036,-0.9241120643335725,0.5711462450592886,0.8052298212305615,1.0,3/18,7.55%,FCHSD2;ERC1;TBC1D24
prerank,inner ear morphogenesis (GO:0042472),0.3262026134564314,0.9235405717670144,0.5720164609053497,0.9169638616407448,1.0,2/22,3.55%,PAX8;PAX2
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.38040966934989806,-0.9232750052791021,0.5529865125240848,0.806758529050551,1.0,2/12,1.71%,ADAMTS12;DCN
prerank,extracellular matrix assembly (GO:0085029),0.3259105257203517,0.923250311758356,0.5785123966942148,0.9167258285330552,1.0,5/23,9.17%,RAMP2;GPM6B;GAS6;NTNG2;NTNG1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.2602418253033559,0.9231435732727858,0.5936170212765958,0.9160094221546968,1.0,11/68,13.35%,TIRAP;MBP;IL17F;TLR2;ARHGEF2;AIF1;F2R;BCL10;HSPD1;POU2AF1;XBP1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.2749637099455776,-0.9228668428562689,0.574757281553398,0.8072942585731306,1.0,9/47,10.66%,KIF13A;CCDC93;ARL3;RAB10;OSBPL5;VAMP5;VAMP2;GGA3;EXOC2
prerank,negative regulation of mitochondrion organization (GO:0010823),0.28706086494701344,0.9226340350521007,0.5861386138613861,0.916432369211652,1.0,5/33,7.85%,TFRC;OMA1;GPX1;CLU;AKT1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.37776918601093834,-0.9225075179182192,0.5727969348659003,0.8076627490728513,1.0,4/13,19.31%,NFAT5;RHOA;TRAF6;IRAK1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.2597047763549539,-0.9224446102422902,0.6291913214990138,0.8073334009568834,1.0,31/57,33.21%,FOXN3;NBN;TAOK3;BRCC3;ATF2;BRSK1;RFWD3;RINT1;STK33;PRKDC;TRIM39;CDC14B;NOP53;MRE11;SDE2;CDK2;CDK5RAP3;WAC;TAOK1;CLSPN;DONSON;TIPIN;ABRAXAS1;FZR1;FANCD2;NEK11;MDC1;RPA2;EME2;RAD9A;BRCA1
prerank,protein localization to chromatin (GO:0071168),-0.3449781425462758,-0.922111348972504,0.5636363636363636,0.8076137031716848,1.0,10/18,37.04%,MCM9;RAD21;NIPBL;PIH1D1;PPHLN1;ESR1;RUVBL2;WAPL;MSH2;MRNIP
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.1968110181849714,-0.9217186739297609,0.8204592901878914,0.8080613883755693,1.0,86/532,14.47%,COL1A2;GAB2;APPL2;LEPR;NFKB1;IL34;PELI2;LIMS1;UBE2N;BRWD1;FOXC1;GRB10;ZEB1;VIM;IL31RA;IL6ST;FOXO3;MAP3K3;GHR;EDA;JAK1;BTRC;KIT;YAP1;IRAK3;IRS1;IL15RA;LBP;ITGB1;IL13RA1;RAP1B;PAK2;ANXA2;STAT3;SHC1;IFIT2;IL16;BCL2;IRAK2;TRIM8;ANXA1;F3;CAMK2D;TRAF3IP2;INPPL1;CTR9;MID1;CDC42;CAMK2G;TNFRSF11B;SP100;PITPNA;IL17RA;FER;TRAF2;PRKCD;ABL2;HIF1A;SMAD4;STX4;CNTFR;GREM2;TRIM5;CAPZA1;PSMF1;HSPA9;UGCG;IRF9;ARF1;FN1;NUMBL;TRIM25;RALA;APPL1;IL6R;CARD14;IRF1;MMP2;LTBR;TEC;PSMB2;TYK2;SLC27A1;VEGFA;STAT1;RORA
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3119455239143655,-0.9215514783361032,0.5688622754491018,0.807975805831002,1.0,3/26,3.96%,ITPR1;ITPR2;IBTK
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.32233849730589703,-0.9214595202365921,0.5674603174603174,0.8077123821231339,1.0,11/22,30.76%,BMP7;BMP4;ROCK1;ANKLE2;INPP5K;INHBA;CDKN1C;PRKRIP1;TESK1;CDA;INHA
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3194302483177363,0.9214007750409985,0.5748898678414097,0.9188338919341695,1.0,5/21,12.78%,PDE2A;NUDT3;HPRT1;HINT1;PDE4D
prerank,regulation of centrosome cycle (GO:0046605),-0.3253269314983063,-0.9213450930875018,0.5625,0.8075083135033208,1.0,5/21,10.16%,VPS4B;CHMP4B;MARK4;CHMP5;CHMP3
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.40468399567958147,-0.9211945098535892,0.5722222222222222,0.8073975153875501,1.0,2/10,3.63%,TGFBR2;CD55
prerank,autonomic nervous system development (GO:0048483),0.33479951683212394,0.9211694947291913,0.5605381165919282,0.9184770449030398,1.0,6/17,21.36%,PHOX2A;SOX4;PHACTR4;EDNRB;KIF26A;SEMA3A
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4077686496723253,-0.921023652007389,0.603448275862069,0.8068455250208902,1.0,3/10,18.50%,NFAT5;NFATC4;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),-0.4077686496723253,-0.921023652007389,0.603448275862069,0.8068455250208902,1.0,3/10,18.50%,NFAT5;NFATC4;NFATC3
prerank,protein complex oligomerization (GO:0051259),0.2456898936039964,0.9208267130418772,0.6463414634146342,0.9183964239218266,1.0,21/85,19.08%,MPP2;ADCY8;KCNC2;AQP11;SNCA;GLRA3;KCNC3;HOMER1;NINJ1;KCNC1;RNF112;BCL10;HGSNAT;MAT2A;ZNHIT6;PNPT1;VSTM5;G3BP2;PDCD6IP;LRRC8A;OXA1L
prerank,regulation of cellular component organization (GO:0051128),0.2318680353838446,0.9203844593571554,0.6400817995910021,0.9186546774898227,1.0,24/135,12.99%,NRG3;TFRC;SPOCK1;RIT2;RAB4B;OGFR;SEMA4D;PAK5;HIP1;HSPA8;BBS10;PRKCQ;WFDC1;MELTF;RAB4A;SGK3;TAOK2;DAB2IP;NET1;IL17RB;TJP1;BCAR1;SSRP1;CD36
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.37042613656023105,-0.9199225051045414,0.5779816513761468,0.8090182411113167,1.0,8/14,33.36%,NMNAT2;ME1;NMNAT3;NMNAT1;CMPK2;AK1;PNP;AK7
prerank,transcription by RNA polymerase III (GO:0006383),-0.3060864799704368,-0.9197445716440328,0.5851851851851851,0.8089573858980832,1.0,12/27,30.54%,TBP;BRF1;SNAPC3;ICE1;GTF3C4;POLR2K;GTF3C1;SNAPC1;POLR3H;GTF3C6;SNAPC5;GTF3A
prerank,protein import into peroxisome membrane (GO:0045046),-0.3263566370074559,-0.9197092102916518,0.5681818181818182,0.8085712429917845,1.0,7/22,20.41%,ABCD3;PXMP4;ABCD2;SLC25A17;FIS1;PXMP2;PEX26
prerank,phagolysosome assembly (GO:0001845),0.38087972659534297,0.9188929141923892,0.5494505494505495,0.9216737562226608,1.0,2/12,10.78%,SYT7;CORO1A
prerank,positive regulation of programmed cell death (GO:0043068),-0.20823595979507317,-0.9187830426387237,0.7434869739478958,0.8103233644987474,1.0,62/272,18.73%,AKAP13;PAWR;BMP4;FOXO3;STK3;TIAM2;ABL1;ARHGEF17;LRRK2;STK17B;IGFBP3;RARG;HMGB1;ITGB1;DNM1L;HOXA5;PHLDA1;IFIT2;REST;MAP3K5;PLEKHG2;FAM162A;CALHM2;AIFM1;VAV2;ADAMTSL4;MARK4;UNC13B;MAP3K20;NGF;NCSTN;PRMT2;JUN;CYP1B1;ARHGEF12;ARHGEF18;BCLAF1;ERCC3;SOS2;FGD1;CASP2;RASSF2;ATF6;RBM5;CCAR1;ING5;LATS1;FGD4;DDX3X;NGEF;TGFB3;ARHGEF11;DAPK1;PTPA;ARHGEF6;TRIO;DAPK2;ARHGEF1;IAPP;TRAF6;DCUN1D3;BMP2
prerank,transepithelial transport (GO:0070633),0.3578073191775518,0.9187185816184823,0.5622406639004149,0.921164191820929,1.0,3/15,5.91%,ABCG2;SLC1A1;SLC1A2
prerank,positive regulation of cell killing (GO:0031343),-0.3712288452069127,-0.9184467465165896,0.5659340659340659,0.810677417048191,1.0,5/13,25.71%,FZD7;CYBA;WNT5A;SYK;DVL2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.2769126265867068,-0.9183431449833711,0.5899419729206963,0.8104637095343835,1.0,9/47,17.06%,PID1;PDGFRB;SLC5A3;TGFBR2;THBS1;PRKCD;AGTR1;CYBA;TLR4
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.31393851838917114,-0.9173873880589908,0.5788461538461539,0.8123000845452735,1.0,10/27,26.52%,NFKB1;ABCA1;ITGAV;NR1H3;AGTR1;IL18;ITGB3;PPARA;MAPK9;LPL
prerank,negative regulation of receptor internalization (GO:0002091),0.37517424994441967,0.9172512814409847,0.5520169851380042,0.9241565416526422,1.0,1/12,1.69%,NECAB2
prerank,amide biosynthetic process (GO:0043604),0.2729365684255973,0.9172234329579056,0.5970464135021097,0.9232102042870982,1.0,4/47,3.41%,SGMS1;PCSK1;FA2H;DEGS2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.2193637675994172,-0.9171688035085819,0.708502024291498,0.8123251985459508,1.0,80/184,34.46%,APPL2;PKD1;INO80;PCM1;CDC14A;BTRC;ALMS1;ODF2;NINL;CEP63;CEP135;PCNT;ANAPC5;ANAPC7;ANAPC4;CSNK1E;ANAPC16;ID2;ERCC3;PSMF1;CUL3;APPL1;MAPRE1;PSMB2;CDC26;CDC14B;YWHAE;AKAP9;UBE2E1;CDC27;DYNC1H1;CEP76;PRKACA;UBE2S;KLHL18;CEP57;CSNK1D;CDK2;PSMC1;NEK6;ANAPC11;CUL1;HAUS7;PSMA3;PSMB6;HAUS8;PLK5;ACTR1A;TFAP4;PSMA4;CDC16;ANAPC1;PSME1;PSMD13;ZFP36L2;HAUS3;CEP41;FZR1;PSMB9;PSMB10;PSMA5;E2F1;UBA52;HAUS4;HAUS5;PLK4;NEK11;CENPE;CEP72;SSNA1;CEP164;PTPN6;PSME4;BUB1B;MAD2L1;RIOK2;PSMD10;CKAP5;DDB1;PSMB8
prerank,positive regulation of growth (GO:0045927),-0.25317269406677145,-0.9171314236256921,0.6320754716981132,0.8119308581031099,1.0,16/64,15.57%,EGFR;TGFBR1;INO80;RPTOR;BCL2;HDGFL2;CDC42;CXCL16;USP47;MMP14;N6AMT1;ADNP2;KLHL22;EXOSC9;DDX3X;CSNK2A1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.3079215779994167,-0.9169867907858337,0.596958174904943,0.8118168891124858,1.0,9/29,29.45%,LDLRAD4;BMP5;IL17RD;VASN;PPP2CA;SPRED2;USF3;SDHAF2;MAD2L2
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.27956953385402944,-0.9166465543541719,0.6023856858846919,0.8121440411581275,1.0,7/40,13.97%,SLC7A11;SLC13A3;ABCC5;SLC38A11;SLC5A6;SLC38A6;SLC27A1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.3404662938233346,0.9165920043472908,0.569327731092437,0.9238869469292876,1.0,5/17,16.62%,MIF;SIRT1;RNF34;RFFL;MDM2
prerank,positive regulation of telomere capping (GO:1904355),-0.3550096527670079,-0.916407008446957,0.5846774193548387,0.8122470043977034,1.0,4/17,15.90%,TNKS2;HNRNPD;NABP2;MAP2K7
prerank,regulation of acute inflammatory response (GO:0002673),0.3385177611474082,0.9162846779793541,0.5787234042553191,0.9237335620238429,1.0,1/18,1.06%,DNASE1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.28175496820050744,0.9159499944849612,0.5613682092555332,0.9236496346663545,1.0,13/42,19.08%,SIRT1;ISG15;RPA3;RPS27A;UBC;POLK;UBB;POLD1;RFC4;POLD3;RFC5;POLI;RFC2
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.28400305463859654,-0.9159417815183287,0.5695732838589982,0.8128378166143188,1.0,16/40,31.74%,UBE2N;SMG1;ABL1;PRKCD;RFWD3;BCLAF1;WDR76;NEK4;KMT5A;UBE2V2;NSMCE4A;FXR1;POLH;CDK9;PARG;RPA2
prerank,second-messenger-mediated signaling (GO:0019932),0.24867410905908735,0.9159361947837449,0.631578947368421,0.922685537698423,1.0,11/82,8.30%,CHRM3;KSR2;RYR2;MCTP1;NOS3;RCAN2;PPP2R1A;PPP1R9A;ACKR4;NDNF;RCAN3
prerank,membrane fusion (GO:0061025),-0.299297967295494,-0.915911255291578,0.5875486381322957,0.8124518859283977,1.0,14/33,24.07%,OPA1;HUWE1;UBXN2B;DNM1L;MYOF;VTI1B;VAMP2;GCA;SNAP23;NAPA;CHP1;NSF;VAPA;USO1
prerank,regulation of transposition (GO:0010528),-0.37399522097931076,-0.9158117605551523,0.6032608695652174,0.8122169533860254,1.0,2/13,16.54%,UBR2;MYBL1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.3110522769566633,-0.91579101166089,0.608534322820037,0.8117899163834849,1.0,8/27,21.39%,NFKB1;BTRC;MAP3K5;MAP3K20;MAP2K7;TNIP2;FBXW11;CUL1
prerank,cell chemotaxis (GO:0060326),0.2574156268977777,0.9157757923074545,0.621676891615542,0.9221313384195191,1.0,9/60,10.53%,LEF1;EPHB1;PLXNB3;CXCL12;DOCK4;PRKCQ;ACKR4;BIN2;PDGFB
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.23306463384498105,-0.9155403168436831,0.6594059405940594,0.811890726919308,1.0,35/117,27.17%,IGF1;ALDH1A2;PCCA;ME2;HLCS;CYP26B1;ABAT;ACADSB;GNPAT;CPT1C;MCCC2;VDAC1;PANK2;ACSF2;ME1;SLC5A6;PNPLA8;ACOT11;GLO1;PDHA1;ECHDC3;CPT1A;AMACR;MECR;ALDH4A1;ACSL4;ACOT6;SCPEP1;GGT5;GBA2;ME3;AASDH;PPARA;LPL;ALOX12
prerank,regulation of cell cycle phase transition (GO:1901987),-0.24363107862132602,-0.9153819404889372,0.6363636363636364,0.8117704442430881,1.0,40/91,34.46%,BTRC;ANAPC5;ANAPC7;ANAPC4;ANAPC16;MN1;ERCC3;PSMF1;FBXW7;PSMB2;CDC26;TRIM39;UBE2E1;CDC27;UBE2S;PSMC1;ANAPC11;CUL1;PSMA3;PSMB6;TFAP4;PSMA4;DBF4;CDC16;ANAPC1;TCIM;PSME1;PSMD13;FZR1;PSMB9;PSMB10;PSMA5;NEK10;NEK11;PSME4;BUB1B;MAD2L1;PSMD10;DDB1;PSMB8
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.33170536380717647,-0.9153334693801332,0.5568862275449101,0.811436995199183,1.0,7/18,22.14%,PRKN;IRS1;REST;CCN3;ADRA2A;SIRT4;KCNB1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.39535516518502717,0.9151854954551023,0.5740740740740741,0.9227237578778322,1.0,3/10,13.05%,HECW1;HECW2;STK39
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.35583113852841247,-0.9146946408004344,0.5717171717171717,0.8124817313502235,1.0,5/15,14.57%,NTRK3;IL16;F3;VEGFA;VEGFD
prerank,hexose biosynthetic process (GO:0019319),-0.2771752554991186,-0.9144309497709115,0.6087824351297405,0.8126120549109122,1.0,10/42,17.38%,RBP4;SLC39A14;AKR1B1;PPARGC1A;CHST15;MDH1;PCK2;PGK1;SLC25A11;CRTC2
prerank,negative regulation of blood pressure (GO:0045776),0.37411636127911385,0.914398823052044,0.5749486652977412,0.9238465402920006,1.0,2/13,12.80%,NOS3;BMPR2
prerank,regulation of biomineral tissue development (GO:0070167),-0.3081495478652314,-0.9142411944980479,0.5730994152046783,0.8125902285772322,1.0,6/26,16.23%,ROCK2;ROCK1;ENPP1;NBR1;BMP2K;ECM1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.38676616218144366,0.9136744698983121,0.589010989010989,0.9247864226321894,1.0,2/10,6.98%,PPM1F;TERF1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.29458863299150573,-0.9130479401500091,0.5928853754940712,0.8148587480605263,1.0,16/32,28.69%,FOXN3;NBN;TAOK3;BRCC3;BRSK1;RINT1;TRIM39;CDC14B;NOP53;MRE11;CDK5RAP3;TAOK1;CLSPN;DONSON;ABRAXAS1;FZR1
prerank,regulation of endocytic recycling (GO:2001135),-0.3835036675782064,-0.913000074804096,0.5814393939393939,0.8144930230380663,1.0,5/11,28.97%,EHD2;ACTN2;EIPR1;ATP9A;EHD1
prerank,protein localization to lysosome (GO:0061462),0.30129296435513875,0.9124062542446585,0.5783664459161147,0.9272908649891765,1.0,13/28,23.72%,SCARB2;NCOA4;GLMP;SORL1;RTN4;M6PR;AP3M1;HGS;VPS4A;SNX16;LMBRD1;SH3BP4;GCC2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.3270765855623805,-0.9117142693107545,0.5862068965517241,0.816978615557878,1.0,3/19,2.79%,DCN;CCBE1;ROBO1
prerank,protein acylation (GO:0043543),-0.2823156289160304,-0.9112153741650826,0.5909980430528375,0.8176722835921338,1.0,14/38,27.88%,KAT2B;EP300;CREBBP;GLUL;ZDHHC13;ING5;GTF2B;ZDHHC1;ZDHHC16;HHAT;SPHK1;ZDHHC8;NAT10;NAA80
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.36488067608952013,-0.911037820897041,0.5772200772200772,0.8176237214892199,1.0,10/15,35.31%,TSEN2;ERN1;TSEN15;CPSF4;RTRAF;CPSF1;RTCB;TSEN54;TRPT1;FAM98B
prerank,engulfment of apoptotic cell (GO:0043652),0.3573628171871145,0.9110022744873597,0.5688888888888889,0.9300308325617612,1.0,5/15,19.79%,ADGRB1;XKR6;MEGF10;XKR4;RAC1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.35833317785385044,-0.9109666363986916,0.5934664246823956,0.8173213887704425,1.0,5/15,13.97%,LDLR;NR1H3;SIK1;FBXW7;SLC27A1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3402232131450647,0.9109414674059653,0.5755555555555556,0.9291861940665388,1.0,6/18,13.28%,TENM4;NOTCH1;TMEM98;OPALIN;TNFRSF21;PTPRZ1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.30820501286742363,0.9108279910756308,0.5667396061269147,0.9284837045252952,1.0,4/26,6.27%,USP44;LCMT1;UBE2C;HECW2
prerank,regulation of cytokine production (GO:0001817),0.22883272853181666,0.9104741277588211,0.6946107784431138,0.9284288871557447,1.0,14/126,11.14%,CADM1;IL17F;HDAC9;MIF;BTNL9;SYT11;ISG15;MOG;RPS6KA5;NPTN;GPNMB;TRIL;IRF7;PPP1R11
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.33442710101562206,-0.9104274143203691,0.5908221797323135,0.8180955003519012,1.0,8/18,22.21%,MAP3K3;RHOJ;FOXC2;ANXA1;VEGFA;FGFBP1;FGF2;SRPX2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3798857162157698,-0.9104212607408338,0.5814393939393939,0.8176378509830233,1.0,7/12,34.01%,BDH2;CHAC2;GSS;GGCT;GCLC;HAGH;CNDP2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.32764643877889965,0.910368445788405,0.5927505330490405,0.9277108007921305,1.0,4/21,10.36%,SLC39A10;PRKCH;GPS2;LPXN
prerank,negative regulation of transferase activity (GO:0051348),-0.3050761349325058,-0.9098669103976471,0.59375,0.8184463153676138,1.0,8/28,20.25%,ABL1;GSK3B;EIF4A2;DTX3L;HNRNPU;INPP5K;PARK7;CDKN1C
prerank,homeostasis of number of cells (GO:0048872),0.37319342967999986,0.9094051329732625,0.565922920892495,0.9293089247161189,1.0,4/12,10.98%,NOS3;NOTCH1;OCIAD1;F2R
prerank,regulation of organelle organization (GO:0033043),-0.244628675535697,-0.9091825063215558,0.6490196078431373,0.8195853884534173,1.0,28/80,24.94%,DIAPH1;EP300;PRKN;DNM1L;PAK2;STX18;CLIC4;ZEB2;USP6NL;MAVS;RHOT1;STX5;ARMH3;SURF4;EHD3;AKAP9;PLXNB1;FIS1;SPEF1;MSN;TAOK1;F11R;PARL;PREB;RHOT2;LMAN1;SAR1B;NEXN
prerank,regulation of response to oxidative stress (GO:1902882),0.39020399398650407,0.9089432605629685,0.5936794582392777,0.9295694666337162,1.0,4/11,16.22%,MCTP1;HEBP2;GGT7;STOX1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.3630058905239718,0.9087714284236512,0.6053719008264463,0.9290388449707828,1.0,3/12,3.74%,RYR2;CTNNA3;BIN1
prerank,piRNA metabolic process (GO:0034587),0.3232441184020791,0.9087328062415223,0.5936794582392777,0.9281344637980546,1.0,3/19,19.27%,TDRD12;PIWIL2;TDRKH
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2533042109766181,-0.9084854028649085,0.6536203522504892,0.8207496937451461,1.0,10/71,8.08%,ADAMTS12;NGLY1;FBXL17;PRKN;HM13;CTSC;CTSH;VPS4B;DDI2;CHMP4B
prerank,positive regulation of cell cycle (GO:0045787),-0.25925724621679674,-0.9082487508125947,0.6434262948207171,0.8208423651377408,1.0,16/62,16.51%,EGFR;PKD1;LRP6;ANKRD17;NUPR1;FGFR2;EIF4E;CCNYL1;HCFC1;PKD2;TTL;USP2;CDC25B;CCND3;CCDC57;CITED2
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.319308532701046,-0.9075910085905737,0.592391304347826,0.8218265672242798,1.0,6/22,14.69%,AKAP13;AEBP1;ABL1;PRUNE1;EFEMP2;APOE
prerank,ATP synthesis coupled proton transport (GO:0015986),0.3464391020390697,0.907501807930489,0.5667396061269147,0.9304012373628823,1.0,5/17,14.80%,ATP5F1D;ATP5F1B;ATP5ME;DMAC2L;ATP5MF
prerank,regulation of isotype switching (GO:0045191),0.36068682270154995,0.9074448138284071,0.5789473684210527,0.9295592597635304,1.0,2/14,9.39%,TFRC;SHLD3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.32621136037066023,-0.9073967566943905,0.603515625,0.8218261451889407,1.0,5/21,7.32%,SULF1;SULF2;EXT1;GLCE;HS2ST1
prerank,positive regulation of heart contraction (GO:0045823),-0.3376205670360903,-0.9073418825377991,0.592,0.821491062581566,1.0,1/19,0.03%,ATP1A2
prerank,negative regulation of insulin secretion (GO:0046676),-0.3421488206132203,-0.9067530213931121,0.5900621118012422,0.8224046891695779,1.0,7/17,22.14%,PRKN;IRS1;REST;CCN3;ADRA2A;SIRT4;KCNB1
prerank,positive regulation of transport (GO:0051050),-0.24089526867242037,-0.9065656059105576,0.6779324055666004,0.8223707138897337,1.0,26/85,26.38%,LRP1;DAB2;CAMK1D;NUMA1;GSK3B;GPC3;IL15RA;ANXA2;ANXA1;MERTK;NR1H3;APOE;RXRA;CYBA;DYNC1H1;INPP5K;ABCA7;AKT2;KMT2A;ZNF205;CHP1;HIP1R;SIRPA;FCER1G;KCTD7;CLIP3
prerank,regulation of actin filament-based movement (GO:1903115),-0.3937238259325241,-0.9064623575586355,0.5860113421550095,0.8221612618272702,1.0,2/10,2.85%,ANK2;PDPN
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.3808814260328629,-0.9064003561959688,0.5942307692307692,0.8218355559825037,1.0,6/11,30.31%,UQCRC1;UQCR10;UQCR11;CYC1;UQCRFS1;CYCS
prerank,protein targeting (GO:0006605),0.23209018716687152,0.9063714994947392,0.6425619834710744,0.9314908699321455,1.0,31/118,20.14%,NLGN1;GDAP1;AQP11;AKAP6;RASSF9;GABARAP;ZDHHC22;CACNG3;GOLGA7;AP4B1;PITRM1;ZDHHC15;TAOK2;HAP1;TIMM22;HACL1;SORL1;SRPRA;TSPO;ZDHHC4;SEC61G;ZDHHC14;VPS37A;HOMER3;RTP4;ARL6;TOMM70;TIMM10B;ZDHHC24;VPS37D;DNAJC19
prerank,replication fork processing (GO:0031297),-0.2841262463166199,-0.9060774097393205,0.6423357664233577,0.8221140110105624,1.0,18/38,35.37%,WRN;RFWD3;FANCM;BRCA2;BOD1L1;MRE11;ZRANB3;PCNA;SMARCAL1;ATR;PRIMPOL;ATRX;SAMHD1;CDK9;EME2;RAD51;CENPX;GEN1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.2908658431314415,0.9059860563578919,0.5911016949152542,0.9315120861892849,1.0,6/34,11.49%,FLT1;TEK;FLT3;DAB2IP;PDGFB;PIK3R3
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.25553113070376243,0.9057822340091456,0.6123260437375746,0.931067347582514,1.0,20/60,19.09%,PRKCQ;KLF4;HSP90AB1;PDGFB;CCT2;DKC1;CCT4;ATM;PARM1;RFC4;PTGES3;XRCC5;CTNNB1;RFC5;HSP90AA1;NAF1;MAPK3;NVL;RFC2;TCP1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.31162910289206736,0.9056369675628995,0.5965665236051502,0.9304402652124523,1.0,7/24,16.84%,DACH1;ACVRL1;TERF2IP;BMPR2;RPS3;CDKN1A;XRCC5
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.29430333258134017,-0.9054950963661801,0.5970961887477314,0.823006420669077,1.0,6/33,7.95%,TCF7L2;ANGPT1;CAST;NUPR1;YAP1;PDPK1
prerank,organelle transport along microtubule (GO:0072384),-0.2916093223321122,-0.9054789524294742,0.6121673003802282,0.8225800470578931,1.0,9/31,19.11%,TRAK1;ARHGAP21;CDC42;NDEL1;RHOT1;COPG2;TMEM201;FBXW11;COPG1
prerank,phosphate ion transmembrane transport (GO:0035435),0.37472190490369994,0.9052752025364423,0.5914221218961625,0.9304254078733059,1.0,3/12,8.09%,SLC37A4;SLC37A1;SLC25A14
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.3807191991458227,-0.9052643549030758,0.5950095969289827,0.8226183923361772,1.0,3/12,12.22%,GSN;TRIM5;TRIM11
prerank,neurotrophin signaling pathway (GO:0038179),0.31978183461465165,0.9052206937387262,0.5720338983050848,0.9295744558031986,1.0,6/21,16.89%,MAGI2;NTRK2;HAP1;BCAR1;RAP1A;DDIT4
prerank,motile cilium assembly (GO:0044458),0.37424056441849046,0.9043653792674572,0.6109936575052854,0.9308546631294083,1.0,2/12,10.49%,DNAAF3;BBS5
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.28925338032865694,-0.9043350924753775,0.5907258064516129,0.8242701251614561,1.0,12/36,22.83%,AFDN;KIF13A;RAB10;VAMP5;VAMP2;GGA3;RILPL2;NECTIN3;VAMP4;RILPL1;GGA2;NSF
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.24474449526545494,-0.9043161698450961,0.6653465346534654,0.8238552348741665,1.0,28/83,26.28%,CCNH;KHDRBS1;CDK16;CDK7;TFDP2;PHF8;EIF4E;MNAT1;RB1;CUL3;CRLF3;HINFP;LATS1;CUL2;ACVR1;RCC1;NASP;CACUL1;INHBA;CDK2;PCNA;CUL1;CDK6;DBF4;CCNE2;EIF4EBP1;NPAT;ORC1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.28879256637887507,0.903854928805059,0.6165254237288136,0.931238924777823,1.0,7/35,10.02%,SPRY3;RASAL3;STMN1;TGFB2;KCTD13;SPRY4;DAB2IP
prerank,B cell homeostasis (GO:0001782),-0.3972092646400991,-0.9036232085068798,0.6046099290780141,0.8249842829135338,1.0,3/10,11.26%,DOCK11;LYN;MEF2C
prerank,pentose-phosphate shunt (GO:0006098),-0.38981959324766036,-0.903051864005325,0.5916334661354582,0.8258693358267641,1.0,6/11,25.89%,DERA;H6PD;PGLS;SHPK;RBKS;RPE
prerank,in utero embryonic development (GO:0001701),-0.3112566469727336,-0.9028175197873067,0.5972495088408645,0.8259326631212246,1.0,9/25,18.73%,TGFBR1;PKD1;FGFR2;IGF2;HINFP;VEGFA;CHD7;TGFB3;BMP2
prerank,sterol biosynthetic process (GO:0016126),-0.2914693450238768,-0.902270139253309,0.6039215686274509,0.8267272825144003,1.0,11/33,24.55%,PRKAG2;INSIG2;ACAA2;HMGCR;SQLE;CYP51A1;FDFT1;SC5D;LBR;ARV1;MVK
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.2621988260688009,0.9021396801741899,0.6565656565656566,0.9347083702117722,1.0,11/57,12.90%,GRIN1;GRIN2A;SIRT1;GRIN2B;PPM1F;ACVR1C;NOD1;F2R;BCL10;NDUFA13;TNFSF10
prerank,innate immune response (GO:0045087),0.21441729356071526,0.902115731004766,0.7494866529774127,0.9337784314989352,1.0,33/217,16.04%,MASP2;PGLYRP1;MBL2;TRIM13;PPARG;SNCA;ISG15;CAPZA2;TRIM43;SRMS;TLR2;TRIM62;TRIM6;IFITM3;TRIM59;SLPI;CYBC1;SMPD1;IRF7;CORO1A;MID2;BCL10;CD40;PJA2;LCN2;TRIM35;DEFA6;POLR3A;B2M;MFHAS1;GCH1;OTULIN;RNASE3
prerank,positive regulation of endocytosis (GO:0045807),-0.26943283552503317,-0.9020270829195063,0.6460905349794238,0.8268237062276297,1.0,8/45,9.29%,LRP1;APPL2;AXL;DAB2;VTN;GPC3;CDC42;HNRNPK
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3165067828929317,0.9019971510396438,0.5983772819472617,0.9320886119307896,1.0,10/23,22.15%,YWHAB;YWHAG;MAPK8;NMT1;PPP3R1;BBC3;CASP8;PPP1R13B;YWHAQ;PPP3CC
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3165067828929317,0.9019971510396438,0.5983772819472617,0.9320886119307896,1.0,10/23,22.15%,YWHAB;YWHAG;MAPK8;NMT1;PPP3R1;BBC3;CASP8;PPP1R13B;YWHAQ;PPP3CC
prerank,negative regulation of anoikis (GO:2000811),-0.3556363515651164,-0.9015224274015127,0.6224299065420561,0.8274857497849842,1.0,4/14,15.52%,ITGB1;BCL2;TLE1;ITGA5
prerank,cytosolic calcium ion transport (GO:0060401),0.29867583216344207,0.9014901599252041,0.5867237687366167,0.932459498622903,1.0,7/28,11.38%,RYR2;CACNA2D1;SLC8A1;ATP2B3;SLC25A23;ADRA1A;JPH3
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.2928492148324799,-0.9003501031945379,0.6228239845261122,0.8296563719528619,1.0,3/29,6.49%,TGFBR3;TPM1;FGFR2
prerank,positive regulation of organelle assembly (GO:1902117),-0.2748400891409844,-0.9001226538397864,0.6385068762278978,0.829693192752261,1.0,16/44,25.92%,ASAP1;NUMA1;RAB3GAP1;STX18;PIP4K2C;MARK4;CNOT2;SDC4;CNOT1;DYNC1H1;LRSAM1;KCTD17;TAPT1;ARHGAP35;SDC1;BBS4
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.27793552539329425,0.9000130619021762,0.6282608695652174,0.9354730761092511,1.0,16/38,20.01%,CLU;KLF4;AKT1;HSP90AB1;CD34;KHSRP;GLA;KLF2;CD36;INSR;ATP2B4;EDN1;HSP90AA1;DDAH1;RAC1;CD47
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.2831503601497378,0.899873632021593,0.6482617586912065,0.9348352647399494,1.0,9/33,17.06%,TERF1;HSP90AB1;PIF1;TERF2IP;NHP2;DKC1;TINF2;PTGES3;HSP90AA1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.2655066637423043,0.8993625710735953,0.6396039603960396,0.9351462075426177,1.0,11/48,12.28%,HDAC9;TMSB4X;SIRT1;KDR;NOS3;ETS1;AKT1;HSPB1;PDGFB;ATP5F1B;CD40
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.37488128004607846,-0.8991362939100913,0.6336448598130842,0.8315310612124792,1.0,6/12,24.90%,GLUD1;ACO2;ACO1;ASS1;SIRT4;IREB2
prerank,regulation of phosphorylation (GO:0042325),-0.2266691794017894,-0.8990646007871412,0.717479674796748,0.8312191179438934,1.0,23/120,13.46%,PRKAG2;EGFR;BMP7;BMP4;EP300;ROCK1;THBS1;RANBP2;LYN;NRP1;NUP42;AR;PLXNB2;FER;ANKLE2;HIF1A;NUP214;FNIP1;TPR;FN1;KCTD20;FZD7;OGT
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.34573976137233614,-0.8987970471653236,0.6040515653775322,0.8313750669625674,1.0,2/17,4.47%,ANK2;SNTA1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.24606649794773652,-0.8984901345716184,0.6626016260162602,0.8316179938308638,1.0,29/70,36.28%,ITGAV;ITGB5;SEC22B;PSMF1;PSMB2;MFSD6;CYBA;LNPEP;TAP2;SNAP23;NCF2;PSMC1;PSMA3;PSMB6;PSMA4;TAP1;FCER1G;PSME1;PSMD13;PSMB9;PSMB10;PSMA5;CALR;PSME4;PSMD10;PSMB8;TAPBP;FCGR1A;PSMD3
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.2441304660258535,-0.8982589010002906,0.6698473282442748,0.8316770576611676,1.0,21/73,20.30%,EGFR;NTRK3;ARAF;RPTOR;TBK1;CREBL2;DOCK7;AXIN1;BRAF;RAPGEF3;NGF;FNIP1;TXN;VEGFA;LATS1;AKAP9;PRKD1;MTCP1;PARK7;EIF4G1;NOS1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.31848281298007364,0.8981275326127472,0.632016632016632,0.937396808432128,1.0,6/22,15.98%,IPO5;CAMK2N1;MEN1;APC;CDKN1A;CDKN1B
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3253619910722115,-0.8979869893074119,0.6054158607350096,0.831361292000191,1.0,10/21,34.21%,GTF2H2;DDB2;PARP1;ERCC3;ERCC1;GTF2H1;GTF2H4;RBX1;RPA2;DDB1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3253619910722115,-0.8979869893074119,0.6054158607350096,0.831361292000191,1.0,10/21,34.21%,GTF2H2;DDB2;PARP1;ERCC3;ERCC1;GTF2H1;GTF2H4;RBX1;RPA2;DDB1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.2954488980668747,-0.8976649959907652,0.6173752310536045,0.8311779361128689,1.0,7/29,23.20%,GPAT4;ACSF2;ACSL6;ACOT11;ACOT9;ACOT8;ACOT6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.2954488980668747,-0.8976649959907652,0.6173752310536045,0.8311779361128689,1.0,7/29,23.20%,GPAT4;ACSF2;ACSL6;ACOT11;ACOT9;ACOT8;ACOT6
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.36173383731784076,-0.8974957024570577,0.572,0.8310887511331085,1.0,3/13,13.22%,D2HGDH;ADHFE1;DLST
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.28619194588549773,-0.8972905697388618,0.6361904761904762,0.8310964941398655,1.0,12/34,19.29%,PTPN13;TNS2;PTPN9;PTPRS;DUSP16;PTPN22;PTPN12;PTPN2;DUSP1;DUSP10;PTPN1;PTPN11
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.3398837755663717,-0.8970688221498407,0.6033519553072626,0.8311055632693218,1.0,7/17,25.63%,BMP4;VEZF1;ATOH8;SFRP4;TMEM100;FGF2;NKX6-1
prerank,vesicle organization (GO:0016050),0.26569227002665474,0.8968715938715174,0.6329670329670329,0.939703429260889,1.0,17/46,23.54%,CAV2;HOOK1;FNBP1L;CD34;AKTIP;SAR1A;CORO1A;CHMP2B;USP8;DNM1;DNAJC13;SORT1;PI4K2A;SNX11;VPS33B;PLEKHJ1;SQSTM1
prerank,retinal metabolic process (GO:0042574),0.3714156879415458,0.8967723090091352,0.5654008438818565,0.9389906944817102,1.0,2/12,5.70%,BCO1;DHRS13
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.2942203823589701,-0.8964166286115317,0.6424361493123772,0.8321211703943413,1.0,17/31,37.47%,UBE2N;BTRC;AXIN1;FBXW7;CDC14B;TOPORS;UBE2S;DCUN1D3;MAGEC2;ARRDC4;FZR1;DCUN1D5;UBE2L3;DCUN1D4;PIN1;GORASP1;SKP1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.2974795762659581,-0.8962127982803856,0.6200787401574803,0.8320763228145709,1.0,8/28,15.45%,FCHSD2;ARHGAP28;PLEKHG2;BRK1;CTTN;LATS1;ARHGAP18;RASA1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.28198370985778776,-0.896109831428454,0.6429942418426103,0.8318636221463753,1.0,9/38,17.05%,BMP5;CFLAR;GSK3B;THBS1;SP100;TRAF2;STX4;DDX3X;SERPINE1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.3917843702938997,-0.8954584249056281,0.6163873370577281,0.8324545450885281,1.0,5/11,24.23%,JAK1;SHC1;STAT5A;STAT5B;SYK
prerank,cellular response to interleukin-2 (GO:0071352),-0.3917843702938997,-0.8954584249056281,0.6163873370577281,0.8324545450885281,1.0,5/11,24.23%,JAK1;SHC1;STAT5A;STAT5B;SYK
prerank,cellular response to type I interferon (GO:0071357),-0.27246481776410736,-0.8946441653711794,0.6576923076923077,0.8333526119830148,1.0,22/41,34.58%,JAK1;IFIT2;SP100;IRF9;IRF1;TYK2;STAT1;OAS2;GBP2;IFI35;IRAK1;IFI27;IFIT3;IRF2;IP6K2;SAMHD1;EGR1;IFITM1;IRF5;PSMB8;IRF8;MYD88
prerank,type I interferon signaling pathway (GO:0060337),-0.27246481776410736,-0.8946441653711794,0.6576923076923077,0.8333526119830148,1.0,22/41,34.58%,JAK1;IFIT2;SP100;IRF9;IRF1;TYK2;STAT1;OAS2;GBP2;IFI35;IRAK1;IFI27;IFIT3;IRF2;IP6K2;SAMHD1;EGR1;IFITM1;IRF5;PSMB8;IRF8;MYD88
prerank,O-glycan processing (GO:0016266),0.2585939734948502,0.894487698889432,0.640625,0.9440530024867104,1.0,8/54,13.23%,GALNT9;GALNT15;GALNT13;GALNT14;GALNT6;GALNT3;B3GNT2;GALNT2
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.32876729319637543,0.8944330486287931,0.6077235772357723,0.9431845531423989,1.0,4/18,8.66%,SIRT1;NME5;AKT1;HSPB1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.2982317520193632,-0.8943591455230465,0.6309751434034416,0.8335284798961683,1.0,8/29,20.15%,WWOX;THBS1;PAK2;TRAF2;LTBR;INHBA;PML;PPP2R1B
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.3259919157493158,0.8943377154438936,0.5991379310344828,0.9424455497259551,1.0,3/18,8.57%,FLT1;PPARG;CCL2
prerank,atrioventricular valve development (GO:0003171),-0.35950726637573555,-0.8940912521197311,0.6182495344506518,0.8336603240884637,1.0,3/14,3.19%,BMPR1A;MDM4;TGFBR2
prerank,positive regulation of exosomal secretion (GO:1903543),-0.35030113428764864,-0.8938534090181242,0.6063432835820896,0.8337336172205323,1.0,5/15,25.59%,VPS4B;SDC4;SNF8;RAB7A;SDC1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.39005493789140044,-0.8937413066724589,0.6254681647940075,0.8335162980691634,1.0,4/10,17.55%,RIPOR2;WASL;APOD;MIA3
prerank,negative regulation of cation channel activity (GO:2001258),0.2990221158902892,0.8935352110889356,0.6494845360824743,0.9435501277191202,1.0,6/26,13.93%,GPR35;KCNAB1;EPO;CALM1;CALM2;CALM3
prerank,protein insertion into membrane (GO:0051205),-0.2895946955926375,-0.8934095216771948,0.626204238921002,0.8337917871704144,1.0,11/32,28.87%,EGFR;TRAM2;VAMP2;STX5;COX18;EMD;GET4;VAPA;STX1A;APP;CCDC47
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.37858666651402845,-0.8933968912477075,0.5988593155893536,0.8333626542231255,1.0,5/11,26.57%,DHX36;ZC3H3;CDC73;AHCYL1;NCBP2
prerank,histone H3 acetylation (GO:0043966),-0.2712698253518123,-0.8933168177812465,0.6647173489278753,0.8330823326826102,1.0,13/40,24.83%,KAT2B;KAT6B;BRPF3;TADA3;KAT14;ING5;BRCA2;TAF5L;TAF6L;TAF12;JADE2;YEATS2;LDB1
prerank,nuclear membrane reassembly (GO:0031468),-0.2579815417022305,-0.8932607539609905,0.62109375,0.8327480523928393,1.0,23/54,35.20%,LMNA;UBXN2B;CHMP4B;CHMP4A;UBE2I;ANKLE2;CHMP3;CC2D1B;RCC1;EMD;NUP98;PPP2CA;NUP43;LBR;NUP160;NUP93;PPP2R2A;BANF1;RAN;NUP133;AHCTF1;REEP4;SEC13
prerank,protein O-linked glycosylation (GO:0006493),0.235167988726954,0.8927563328426812,0.6971544715447154,0.9446573593902607,1.0,16/96,13.54%,TMTC2;GALNT9;GALNT15;GALNT13;MGAT5B;EOGT;GALNT14;GALNT6;SLC35C1;PLOD3;GALNT3;ST8SIA6;GALNTL6;B3GNT2;GALNT2;POMGNT2
prerank,regulation of centriole replication (GO:0046599),-0.3408767666857395,-0.8927087848347048,0.6082089552238806,0.8335141654424105,1.0,5/17,17.06%,KAT2B;ALMS1;SPICE1;CEP295;CEP76
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.23894756599988512,0.8926384037994368,0.7006237006237006,0.9439720065785091,1.0,18/86,16.47%,CHEK1;ATF3;EPAS1;PSMA1;RPS27A;UBC;EPO;PSMD12;UBB;PSMA6;PSMB3;KLF2;HIGD1A;PSME3;ATF4;STOX1;PSMA2;PSMC3
prerank,regulation of membrane repolarization (GO:0060306),0.36881322975050446,0.8923394125283697,0.6089743589743589,0.9437667519945692,1.0,2/13,3.52%,AKAP6;CACNA2D1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.2301566885945355,-0.89205737809962,0.7017543859649122,0.8345346121540244,1.0,38/104,27.39%,LRP6;KSR1;ABL1;CCNT2;UVRAG;CCNH;CCNT1;RPTOR;CDK7;MAP2K1;CCNK;MNAT1;RHOA;RB1;TELO2;TRIB2;SLC27A1;DDX3X;CCND3;CNPPD1;SYAP1;SLC8A3;MTCP1;SNF8;CAB39;PPP2CA;PIH1D1;CDK5RAP3;EZH2;BCCIP;GTF2H1;CCNJ;CCNE2;IRGM;INCENP;ADRB2;TESK1;CAMK1
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.353741270357643,-0.8920481712561819,0.625,0.834087096852127,1.0,2/14,8.95%,IGF1;LDLR
prerank,glutamate metabolic process (GO:0006536),-0.3215566756102978,-0.8919073377082024,0.6193293885601578,0.8339372434023634,1.0,8/19,28.71%,GLUD1;GLUL;PRODH;OAT;ALDH18A1;DGLUCY;GCLC;GOT1
prerank,rRNA 3'-end processing (GO:0031125),-0.3884615867780386,-0.891880081560913,0.6296992481203008,0.8335294958772572,1.0,4/10,15.81%,ERI3;ERI2;EXOSC9;EXOSC10
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.31475246120485345,-0.8916520722690776,0.6053130929791272,0.8335681136053968,1.0,6/23,20.40%,SLC9A1;SLC12A7;ATP6V0A4;SLC12A2;SLC12A8;SLC12A9
prerank,histone H4-K5 acetylation (GO:0043981),-0.3470409221804758,-0.8912326320757403,0.5915492957746479,0.8336182056821134,1.0,6/15,23.29%,KANSL2;HCFC1;KAT8;OGT;KANSL3;JADE2
prerank,histone H4-K8 acetylation (GO:0043982),-0.3470409221804758,-0.8912326320757403,0.5915492957746479,0.8336182056821134,1.0,6/15,23.29%,KANSL2;HCFC1;KAT8;OGT;KANSL3;JADE2
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.33297039605731366,-0.8908780093379469,0.638996138996139,0.8339359310736335,1.0,4/18,17.26%,ROCK2;EPHA4;IFNGR1;PICALM
prerank,positive regulation of T cell proliferation (GO:0042102),-0.2573670351186752,-0.890436464033302,0.6835443037974683,0.8344185070618966,1.0,6/55,8.43%,IGF1;IGFBP2;IL6ST;HMGB1;ANXA1;IGF2
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.3438746985494624,0.8900258761796923,0.5767543859649122,0.9488053097715324,1.0,8/15,26.46%,NME2;ENTPD3;AK5;ENTPD1;ENTPD5;ENTPD7;AK4;ENTPD2
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.23034013885082225,-0.8899827418490224,0.7348927875243665,0.8349886962921232,1.0,35/109,28.95%,GAB2;NFKB1;BTRC;MAP2K4;PAK2;SHC1;LYN;PDPK1;VAV2;PLCG1;FER;JUN;PSMF1;TEC;PSMB2;MAP2K7;TRAF6;NFATC3;FBXW11;MAP3K1;PSMC1;CUL1;PIK3R1;PSMA3;PSMB6;PSMA4;SYK;FCER1G;MAPK9;SOS1;PSME1;PSMD13;PSMB9;PSMB10;PSMA5
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.24734415798335982,-0.889286912971734,0.6857670979667283,0.8360145245877769,1.0,25/70,25.24%,PARVA;ITGAV;LAMC3;RADIL;ARL13B;NRP1;ATRNL1;FER;RHOA;MEF2C;RB1;FN1;RILPL2;ITGA4;TBCD;RILPL1;ITGB3;SIPA1L3;PIK3R1;LAMB2;LAMC1;ANTXR1;DACT2;UNK;ITGA8
prerank,positive regulation of heart rate (GO:0010460),0.33745310263670025,0.889061862932006,0.6162280701754386,0.9503611948632531,1.0,6/17,16.52%,ADRB1;RYR2;ADRA1D;ADRA1A;PDE4D;EDN1
prerank,mitotic DNA replication (GO:1902969),-0.38775733758316955,-0.8889824375402563,0.6295585412667947,0.8362507176937922,1.0,7/10,39.05%,MCM6;MCM4;MCMDC2;CDC45;POLA1;GINS1;MCM2
prerank,cellular response to osmotic stress (GO:0071470),-0.3171791876304763,-0.8888108314427485,0.6118067978533095,0.8361628858477872,1.0,7/21,22.76%,MYLK;LRRC8D;YBX3;PKD2;DDX3X;CAB39;ZFAND1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.2603295824658987,0.888739579651986,0.6599597585513078,0.9502091744634839,1.0,11/54,13.09%,MINAR1;CAMLG;ADGRB1;IVNS1ABP;COPS9;ISG15;AKT1;RPL5;SMAD7;PER2;RPS3
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.33575604702146394,-0.8883144974438717,0.6469465648854962,0.8368122436147213,1.0,6/17,18.12%,TPM1;MEF2C;EFEMP2;TGFB3;PDCD4;SOD2
prerank,cardiocyte differentiation (GO:0035051),-0.38417939462758266,-0.8882522976917928,0.6010928961748634,0.8364945995582147,1.0,5/10,22.22%,AKAP13;SIK1;EEF1AKMT4-ECE2;BMP2;GATA6
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.35043133042178676,0.8881954189581828,0.5927505330490405,0.9506015432520508,1.0,2/14,9.39%,TFRC;SHLD3
prerank,purine-containing compound catabolic process (GO:0072523),0.3620518295591276,0.8878463730880783,0.6231263383297645,0.9505669934513687,1.0,2/13,9.72%,GPX1;NT5C
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3163661818952834,0.8875555824664251,0.6420581655480985,0.9503102519241636,1.0,4/20,10.04%,AMPD1;GART;HPRT1;GMPR2
prerank,telomere capping (GO:0016233),-0.3351780012456232,-0.8874262101299437,0.6387832699619772,0.8378196765364663,1.0,7/16,20.36%,NBN;PRKDC;CTC1;MRE11;DCLRE1A;TERF2;STN1
prerank,positive regulation of protein transport (GO:0051222),0.24723339464171007,0.8873498439593871,0.6748971193415638,0.9498500335460167,1.0,6/67,5.71%,CD33;PRR5L;TENM1;APBB1;APBB3;TGFB2
prerank,manganese ion transport (GO:0006828),0.3522396641993023,0.8869859879321124,0.6263269639065817,0.9498122757697408,1.0,3/14,12.06%,TRPC5;SLC39A8;TRPC1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.3368758040210879,0.8869302444602162,0.6319018404907976,0.9489708774327371,1.0,3/16,7.40%,PPP1R16B;IL12A;APLNR
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.24119875300395488,0.8869037205909192,0.7086776859504132,0.9480560724919556,1.0,13/75,11.42%,PRKAR2B;IPO5;SPRY3;SIRT1;SLC8A1;PTPRJ;AKT1;SPRY4;UCHL1;DAB2IP;SMPD1;MEN1;APC
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.25750248758663896,-0.8869003199712204,0.6581532416502947,0.8385194713339438,1.0,14/53,20.23%,PKD1;ARAF;PRKN;RAD23B;NUPR1;UFL1;PSMF1;FBXW7;RHBDF1;APOE;PSME3IP1;PRKACA;TMTC3;DESI1
prerank,peptidyl-arginine modification (GO:0018195),0.34347530797255743,0.8868782521200965,0.6122047244094488,0.947138258153311,1.0,3/15,12.89%,NDUFAF5;PRMT7;ART3
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.32895806479546397,-0.8867378760108856,0.6037383177570094,0.8384129498390522,1.0,9/19,24.23%,ZMIZ1;AXL;ZBTB1;MMP14;PRKDC;RHOH;PPP2R3C;XRCC6;SYK
prerank,regulation of phagocytosis (GO:0050764),0.2602461029667429,0.8865917413001428,0.6728395061728395,0.9468776682091595,1.0,6/53,7.94%,SYT7;SYT11;IL2RG;GAS6;TLR2;DYSF
prerank,negative regulation of protein secretion (GO:0050709),-0.2694337905618287,-0.8865646331372644,0.6645962732919255,0.8383229094100683,1.0,14/38,22.14%,PRKN;IRS1;REST;CCN3;NR1H3;SERGEF;RHBDF1;APOE;ADRA2A;HMGCR;CYP51A1;SIRT4;DPH3;KCNB1
prerank,chromosome condensation (GO:0030261),-0.27709821580047433,-0.8863912854749214,0.6548323471400395,0.8382506312562212,1.0,11/36,21.25%,ACIN1;PHF8;SMC4;AKAP8L;AIFM1;RB1;MCPH1;CSNK2A1;H1-0;KMT5A;NCAPD3
prerank,base-excision repair (GO:0006284),0.2618826098283399,0.8863699588369325,0.6753507014028056,0.9464401072178574,1.0,13/48,19.08%,HMGA2;LIG3;RPA3;UNG;APEX1;POLG;POLD1;PRMT6;RFC4;POLD3;RFC5;ADPRS;RFC2
prerank,regulation of T cell cytokine production (GO:0002724),-0.3465044828298188,-0.8861427830306824,0.6334012219959266,0.8383464683630123,1.0,4/15,18.44%,CD55;TRAF2;TRPM4;TRAF6
prerank,"phagocytosis, engulfment (GO:0006911)",-0.2806247694732231,-0.8853635673399446,0.6393129770992366,0.8395635665332423,1.0,9/36,18.30%,GULP1;GSN;THBS1;VAMP7;CDC42;RHOBTB2;DOCK1;RHOBTB1;RHOH
prerank,lymphocyte migration (GO:0072676),0.27641529947510834,0.8852722643989481,0.6680761099365751,0.9482509155553555,1.0,7/32,20.59%,CCL2;RET;CCL25;CKLF;S1PR1;CCL13;CCL19
prerank,pre-replicative complex assembly (GO:0036388),0.246485830353793,0.8850977508046293,0.7098765432098766,0.9477242717671097,1.0,14/64,20.20%,PSMA1;RPS27A;UBC;PSMD12;UBB;PSMA6;PSMB3;MCM3;PSME3;PSMA2;PSMC3;PSMB7;ORC6;MCM8
prerank,sarcomere organization (GO:0045214),0.29731861925643943,0.8850703474458775,0.5995717344753747,0.9468106927290977,1.0,4/27,9.67%,MYH6;FHOD3;WDR1;TCAP
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.23642014831225208,-0.8849542360480641,0.7148514851485148,0.8400034242581017,1.0,15/78,15.49%,EGFR;NR2F2;PKD1;CCNT2;CCNH;CCNT1;CDK7;CCNK;MNAT1;CCNYL1;PKD2;CDK5RAP1;LATS1;CCND3;CNPPD1
prerank,isotype switching (GO:0045190),-0.39086841696413327,-0.8848953595480118,0.6011787819253438,0.839654918155728,1.0,6/10,36.29%,RNF8;MSH6;EXOSC3;BATF;LIG4;MSH2
prerank,error-free translesion synthesis (GO:0070987),0.3114876524200545,0.8847276347945179,0.643312101910828,0.9467366623094118,1.0,8/22,19.08%,RPA3;RPS27A;UBC;UBB;POLD1;RFC4;RFC5;RFC2
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.36397299833185304,-0.8847013241778595,0.6523297491039427,0.8396062467417781,1.0,3/13,10.64%,RBPJ;TGFBR2;SMAD4
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.30846965987445474,-0.8845880774658323,0.6254752851711026,0.8393907052490162,1.0,6/23,14.10%,GHR;KIT;PIBF1;CYP1B1;HES1;CRLF3
prerank,endocytic recycling (GO:0032456),-0.25752596136776845,-0.8844192488593615,0.6756198347107438,0.8393050856512337,1.0,21/50,35.86%,CCDC93;ANKRD50;VPS26C;EHD2;VPS39;ANKRD27;EHD3;ACAP2;EHD4;EIPR1;SNF8;SNX12;PTPN23;RAB7A;ARL4C;EHD1;ARF6;DENND1B;MICALL1;CCDC22;STX6
prerank,regulation of epithelial cell differentiation (GO:0030856),0.33280639966029274,0.883964651668527,0.6424361493123772,0.9477458688005693,1.0,4/17,13.89%,AJAP1;CD24;APOLD1;DLL1
prerank,histone H4 acetylation (GO:0043967),-0.2622973028860533,-0.883659902031421,0.666030534351145,0.8405554392754848,1.0,18/47,23.29%,EP300;TRRAP;ZZZ3;HAT1;ATF2;KANSL2;TADA3;HCFC1;KAT8;OGT;ING5;BRCA2;MSL2;EPC1;MSL3;KANSL3;KMT2A;JADE2
prerank,cardiolipin metabolic process (GO:0032048),0.3421554770991379,0.883355836346039,0.5977777777777777,0.9483063010714924,1.0,3/13,11.17%,HADHA;CRLS1;PTPMT1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.37696495678738545,0.8832655669540451,0.6260683760683761,0.9475454200238972,1.0,3/10,13.37%,TIRAP;NINJ1;WDFY1
prerank,mammary gland development (GO:0030879),0.3164423386449577,0.8832443151506482,0.6103896103896104,0.9466278009344741,1.0,3/21,6.67%,ERBB4;NRG1;WNT7B
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.23522932827205234,-0.882666263751619,0.7289156626506024,0.8422184446824647,1.0,39/88,36.28%,FBXL7;FBXL17;BTRC;FBXL4;FBXL12;PSMF1;FBXL18;AMN1;FBXW7;PSMB2;CUL2;FBXO38;FBXW5;FBXW11;PSMC1;CUL1;FBXW4;PSMA3;PSMB6;PSMA4;FBXL14;FBXO4;PSME1;PSMD13;FBXL3;PSMB9;RBX1;PSMB10;PSMA5;FBXL8;FBXO9;CCNF;PSME4;FBXL13;PSMD10;PSMB8;CUL5;FBXL6;PSMD3
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.30970120776537596,0.8826266706272833,0.6228813559322034,0.9472207371782956,1.0,6/23,16.10%,CYP2E1;HPGD;ACOT7;FADS1;LTA4H;GSTM1
prerank,response to lipopolysaccharide (GO:0032496),0.2202902439030608,0.8824524855698499,0.7429805615550756,0.9466913732125228,1.0,26/138,15.29%,PDE4B;TIRAP;GIT1;S100A9;S100A8;SNCA;NOS3;IL12A;HNRNPA0;IFNAR1;TRIM6;CCL2;DAB2IP;SLPI;GGT7;F2R;BCL10;MAPK8;GGT1;XBP1;SCARB1;DEFA6;TAB2;PELI1;MAPKAPK2;GCH1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.325039314175935,-0.8822805040105371,0.6372360844529751,0.8425927080410197,1.0,10/20,30.91%,BCL2;CAMK2D;ATP2A2;PML;FIS1;KCTD17;WFS1;CCDC47;BAK1;HERPUD1
prerank,anterograde axonal transport (GO:0008089),0.27549219040614303,0.8816631582978858,0.6592741935483871,0.9476582344407957,1.0,5/37,10.93%,DLG2;KIF1A;AP3B2;HSPB1;HAP1
prerank,modulation by host of symbiont process (GO:0051851),0.2817954802928655,0.881370892046241,0.6216216216216216,0.9474126236709413,1.0,3/31,4.17%,LEF1;HMGA2;SMARCB1
prerank,regulation of anoikis (GO:2000209),-0.32067860058799,-0.8809933064366776,0.6349809885931559,0.8449518154797557,1.0,5/19,15.52%,ITGB1;BCL2;TLE1;SIK1;ITGA5
prerank,vesicle transport along actin filament (GO:0030050),0.31803177357074364,0.880574093593381,0.6227180527383367,0.9484161613335863,1.0,6/19,17.93%,MYO1E;FNBP1L;MYO6;ACTN4;MYO5A;MYO19
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.2548903640020349,-0.8802796345660702,0.6872509960159362,0.8460098300520272,1.0,8/55,13.30%,PID1;PDGFRB;PRKN;TGFBR2;THBS1;CYP1B1;AGTR1;SIRT5
prerank,gastrulation (GO:0007369),-0.3408816843087151,-0.8800804287309232,0.6159844054580896,0.8459559536791448,1.0,2/15,5.49%,GPC3;SMAD2
prerank,membrane protein proteolysis (GO:0033619),-0.2785685646637527,-0.8798825076335924,0.6707070707070707,0.8459229104526499,1.0,16/37,26.87%,DAG1;NFKB1;HM13;CTSH;NCSTN;ADAM9;MBTPS2;ADAM19;MBTPS1;CLPP;TRAF6;SPPL3;PARL;BACE2;SPPL2A;ERAP1
prerank,positive regulation of innate immune response (GO:0045089),-0.28811086679447384,-0.8798775469751072,0.651031894934334,0.8454713983536561,1.0,8/30,18.69%,LBP;PLSCR1;DHX9;UBE2K;MAVS;RIOK3;IFI35;WNT5A
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.23412503744902502,0.8798213264867438,0.7467532467532467,0.9492812057846961,1.0,9/86,6.44%,NAV3;PROX1;TENM1;BIN1;GPX1;OCLN;PAK1;WDR1;CLU
prerank,cochlea morphogenesis (GO:0090103),0.3844860895072571,0.8798026917486452,0.6412371134020619,0.9483643265902657,1.0,1/10,3.55%,PAX2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.3537967451805893,-0.8790621296448742,0.642023346303502,0.8468199415082516,1.0,3/14,10.38%,MEOX2;THBS1;RHOA
prerank,protein processing (GO:0016485),-0.22572081358437204,-0.8787019397349142,0.7443181818181818,0.8471636980163397,1.0,30/102,22.61%,AEBP1;PCSK5;HM13;CTSH;F3;DDI2;ECE1;SEC11C;NCSTN;LONP2;MMP14;YME1L1;ADAM19;CPM;CASP2;OGT;CPXM2;PTCH1;STOML2;SPRTN;SEC11A;CPXM1;SDE2;EEF1AKMT4-ECE2;SPPL3;CLN5;FXN;PARL;MYRF;CTSL
prerank,regulation of protein polymerization (GO:0032271),-0.27759038439242806,-0.8785908675394143,0.6914285714285714,0.8469221302396819,1.0,9/35,15.45%,FCHSD2;ARHGAP28;ABL1;PRUNE1;PLEKHG2;CTTN;LATS1;ARHGAP18;RASA1
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.29279611048843734,-0.8777751661134682,0.6569200779727096,0.8482068243124976,1.0,8/28,16.42%,EGFR;WWP2;NIBAN2;NOTCH3;MMP14;FBXW7;TSPAN15;ARRB1
prerank,regulation of oxidoreductase activity (GO:0051341),-0.3519450970051583,-0.8775587210035024,0.5947955390334573,0.8482114897713304,1.0,6/13,33.97%,ABL1;ABL2;SIRT4;SZT2;MT3;ATP7A
prerank,carbohydrate catabolic process (GO:0016052),0.27879727540744,0.8774020198098468,0.6778947368421052,0.953410043767868,1.0,12/38,21.43%,PGAM4;PGAM1;NEU2;ALDOC;GCK;PFKFB2;GAPDHS;NEU1;ENO2;LDHA;NEU4;GPI
prerank,response to tumor necrosis factor (GO:0034612),-0.234152806534714,-0.8772346485175374,0.7458256029684601,0.848466434288996,1.0,17/91,19.06%,PID1;ADAMTS12;ZFAND6;AFF3;GSDME;DHX9;NUB1;CXCL16;ADAM9;YBX3;GBP3;MAP2K7;GBP2;NPNT;INPP5K;TANK;SMPD4
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.2739931032792315,0.8772115096321124,0.6545064377682404,0.9529293848743545,1.0,11/39,18.10%,MYO1E;KIF1A;FNBP1L;BICDL1;MYO6;HAP1;PPFIA2;ACTN4;MYO5A;MYO19;SYT4
prerank,cardiac ventricle development (GO:0003231),0.3143104248505597,0.8772025383673606,0.6148936170212767,0.9519844178135038,1.0,3/20,5.71%,HEY1;PDE2A;NOTCH1
prerank,glucan catabolic process (GO:0009251),0.3389442537474848,0.877042025686051,0.6336633663366337,0.951384773945136,1.0,2/15,2.01%,PHKG1;PGM2L1
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3079863789872522,-0.8767872924619972,0.638733705772812,0.8489899949775125,1.0,8/23,17.28%,PRKN;ABL1;LRRK2;SLC9A1;ADCY6;GABPA;GNB1;PRKACA
prerank,cellular response to hypoxia (GO:0071456),-0.21965045908514325,-0.8766677276072204,0.7804878048780488,0.8488004196192975,1.0,45/126,28.95%,MDM4;BMP7;EP300;PTGIS;ARNT;LMNA;UBQLN1;CREBBP;MTOR;FAM162A;EGLN3;HIF1A;LIMD1;ACAA2;PSMF1;NPEPPS;PGK1;PSMB2;VEGFA;RORA;CUL2;NOP53;CPEB1;SLC8A3;CARD16;P4HB;TERT;PSMC1;HIF3A;BNIP3;TBL2;GATA6;PSMA3;PSMB6;HYOU1;PSMA4;TWIST1;PSME1;PSMD13;EGLN2;MT3;PSMB9;RBX1;PSMB10;PSMA5
prerank,maturation of LSU-rRNA (GO:0000470),0.29833038312790305,0.8764166645908885,0.6448202959830867,0.9520086253162606,1.0,8/26,15.82%,RPF2;RPL7;RPL10A;RPL7A;NHP2;NOP2;ZNHIT6;DDX18
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.3150206700925765,-0.8758067403426535,0.6605839416058394,0.8502187839354133,1.0,3/21,9.10%,PAG1;PIBF1;PTPN22
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.291614924237778,-0.8756420947211199,0.6754716981132075,0.8501171574994473,1.0,16/29,29.73%,PRKN;LIMA1;PLEKHH2;ARFGEF1;PRKCD;SMAD4;MYADM;HIP1R;SLIT2;KANK1;TWF2;TWF1;SSH3;SSH2;KANK4;PFN2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.26986117786943165,0.8753024490132579,0.673866090712743,0.9538108298227544,1.0,5/41,9.00%,CD33;SYT11;GAS6;CD34;POMC
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.3763067785958027,-0.8752612072541733,0.6282306163021869,0.8504690596121498,1.0,2/10,11.60%,RC3H1;NFKBIZ
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.33098301150335807,-0.874456851484715,0.6438848920863309,0.8517166119590489,1.0,10/18,31.09%,RIPOR2;TNFAIP1;ABL2;CUL3;MYOC;ARHGAP35;KANK1;SCAI;MET;CCDC125
prerank,positive regulation of ion transport (GO:0043270),-0.25694167824489567,-0.8743316314133255,0.7022900763358778,0.8515164093885498,1.0,15/48,22.23%,ANK2;MYLK;FHL1;DLG1;VAMP7;CACNA1D;ACTN2;ATP2B1;P2RX4;ADRA2A;STIM2;GPD1L;AHCYL1;WFS1;ORAI1
prerank,regulation of phosphatase activity (GO:0010921),-0.303224422566364,-0.8740109065192798,0.6487985212569316,0.8517703936618544,1.0,11/24,33.23%,SH3RF2;PTPA;GPATCH2;BMP2;CDK5RAP3;CHP1;PPP1R2;PPP6R2;HTT;SH2D4A;URI1
prerank,mitochondrion transport along microtubule (GO:0047497),0.34706220479830274,0.8739167525493043,0.6460176991150443,0.956280631479268,1.0,2/13,8.19%,SYBU;UBB
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.32379249926777576,0.8739167077301001,0.6236323851203501,0.9553195454174799,1.0,9/18,20.99%,TIMM21;COA5;FASTKD3;COX16;COX17;BCS1L;COA3;OXA1L;SCO1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.33408405161734533,-0.8739154016071383,0.6373831775700934,0.8515227535577378,1.0,2/17,4.47%,ANK2;SNTA1
prerank,regulation of necroptotic process (GO:0060544),-0.305549005428434,-0.8733996605799985,0.6435845213849287,0.8521714050000752,1.0,4/23,13.46%,CFLAR;FLOT2;YBX3;OGT
prerank,axonemal dynein complex assembly (GO:0070286),0.29439521095943466,0.8731764305714752,0.6583333333333333,0.956175330637482,1.0,4/27,10.27%,DNAAF3;LRRC49;CFAP100;DNAAF2
prerank,cAMP metabolic process (GO:0046058),-0.3579707872636603,-0.8728022717870184,0.653558052434457,0.8529948633670261,1.0,4/13,7.65%,ADCY9;ADCY5;ADCY1;ADCY6
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.2766625247932348,0.8721981557477284,0.6918489065606361,0.9575977855760461,1.0,6/33,16.59%,SLA2;THY1;PTPRJ;BCL10;RPS3;RAB29
prerank,apoptotic process (GO:0006915),-0.2064842404887436,-0.8721341672776911,0.8276553106212425,0.8539857775699843,1.0,41/203,17.68%,NOTCH2;PAWR;RNF152;CFLAR;EP300;STK3;CYFIP2;TGFBR2;ZBTB16;PLSCR1;IFIT2;BCL2;MTOR;FAM162A;AIFM1;VDAC1;CASP12;TNFAIP1;EGLN3;MAGI3;PRKCD;DMPK;AKAP1;NCKAP1;CDK11B;BCLAF1;PARP1;ERCC3;CASP2;IRF1;OGT;FAP;RFK;DAPK1;ARHGEF6;PDCD4;GLRX2;DAPK2;BCL2L13;IAPP;DAP
prerank,regulation of intracellular pH (GO:0051453),-0.28274182657820096,-0.8719045691208939,0.6622137404580153,0.854021967435483,1.0,12/34,26.22%,LRRK2;SLC4A10;SLC9A1;SLC9A8;SLC9A2;SLC4A3;CHP1;GPR89B;GPR89A;SLC9A9;SLC26A6;SLC9B1
prerank,regulation of immune response (GO:0050776),0.2175375274535816,0.8715570383957696,0.7834008097165992,0.9581989722290537,1.0,12/135,9.51%,CD33;LRP8;TIRAP;KLRC1;SPPL2B;SLA2;TGFB2;CD34;LAIR1;CD300LF;ICAM2;CD200R1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.23928355446614158,0.8713650601939122,0.7304347826086957,0.9577199155067885,1.0,10/73,13.50%,TIRAP;IL17F;MIF;TLR2;CLU;PTPRJ;HSPB1;ARHGEF2;BCL10;PSEN1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.33666101588497543,0.8709319784430334,0.6346555323590815,0.9578164127208293,1.0,15/15,66.37%,KYAT1;KYNU;TAT;GSTZ1;QDPR;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;HGD;FAH;IL4I1;KMO
prerank,maturation of SSU-rRNA (GO:0030490),0.2733436224560887,0.8707125256442207,0.6807610993657506,0.9573434393140099,1.0,4/34,6.86%,TSR3;RPS19;RPS8;RPS16
prerank,basement membrane organization (GO:0071711),-0.34909103475284387,-0.8706710420530916,0.6410748560460653,0.8561492506123756,1.0,3/14,5.98%,NID1;FLRT2;NID2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.26443508271351246,0.8701161006777137,0.6960167714884696,0.9578113606831923,1.0,9/42,21.01%,RPS19;ADGRB1;RPL30;DROSHA;DEFA6;RNASE3;OPTN;CHGA;RNASE7
prerank,cholesterol metabolic process (GO:0008203),-0.24298110675276402,-0.8699772148393851,0.7077534791252486,0.8571689367505391,1.0,19/68,26.16%,ABCA1;CYP27A1;SOAT1;INSIG2;OSBPL5;ACAA2;APOE;RXRA;HMGCR;SQLE;CYP51A1;FDX1;FDFT1;LBR;ARV1;MVK;GBA2;SCAP;CLN8
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.3771015025666993,-0.8698393475805111,0.6551724137931034,0.8569956192344781,1.0,4/10,24.92%,COMT;SARDH;ALDH7A1;HNMT
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.28344268638400144,0.8698121700719045,0.683982683982684,0.9575981559799931,1.0,11/32,19.85%,MAGI2;PPP1R16B;HSP90AB1;SMPD1;CALM1;DUSP26;CALM2;CALM3;PPIA;CAMTA1;PPP2R5A
prerank,sulfur compound transport (GO:0072348),-0.29865079429649827,-0.8693331696746106,0.6660117878192534,0.8575542916947607,1.0,8/27,19.26%,SLC6A13;SLC13A4;SLC26A7;LRRC8D;SLC5A6;SLC27A1;SLC25A11;MGST1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.35066309392960726,0.869189648813693,0.6325167037861915,0.9581949612140529,1.0,4/12,13.93%,CALM1;PDE4D;CALM2;CALM3
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3597175697861632,-0.8691225981320183,0.6445672191528545,0.8575724519594614,1.0,5/12,26.62%,ACSL1;ACOX1;ELOVL1;ACOT8;ELOVL5
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.2291510422436,0.8690159216252806,0.7875751503006012,0.9576849053041115,1.0,19/94,16.47%,ST18;TOLLIP;PSMA1;RPS6KA5;PLCB1;RPS27A;UBC;PSMD12;UBB;PSMA6;PSMB3;NOD1;NFKBIA;TAB2;PSME3;PELI1;IL1RAP;PSMA2;PSMC3
prerank,response to ionizing radiation (GO:0010212),-0.23962210865723385,-0.8689206891018209,0.7221135029354208,0.8575477047072856,1.0,34/70,37.19%,EYA1;INO80;SPIDR;ANXA1;BRCC3;RNF8;CLK2;BRSK1;XRCC4;RFWD3;NABP2;PRKAA1;DCUN1D3;TANK;COP1;BRAT1;USP28;PAXIP1;EYA3;MAPK14;ABRAXAS1;IKBIP;TNKS1BP1;INTS7;FANCD2;RAD9A;RAD51;LIG4;BRCA1;ECT2;GADD45A;MSH2;MRNIP;TP53
prerank,secondary alcohol biosynthetic process (GO:1902653),0.2843434634515499,0.8676958591455953,0.6666666666666666,0.9599483136786359,1.0,14/30,23.23%,MVD;HSD17B7;IDI1;DHCR7;PLPP6;HMGCS1;ACAT2;TM7SF2;EBP;MSMO1;FDPS;NSDHL;PMVK;LSS
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.36804421869812326,-0.8676290980916112,0.6470588235294118,0.8598178567841008,1.0,2/11,4.04%,PDPN;RREB1
prerank,regulation of glycogen metabolic process (GO:0070873),0.35248001370612864,0.867488631631787,0.6361746361746362,0.9594666098724777,1.0,2/12,7.85%,KHK;AKT1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.28823860577434546,-0.8667249696919544,0.6593625498007968,0.8612639001051828,1.0,9/30,26.21%,UGGT2;STT3A;DPM1;RPN1;ST6GAL1;DPM3;LMAN1;MCFD2;ASGR1
prerank,regulation of myotube differentiation (GO:0010830),-0.3029187201270858,-0.8665261288809358,0.6839080459770115,0.8612225111889721,1.0,13/24,28.23%,HDAC4;CCN3;DMPK;MMP14;SIK1;BHLHE41;MAML1;HDAC1;FBXO22;TMEM119;MAPK14;HDAC3;SMYD1
prerank,iron ion transmembrane transport (GO:0034755),0.3848642146863598,0.8663109340336994,0.6493506493506493,0.9614465937532187,1.0,3/10,10.94%,SLC40A1;SLC25A37;SLC39A8
prerank,glutathione metabolic process (GO:0006749),0.26494295291574144,0.8660206067616554,0.6989473684210527,0.9611565365589494,1.0,6/38,11.79%,GSTA4;GPX1;GSTM5;GGT7;NAT8;GGT1
prerank,tRNA processing (GO:0008033),-0.2484385977151788,-0.8659781107301755,0.7392996108949417,0.8619170006102828,1.0,23/61,26.26%,FARS2;TRMT9B;NSUN6;TSEN2;QTRT2;TSEN15;TYW5;NSUN2;METTL1;ELP5;FTSJ1;KARS1;PUS3;CDKAL1;LCMT2;CPSF4;TRNT1;DTWD1;RTRAF;TRMT1;DTWD2;CPSF1;ELAC2
prerank,response to interferon-beta (GO:0035456),-0.3032618661193706,-0.8658177557458241,0.676923076923077,0.8618121039255098,1.0,9/22,28.37%,PLSCR1;UBE2K;IRF1;STAT1;IKBKE;SHFL;IRGM;HTRA2;CDC34
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3215201637779045,0.8656434965307757,0.6523605150214592,0.9611217296244462,1.0,6/17,22.95%,NLGN1;SYT10;CACNA1I;SYT4;SLC4A8;RAB3A
prerank,actin filament network formation (GO:0051639),0.3554162152734148,0.8654956833037162,0.6176470588235294,0.9605264759382338,1.0,2/11,5.86%,FHOD3;SPIRE2
prerank,acute inflammatory response (GO:0002526),-0.3074500402568048,-0.8654002527964795,0.6613545816733067,0.8622247861700975,1.0,4/23,12.71%,LBP;PLSCR1;F3;IL6R
prerank,negative regulation of platelet activation (GO:0010544),-0.32610143115654233,-0.8653367053539871,0.6797642436149313,0.8618998243337461,1.0,4/16,14.69%,PDGFRA;CD9;PRKCD;APOE
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3107330010439963,0.8652903030054166,0.6742596810933941,0.959123074864538,1.0,5/20,19.55%,GSTA4;GSTM5;ESD;GSTM1;MGST3
prerank,glutathione derivative metabolic process (GO:1901685),0.3107330010439963,0.8652903030054166,0.6742596810933941,0.959123074864538,1.0,5/20,19.55%,GSTA4;GSTM5;ESD;GSTM1;MGST3
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.2640005563094724,0.8650444182608477,0.6794871794871795,0.9587446371942208,1.0,5/43,9.00%,CD33;SYT11;GAS6;CD34;POMC
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3869598517620199,-0.8648685560507414,0.6534090909090909,0.8624254704792939,1.0,5/10,21.03%,PIBF1;PTPN2;PARP14;NF2;PPP2CA
prerank,regulation of axon guidance (GO:1902667),-0.3794968263600841,-0.8647078875280393,0.6256781193490054,0.862285489287157,1.0,3/10,14.35%,NRP1;ZSWIM8;VEGFA
prerank,response to progesterone (GO:0032570),0.32005325617741776,0.864128879671045,0.673728813559322,0.9599584311540759,1.0,4/18,12.17%,ABHD2;TGFB2;UBE3A;WBP2
prerank,quinone biosynthetic process (GO:1901663),0.3457049838795413,0.8640752800385519,0.6537678207739308,0.9591366706702932,1.0,2/14,5.49%,COQ2;COQ7
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.3719325865774057,-0.8640015882556944,0.6436567164179104,0.8632783368060377,1.0,4/11,17.26%,ACTN2;LEPROTL1;LEPROT;PICALM
prerank,regulation of protein transport (GO:0051223),-0.29230676197080663,-0.8634086121840626,0.6598130841121496,0.8640365806530775,1.0,10/27,24.34%,DNAJC1;STXBP5;WWP2;DISP1;NDEL1;RHBDF1;PTPN1;CHP1;LLGL2;SNX12
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.3459097002595572,-0.8628023183022904,0.6482142857142857,0.8648251786425931,1.0,4/13,10.73%,AXL;TRIM44;DHX9;MAVS
prerank,secretion (GO:0046903),0.3341812313926368,0.8626895915402101,0.6274509803921569,0.9614831216649934,1.0,2/14,6.64%,RIMS1;GUCA1B
prerank,response to hexose (GO:0009746),-0.2945520773188044,-0.8623839594470546,0.6728624535315985,0.8652270801034482,1.0,8/25,23.12%,TCF7L2;THBS1;VAMP2;SELENOS;ZBED3;EIF2B4;PFKL;EIF2B5
prerank,exit from mitosis (GO:0010458),0.34581409931148827,0.8621887780585706,0.642706131078224,0.961719600999233,1.0,7/12,22.74%,UBE2C;CLASP2;CLASP1;CHMP7;CHMP2A;SIRT7;EPS8
prerank,negative regulation of B cell proliferation (GO:0030889),-0.364889404344335,-0.8618480790318086,0.6497277676950998,0.8659119115688126,1.0,2/11,6.87%,RC3H1;LYN
prerank,immunoglobulin mediated immune response (GO:0016064),-0.38036874013539135,-0.8617675950804851,0.6630630630630631,0.8656003393588982,1.0,6/10,51.79%,FCER1G;CD81;CD27;FCGR2B;TLR8;CARD9
prerank,regulation of cellular response to heat (GO:1900034),0.23677622654359062,0.8617406628057629,0.7510204081632653,0.9618220242995964,1.0,27/77,22.31%,CAMK2A;SIRT1;NUP210;HSPA8;RPA3;HSP90AB1;CD34;NUP62;NUP205;ATM;MAPKAPK2;NUP54;FKBP4;PTGES3;CHORDC1;HSP90AA1;MLST8;IER5;MAPK3;NUP85;BAG2;BAG1;CRYAB;RAE1;NUP107;AKT1S1;DNAJC2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3532673647620601,-0.8614288985222496,0.6628352490421456,0.8658266537540305,1.0,9/13,36.04%,MMS19;CIAO1;NFU1;YAE1;GLRX5;BOLA2;LTO1;GLRX3;CIAO2B
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.22058198195901435,0.8609697295277573,0.7916666666666666,0.962633451898916,1.0,22/114,18.81%,ST18;TMSB4X;PSMA1;TNFRSF9;TRAF1;TNFSF13B;PSMD12;PSMA6;PSMB3;TNFRSF12A;CD40;TNFRSF25;ACTN4;NFKBIA;PSME3;PSMA2;PSMC3;CDIP1;TNFRSF1A;ILK;PSMB7;RIPK1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.32187062799366695,-0.8609165329581523,0.6806883365200764,0.8664187286156277,1.0,6/18,25.98%,PAG1;PTPN22;WNK1;MIA3;ASS1;PPARA
prerank,RNA methylation (GO:0001510),-0.24472110865054686,-0.8609100545683159,0.7218045112781954,0.8659729805102544,1.0,25/60,32.96%,ZCCHC4;WTAP;NSUN6;NSUN3;TGS1;DIMT1;METTL2A;METTL2B;BUD23;NSUN2;METTL1;THUMPD3;FTSJ1;LCMT2;GTPBP3;ZC3H13;WDR6;MTO1;TRMT44;TRMT10C;TRMT61B;TYW3;ALKBH8;MRM2;TRMT12
prerank,lysosome localization (GO:0032418),-0.2706749157156626,-0.8608834841692631,0.7121848739495799,0.8655872695439504,1.0,18/37,42.07%,TFEB;KIT;NDEL1;PIK3CD;SYTL4;PLEKHM2;SPAG9;KIF5B;S100A13;KLC2;SNAPIN;RAB34;MYH9;PIK3CG;BORCS6;MILR1;HPS6;ARL8B
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.24410085427140288,0.8608495477677096,0.7196078431372549,0.9619665804781733,1.0,12/62,13.35%,CXCL12;SIRT1;NME5;CLU;RTKN2;EPO;AKT1;TPT1;HSPB1;ARHGEF2;NDUFA13;XBP1
prerank,regulation of phospholipid metabolic process (GO:1903725),0.37310255723431984,0.8607872433753109,0.6469387755102041,0.9611476794988708,1.0,5/10,22.84%,MFSD2A;DNAJC19;MTMR9;ABCA3;MTMR2
prerank,regulation of viral entry into host cell (GO:0046596),0.2845545293853167,0.8607300923411649,0.6766467065868264,0.9603620995638681,1.0,6/30,10.96%,HS3ST5;TRIM62;TRIM6;IFITM3;TMPRSS4;MID2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.2850572323907754,-0.8607103658801039,0.6685288640595903,0.8654907565218896,1.0,15/28,34.10%,KMT5B;SHLD2;PARP9;KMT5C;DTX3L;PRKDC;SMCHD1;HSF1;ACTR2;MAD2L2;PARP3;TFIP11;NUDT16L1;PNKP;ERCC6
prerank,myeloid cell differentiation (GO:0030099),0.25569543861010974,0.8604566253534154,0.7248995983935743,0.9600812148535934,1.0,9/47,14.49%,ALAS2;TIRAP;RPS19;TAL1;EPO;HIPK2;RPS14;SNRK;MFHAS1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.3710389546878239,0.8600630279424683,0.6169265033407573,0.960038700576754,1.0,3/10,15.06%,HSPA5;CCL2;ATF4
prerank,positive regulation of protein depolymerization (GO:1901881),0.3634120475734969,0.8600345696899742,0.6475770925110133,0.9591593023929627,1.0,2/11,8.94%,WDR1;STMN2
prerank,cellular response to topologically incorrect protein (GO:0035967),0.28143597343063936,0.8593683583609977,0.6895074946466809,0.959785148745218,1.0,4/31,5.53%,HSPA13;PACRG;HSPA8;HSPA5
prerank,alpha-amino acid metabolic process (GO:1901605),-0.2584589409234898,-0.8571215856562575,0.7140077821011673,0.8724842299952067,1.0,11/45,21.01%,ASPA;MMUT;NOX4;GLUD1;MTHFR;GLUL;ASPG;OAT;THAP4;ALDH18A1;ASS1
prerank,regulation of mRNA metabolic process (GO:1903311),-0.36851293062933854,-0.8569333268626953,0.6533101045296167,0.8724214782532054,1.0,3/11,11.18%,DHX9;SAFB2;CDK11B
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.2994162772304143,-0.8568353412167449,0.682261208576998,0.8721539292381362,1.0,6/25,9.33%,ANK2;COA8;SLC6A9;ACTN2;WNK4;WNK1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.3106698479926275,0.8563846145613324,0.6554455445544555,0.9657082098931521,1.0,8/19,14.94%,BIN1;NTRK2;CLU;RTN2;HAP1;RTN1;SORL1;RTN4
prerank,cellular response to virus (GO:0098586),-0.2760472105418211,-0.8557913092807679,0.7039848197343453,0.873852061174151,1.0,6/30,15.01%,GBF1;GSDME;HIF1A;RIOK3;ARF1;DDX3X
prerank,ubiquinone biosynthetic process (GO:0006744),0.3379767148033369,0.8555804388364515,0.6859504132231405,0.9666018308223936,1.0,2/15,5.49%,COQ2;COQ7
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.37419561733364715,0.8555240652556692,0.6353467561521253,0.9658063052585583,1.0,4/10,16.82%,DGKH;F2R;PRKD3;GAP43
prerank,regulation of T cell differentiation (GO:0045580),0.2720739724237985,0.8552829923206449,0.7090163934426229,0.965454493301677,1.0,7/33,14.70%,IL7;CAMK4;PRDM1;FANCA;TCF7;XBP1;NFATC2
prerank,regulation of myoblast fusion (GO:1901739),-0.36094592497091516,-0.8552635001663762,0.666030534351145,0.8744733647688158,1.0,3/11,8.04%,CFLAR;RIPOR2;EHD2
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.31418914311407936,-0.8551814895828931,0.6934579439252336,0.8741647504759561,1.0,7/18,27.19%,CCT6A;CEP135;CCT8;CCT5;CEP295;CHP1;CCT3
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.3541002398199142,0.8551682315426301,0.6390658174097664,0.9647858611346297,1.0,1/12,1.67%,HUS1B
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.28501189957227535,-0.8551437151870587,0.7117988394584139,0.8737864274312086,1.0,8/26,20.05%,ADCY5;CDK16;STXBP4;STX4;TRPM4;ADRA2A;ANO1;C2CD2L
prerank,negative regulation of calcium ion transport (GO:0051926),0.33473834932626145,0.8544912474132289,0.6723044397463002,0.9653926653351192,1.0,3/15,7.83%,CD33;SLC30A1;EPO
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.3322032848355737,0.8531884556641444,0.662870159453303,0.967383723575498,1.0,3/15,5.71%,STOX2;CELF4;TGFB2
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.273510014646854,-0.8527948896201353,0.7025440313111546,0.8781394223821678,1.0,3/32,2.60%,FHIT;DDX5;EP300
prerank,ubiquinone metabolic process (GO:0006743),0.33602820949000983,0.8522951772465502,0.6638477801268499,0.9685542452840483,1.0,2/15,5.49%,COQ2;COQ7
prerank,peptidyl-amino acid modification (GO:0018193),-0.36753189056444907,-0.8520135252751572,0.6912350597609562,0.879249392763117,1.0,3/10,15.83%,TTLL4;FKBP10;FKBP7
prerank,regulation of receptor binding (GO:1900120),-0.3705394650522561,-0.8516363641045942,0.6467289719626168,0.879539248929177,1.0,4/10,29.89%,GREM2;ATP2A2;ATP2A3;PTPRF
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3236021154693379,0.8515664725445073,0.6693386773547094,0.9692901104500845,1.0,2/16,2.01%,PHKG1;PGM2L1
prerank,Rac protein signal transduction (GO:0016601),-0.31434365822352434,-0.8513902911264095,0.6976744186046512,0.8795800985541536,1.0,5/18,18.30%,BRK1;NCKAP1;WASF1;FARP2;RHOH
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3280249012799178,0.8513255584861948,0.6378947368421053,0.9688888919797586,1.0,3/14,10.02%,HSPA5;FICD;DAB2IP
prerank,organelle fission (GO:0048285),0.2942594905098736,0.8509972236236212,0.7030567685589519,0.9686668669039248,1.0,2/24,1.83%,DNM3;GDAP1
prerank,cellular response to mechanical stimulus (GO:0071260),-0.25947776327173144,-0.8509723589003865,0.7290076335877863,0.8799588320019227,1.0,13/46,22.36%,PIEZO2;NFKB1;SLC9A1;MAP2K4;CASP2;IRF1;LTBR;TLR4;MAP3K14;MAP3K1;CNN2;BNIP3;F11R
prerank,peptidyl-glutamic acid modification (GO:0018200),0.29861261956606594,0.8507945361185723,0.6892778993435449,0.9682114131270347,1.0,2/24,2.48%,TTLL7;AGBL4
prerank,neuromuscular junction development (GO:0007528),-0.3016370980674272,-0.8504805274925317,0.6712062256809338,0.8804969194702931,1.0,4/24,8.81%,PDZRN3;LRRK2;UNC13C;UNC13B
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.3569181389496539,0.8503296104158178,0.649890590809628,0.9683618411551603,1.0,3/11,10.74%,CXCL12;GAS6;IRF7
prerank,regulation of neurogenesis (GO:0050767),-0.24355963024352723,-0.8503077128882521,0.7641509433962265,0.8803825574512424,1.0,12/55,17.88%,APPL2;PCM1;YAP1;DOCK7;REST;PRUNE1;HES1;NUMBL;BHLHE41;NUMB;HEYL;CX3CR1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3006180442564189,0.8497573106592057,0.6963906581740976,0.968638947389134,1.0,4/22,10.98%,ERBB4;NOTCH1;OCIAD1;F2R
prerank,negative regulation of viral life cycle (GO:1903901),-0.3316924770246964,-0.8488714158267958,0.6627906976744186,0.8828185455900843,1.0,3/15,12.22%,GSN;TRIM5;TRIM11
prerank,regulation of mitotic nuclear division (GO:0007088),-0.24303221955536258,-0.8488139166300053,0.7591836734693878,0.8824701065267276,1.0,13/55,18.47%,IGF1;BMP7;PDGFRB;BMP4;OBSL1;IGF2;CDK13;TOM1L2;DUSP1;RCC1;PRMT5;PHIP;NME6
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.3531781764924712,0.848605825805839,0.6450304259634888,0.9703237331456057,1.0,2/11,10.23%,NOVA2;ZNF445
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.3716301257173453,0.8482543477693808,0.6636771300448431,0.9702129439916588,1.0,2/10,8.05%,CD24;HSP90AB1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2738927441222294,0.8474442240403749,0.7280163599182005,0.971043924780934,1.0,5/32,8.66%,MFSD2A;PCYT1B;CHKA;CSNK2B;SLC44A5
prerank,B cell activation (GO:0042113),-0.234617632480743,-0.8473969296402655,0.7935871743486974,0.8848729255459317,1.0,14/68,18.13%,HDAC4;KIT;ITGB1;DCAF1;BCL2;CEBPG;PTPN2;MEF2C;TCF3;ITGA4;KLF6;PIK3CD;CTPS1;BLNK
prerank,positive regulation of peptidase activity (GO:0010952),-0.30702252736257546,-0.8472844345636565,0.6841085271317829,0.8846253929052791,1.0,7/20,27.42%,CTSH;NCSTN;RCN3;VCP;TANK;PSME1;GRN
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.25479625869714795,0.847246642265531,0.7525773195876289,0.9705668475495388,1.0,5/45,6.92%,CAMK2A;MT2A;IRF6;NCAM1;TRIM62
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.2891845621505149,0.8472189253222996,0.6790123456790124,0.9696881455247257,1.0,3/25,5.53%,HSPA13;HSPA8;HSPA5
prerank,peptidyl-asparagine modification (GO:0018196),-0.2800394531123299,-0.8468586632044621,0.7090909090909091,0.8850157454817859,1.0,9/31,26.21%,UGGT2;STT3A;DPM1;RPN1;ST6GAL1;DPM3;LMAN1;MCFD2;ASGR1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.35567848033184263,0.846141493468608,0.6659919028340081,0.9711854849181952,1.0,1/11,0.43%,ST18
prerank,mitotic cytokinesis (GO:0000281),-0.2547322615874956,-0.8460804575196494,0.7524177949709865,0.886084960156807,1.0,7/47,8.08%,ROCK2;SON;ROCK1;ARL3;SNX9;KLHDC8B;CHMP4B
prerank,myelin maintenance (GO:0043217),0.3671394036432247,0.8459920785104472,0.6470588235294118,0.9705691702550109,1.0,2/10,6.91%,CLU;EPB41L3
prerank,cell-substrate junction assembly (GO:0007044),-0.27068032596835107,-0.8458559956350938,0.7076612903225806,0.8860632769089216,1.0,8/33,15.35%,SORBS1;BCR;ACTN2;PTPRK;LAMA3;FN1;CTTN;WHAMM
prerank,t-circle formation (GO:0090656),-0.3707514646729343,-0.8458434106039093,0.6708860759493671,0.884694574508484,1.0,4/10,23.15%,NBN;WRN;SMARCAL1;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.3707514646729343,-0.8458434106039093,0.6708860759493671,0.884694574508484,1.0,4/10,23.15%,NBN;WRN;SMARCAL1;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.3707514646729343,-0.8458434106039093,0.6708860759493671,0.884694574508484,1.0,4/10,23.15%,NBN;WRN;SMARCAL1;ERCC1
prerank,positive regulation of DNA recombination (GO:0045911),-0.28333645064900354,-0.8452525627356493,0.7281553398058253,0.8854142804778176,1.0,14/27,29.45%,KMT5B;FUS;WDR48;SHLD2;PARP1;KMT5C;MMS19;ARID2;PRDM9;PAXIP1;ACTR2;FANCB;TIMELESS;MAD2L2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.3141717147222473,0.8450952858438323,0.6903765690376569,0.9716297408471876,1.0,7/18,19.09%,RUVBL1;NHP2;CCT2;DKC1;CCT4;NAF1;TCP1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.22092430116817893,-0.8442010463957303,0.8310679611650486,0.8870777200191113,1.0,28/94,23.18%,PCM1;ALMS1;ODF2;NINL;CEP63;CEP135;CEP162;PCNT;MARK4;CSNK1E;RAB3IP;RAB11A;CC2D2A;MAPRE1;C2CD3;YWHAE;AKAP9;DYNC1H1;CEP76;PRKACA;TCTN1;CEP57;CSNK1D;CEP89;NPHP1;HAUS7;HAUS8;ACTR1A
prerank,actin filament-based transport (GO:0099515),-0.3082028428642376,-0.8440983816480502,0.6620825147347741,0.8868158397537207,1.0,4/21,12.49%,SYNE2;MYO1B;WASL;MYO1F
prerank,stabilization of membrane potential (GO:0030322),0.3224812525826254,0.843824839742213,0.68,0.9735340167584652,1.0,4/16,8.25%,KCNK13;KCNK10;KCNK9;KCNK1
prerank,N-glycan processing (GO:0006491),0.3165891682884406,0.8435323224516055,0.692144373673036,0.973275677984572,1.0,4/18,11.67%,ST8SIA4;ST8SIA1;ST8SIA6;ST8SIA3
prerank,telomere organization (GO:0032200),0.25497625994447276,0.8428536092871607,0.7430278884462151,0.9738995646088363,1.0,12/43,16.84%,HUS1B;RPA3;TERF1;H3-3A;TERF2IP;APEX1;POLD1;ATM;TINF2;POLD3;PTGES3;XRCC5
prerank,ear morphogenesis (GO:0042471),-0.30093594814749736,-0.842852034802607,0.7026022304832714,0.888820003641057,1.0,6/20,16.85%,ZIC1;OSR1;FGFR2;NIPBL;CHD7;SIX1
prerank,endodermal cell fate commitment (GO:0001711),-0.36896762496268837,-0.8427508537038082,0.6698841698841699,0.8885668399363617,1.0,3/10,20.20%,CTR9;RTF1;CDC73
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.33971525051190693,-0.8425919043718928,0.6891891891891891,0.8884099378670578,1.0,4/13,13.03%,SRSF10;PRPF6;PRPF3;USP4
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.3357027814974419,-0.8418369070436489,0.7019748653500898,0.8894668565088002,1.0,6/14,28.75%,THBS1;PLCG1;ITGA4;PDCD4;PRKCI;GPER1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.2303770436079118,-0.8417042018848058,0.8036072144288577,0.8892585862099429,1.0,9/65,10.19%,EGFR;ERRFI1;ARAP1;RNF115;PTPN3;CDC42;FER;PTPN12;PTPN2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.2182718199963283,-0.841359511245424,0.8018348623853211,0.8894774831581231,1.0,26/93,22.56%,SASH1;CCN2;HMGB1;AXIN1;SH3RF1;TAOK3;MAP3K5;MID1;RELL1;TRAF2;FZD7;RASSF2;LTBR;TPD52L1;SH3RF2;EIF2AK2;VEGFA;TRAF3;SH3RF3;TRAF6;BMP2;SPHK1;TAOK1;WNT16;KLHDC10;TRAF5
prerank,histone exchange (GO:0043486),-0.26700064207381013,-0.8410866366041305,0.7452471482889734,0.8895257095910735,1.0,20/37,39.47%,RNF8;HJURP;SPTY2D1;CENPP;ANP32E;NASP;ITGB3BP;CENPT;ACTR6;DMAP1;KNL1;MIS18BP1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.2514672517121993,0.8408110279142821,0.7316017316017316,0.9775377597651207,1.0,12/48,13.93%,AKAP6;SNCA;THY1;APLNR;F2R;UBASH3B;CALM1;JPH3;TRPC1;PDE4D;CALM2;CALM3
prerank,ketone body metabolic process (GO:1902224),-0.37249673965104024,-0.8405282441954653,0.6956521739130435,0.8901508463061695,1.0,3/10,20.83%,ACSS3;BDH2;OXCT1
prerank,regulation of cellular senescence (GO:2000772),-0.27616801836627863,-0.8404879954341572,0.7074569789674953,0.889769283204542,1.0,14/28,28.67%,MAP3K3;ZKSCAN3;SLC30A10;YBX1;NEK4;TERF2;TERT;NEK6;CDK6;TWIST1;NUAK1;RSL1D1;VASH1;CGAS
prerank,ruffle organization (GO:0031529),-0.31632773621936067,-0.8396431714413592,0.6817325800376648,0.890949503165918,1.0,9/16,31.21%,TPM1;LIMA1;ARFIP2;CARMIL1;INPP5K;AIF1L;PLEKHA1;ARF6;CORO1B
prerank,cellular copper ion homeostasis (GO:0006878),0.3232719672069721,0.8395814373031615,0.6873706004140787,0.9793225749236748,1.0,1/14,0.97%,MT2A
prerank,regulation of histone acetylation (GO:0035065),0.2677255526699953,0.8392118744533701,0.7120622568093385,0.9791722578958952,1.0,5/33,10.21%,CHEK1;SNCA;RPS6KA5;IWS1;SET
prerank,regulation of transport (GO:0051049),-0.26534248200772215,-0.8390444896533098,0.7457627118644068,0.8916902409658316,1.0,8/36,15.09%,LEPR;PRKN;LRRK2;NRP1;VAMP2;WWC1;RAB11A;MBTPS1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.2654588553157229,0.8387902279218227,0.7319587628865979,0.9791563830594199,1.0,10/37,17.03%,RPA3;RPS27A;UBC;POLK;UBB;ERCC2;POLD1;RFC4;POLD3;RFC5
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.32881066584580354,-0.8386618033202761,0.6896551724137931,0.8919729507353018,1.0,4/15,11.12%,OSBPL8;OSBPL11;ABHD5;PLIN3
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.2314995312246839,0.8383405632528756,0.7931726907630522,0.9792513568381662,1.0,19/72,18.02%,COPS6;LIG3;RPA3;RPS27A;UBC;XAB2;POLK;UBB;ERCC2;POLR2J;POLR2B;POLR2I;POLD1;RFC4;POLD3;RFC5;POLR2G;AQR;TCEA1
prerank,protein polyglutamylation (GO:0018095),0.35249620044010127,0.8378442505707611,0.6911447084233261,0.9794112328632922,1.0,1/11,2.43%,TTLL7
prerank,response to estrogen (GO:0043627),-0.27349799316492407,-0.8369648564079367,0.722735674676525,0.8947897347801663,1.0,6/31,16.51%,EP300;KMT2D;BCAS3;AR;TRIM25;CITED2
prerank,granulocyte differentiation (GO:0030851),0.3092431557204617,0.8369568720115292,0.6567164179104478,0.9803958924547675,1.0,2/18,5.90%,LEF1;TAL1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.346149612754896,-0.836878098217525,0.6843137254901961,0.894486701119558,1.0,6/12,22.87%,RFWD3;PRKDC;SDE2;CDK2;WAC;PLK5
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.24897813616956055,-0.836273864873617,0.7552182163187856,0.8951943211391348,1.0,8/48,9.57%,ZMIZ1;KAT2B;EP300;ARID1B;SF3B1;TBP;TAF1D;PHF2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.2779266228828573,0.8360639977634639,0.734341252699784,0.9814585862831047,1.0,6/29,12.28%,RPS27A;UBC;UBB;CD300LF;IRF7;CD40
prerank,positive regulation of cytokine production (GO:0001819),-0.19024624347017335,-0.8360576538017532,0.9389002036659878,0.8951192347384959,1.0,54/292,19.31%,ROCK2;SULF1;FOXP1;NFKB1;IL6ST;EP300;CCBE1;ARNT;PLA2R1;TBK1;SULF2;LBP;PIBF1;HMGB1;CREBBP;STAT3;EIF2AK3;IL16;DHX9;ANXA1;F3;CEBPG;RUNX1;DHX36;IL17RA;PTPN22;CYP1B1;TRAF2;HIF1A;MAVS;APPL1;IL6R;IRF1;EIF2AK2;PRKDC;RORA;PRKCZ;IL17D;C1QTNF3;CYBA;STOML2;MRE11;AFAP1L2;ADRA2A;IL18;PIK3CD;SERPINE1;TLR4;POLR2H;TRAF6;WNT5A;PARK7;PTPN11;IRAK1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.2954022680182484,0.835965441191498,0.7074688796680498,0.9807327236178901,1.0,4/23,12.18%,METAP2;GUCA1B;CALM1;NMT1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.21549585990000888,0.835709232199447,0.8395833333333333,0.9803927763433391,1.0,12/112,9.72%,CD33;TIRAP;MIF;SYT11;GAS6;TLR2;CLU;PTPRJ;CD34;HSPB1;POMC;ARHGEF2
prerank,tRNA 5'-end processing (GO:0099116),0.32499588038781163,0.8355923738340153,0.6973094170403588,0.9797295903796189,1.0,5/15,21.78%,RPP40;RPP30;POP5;HSD17B10;POP1
prerank,lysosome organization (GO:0007040),-0.26504923597268426,-0.8355846601232657,0.7484909456740443,0.8955566053146502,1.0,6/36,7.43%,ABCA1;TFEB;LRRK2;ZKSCAN3;MTOR;TPCN2
prerank,negative regulation of neuron death (GO:1901215),0.2221196392917126,0.8355524883577025,0.8323353293413174,0.9789129306162968,1.0,19/93,15.06%,MAG;FOXQ1;SNCA;NTRK2;VSTM2L;UNC5B;AKT1;NDNF;GPNMB;CD34;CCL2;CD200R1;RETREG1;SET;F2R;SORL1;PTPRZ1;PPT1;ATF4
prerank,regulation of exit from mitosis (GO:0007096),-0.2587716790520251,-0.8351762099793894,0.7695238095238095,0.8958809554361706,1.0,14/38,25.04%,CDC14A;ANAPC5;ANAPC7;ANAPC4;ANAPC16;CDC26;CDC14B;UBE2E1;CDC27;UBE2S;ANAPC11;CDC16;ANAPC1;PHB2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.3537606510099301,0.8350706216889496,0.6943820224719102,0.9790646420884006,1.0,2/11,13.35%,SIRT1;XBP1
prerank,negative regulation of GTPase activity (GO:0034260),-0.3007213402838092,-0.8348485175679069,0.7231329690346083,0.8960652616641293,1.0,5/22,9.33%,LRRK2;BCAS3;ARFGEF1;GMIP;WNK1
prerank,negative regulation of viral genome replication (GO:0045071),0.25850296049849153,0.8348183800682367,0.768762677484787,0.978692639953117,1.0,6/40,10.26%,PROX1;HMGA2;ISG15;TRIM6;IFITM3;SLPI
prerank,response to ketone (GO:1901654),0.2867197331604792,0.834679694096483,0.7167381974248928,0.978063945560723,1.0,6/24,12.17%,ABHD2;TGFB2;SLIT3;UBE3A;ABCB4;WBP2
prerank,mitotic nuclear membrane organization (GO:0101024),-0.2430439601996983,-0.8341547916264237,0.7490272373540856,0.8964573839472217,1.0,22/51,35.20%,LMNA;CHMP4B;CHMP4A;UBE2I;ANKLE2;CHMP3;CC2D1B;RCC1;EMD;NUP98;PPP2CA;NUP43;LBR;NUP160;NUP93;PPP2R2A;BANF1;RAN;NUP133;AHCTF1;REEP4;SEC13
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.2430439601996983,-0.8341547916264237,0.7490272373540856,0.8964573839472217,1.0,22/51,35.20%,LMNA;CHMP4B;CHMP4A;UBE2I;ANKLE2;CHMP3;CC2D1B;RCC1;EMD;NUP98;PPP2CA;NUP43;LBR;NUP160;NUP93;PPP2R2A;BANF1;RAN;NUP133;AHCTF1;REEP4;SEC13
prerank,mitochondrial translational elongation (GO:0070125),0.22415918721805403,0.8341505647201211,0.8199608610567515,0.9782345523588342,1.0,30/88,24.31%,MRPS25;MRPL14;MRPS12;MRPL49;TUFM;MRPS18A;MRPL13;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;MRPL54;MRPS5;MRPS22;MRPS35;MRPS28;MRPL18;OXA1L;MRPL37;MRPL2;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23;TSFM;MRPL17;MRPL19;MRPL15
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.3588449156920972,-0.8338154043198063,0.7184115523465704,0.8966435732552518,1.0,6/11,28.62%,MSH3;ZRANB3;SMARCAL1;DONSON;TIPIN;TIMELESS
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.28304201454864464,-0.8335683923794546,0.739961759082218,0.8966611584684345,1.0,8/27,22.07%,SMG6;PDGFRB;NIBAN2;NABP2;PARP4;TERF2;FGFR4;FGF2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.2611876120176106,0.8335116988571006,0.7430278884462151,0.9787120930404912,1.0,6/35,10.98%,ERBB4;NOTCH1;SOCS1;OCIAD1;BCL3;F2R
prerank,protein palmitoylation (GO:0018345),0.2732649083204612,0.8331474985717345,0.7094736842105264,0.9785489205893183,1.0,8/30,19.57%,ZDHHC22;ZDHHC17;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14;PORCN;ZDHHC24
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.3384965433484251,0.8330632553482967,0.6680851063829787,0.9778185113887331,1.0,5/11,23.97%,TIMM22;NDUFA13;TOMM70;TIMM10B;ROMO1
prerank,regulation of chromatin binding (GO:0035561),-0.3686572369522339,-0.8327178905358287,0.6985294117647058,0.8978452771663394,1.0,3/10,13.50%,BTAF1;PARP9;DTX3L
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.3509650008296805,-0.8325929261622101,0.7020872865275142,0.8976249650668755,1.0,4/12,15.83%,GMPS;PPAT;ATIC;PAICS
prerank,negative regulation of protein binding (GO:0032091),-0.22726033833509224,-0.8323235467247843,0.8058823529411765,0.8976758912889479,1.0,24/71,27.39%,DAB2;ROCK1;LRRK2;GSK3B;STYX;IFIT2;DACT1;CSNK1E;USP33;NES;PRKCD;ATP2A2;ITGA4;PSME3IP1;PARK7;CARD16;ATP2A3;GTF2F1;TMBIM6;GNL3L;CFHR2;KDM1A;ADRB2;CAMK1
prerank,cristae formation (GO:0042407),0.28443963402987565,0.8322382661835458,0.7057613168724279,0.9786118331471182,1.0,12/27,25.50%,ATP5F1D;ATP5F1B;ATP5ME;DMAC2L;ATP5MF;UQCC3;CHCHD6;ATP5MG;IMMT;ATP5PF;MICOS13;ATP5MC3
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.27374782121497315,0.8320204403540256,0.7429805615550756,0.9781711318102001,1.0,6/30,12.28%,RPS27A;UBC;UBB;CD300LF;IRF7;CD40
prerank,dopaminergic neuron differentiation (GO:0071542),0.30640624469041394,0.831749654574494,0.6882845188284519,0.9777968372102507,1.0,1/19,0.21%,PHOX2A
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.3533556152272362,-0.8315865080066723,0.6930147058823529,0.898621251609251,1.0,1/11,0.80%,AFDN
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3401486395187642,0.831507712714183,0.6803455723542117,0.9773842184346941,1.0,3/13,12.19%,ALG3;ALG1;ALG8
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.327162587677839,0.83085878673959,0.7051282051282052,0.9778101607064577,1.0,2/14,4.74%,CHKA;PISD
prerank,cognition (GO:0050890),0.2534919970287928,0.8307879331856651,0.7739872068230277,0.9770345354637062,1.0,7/42,13.25%,GRM5;PTCHD1;MFSD2A;NSUN5;TTC8;DGCR2;GPR155
prerank,neural crest cell differentiation (GO:0014033),0.3047787076866671,0.8307778597034864,0.7170212765957447,0.9761472843286175,1.0,3/18,6.08%,NRG1;CDH2;CYP26C1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3276740017308995,-0.8307380980706033,0.6691176470588235,0.8997206887601884,1.0,6/14,24.38%,EHHADH;ACOX1;DECR2;AMACR;ACOT8;ACOX3
prerank,tRNA aminoacylation (GO:0043039),0.254043560207889,0.830659150277752,0.7613882863340564,0.9754758618851851,1.0,8/37,14.45%,VARS1;GARS1;RARS1;FARSB;AIMP2;GATB;IARS1;GATC
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.29424952296128337,0.8303440102998187,0.7056451612903226,0.9752446468227364,1.0,7/21,21.48%,PGM2L1;TALDO1;GCK;TKT;RPIA;GPI;G6PC3
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.23892283557342192,-0.8299073966911718,0.7554240631163708,0.9008312890912611,1.0,21/55,34.46%,FBXL7;FHL1;USP47;PSMF1;PSMB2;PSMC1;CUL1;PSMA3;PSMB6;PSMA4;AVEN;PSME1;PSMD13;PSMB9;RBX1;PSMB10;PSMA5;PINX1;PSME4;PSMD10;PSMB8
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.3455266777403109,-0.8297354759054245,0.684931506849315,0.9007052758887595,1.0,10/12,61.32%,IL18;SLC11A1;CCR2;IL12RB1;IL23A;IL12B;IL23R;XCL1;IL1B;IL18R1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3155573177161917,0.82968663035709,0.7072649572649573,0.9757467418304899,1.0,6/15,22.44%,NTRK2;HAP1;BCAR1;DDIT4;SORT1;BDNF
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.295624668796885,-0.8294591050487158,0.724202626641651,0.9007557090911386,1.0,5/22,11.64%,GTF2H2;RAD23B;DDB2;PARP1;ERCC3
prerank,"phototransduction, visible light (GO:0007603)",-0.32577504421356596,-0.8285621181155485,0.7129629629629629,0.9019537038814909,1.0,8/14,47.44%,ABCA4;GNB1;SAG;PDE6A;CNGB1;PDE6G;GNA11;PDE6B
prerank,regulation of cell-substrate adhesion (GO:0010810),0.24842789650011016,0.8282742467684331,0.7636761487964989,0.9778461782972815,1.0,7/42,11.96%,SPOCK1;PPM1F;THY1;NOTCH1;NDNF;PDGFB;FZD4
prerank,cellular response to interferon-beta (GO:0035458),-0.32651844206304925,-0.8280574763035609,0.7148217636022514,0.9024336510922444,1.0,6/14,28.37%,UBE2K;IRF1;STAT1;IRGM;HTRA2;CDC34
prerank,neuron projection fasciculation (GO:0106030),0.3626904979039858,0.8280458963652632,0.6928104575163399,0.9773897908548956,1.0,5/10,20.93%,NRCAM;CNTN4;RTN4;AMIGO1;CDK5R1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.31975992194254566,-0.8278036112538604,0.7055555555555556,0.902412575255949,1.0,4/15,10.55%,RIPOR2;RAPGEF3;EHD2;ADAM9
prerank,regulation of cellular pH (GO:0030641),0.2716080954136407,0.8276854147096802,0.7367303609341825,0.9772481987303266,1.0,5/29,11.52%,SLC4A1;CA2;ATP6AP1;ATP1A4;ATP5F1B
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.26781916718776366,-0.8276613887855934,0.7427466150870407,0.9022051458947378,1.0,8/33,14.69%,MEOX2;HMGB1;THBS1;JUP;RHOA;MEF2C;ANGPT2;APOE
prerank,ether lipid metabolic process (GO:0046485),-0.3256520693377877,-0.826510230247582,0.7030075187969925,0.9038938119451088,1.0,2/14,5.37%,AGMO;GNPAT
prerank,negative regulation of protein transport (GO:0051224),0.28433005029616376,0.8263848469019054,0.7343096234309623,0.9790734674177307,1.0,3/25,4.98%,PPM1F;RHBDF2;IL12A
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.2924198409319769,-0.8260508189511838,0.7082494969818913,0.9042621448654403,1.0,7/21,18.96%,DCN;BGN;CHST15;CHST11;CHPF2;CHSY1;CHST12
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.2964340341581131,0.8258220203227425,0.7525354969574036,0.9793423460003554,1.0,5/21,16.89%,CNKSR3;PPM1F;SMAD7;PDE4D;DDIT4
prerank,regulation of interferon-beta production (GO:0032648),-0.24189674303810527,-0.8253150532314424,0.7819548872180451,0.9052122348017674,1.0,17/46,27.24%,TBK1;PTPRS;DHX9;RNF216;MAVS;RIOK3;IRF1;DDX3X;TRAF3;OAS2;TLR4;PTPN11;NLRC3;POLR3D;SIRPA;CACTIN;DHX58
prerank,regulation of cellular component size (GO:0032535),-0.27617027732238164,-0.8252744733342302,0.7243243243243244,0.9048398260289988,1.0,5/30,8.41%,RPTOR;RARG;RAB22A;MTOR;VAV2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.3460229045641398,-0.8250561023566689,0.7025948103792415,0.9047631550930558,1.0,7/11,48.54%,P2RX4;PLCG2;TREM2;P2RX5;TRAT1;CCL4;NEUROD2
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2703377602068683,-0.8249299633446082,0.7547892720306514,0.9045300990031385,1.0,7/31,14.72%,DIS3L2;DDX6;DCP1A;CNOT8;DCP1B;EDC3;EXOSC9
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3105887968769524,0.8244591713733596,0.7272727272727273,0.9812329563460825,1.0,2/17,4.64%,HDAC9;PCSK6
prerank,positive regulation of T cell differentiation (GO:0045582),-0.261791927330506,-0.8242640845750107,0.7775590551181102,0.9052771231323573,1.0,3/36,1.79%,GLI3;ZMIZ1;GLI2
prerank,integrated stress response signaling (GO:0140467),0.3223958631501707,0.8240016552330951,0.6929824561403509,0.9812985825083974,1.0,3/14,8.57%,OMA1;HSPA5;CCL2
prerank,establishment of vesicle localization (GO:0051650),-0.30925499150173147,-0.8239866795875673,0.700381679389313,0.9053413851966885,1.0,7/18,27.18%,TMEM230;SPG11;RAB11A;CCDC186;TOR1A;KIF5B;TESK1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.21229262349488195,-0.8236199309547656,0.8670634920634921,0.9055862144242296,1.0,32/113,24.26%,TRABD2B;ABCA1;MPP7;ASAP1;GTF2H2;GSK3B;SPIDR;RAP1B;BRK1;DDB2;UNC13B;PARP1;ERCC3;FNIP1;SLF1;USP50;VEGFA;DDX3X;ICE1;TLR4;VCP;RHOC;PARK7;AJUBA;EIF4G1;BMF;PIH1D1;ATR;ERCC1;GNL3L;SYK;GTF2H1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.2966543566322058,0.8234878111306286,0.7249466950959488,0.9814316779064433,1.0,5/18,17.85%,SLA2;BCAR1;GPLD1;SH2B2;C3AR1
prerank,regulation of mRNA catabolic process (GO:0061013),0.20748938481921073,0.8232085580726805,0.8822355289421158,0.9811535537398806,1.0,25/121,17.11%,PRR5L;EXOSC5;YWHAB;PSMA1;HSPA8;RPS27A;UBC;AKT1;PSMD12;UBB;PSMA6;HSPB1;PSMB3;KHSRP;PABPC1;SET;APEX1;ANP32A;PSME3;MAPKAPK2;CARHSP1;PSMA2;EXOSC4;PSMC3;PNPT1
prerank,regulation of T cell activation (GO:0050863),0.2540406348134212,0.8227184596193232,0.7775467775467776,0.9812306792541134,1.0,6/42,12.37%,THY1;PRKCQ;GPNMB;CCL2;CYRIB;HSPD1
prerank,regulation of amyloid fibril formation (GO:1905906),0.31832930652870045,0.8226702523825297,0.6673728813559322,0.9804234380111922,1.0,4/15,13.50%,PFDN5;CLU;PFDN6;PSEN1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.20634008234939435,0.8222647399987328,0.8755020080321285,0.9803164418582957,1.0,28/124,19.82%,CAMK2A;LEF1;AP2M1;PSMA1;PLCB1;FZD6;GNG2;PSMD12;PSMA6;PSMB3;AP2B1;VANGL2;CELSR2;CALM1;DVL1;FZD4;PFN1;PPP3CA;PSME3;PSMA2;PSMC3;CTNNB1;PRICKLE2;AGO4;PSMB7;PPP3R1;RAC1;ARRB2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.293729366534405,0.8221473279261654,0.7347368421052631,0.9796569255097763,1.0,4/22,10.70%,NDOR1;IBA57;ISCU;ISCA2
prerank,positive regulation of integrin activation (GO:0033625),-0.3450530966937272,-0.8217224545413148,0.7087378640776699,0.9086047728766975,1.0,2/11,13.62%,RAP1B;P2RY12
prerank,response to organophosphorus (GO:0046683),0.3121512419948838,0.8216601017568395,0.6813953488372093,0.9797633248540826,1.0,3/16,13.39%,KCNJ11;P2RX7;VGF
prerank,myeloid dendritic cell activation (GO:0001773),-0.34784774993660544,-0.8214791412228749,0.7035087719298245,0.9085416493862453,1.0,2/12,5.01%,TGFBR2;HMGB1
prerank,inorganic anion transport (GO:0015698),-0.2412915865248881,-0.8212706549919441,0.7819706498951782,0.9084584833259032,1.0,8/53,11.09%,SLC13A4;SLC26A7;ENPP1;SLC4A10;CLCN2;CLIC4;ENPP3;SLC5A5
prerank,regulation of ATP metabolic process (GO:1903578),-0.2409154403918865,-0.8210470031499171,0.7806324110671937,0.9084497001018413,1.0,15/54,25.84%,PRKAG2;EP300;RANBP2;NUP42;HIF1A;NUP214;TPR;OGT;ATP5IF1;NUP98;FIS1;NUP43;NUP160;ZBTB7A;NUP93
prerank,cellular lipid catabolic process (GO:0044242),-0.2767506911962198,-0.8210123885035782,0.7522441651705566,0.908047105934069,1.0,12/27,35.98%,CYP1B1;LPIN2;ACOX1;ABHD12;LPIN3;ACOT8;MT3;ANGPTL3;NUDT19;SMPDL3B;FAAH;ACADL
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.24677404118054738,-0.8205155599502931,0.7716390423572744,0.9085240252128781,1.0,15/46,22.71%,PARVA;ITGAV;LAMC3;RADIL;NRP1;ATRNL1;FER;RHOA;FN1;ITGA4;ITGB3;PIK3R1;LAMB2;LAMC1;ANTXR1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.2441373878864576,-0.8202414183411197,0.7862745098039216,0.9085717719210356,1.0,8/48,13.46%,PRKAG2;EP300;RANBP2;NUP42;HIF1A;NUP214;TPR;OGT
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.3346633337923818,-0.8201661530485453,0.7282608695652174,0.9082262533305114,1.0,2/13,2.60%,GLI2;BMP4
prerank,regulation of B cell differentiation (GO:0045577),-0.3143649551904427,-0.819960070223254,0.7307692307692307,0.9081307466796438,1.0,8/17,32.39%,ID2;MMP14;INHBA;PPP2R3C;SYK;ZFP36L2;INHA;CD27
prerank,regulation of double-strand break repair (GO:2000779),-0.25523103372632805,-0.8196817492234324,0.7985480943738656,0.9081974420926983,1.0,9/39,12.73%,RNF169;TRIP12;SPIDR;UBR5;PPP4C;PPP4R2;SETD2;SHLD2;SLF1
prerank,regulation of lymphocyte migration (GO:2000401),0.35697910966486984,0.8193391045532038,0.7056451612903226,0.9835386717413085,1.0,2/10,7.85%,JAM2;AKT1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3332440617498882,-0.8193249852670191,0.7590132827324478,0.9083793659982984,1.0,2/14,5.31%,IL34;THBS1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.28796023329916753,0.8190381369635663,0.7361963190184049,0.9832647304381368,1.0,3/22,6.07%,PROX1;TOX;TAFA1
prerank,striated muscle contraction (GO:0006941),-0.23951014446090685,-0.8189857119194122,0.8174757281553398,0.9085532197683621,1.0,2/53,1.48%,ATP1A2;TPM1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.2855436589714557,0.8189525337622566,0.7371794871794872,0.982514108930082,1.0,3/23,6.67%,PAX8;PAX2;LHX1
prerank,positive regulation of secretion by cell (GO:1903532),0.22533575570147238,0.8186790773087095,0.8312236286919831,0.9821710228806628,1.0,7/70,5.71%,CD33;CADPS;APBB1;SNCA;GRK2;APBB3;TGFB2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.3331000777659914,-0.818523678425407,0.7123552123552124,0.9089627103465845,1.0,9/14,35.31%,TSEN2;TSEN15;CPSF4;RTRAF;CPSF1;RTCB;TSEN54;TRPT1;FAM98B
prerank,cholesterol homeostasis (GO:0042632),-0.23236734197176867,-0.8181618651066938,0.7971887550200804,0.9091427549228788,1.0,11/64,16.37%,ABCA1;CYP7B1;LIMA1;SOAT1;LDLR;NR1H3;NPC2;RORA;APOE;EPHX2;IL18
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.3520573452145196,-0.8180294006653862,0.7048543689320388,0.9089120272479035,1.0,4/10,30.09%,ABCD2;NR1H3;ELOVL5;MLXIPL
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.29603699742393963,-0.8179301076306522,0.7237569060773481,0.9086270590490026,1.0,5/21,21.85%,CYP26B1;LPIN2;ACOX1;LPIN3;ACOT8
prerank,negative regulation of response to wounding (GO:1903035),0.3008203762456815,0.8177399708433664,0.6764091858037579,0.9831279846862796,1.0,3/19,9.10%,GIT1;AJAP1;RTN4R
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.30196097113400655,-0.8175822532729782,0.7231638418079096,0.9087955051866073,1.0,5/18,22.63%,ROCK1;ITGB1;ITGA4;CX3CR1;VCAM1
prerank,fatty acid metabolic process (GO:0006631),-0.2078137205763777,-0.8172614675883577,0.8953488372093024,0.9089111742543524,1.0,32/115,27.17%,ACSL1;ACADSB;ABCD3;GNPAT;ACADM;CPT1C;PPARGC1A;ABCD2;CPT2;ACSF2;PON2;ACSL6;PNPLA8;ACOT11;ECHDC3;ACAD9;LPIN2;ACOX1;LPIN3;CBR4;CPT1A;MECR;ACSL4;ACOT8;ACOT6;GGT5;PON3;ACSBG1;AASDH;PPARA;LPL;ALOX12
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.2297930843462244,-0.8170996464898306,0.8037190082644629,0.9087305902896926,1.0,28/63,37.79%,MDM4;EP300;TFDP2;RFWD3;CNOT8;CASP2;PRKDC;CNOT2;CNOT1;SDE2;CNOT10;CDK2;PCNA;PML;WAC;CNOT4;CRADD;TNKS1BP1;PCBP4;E2F1;RPA2;PLAGL1;RBL2;GADD45A;SFN;TP53;PLK3;TRIAP1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.3239355889989272,0.8166395770493077,0.7060085836909872,0.9844174735823309,1.0,3/13,13.89%,NOTCH1;EID2B;DLL1
prerank,acute-phase response (GO:0006953),0.33071087831616264,0.8163759263965161,0.7158119658119658,0.9840886764928273,1.0,1/12,0.94%,MBL2
prerank,inflammatory response (GO:0006954),-0.19428438431816256,-0.8163040141277027,0.9333333333333333,0.9097244657140258,1.0,34/195,18.73%,NFKB1;HDAC4;TPST1;KIT;TBK1;HMGB1;HSPG2;THBS1;STAT3;ADCY1;NOX4;ANXA1;TRAF3IP2;ABCF1;NFATC4;AGTR1;PARP4;SCUBE1;IL17D;BDKRB2;CYBA;AFAP1L2;LOXL3;IL18;CMKLR1;PIK3CD;TLR4;PTGDR;PTGFR;BLNK;PXK;MGLL;NFATC3;BMP2
prerank,positive regulation of inflammatory response (GO:0050729),0.21910287114818353,0.8162862005306487,0.8135245901639344,0.9833873511688891,1.0,8/86,7.46%,RPS19;S100A9;S100A8;PDE2A;SNCA;ETS1;TLR2;NINJ1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.33220747396096806,-0.816271406704187,0.7380497131931166,0.9093130217718247,1.0,6/13,22.16%,NUPR1;EIF2AK3;NR1H3;MBTPS2;LPCAT3;WFS1
prerank,intermediate filament organization (GO:0045109),-0.31152553838726804,-0.8162194140971866,0.7121495327102804,0.9089339773741085,1.0,6/17,35.82%,VIM;GFAP;DES;BFSP1;TCHH;KLHL24
prerank,sterol homeostasis (GO:0055092),-0.23080648153402378,-0.8157929761935899,0.8091451292246521,0.9092567608776041,1.0,11/65,16.37%,ABCA1;CYP7B1;LIMA1;SOAT1;LDLR;NR1H3;NPC2;RORA;APOE;EPHX2;IL18
prerank,negative regulation of histone modification (GO:0031057),0.3268159030350572,0.8157647546901539,0.7510548523206751,0.9835289334541575,1.0,3/14,13.35%,SNCA;SET;PRMT6
prerank,endothelial cell development (GO:0001885),0.27513896205110056,0.8155998181317567,0.7424242424242424,0.982984093671217,1.0,8/25,16.74%,ROBO4;PDE2A;PPP1R16B;PECAM1;MARVELD2;PDE4D;RAP1A;SOX18
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.3095027469341275,-0.8154419317455505,0.7260536398467433,0.909400177592453,1.0,8/17,37.13%,DNM1L;BCL2;SOD2;FIS1;GGCT;BAK1;SFN;TIMM50
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.3433082824797573,-0.8150618072195702,0.7050092764378478,0.9096115340865436,1.0,3/11,14.28%,NBL1;CCN3;DUSP1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3334957941530763,0.814682081561707,0.7149220489977728,0.9838828900106212,1.0,4/13,14.63%,NAXE;NUDT12;NAMPT;NAXD
prerank,positive regulation of protein polymerization (GO:0032273),-0.2290409382338851,-0.8145928564944989,0.8210735586481114,0.9099720265485117,1.0,15/65,15.90%,FCHSD2;BAIAP2L1;NUMA1;SNX9;VASP;FER;CDC42EP5;NCKAP1;MAPRE1;TOGARAM1;CTTN;NCK1;AKAP9;NCK2;CARMIL1
prerank,lysine catabolic process (GO:0006554),-0.3336897321667084,-0.8145272171520564,0.7245508982035929,0.9091560117496882,1.0,8/12,40.20%,DLST;ALDH7A1;PIPOX;PHYKPL;GCDH;HYKK;AASS;DLD
prerank,lysine metabolic process (GO:0006553),-0.3336897321667084,-0.8145272171520564,0.7245508982035929,0.9091560117496882,1.0,8/12,40.20%,DLST;ALDH7A1;PIPOX;PHYKPL;GCDH;HYKK;AASS;DLD
prerank,maintenance of protein location in nucleus (GO:0051457),-0.29154264610029756,-0.8141160881474628,0.7387033398821218,0.9094326066024072,1.0,11/20,28.18%,TAF3;SP100;TAF8;TOPORS;HNRNPU;MORC3;PARK7;PML;SUN2;BBS4;CHCHD10
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.3162078290948762,-0.8137943022112926,0.7131630648330058,0.9095682879017346,1.0,8/15,34.58%,USP50;EIF2AK2;DDX3X;TLR4;NLRC3;NLRP2B;DHX33;MYD88
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.324089591097722,-0.813612495734826,0.7398843930635838,0.9094112926230268,1.0,7/14,31.70%,RCC1L;RMND1;RPUSD4;MPV17L2;TRMT10C;C1QBP;MRPS27
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.3323094824289606,-0.8133599900725118,0.7192660550458716,0.9094093574805465,1.0,2/13,2.80%,ZMIZ1;ARID1B
prerank,response to interferon-alpha (GO:0035455),0.31026206816558977,0.8132657239538719,0.702355460385439,0.9857295216884743,1.0,7/16,21.59%,GAS6;IFNAR1;IFITM3;ADAR;KLHL20;BST2;RO60
prerank,regulation of cellular protein metabolic process (GO:0032268),0.24028605806627296,0.8131595871390132,0.8132780082987552,0.9850141654861894,1.0,5/47,7.85%,GRM5;RPL10;NANOS3;KLF4;AKT1
prerank,cholesterol biosynthetic process (GO:0006695),0.2650021631439064,0.8127480430276908,0.7599164926931107,0.9849630940074957,1.0,14/31,23.23%,MVD;HSD17B7;IDI1;DHCR7;PLPP6;HMGCS1;ACAT2;TM7SF2;EBP;MSMO1;FDPS;NSDHL;PMVK;LSS
prerank,blood vessel endothelial cell migration (GO:0043534),-0.2915034028662248,-0.8126998096806229,0.7596153846153846,0.9101419362541358,1.0,9/22,24.29%,EFNB2;ROBO1;NRP1;VEGFA;NR4A1;MIA3;FGF2;EPHB4;SLIT2
prerank,regulation of protein localization (GO:0032880),-0.23580480715125843,-0.8126265502929375,0.7969348659003831,0.9098013537935545,1.0,23/58,27.68%,AFDN;WDPCP;DLG1;UFL1;CSNK1E;PARP1;TRIM5;TPR;TRIM25;FBXW7;DZIP1L;PICALM;ITGB3;DVL3;PLEKHM2;BORA;RAB9A;TRIM68;KDM1A;RSL1D1;TESK1;CAMK1;TRIM46
prerank,regulation of keratinocyte migration (GO:0051547),-0.33680526300996105,-0.8122943176314578,0.701171875,0.9099257167962749,1.0,3/12,10.55%,MAP4K4;MTOR;ADAM9
prerank,negative regulation of cell cycle process (GO:0010948),-0.23085285908179884,-0.8121225096052528,0.8225806451612904,0.9097389775487041,1.0,24/61,33.38%,BMP7;BMP4;RBBP8;CBX5;TFDP2;TOM1L2;PCGF2;PCGF6;EHMT1;L3MBTL2;EPC1;NME6;TERF2;EZH2;PPP1R10;APAF1;GPER1;FOXO4;WAPL;E2F1;ZFYVE19;RAD51;BRCA1;E2F6
prerank,regulation of fibroblast migration (GO:0010762),0.29008343715449025,0.8120803069668316,0.743801652892562,0.9853278063132256,1.0,8/20,20.29%,PRR5L;RFFL;ARHGEF7;CORO1C;DDR2;GNA12;RAC1;HYAL2
prerank,neuron fate commitment (GO:0048663),0.319100530922169,0.8120228295015516,0.7111111111111111,0.9845534786564459,1.0,1/14,0.66%,MYT1L
prerank,mitochondrion organization (GO:0007005),-0.19763643142429252,-0.8117839751385252,0.9334677419354839,0.9098728289019682,1.0,53/165,28.75%,PID1;TRAK1;OPA1;PRKN;LRRK2;MEF2A;DNM1L;CXADR;VPS13D;AFG1L;IFIT2;MIGA2;PPARGC1A;AIFM1;MTX3;GABPA;HCFC1;RHOT1;PARP1;NRF1;YME1L1;VPS13C;SIRT5;WASF1;STOML2;AIP;MGME1;PARK7;FIS1;TERT;PYROXD2;TOMM7;FMC1;WDR81;BNIP3;SSBP1;SIRT4;RHOT2;SIRT3;PHB2;CLUH;TIMM13;SAMM50;MFN2;TIMM44;HIGD2A;LONP1;MYH14;MUL1;CHCHD10;SUPV3L1;MIGA1;TOMM5
prerank,cytoplasmic translational initiation (GO:0002183),-0.3057123057322057,-0.8116898423015777,0.7304964539007093,0.9095731720905516,1.0,5/17,19.50%,EIF4A2;DENR;EIF3A;RBM4;EIF4G1
prerank,tryptophan metabolic process (GO:0006568),0.33657648609629043,0.8116849037320227,0.6943866943866944,0.9843236008983434,1.0,11/11,66.37%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;ATP7A;KMO
prerank,transition metal ion homeostasis (GO:0055076),-0.26877511941983945,-0.8116591468897817,0.7833655705996132,0.9091649294068673,1.0,4/28,8.89%,CP;PRKN;SLC39A14;XIAP
prerank,macrophage activation (GO:0042116),0.26048174322367296,0.8116194108765392,0.7892561983471075,0.9835629445169922,1.0,6/34,12.62%,CD93;SNCA;CLU;DYSF;AIF1;ITGAM
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.3391442972287255,-0.8115676704648608,0.7387218045112782,0.9088689193894627,1.0,5/13,22.55%,AXL;ZBTB1;IL18;LAMP1;TICAM1
prerank,negative regulation of endocytosis (GO:0045806),-0.28553772626269297,-0.8114398663018576,0.7552182163187856,0.9086413422695266,1.0,8/24,22.47%,EPHA3;NR1H3;RUBCN;PICALM;PRKD1;LRSAM1;ABCA7;CD300A
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.2339708446239352,-0.8113654605006488,0.8023952095808383,0.908317815425662,1.0,9/51,17.05%,PTN;IL34;HMGB1;THBS1;IL6R;VEGFA;VEGFD;CMKLR1;SERPINE1
prerank,response to organonitrogen compound (GO:0010243),0.25675139147455533,0.8112486820504101,0.7848360655737705,0.9834047043401289,1.0,6/38,11.03%,GLRA1;GLRA3;MEAK7;TRPM2;GLRA2;BRSK2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.3486450022078028,-0.8103301385205443,0.7326732673267327,0.9096461378478721,1.0,3/11,22.55%,SCARA3;TNIP2;TICAM1
prerank,copper ion transport (GO:0006825),0.33596961587908597,0.8092092732045729,0.7119815668202765,0.9864175339793956,1.0,3/11,15.24%,STEAP2;ATOX1;COX17
prerank,positive regulation of histone acetylation (GO:0035066),-0.28004808558351857,-0.8088947694335837,0.76171875,0.9116880716362873,1.0,11/23,29.92%,BRD7;PPARGC1A;SMAD4;ARRB1;NOS1;PIH1D1;PAXIP1;RPS6KA4;RUVBL2;SPHK2;GLYR1
prerank,negative regulation of kinase activity (GO:0033673),0.22901667527333044,0.8087048071340477,0.8274509803921568,0.9864853781895953,1.0,12/62,12.35%,CAMK2N1;PPM1F;SNCA;THY1;TRIB3;AKT1;YWHAG;HSPB1;UBASH3B;CEP43;DVL1;EPHA1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.3492398748584847,-0.8081967887432616,0.7234432234432234,0.9124323996835427,1.0,2/11,2.80%,ZMIZ1;ARID1B
prerank,amyloid fibril formation (GO:1990000),0.23433017220967817,0.8075333102437577,0.8247422680412371,0.987884473021126,1.0,12/51,14.48%,SNCA;PSENEN;RPS27A;UBC;UBB;H3-3A;NAT8;TSPAN14;SERF1A;CD36;SORL1;B2M
prerank,positive regulation of protein maturation (GO:1903319),-0.3497408493881004,-0.8073053708495849,0.7062256809338522,0.9134854009206668,1.0,1/11,2.62%,CCBE1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.23809837943274667,-0.8063946363074446,0.7861386138613862,0.9140915329001492,1.0,16/50,25.84%,PUM2;TNRC6A;RANBP2;PUM1;NUP42;NUP214;TPR;POLR2H;EIF4G1;NUP98;NUP43;POLR2K;AGO1;NUP160;POLR2E;NUP93
prerank,regulation of gene silencing by RNA (GO:0060966),-0.23809837943274667,-0.8063946363074446,0.7861386138613862,0.9140915329001492,1.0,16/50,25.84%,PUM2;TNRC6A;RANBP2;PUM1;NUP42;NUP214;TPR;POLR2H;EIF4G1;NUP98;NUP43;POLR2K;AGO1;NUP160;POLR2E;NUP93
prerank,regulation of nervous system development (GO:0051960),-0.25246935263171405,-0.8059082894217477,0.8088803088803089,0.9144444459282877,1.0,9/37,18.13%,PTN;YAP1;DOCK7;PRUNE1;HES1;BHLHE41;HEYL;CX3CR1;LGI4
prerank,telomere maintenance (GO:0000723),-0.23758622286217518,-0.8054612898624942,0.8258196721311475,0.9147327470481653,1.0,17/50,22.70%,SMC6;NBN;NSMCE2;WRN;SP100;SMC5;RAD51D;PARP1;PRKDC;CTC1;MRE11;TERF2;PCNA;STN1;TERT;XRCC6;ATR
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.23708941231387565,-0.8053858476198094,0.8350730688935282,0.9144064417805273,1.0,13/52,21.57%,HUWE1;SAE1;TFDP2;ABLIM3;BCL2;LEPROT;NPEPPS;FBXW7;YWHAE;UBL5;UBE2D3;TOMM7;ARIH2
prerank,aerobic respiration (GO:0009060),0.28860122600605526,0.8052962784828563,0.7388663967611336,0.9912554532346914,1.0,3/20,8.09%,SDHC;ATP5F1D;SLC25A14
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.250979640224092,0.8046603828831962,0.8268041237113402,0.9915599770381998,1.0,10/39,17.03%,RPA3;RPS27A;UBC;POLK;UBB;ERCC2;POLD1;RFC4;POLD3;RFC5
prerank,regulation of cellular response to stress (GO:0080135),-0.2077939802929006,-0.8043369462186194,0.9118236472945892,0.915746555321922,1.0,17/115,10.89%,ROCK2;EP300;SMG1;PRKN;ABL1;NUPR1;GSK3B;RPTOR;RANBP2;CREBBP;MTOR;CAMK2D;NUP42;CAMK2G;BAG3;NUP214;MBTPS2
prerank,negative regulation by host of viral transcription (GO:0043922),-0.3306924371663778,-0.80433098682368,0.7176015473887815,0.9152994675178094,1.0,5/12,23.60%,REST;JUN;HDAC1;INPP5K;TFAP4
prerank,negative regulation of interleukin-6 production (GO:0032715),0.273205033510293,0.8042965535961041,0.7584650112866818,0.9913205388725731,1.0,4/27,9.64%,SYT11;GAS6;CD200R1;FOXJ1
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.3501643038722706,-0.8042593326589424,0.7074569789674953,0.9149692113148326,1.0,3/10,10.55%,MAP4K4;MTOR;ADAM9
prerank,positive regulation of rRNA processing (GO:2000234),-0.346674495723177,-0.8038326565890604,0.7120921305182342,0.9152345719945433,1.0,3/10,16.68%,WDR43;DIMT1;BUD23
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.30745567791962514,-0.8032470202410622,0.7514231499051234,0.9157339864773226,1.0,8/16,30.37%,PID1;PPARGC1A;PARP1;VCP;PPARA;ANTKMT;SPHK2;ENO1
prerank,cGMP biosynthetic process (GO:0006182),-0.347606081687855,-0.8031356079421975,0.7388059701492538,0.9154668564713209,1.0,2/10,17.44%,GUCY1A1;NPR2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.274055985766332,0.8031008710880926,0.744136460554371,0.9926199569060699,1.0,7/25,14.94%,HIP1;AKT1;NUP62;PDE6H;HAP1;CCDC88A;RTN4
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2896471015563579,-0.8030697840859287,0.7710371819960861,0.9151253223838791,1.0,12/20,34.01%,PLOD2;PLSCR1;PTDSS1;SLC27A1;CHAC2;GSS;PTDSS2;GGCT;GCLC;HAGH;GAMT;CNDP2
prerank,GPI anchor metabolic process (GO:0006505),-0.2749352238452519,-0.8030217808022613,0.7859848484848485,0.9147592506407183,1.0,11/26,32.02%,PIGN;DPM1;MPPE1;PIGH;PIGC;DPM3;PIGA;PIGZ;PIGP;PIGF;PIGO
prerank,chromatin assembly or disassembly (GO:0006333),-0.3384151960721337,-0.8030118570049086,0.722007722007722,0.9143201313606067,1.0,1/11,1.47%,HDAC8
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.32535412659585866,-0.8027080003008191,0.7260536398467433,0.9143944840379626,1.0,5/13,11.08%,MOV10;RC3H1;ZC3HAV1;UPF1;CNOT8
prerank,tryptophan catabolic process (GO:0006569),0.33657648609629043,0.8025368320001456,0.7308488612836439,0.9928180517330203,1.0,11/11,66.37%,KYAT1;KYNU;AFMID;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KMO
prerank,regulation of protein localization to centrosome (GO:1904779),0.34850157580898083,0.80177496578938,0.7450110864745011,0.9933625395489868,1.0,3/10,11.42%,BICD1;NUP62;APC
prerank,regulation of nuclear division (GO:0051783),-0.2846921282923891,-0.8014048448528662,0.7490421455938697,0.9161029171745956,1.0,7/20,26.28%,OBSL1;CDK13;RCC1;PRMT5;CUL7;BORA;CCDC8
prerank,placenta development (GO:0001890),0.3244168847624348,0.8013291798792697,0.7306889352818372,0.9932512075464556,1.0,2/12,12.49%,PPARG;E2F7
prerank,RNA modification (GO:0009451),0.22988841683683356,0.8005658363356345,0.8411016949152542,0.9937535384904845,1.0,6/54,8.23%,TSR3;AARS2;QTRT1;NSUN5;TFB1M;RBM15B
prerank,negative regulation of viral release from host cell (GO:1902187),-0.32684254558900505,-0.8001013016567989,0.7271062271062271,0.9178179289864553,1.0,4/13,12.22%,TRIM8;CHMP3;TRIM5;TRIM11
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.2935989533147397,0.7999050687664163,0.7619047619047619,0.9941066673745697,1.0,5/19,14.31%,HNRNPC;TERF1;TEN1;PIF1;TINF2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.32496963603755297,-0.7995504079047395,0.7367387033398821,0.9182933970831292,1.0,3/12,13.99%,CBLB;F3;APOD
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.24720367564339035,0.7991124151700786,0.8073022312373225,0.9946045387454645,1.0,10/40,16.00%,BICD1;MAGI2;AHI1;HIP1;CLU;SGIP1;INSR;PPT1;B2M;TBC1D5
prerank,DNA replication (GO:0006260),-0.20549593524760268,-0.7990021557584412,0.908,0.9187246917012472,1.0,40/105,33.30%,RBMS1;RBBP8;TOP1;BAZ1A;NBN;NT5M;WRN;UPF1;MCM9;REV1;ING5;MCM6;MRE11;HELB;CDK2;POLA2;RPAIN;CLSPN;ATR;DBF4;DONSON;POLE2;NAP1L1;RECQL5;KIN;TIPIN;ORC1;MCM4;TIMELESS;IGHMBP2;TOP1MT;POLD2;RPA2;RMI2;CDC45;PNKP;RAD9A;POLA1;BRCA1;PCLAF
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.309751532775938,-0.7989144921676037,0.7279843444227005,0.9184295281334148,1.0,6/16,25.15%,ABHD5;LDLR;NR1H3;SLC27A1;DAGLB;PNPLA2
prerank,establishment of melanosome localization (GO:0032401),-0.29800374721930795,-0.7985528990387321,0.7509505703422054,0.9186078179143601,1.0,6/19,28.47%,SHROOM2;RAB11A;BLOC1S5;BBS4;BBS2;MLPH
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3242706519339633,0.7982403569115712,0.75054704595186,0.9952832531317288,1.0,4/12,16.80%,MFSD2A;ACSL3;SOAT2;MTTP
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.3133214260485596,0.7976584826322257,0.745417515274949,0.9954644413229466,1.0,3/16,18.07%,SLC2A5;BMPR2;DDAH1
prerank,positive regulation of lipid storage (GO:0010884),-0.2817062640999469,-0.7975839147891891,0.7657142857142857,0.9198196462496775,1.0,9/21,34.22%,NFKB1;OSBPL11;PLIN3;IKBKE;LPL;EHD1;FITM2;MSR1;C3
prerank,lipoxygenase pathway (GO:0019372),0.3144146993613243,0.7974247540697165,0.7422680412371134,0.9950065421696371,1.0,2/14,9.69%,GPX1;HPGD
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.32291230473023325,0.7974201698754841,0.7738589211618258,0.993256270891348,1.0,4/12,14.93%,MELTF;SPRY4;ACTN4;CORO1C
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.32291230473023325,0.7974201698754841,0.7738589211618258,0.993256270891348,1.0,4/12,14.93%,MELTF;SPRY4;ACTN4;CORO1C
prerank,regulation of microtubule-based movement (GO:0060632),0.33251774062618145,0.7971856574474999,0.7330415754923414,0.9928148055417625,1.0,2/11,10.93%,MAP2;HAP1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3525534893532317,-0.7969804725122331,0.7262357414448669,0.9203648511825199,1.0,3/10,16.60%,PTPN22;DUSP10;PDCD4
prerank,lipid catabolic process (GO:0016042),0.29573007159679965,0.7969261795660578,0.7635983263598326,0.9923908691462635,1.0,3/18,14.41%,LIPE;HSD11B1;PPT1
prerank,proteoglycan biosynthetic process (GO:0030166),0.26385112688701107,0.7962503558368733,0.8091106290672451,0.9927326360472358,1.0,4/31,5.76%,B3GAT1;CHST9;B3GAT2;CSGALNACT1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3326563100120167,0.7961996861168171,0.7484143763213531,0.9919430527148676,1.0,4/11,13.20%,TERF1;CCT2;DKC1;CCT4
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3114327539034294,0.7959187860907144,0.744136460554371,0.9915411882074565,1.0,2/15,3.32%,MIF;SIRT1
prerank,organophosphate catabolic process (GO:0046434),0.3322022360908323,0.7954814058291707,0.729490022172949,0.9914356082405867,1.0,1/11,4.80%,ENPP2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.23671667575631,-0.7954578878434122,0.8092485549132948,0.9223539887719309,1.0,25/48,37.19%,EP300;ABL1;BCL2;HIPK1;CASP2;PRKDC;TOPORS;IKBKE;MSH6;PML;USP28;BAG6;HTRA2;BCL2L2;BAK1;E2F1;HIC1;SNW1;BCL2L11;TNFRSF1B;BRCA1;PYCARD;MSH2;SFN;TP53
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.3497212731389165,0.7954065841635273,0.7298474945533769,0.9907096968151816,1.0,3/10,14.01%,ACER2;NEXMIF;JAM3
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.19417945419674035,0.7951680592260845,0.9333333333333333,0.9902370746303744,1.0,32/163,18.54%,PDE4B;BTNL9;VAV3;SLA2;PSMA1;THY1;MOG;PAK1;PRKCQ;PTPRJ;EIF2B3;PSMD12;PSMA6;PSMB3;SKAP1;TNFRSF21;BCL10;RFTN1;PDE4D;BCAR1;TAB2;PSME3;PAK3;NFATC2;CD38;PSMA2;PSMC3;BTK;SH2B2;FYN;NCKAP1L;PSMB7
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.33538492551755766,-0.7948965164061598,0.744916820702403,0.9227419547932475,1.0,2/12,6.19%,NCOR1;STAT3
prerank,cellular response to UV (GO:0034644),-0.21508718609864022,-0.7940964127968169,0.8795180722891566,0.9235821066500393,1.0,24/76,25.54%,INO80;EP300;CREBBP;DHX36;PTPRK;IMPACT;DDB2;ZBTB1;PRKCD;USP47;PARP1;EIF2AK4;MMP2;SDE2;MFAP4;PCNA;CARD16;BMF;PPID;ATR;ERCC1;USP28;ACTR5;KDM1A
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.27949221890130976,-0.7939218030302814,0.7621722846441947,0.9234190906384516,1.0,8/23,36.06%,AXL;HMGB1;TLR4;INHBA;INHA;C1QBP;NR1H4;CD274
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.27969510865382147,-0.7936280492503434,0.7762376237623763,0.9234484906088801,1.0,6/22,16.75%,ERI3;ERI2;URB1;EXOSC9;EXOSC10;WDR12
prerank,positive regulation of dephosphorylation (GO:0035306),0.2699466700791169,0.7934373486518371,0.7858672376873662,0.9924594162941635,1.0,9/27,20.69%,PPP1R16B;SMPD1;CALM1;CALM2;CALM3;PPIA;CAMTA1;PPP2R5A;MTMR9
prerank,regulation of pH (GO:0006885),-0.33561327552014625,-0.7934367040895938,0.775894538606403,0.9233086197441562,1.0,2/11,7.10%,SLC9A1;ATP6V0A4
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.3307960422844939,-0.7918185408950473,0.7458256029684601,0.9254237431095588,1.0,3/12,12.04%,HDAC8;RAD21;RB1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.34495594051815726,0.7918165287868123,0.7217573221757322,0.9944900514789472,1.0,2/10,10.02%,NELL1;DAB2IP
prerank,global genome nucleotide-excision repair (GO:0070911),-0.2694939023151807,-0.7917870360160274,0.7985212569316081,0.925017095194074,1.0,5/26,11.64%,GTF2H2;RAD23B;DDB2;PARP1;ERCC3
prerank,positive regulation of vasoconstriction (GO:0045907),0.31552715446206314,0.7914987477283801,0.7489361702127659,0.9941891638011895,1.0,3/13,10.98%,ADRA1D;ADRA1A;F2R
prerank,heterochromatin assembly (GO:0031507),-0.28657423331922804,-0.7912819707068349,0.7775735294117647,0.925402408913334,1.0,6/20,18.57%,EZH1;BAZ2A;MBD2;HDAC1;SMCHD1;RRP8
prerank,protein localization to mitochondrion (GO:0070585),0.3338440929109201,0.7910113289217384,0.7142857142857143,0.9942146544025788,1.0,3/11,11.34%,ISG15;AKT1;MTCH2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.31340117201822915,-0.7910037980706216,0.7536231884057971,0.9253891183972941,1.0,6/14,25.98%,IRS1;ABCD2;LONP2;AKT2;TWIST1;PPARA
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.24023023327895712,-0.7909410014215953,0.8469184890656064,0.925036432489317,1.0,18/43,26.74%,FOXN3;NBN;TAOK3;BRCC3;BRSK1;NABP2;RINT1;TRIM39;CDC14B;NOP53;MRE11;NAE1;CDK5RAP3;TAOK1;CLSPN;DONSON;ORC1;ABRAXAS1
prerank,renal absorption (GO:0070293),-0.35281585729036924,-0.790831352542525,0.7557692307692307,0.924730966612493,1.0,2/10,8.88%,GSN;WNK4
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2607492703819382,-0.7907169467565,0.809433962264151,0.9244404419101688,1.0,7/31,14.58%,USP7;BRCC3;USP33;ABRAXAS2;USP50;OTUD4;USP13
prerank,positive regulation of interferon-beta production (GO:0032728),-0.2486455564161707,-0.788948749688467,0.8305400372439479,0.9267888828595733,1.0,9/33,19.29%,TBK1;DHX9;MAVS;RIOK3;IRF1;DDX3X;OAS2;TLR4;PTPN11
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.31024282241630224,0.7888412889904033,0.734475374732334,0.9970444062439934,1.0,3/14,13.52%,CSTF2T;CSTF2;CPSF2
prerank,microtubule-based transport (GO:0099111),0.321908349026993,0.7883340036541412,0.7537473233404711,0.9970770295998108,1.0,12/12,67.83%,SPEF2;DNAAF2;DYNC1I2;DYNC1I1;DNAAF4;CCDC40;SPA17;SPAG17;ADCY10;ROPN1L;CABYR;HTT
prerank,protein localization to kinetochore (GO:0034501),-0.30912540637908725,-0.7875312595063535,0.7551020408163265,0.9285874125671206,1.0,8/14,44.55%,IK;CENPT;KNL1;TTK;RCC2;SPDL1;MTBP;CDK1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.31127166825260666,0.7870117174677742,0.7516059957173448,0.9984710078728675,1.0,1/13,2.94%,PTPRT
prerank,indolalkylamine catabolic process (GO:0046218),0.33655536028119515,0.786620658211563,0.7291666666666666,0.9982610346660961,1.0,10/10,66.37%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KMO
prerank,regulation of histone deacetylation (GO:0031063),-0.31427079692673876,-0.7865012862873025,0.7359223300970874,0.9297935696621128,1.0,6/13,29.49%,CAMK2D;AKAP8L;NIPBL;SAP30BP;ZBTB7B;SPHK2
prerank,DNA integrity checkpoint signaling (GO:0031570),0.24575607504968788,0.786110342094557,0.8193548387096774,0.9982456742177458,1.0,2/36,1.67%,CHEK1;HUS1B
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.3294807857913812,0.7861062171360359,0.7628205128205128,0.9973872695968784,1.0,5/12,19.29%,FDX2;TSPOAP1;TSPO;STARD3NL;STARD3
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3063830376479925,0.7859438481270394,0.734341252699784,0.9967847771400276,1.0,3/15,8.66%,TMSB4X;NOTCH1;HSPB1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.3386005759049014,0.7858591054149037,0.7291666666666666,0.9960534827056917,1.0,2/10,7.85%,SNCA;AKT1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.33136765983512234,0.7858246796620406,0.709051724137931,0.9952534408733676,1.0,5/10,24.63%,TERF2IP;APEX1;RTEL1;ACD;DCLRE1B
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.33296313137668765,0.7855464224976674,0.7310195227765727,0.993134795279744,1.0,6/11,24.21%,ACOT7;PANK4;PANK3;PPCS;PANK1;ACAT1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.33296313137668765,0.7855464224976674,0.7310195227765727,0.993134795279744,1.0,6/11,24.21%,ACOT7;PANK4;PANK3;PPCS;PANK1;ACAT1
prerank,coenzyme A biosynthetic process (GO:0015937),0.33296313137668765,0.7855464224976674,0.7310195227765727,0.993134795279744,1.0,6/11,24.21%,ACOT7;PANK4;PANK3;PPCS;PANK1;ACAT1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.2966275377923864,-0.7853121718866767,0.7836812144212524,0.9311867413417912,1.0,10/17,32.59%,EMC2;EMC7;EMC9;GET4;EMC4;BAG6;EMC10;EMC3;GET3;EMC6
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.23092930210385706,-0.7852530450341857,0.8514851485148515,0.9308160641227693,1.0,19/51,28.30%,SMG6;TNKS2;CCT6A;XRN1;CCT8;CTC1;CCT5;EXOSC10;MAP2K7;HNRNPU;TERF2;STN1;ATR;GNL3L;FBXO4;NEK7;CCT3;NAT10;PARN
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.33765662295142046,-0.7847907297217842,0.7439703153988868,0.9310897886854651,1.0,2/10,21.47%,RC3H1;SCRIB
prerank,protein methylation (GO:0006479),-0.24299148087258587,-0.7845786417476814,0.8361581920903954,0.9309710586403347,1.0,14/40,22.27%,NSD1;NSD3;SETD3;PRMT2;N6AMT1;EHMT1;PCMT1;METTL21A;PRMT5;PRMT8;EEF2KMT;NTMT1;EZH2;CAMKMT
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.2171385711577471,-0.7845622467002102,0.8794178794178794,0.9305421165162368,1.0,26/67,36.28%,ITGAV;ITGB5;SEC22B;PSMF1;PSMB2;CYBA;TAP2;SNAP23;NCF2;PSMC1;PSMA3;PSMB6;PSMA4;TAP1;PSME1;PSMD13;PSMB9;PSMB10;PSMA5;CALR;PSME4;PSMD10;PSMB8;TAPBP;FCGR1A;PSMD3
prerank,zymogen activation (GO:0031638),-0.24080337172951755,-0.7844492279362237,0.8200757575757576,0.9302605203967128,1.0,6/39,13.27%,CYFIP2;PLAT;CTSH;ASPH;MMP14;PGK1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.297949084543959,-0.7842563208300717,0.7574626865671642,0.9300957506586185,1.0,7/16,26.25%,TELO2;KLHL22;SIK3;GPR137B;LARS1;PIH1D1;RRAGA
prerank,vitamin D metabolic process (GO:0042359),-0.32526790429321206,-0.7840462825267391,0.7669724770642202,0.9299550233956088,1.0,10/13,56.55%,PIAS4;CUBN;CYP2R1;LGMN;LRP2;VDR;CYP1A1;CYP24A1;FGF23;CYP27B1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.3227527397166483,-0.7835469513024199,0.7562380038387716,0.9303069603758356,1.0,4/13,13.88%,OS9;EDEM1;ERLEC1;UBAC2
prerank,regulation of hormone secretion (GO:0046883),-0.30935349073659285,-0.7832509753778452,0.7839851024208566,0.9302873022446572,1.0,3/15,8.46%,SNX6;ANXA1;VAMP2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2612504879308934,0.7831499463889067,0.8145833333333333,0.996310994652902,1.0,3/27,6.50%,CHKA;PISD;PLAAT1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.3230909026371655,-0.7829910008245903,0.7740667976424361,0.9302356745825091,1.0,5/13,30.93%,RHOT1;BNIP3;BMF;RHOT2;BCL2L11
prerank,microvillus organization (GO:0032528),-0.3230025976925471,-0.7827583422062879,0.7690839694656488,0.9301195697931888,1.0,4/13,16.62%,RAP1B;MAP4K4;RAPGEF2;FXYD5
prerank,mitochondrial translational termination (GO:0070126),0.20964436660392594,0.7826237967085107,0.91015625,0.9963678346165541,1.0,28/88,24.31%,MRPS25;MRPL14;MRPS12;MRPL49;MRPS18A;MRPL13;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;MRPL54;MRPS5;MRPS22;MRPS35;MRPS28;MRPL18;OXA1L;MRPL37;MRPL2;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23;MRPL17;MRPL19;MRPL15
prerank,cranial nerve development (GO:0021545),0.3311473645552053,0.7825985513292701,0.7346491228070176,0.9955436653232491,1.0,2/11,13.04%,PAX2;TMEM126A
prerank,regulation of lipase activity (GO:0060191),0.31056141453392694,0.7819641771139578,0.757700205338809,0.9957034120064028,1.0,2/13,4.64%,SNCA;PCSK6
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.28786778420038606,0.7818417845781499,0.7663755458515283,0.9950339356715164,1.0,3/19,12.62%,TIRAP;TRIL;ITGAM
prerank,regulation of viral life cycle (GO:1903900),-0.2803280144545899,-0.7817808936954446,0.7948243992606284,0.9312307466991926,1.0,5/21,14.08%,AXL;KPNA6;TRIM5;TRIM25;NECTIN2
prerank,regulation of protein modification process (GO:0031399),-0.22684655815605514,-0.7815305748540874,0.847953216374269,0.9311624728484267,1.0,21/50,30.62%,KAT2B;LYN;IGF2;PLXNB2;FER;FNIP1;FN1;FKTN;NOP53;PHIP;PML;PPP2CA;SPRED2;ATG14;RABL3;CCAR2;WARS1;MT3;CDK9;ATG10;PARG
prerank,regulation of DNA recombination (GO:0000018),-0.2554841887887513,-0.7810799918597162,0.811787072243346,0.931393792630146,1.0,10/32,19.85%,SPIDR;PPP4C;PPP4R2;SETD2;SHLD2;MSH3;MRE11;ZRANB3;MSH6;H1-0
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.2999583178898173,-0.7807829647097063,0.7609489051094891,0.931387586800269,1.0,6/16,21.03%,PIBF1;LEPROT;PTPN2;PARP14;NF2;PPP2CA
prerank,non-motile cilium assembly (GO:1905515),-0.25533968709861576,-0.7801793560167828,0.8365384615384616,0.93189460998825,1.0,9/30,19.76%,PCM1;PIBF1;ARL13B;IFT88;C2CD3;TOGARAM1;CSNK1D;GORAB;CEP89
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.3292215242898652,-0.7796853720697537,0.7861060329067642,0.9322214537908102,1.0,6/12,30.93%,ATF6;ERN1;PTPN1;PIK3R1;BAK1;BCL2L11
prerank,regulation of astrocyte differentiation (GO:0048710),0.3110248498040671,0.779635080460926,0.7716701902748414,0.9978093232788525,1.0,2/12,5.71%,BIN1;NOTCH1
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.33537410583241384,-0.7795217158512174,0.775047258979206,0.932045684372576,1.0,3/11,9.97%,STX18;VCPIP1;ATL2
prerank,negative regulation of response to external stimulus (GO:0032102),-0.2019270084979533,-0.7792871698071798,0.9295238095238095,0.9319239391920079,1.0,30/105,24.55%,PTGIS;IRAK3;TRAFD1;PTPRS;MAPKBP1;EPHA4;PCBP2;CCN3;SELENOS;NR1H3;PTPN2;ENPP3;PRKCD;CD109;RB1;ILRUN;RORA;APOE;C1QTNF3;FEM1A;SERPINE1;METRNL;CARD16;SHARPIN;LPCAT3;FGF2;MAPK7;NLRC3;SIRPA;MVK
prerank,iron-sulfur cluster assembly (GO:0016226),0.27211089206548456,0.7787917897148189,0.805439330543933,0.9983219454971378,1.0,4/24,10.70%,NDOR1;IBA57;ISCU;ISCA2
prerank,regulation of spindle organization (GO:0090224),-0.2933021272347334,-0.7782243034539218,0.7878787878787878,0.9330750600493847,1.0,10/18,38.90%,NUMA1;SENP6;MAP9;DYNC1H1;BORA;PARP3;TACC3;TPX2;FSD1;RNF4
prerank,glutathione biosynthetic process (GO:0006750),-0.3321677381649499,-0.7781438943264347,0.7821969696969697,0.9327278950111251,1.0,6/11,34.01%,CHAC2;GSS;GGCT;GCLC;HAGH;CNDP2
prerank,regulation of neuron apoptotic process (GO:0043523),0.20501499808452575,0.7779379703926264,0.905811623246493,0.9988595247764361,1.0,13/96,10.98%,MAG;GRID2;TRIM2;FOXQ1;NTRK2;TGFB2;VSTM2L;UNC5B;NDNF;CCL2;RETREG1;SET;F2R
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.30448138075853987,-0.7778731446831028,0.7546816479400749,0.9322484149130976,1.0,4/15,16.87%,TNRC6B;DHX36;TNRC6C;CNOT1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.30448138075853987,-0.7778731446831028,0.7546816479400749,0.9322484149130976,1.0,4/15,16.87%,TNRC6B;DHX36;TNRC6C;CNOT1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.2333282495412697,0.7770901552281982,0.8451612903225807,0.9993268864614786,1.0,8/43,13.89%,RYR2;AHI1;NOTCH1;APLNR;VANGL2;BBS5;SOX17;DLL1
prerank,cellular response to pH (GO:0071467),-0.2982564745942516,-0.776931538556574,0.7944954128440367,0.9332163352193953,1.0,11/17,41.96%,SLC9A1;IMPACT;CHP1;MCOLN1;GPR68;PKD2L1;PKD1L3;HVCN1;KCNK4;RAB11FIP5;HYAL1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.33851714748715667,-0.7769069205875003,0.7701375245579568,0.9328062635492729,1.0,2/10,4.78%,RARB;RARG
prerank,DNA replication checkpoint signaling (GO:0000076),0.29843660370691555,0.7767277084379831,0.7587719298245614,0.9990651184819939,1.0,1/16,1.67%,HUS1B
prerank,positive regulation of cell development (GO:0010720),-0.2520481057054955,-0.7766870481552163,0.8209255533199196,0.9326649413899066,1.0,11/31,30.32%,BMP4;NIBAN2;NUMBL;PDE3A;NUMB;CX3CR1;SOX11;NAP1L1;NKX6-1;GPER1;SNW1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.329424885554504,0.7764543251081902,0.7541666666666667,0.9986362847985656,1.0,2/10,13.78%,SIRT1;DNMT1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.20792008518406888,0.7761536006587978,0.9176706827309237,0.998256973698247,1.0,17/85,17.09%,MAGI2;AP2M1;PSMA1;FZD6;PSMD12;PSMA6;PSMB3;AP2B1;VANGL2;CELSR2;DVL1;FZD4;PFN1;PSME3;PSMA2;PSMC3;PRICKLE2
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.34665907102600013,-0.7750368404938011,0.75,0.9346752979707084,1.0,3/10,14.52%,DPP4;FAP;EMILIN1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.24186678680018836,-0.7748845355748772,0.8546511627906976,0.9344409605918581,1.0,8/37,15.47%,NUPR1;GSDME;DNM1L;BCL2;BCLAF1;BECN1;NCK1;SFPQ
prerank,DNA damage checkpoint signaling (GO:0000077),-0.2627050830109243,-0.7745904383311351,0.8326923076923077,0.9344315924227449,1.0,12/28,29.39%,CEP63;NBN;CDC5L;MAP3K20;STK33;HINFP;CLSPN;ATR;USP28;DONSON;INTS7;E2F1
prerank,microtubule polymerization (GO:0046785),-0.26007349384627687,-0.774457042966981,0.8147410358565738,0.9341785924080427,1.0,9/28,19.75%,TUBGCP6;TUBGCP2;NDEL1;RANBP9;AKAP9;CCDC57;MAP7D3;CSNK1D;TUBGCP4
prerank,cellular response to interferon-gamma (GO:0071346),0.20574959743470334,0.7741317202758989,0.9307692307692308,1.0,1.0,11/88,12.16%,CAMK2A;MT2A;IRF6;NCAM1;TLR2;TRIM62;CCL2;AIF1;IRF7;GBP4;AQP4
prerank,development of primary male sexual characteristics (GO:0046546),0.24964163918395868,0.7735195234707242,0.8174442190669371,1.0,1.0,3/34,5.71%,KITLG;SRD5A2;TGFB2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.3162209519753438,-0.7729150762978924,0.7558139534883721,0.936003555067796,1.0,3/13,18.42%,NIBAN2;EMILIN1;PTPN1
prerank,protein-DNA complex assembly (GO:0065004),-0.19687210810699046,-0.7726524239226636,0.9464285714285714,0.9359566176050977,1.0,44/116,35.64%,TCF4;GTF2H2;KAT6B;RAD23B;CCNH;CDK7;DDB2;MNAT1;PARP1;ERCC3;PSMF1;SPTY2D1;PSMB2;MCM6;ANP32B;DMC1;PSMC1;PSMA3;PSMB6;NAP1L4;PSMA4;GTF2H1;NAP1L1;ORC1;PSME1;PSMD13;GTF2H4;ATRX;MCM4;PSMB9;RBX1;PSMB10;PSMA5;UBA52;NAP1L2;RPA2;PSME4;RAD51;CHAF1A;PSMD10;DDB1;PSMB8;NAP1L3;NPM1
prerank,regulation of phosphate metabolic process (GO:0019220),0.28445339451536705,0.7726007891508249,0.7698744769874477,1.0,1.0,5/16,19.87%,PGAM1;CD24;PSEN1;BARD1;SMG5
prerank,regulation of T cell chemotaxis (GO:0010819),-0.32682160731987586,-0.7721892660379599,0.7758284600389863,0.9361840711522997,1.0,6/11,39.64%,WNK1;WNT5A;ADAM10;CCR2;ADAM17;CXCL10
prerank,protein import into mitochondrial matrix (GO:0030150),0.28228272090835077,0.7719423921857804,0.7710583153347732,1.0,1.0,6/18,23.97%,TIMM21;DNAJC15;TOMM70;DNAJC19;TIMM17B;ROMO1
prerank,cellular response to oxygen levels (GO:0071453),0.33377619930659364,0.7715775537110032,0.7864693446088795,1.0,1.0,3/10,15.05%,ATP6V1A;ATP6AP1;TMEM199
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.27030731909307826,-0.7713452201522478,0.8169811320754717,0.93694076042706,1.0,5/22,18.44%,CD55;ZBTB1;TRAF2;FBXO38;TRAF6
prerank,translational termination (GO:0006415),0.20264571861482128,0.7708456118444122,0.9132947976878613,1.0,1.0,30/95,24.61%,MRPS25;MRPL14;MRPS12;MRPL49;ETF1;MRPS18A;MRPL13;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;MRPL54;MRPS5;MRPS22;MRPS35;MRPS28;MRPL18;OXA1L;MRPL37;MRPL2;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23;MRPL17;MRPL19;MRPL15;GSPT2
prerank,protein import into nucleus (GO:0006606),0.21710881240483787,0.7708244157908204,0.902,1.0,1.0,8/66,9.92%,IPO5;IPO4;MMP12;RPL23;NXT1;AKT1;FAM53B;NUP62
prerank,L-glutamate transmembrane transport (GO:0015813),0.3417201861451989,0.7700015935331367,0.7607758620689655,1.0,1.0,2/10,5.91%,SLC1A1;SLC1A2
prerank,synaptonemal complex assembly (GO:0007130),-0.30212631121104316,-0.7696807753959071,0.7769784172661871,0.9384507991607334,1.0,8/15,47.23%,RAD21;BAG6;P3H4;TEX11;REC8;SYCE2;TEX12;STAG3
prerank,synaptonemal complex organization (GO:0070193),-0.30212631121104316,-0.7696807753959071,0.7769784172661871,0.9384507991607334,1.0,8/15,47.23%,RAD21;BAG6;P3H4;TEX11;REC8;SYCE2;TEX12;STAG3
prerank,androgen metabolic process (GO:0008209),0.28503203854947673,0.7694810356203338,0.8081896551724138,1.0,1.0,5/18,20.73%,SRD5A2;HSD17B7;HSD17B10;SRD5A1;HSD17B4
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.2867237563467054,0.7694778755205618,0.7716049382716049,1.0,1.0,5/17,16.89%,CALM1;SMAD7;CALM2;CALM3;DDIT4
prerank,regulation of tissue remodeling (GO:0034103),-0.2920503504738273,-0.7689505147447865,0.7878228782287823,0.9390422730416188,1.0,4/18,16.91%,LEPR;RUNX1;IL18;SUCO
prerank,purine-containing compound biosynthetic process (GO:0072522),0.26291449002364053,0.76851522275214,0.8016701461377871,1.0,1.0,5/25,10.04%,AMPD1;GART;HPRT1;MTHFD1;GMPR2
prerank,regulation of protein localization to cell surface (GO:2000008),0.2516891504186051,0.7684857996693789,0.8475609756097561,1.0,1.0,4/33,8.05%,GPM6B;TMEM35A;STX3;HSP90AB1
prerank,triglyceride metabolic process (GO:0006641),-0.22764543964195508,-0.7677434860295073,0.8752436647173489,0.9403635749677238,1.0,12/48,27.49%,AGMO;GK5;GPAT4;MOGAT3;APOE;LPIN2;LPIN3;GPAT3;LMF1;PNPLA2;LPL;SEL1L
prerank,nucleoside salvage (GO:0043174),0.33279788021409007,0.7676479672087766,0.7702407002188184,1.0,1.0,2/10,7.35%,UCKL1;HPRT1
prerank,negative regulation of DNA replication (GO:0008156),-0.3143751002311484,-0.7676445645468435,0.7836812144212524,0.9400560528949073,1.0,9/13,45.16%,PDS5A;S100A11;CDAN1;ATR;WAPL;GMNC;TSPYL2;GMNN;CDC6
prerank,maintenance of protein localization in organelle (GO:0072595),-0.2834325093979795,-0.7672445633904423,0.7865168539325843,0.9401552320995122,1.0,11/19,33.25%,TAF3;TAF8;TOPORS;HNRNPU;MORC3;PML;TAPT1;BBS4;CHCHD10;ARL2;HK2
prerank,gonad development (GO:0008406),-0.23650124574113163,-0.7667312591884908,0.8796116504854369,0.940404997124051,1.0,5/41,10.01%,NR2F2;WNT4;KIT;AR;CSDE1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.26596091959140544,-0.7664491779340132,0.826,0.9403263892571779,1.0,13/25,29.73%,YAP1;ARHGAP24;PRKCD;ODF2L;CAPZB;CDK10;TBC1D7;TCHP;SLIT2;ARHGAP44;KANK1;TESK1;PFN2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.24122323944373456,0.7661697273762312,0.8648068669527897,1.0,1.0,5/38,10.02%,OTUD7A;SIRT1;CARD19;TRIM59;DAB2IP
prerank,positive regulation of defense response (GO:0031349),0.20861801500911464,0.7661666720134348,0.8865096359743041,1.0,1.0,8/89,7.46%,S100A9;S100A8;PDE2A;SNCA;NPAS2;ETS1;TLR2;NINJ1
prerank,nucleotide-excision repair (GO:0006289),0.20117193275412254,0.7655263218539952,0.9458917835671342,1.0,1.0,24/101,19.08%,HUS1B;SIRT1;COPS6;LIG3;RPA3;RPS27A;UBC;XAB2;POLK;UBB;ERCC2;POLR2J;POLR2B;POLR2I;BRIP1;POLD1;RFC4;POLD3;RFC5;POLR2G;AQR;TCEA1;ATXN3;RFC2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.31895064772325754,-0.76523134692779,0.7879341864716636,0.9415603280715689,1.0,1/12,5.92%,NBN
prerank,protein import (GO:0017038),0.20615966182380654,0.7645720623898186,0.93,1.0,1.0,9/84,9.92%,IPO5;IPO4;MMP12;GDAP1;NXT1;CLU;AKT1;FAM53B;NUP62
prerank,sphingosine metabolic process (GO:0006670),-0.2839802256785626,-0.7644302094231437,0.7980769230769231,0.942252439821438,1.0,3/17,8.29%,PLPP3;ASAH2;ACER3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.2590914265457178,-0.7641468613573953,0.8114285714285714,0.9422045082436225,1.0,8/25,20.15%,EPHA4;RPL11;PSMF1;TRIM39;PDCL3;CSNK2A1;PSME3IP1;PML
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.30513809553364557,0.7638922885197522,0.7871900826446281,1.0,1.0,2/13,4.79%,TMSB4X;NOS3
prerank,regulation of smooth muscle contraction (GO:0006940),-0.27795351052396466,-0.763641043576212,0.7937743190661478,0.9424441158127509,1.0,8/20,29.63%,PLCE1;SETD3;ATP2B1;CTTN;SPHK1;NMU;ADRB2;CAV1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3102854403834448,0.7627064258044751,0.7877551020408163,1.0,1.0,2/12,8.99%,THY1;SKAP1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.2507393971656609,-0.7625635972950597,0.875,0.9434935718698406,1.0,10/30,22.47%,PIBF1;PTPN2;PRKCD;PARP14;PRKCZ;SH3BP5L;MVP;NF2;PPP2CA;CD300A
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3308643525202435,0.7625063426437416,0.8079470198675497,1.0,1.0,11/11,66.94%,LPO;RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3;PKD1L3;PKD2L1
prerank,microvillus assembly (GO:0030033),-0.30503513863425646,-0.7624884005073016,0.795880149812734,0.943151615448733,1.0,4/14,16.62%,RAP1B;MAP4K4;RAPGEF2;FXYD5
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.2898837847186594,0.7623185746908574,0.8052516411378556,1.0,1.0,2/17,9.84%,CXCL12;AIF1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2259001169280609,0.7622344848106155,0.8864970645792564,1.0,1.0,9/50,13.09%,MINAR1;CAMLG;ADGRB1;IVNS1ABP;ISG15;AKT1;SMAD7;PER2;RPS3
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.22476630718933543,-0.7616437163352427,0.9024856596558317,0.9438755483196886,1.0,18/51,37.77%,HMGB1;STAT3;IL16;GSDMD;USP50;TLR4;WNT5A;TMEM106A;LPL;S100A13;APP;EGR1;PYCARD;MYD88;RIPK2;FZD5;AGER;CASP1
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.24766708167548102,-0.7613195407122195,0.8319672131147541,0.9438725904047913,1.0,15/33,35.34%,GLUD1;GLUL;PRODH;OAT;ALDH18A1;NIT2;ALDH4A1;SIRT4;DGLUCY;GCLC;GOT1;CAD;PYCR2;GOT2;PYCR3
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.26660472235841565,-0.7613171088495594,0.8460038986354775,0.9434220381066479,1.0,9/24,23.94%,TNKS2;PARP1;XRN1;CTC1;EXOSC10;HNRNPU;TERF2;STN1;GNL3L
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.2990318686979202,-0.7612271328210242,0.8062730627306273,0.9431001481255866,1.0,4/15,12.80%,NLGN2;STXBP1;SYN3;USP46
prerank,epithelial cell development (GO:0002064),-0.2819618905126009,-0.7610708713919202,0.8250497017892644,0.9428611643589704,1.0,15/20,51.26%,WNT5B;RILPL2;RILPL1;SIPA1L3;DACT2;BFSP1;EXPH5;ACTA2;TMEM79;WNT7A;PKHD1;POF1B;GRHL2;RAB25;ROS1
prerank,mitochondrial translation (GO:0032543),0.19830957468468668,0.7609247320895762,0.9557692307692308,1.0,1.0,34/104,24.48%,MRPS25;MRPL14;MRPS12;MRPL49;TUFM;MRPS18A;MRPL13;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;GATB;GATC;NDUFA7;MRPL54;MRPS5;MRPS22;MRPS35;MRPS28;MRPL18;OXA1L;MRPL37;MRPL2;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23;TSFM;MRPL17;MRPL19;MRPL15;FASTKD2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2503259920415804,-0.7607909918859996,0.8421052631578947,0.9427812632604105,1.0,11/29,28.68%,YTHDF3;UBE2K;PTPN2;MAVS;PTPN1;WNT5A;PTPN11;USP18;CACTIN;MUL1;SAMHD1
prerank,membrane raft organization (GO:0031579),0.2925599107470945,0.7596394968444339,0.7906976744186046,1.0,1.0,4/15,14.41%,FA2H;NAXE;RFTN1;PPT1
prerank,mitotic chromosome condensation (GO:0007076),-0.2557456368840509,-0.759273188956607,0.8368121442125237,0.9444332001253671,1.0,8/26,21.25%,PHF8;SMC4;AKAP8L;RB1;MCPH1;CSNK2A1;KMT5A;NCAPD3
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.3194268785847839,0.7589106644365642,0.8083700440528634,1.0,1.0,1/12,1.18%,ADCY8
prerank,skeletal muscle contraction (GO:0003009),0.2807259938453807,0.7587959774273675,0.8177874186550976,1.0,1.0,19/19,71.96%,TCAP;STAC2;STAC;TNNI3;STAC3;MYH7;MYH3;MYH8;CHRNA1;TNNT1;JSRP1;TNNC2;TNNI2;RCSD1;CCDC78;TNNC1;TNNI1;TNNT3;MYH14
prerank,regulation of chemokine production (GO:0032642),0.23917109067671835,0.7586304917450812,0.8660907127429806,1.0,1.0,4/36,9.84%,CSF1R;IL7;TLR2;AIF1
prerank,defense response to protozoan (GO:0042832),0.31289525498811316,0.7584940127586756,0.8076923076923077,1.0,1.0,3/12,12.28%,BATF2;GBP4;CD40
prerank,positive regulation of receptor internalization (GO:0002092),0.264615949330182,0.7581859646239762,0.8237791932059448,1.0,1.0,2/22,2.98%,MAGI2;AHI1
prerank,B cell proliferation (GO:0042100),-0.2836803252232203,-0.7578158938083976,0.7889733840304183,0.9459134790982122,1.0,3/17,17.07%,BCL2;MEF2C;CTPS1
prerank,regulation of adaptive immune response (GO:0002819),0.2862785733658229,0.7576996213939243,0.7875536480686696,1.0,1.0,3/18,10.74%,SIRT1;SKAP1;IRF7
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.25897755358790536,-0.7576659460974203,0.8415300546448088,0.9456605311806408,1.0,9/24,23.64%,JPH1;CAMK2D;SELENON;PKD2;SRI;PRKACA;NOS1;GSTM2;JPH2
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.2472172186116851,-0.7575570608682002,0.8363636363636363,0.9453646354645743,1.0,18/32,45.38%,CDK16;TFDP2;ID2;RB1;HINFP;PCNA;NPAT;ORC1;E2F1;CDC45;POLA1;CDK15;CDK18;CDK5;CCNE1;CDC6;ESRRB;FBXO5
prerank,spermatid development (GO:0007286),0.24910390177341318,0.7573466232969635,0.8456659619450317,1.0,1.0,6/32,18.22%,JAM2;NME5;IQCG;CIB1;ING2;YTHDC2
prerank,negative regulation of lipid metabolic process (GO:0045833),0.2652052702638469,0.7573068420435239,0.8191056910569106,0.9997479254303916,1.0,2/22,6.02%,HCAR2;ALK
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2642310745424502,0.7572724457242166,0.8148936170212766,0.9989589895923118,1.0,4/23,8.19%,COPS6;RPS27A;UBC;UBB
prerank,ATP transport (GO:0015867),0.32632563758146077,0.7572297299383176,0.777542372881356,0.9982003381643323,1.0,5/10,26.16%,SLC25A42;CD47;ABCC6;SLC25A5;SLC25A4
prerank,triglyceride homeostasis (GO:0070328),0.2537346548355097,0.7569935817254143,0.8193548387096774,0.9977225557147211,1.0,5/26,13.47%,SIRT1;DGAT2;ANGPTL4;XBP1;SCARB1
prerank,copper ion homeostasis (GO:0055070),0.28031178508546734,0.756979788196813,0.8097251585623678,0.9969136031178184,1.0,1/17,0.97%,MT2A
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.23859689861181596,-0.7568097477881082,0.8700564971751412,0.9459477340237905,1.0,8/36,16.17%,RBBP8;CBX5;TFDP2;PCGF2;PCGF6;EHMT1;L3MBTL2;EPC1
prerank,regulation of T cell migration (GO:2000404),0.2871355468662819,0.756705807001892,0.8064516129032258,0.9964843149050119,1.0,3/18,9.84%,CXCL12;CD200R1;AIF1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.3340299660829738,-0.7566857060647281,0.7917485265225933,0.9456604997149222,1.0,2/10,6.87%,KIT;LYN
prerank,regulation of microglial cell activation (GO:1903978),0.2996323508686213,0.7566692558670142,0.8146551724137931,0.9957105437849556,1.0,1/15,2.83%,SYT11
prerank,tRNA wobble base modification (GO:0002097),-0.3008717956392702,-0.7561210288748237,0.8011152416356877,0.9459744884694872,1.0,10/14,44.07%,TRMT9B;ALKBH1;DPH3;GTPBP3;MTO1;ALKBH8;MOCS3;ADAT2;CTU2;CTU1
prerank,negative regulation of ATPase activity (GO:0032780),0.2831092901534914,0.7559083043468722,0.802660753880266,0.9959242580100848,1.0,4/16,23.03%,SIRT1;VCPKMT;OXA1L;TNNI3
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.24157834489724578,0.7558351520602561,0.843687374749499,0.9952138182670751,1.0,6/33,11.60%,HIP1;AKT1;NUP62;PDE6H;HAP1;CCDC88A
prerank,protein autoprocessing (GO:0016540),0.2855382060746885,0.7558057018259424,0.8294736842105264,0.9944456365822577,1.0,1/17,2.06%,OMA1
prerank,response to gamma radiation (GO:0010332),0.2549100887564204,0.755718390841004,0.819672131147541,0.9937402094988511,1.0,7/24,16.84%,TMEM109;TRIM13;MEN1;ATM;HRAS;MDM2;XRCC5
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.2800550735961279,-0.7554600120024417,0.8208955223880597,0.9464248726188341,1.0,7/18,25.69%,LBP;SBNO2;ENPP3;IFI35;KARS1;SYK;FCER1G
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.24329665960306343,-0.7553970315840653,0.8587570621468926,0.946055050068386,1.0,4/33,10.81%,IL34;ACIN1;RUNX1;ID2
prerank,nucleus organization (GO:0006997),0.22337062219493015,0.7549265932024916,0.881104033970276,0.9940541851040033,1.0,14/47,21.15%,SYNE1;RPS19;BIN1;SUN1;LEMD2;NUP205;REEP3;NUP54;CHMP2B;PITPNB;PDCD6IP;VPS4A;CHMP7;CHMP2A
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.29917518083899314,-0.7541864845799083,0.8153846153846154,0.9472744882187197,1.0,9/15,33.50%,DHX36;MKNK2;DDX3X;VCP;ZFAND1;HSF1;GSTO1;PPIF;GSTO2
prerank,nucleosome assembly (GO:0006334),-0.24469369048347328,-0.7541457254758662,0.8774703557312253,0.9468779930857014,1.0,7/31,16.41%,KAT6B;UBN1;HAT1;CABIN1;SPTY2D1;ANP32B;NASP
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.26338398518622663,0.7540951911623537,0.8448275862068966,0.9944185777754128,1.0,6/22,13.93%,GPNMB;TAOK2;PDGFB;CALM1;CALM2;CALM3
prerank,cellular response to fluid shear stress (GO:0071498),-0.3192121362993659,-0.7539162689861598,0.7912713472485768,0.9467219095135702,1.0,7/12,29.84%,MEF2C;PKD2;ASS1;MAPK7;MTSS1;HDAC3;NFE2L2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.2598952205856634,0.7538222901848999,0.8376237623762376,0.9939948301935596,1.0,6/24,14.15%,RPS27A;UBC;UBB;NOD1;RNF34;TAB2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.2773502961631024,-0.7532764883737226,0.822429906542056,0.9471527602599816,1.0,12/20,38.41%,TXNIP;TXN;P2RX4;IL18;SUGT1;PSTPIP1;APP;PYCARD;C3;NT5E;CASP1;ANO6
prerank,rRNA catabolic process (GO:0016075),0.28613606294949706,0.7532640809007852,0.8168421052631579,0.9939596845923767,1.0,1/16,0.91%,EXOSC5
prerank,positive regulation of immunoglobulin production (GO:0002639),0.24281572314482222,0.7530186911790407,0.8658536585365854,0.9934803401908686,1.0,1/31,0.14%,TFRC
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.30909025592821776,0.7528269272951591,0.8147368421052632,0.9929301888120928,1.0,3/12,11.30%,SIRT1;TRIB3;ERLIN2
prerank,positive regulation of TOR signaling (GO:0032008),-0.23172304916833114,-0.7515028353314669,0.8738229755178908,0.949074637257526,1.0,21/40,41.51%,RPTOR;FNIP1;WDR59;TELO2;RICTOR;KLHL22;SIK3;GPR137B;LARS1;PIH1D1;RRAGA;HDAC3;RRAGC;SEC13;LAMTOR4;SEH1L;LAMTOR5;MIOS;WDR24;HTR6;TREM2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.19000413442688327,-0.7514841752048612,0.9518304431599229,0.9486503401022874,1.0,63/125,40.15%,EML4;MAP4;RANBP2;PCNT;NDEL1;SETD2;DYNC1LI1;MAPRE1;NUDC;ZWINT;CENPP;RCC1;SKA2;PTPA;PMF1;DYNC1H1;EFHC1;NUP98;WDR62;NEK6;NUP43;TAOK1;ITGB3BP;XPO1;TBCE;NUP160;BCCIP;CENPT;SUN2;INCENP;KIF11;STIL;DSN1;KNL1;CENPE;CENPU;BUB1B;RAN;KIF2A;MAD2L1;TACC3;NUP133;CKAP5;AHCTF1;TTK;SEC13;RCC2;B9D2;CENPI;DCTN6;CENPH;SEH1L;NDC80;CENPF;NSL1;KIF4A;CENPN;PAFAH1B1;KNTC1;SPDL1;CENPA;TUBG2;SGO1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.2513071200562345,-0.7514577612939842,0.8253358925143954,0.9482383117996454,1.0,10/27,26.78%,RRM2B;CTPS2;AK6;DTYMK;CTPS1;NUDT13;NME1;RRM1;GSR;AK1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.24239200542375683,0.751103205214854,0.869653767820774,0.9945120802013112,1.0,1/34,0.22%,SLC7A5
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.22399695083727608,-0.7503753725271519,0.9087378640776699,0.9492182807487626,1.0,10/49,19.17%,LBP;HMGB1;STAT3;F3;MAVS;IL17D;AFAP1L2;SERPINE1;TLR4;PARK7
prerank,male gonad development (GO:0008584),0.24200651245988164,0.7502019232538821,0.8617886178861789,0.9949535772845866,1.0,3/34,5.71%,KITLG;SRD5A2;TGFB2
prerank,cellular macromolecule catabolic process (GO:0044265),-0.2183404276538758,-0.7500801491271326,0.9001848428835489,0.9491783842554561,1.0,16/49,28.33%,NGLY1;PRKN;OGA;RAB12;HNRNPD;ADAMTS9;XRN2;MANBA;MTREX;SIDT2;MAGEC2;SIAH2;PABPC4;HTRA2;DNASE1L1;SUPV3L1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.1845621622043757,-0.7491398128227191,0.978,0.9499690863414675,1.0,52/145,32.43%,FBXL7;PCM1;FHL1;ALMS1;ODF2;NINL;CEP63;CEP135;VPS4B;RAD51B;PCNT;CSNK1E;USP47;PSMF1;RAB11A;MAPRE1;PSMB2;CDC25B;YWHAE;AKAP9;DYNC1H1;CEP76;PRKACA;CEP57;CSNK1D;CDK2;PSMC1;CUL1;HAUS7;PSMA3;PSMB6;HAUS8;RAD51C;ACTR1A;PSMA4;AVEN;PSME1;PSMD13;HAUS3;CEP41;PSMB9;RBX1;PSMB10;PSMA5;HAUS4;HAUS5;PLK4;PINX1;CEP72;SSNA1;CEP164;PSME4
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.20392438010885994,0.7490131522218711,0.937246963562753,0.9957689760395411,1.0,10/74,8.88%,EPAS1;PSMA1;NOTCH1;RPS27A;UBC;EPO;PSMD12;UBB;PSMA6;PSMB3
prerank,UV protection (GO:0009650),0.32228681345673466,0.7489346413167245,0.7838983050847458,0.9950565692462578,1.0,2/10,9.30%,GPX1;ERCC2
prerank,T cell receptor signaling pathway (GO:0050852),0.18568726799132768,0.748829707853633,0.9798387096774194,0.9943751466556394,1.0,21/138,14.56%,PDE4B;BTNL9;PSMA1;THY1;MOG;PAK1;PRKCQ;PTPRJ;EIF2B3;PSMD12;PSMA6;PSMB3;SKAP1;TNFRSF21;BCL10;RFTN1;PDE4D;BCAR1;TAB2;PSME3;PAK3
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.23779205572755735,0.7488068632087499,0.8844621513944223,0.9935918595897746,1.0,7/35,14.48%,BICD1;HIP1;SNAP91;CLU;SGIP1;PPT1;B2M
prerank,regulation of viral transcription (GO:0046782),0.2321812937144715,0.748538832488495,0.8713692946058091,0.9931483085613555,1.0,8/39,12.66%,TRIM13;TRIM62;IFITM3;POLR2J;POLR2B;MID2;POLR2I;NELFCD
prerank,acylglycerol catabolic process (GO:0046464),0.24894933852241796,0.7482991547691796,0.8568464730290456,0.9926705651879838,1.0,3/30,11.46%,ABHD2;LIPE;FABP5
prerank,regulation of receptor internalization (GO:0002090),-0.236672630543054,-0.7482848308266645,0.9007633587786259,0.9506005627518096,1.0,10/35,26.85%,ANGPT1;DLG4;MKLN1;ARF1;VEGFA;ARRB1;SFRP4;ANKRD13B;EGF;CD63
prerank,regulation of viral release from host cell (GO:1902186),0.26952831007643113,0.747845870458361,0.819327731092437,0.9924352376476682,1.0,8/21,21.15%,TRIM13;TRIM62;MID2;TRIM35;CHMP2B;VPS4A;TRIM21;CHMP2A
prerank,neurogenesis (GO:0022008),-0.23027985339510515,-0.747806413285873,0.8941176470588236,0.950743836008224,1.0,5/43,7.19%,LPAR1;TRAK1;RYK;DAGLA;ANXA1
prerank,cellular response to chemokine (GO:1990869),-0.22285691337663946,-0.7470596788595641,0.895910780669145,0.9512284171139606,1.0,6/46,14.28%,FOXC1;RIPOR2;WNK1;SLC12A2;RHOA;DUSP1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.21152683032814318,-0.746925877705679,0.9152215799614644,0.9509471894759325,1.0,4/59,4.01%,ALDH1A2;CYP7B1;CYP27A1;ABCD3
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.2683635972343183,-0.7465359763703775,0.8220973782771536,0.950979766043813,1.0,5/21,12.14%,DAG1;HM13;NCSTN;ADAM9;ADAM19
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.29339315486973094,-0.7465009040818364,0.8173758865248227,0.9505616380021937,1.0,3/15,8.65%,RAB10;RAB3GAP1;EDEM1
prerank,bile acid biosynthetic process (GO:0006699),-0.2599132817372247,-0.7459357504909663,0.8513011152416357,0.9508738653974654,1.0,6/24,22.80%,CYP7B1;CYP27A1;OSBPL9;AMACR;ACOT8;OSBPL3
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.3198067269286973,-0.7458877344935129,0.8175046554934823,0.9504837256624105,1.0,3/11,11.43%,ENPP3;TPK1;CTPS2
prerank,regulation of cell cycle process (GO:0010564),0.19318298139374665,0.7458249213797583,0.9708333333333333,0.9942977124568884,1.0,15/104,13.93%,CHEK1;GIT1;CAV2;HMGA2;BUB1;KNSTRN;SPAG5;CCP110;CALM1;APC;KLHL9;L3MBTL1;SND1;CALM2;CALM3
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.2075073868703053,-0.745496782937791,0.9209486166007905,0.9504816253233803,1.0,32/69,34.26%,PRKN;SLC30A10;SNX6;BCL2;PPARGC1A;NGF;HIF1A;MEF2C;NFATC4;APOE;RASA1;TGFB3;SIX1;CX3CR1;SOD2;PARK7;NRBP2;WFS1;NONO;PRKCI;GRN;MT3;SIX4;CLCF1;GDNF;TYRO3;CRLF1;NTF3;LIG4;AGAP2;ADAM8;MDK
prerank,positive regulation of RNA splicing (GO:0033120),-0.24718693326731966,-0.7454269030070595,0.8528301886792453,0.9501234872294596,1.0,12/29,33.12%,U2AF2;DAZAP1;ERN1;NUP98;PIK3R1;RBM22;DYRK1A;SNW1;THRAP3;SF3B4;RBMX;HSPA1A
prerank,ESCRT III complex disassembly (GO:1904903),-0.3297185339281571,-0.74514137852003,0.8212290502793296,0.949572611030667,1.0,2/10,9.41%,VPS4B;CHMP5
prerank,ESCRT complex disassembly (GO:1904896),-0.3297185339281571,-0.74514137852003,0.8212290502793296,0.949572611030667,1.0,2/10,9.41%,VPS4B;CHMP5
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.24993608710653156,-0.7448997431213761,0.8850574712643678,0.9494200934066304,1.0,5/30,17.06%,PIBF1;HMGB1;STAT3;PRKCZ;TLR4
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.31055371386419717,0.7447631380334334,0.789010989010989,0.9948883734432933,1.0,2/11,11.89%,SEMA6A;KLF2
prerank,actin-myosin filament sliding (GO:0033275),0.2320126665473839,0.7446761963899788,0.8653061224489796,0.9933968609980557,1.0,5/38,9.67%,MYH6;MYL1;TMOD1;MYL6;TCAP
prerank,muscle filament sliding (GO:0030049),0.2320126665473839,0.7446761963899788,0.8653061224489796,0.9933968609980557,1.0,5/38,9.67%,MYH6;MYL1;TMOD1;MYL6;TCAP
prerank,magnesium ion transport (GO:0015693),0.30429792342114276,0.7446261366518302,0.8314855875831486,0.9926477760227995,1.0,5/12,18.77%,NIPA1;NIPAL3;NIPAL4;MMGT1;MAGT1
prerank,intracellular protein transmembrane transport (GO:0065002),0.22543722466473043,0.7440241863774598,0.9197530864197531,0.992636712817995,1.0,10/42,20.14%,HSPA5;CHCHD4;TIMM21;DNAJC15;RTN2;HSPD1;SEC61G;TOMM70;SEC61A2;DNAJC19
prerank,prostanoid metabolic process (GO:0006692),-0.3043394895055858,-0.7437307159610459,0.8183556405353728,0.9504235092107767,1.0,6/13,34.15%,PTGS1;PTGES;ACOX1;CYP2S1;PTGR2;PTGR1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.21433256875997322,0.7431356335548426,0.9120654396728016,0.9930046919543207,1.0,13/56,15.36%,ANLN;ANK3;STMN1;SPIRE2;TRIM36;RAB35;NUSAP1;SPTBN1;APC;CIT;EFHC2;BIN3;MYH10
prerank,reverse cholesterol transport (GO:0043691),-0.3044242785329646,-0.7422268660609458,0.8267716535433071,0.951887630210964,1.0,2/13,14.69%,ABCA1;APOE
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.3113173963900839,0.7422010482054975,0.7966101694915254,0.9933996756135096,1.0,2/11,9.33%,SMARCB1;DDX11
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3084744455849372,-0.7421308156796473,0.7857142857142857,0.9515623211732701,1.0,6/12,28.10%,CCT6A;CCT8;CCT5;GNL3L;CCT3;GNL3
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.28132885696682236,0.7415847321187071,0.813953488372093,0.9933694301682525,1.0,5/15,20.91%,ORMDL1;ORMDL2;SAMD8;TNFRSF1A;RACK1
prerank,B cell receptor signaling pathway (GO:0050853),0.23831835707802942,0.7409924960398374,0.8845360824742268,0.9933424379719005,1.0,8/32,18.43%,VAV3;RFTN1;BCAR1;NFATC2;CD38;BTK;SH2B2;NCKAP1L
prerank,cellular response to amino acid stimulus (GO:0071230),-0.23750221551739634,-0.740988191315983,0.8765182186234818,0.9525202143798361,1.0,7/33,13.74%,UBR2;RPTOR;MTOR;SESN1;UBR1;CASTOR2;KLHL22
prerank,folic acid metabolic process (GO:0046655),-0.2700877449955638,-0.7405368106061886,0.8414872798434442,0.9526346530661499,1.0,3/18,17.38%,MTHFR;MTHFD2L;ALDH1L1
prerank,glucose metabolic process (GO:0006006),0.21531155281340927,0.7403258875247956,0.9212765957446809,0.9934012943684196,1.0,9/58,15.06%,OMA1;PGAM1;KCNJ11;SLC37A4;ALDOC;GDPGP1;PER2;ADPGK;ATF4
prerank,bile acid metabolic process (GO:0008206),-0.2520029950632213,-0.7401626393308688,0.8716981132075472,0.9526589527103213,1.0,7/27,24.75%,CYP7B1;CYP27A1;OSBPL9;AMACR;ACOT8;OSBPL3;GBA2
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.3045583681570814,-0.7401374967734946,0.8277777777777777,0.9522399908025446,1.0,3/13,16.50%,ENPP1;ENPP3;ENTPD6
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.2514869531052451,-0.740077378597098,0.8370221327967807,0.9518756139271415,1.0,5/25,12.67%,B3GALT1;EXT1;HS2ST1;NDST1;NDST2
prerank,pore complex assembly (GO:0046931),-0.2743495188258239,-0.7398651341937063,0.8536585365853658,0.9516835707086401,1.0,3/19,12.55%,AFDN;TPR;GSDMD
prerank,aspartate family amino acid metabolic process (GO:0009066),0.26889161418448504,0.7397660908167494,0.841897233201581,0.9932956224963301,1.0,3/18,9.32%,SMS;ASNS;MTHFD1
prerank,mitochondrial transport (GO:0006839),0.214708887208874,0.7397606669667566,0.9192546583850931,0.9925028730553167,1.0,20/53,26.37%,GDAP1;PITRM1;TIMM22;TMEM14C;TSPO;BCS1L;HSP90AA1;TOMM70;OXA1L;STARD3;TIMM10B;DNAJC19;ABCB10;TIMM17B;BCAP31;SLC25A5;MFF;TOMM22;SLC25A4;MTX2
prerank,positive regulation of phosphatase activity (GO:0010922),0.26319760485680904,0.7395755605768642,0.8565310492505354,0.9919496699850278,1.0,6/21,16.44%,MAGI2;HSP90AB1;CALM1;CALM2;CALM3;GPLD1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.2820742016281494,-0.7394980122758732,0.8149532710280374,0.9516809213826024,1.0,7/16,29.98%,PIGN;PIGH;PIGC;PIGA;PIGZ;PIGP;PIGF
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.2162298640402015,-0.7389562584205697,0.9089026915113871,0.951881346845959,1.0,22/54,37.79%,MDM4;EP300;TFDP2;CNOT8;CASP2;CNOT2;CNOT1;CNOT10;PCNA;PML;CNOT4;CRADD;TNKS1BP1;PCBP4;E2F1;PLAGL1;RBL2;GADD45A;SFN;TP53;PLK3;TRIAP1
prerank,regulation of macrophage migration (GO:1905521),0.32389830899273686,0.7389160771786515,0.8,0.992019033766162,1.0,2/10,9.51%,MTUS1;CD200R1
prerank,mesoderm development (GO:0007498),0.2738742706873908,0.7386604631220114,0.8410596026490066,0.9915245100935857,1.0,1/18,1.85%,TIE1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.3068414647260544,0.7385896964356148,0.8095238095238095,0.9908102970965642,1.0,2/11,6.58%,ANK3;PRKCQ
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.2912967464581374,-0.7384501303469015,0.8191881918819188,0.9520419927733061,1.0,2/15,11.07%,MOXD1;SAT1
prerank,ceramide catabolic process (GO:0046514),0.2870735240522327,0.7384338458966401,0.8105726872246696,0.9902124812472167,1.0,6/14,20.88%,ACER2;NEU2;GLA;HEXB;NEU1;NEU4
prerank,membrane repolarization during action potential (GO:0086011),0.29535915823253167,0.7375998152793494,0.8341013824884793,0.9904121705563332,1.0,3/13,13.66%,KCND3;ATP1A1;ATP1B1
prerank,regulation of G0 to G1 transition (GO:0070316),-0.22902154086168958,-0.7374809639932965,0.8759398496240601,0.95275874181005,1.0,8/38,16.17%,RBBP8;CBX5;TFDP2;PCGF2;PCGF6;EHMT1;L3MBTL2;EPC1
prerank,stress-activated MAPK cascade (GO:0051403),0.20878480473510372,0.7366823956304872,0.9297872340425531,0.9907641085833073,1.0,17/61,19.16%,MAP4K2;SH2D3C;TNFRSF19;RPS27A;UBC;UBB;GPS2;TAOK2;NOD1;MAPK8;MAP3K11;TAB2;MAPK10;PTGER4;MAPK3;ADORA2B;NOD2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.3160501610478468,0.736547082026168,0.8038379530916845,0.9901423613246523,1.0,2/10,10.58%,KLF4;TLE5
prerank,lipid biosynthetic process (GO:0008610),-0.19840062215502915,-0.7363958558700961,0.9471766848816029,0.9535845698900466,1.0,25/77,32.75%,ACSL1;PRKAA2;ABCD3;GNPAT;AGPAT4;PDSS2;GPAT4;ACSL6;HMGCR;PRKAA1;CBR4;CYP51A1;LPCAT1;DHRS11;FDFT1;MVK;CLN8;LPL;OXSM;PDSS1;DOLPP1;FITM2;STAR;MCAT;SREBF1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.284807307084549,-0.7354100806021074,0.8202676864244742,0.9543645205020928,1.0,7/16,24.20%,AMPD3;GMPS;PPAT;ATIC;PAICS;AMPD2;NUDT2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.3065822598169918,0.7349724593953463,0.7974413646055437,0.9912777893239468,1.0,5/11,19.20%,IPO4;H3-3A;HIRA;RBBP4;ASF1A
prerank,translesion synthesis (GO:0019985),0.2261719295383633,0.7348148308810096,0.889344262295082,0.990676286373883,1.0,12/42,19.08%,ISG15;RPA3;RPS27A;UBC;POLK;UBB;POLD1;RFC4;POLD3;RFC5;POLI;RFC2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.21551587238308115,-0.7348045594494714,0.912621359223301,0.9546016265031925,1.0,13/49,21.24%,NUPR1;GSDME;DNM1L;UBQLN1;EIF2AK3;BCL2;BCLAF1;BECN1;DDX3X;DAPK2;FIS1;P4HB;BMF
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.23221872872995486,-0.734636290580942,0.883495145631068,0.954355619806161,1.0,5/39,7.58%,ANK2;FHL1;WWP2;PTPN3;CACNA1D
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.20195677290731415,-0.7344142549134267,0.9543650793650794,0.9541693420915909,1.0,20/70,28.95%,FOXC1;ABL1;YAP1;RUNX1;PSMF1;TCF3;PSMB2;EIF2AK2;PRKDC;PSMC1;KMT2A;PSMA3;PSMB6;PSMA4;LDB1;PSME1;PSMD13;PSMB9;PSMB10;PSMA5
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.202805618217206,0.7342947393273243,0.9404255319148936,0.9905509993821833,1.0,7/69,9.72%,TIRAP;MIF;TLR2;CLU;PTPRJ;HSPB1;ARHGEF2
prerank,phospholipid dephosphorylation (GO:0046839),0.22970793566741934,0.7339215914463725,0.8837209302325582,0.9902195015678491,1.0,6/37,10.11%,PLPPR1;PLPPR5;SGPP2;PLPPR4;PLPP4;MTMR6
prerank,sulfur amino acid metabolic process (GO:0000096),-0.25202509712378707,-0.7327049921727894,0.8571428571428571,0.9557479235450955,1.0,10/24,34.64%,MMUT;NOX4;MTHFR;TXN2;CBS;GCLC;CDO1;MTR;CTH;ADO
prerank,organelle fusion (GO:0048284),-0.2581108228793103,-0.7325299626268458,0.8402255639097744,0.955503392883185,1.0,4/22,11.22%,OPA1;EEA1;MIGA2;STX4
prerank,lipid oxidation (GO:0034440),-0.30673219024056214,-0.7323575148294756,0.8195488721804511,0.9552701961872978,1.0,3/12,27.17%,PPARGC1A;ACOX1;ALOX12
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.2534352699646459,0.7322728517653758,0.8571428571428571,0.9913632579280448,1.0,4/21,14.49%,YWHAB;PPP1R16B;PPP1R11;MFHAS1
prerank,negative regulation of innate immune response (GO:0045824),-0.23673381534668014,-0.7320474450336267,0.8824701195219123,0.9551976203011248,1.0,14/34,31.95%,SERPING1;YTHDF3;IRAK3;TRAFD1;PTPN2;USP18;NLRC3;CACTIN;DHX58;GRN;MUL1;SAMHD1;TNFAIP3;TYRO3
prerank,intestinal absorption (GO:0050892),0.2952348985054114,0.7313272158777595,0.8364779874213837,0.9916878146680241,1.0,2/13,12.99%,SLC2A5;CD36
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.2283073761705377,-0.7311639908844498,0.8980769230769231,0.9557597688278173,1.0,16/39,31.70%,PI4KA;SMG1;PIP4K2C;TTC7B;EFR3A;PIK3C3;SOCS7;PIK3CD;ITPKC;PIK3R1;PI4K2B;IP6K2;PI4KB;CISH;SOCS3;PIK3C2A
prerank,sister chromatid segregation (GO:0000819),-0.23663204768170626,-0.7307976703471085,0.8757281553398059,0.9557247392202416,1.0,7/31,17.63%,INO80;SMC4;RB1;KLHL22;ZWINT;LATS1;TOP2B
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2520855496473573,0.7298820174335873,0.8421052631578947,0.9926611869773753,1.0,6/24,15.53%,ATF3;HSPA5;NOTCH1;KLF2;ATF4;CHD6
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.31388380055948295,-0.7294344334062741,0.8415300546448088,0.9568880374334948,1.0,6/12,30.47%,CYP26B1;DHRS3;CNOT1;EZH2;SNW1;CALR
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.3151770262892184,-0.728285208211084,0.8330097087378641,0.9577965227628964,1.0,5/10,38.70%,WNK1;WNT5A;ADAM10;CCR2;ADAM17
prerank,defense response to virus (GO:0051607),-0.1902547066713632,-0.7280337692348363,0.9582504970178927,0.9576304660299064,1.0,28/100,28.68%,FLNA;MOV10;PLSCR1;IFIT2;BCL2;SETD2;MAVS;AKAP1;TRIM5;IRF1;EIF2AK2;STAT1;OAS2;ZDHHC1;MAP3K14;SHFL;IFI27;MLKL;IFIT3;BNIP3;IRF2;NCBP3;ABCC9;PHB2;PDE12;ZMYND11;CGAS;SAMHD1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.3211109895935513,-0.726978425933565,0.8223443223443223,0.9583517917558794,1.0,2/10,12.11%,PLA2G4A;PNPLA8
prerank,regulation of neutrophil migration (GO:1902622),0.3062113549743756,0.7269268880698694,0.8148984198645598,0.9953023821597318,1.0,3/10,19.79%,JAM3;NCKAP1L;RAC1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.2404441902936114,0.7262220981647243,0.8512931034482759,0.9953518487450654,1.0,11/30,20.79%,GPX1;NOS3;ARHGEF2;RNF34;TNFSF10;RFFL;FAIM2;TMBIM1;RIPK1;FAIM;CASP8
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.22980329228868374,-0.725119706145562,0.9042357274401474,0.9599681138668564,1.0,13/35,27.10%,PDGFRB;PPP1R12A;GSK3B;MTOR;BOD1L1;PTPA;CD300A;PPP1R2;CRY2;MASTL;NUAK1;BOD1;PPP1R15B
prerank,protein N-linked glycosylation (GO:0006487),0.2025133652723268,0.7248508334829392,0.9435483870967742,0.9961681154511862,1.0,12/66,16.35%,GAL3ST1;MGAT5B;ALG3;PMM1;ALG1;MGAT4C;SLC39A8;TMEM258;ALG8;OSTC;OST4;MGAT1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.28668301678517927,0.7248445930294952,0.8430962343096234,0.995380026401591,1.0,1/14,0.92%,TIRAP
prerank,mRNA stabilization (GO:0048255),-0.22136055429960824,-0.7248421730895339,0.9259259259259259,0.9598388811644579,1.0,10/40,18.35%,SYNCRIP;EIF4ENIF1;FUS;DHX9;LARP1;YBX3;YBX1;HNRNPU;TENT5A;PAIP1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.3042304795380367,0.7244899383719926,0.8134490238611713,0.9941829005281917,1.0,10/10,69.60%,CEP250;GRM6;RPE65;CACNA2D4;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.3042304795380367,0.7244899383719926,0.8134490238611713,0.9941829005281917,1.0,10/10,69.60%,CEP250;GRM6;RPE65;CACNA2D4;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1
prerank,mitochondrial transcription (GO:0006390),-0.3141518549918776,-0.724291911971911,0.8075471698113208,0.9599971769292542,1.0,1/10,2.65%,FOXO3
prerank,regulation of osteoclast differentiation (GO:0045670),-0.23459354966716994,-0.7241681536814059,0.9024856596558317,0.9596885038598879,1.0,6/33,19.93%,FBN1;MTOR;TLR4;TRAF6;GPR137B;TCTA
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.27315064338143547,-0.7240834387538281,0.826171875,0.9593381504008491,1.0,9/16,39.62%,NUPR1;VCP;PDE12;MLXIPL;PPIF;ATP7A;COX7A2L;SHMT2;UQCC2
prerank,negative regulation of DNA recombination (GO:0045910),-0.21951709193344382,-0.7225780755291601,0.9166666666666666,0.9605109228095119,1.0,21/43,33.58%,KLHL15;SHLD2;MSH3;SMCHD1;ZRANB3;HELB;POLR2H;MSH6;TERF2;H1-0;POLR2K;POLR2E;UBQLN4;FANCB;ATRX;POLR2D;CGAS;MAD2L2;PARP3;RMI2;PARPBP
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.28080551471750126,0.7223387912937673,0.8340248962655602,0.9958850631147556,1.0,2/15,7.85%,PPARG;AKT1
prerank,pre-miRNA processing (GO:0031054),-0.2862035191670794,-0.7222724372522007,0.84251968503937,0.9603949784279322,1.0,2/14,7.79%,DICER1;TUT4
prerank,vacuolar acidification (GO:0007035),-0.25648421499063345,-0.7220920586481261,0.8689788053949904,0.9601330131100988,1.0,10/21,37.52%,ATP6V0D1;ATP6V0A4;TCIRG1;CLN5;DMXL1;GRN;ATP6V0D2;CLN6;SLC11A1;TMEM9
prerank,microtubule bundle formation (GO:0001578),0.2209494499767672,0.7219606700461988,0.9161554192229039,0.9955315148803394,1.0,7/42,14.97%,SPAG16;MTCL1;TPPP;FOXJ1;DCX;CAPN6;TPPP3
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.31789518673747685,-0.7218570585602108,0.8255395683453237,0.9599490057853536,1.0,6/10,37.64%,RFWD3;WDR76;CCAR2;RPA2;FEM1B;ETAA1
prerank,UV-damage excision repair (GO:0070914),-0.29521671004447114,-0.7217171429074508,0.8320610687022901,0.9596346014348954,1.0,2/12,8.78%,INO80;DDB2
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.23818797663018523,-0.7215991739742434,0.8976833976833977,0.9593160827658604,1.0,10/30,26.62%,ACSL1;ABCD3;ABCD2;ACSL6;ABCD4;HACD4;ACOX1;ELOVL1;ACSBG1;ELOVL5
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.23046212327683807,0.7215442561242276,0.9133192389006343,0.9952519026599804,1.0,7/33,14.11%,ACER2;FERMT3;TGFB2;NEXMIF;RET;JAM3;CIB1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.30474587884561344,-0.7213434613861343,0.8330097087378641,0.9591618802358229,1.0,2/11,12.68%,NUPR1;YBX3
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.2788390960195123,-0.7202363166978104,0.8505747126436781,0.9594857366526289,1.0,3/15,14.64%,DTNBP1;AP3B1;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.2788390960195123,-0.7202363166978104,0.8505747126436781,0.9594857366526289,1.0,3/15,14.64%,DTNBP1;AP3B1;BLOC1S5
prerank,serine family amino acid metabolic process (GO:0009069),0.27381866263034776,0.7195239182023111,0.8650963597430407,0.9967480222373118,1.0,5/16,21.06%,SEPHS2;MTHFD1;SRR;THNSL2;SEPSECS
prerank,purine-containing compound salvage (GO:0043101),0.2941083588857173,0.7192912601699525,0.8160676532769556,0.996215551340999,1.0,3/12,10.04%,AMPD1;HPRT1;GMPR2
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.30203011344387665,-0.7191386021007853,0.8478260869565217,0.9602583708813182,1.0,5/11,28.52%,EGLN3;P4HA2;P4HB;P4HA1;EGLN2
prerank,genitalia development (GO:0048806),-0.29267118626876265,-0.7190956367145889,0.834307992202729,0.9598600883805617,1.0,4/12,19.29%,PKD1;CHD7;WNT5A;PTPN11
prerank,regulation of cellular protein catabolic process (GO:1903362),0.2602020808193667,0.7169933103205282,0.865979381443299,0.9979932170205671,1.0,1/18,0.29%,NELL1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.2775105657138039,0.716831892364936,0.8293736501079914,0.9973749566358728,1.0,7/16,25.12%,SCD;PPT1;ACSS1;PPCS;ACAT1;HSD17B8;DIP2A
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.2688572121374925,-0.7159011263904785,0.8527131782945736,0.9627531556972795,1.0,9/17,44.55%,IK;RB1;BOD1;KNL1;TTK;SPDL1;CENPA;MTBP;CDK1
prerank,regulation of immunoglobulin production (GO:0002637),-0.25170529171093203,-0.7158473868188885,0.8831417624521073,0.9623623231508973,1.0,2/23,11.22%,RBP4;STX4
prerank,synaptic vesicle localization (GO:0097479),0.2901458179693921,0.7158383585395125,0.8593073593073594,0.9976590680568449,1.0,1/13,1.68%,NLGN1
prerank,negative regulation of coagulation (GO:0050819),0.280410914888715,0.7144861254832162,0.859375,0.9983259749969462,1.0,5/14,20.19%,HS3ST5;CD34;PROC;EDN1;PROCR
prerank,negative regulation of B cell activation (GO:0050869),-0.26143665439100133,-0.7138777746287108,0.8579136690647482,0.9639463752053589,1.0,10/21,38.05%,RC3H1;LYN;ID2;INHBA;CD300A;TNFAIP3;INHA;PARP3;FCGR2B;BANK1
prerank,response to hydrogen peroxide (GO:0042542),-0.2137589505544649,-0.7134437411439642,0.9484346224677717,0.9639496371600356,1.0,19/45,32.67%,ABL1;ANXA1;MAP3K5;IMPACT;CYP1B1;PRKCD;ADAM9;APTX;GLRX2;PARK7;FXN;MAPK7;SIRPA;PLEKHA1;NFE2L2;TNFAIP3;PPIF;STK26;CAT
prerank,coenzyme A metabolic process (GO:0015936),0.2782057442383355,0.7133216430980177,0.8347639484978541,0.9987897574236085,1.0,5/14,20.58%,ACOT7;PANK4;PANK3;PPCS;PANK1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.2534457381011132,0.7125266524394097,0.9036402569593148,0.9988427489091565,1.0,4/20,13.05%,HECW1;HECW2;EPO;STK39
prerank,DNA-dependent DNA replication (GO:0006261),0.17733019135096773,0.7119093937303075,0.993963782696177,0.9987287728606659,1.0,26/128,20.20%,GINS2;PSMA1;NOC3L;RPA3;RPS27A;UBC;PSMD12;UBB;PSMA6;PSMB3;RECQL;MCM3;POLG;POLD1;PSME3;RFC4;POLD3;PSMA2;PSMC3;RFC5;PSMB7;ORC6;RFC2;WDHD1;CDK2AP1;MCM8
prerank,heart looping (GO:0001947),0.21947995724317637,0.7115594834508472,0.921443736730361,0.9983237805692607,1.0,7/39,13.89%,AHI1;NOTCH1;APLNR;VANGL2;BBS5;SOX17;DLL1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.2559553306283663,0.7113657723969203,0.883668903803132,0.9977403681252724,1.0,3/21,9.55%,MBOAT1;PLA2G12A;OSBPL10
prerank,regulation of cholesterol esterification (GO:0010872),-0.30754808602083317,-0.7112040470176655,0.8158914728682171,0.9658198130259696,1.0,2/10,14.69%,AGTR1;APOE
prerank,gluconeogenesis (GO:0006094),-0.22026106734146547,-0.7112030135067193,0.91796875,0.965376788224475,1.0,8/39,17.38%,RBP4;SLC39A14;PPARGC1A;MDH1;PCK2;PGK1;SLC25A11;CRTC2
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.2601923622554094,-0.7111093413297207,0.8931297709923665,0.9650174096362201,1.0,14/19,56.77%,APOE;SLC5A7;NQO1;CHRNA4;CHRFAM7A;CHRNA7;CHRNB2;ACHE;COLQ;CHRNA5;CHRNA3;CHRNE;CHRNB4;CHRNB3
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.22265631326815472,-0.7104723558480858,0.9105058365758755,0.9652440470773597,1.0,11/35,28.30%,TNKS2;CCT6A;DHX36;CCT8;CCT5;MAP2K7;ATR;FBXO4;NEK7;CCT3;PARN
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.2423641060792924,0.7100268326038608,0.8929961089494164,0.9983369769442851,1.0,1/25,0.22%,SLC7A5
prerank,positive regulation of interleukin-2 production (GO:0032743),0.241236039466815,0.7095013718441967,0.875,0.9981430578502799,1.0,4/25,13.09%,PDE4B;SPTBN1;PDE4D;RPS3
prerank,endoderm development (GO:0007492),0.28625056549462674,0.7090137286830169,0.8318385650224215,0.9978954799114161,1.0,3/13,15.40%,LHX1;SOX17;SOX7
prerank,cellular response to tumor necrosis factor (GO:0071356),0.17086347383425726,0.7086940665443998,0.9957627118644068,0.9974307482498154,1.0,31/175,18.81%,ST18;TMSB4X;SIRT1;PSMA1;TNFRSF9;TRAF1;TNFSF13B;AKT1;PSMD12;PSMA6;CCL2;PSMB3;ARHGEF2;TNFRSF21;DAB2IP;TNFRSF12A;CD40;TNFRSF25;ACTN4;RPS3;NFKBIA;CIB1;PSME3;PSMA2;PSMC3;CDIP1;CCL25;TNFRSF1A;ILK;PSMB7;RIPK1
prerank,histone H3 deacetylation (GO:0070932),0.27508693579361565,0.7086539389548322,0.8816067653276956,0.996680011988642,1.0,2/15,3.32%,HDAC9;SIRT1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.20764014370882433,0.7085980660610519,0.9334719334719335,0.9959446822336889,1.0,12/50,21.86%,PSMA1;PSMD12;PSMA6;PSMB3;PSME3;PSMA2;PSMC3;PSMB7;ODC1;OAZ1;AZIN1;PSMD7
prerank,axonal fasciculation (GO:0007413),-0.29863947591749107,-0.708259181226403,0.8514492753623188,0.9670762670997262,1.0,5/12,26.51%,EPHA3;EPHA4;MEGF8;ARHGAP35;EPHB3
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.24332715692005424,-0.7074410579342921,0.8957169459962756,0.9674636225372087,1.0,5/24,20.53%,PLA2G4A;PNPLA8;SLC27A1;LPCAT1;CDS2
prerank,cilium-dependent cell motility (GO:0060285),-0.24976304396768007,-0.7073241637633444,0.8867562380038387,0.9671285433714316,1.0,7/22,27.75%,CFAP44;CCDC39;EFHC1;DNAH8;GAS8;RSPH9;DNAH2
prerank,protein deneddylation (GO:0000338),-0.3132375167385991,-0.70629518602643,0.8449905482041588,0.967734611183353,1.0,5/10,30.57%,COPS2;COPS8;TOR1A;GPS1;COPS5
prerank,negative regulation of leukocyte activation (GO:0002695),0.2717513503402922,0.7055067266786043,0.847682119205298,0.9983070663859486,1.0,2/15,8.95%,LRFN5;CD300LF
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.21073621047436458,0.7052984630639278,0.936046511627907,0.9977266926300429,1.0,9/50,16.22%,ACTB;CCND1;CAMK2N1;HSP90AB1;CDK5R2;CCNB2;CDKN1A;CDKN1B;STOX1
prerank,signal transduction in response to DNA damage (GO:0042770),-0.20651895330167888,-0.7041293306264861,0.9378427787934186,0.9694651165970982,1.0,18/49,29.45%,MDM4;ABL1;CEP63;NBN;CDC5L;MAP3K20;STK33;HINFP;CLSPN;ATR;USP28;PAXIP1;DONSON;MAPK14;ATRX;INTS7;E2F1;MAD2L2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.28371086168821225,-0.7036807488775901,0.8568773234200744,0.9694358095895892,1.0,2/13,6.94%,UPP2;NT5M
prerank,transcription preinitiation complex assembly (GO:0070897),-0.3003340700158599,-0.7036774096569577,0.8607350096711799,0.9689935006102143,1.0,4/12,26.79%,TBP;GTF2B;TAF12;TAF7
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.18676184848116537,-0.7036256336598543,0.9766990291262136,0.9686034065026601,1.0,33/84,34.46%,ANAPC5;ANAPC7;ANAPC4;ANAPC16;PSMF1;RB1;CUL3;PSMB2;CDC26;UBE2E1;CDC27;UBE2S;CDK2;PSMC1;ANAPC11;ECRG4;PSMA3;PSMB6;PSMA4;CDC16;ANAPC1;PSME1;PSMD13;FZR1;PSMB9;PSMB10;PSMA5;UBA52;PSME4;BUB1B;MAD2L1;PSMD10;PSMB8
prerank,ncRNA metabolic process (GO:0034660),0.2179918475059744,0.7030983140276642,0.9345991561181435,0.9990832622726529,1.0,8/37,19.27%,TDRD12;KHSRP;DTD1;DROSHA;BCDIN3D;PIWIL2;MEPCE;TDRKH
prerank,regulation of ruffle assembly (GO:1900027),0.2441522070446035,0.7007871673234416,0.8851351351351351,1.0,1.0,5/23,16.75%,NLGN1;FAM98A;HRAS;PFN1;EVL
prerank,positive regulation of stem cell proliferation (GO:2000648),0.2609322142213262,0.7003897003953474,0.867237687366167,1.0,1.0,3/17,15.35%,HMGA2;THPO;PDCD2
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.2618831759610467,0.7002778629916707,0.8817204301075269,0.9994934538816744,1.0,2/17,10.77%,PLA2G12A;CRLS1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.30797436947348333,-0.7000922657271952,0.8392523364485981,0.9715612079168076,1.0,3/10,13.88%,OS9;ERLEC1;UBAC2
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.2887843065191996,0.699241374376002,0.8552915766738661,0.9989672237151465,1.0,5/11,19.15%,CCT2;DKC1;CCT4;TCP1;MEPCE
prerank,regulation of protein localization to Cajal body (GO:1904869),0.2887843065191996,0.699241374376002,0.8552915766738661,0.9989672237151465,1.0,5/11,19.15%,CCT2;DKC1;CCT4;TCP1;MEPCE
prerank,positive regulation of T cell migration (GO:2000406),0.2552276539086548,0.6989223476009432,0.8842105263157894,0.9985142317000473,1.0,4/20,16.96%,CXCL12;AIF1;STK39;DOCK8
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.2245203213793766,-0.6989220431331746,0.927734375,0.97219463830565,1.0,11/36,27.06%,ITGB1;NRP1;HIF1A;FBXW7;HDAC1;ADRA2A;HBEGF;PARK7;HDAC2;EGF;ADRB2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.19110107881243502,0.6982759920168136,0.9818913480885312,0.9983357894153457,1.0,7/73,8.88%,KITLG;PSMA1;TAL1;LMO2;PSMD12;PSMA6;PSMB3
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.2929983152947019,-0.6981030367123958,0.8761904761904762,0.9725274066311366,1.0,6/12,33.21%,YTHDC1;SMCHD1;HNRNPU;PCGF3;CDYL;BRCA1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2711472645384201,-0.6961210965907866,0.8861480075901328,0.9738713002502738,1.0,9/15,40.67%,YTHDF3;PTPN2;USP18;CACTIN;MUL1;SAMHD1;TTLL12;NLRC5;YTHDF2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.29116228533892086,0.6958736910971144,0.8258064516129032,0.9998613978901246,1.0,1/11,6.58%,PRKCQ
prerank,phagosome acidification (GO:0090383),-0.23748292200598325,-0.6958271784401246,0.8986866791744841,0.973690984584174,1.0,3/26,7.10%,ATP6V1B2;ATP6V0D1;ATP6V0A4
prerank,phagosome maturation (GO:0090382),0.22101743496063395,0.6957312154998843,0.919917864476386,0.999230979890863,1.0,15/35,24.78%,ATP6V1F;ATP6V1A;CORO1A;ATP6V1C1;ATP6V0B;RAB31;ATP6V0A1;ATP6V0E2;ATP6V1D;RAB32;RAB14;ATP6V1G1;ATP6V0C;ATP6V1E1;MREG
prerank,cellular respiration (GO:0045333),0.21553050651050915,0.6955831329972934,0.9195876288659793,0.9985978622864853,1.0,10/41,19.08%,SDHC;ATP5F1D;SLC25A14;ETFDH;ETFB;ETFA;UQCRH;NR4A3;COX10;OXA1L
prerank,DNA biosynthetic process (GO:0071897),0.26532670665425756,0.6953265902157895,0.8464730290456431,0.9980771274493735,1.0,7/16,24.94%,SIRT1;POLD1;POLD3;PPIA;CDKN2D;RFC3;TYMS
prerank,serine family amino acid catabolic process (GO:0009071),-0.30478533121774043,-0.6951347344213988,0.8587155963302753,0.97388664596288,1.0,7/10,47.57%,AMT;CBS;SHMT2;DLD;SHMT1;GLDC;DAO
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.2557903572078957,-0.6946875434797836,0.8880597014925373,0.9738592448957338,1.0,4/18,14.78%,VPS4B;RAD51B;RAB11A;CDC25B
prerank,regulation of viral genome replication (GO:0045069),0.19799639438415398,0.6946838197536446,0.9384920634920635,0.9979131684029303,1.0,7/56,11.11%,PROX1;ISG15;TRIM6;IFITM3;PABPC1;SLPI;HACD3
prerank,embryonic heart tube development (GO:0035050),-0.27605607303722374,-0.6931497980680668,0.8775894538606404,0.9747930912654417,1.0,5/14,19.73%,HES1;ACVR1;CITED2;TBX2;MEGF8
prerank,cellular response to inorganic substance (GO:0071241),0.2500144974532442,0.6926260103195216,0.906318082788671,0.99911113067058,1.0,3/21,11.72%,KCNC2;DDX11;FOXO1
prerank,AMP metabolic process (GO:0046033),0.27367754483653567,0.6926235762550562,0.8556485355648535,0.99834082227832,1.0,1/13,2.26%,AMPD1
prerank,protein prenylation (GO:0018342),-0.30847816677647294,-0.692180262637448,0.8549905838041432,0.9752448786633937,1.0,5/10,28.38%,RABGGTB;CHM;CHML;FNTA;RCE1
prerank,negative regulation of phosphatase activity (GO:0010923),0.23576166997435116,0.6918805885562898,0.9028077753779697,0.9982789457690044,1.0,4/25,11.14%,SEMA4D;ZCCHC9;TGFB2;PPP1R11
prerank,adipose tissue development (GO:0060612),-0.29288464374080986,-0.6918683674156987,0.8629629629629629,0.975070319290744,1.0,3/11,12.29%,SH3PXD2B;PGRMC2;ARID5B
prerank,leukocyte cell-cell adhesion (GO:0007159),0.24035003391195936,0.6916905563549441,0.8969072164948454,0.9976946096423281,1.0,3/24,7.46%,SEMA4D;FERMT3;PECAM1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.24158186876419807,-0.6913926994473274,0.905511811023622,0.9750326611628878,1.0,4/22,11.97%,PHF8;EIF2AK3;MTOR;WDR43
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.24113228352526475,0.6892702083306068,0.9057017543859649,0.9990968156563124,1.0,2/23,9.15%,MBOAT1;PLA2G12A
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.27564374934514646,-0.6889061701745093,0.8943248532289628,0.9767838061120777,1.0,3/14,10.19%,IRS1;PPARGC1A;PTPN2
prerank,cGMP metabolic process (GO:0046068),0.27973091081112794,0.6885089508467283,0.8559322033898306,0.9989961453125028,1.0,1/12,3.41%,PDE2A
prerank,snRNA 3'-end processing (GO:0034472),0.25210645513809904,0.6877845740495617,0.8962472406181016,0.998879812807932,1.0,5/19,20.81%,EXOSC5;INTS2;EXOSC4;TOE1;INTS5
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.23596305266642875,-0.6877814723228475,0.9149338374291115,0.9773325314367378,1.0,3/22,10.21%,RNF115;VPS4B;VPS37C
prerank,detection of visible light (GO:0009584),-0.2598222777397688,-0.6874906459799257,0.8960573476702509,0.9771394571272672,1.0,1/16,5.63%,ABCA4
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.2317559674538512,0.6869695451461856,0.9323770491803278,0.9988730766468884,1.0,4/26,8.66%,SIRT1;NME5;AKT1;HSPB1
prerank,negative regulation of hormone secretion (GO:0046888),-0.30128367056977995,-0.685872353569555,0.8556149732620321,0.9780525858917791,1.0,1/10,8.40%,GJA1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.18894529963564835,0.6853493472816755,0.9776876267748479,0.9994919823913152,1.0,12/72,15.41%,DNASE1;MEI4;RPA3;RPS27A;UBC;POLK;UBB;ERCC2;POLD1;DDX1;RFC4;POLD3
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.28656076061986385,0.685253837329274,0.891832229580574,0.9988098659538243,1.0,2/11,12.62%,CAMK4;ITGAM
prerank,T cell homeostasis (GO:0043029),0.2979079290644241,0.6844122816987088,0.8694690265486725,0.9987516482140166,1.0,2/10,18.43%,AKT1;NCKAP1L
prerank,mesoderm formation (GO:0001707),-0.25924564105489856,-0.6842449266791042,0.8766859344894027,0.9789822083537676,1.0,5/17,25.96%,ITGB1;SMAD2;ITGB3;ITGA8;SNAI1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.26706289438065006,0.6839490442340302,0.8923076923076924,0.9983650600332343,1.0,1/15,1.67%,HUS1B
prerank,membrane lipid catabolic process (GO:0046466),-0.3030916030411208,-0.6833315226707284,0.8617886178861789,0.9792994896519346,1.0,4/10,21.70%,PDXDC1;CYP1B1;NAGA;SMPD2
prerank,triglyceride catabolic process (GO:0019433),0.2516485586886895,0.6832443530561104,0.8893617021276595,0.998222494657004,1.0,19/19,74.87%,FABP5;PNPLA3;APOC3;FABP6;LIPI;PNPLA5;PNPLA1;PNLIPRP2;FABP2;CPS1;LIPG;FABP3;FABP12;FABP4;LIPC;LIPH;FABP7;LPL;PNPLA2
prerank,positive regulation of transmembrane transport (GO:0034764),-0.27763116257089215,-0.6831739443250152,0.8606701940035273,0.9789847105728937,1.0,2/13,7.42%,ACSL1;BRAF
prerank,mitochondrial gene expression (GO:0140053),0.21154169719424906,0.6829076872326598,0.9539748953974896,0.9977340372856024,1.0,14/42,22.27%,MRPS12;MRPS18A;MRPS7;MRPS14;MRPL23;GATB;FASTKD5;GATC;NDUFA7;MRPS28;MRPL2;PTCD3;TFB2M;MRPL16
prerank,negative regulation of T cell activation (GO:0050868),-0.2158302934458963,-0.6826677169241198,0.9333333333333333,0.9789881225966975,1.0,6/35,22.91%,PAG1;RIPOR2;PTPN22;SDC4;DLG5;CD80
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.2234441241901715,0.6822192245025895,0.9248434237995825,0.9975982180488028,1.0,9/30,18.25%,ANK3;PREPL;GOLGA7;SPTBN1;MACF1;RAB31;BBS1;BLZF1;OPTN
prerank,positive regulation of myelination (GO:0031643),0.2851094646252641,0.6819953775806056,0.8676789587852495,0.9970149209502397,1.0,2/11,8.86%,TENM4;TPPP
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.29683702594111716,-0.681336827413432,0.8830188679245283,0.9796302953755961,1.0,1/10,2.79%,DICER1
prerank,regulation of establishment of planar polarity (GO:0090175),-0.1789906189363627,-0.6803313641989146,0.9921875,0.9800045039533174,1.0,27/88,28.95%,SMURF2;FZD2;VANGL1;CDC42;DACT1;RHOA;PSMF1;FZD7;PSMB2;DAAM1;ROR2;SMURF1;WNT5A;FZD1;PSMC1;SPEF1;DVL3;PSMA3;PSMB6;AP2A1;PSMA4;DVL2;PSME1;PSMD13;PSMB9;PSMB10;PSMA5
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.29351401645945463,-0.6802859259772716,0.8620689655172413,0.9795938707064111,1.0,4/11,22.12%,LMNA;SMAD4;P2RX4;MLIP
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.2994826205422286,-0.6799917696914647,0.8541266794625719,0.9794108127125807,1.0,3/10,14.95%,CCT6A;CCT8;CCT5
prerank,regulation of store-operated calcium entry (GO:2001256),-0.2984425894038345,-0.679809433282362,0.8625954198473282,0.979117337642767,1.0,1/10,0.81%,STIM1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.2783022842973314,-0.6793289111725381,0.8869731800766284,0.9790646050521142,1.0,5/13,20.81%,GLUD1;GLUL;PRODH;NOS1;ALDH4A1
prerank,regulation of superoxide anion generation (GO:0032928),-0.2715202331932279,-0.6790817010694801,0.9017857142857143,0.9788119731717436,1.0,3/14,24.23%,PRKCD;AATF;SYK
prerank,regulation of lipid kinase activity (GO:0043550),-0.2910432694260743,-0.6789630959799451,0.8704761904761905,0.9784534467369591,1.0,4/11,21.62%,WDR91;RB1;WDR81;PIK3R1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.24585107236962547,0.6780720347850114,0.881104033970276,0.9994262756252448,1.0,5/19,15.41%,AMPD1;HPRT1;GMPR2;POLD1;POLD3
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.26897579004696287,-0.6764799446239801,0.9022556390977443,0.9800126763175888,1.0,9/15,33.45%,ANAPC7;TPR;CDC27;NEK6;CDC16;ANAPC1;CENPE;RIOK2;TACC3
prerank,determination of heart left/right asymmetry (GO:0061371),0.2042431762815184,0.6763380520889865,0.9658119658119658,1.0,1.0,7/42,13.89%,AHI1;NOTCH1;APLNR;VANGL2;BBS5;SOX17;DLL1
prerank,response to interferon-gamma (GO:0034341),0.18774951144699295,0.675408583011188,0.9837067209775967,1.0,1.0,17/67,21.51%,SNCA;TLR2;CCL2;IFITM3;AIF1;GBP4;AQP4;CD40;GCH1;CCL25;CD47;TRIM21;BST2;CCL13;CCL19;RPL13A;EPRS1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.2951695511967584,-0.6747593954484221,0.8530534351145038,0.9809327171102916,1.0,5/10,33.18%,CD9;PRKCD;ALOX12;RDX;ADAMTS18
prerank,nitric oxide biosynthetic process (GO:0006809),0.26507462826576056,0.6739060083746328,0.893305439330544,1.0,1.0,3/13,15.29%,NOS3;AKT1;GCH1
prerank,defense response to symbiont (GO:0140546),-0.17849085185423288,-0.6737246848790687,0.9881656804733728,0.981319339430636,1.0,25/92,28.68%,FLNA;MOV10;PLSCR1;IFIT2;BCL2;SETD2;MAVS;TRIM5;IRF1;EIF2AK2;STAT1;OAS2;MAP3K14;SHFL;IFI27;MLKL;IFIT3;BNIP3;IRF2;NCBP3;ABCC9;PDE12;ZMYND11;CGAS;SAMHD1
prerank,calcium import into the mitochondrion (GO:0036444),-0.29745244773957,-0.6734327350967309,0.8705035971223022,0.981129173093884,1.0,2/10,14.26%,MCU;MICU1
prerank,nerve growth factor signaling pathway (GO:0038180),0.29491656994433674,0.6734178143389875,0.8660714285714286,1.0,1.0,1/10,2.73%,MAGI2
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.2409253363470073,0.6734115430272627,0.9033613445378151,0.99783471776665,1.0,6/20,18.31%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.2409253363470073,0.6734115430272627,0.9033613445378151,0.99783471776665,1.0,6/20,18.31%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.2409253363470073,0.6734115430272627,0.9033613445378151,0.99783471776665,1.0,6/20,18.31%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,nitric oxide metabolic process (GO:0046209),0.2605257771647734,0.6728848465835034,0.9004149377593361,0.9974952378741175,1.0,3/14,15.29%,NOS3;AKT1;GCH1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.27444530400819256,0.6728168248839015,0.8985507246376812,0.9967929228702963,1.0,5/12,20.12%,HSPA5;SGTB;SEC61G;SGTA;SEC61A2
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.17539111303228722,-0.6726762203939783,0.9959432048681541,0.9808476700334622,1.0,25/104,28.95%,NFKB1;EP300;BTRC;PAK2;CREBBP;LYN;PDPK1;PRKCD;PSMF1;PSMB2;PRKACA;TRAF6;FBXW11;PSMC1;CUL1;PSMA3;PSMB6;PSMA4;SYK;FCER1G;PSME1;PSMD13;PSMB9;PSMB10;PSMA5
prerank,cellular response to lectin (GO:1990858),-0.17539111303228722,-0.6726762203939783,0.9959432048681541,0.9808476700334622,1.0,25/104,28.95%,NFKB1;EP300;BTRC;PAK2;CREBBP;LYN;PDPK1;PRKCD;PSMF1;PSMB2;PRKACA;TRAF6;FBXW11;PSMC1;CUL1;PSMA3;PSMB6;PSMA4;SYK;FCER1G;PSME1;PSMD13;PSMB9;PSMB10;PSMA5
prerank,regulation of protein localization to cell periphery (GO:1904375),0.24972754643009562,0.6726656976961592,0.8949671772428884,0.9961605714354954,1.0,1/18,0.76%,ACTB
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.21723790756448813,-0.6704463965940521,0.9366852886405959,0.9821486727020978,1.0,6/33,10.39%,ABL1;ANXA1;MAP3K5;IMPACT;CYP1B1;PRKCD
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.25562244372628884,0.6703008195602544,0.9013806706114399,0.9972833075999028,1.0,2/15,10.48%,PPARG;MID1IP1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.17431337793247922,-0.6701081793571767,0.9979879275653923,0.9819702839579153,1.0,25/105,28.95%,NFKB1;EP300;BTRC;PAK2;CREBBP;LYN;PDPK1;PRKCD;PSMF1;PSMB2;PRKACA;TRAF6;FBXW11;PSMC1;CUL1;PSMA3;PSMB6;PSMA4;SYK;FCER1G;PSME1;PSMD13;PSMB9;PSMB10;PSMA5
prerank,negative regulation of transmembrane transport (GO:0034763),-0.2945767308405027,-0.6700367093955774,0.9009174311926605,0.9815774516700928,1.0,3/10,21.11%,THBS1;INPP5K;AKT2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.283455225394408,0.6682864468183864,0.875,0.9981489035836202,1.0,2/10,11.63%,ING4;HIPK2
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.19354929283230538,0.6678011056632945,0.979253112033195,0.9977662330531251,1.0,11/59,14.15%,TBKBP1;TLR2;RPS27A;UBC;AKT1;UBB;DAB2IP;BCL3;BCL10;NFKBIA;TAB2
prerank,negative regulation of immune response (GO:0050777),-0.16291927964860026,-0.6676814219237378,1.0,0.9829096152475776,1.0,16/154,11.35%,COL3A1;ADCY9;ADCY5;IRAK3;TRAFD1;RC3H1;ADCY1;LYN;MAPKBP1;RAMP1;ADCY6;PCBP2;PLCG1;FER;ENPP3;YES1
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.18664230264402815,-0.6667729218881533,0.9619771863117871,0.9831331455432999,1.0,23/61,34.46%,PRKAG2;PANK2;PSMF1;SIRT5;PSMB2;FGFR4;PSMC1;PSMA3;PSMB6;PSMA4;PPARA;PSME1;PSMD13;PSMB9;PSMB10;PSMA5;CAV1;PSME4;PDK4;NQO1;NR1H4;PSMD10;PSMB8
prerank,N-terminal protein amino acid modification (GO:0031365),0.259523961796324,0.666104605022616,0.8995633187772926,0.9982460786721172,1.0,1/14,3.36%,METAP2
prerank,mismatch repair (GO:0006298),-0.22635882949671643,-0.6651338597469083,0.9285714285714286,0.9838665431176076,1.0,8/27,23.15%,ABL1;MLH1;SETD2;MCM9;MSH3;MSH6;PCNA;ERCC1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.22044288740025447,0.6645780134872812,0.9254658385093167,0.9986022445947751,1.0,3/26,7.85%,ACER2;NOS3;AKT1
prerank,respiratory electron transport chain (GO:0022904),0.26511733423251793,0.6639105117582884,0.8881720430107527,0.9983310323692176,1.0,4/14,16.33%,ETFDH;ETFB;ETFA;GPD2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.21147757585496368,-0.6638766245633594,0.941398865784499,0.9843373989743522,1.0,10/32,28.30%,TNKS2;CCT6A;CCT8;CCT5;MAP2K7;ATR;FBXO4;NEK7;CCT3;PARN
prerank,alcohol catabolic process (GO:0046164),-0.2871498343461635,-0.6637108421075573,0.8959537572254336,0.9840166514973735,1.0,2/10,14.69%,CYP27A1;APOE
prerank,regulation of interleukin-1 beta production (GO:0032651),0.18406244840066932,0.6637064582990952,0.9854166666666667,0.997727674755283,1.0,7/66,12.99%,CD33;GIT1;HSPB1;F2R;P2RX7;CPTP;CD36
prerank,protein import into peroxisome matrix (GO:0016558),-0.27255751207140116,-0.6635255587769672,0.9041353383458647,0.9837052885431635,1.0,8/12,44.03%,PEX6;PEX7;PEX26;PEX10;PEX16;PEX12;PEX1;PEX14
prerank,regulation of inclusion body assembly (GO:0090083),0.28151427851284305,0.6632052801030418,0.890295358649789,0.9973241308749197,1.0,3/11,16.65%,SACS;DNAJA4;DNAJB2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.2868701831183069,-0.6626095874652276,0.8911439114391144,0.9839338419717177,1.0,3/11,13.97%,LDLR;NR1H3;SLC27A1
prerank,intracellular pH reduction (GO:0051452),-0.21314578308382467,-0.661332847933788,0.960377358490566,0.9844118402357478,1.0,11/33,29.61%,ATP6V1B2;ATP6V0D1;ATP6V0A4;TCIRG1;GPR89B;GPR89A;ATP6V1G2;DMXL1;RAB7A;RAB39A;ATP6V0D2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.2817609324291364,0.6611371203729761,0.8792372881355932,0.9980679099469459,1.0,2/11,13.05%,BIN1;STK39
prerank,oligodendrocyte differentiation (GO:0048709),0.23985008805488642,0.6608502188167489,0.9130434782608695,0.9975095180424559,1.0,5/19,16.94%,NSUN5;EIF2B3;TPPP;PTPRZ1;HES5
prerank,lymphocyte proliferation (GO:0046651),-0.23382478671993734,-0.6600115942413161,0.9196261682242991,0.9848968900233416,1.0,6/22,25.84%,ELF4;BCL2;MEF2C;CTPS1;MSN;LMBR1L
prerank,nuclear body organization (GO:0030575),0.2717352198156717,0.659331093837383,0.8903225806451613,0.9978450244854934,1.0,2/12,11.63%,ETS1;HIPK2
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.26886377903327063,0.65882297485011,0.8717948717948718,0.9974621968975077,1.0,12/12,73.13%,RMDN1;MAD1L1;MIS12;CHAMP1;CDT1;CENPC;KIF2C;NUF2;NDC80;SEH1L;CENPE;BOD1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.25946167758749705,-0.6586189170199154,0.9027237354085603,0.9854450626503501,1.0,6/14,30.89%,FOXO3;EARS2;FASTKD1;MRPL12;POLRMT;TWNK
prerank,protein targeting to membrane (GO:0006612),0.17569938863863982,0.6575446591598784,0.9959839357429718,0.9976008554653389,1.0,18/83,19.95%,GDAP1;AQP11;ARL6IP1;ZDHHC22;SGTB;GOLGA7;ZDHHC15;TAOK2;SRPRA;ZDHHC4;ZDHHC14;VPS37A;RTP4;ARL6;PEX3;SGTA;ZDHHC24;VPS37D
prerank,pancreas development (GO:0031016),0.2678185992678905,0.6574285206424441,0.9063136456211812,0.9969431092062045,1.0,2/12,10.31%,PROX1;FOXF1
prerank,steroid catabolic process (GO:0006706),-0.2898381779221292,-0.6573500000159013,0.8783542039355993,0.9858758273498729,1.0,2/10,20.29%,HSD17B11;SPP1
prerank,canonical glycolysis (GO:0061621),-0.23308975182094344,-0.6568899762844865,0.9415204678362573,0.9852965928007108,1.0,11/24,33.25%,FOXK1;PGK1;FOXK2;PFKP;PKM;PFKM;PFKL;ALDOA;ENO3;ENO1;HK2
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.23308975182094344,-0.6568899762844865,0.9415204678362573,0.9852965928007108,1.0,11/24,33.25%,FOXK1;PGK1;FOXK2;PFKP;PKM;PFKM;PFKL;ALDOA;ENO3;ENO1;HK2
prerank,postreplication repair (GO:0006301),-0.19603929239963322,-0.6566956822963698,0.9686888454011742,0.984983639809206,1.0,23/45,36.29%,UBE2N;WDR33;PARP10;ZBTB1;TRIM25;REV1;UBE2B;SPRTN;VCP;PCNA;POLN;UBE2V2;PRIMPOL;POLH;UBA52;POLD2;FAAP20;RPA2;BRCA1;PCLAF;RFC1;POLD4;MSH2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.23276002486611524,0.6558758038604835,0.9149377593360996,0.9973123946406708,1.0,6/21,18.31%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,tRNA wobble uridine modification (GO:0002098),-0.26360229154973136,-0.655336118595068,0.9259962049335864,0.9854815187053163,1.0,7/14,34.93%,TRMT9B;DPH3;GTPBP3;MTO1;TRMU;ALKBH8;MOCS3
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.21950469674765966,-0.6551055345596779,0.9295499021526419,0.9852028538916286,1.0,6/29,14.72%,DDX6;DCP1A;CNOT8;DCP1B;EDC3;EXOSC9
prerank,rRNA methylation (GO:0031167),0.23086764987860386,0.6537484170510268,0.9312638580931264,0.9980428169542128,1.0,4/22,11.78%,NSUN5;TFB1M;FBL;NOP2
prerank,neuron projection organization (GO:0106027),-0.25979808205696064,-0.6525218285627159,0.8901515151515151,0.9865334423664808,1.0,3/15,12.30%,GSK3B;ABCD2;ARF1
prerank,cellular response to interleukin-1 (GO:0071347),0.16162660718560462,0.6520599441262647,1.0,0.9984065878455347,1.0,30/143,20.59%,ST18;TOLLIP;PSMA1;RPS6KA5;PLCB1;RPS27A;UBC;PSMD12;UBB;PSMA6;CCL2;PSMB3;NOD1;DAB2IP;CD40;NFKBIA;TAB2;PSME3;PELI1;IL1RAP;PSMA2;PSMC3;CCL25;MAPK3;PSMB7;NOD2;CD47;HYAL2;CCL13;CCL19
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.1931387794173925,0.6518024270551562,0.9829787234042553,0.9978388665288018,1.0,5/48,8.64%,PPARG;GAS6;ISG15;SLIT3;GPS2
prerank,regulation of cholesterol storage (GO:0010885),-0.2523773915739672,-0.6514889244484036,0.906934306569343,0.9867745079763734,1.0,6/15,32.20%,ABCA1;NR1H3;PPARA;LPL;EHD1;MSR1
prerank,protein localization to condensed chromosome (GO:1903083),-0.2704375647274456,-0.6503265356140147,0.9022988505747126,0.9870903635930705,1.0,1/12,5.08%,IK
prerank,steroid metabolic process (GO:0008202),-0.18059813334557406,-0.6501759864847931,0.9925650557620818,0.9867497988565747,1.0,15/72,24.75%,CYP7B1;CYP26B1;CYP27A1;CYP1B1;SULT1A1;PIAS4;CUBN;CYP51A1;AMACR;DHRS11;FDX1;FDFT1;ARV1;CYP2R1;GBA2
prerank,positive regulation of cellular respiration (GO:1901857),0.2777424468445041,0.6484828812102522,0.8730853391684902,0.9992464938482042,1.0,2/11,8.51%,IFNAR1;ISCU
prerank,regulation of aerobic respiration (GO:1903715),0.2473390358591108,0.6475589615942615,0.9281314168377823,0.9991257721159883,1.0,1/15,3.28%,COX7A1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.18777904253799885,0.647172969838966,0.9707724425887265,0.9986142212046333,1.0,12/53,21.86%,PSMA1;PSMD12;PSMA6;PSMB3;PSME3;PSMA2;PSMC3;PSMB7;ODC1;OAZ1;AZIN1;PSMD7
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.2738568238978156,-0.6470898353937601,0.8958333333333334,0.9882808757524775,1.0,6/11,51.17%,AGTR1;ABCG1;LIPC;PLA2G5;PLA2G3;PLA2G7
prerank,regulation of cell aging (GO:0090342),-0.27668221095245027,-0.646924237701228,0.904572564612326,0.9879469897550107,1.0,6/11,26.83%,LMNA;NEK4;NEK6;NUAK1;RSL1D1;VASH1
prerank,ether lipid biosynthetic process (GO:0008611),-0.2833302720643524,-0.6468974265234823,0.8990990990990991,0.9875252549671483,1.0,6/10,31.99%,GNPAT;PLA2G4A;PEX7;CHPT1;PLA2G4C;PEDS1
prerank,polyamine metabolic process (GO:0006595),0.26010283477651513,0.6451160092485742,0.9057815845824411,0.9991871882100404,1.0,5/13,21.49%,SMS;SMOX;SAT2;ODC1;HDAC6
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.20003411262079754,0.6445789865860723,0.9828693790149893,0.9987817623029194,1.0,8/37,19.05%,DNASE1;ENTPD3;RNASEH2A;SND1;DFFB;RNASE3;PNPT1;ENTPD1
prerank,positive regulation of exocytosis (GO:0045921),0.20260349941742473,0.6443955799968214,0.9608247422680413,0.9981374434226525,1.0,10/35,21.15%,CADPS;SNCA;ATP6AP1;CFTR;CLASP2;PDCD6IP;HGS;VPS4A;CLASP1;CHMP2A
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.2540644377289027,0.6443717830770292,0.9159663865546218,0.9974152892982286,1.0,4/14,21.89%,BCL10;RPS3;RAB29;CARD11
prerank,mitochondrial fusion (GO:0008053),0.23572724697799902,0.6428857625152707,0.9096774193548387,0.9975444185312398,1.0,4/18,15.74%,GDAP1;MIEF1;USP30;MFN1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.2178437442976874,-0.6418781297111084,0.9392712550607287,0.9902014572356233,1.0,7/26,20.96%,UBE2N;ALPK1;IRAK2;TRAF6;IRAK1;MAP2K6;AAMP
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.24078892157817464,0.640998733895166,0.925,0.9978935307795194,1.0,3/18,12.16%,SPEF2;DNAAF2;AQP4
prerank,actin nucleation (GO:0045010),-0.22977287098971189,-0.6401193418088488,0.9256505576208178,0.9908528884495165,1.0,9/21,37.58%,IQGAP2;ARPC2;WHAMM;LMOD1;ACTR2;ARPC5;JMY;ARPC3;ARPC4
prerank,positive regulation of phagocytosis (GO:0050766),-0.19122685550211418,-0.6399784259409548,0.9788461538461538,0.9905030728936228,1.0,4/47,7.53%,APPL2;CAMK1D;IL15RA;MERTK
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.18615996655197198,-0.6382604124165656,0.9923076923076923,0.9910806413412141,1.0,7/54,10.22%,CFLAR;PRKN;TAX1BP1;UBE2K;HIPK1;PTPN2;TRAF2
prerank,regulation of protein metabolic process (GO:0051246),-0.19366675255692745,-0.6374118959899547,0.969147005444646,0.9911310518895449,1.0,11/44,23.28%,ROCK2;LDLR;SPOPL;APOE;CENATAC;TRAF3;ABCA7;SNF8;WFS1;PARL;MAPK7
prerank,melanosome localization (GO:0032400),-0.23143950623075066,-0.6368182696479235,0.9477756286266924,0.9910156569206666,1.0,6/21,28.47%,SHROOM2;RAB11A;BLOC1S5;BBS4;BBS2;MLPH
prerank,inner mitochondrial membrane organization (GO:0007007),0.19085433797024742,0.6364900461169688,0.9834368530020704,0.9998056730418092,1.0,13/47,19.63%,ATP5F1D;TIMM22;ATP5F1B;ATP5ME;NDUFA13;GHITM;DMAC2L;ATP5MF;UQCC3;TOMM70;CHCHD6;TIMM10B;ATP5MG
prerank,sphingoid metabolic process (GO:0046519),-0.26523380609889163,-0.6355414697187131,0.9220532319391636,0.9913037301953641,1.0,2/12,6.47%,PLPP3;ASAH2
prerank,establishment of spindle localization (GO:0051293),-0.24877893271148122,-0.6344057338784712,0.9210526315789473,0.9915074178817695,1.0,4/14,23.94%,MAP4;ZBED3;DYNC1H1;LLGL2
prerank,vasoconstriction (GO:0042310),0.2678578902588594,0.6340364247112218,0.8888888888888888,1.0,1.0,3/11,18.03%,SLC8A1;EDN1;EDNRB
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.17236694028506183,0.6337032913493156,0.9941060903732809,0.9991595408188817,1.0,12/78,16.38%,SH3GL2;AP2M1;CAPZA2;DYNLL1;AP1S2;AP2B1;ACTR10;DCTN1;AP1B1;DCTN2;DYNC1LI2;DYNLL2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.17236694028506183,0.6337032913493156,0.9941060903732809,0.9991595408188817,1.0,12/78,16.38%,SH3GL2;AP2M1;CAPZA2;DYNLL1;AP1S2;AP2B1;ACTR10;DCTN1;AP1B1;DCTN2;DYNC1LI2;DYNLL2
prerank,I-kappaB phosphorylation (GO:0007252),0.27662657819377234,0.6325332536532297,0.9200863930885529,0.9990867510585305,1.0,2/10,10.02%,TLR2;DAB2IP
prerank,protein homotetramerization (GO:0051289),0.1906798652404151,0.6324048698711915,0.9795081967213115,0.9984248620689674,1.0,8/49,15.69%,HCN1;RYR3;TRPM2;HPRT1;AQP4;GOLGA2;B2M;GLS
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.22925760695765185,-0.6319682913771577,0.9622266401590457,0.9923942382724618,1.0,3/19,17.38%,MTHFR;MTHFD2L;ALDH1L1
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.26388282806932095,-0.6318250448714715,0.9226415094339623,0.9920310810208085,1.0,9/12,50.23%,NEK6;PRKCA;LPIN1;CDK1;VRK1;PLK1;CCNB1;NEK9;PRKCB
prerank,positive regulation of leukocyte migration (GO:0002687),-0.2145396648253003,-0.6312257384805543,0.9696356275303644,0.9919197698871249,1.0,4/27,17.55%,PTN;IL6R;VEGFA;MIA3
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.26522178487942416,-0.6309426523417554,0.9348659003831418,0.9916405974748036,1.0,1/12,2.20%,B3GALT1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2128047283199192,0.6306826234798135,0.9660297239915074,0.998626664430872,1.0,2/27,3.32%,MIF;SIRT1
prerank,organophosphate biosynthetic process (GO:0090407),0.19713692466409452,0.6294581683495444,0.9714867617107943,0.9985830284363325,1.0,11/37,19.84%,MBOAT1;GPAM;FADS1;GK;PIP5K1A;IPMK;TKT;IP6K1;PCYT2;IPPK;PPIP5K1
prerank,cellular response to gamma radiation (GO:0071480),-0.23910324738564903,-0.6293820445015144,0.937381404174573,0.9920305753597372,1.0,7/17,25.54%,YAP1;WRN;MAP3K20;XRCC6;ATR;HSF1;KDM1A
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.2466435200188544,-0.6285012544470201,0.9300567107750473,0.9920735032530501,1.0,5/15,26.52%,NFKB1;AGTR1;IL18;MAPK9;LPL
prerank,nucleosome disassembly (GO:0006337),0.2472189930666837,0.6283369216821888,0.9369565217391305,0.9977208135864458,1.0,3/14,14.94%,SMARCB1;SET;SMARCD1
prerank,chromatin disassembly (GO:0031498),0.2472189930666837,0.6283369216821888,0.9369565217391305,0.9977208135864458,1.0,3/14,14.94%,SMARCB1;SET;SMARCD1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.2075962931405177,0.628315384302638,0.9686192468619247,0.9969948088378322,1.0,5/29,17.08%,LPCAT2;TMEM86B;PLA2G12A;DBI;PLA2G4E
prerank,double-strand break repair via break-induced replication (GO:0000727),0.24974381880661456,0.6276774402111424,0.9210526315789473,0.9965911090773834,1.0,2/12,12.09%,GINS2;MCM3
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.16813571376544517,0.6271328307887812,1.0,0.9961374099600601,1.0,11/82,12.61%,PRKAR2B;KCNH5;PPP2R1A;DYNLL1;CCP110;HAUS2;TUBB4A;YWHAG;CEP43;TUBA4A;DCTN1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.17375351359050445,-0.6262188115544444,0.9919354838709677,0.9928706809409082,1.0,27/72,34.46%,DICER1;BTRC;TRAF2;PSMF1;CARD14;COPS8;PSMB2;MAP3K14;TRAF6;FBXW11;IRAK1;PSMC1;CUL1;PSMA3;PSMB6;PSMA4;NFKB2;PSME1;PSMD13;PSMB9;PSMB10;PSMA5;BIRC3;TLR3;PSME4;PSMD10;PSMB8
prerank,positive regulation of mRNA processing (GO:0050685),-0.2238675949523764,-0.6261455304197469,0.963531669865643,0.9924666260245577,1.0,9/21,32.71%,DHX36;DAZAP1;NUP98;CDC73;NCBP2;SNW1;THRAP3;SF3B4;RBMX
prerank,negative regulation of centrosome duplication (GO:0010826),-0.2677212977853879,-0.6256271636362726,0.9310344827586207,0.9923148382542586,1.0,1/11,2.45%,KAT2B
prerank,centromere complex assembly (GO:0034508),-0.1985594052009519,-0.625353355846743,0.9657794676806084,0.992016741828904,1.0,21/36,44.00%,HJURP;CENPP;NASP;ITGB3BP;CENPT;POGZ;KNL1;MIS18BP1;CENPE;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPF;CENPN;CENPA;CENPQ;OIP5;DLGAP5
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.20706820843431795,0.6250619544199201,0.9606126914660832,0.9964903587974817,1.0,6/29,15.81%,ELOVL7;TECR;SCD;HACD1;PPT1;ACSL3
prerank,mRNA methylation (GO:0080009),-0.24025950977318228,-0.6243496576495408,0.9127134724857685,0.9920816955684908,1.0,5/15,30.77%,WTAP;NSUN2;ZC3H13;TRMT10C;TRMT61B
prerank,ncRNA export from nucleus (GO:0097064),-0.19719670201199685,-0.6231910604542847,0.9705304518664047,0.9922323799845983,1.0,16/36,36.65%,RANBP2;NUP42;PHAX;NUP214;TPR;NUP98;NUP43;NUP160;NUP93;NCBP2;RAN;NUP133;NUP88;SEC13;NPM1;SEH1L
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.256655083319392,-0.6227169001396254,0.927063339731286,0.9920236220221073,1.0,4/13,22.78%,CYFIP2;ASPH;TBC1D10A;PERP
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.2547198026128818,0.6217230107505128,0.9326732673267327,0.9975192712178296,1.0,1/12,6.58%,PRKCQ
prerank,ncRNA catabolic process (GO:0034661),0.2026461047814882,0.6201249675906917,0.9668737060041408,0.9976002952287013,1.0,2/28,4.62%,EXOSC5;LIN28B
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.20305840871114864,-0.6198481997905679,0.9585798816568047,0.99301659848268,1.0,14/31,42.52%,RC3H1;LYN;SDC4;DLG5;CD300A;CD80;SOX11;CEBPB;CD274;FCGR2B;CD86;LST1;LILRB1;IL4I1
prerank,positive regulation of viral genome replication (GO:0045070),-0.2021257916669612,-0.6195240896336437,0.9641434262948207,0.9927298882459986,1.0,9/29,30.67%,LARP1;DDX3X;PPIH;TOP2B;PPID;PPARA;PDE12;ADARB1;NR5A2
prerank,negative regulation of receptor binding (GO:1900121),-0.27381826302288603,-0.6190794255073163,0.924953095684803,0.9925054257907171,1.0,3/10,29.89%,ATP2A2;ATP2A3;PTPRF
prerank,DNA replication initiation (GO:0006270),-0.18941822655702056,-0.6178304652891123,0.9697542533081286,0.9926540152833989,1.0,20/37,40.33%,MCM6;PRIM2;POLE4;CDK2;POLA2;DBF4;POLE2;ORC1;MCM4;CDC34;RPA2;CDC45;POLA1;POLE;PRIM1;MCM2;MCM7;MCM5;MCM10;POLE3
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.2535325444019607,-0.6162997815762669,0.943359375,0.9929756955042552,1.0,1/13,2.20%,B3GALT1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.22201953248972384,0.6157348476991604,0.9554140127388535,0.9989910139054933,1.0,3/20,11.42%,IPO5;MEN1;APC
prerank,endosome organization (GO:0007032),-0.18886636682936545,-0.6155337066777542,0.9765765765765766,0.9929130239877807,1.0,11/41,25.52%,EEA1;RAB22A;SNX10;USP50;TMCC1;PLEKHF1;ALS2;PI4K2B;WASHC4;PHETA1;ARFGEF2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.2430847279115133,-0.6145931108364652,0.9441340782122905,0.9929568714514091,1.0,3/14,12.99%,PKD1;PKD2;SUFU
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.2546705703308511,0.614257657540194,0.9506437768240343,0.9989514863960061,1.0,1/12,3.61%,PPARG
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.24655649456981585,-0.6139613379524769,0.939047619047619,0.9928203483008571,1.0,6/14,27.10%,PPP2CB;DUSP1;NCK1;PPP2CA;PPP2R2C;PPP1R15B
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.20417926239963985,0.6123112338567946,0.9718875502008032,0.9990926558851105,1.0,11/28,24.51%,RPS27A;UBC;UBB;NOD1;TAB2;OTULIN;NOD2;CASP8;ITCH;UBE2V1;CYLD
prerank,vitamin transport (GO:0051180),0.20588374770232976,0.6114673440613508,0.974304068522484,0.9987360673053293,1.0,3/29,7.96%,ABCG2;SLC52A2;SLC52A3
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.17136998575780532,-0.6108427068632954,0.9919839679358717,0.9938099999897126,1.0,24/65,34.46%,FBXL7;FHL1;USP47;PSMF1;NABP2;PSMB2;PSMC1;CUL1;CDK5RAP3;PSMA3;PSMB6;PSMA4;AVEN;PSME1;PSMD13;PSMB9;RBX1;PSMB10;PSMA5;ZFYVE19;PINX1;PSME4;PSMD10;PSMB8
prerank,positive regulation of cilium assembly (GO:0045724),0.22516391509730735,0.6099519543272028,0.9493392070484582,0.9986812032457976,1.0,6/18,20.66%,CCP110;HAP1;CCDC88A;ENTR1;FUZ;CROCC
prerank,sphingoid biosynthetic process (GO:0046520),-0.2564641557168234,-0.6090419024545051,0.9314814814814815,0.9937533044051124,1.0,5/11,29.80%,ASAH2;ACER3;SPHK1;SPHK2;ASAH1
prerank,sphingosine biosynthetic process (GO:0046512),-0.2564641557168234,-0.6090419024545051,0.9314814814814815,0.9937533044051124,1.0,5/11,29.80%,ASAH2;ACER3;SPHK1;SPHK2;ASAH1
prerank,lymphocyte chemotaxis (GO:0048247),-0.19476533205190466,-0.607726997113298,0.9662288930581614,0.9938830302381967,1.0,3/34,9.73%,CYP7B1;SLC12A2;CXCL16
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.270680148233415,-0.6071694354835371,0.9333333333333333,0.9936972315738007,1.0,1/10,2.86%,PRKN
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.16547261247436432,0.6068202338232552,0.998,0.9993404612627083,1.0,12/79,16.38%,SH3GL2;AP2M1;CAPZA2;DYNLL1;AP1S2;AP2B1;ACTR10;DCTN1;AP1B1;DCTN2;DYNC1LI2;DYNLL2
prerank,icosanoid biosynthetic process (GO:0046456),0.2597369677362332,0.6058330807112222,0.9360341151385928,0.9990549006808412,1.0,3/10,19.55%,FADS1;LTA4H;MGST3
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.1941851517108115,0.6057039175189893,0.9752066115702479,0.9983803746964061,1.0,4/31,12.37%,CHCHD4;TIMM21;DNAJC15;HSPD1
prerank,cellular response to estrogen stimulus (GO:0071391),-0.24767910253940656,-0.604921111104924,0.9460966542750929,0.994258733000888,1.0,2/14,7.88%,BCAS3;AR
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.2393799056733521,-0.6047105624045538,0.9244186046511628,0.9939056975550873,1.0,8/14,41.58%,ECE1;AGTR1;EDN3;ACE2;CORIN;ENPEP;ACE;RASL10B
prerank,regulation of sensory perception of pain (GO:0051930),-0.256441530427574,-0.6046904108895144,0.9406130268199234,0.9934714807982907,1.0,4/11,21.58%,CCN3;MGLL;ZFHX2;TMEM100
prerank,positive regulation of immune response (GO:0050778),-0.16997181785100174,-0.6044887286230127,0.9980582524271845,0.9931196227568285,1.0,9/64,19.94%,IL6ST;PLSCR1;DHX9;STX4;RIOK3;EIF2AK4;CYBA;IFI35;KARS1
prerank,phasic smooth muscle contraction (GO:0014821),0.2646246547828271,0.6031368414724452,0.933920704845815,0.9987317444147885,1.0,10/10,73.55%,EDN1;EDNRB;PTGER3;EDN2;DRD2;HTR1D;TIFAB;HTR2B;GDNF;EDN3
prerank,regulation of ERAD pathway (GO:1904292),-0.25916855736359024,-0.6024352799931977,0.9530332681017613,0.9935499120149719,1.0,6/11,30.91%,RNFT1;TMEM259;USP13;BAG6;USP19;HERPUD1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.2486828218564474,-0.6024038272472957,0.9365942028985508,0.9931305080303925,1.0,3/12,17.43%,BTRC;CDC14B;UBE2S
prerank,leukotriene biosynthetic process (GO:0019370),0.23984382864881967,0.6020869980084684,0.9594594594594594,0.9984685631689824,1.0,4/14,19.55%,GGT7;GGT1;LTA4H;MGST3
prerank,DNA strand elongation (GO:0022616),0.22326436723477094,0.6014993938124293,0.9443298969072165,0.9979887623528783,1.0,4/18,15.41%,GINS2;MCM3;RFC4;POLD3
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.24271249257988886,0.6013563571124249,0.9344978165938864,0.9966064984665784,1.0,3/11,13.93%,CALM1;CALM2;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.24271249257988886,0.6013563571124249,0.9344978165938864,0.9966064984665784,1.0,3/11,13.93%,CALM1;CALM2;CALM3
prerank,cellular response to ionizing radiation (GO:0071479),0.17969927484398157,0.6013269386543736,0.9810126582278481,0.9958947586897735,1.0,10/47,16.84%,TMEM109;SIRT1;EEF1D;NET1;KDM4D;ATM;HRAS;CDKN1A;MDM2;XRCC5
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.2493940455578073,0.601292528093604,0.9467455621301775,0.9951823293673913,1.0,2/11,11.63%,ING4;HIPK2
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.1985595717018126,-0.6004778639529657,0.9703153988868275,0.9930506791981694,1.0,17/29,43.55%,HJURP;CENPP;NASP;ITGB3BP;CENPT;KNL1;MIS18BP1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA;CENPQ;OIP5
prerank,CENP-A containing chromatin organization (GO:0061641),-0.1985595717018126,-0.6004778639529657,0.9703153988868275,0.9930506791981694,1.0,17/29,43.55%,HJURP;CENPP;NASP;ITGB3BP;CENPT;KNL1;MIS18BP1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA;CENPQ;OIP5
prerank,dendritic cell chemotaxis (GO:0002407),-0.23814204755528068,-0.5997019200790654,0.9481481481481482,0.9929415231962228,1.0,7/14,38.77%,HMGB1;TRPM4;GPR183;CCR5;CCR2;PIK3CG;CXCR4
prerank,regulation of vacuole organization (GO:0044088),-0.21210671628904137,-0.5994210575220665,0.9631782945736435,0.9926126937431041,1.0,8/20,31.73%,ANXA2;IFT88;MTMR3;NPRL3;RAB5A;ENO3;ENO1;NPRL2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.21681745199914743,-0.599011090739338,0.9654510556621881,0.9923372482624322,1.0,4/21,14.78%,VPS4B;RAD51B;RAB11A;CDC25B
prerank,aromatic amino acid family metabolic process (GO:0009072),0.2536243515445212,0.5984077190489362,0.9389978213507625,0.9956282910877595,1.0,3/10,23.06%,ASRGL1;KYAT1;KYNU
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.23480574621415157,-0.5969764786137386,0.9408396946564885,0.992739505739745,1.0,5/14,38.70%,WNK1;WNT5A;ADAM10;CCR2;ADAM17
prerank,regulation of interleukin-10 production (GO:0032653),-0.18416630334627498,-0.5963554786127917,0.9871323529411765,0.9925318581874303,1.0,6/44,17.06%,PIBF1;HMGB1;STAT3;TRIB2;PRKCZ;TLR4
prerank,protein deacylation (GO:0035601),0.21092944629299837,0.5943323660458959,0.9804347826086957,0.9964982757726045,1.0,9/23,21.92%,SIRT1;LYPLA1;SIN3A;PPT1;ABHD17C;HDAC7;NOTUM;HDAC6;SIRT7
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.23623142222403276,-0.5936456351872054,0.9528795811518325,0.9931717794276121,1.0,6/14,37.61%,NUDT5;ENTPD6;NUDT1;NUDT16;NUDT18;ADPRM
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.21006095098274571,-0.5911214630187711,0.9643527204502814,0.993698898998182,1.0,7/23,27.45%,DICER1;HMGB1;H1-0;EXOG;DNASE2;CECR2;DNASE1L1
prerank,amino sugar metabolic process (GO:0006040),0.254309223314113,0.5909449558907992,0.9461697722567288,0.9970692038683541,1.0,1/10,5.76%,CSGALNACT1
prerank,purine ribonucleotide transport (GO:0015868),-0.22629997981147004,-0.5907397894349499,0.9588014981273408,0.9934048815803616,1.0,6/16,30.55%,LRRC8D;ABCC5;SLC25A17;SLC25A24;SLC35B2;SLC17A9
prerank,cilium movement (GO:0003341),-0.17684120126922215,-0.5905410457667223,0.9901380670611439,0.9930441453296932,1.0,32/47,49.19%,ODAD1;CCDC39;CFAP251;SPEF1;DNAAF5;DNAH11;GAS8;RSPH9;CFAP61;DNAI4;CFAP70;DNHD1;CABYR;CFAP53;ROPN1L;ODAD2;ADCY10;CFAP54;SPAG17;ODAD3;SPA17;ODAD4;TEKT2;DNAH17;CFAP206;CCDC40;CCDC63;CFAP91;TEKT5;DNAAF4;TTC29;DNAH1
prerank,RNA catabolic process (GO:0006401),-0.17583555189788336,-0.5883081899430062,0.9961904761904762,0.9934087145647666,1.0,15/46,34.02%,DIS3L2;HNRNPD;XRN2;ERN1;MTREX;CNOT10;SIDT2;PABPC4;LSM6;ZFP36L2;SUPV3L1;NUDT16;NUDT16L1;HSPA1A;RNASEH2C
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.25225960331408487,0.5857713778050563,0.9452954048140044,0.9982407658141724,1.0,10/10,74.79%,ATP5F1D;ATP5MG;ATP5MC3;ATP5PO;ATP5PD;VPS9D1;ATP5F1C;ATP5F1A;ATP5MC2;ATP5MC1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.20403320823063625,-0.5839614174852139,0.9789674952198852,0.9945868634282032,1.0,11/25,33.25%,FOXK1;PGK1;FOXK2;PFKP;PKM;PFKM;PFKL;ALDOA;ENO3;ENO1;HK2
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.21925748660457695,-0.5833489621136975,0.9648798521256932,0.9943697110872609,1.0,6/18,26.62%,ACSL1;ACSL6;ACSL4;ELOVL1;ACSBG1;ELOVL5
prerank,nuclear envelope organization (GO:0006998),-0.2126785164727843,-0.5831634119500032,0.9648798521256932,0.9940034819446808,1.0,6/20,25.84%,DMPK;EMD;TOR1A;NEMP1;SUN2;NUP93
prerank,determination of left/right symmetry (GO:0007368),-0.1828234430694787,-0.579667797583677,0.9873873873873874,0.9947627957034163,1.0,7/36,20.98%,SMO;PKD2;CCDC39;CITED2;MEGF8;ZIC3;GALNT11
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.19040013392120123,0.5790588352059718,0.9919028340080972,0.9998286644438615,1.0,11/31,23.00%,YWHAB;YWHAG;MAPK8;NMT1;PPP3R1;BBC3;CASP8;PPP1R13B;YWHAQ;PPP3CC;BAX
prerank,tRNA metabolic process (GO:0006399),-0.22065414205588024,-0.5777338467315088,0.9582542694497154,0.994961152762864,1.0,1/17,1.82%,FARS2
prerank,regulation of catabolic process (GO:0009894),-0.21834704619092865,-0.577296257876123,0.96875,0.9946510459500874,1.0,4/18,20.21%,ITGB1;FAP;CENATAC;SNF8
prerank,mRNA modification (GO:0016556),-0.20088607323913998,-0.5772544564465137,0.9769673704414588,0.9942304887875192,1.0,11/22,43.62%,WTAP;NSUN2;PUS3;ZC3H13;TRMT10C;TRMT61B;PUS1;CBLL1;RPUSD2;TRMT61A;VIRMA
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.2558343220037855,-0.5765759209228801,0.9653379549393414,0.9940037143956523,1.0,2/10,15.90%,ACTN2;CARMIL1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.18769898652457287,0.5763476003214715,0.989406779661017,0.9999970811494457,1.0,8/31,23.23%,SRD5A2;SCP2;GCH1;NOXRED1;LIAS;SRD5A1;GPHN;LSS
prerank,pseudouridine synthesis (GO:0001522),-0.23482356583136033,-0.5751370101931589,0.9576427255985267,0.9940087233282591,1.0,7/13,40.74%,PUS10;PUS3;GAR1;PUS1;PUS7L;PUSL1;RPUSD2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.15812162517517983,-0.5749137437494329,1.0,0.9936478977648812,1.0,19/72,27.47%,MDM4;EP300;NBN;TFDP2;SP100;CNOT8;CASP2;CNOT2;CNOT1;CNOT10;PCNA;PML;TFAP4;PAXIP1;CNOT4;CRADD;TNKS1BP1;PCBP4;ATRX
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.2164443989088563,-0.5747438492734208,0.9822380106571936,0.9932667260189505,1.0,3/18,21.18%,ABL1;PRKDC;XRCC6
prerank,regulation of cellular respiration (GO:0043457),-0.21929827075737662,-0.5742109035870442,0.9567779960707269,0.9929999786684167,1.0,10/17,44.20%,CBFA2T3;NOP53;VCP;NOA1;IDE;PRDM16;SHMT2;TRAP1;IFNLR1;NOS2
prerank,histone H2A acetylation (GO:0043968),0.2163319607281455,0.5740173592465574,0.9485458612975392,1.0,1.0,2/16,6.91%,RUVBL1;YEATS4
prerank,positive regulation of type 2 immune response (GO:0002830),-0.233445007109359,-0.5738980242172356,0.9582542694497154,0.992649864669575,1.0,7/14,45.04%,PRKCZ;IL18;CD81;DENND1B;CD86;RARA;NLRP3
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.19098619492745172,0.5738231410557775,0.9779116465863453,0.9994013584146003,1.0,10/28,24.28%,GABARAP;DAB2IP;DELE1;TNFRSF1A;DDX47;SORT1;CASP8;TNFRSF10B;BAX;CASP8AP2
prerank,protein localization to vacuole (GO:0072665),0.2265051164542657,0.5731925927377073,0.9474885844748858,0.9988883155853613,1.0,13/13,77.37%,GLMP;RTN4;LMBRD1;SH3BP4;MFSD1;SH3GLB1;ATP13A2;RNF128;LAMTOR5;LAMTOR4;CD81;KPTN;SZT2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.22548807389572845,0.570832020484707,0.9473684210526315,0.9988814254206688,1.0,2/15,12.00%,TGFB2;SMAD7
prerank,ribosomal subunit export from nucleus (GO:0000054),0.23246908154937507,0.5706649054167144,0.9613034623217923,0.9982094958000209,1.0,13/13,76.77%,RPS15;NMD3;EIF6;NOP9;LSG1;LTV1;ABCE1;NPM1;NUP88;RAN;RRS1;XPO1;SDAD1
prerank,adenine nucleotide transport (GO:0051503),-0.2130612652072543,-0.5698037720496462,0.9720670391061452,0.9934905514004735,1.0,6/17,30.55%,LRRC8D;ABCC5;SLC25A17;SLC25A24;SLC35B2;SLC17A9
prerank,negative regulation of potassium ion transport (GO:0043267),0.2331996766180533,0.5690930113039626,0.9528907922912205,0.9979618550791061,1.0,2/13,13.05%,BIN1;STK39
prerank,negative regulation of chemokine production (GO:0032682),-0.22296072407199446,-0.5684350014194937,0.9638095238095238,0.9934617407219226,1.0,4/14,28.11%,APOD;C1QTNF3;SIRPA;MUL1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.21911752119081662,-0.5666764673051493,0.9849340866290018,0.9935344822113312,1.0,6/17,38.01%,PLA2G4A;MBOAT7;PLA2G4C;LCLAT1;PLAAT3;PLA2G4F
prerank,meiosis I (GO:0007127),0.19493172997861088,0.5647757058012015,0.9741935483870968,0.9985259245375221,1.0,22/23,69.08%,ZCWPW1;ING2;FOXJ3;PTTG1;FOXJ2;BTBD18;MEIOC;DNMT3L;MEI1;CCNA1;MEIKIN;MOV10L1;BRDT;SLC25A31;MEIOB;DDX4;TDRD9;SYCP3;SGO1;ZSCAN21;HSF2BP;BCL2L11
prerank,lipoprotein catabolic process (GO:0042159),-0.23822134694792568,-0.5645532262470329,0.9516441005802708,0.9937184317085115,1.0,4/11,24.65%,ABHD17B;APOE;ABHD10;LYPLA2
prerank,cellular response to superoxide (GO:0071451),-0.24706532261495062,-0.5628188498234202,0.9655831739961759,0.9937709172704858,1.0,6/10,33.97%,SOD3;SOD2;PRDX2;CCS;MT3;ATP7A
prerank,diol biosynthetic process (GO:0034312),-0.21891868491089791,-0.5616312972303248,0.9761029411764706,0.9936926241797795,1.0,2/15,8.29%,ASAH2;ACER3
prerank,glycine metabolic process (GO:0006544),-0.2337416707954327,-0.5540448247150979,0.9723756906077348,0.9952900448737009,1.0,7/12,46.51%,AMT;SHMT2;DLD;GCAT;SHMT1;GLDC;GLYAT
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.232283221281274,-0.5500167735331551,0.9732313575525813,0.9958745493006308,1.0,1/12,3.21%,LRRK2
prerank,protein neddylation (GO:0045116),-0.22307728402813645,-0.5483459962375066,0.9616122840690979,0.9958422257796969,1.0,5/13,32.25%,DCUN1D3;NAE1;RBX1;DCUN1D5;DCUN1D4
prerank,determination of bilateral symmetry (GO:0009855),0.18589031652043045,0.5480093125386469,0.9934354485776805,1.0,1.0,7/24,23.70%,NOTCH1;FOXJ1;DLL1;ARL6;DNAH5;NPHP3;TBX1
prerank,macrophage migration (GO:1905517),0.2168255753193336,0.5472237629654431,0.9704016913319239,1.0,1.0,3/13,18.53%,CCL2;EDNRB;CKLF
prerank,negative regulation of cyclase activity (GO:0031280),-0.2162954756610534,-0.5467264166654798,0.9702602230483272,0.9957868087718669,1.0,1/14,6.17%,ADGRV1
prerank,extracellular transport (GO:0006858),-0.2295236578286794,-0.5462203148937856,0.9544554455445544,0.995464374288659,1.0,1/12,3.56%,WWP2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.22179253008636696,-0.5438703338511284,0.9700934579439252,0.9955534238282822,1.0,1/13,6.17%,ADGRV1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.20508793741481535,-0.543404060681478,0.9884836852207294,0.9952318812102331,1.0,3/18,14.69%,NCSTN;ADAM19;APOE
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.16950513903729553,0.542430557769866,0.9936440677966102,1.0,1.0,9/38,20.14%,IPO4;RUVBL1;H3-3A;HIRA;CENPL;RBBP4;SMARCA5;ASF1A;CENPO
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.19882982729515428,-0.5404195522127915,0.982725527831094,0.9954389264888373,1.0,4/19,19.54%,CYBA;ACOX1;PARK7;PRDX2
prerank,sympathetic nervous system development (GO:0048485),-0.21171800909060595,-0.5387294421385973,0.980565371024735,0.9953797010075837,1.0,5/15,35.06%,NRP1;SOX11;NRP2;GDNF;SEMA3F
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.21344761178274635,-0.5374705982865344,0.9853479853479854,0.995214442926231,1.0,2/14,10.21%,ENPP1;ENPP3
prerank,chromatin assembly (GO:0031497),0.17196879972359913,0.537466766526829,0.996,1.0,1.0,9/38,20.78%,SIRT1;HMGA2;H3-3A;NAA60;RBBP4;SMARCA5;CTCF;ASF1A;NOC2L
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.23010205255813554,0.5369975214461501,0.9527896995708155,1.0,1.0,2/10,12.99%,AKT1;CD36
prerank,snRNA metabolic process (GO:0016073),-0.19994458299442605,-0.5334928701620558,0.9831460674157303,0.9956025685817794,1.0,3/17,18.69%,INTS4;MTREX;INTS6
prerank,melanosome transport (GO:0032402),-0.20012789349948965,-0.5297854934988107,0.9885714285714285,0.9954560305410092,1.0,5/18,28.47%,RAB11A;BLOC1S5;BBS4;BBS2;MLPH
prerank,pigment granule transport (GO:0051904),-0.20012789349948965,-0.5297854934988107,0.9885714285714285,0.9954560305410092,1.0,5/18,28.47%,RAB11A;BLOC1S5;BBS4;BBS2;MLPH
prerank,receptor recycling (GO:0001881),-0.23003588177265288,-0.5241931499985584,0.9684014869888475,0.9960123797112506,1.0,3/10,25.52%,EHD3;PHETA1;ARFGEF2
prerank,regulation of integrin activation (GO:0033623),-0.2001358849903766,-0.522319499582757,0.9869402985074627,0.9959249346008774,1.0,4/15,27.42%,RAP1B;FARP2;FBLIM1;FERMT2
prerank,negative regulation of bone remodeling (GO:0046851),0.21602778981321588,0.5194550548944615,0.9656652360515021,1.0,1.0,2/11,11.32%,UBASH3B;P2RX7
prerank,eye photoreceptor cell development (GO:0042462),0.20246391424369534,0.5191274943041878,0.9765957446808511,1.0,1.0,2/15,13.51%,THY1;RORB
prerank,chromatin remodeling at centromere (GO:0031055),-0.1682961857514844,-0.5166546884757488,0.9925650557620818,0.9964069972921576,1.0,15/31,39.47%,HJURP;CENPP;NASP;ITGB3BP;CENPT;KNL1;MIS18BP1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA
prerank,tRNA transport (GO:0051031),-0.16293926229686045,-0.5151664424619508,0.9941520467836257,0.9962162477726877,1.0,9/35,25.84%,RANBP2;NUP42;NUP214;TPR;YBX1;NUP98;NUP43;NUP160;NUP93
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.19631952305312256,0.5146802671356492,0.9829787234042553,1.0,1.0,5/16,21.38%,CELF4;CIRBP;PRDX6;RBMXL1;RBM3
prerank,positive regulation of bone resorption (GO:0045780),-0.22290848839501398,-0.5118802709182593,0.9714795008912656,0.9962789799141906,1.0,4/11,34.08%,SPP1;PRKCA;SYK;ADAM8
prerank,nuclear membrane disassembly (GO:0051081),-0.2041903156766818,-0.5105628911150886,0.9925093632958801,0.9960414827448888,1.0,10/14,50.23%,AKAP8L;NEK6;PRKCA;LPIN1;CDK1;VRK1;PLK1;CCNB1;NEK9;PRKCB
prerank,outer dynein arm assembly (GO:0036158),-0.20050696012455282,-0.5033742020381611,0.9904214559386973,0.996631359002997,1.0,10/14,48.27%,DNAL1;ODAD1;DNAH8;DNAAF5;ODAD2;ODAD3;ODAD4;DNAH17;CCDC63;DNAAF4
prerank,dendritic cell migration (GO:0036336),-0.19239019102215527,-0.5032084292970528,0.9867924528301887,0.9962271231708887,1.0,2/16,13.02%,HMGB1;TRPM4
prerank,cellular response to radiation (GO:0071478),0.15221623988531802,0.5023065514266216,1.0,1.0,1.0,5/40,14.43%,SIRT1;EEF1D;NET1;KDM4D;CDKN1A
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.1510630361477121,-0.5022738959152258,0.9962264150943396,0.9959384590039595,1.0,15/45,37.77%,STAT3;GSDMD;USP50;TLR4;WNT5A;TMEM106A;LPL;APP;EGR1;PYCARD;MYD88;RIPK2;FZD5;AGER;CASP1
prerank,negative regulation of lyase activity (GO:0051350),-0.19112168314433514,-0.49997414761263353,0.9888888888888889,0.9958095556526219,1.0,1/16,6.17%,ADGRV1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.1629248765340703,0.49781910515308425,0.9978401727861771,1.0,1.0,3/29,15.10%,MEI4;ZCWPW1;SYCP2
prerank,heterocycle biosynthetic process (GO:0018130),-0.20323861388741513,-0.49743471856226334,0.9887640449438202,0.9956970637787179,1.0,8/14,43.61%,MOCS1;NFS1;PYCR2;MOCS3;PYCR3;PYCR1;MOCS2;ALOX5
prerank,negative regulation of interleukin-10 production (GO:0032693),0.19163419487577749,0.49723745976347605,0.9889624724061811,1.0,1.0,2/16,13.89%,TNFRSF21;DLL1
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.16129801402396068,0.4918143775365685,1.0,1.0,1.0,9/32,21.99%,NUP210;NOL6;NUP62;NUP205;NUP54;NUP85;RAE1;XPOT;NUP107
prerank,tRNA export from nucleus (GO:0006409),0.16129801402396068,0.4918143775365685,1.0,1.0,1.0,9/32,21.99%,NUP210;NOL6;NUP62;NUP205;NUP54;NUP85;RAE1;XPOT;NUP107
prerank,inositol phosphate biosynthetic process (GO:0032958),0.20649636160981674,0.4909476353734539,0.9877049180327869,1.0,1.0,4/11,19.84%,IPMK;IP6K1;IPPK;PPIP5K1
prerank,regulation of B cell activation (GO:0050864),0.16628283974346947,0.4891204229016527,0.9956043956043956,1.0,1.0,24/25,71.87%,FOXJ1;SH3KBP1;NOD2;ZFP36L1;AHR;LAPTM5;SAMSN1;TLR9;IGLL1;MZB1;TNFSF4;IL10;CD19;SLAMF8;IL6;CD22;IL4;THEMIS2;IKZF3;IL4I1;BANK1;FCGR2B;TNFAIP3;ZFP36L2
prerank,toxin transport (GO:1901998),-0.21627084143116496,-0.4876126191362186,0.9803536345776032,0.9964003935460887,1.0,4/10,31.97%,ANTXR2;ANTXR1;SLC22A2;ADAM10
prerank,L-serine metabolic process (GO:0006563),0.20837338630367686,0.48635620489614073,0.9933481152993349,1.0,1.0,3/10,20.35%,PHGDH;SERINC3;SRR
prerank,negative regulation of cell division (GO:0051782),0.20531632598299407,0.4842605236984239,0.9955257270693513,1.0,1.0,5/11,26.21%,E2F7;ORC6;VPS4A;SUSD2;CHMP4C
prerank,snRNA processing (GO:0016180),0.18084417736141778,0.4820128824707437,0.9869565217391304,1.0,1.0,5/16,20.81%,INTS2;INTS11;INTS10;TOE1;INTS5
prerank,inner dynein arm assembly (GO:0036159),0.20462672317628705,0.4777553803690465,0.9865771812080537,1.0,1.0,1/10,9.02%,CFAP100
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.1843922651933701,0.4732942812231433,0.9896907216494846,1.0,1.0,14/14,81.58%,ATP6AP1;POU4F2;IFNG;TYROBP;IL23R;IL12B;TNFSF11;TNF;IL23A;OCSTAMP;CCR1;POU4F1;CSF1;TRAF6
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.19327771709932723,-0.46937625899839797,0.9907235621521335,0.9976772444220985,1.0,2/13,24.23%,PRKCD;SYK
prerank,negative regulation of T cell proliferation (GO:0042130),-0.15686098863660292,-0.4692260012923861,1.0,0.9972618969856849,1.0,5/28,22.91%,RC3H1;SDC4;SCRIB;DLG5;CD80
prerank,ncRNA 3'-end processing (GO:0043628),0.18696634856855843,0.46818806191135603,0.9826086956521739,1.0,1.0,14/14,81.32%,ERI1;INTS2;TOE1;INTS5;INTS8;INTS12;PTCD1;SSB;INTS6L;INTS7;ELAC2;TRNT1;INTS14;INTS6
prerank,nuclear pore organization (GO:0006999),0.1761283209734931,0.44080004310336174,0.9957081545064378,1.0,1.0,3/14,15.33%,NUP205;RTN4;NUP54
prerank,nuclear pore complex assembly (GO:0051292),-0.19517282172961714,-0.43709658508046106,0.988527724665392,0.9989054706495099,1.0,4/10,34.00%,TPR;NUP98;NUP93;AHCTF1
prerank,leukotriene metabolic process (GO:0006691),0.15675529008434322,0.43513341901354163,1.0,1.0,1.0,4/19,19.55%,GGT1;MAPKAPK2;LTA4H;MGST3
prerank,male meiosis I (GO:0007141),0.1654527188245635,0.43507162416627965,0.9957805907172996,1.0,1.0,16/16,83.47%,ING2;FOXJ3;FOXJ2;BTBD18;MEIOC;DNMT3L;CCNA1;MOV10L1;BRDT;SLC25A31;DDX4;TDRD9;SYCP3;ZSCAN21;HSF2BP;MYBL1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.17098982163554124,0.43490501488714883,0.9978165938864629,0.9996073412888339,1.0,2/14,13.50%,PSENEN;PSEN1
prerank,pinocytosis (GO:0006907),-0.1873737630699368,-0.43116086197492964,0.994413407821229,0.99876597215165,1.0,8/10,49.65%,CARMIL1;PYCARD;MAPKAPK3;RAB34;DOCK2;AHSG;SNX33;SNX5
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.15148612697811523,0.429357491646571,0.9978401727861771,0.9991686363244533,1.0,8/23,25.47%,TIMM22;NDUFA13;HSP90AA1;TOMM70;TIMM10B;BAX;ROMO1;TOMM22
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.15060329726153698,-0.4193650604164405,0.9980806142034548,0.9987973159873137,1.0,3/22,15.61%,RUNX1;IRF1;DUSP10
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.15540493549657286,0.40789259404754374,1.0,0.9991695028506856,1.0,1/16,6.76%,HFM1
